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Summary  
Background to the study  
OLA can give rise to certain problems:   
1. A significant decrease in lung volume is reported to occur in the dependent lung during OLA in the LDP.  
This decrease in lung volume can result in an acute increase in opposition to RV ejection.  The potential 
problem is that the right ventricle is a thin walled structure that can generate considerably less work than 
the thicker walled LV.  It possesses little reserve to deal with an acute rise in afterload as may occur during 
acute lung injury or after lung resection.   Therefore, this increase in afterload during OLA may potentially 
impair RV-PA coupling.  Albeit this potential problem exists, the changes in RV afterload and how the right 
ventricle performs during OLA have not been well studied.  
2. Arterial hypoxemia, due mainly to venous blood being shunted via the non-ventilated lung, may present a 
clinical problem during one lung ventilation.   
a. The relative resistances of the pulmonary vascular beds of the dependent ventilated and non-
dependent non-ventilated lungs are an important factor governing shunting and thus arterial 
oxygenation during one lung anesthesia.  A high non-ventilated lung PVR and low ventilated lung 
PVR will facilitate good arterial oxygenation during OLA.  An increase in non-ventilated lung PVR 
is governed predominantly by hypoxic pulmonary vasoconstriction.  A low opposition to 
pulmonary blood flow in the dependent lung is facilitated predominantly by a high alveolar oxygen 
tension and normal lung volume, albeit other factors also play a role in this regard.   
b. The saturation and oxygen content of mixed venous blood will contribute significantly to the 
arterial oxygenation in the presence of a large shunt as occurs during OLA. 
i. On the one hand, venous desaturation as a cause of hypoxemia during one lung 
anesthesia has not as yet been systematically addressed in the literature.   
ii. On the other hand, if RV afterload increases to such a degree that it leads poor RV 
performance, this may cause impairment of global circulatory efficiency and lead to 
mixed venous desaturation. The question that has been raised is whether inotrope 
infusions could improve RV and LV performance, cardiac output, and thereby the 
efficiency of the circulation.  Increases in the efficiency of the circulation will result in an 
improvement in mixed venous and arterial oxygenation in the presence of a large 
shunt.  Nonetheless, the administration of inotrope infusions in the presence of a shunt 
and during OLA has been reported to aggravate hypoxemia.  Thus at the time of 
conducting the study, conflicting reports of whether increasing cardiac output and 
thereby mixed venous oxygenation would increase or decrease arterial oxygenation 
during OLA 
 
In the light of the above, the researcher thus investigated RV afterload, RV performance and coupling to its load 
during OLA.  The study also addressed the question whether different levels of inotrope infusion or PEEP had 
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beneficial or deleterious effects on RV afterload, RV performance and coupling to its load during OLA.  Furthermore, 
if cardiac output increased during OLA secondary to the infusion of inotropes, would this improve the efficiency of the 
circulation, mixed venous oxygenation and thus the arterial oxygenation during OLA, or would it worsen shunt and 
arterial oxygenation during OLA?   
Control group:  OLA and the opposition to pulmonary flow  
Pulmonary arterial elastance increased by between 18 to 36% during OLA and mean PAP rose by 32% after 
initiation of OLA   This increase in mean PAP on initiation of OLA is greater than that observed by certain 
investigators but similar to that seen previously in patients with damaged lungs.  The question arose as to why 
pulmonary artery pressure rises during OLA?  From consideration of Ohm’s law, pressure may be regarded as the 
product of flow and resistance (Mark, Slaughter et al. 2000).  The increase in mean PAP during OLA is due to two 
reasons.   
1. Firstly, the pressure versus flow curve is likely to be steeper during OLA.  This is because pulmonary 
vascular recruitment and dilatation (pulmonary vascular reserve) is more limited in scope in these patients 
than is usual and most likely accounts for the increase in pulmonary artery pressure during OLA.  The 
reasons for the limited pulmonary vascular reserve in the DL during OLA include: 
a. The pulmonary vascular bed of patients subjected to OLA is frequently abnormal because of its 
underlying pathology,  
b. During OLA in the lateral decubitus position, lung volume decreases to a greater degree than 
during two-lung anesthesia (Klingstedt, Hedenstierna et al. 1990).   
c. This decrease in lung volume will be further aggravated by DLT malpositions, secretions and 
blood, and absorption atelectasis due to the use of high concentrations of oxygen (Hedenstierna 
1998; Krucylak, Naunheim et al. 1996).   
d. Excessive amounts of extrinsic or intrinsic PEEP during OLA can compress the intra-alveolar 
capillaries and deleteriously affect the pulmonary vascular resistance (Ducros, Moutafis et al. 
1999; Inomata, Nishikawa et al. 1997; Bardoczky, Yernault et al. 1996; Yokota, Toriumi et al. 
1996).   
2. Secondly, there is greater flow through this vascular bed that possesses a higher resistance.   
   
It is noteworthy that the increase in mean PAP did not exceed a value of 25 mm Hg during OLA, even though cardiac 
output increased by 30%.  However, in studies conducted in patients with “damaged lungs”, greater increases in PA 
pressure (accompanied by a decrease in RVEF) have been reported to occur on PA ligation.  A question arises as to 
why differences exist between PA clamping and OLA?  The answer may well be that the observed plateau in the rise 
of PA pressure during OLA is as a result of progressive diversion of flow to the NDL as PA pressure rises.  Support 
for such a suggestion comes from the observation that concomitant with increases in PA pressure during OLA, HPV 
is progressively inhibited and shunt fraction progressively rises.  This increase in shunt fraction that has been 
observed to occur as PA pressure rises, reflects an increase in diversion of pulmonary blood flow to the NDL.  The 
impact of diversion of this blood to the NDL is that it possibly acts as a safety mechanism limiting increases in PA 
pressure and other indices of opposition to pulmonary flow during OLA.  This “blow-off effect” will protect the RV until 
PA clamping occurs.    
Summary 
 
5 
Control group:  OLA and RV function  
The current study represented the opportunity to investigate the significance of the abovementioned increases in PA 
pressures and elastance on RV performance during OLA.  The current study indicates that at the moderate (30%) 
increases in PAP that accompanied the initiation of OLA, RV performance, as judged by stroke volume, cardiac 
index, RVEF and RVSWI, did not deteriorate compared to the baseline awake status.  In fact, cardiac output 
increased following surgical incision: this was probably due to sympathetic nervous system stimulation.  This 
observation also fits in with other studies in which RV performance usually only begins to deteriorate when indices of 
opposition to RV ejection reach 200 to 250% of baseline.  Furthermore, a constant preload, as indicated by 
unchanged central venous and pulmonary artery wedge pressures, and right ventricular end-diastolic volumes were 
observed throughout the study period.  In other words, this increase in RV afyterlad did not cuse the RV to dilate 
durign OLA. 
 
The relationship between stroke work and afterload will vary, depending on the contractile reserve of the ventricle.  In 
this regard, it could be concluded that under the conditions operative in the current study, the RV was operating on 
the upslope of the RVSWI versus Ea relationship.  This supports the observation that RV function is well preserved 
during OLA. 
 
In conclusion, regarding the indices of opposition to pulmonary flow and RV performance during OLA, it can be 
concluded that: 
1. Opposition to RV ejection increases.  This is evidenced by a 30% rise in mean PAP and 18 to 36% 
increase in pulmonary arterial elastance. 
2. Right ventricular performance as indicated by RVSWI, RVEF and stroke volume does not decrease during 
OLA compared with when the patients awake or subjected to two-lung anesthesia.   
3. Furthermore, coupling between the RV and its load is well preserved during OLA.  This would imply that 
the RV operates at close to maximal efficiency during OLA and that RV stroke work reserve is present 
during OLA.  It is likely that the RV, which continues operating as a flow pump as it does in normal life, 
easily copes with the small increases in RV afterload during OLA.      
Dobutamine during OLA: opposition to pulmonary flow and RV 
performance 
The effects of dobutamine infusions on RV performance during OLA can be summarised as follows: 
1. Low rates of dobutamine infusion (3 ug.kg-1.min-1) increased cardiac output, stroke volume, and RVSWI.  
The administration of dobutamine 3 ug.kg-1.min-1 was not accompanied by increases in RV afterload.  
Therefore, low infusion rates of dobutamine did benefit RV-PA coupling during OLA. 
2. However, administration of higher dosages of dobutamine (5 and 7 ug.kg-1.min-1) during OLA was 
associated with increases in certain indices of opposition to pulmonary blood flow.  For example, PA 
elastance, mean PA pressure, and PVR increased by 30% to 40% compared to both when the patients 
were awake and when both lungs were being ventilated.  Furthermore, PA compliance decreased by up to 
61% when dobutamine 5 and 7 ug.kg-1.min-1 were infused compared to the OLA step when dobutamine 
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was not administered.   The increases in mean PAP and PVR are considered to be of limited clinical 
significance.  However, the decrease in PA compliance during the infusion of the highest dosage of 
dobutamine is clinically significant.  PA compliance represents one of the factors determining vascular 
impedance in the Windkessel model of the circulation. The increases in opposition to pulmonary flow and 
lack of progressive increase in indices of RV performance are in contrast to what is expected to occur on 
administration of increasing dosages of the inotrope and pulmonary vasodilator, dobutamine.  The reasons 
for the increase in opposition to pulmonary flow include exhaustion of the pulmonary vascular reserve 
during OLA at the high cardiac indices of 5 to 5.5 l.min-1.m-2.  This aspect overshadowed the expected 
pulmonary vasodilator effects of dobutamine.  Moreover, it is probable that the increase in RV afterload 
was significant enough to prevent right ventricular performance increasing as would be expected 
with the administration of progressively higher dosages of inotrope.   
 
While dobutamine was being administered during OLA, mean PAP increased to a maximum of 24.9 ± 6.2 mm Hg at 
a cardiac index of 5.5 ± 1.2 l.min-1.m-2.  However during OLA, in the control group, mean PAP was 24.0 ± 7.7 mm Hg 
at the maximum cardiac index of 4.4 ± 1.1 l.min-1.m-2.  This represented a relatively limited rise in PA pressure 
compared with administration of dobutamine alone.  The most likely reason why there may have been a limited 
increase in mean PAP while dobutamine was being administered is that the “blow off” effect of the NDL vasculature 
limited the rise in PA pressure. 
Oxygenation during OLA 
With regard to oxygen flux, venous and arterial oxygenation during OLA in the control group, the following was 
observed: 
1. Induction of anesthesia and the approximately 1O Celsius decrease in temperature induced an 
approximately 40% decrease in VO2 that continued during OLA.   
2. Initiation of OLA resulted in an increase in cardiac output compared to baseline OLA and awake states.   
3. The consequence was an increase in S O2 from 75% and P O2 from 5.4 kPa when the patients were 
awake to a P O2 of 9.0 ± 1.7 kPa and S O2 of 90.6 ± 4.7% during one-lung anesthesia. 
4. During OLA, the significant increase in venous oxygenation resulted in an increase in arterial oxygenation 
compared to the awake state in spite of the approximately 37% shunt occuring during OLA. 
5. Under conditions in the present study, dobutamine administration during OLA did not improve, but 
maintained the already high venous and arterial oxygenation compared with OLA alone.  Therefore, the 
study hypothesis, that dobutamine would induce improvement in RVF and the increase in cardiac output 
during OLA would improve arterial oxygenation, does not hold in the current study.  The hypothesis that 
dobutamine administration and improving cardiac output during OLA would increase arterial oxygenation 
was therefore rejected.    
 
However, the rejection of the hypothesis means that the findings of the current study are in contrast to the findings of 
Mathru et al, and Nomoto and Kawamura.  These authors demonstrated that inotrope administration resulted in an 
increase in arterial oxygenation.  Nonetheless, the different results are not at odds with each other.  In fact, these 
differences help to clarify the effect of increases in cardiac output on arterial oxygenation in the presence of a 
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significant shunt.  The differences between the studies can be explained in the following way.  Conditions in the 
current study resulted in a favourable DO2/VO2 ratio and a high starting P O2 even before dobutamine administration 
was commenced.  Therefore the venous saturations were on the flat part of the oxygen dissociation curve and also 
on the flat part of the relationship between cardiac output and arterial oxygen content originally described by Kelman, 
Nunn and colleagues.  Further increases in cardiac output and the DO2/VO2 ratio would not be expected to, and did 
not, increase P O2, S O2, or C O2.  Thus, arterial oxygenation content and saturation did not change subsequent 
to the increase in cardiac output associated with the administration of dobutamine in the current study.  In contrast, in 
the Mathru study, the low starting venous saturations and tensions were improved by increases in the DO2/VO2 ratio.  
As the starting venous saturation was “low,” significant benefit in arterial oxygenation was obtained on increasing 
cardiac output in that study.   
 
One significant concern for the clinician regarding the administration of the inotrope dobutamine during OLA is that it 
may increase shunt fraction (Qs/Qt) and thereby decrease arterial oxygenation during one lung ventilation.  The 
influence of dobutamine on arterial oxygenation during OLA may theoretically be related to the balance of the 
following divergent effects: 
 
1. By improving the relationship between oxygen delivery and consumption, dobutamine increases P O2.  
This increase will benefit arterial oxygenation in the presence of a large shunt, 
2. The above has to be weighed against possible increases in VO2 induced by dobutamine, the consequence 
of which will be a decrease in P O2.  Such increases in VO2 were not seen on administration of 
dobutamine in the current study, 
3. An increase in PA pressure accompanying the increased cardiac output will oppose HPV and increase 
shunt in both the dependent and non-dependent lungs, 
4. Direct inhibition of HPV by dobutamine and, 
5. The influence of P O2 on HPV (i.e. high levels of venous oxygenation will inhibit whereas low levels will 
potentiate HPV). 
 
Nonetheless, in spite of the concerns (risk) of hypoxemia on administering dobutamine during OLA, dobutamine 
administration did not decrease PaO2 or arterial oxygen saturation, and neither did it increase the cost of oxygenation 
compared to when OLA was conducted in the absence of dobutamine infusions.  In addition, the findings of studies 
conducted by Mathru and colleagues, Nomoto and Kawamura and the current study indicate that under usual clinical 
conditions present during OLA in the LDP, the administration of low dosages of dobutamine do not increase shunt 
fraction.  In fact, the beneficial effect of the increase in cardiac output on venous oxygenation resulted in an increase 
in arterial oxygenation in the study by Mathru and colleagues; similar mechanisms were most likely operative in the 
study conducted by Nomoto and Kawamura.    
 
Therefore, there is currently no evidence that the administration of dobutamine in dosages of up to 7 ug.kg-1.min-1 
increases shunt and worsens arterial oxygenation in humans subjected to OLA in the LDP.  It is apparent that the 
vasodilatory effects of dobutamine resulting in a possible increase in shunt fraction (Qs/Qt) is therefore not the only 
factor to consider when studying its effects on arterial oxygenation.  What is also of great relevance when 
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considering the effects of an inotrope on arterial oxygenation is the effect of inotropic drugs on the venous oxygen 
content.   It is possible that Qs/Qt could be increased by the administration of inotrope.  Nonetheless, if venous 
oxygenation is favourably affected by the administration of dobutamine, then a depressant effect on arterial 
oxygenation by an increase in the amount of blood passing via the shunt may be negated.  If the increase in venous 
oxygenation is very significant, there may even be benefits in terms of arterial oxygenation, as was the case in the 
current study.   
 
This approach to how the quality of the blood passing via the shunt affects arterial oxygenation shifts the emphasis 
on prevention and treatment of hypoxemia during OLA from the lung to the efficacy of the circulation.  In other words, 
the emphasis is shifted from what predominantly happens to the non-ventilated lung (HPV) to primarily the efficacy of 
oxygen flux during OLA. 
Extrinsic and intrinsic PEEP and OLA 
The effects of PEEP on hemodynamics and oxygenation observed during OLA in the current study may be 
summarised as follows.  When PEEP5 was applied to the DL during OLA in the current study: 
1. Neither right ventricular function, hemodynamics, oxygen flux nor arterial oxygenation was affected by the 
application of PEEP5 compared to the step when no external PEEP was applied. 
2. Significant amounts of intrinsic PEEP were present during OLA in the control group patients.  The degree 
of intrinsic PEEP was weakly related to the degree of obstructive airways disease present on preoperative 
LFT’s.   
3. The most likely reason why PEEP5 did not make a difference to oxygenation or hemodynamics was the 
existence of similar amounts of intrinsic PEEP during OLA.  These findings confirm Myles’s contention that 
low levels of intrinsic PEEP may have salutary effects on oxygenation during OLA. 
  
When PEEP10 was applied to the DL during OLA in the current study, it led to a decrease in stroke volume.  This 
decrease is predominantly due to a decrease in preload, as PVR does not increase to levels that are known to impair 
RV performance.  The decrease in the DO2/VO2 ratio that was induced by PEEP10 predictably decreases P O2 and 
can potentially lead to impairment of arterial oxygenation.  It can therefore be concluded that greater (excessive) 
amounts of PEEP under more unfavourable circulatory conditions than were observed in the current study, may have 
deleterious cardio-respiratory effects.   
 
In summary, optimising DL volume plays an important role in determining arterial oxygenation.  However, the 
therapeutic index for PEEP is narrow and the anesthesiologist needs to know firstly when the lung volume of the DL 
approaches FRC and secondly, how to avoid dynamic hyperinflation of that lung.   One significant problem is that the 
best method of monitoring FRC during OLA is not clear at present. 
Summary (Afrikaans) 
Agtergrond tot die studie 
Eenlongnarkose mag tot sekere probleme aanleiding gee. 
 
’n Betekenisvolle afname in volume van die onderlong vind in die laterale decubitus posisie tydens eenlongnarkose 
plaas.  Hierdie afname in longvolume mag egter ’n akute verhoging in regter ventrikulêre nalading tot stand bring.  
Die probleem is egter dat die regter ventrikel ’n dunwandige struktuur is wat potensieel baie minder werk as die 
dikwandige linker ventrikel kan genereer.  Die regter ventrikel het min reserwe om ’n akute verhoging in nalading te 
weerstaan soos wat gebeur met akute longbesering of na longreseksie.  Dus die verhoging in nalading wat gepaard 
gaan met eenlongnarkose mag die koppeling tussen die regter ventrikel en die pulmonale arterie belemmer.  
Alhoewel hierdie potensiële probleem bestaan, is die verandering albei in regter ventrikulêre nalading en hoe die 
regter ventrikel funksioneer tydens eenlongnarkose nog nie goed bestudeer nie.   
1. Arteriële hipoksemie, hoofsaaklik te wyte aan die groot aftakking via die long wat nie geventileer word nie, 
mag kliniese probleme tydens eenlongnarkose teweegbring. 
2. Die weerstand wat die pulmonale vaskulêre beddens van die geventileerde en nie-geventileerde longe bied 
teen bloedvloei is belangrike faktore wat aftakking en dus arteriële oksigenasie tydens eenlongnarkose 
beheer.  ’n Hoë weerstand van die nie-geventileerde long en ’n lae weerstand van die geventileerde long 
se pulmonale vaskulêre beddens sal bevredigende arteriële oksigenasie tydens eenlongnarkose fasiliteer.  
’n Verhoging in die pulmonale vaskulêre weerstand van die nie-geventileerde long is hoofsaaklik te wyte 
aan hipoksiese pulmonale vasokonstriksie.  ’n Lae pulmonale vaskulêre weerstand in die geventileerde 
onderlong is hoofsaaklik gefasiliteer deur ’n hoë alveolêre suurstofspanning en ’n normale long volume, 
alhoewel alle faktore ook ’n rol in hierdie verband speel. 
3. In die teenwoordigheid van die groot aftakking wat bestaan tydens eenlongnarkose, sal die saturasie en 
suurstof inhoud van gemeng veneuse bloed ’n betekenisvolle bydrae aan arteriële oksigenasie maak. 
a. Veneuse saturasie as ’n oorsaak van hipoksemie tydens eenlongnarkose, is nog nie sistematies 
in die literatuur ondersoek nie. 
b. Indien regter ventrikulêre nalading tot so ’n mate verhoog dat dit tot swak ventrikulêre uitwerp lei, 
mag dit ’n oorsaak wees van ontoereikendheid van die globale bloedsomloop en tot gemeng 
veneuse desaturasie lei.  Die vraag is dus of verhoging van die kardiale omset deur inotrope 
ondersteuning die toereikendheid van die sirkulasie kan verbeter.  Verbeterde sirkulasie 
toereikendheid sal tot ’n verhoging in gemeng veneuse en arteriële oksigenasie lei in die 
teenwoordigheid van ’n groot aftakking.  Nietemin, die toediening van inotrope in die 
teenwoordigheid van ’n groot aftakking tydens eenlongnarkose gerapporteer om hipoksemie te 
vererger tydens eenlongnarkose.  Dus ten tye van die uitvoer van dié studie, is daar uitdrukking 
gegee tot teenstrydige opinies in die literatuur oftewel verhoging in kardiale omset arteriële 
oksigenasie sal verbeter of versleg tydens eenlongnarkose. 
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In die lig van die agtergrond hierbo, het die navorser dus regter ventrikulêre nalading, regter ventrikulêre funksie en 
koppeling van die regter ventrikel met sy lading tydens eenlongnarkose ondersoek.  Die studie het ook die vraag 
benader of inotroop infusies of PEEP goeie of slegte gevolge sou hê op regter ventrikulêre nalading, regter 
ventrikulêre funksie en koppeling van die regter ventrikel aan sy lading tydens eenlongnarkose.  Sou die kardiale 
omset en die toereikendheid van die sirkulasie sou verbeter sekondêr tot die toediening van inotrope tydens 
eenlongnarkose, gemeng veneuse oksigenasie en dus arteriële oksigenasie tydens eenlongnarkose verbeter, of sou 
dit aftakking en arteriële oksigenasie versleg tydens eenlongnarkose? 
Kontrole groep 
Pulmonêre elastansie het tussen 18 en 36% verhoog en gemene pulmonale arterie druk het met 32% tydens 
eenlongnarkose vermeerder.  Die verhoging in gemene pulmonale arterie druk met die aanvang van eenlongnarkose 
is groter as die waardes gesien deur sekere navorsers maar gelyk met waardes gevind in pasiënte met beskadigde 
longe.  Die vraag ontstaan dan hoekom styg pulmonale arterie druk tydens eenlongnarkose?  volgens Ohm se Wet, 
mag druk as die veelvoud van vloei en weerstand beskou word.  Die verhoging in gemene pulmonale arterie druk 
tydens eenlongnarkose is daarvolgens hoofsaaklik te wyte aan twee redes. 
1. Eerstens, die kurwe van druk teenoor vloei is waarskynlik styler tydens eenlongnarkose.  Hierdie is omdat 
pulmonale vaskulêre werwing en verwyding (pulmonale vaskulêre reserwe) is meer beperk as nornaal in 
pasiënte met longsiekte.  Hierdie is die waarskynlikste rede hoekom pulmonale arterie druk tydens 
eenlongnarkose verhoog.  Die redes hoekom die pulmonale vaskulêre reserwe in die onderste long tydens 
eenlongnarkose beperk is sluit in die volgende: 
1.1 Die pulmonale vaskulêre bed van pasiënte onderwerp aan eenlongnarkose mag abnormaal wees weens 
die onderliggende long patologie,  
1.2 Tydens eenlongnarkose in die laterale decubitus posisie, is long volume in hoë mate verminder as tydens 
tweelongnarkose, 
1.3 Die voorafgenoemde vermindering in longvolume sal verder verminder word deur wanposisies van die 
dubbellumenbuis, sekresies en bloed, en absorpsie atelektase. 
1.4 Te hoë vlakke van PEEP, oftewel intrinsiek of ekstrensiek van oorsprong, sal die intraalveolêre vate 
toedruk en so die pulmonale vaskulêre weerstand verhoog. 
2. Tweedens, is daar groter vloei deur hierdie vaskulêre bed wat ‘n hoër weerstand bevat. 
 
Dit is opmerkingswaardig dat die verhoging in gemene pulmonale arterie druk ‘n waarde van 25 mmHg nie oorskry 
het nie tydens eenlongnarkose, alhoewel kardiale omset met 30% verhoog het.  In pasiënte met beskadigde longe, 
het vorige studies egter bewys dat groter verhoging in PA druk gebeur tydens afbinding van die pulmonale arterie.  
Die vraag ontstaan dus hoekom daar verskille bestaan tussen wat gebeur tydens afbind van die pulmonale arterie en 
eenlongnarkose?  Die antwoord mag wees dat die beperking in die styging in PA druk tydens eenlongnarkose as 
gevolg van ‘n progressiewe afleiding van bloedvloei na die nie-geventileerde long gebeur sodra pulmonale arterie 
druk styg tydens eenlongnarkose.  Die implikasie van die afleiding van bloed na die nie geventileerde long is dat dit 
as ‘n veiligheids meganisme optree en verdere styging in pulmonale arterie druk beperk tydens eenlongnarkose.  
Hierdie afblaas meganisme sal die regter ventrikel beskerm tot en met PA afbind. 
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Kontrole groep:  eenlongnarkose en regter ventrikulêre funksie 
Die huidige studie bied die geleentheid om die betekenis van die voorafgenoemde verhoging in PA drukke en 
elastansie op regter ventrikulêre funksie tydens eenlongnarkose te ondersoek.  Die huidige studie dui aan dat die 
30% verhoging in pulmonale arterie druk wat met die aanvang van eenlongnarkose plaasvind, glad nie regter 
ventrikulêre funksie belemmer nie indien dit vergelyk word met die basislyn wakker staat.  In teendeel, kardiale 
omset het verhoog na chirurgiese insnyding: hierdie verhoging is waarskynlik te wyte aan simpatiese senuwee 
stimulasie na die chirurgiese insnyding.  Hierdie waarnemings pas in ook met ander studies waartydens regter 
ventrikulêre ejeksie alleenlik begin om af te neem indien die indekse van opposisie tot regter ventrikulêre ejeksie 200 
tot 250% van basislyn bereik.  Verder, die induksie van voorlading, naamlik sentrale veneuse druk, pulmonale arterie 
wigdruk en regter ventrikulêre einddiastoliese volumes is onveranderd tydens die huidige studie; dit beteken die 
ventrikel het nie gedilateer het nie tydens die verhoging in regter ventrikulêre nalading. 
 
Die verband tussen slagwerk en nalading sal varieer, afhanklik van die kontraktiele status van die ventrikel.  In 
hierdie opsig, kon ons aflei dat die regter ventrikel, onder omstandighede wat tydens diė studie plaasgevind het, 
gefunksioneer het op die stygende been van die verband tussen regter ventrikulêre slagwerk en pulmonale arterie 
elastansie.  Hierdie waarneming ondersteun die argument in die vorige paragraaf dat die regter ventrikel funksie 
behoue is tydens eenlongnarkose. 
 
Ter opsomming omtrent die indekse van opposisie tot pulmonale vloei en regter ventrikulêre funksie tydens 
eenlongnarkose: 
1. Opposisie tot regter ventrikulêre uitwerp verhoog.  Die bewys hiervoor is ’n 30% verhoging in gemene 
pulmonale arterie druk en ’n 36% verhoging in pulmonale arterie elastansie. 
2. Ten spyte van die verhoging in weerstand teen RV uitwerping, het regter ventrikulêre funksie (soos bepaal 
deur regter ventrikulêre slagwerk indeks, regter ventrikulêre ejeksie fraksie en slag volume), nie verminder 
tydens eenlongnarkose in vergelyking met die waardes verkry wanneer die pasiënte wakker is of aan 
tweelongnarkose onderwerp is. 
3. Ons kon ook aflei dat die koppeling tussen die regter ventrikel en sy lading goed behoue is tydens 
eenlongnarkose.  Die implikasie hiervan is dat regter ventrikulêre slagwerk reserwe teenwoordig is tydens 
eenlongnarkose.  Tydens eenlongnarkose funksioneer die regter ventrikel as ’n vloeipomp, net soos in 
normale lewe; dit beteken dat en die klein verhoging in regter ventrikulêre nalading wat ondervind word 
tydens eenlongnarkose maklik getolereer word.  
Dobutamien tydens eenlongnarkose:  opposisie tot pulmonale vloei en 
regter ventrikulêre funksie 
Die uitwerking van dobutamien op regter ventrikulêre funksie tydens eenlongnarkose kan as volg opgesom word: 
1. Lae dosisse dobutamien (3 µg.kg-1.min-1) verhoog kardiale omset, slagvolume en regter ventrikulêre 
slagwerkindeks.  Die toediening van dobutamien 3 µg.kg-1.min-1 het nie saamgegaan met ‘n verhoging in 
regter ventrikulêre nalading nie.  Dus, lae dosisse van dobutamien het wel die koppeling tussen die regter 
ventrikel en die pulmonale vaskulatuur tydens eenlongnarkose verbeter.   
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2. Nietemin, albei die hoër dosisse van dobutamien (5 en 7 µg.kg-1.min-1) tydens eenlongnarkose het 
verhogings in die opposisie tot pulmonale bloedvloei teweeggebring.  Byvoorbeeld, PA elastansie, gemene 
PA druk en pulmonale vaskulêre weerstand het met 30 tot 40% verhoog in vergelyking met die waardes 
gekry toe die pasiënte wakker was en toe albei longe geventileer is.  ’n Belangrike opmerking in hierdie 
opsig is dat pulmonale arterie vervormbaarheid tydens eenlongnarkose met 61% verminder het tydens 
albei dobutamien 5 en 7 µg.kg-1.min-1.  Die verhogings in gemene pulmonale arterie druk en pulmonale 
vaskulêre weerstand is, volgens mening, nie van kliniese of statistiese betekenis nie, alhoewel die 
vermindering in PA vervormbaarheid tydens die dobutamien 7 µg.kg-1.min-1 infusie wel van kliniese 
betekenis is.  PA vervormbaarheid weerspieël een van die faktore wat vaskulêre impedansie in die 3-
element Windkessel model van sirkulasie het.  Die verhoging in opposisie tot pulmonale vloei en die 
afwesigheid van progressiewe verhogings in indekse van regter ventrikulêre funksie is nie wat verwag word 
indien die dosisse van die inotroop en pulmonale vasodilator dobutamien, progressief verhoog word.  Die 
redes hoekom die opposisie tot pulmonale vloei verhoog tydens die toediening van dobutamien sluit in die 
uitwissing van die pulmonale vaskulêre reserwe tydens eenlongnarkose.  Tydens die hoë kardiale indekse 
van 5 tot 5.5 µg.kg-1.min-1.  is die pulmonale vaskulêre reserwe uitgeput en die meganisme het die 
verwagte pulmonale vaskulêre vasodilatasie van dobutamien oorskadu.  Bowendien is dit waarskynlik dat 
die verhoging in regter ventrikulêre nalading betekenisvol genoeg was om te verhoed dat regter 
ventrikulêre funksie progressief verhoog soos sou verwag word met die administrasie van hoër dosisse 
inotroop. 
 
Die administrasie van dobutamien tydens eenlongnarkose het gemene pulmonale arterie druk verhoog tot ’n 
maksimum van 24,9 ± 6.2 mm Hg teen ’n kardiale indeks van 5.5 ± 1.2 l.min-1.m2.  Nietemin is gemene pulmonale 
arterie druk 24.0 ± 7.7 mm Hg teen die maksimum kardiale indeks in die kontrole groep van 4.4 ± 1.1 l.min-1.m-2 
tydens eenlongnarkose in die kontrole groep.  Hierdie weerspieël dus ’n relatief beperkte verhoging in pulmonale 
arterie druk in vergelyking met die verhoging in pulmonale arterie druk wat gebeur het tydens die administrasie van 
dobutamien.  Die waarskynlikste rede hoekom daar ’n beperkte verhoging in pulmonale arterie druk sou gewees het 
tydens die infusie van dobutamien is die afblaas effek van die nie-geventileerde long wat die verhoging in PA druk 
beperk het. 
Oksigenasie tydens eenlongnarkose 
Die volgende waarnemings is gemaak in verband met suurstof vloed, veneuse en arteriële oksigenasie tydens 
eenlongnarkose in die kontrole groep: 
 
1. Die kombinasie van Induksie van narkose en die 1ºC vermindering in temperatuur het saamgegaan met ’n 
40% vermindering in suurstof verbruik tydens twee long narkose.  Hierdie vermindering in suurstof verbruik 
het voortgegaan tydens eenlongnarkose. 
2. Die aanvang van eenlongnarkose is geassosieerd met ’n verhoging in kardiale omset in vergelyking met 
albei die basislyn eenlongnarkose en wakker state. 
3. Die gevolge van punte 1 en 2 hierbo is dat die gemengde veneuse suurstof saturasie vanaf 75% en die 
gemeng veneuse suurstof spanning vanaf 5.4 kPa (toe die pasiënte wakker was) gestyg het tydens 
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eenlongnarkose tot 90.6 ± 4.7% en 9 ± 1.7kPa respektiewelik. 
4. Tydens eenlongnarkose het die betekenisvolle verhoging in veneuse oksigenasie veroorsaak dat daar ’n 
verhoging in arteriële oksigenasie was in vergelyking met wanneer die pasiënte wakker was.  Hierdie 
styging in arteriele oksigenasie was ten spyte van die 37% aftakking wat teenwoordig was tydens 
eenlongnarkose. 
5. Onder toestande in die huidige studie, het dobutamien tydens eenlongnarkose nog arteriële nog veneuse 
oksigenasie verbeter nie, maar die arteriele oksigenasie het konstant gebly.  ’n Belangrike observasie wat 
daarmee saamgaan is dat dobutamien toediening nie met ’n daling in arteriële suurstof spanning 
geassosieer is nie.  Vervolgens, die hipotese dat die verhoging in kardiale omset geassosieer met 
dobutamien toediening tydens eenlongnarkose ’n verhoging in arteriële oksigenasie beweeg bring, is dus 
verwerp. 
 
Die verwerping van die hipotese van die deel van die studie beteken dat die bevindinge die teenoorgestelde is van 
die studies gepubliseer deur Mathru en sy kollegas en Nomoto en Kawamura.  Hierdie outeurs het gedemonstreer 
dat die toediening van inotrope ’n verhoging in arteriële oksigenasie teweeg gebring het.  Nietemin is die 
teenoorgestelde gevolgtrekkinge nie teenstrydig met mekaar nie.  Inteendeel hierdie verskille help ons om die effek 
van ’n verhoging in kardiale omset of arteriële oksigenasie in die teenwoordigheid van ’n betekenisvolle aftakking 
duidelik te maak.  Die verskille tussen die studies kan op die volgende manier verduidelik word.  Toestande wat in 
die huidige studie teenwoordig was het veroorsaak dat die verband tussen suurstof lewering en verbruik baie hoog 
was en dat die gemeng veneuse suurstof spanning baie hoog was om mee te begin alvorens dobutamien geinfuseer 
is.  Dus is die veneuse saturasies op die plat deel van albei die suurstof dissosiasie kurwe en ook van die verband 
tussen kardiale omset en arteriële suurstof inhoud oorspronklik deur Kelman, Nunn en kollegas beskryf.  Verdere 
verhogings in kardiale omset sou dus nie verwag word, en het nie, verhogings in gemeng veneuse suurstof 
spanning, gemeng veneuse suurstof saturasie of gemeng veneuse suurstof inhoud teweeg gebring.  Dus, arteriële 
suurstof inhoud en saturasie het nie verander na die verhoging in kardiale omset wat teweeg gebring is deur die 
toediening van dobutamien in die huidige studie.  Inteendeel, in die studie deur Mathru en kollegas, is die lae 
aanvanklike veneuse saturasie en spanning verbeter deur verhogings in die verband tussen suurstoflewering en 
suurstofverbruik.  Omdat die veneuse saturasie aan die begin van die Mathru studie laag was, is betekenisvolle 
voordeel in arterieël oksigenasie teweeg gebring deur om die kardiale omset te verhoog. 
 
’n Groot bekommernis vir die klinikus is dat die aftakking mag verhoog met die toediening van die inotroop 
dobutamien tydens eenlongnarkose en, op die manier, arteriële oksigenasie mag verminder.  Die invloed van 
dobutamien op arteriële oksigenasie tydens eenlongnarkose mag teoreties te wyte wees aan die balans van die 
volgende uiteenlopende faktore: 
1. Deur om die verband tussen suurstof lewering en verbruik te verbeter, sal dobutamien gemeng veneuse 
suurstof spanning verhoog.  Hierdie verhoging sal arteriële oksigenasie verbeter in die teenwoordigheid 
van ’n groot aftakking, 
2. Die bogenoemde moet teenoor potensiële verhogings in suurstofverbruik deur dobutamien oorweeg word.  
Die gevolge hiervan sou potensieel ’n vermindering in gemeng veneuse suurstof spanning wees.  Sulke 
verhogings in suurstof verbruik is nie tydens die huidige studie gesien nie, 
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3. ’n Verhoging in pulmonale arterie druk wat saamgaan met die verhoogde kardiale omset sal hipoksiese 
pulmonale vasokonstriksie teenwerk wat die aftakking in albei die geventileerde en nie geventileerde longe 
sal verhoog, 
4. Direkte inhibisie van hipoksiese pulmonale vasokonstriksie deur dobutamien en, 
5. Die invloed van gemeng veneuse suurstof spanning op hipoksiese pulmonale vasokonstriksie moet ook 
oorweeg word (d.i. hoe gemeng veneuse suurstof parsiele druk sal hipoksiese pulmonale vasokonstriksie 
inhibeer). 
 
Nietemin, ten spyte van die bekommernisse rondom hipoksemie tydens die toediening van dobutamien tydens 
eenlongnarkose, het dobutamien toediening nie ’n verlaging in arteriële suurstof spanning teweeg gebring nie, en 
ook het dit nie die koste van oksigenasie verhoog nie.  Verder, die bevindinge van studies tydens eenlongnarkose in 
die laterale decubitus posisie deur Mathru en sy kollegas, Nomota en Kawamura en ook die huidige studie, dui aan 
dat die toediening van lae dosisse van dobutamien nie toe ’n verhoging in aftakking lei nie.  Inteendeel, die 
voordelige effekte van die verhoging in kardiale omset op veneuse saturasie het veroorsaak dat daar ’n verhoging in 
arteriële saturasie is in die studie deur Mathru en sy kollegas soortgelyke meganismes is waarskynlik ook van 
toepassing in die studie wat gedoen is deur Nomoto en Kawamura. 
 
Dus, dwars deur die literatuur, is daar geen huidiglike bewys dat die toediening van dobutamien tot en met dosisse 
van 7µg.kg-1.min-1 aftakking verhoog of arteriële oksigenasie versleg in mense onderworpe aan eenlongnarkose in 
die laterale decubitus posisie.  Dit is duidelik dat die vasodilatoriese effekte van dobutamien wat moontlik ’n 
verhoging in aftakking fraksie teweeg kan bring, nie die enigste faktore is om te oorweeg wanneer die middel se 
invloed op arteriële oksigenasie bestudeer word nie.  Dit is ook van kliniese belang om die invloed van inotrope 
middels op veneuse suurstof inhoud te oorweeg.  Dit is moontlik dat ’n aftakking verhoog kan word deur die 
toediening van ’n inotroop.  Nietemin, mag die negatiewe effek wat die toediening van ’n inotroop sal inhou op 
arteriële oksigenasie deur middel van sy verhoging in aftakking, negeer word indien veneuse oksigenasie voordelig 
beïnvloed is.  Verder, indien die verhoging in veneuse oksigenasie wat teweeggebring word deur die toediening van 
inotrope baie betekenisvol is, mag die gevolg hiervan wees dat arteriële oksigenasie voordelig beïnvloed word soos 
die geval in die huidige studie was. 
 
Die huidige benadering waar die kwaliteit van die bloed wat deur die aftakking vloei die arteriële oksigenasie 
beïnvloed, skuif die klem van voorkoming en behandeling van hipoksemie tydens eenlongnarkose van die long na 
die toereikendheid van die sirkulasie.  Met ander woorde, die klem is geskuif van wat gebeur in die nie-geventileerde 
long (hipoksie pulmonale vasokonstriksie) tot primêr die toereikendheid van suurstof flux tydens eenlongnarkose.  
Ekstrinsieke en intrinsieke PEEP tydens eenlongnarkose 
Die invloed van PEEP op hemodinamika en oksigenasie tydens eenlongnarkose in die huidige studie mag as volg 
opgesom word.  Toe PEEP5 tydens eenlongnarkose toegedien is: 
1. Nie regter ventrikulêre funksie, hemodinamika, suurstof flux nog arteriële oksigenasie is beïnvloed deur die 
toediening van PEEP5 in vergelyking met die stap wanneer geen eksterne PEEP toegedien is nie. 
2. Betekenisvolle hoeveelhede intrinsieke PEEP is teenwoordig tydens eenlongnarkose in die kontrole groep.  
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Die hoeveelheid intrinsieke PEEP wat teenwoordig was, is swak maar betekenisvol verwant aan die graad 
obstruktiewe lugwegsiekte wat teenwoordig was gemeet deur pre-operatiewe longfunksie toetse.   
3. Die waarskynlikste rede hoekom PEEP5 nie ’n verskil gemaak het aan oksigenasie of hemodinamika nie is 
die teenwoordigheid van soortgelyke hoeveelhede intrinsieke PEEP tydens eenlongnarkose.  Hierdie 
bevinding bevestig Myle’s se beweringe dat lae vlakke intrinsieke PEEP voordelige effekte op oksigenasie 
tydens eenlongnarkose mag hê. 
 
PEEP10 toediening aan die onderlong tydens eenlongnarkose in die huidige studie het tot ’n vermindering in 
slagvolume gelei.  Hierdie vermindering is primêr veroorsaak deur ’n vermindering in voorlading en nie die gevolg 
van ’n verhoging in pulmonale vaskulêre weerstand nie.  Die gevolgtrekking is gemaak omdat regerventrikulere 
enddiastoliese volume verlaag het maar pulmonale vaskulêre weerstand het nie verhoog tot vlakke wat bekend is om 
regter ventrikulêre funksie te belemmer nie.  Die vermindering in die verhouding tussen suurstof lewering en suurstof 
verbruik wat geïnduseer is deur PEEP10 het (voorspelbaar) gemeng veneuse suurstof spanning verminder en kon 
potensieël gelei het tot belemmering in arteriële oksigenasie.  Indien minder voordelige sirkulatoriese toestande 
geheers het tydens die huidige studie, sou groter (oorbodige) hoeveelhede PEEP slegter kardiorespiratoriese 
gevolge tot gevolg gehad het. 
 
Ter opsomming, optimalisering van die volume van die onderlong tydens eenlongnarkose speel ’n belangrike rol in 
die bepaling van arteriële oksigenasie.  Nietemin, die terapeutiese indeks vir PEEP is nou en die narkotiseur het die 
behoefte om te weet wanneer die volume van die onderlong optimaal is.  In die opsig, is ’n betekenisvolle probleem 
tydens eenlongnarkose dat meting van funksionele residuele kapasiteit nie huidiglik maklik is nie. 
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 1. Literature Review 
1.1 The relevance of the right ventricle (RV) 
Relatively little information exists concerning the physiology and pathophysiology of the normal right ventricle, as 
compared to the considerable knowledge regarding left ventricular function.  The reasons for the emphasis placed on 
the left ventricle are: 
¾ The thicker walled left ventricle generates considerably more hydraulic power than the relatively thin walled 
right ventricle.  This thicker walled chamber dominates our physiological considerations of normal and 
abnormal cardiac function (Piene 1986; Ferlinz 1982).  The current prevalence of ischemic heart disease 
and systemic hypertension predominantly express their deleterious effects on the left ventricle.  Thus, the 
perception exists that the LV is the chamber that presents an immediate threat to human life if it fails.  
¾ Studies of right ventricular function initiated as long ago as the 1940’s left the impression that the right 
ventricle, under normal physiological conditions, is an unimportant and dispensable “flow pump” (Rigolin, 
Robiolio et al. 1995; Sunagawa, Maughan et al. 1983; Ferlinz 1982; Sade and Castaneda 1975; Donald 
and Essex 1954; Kagan 1952). 
The question then arises whether the RV is of importance in human physiology or is it a dispensable pump?  The 
issue may be examined using two approaches.  On the one hand, the validity of the concept of the ‘dispensable’ right 
ventricle needs to be examined.  This will be approached by examining the history of the concept of the “dispensable 
RV”.  On the other hand, evidence needs to be lead of situations when the right, rather than the left ventricle, is the 
significant factor in limiting survival of the organism. 
1.2 The right ventricle, dispensable or essential pumping chamber?  
1.2.1 The concept of the dispensable right ventricle 
Isaac Starr and co-workers conducted a study with the stated aim of to demonstrating the fallacy of the concept of 
univentricular failure (Bakos 1950).  At the time, a debate was being conducted whether a rise in central venous 
pressure could be an indication of left, rather than right, ventricular failure (Bakos 1950; Starr, Jeffers et al. 1943).  
An approach to solve this problem was developed whereby the free wall of the right ventricle was inactivated and the 
physiological consequences thereof were then studied.  The free walls of canine right ventricles were inactivated by 
cauterising them with a soldering iron, but without perforating the ventricle.  An alternative model also used by these 
authors was to inactivate the RV free wall by selectively ligating the coronary arteries that supply it.  The left ventricle 
was spared.  An insignificant rise of only one to two cm H2O in central venous pressure was observed after either 
method of RV free wall inactivation was applied.  Starr and his colleagues therefore observed that the RV was not 
essential for maintenance of circulatory homeostasis in their experimental dog models.  Incidentally, their conclusions 
were that the rise in central venous pressure seen in cardiac disease is not necessarily associated with selective 
failure of the right ventricle. 
 
Starr’s original article prompted the conduct of similar experiments that studied aspects of right ventricular function 
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(Sunagawa, Maughan et al. 1983; Donald and Essex 1954; Kagan 1952; Bakos 1950).  Bakos subsequently 
demonstrated that right ventricular stroke volume was maintained and pulmonary artery pressures were unchanged 
despite the damage sustained on RV free wall inactivation (Bakos 1950).  Furthermore, both Kagan (Kagan 1952), 
and Donald and Essex (Donald and Essex 1954) suggested that such damaged right ventricles sustained their 
performance even in the face of pulmonary artery constriction.  The source of power for the maintenance of the 
circulation after the destruction of the right ventricular free wall was at the time never satisfactorily resolved 
(Sunagawa, Maughan et al. 1983).  Proposed explanations have included: 
1. Residual deeper undamaged muscle fibres of the right ventricular free wall (Sunagawa, Maughan et al. 
1983; Bakos 1950);   
2. Mechanical transmission of left ventricular energy by encircling bands of muscle (Kagan 1952).  However, 
the absence of visible contraction of the right ventricular free wall in the aforementioned experiments does 
not support this hypothesis (Sunagawa, Maughan et al. 1983) or, 
3. Contributions from the interventricular septum (Sunagawa, Maughan et al. 1983; Ferlinz 1982; Donald and 
Essex 1954; Kagan 1952). 
 
These experiments lead to the following consensus.  The right ventricle is predominantly a passive conduit and its 
function as a pump is largely superfluous (Rittenhouse, Berger et al. 1978).  The next logical step was to attempt 
exclusion of the right ventricle from the circulation (Sade and Castaneda 1975).  The desire to exclude the right 
ventricle from pumping blood through the pulmonary circulation was prompted in an attempt to help patients with 
congenital obstructive and shunt lesions of the right side of the heart (Lake 1999; Sade and Castaneda 1975).  Sade 
and Castaneda (Sade and Castaneda 1975) reviewed the historical development of attempts to bypass the RV in an 
article with the unfortunate title of “The Dispensable Right Ventricle” (Ferlinz 1982).  During the first attempts in 1949 
at performing these bypass procedures, dogs did not survive acute exclusion of the right ventricle from the circulation 
when the venous return was shunted directly into the pulmonary artery.  (It must be noted that this observation 
contradicts the conclusion that the RV is a dispensable chamber.)  Following these initial futile attempts to bypass the 
RV, a novel approach was described in 1954.  This involved the performance of a prior procedure during which 
tricuspid stenosis was created.  The presence of tricuspid stenosis induced right atrial hypertrophy (Sade and 
Castaneda 1975; Nuland, Glenn et al. 1958).  What is noteworthy is the animals did subsequently survive if the 
hypertrophied right atrium was anastomosed to the pulmonary artery and acted as the pumping chamber (Sade and 
Castaneda 1975).  Glenn, in 1954, achieved partial RV exclusion by performing a superior vena cava to right 
pulmonary artery anastomosis (Sade and Castaneda 1975; Fontan and Baudet 1971; Nuland, Glenn et al. 1958; 
Patino, Glenn et al. 1956).  Robisek and his colleagues eventually achieved success in 1956 in totally bypassing the 
right heart.  They did this by anastomosing the inferior vena cava to the left atrium, in addition to performing a Glenn 
shunt (Bergel and Milnor 1965; Sade and Castaneda 1975; Nuland, Glenn et al. 1958).  Only in 1969, did Fontan and 
Baudet perform a total cavo-pulmonary shunt in humans (Robicsek 1992; Gale, Danielson et al. 1980; Fontan and 
Baudet 1971). 
 
The statement made by Sade and Casteneda that the right-sided pumping chamber is dispensable, is not 
unequivocally upheld after close scrutiny of the literature.  The reasons for casting doubt on the “dispensability” of the 
RV include: 
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1. In most of the studies, the animals used had normal pulmonary vasculature.  It is well described that the 
right ventricle becomes progressively more important as pulmonary vascular resistance rises (Sunagawa, 
Maughan et al. 1983; Kagan 1952).  Furthermore, criteria for a successful outcome when doing procedures 
that exclude the right heart heavily emphasize the presence of a low pulmonary vascular resistance (Morel, 
Costabella et al. 1990; Sade and Castaneda 1975). 
2. Guiha et al, prompted by their experience with 6 cases of inferior infarction complicated by right ventricular 
myocardial infarction and failure, repeated Starr’s original experiment (Sunagawa, Maughan et al. 1983).  
Unlike the other investigators before them (Donald and Essex 1954; Kagan 1952; Bakos 1950; Starr, 
Jeffers et al. 1943), their experimental protocol also included measurement of aortic flow and the 
response of the ventricles to volume loading.  Right ventricular end-diastolic pressure did not increase 
significantly from before (2.6 mmHg) to after (5 mmHg) cauterisation.  Furthermore, pulmonary artery 
pressures were unchanged.  This is in keeping with the results of previous experiments.  However, these 
normal pressures belied considerable impairment of ventricular function as evidenced by a 20% decrease 
in aortic blood flow and a marked shift to the right in the right ventricular function curve (Sunagawa, 
Maughan et al. 1983).  After destruction of the right ventricle, the left ventricular (LV) function curves did 
not change significantly but left ventricular filling decreased (Sunagawa, Maughan et al. 1983).  This 
observation is supported if Starr’s original work is closely examined.   It is evident that decreases in mean 
arterial blood pressure (from 130 to 70 mmHg) did occur on cautery of the RV free wall (Starr, Jeffers et al. 
1943).  This emphasises the role that ventricular-ventricular systolic interaction has in determining cardiac 
performance.   
3. Contributions from the left side of the circulation may support the failing right ventricle (Rittenhouse, Berger 
et al. 1978; Raines, LeWinter et al. 1976).  However, when an increase in stroke work is needed (due to an 
increase in cardiac output as during exercise, or increase in right ventricular ejection pressure), this 
mechanism may be inadequate to sustain an adequate circulation (Rittenhouse, Berger et al. 1978). 
4. Destruction of the right ventricular free wall was always performed in animal models in which the 
pericardium had been opened (Sunagawa, Maughan et al. 1983; Donald and Essex 1954; Kagan 1952; 
Bakos 1950; Starr, Jeffers et al. 1943).  An intact pericardium limits the great compliance and 
distensibility of the right ventricle, and plays a significant role in ventricular interdependence.  Left 
ventricular function may have been more compromised and the rise in right ventricular end-diastolic 
pressure greater, if the integrity of the pericardium had been preserved (Milnor 1982c). 
5. The majority of the studies relied on measurement of right ventricular end-diastolic pressure (RVEDP) and 
did not measure end-diastolic volume (RVEDV) of the right ventricle.  The relationship between end-
diastolic pressure and end-diastolic volume of the compliant right ventricle has frequently been reported to 
be poor (Diebel, Wilson et al. 1992; Dhainaut and Squara 1992; Martyn, Snider et al. 1981).  
1.2.2   Right ventricular function critical to survival 
In contrast to the concept of the dispensable right ventricle, we will briefly examine situations where the right ventricle 
may be the ventricle that determines survival by being the limiting factor in the circulation (Nyhan 2001; Nyhan 2001). 
1.2.2.1 Respiratory Failure  
In 1977, Zapol and Snider first described that pulmonary hypertension occurs during acute lung injury (ALI) or adult 
Chapter 1.  Literature review
 
28 
respiratory distress syndrome (ARDS), in spite of correction of arterial hypoxemia (Zapol and Snider 1977).  Both 
they and others have observed that the ability of the right ventricle to sustain an acutely imposed workload was an 
important factor in the ultimate survival or death of the patient with ALI (Brunet, Dhainaut et al. 1988; Zapol and 
Snider 1977).  Survival from ARDS has been associated with a lower pulmonary vascular resistance (PVR) 
(Shoemaker and Kram 1998; Sturm, Lewis, Jr. et al. 1979) and improvement in right ventricular function with time 
(Eddy, Rice et al. 1988). 
1.2.2.2 Sepsis 
Clowes and colleagues, in a remarkable and prophetic article published in 1969, accurately documented that the 
circulatory insufficiency and inadequate delivery of oxygen to the tissues seen in sepsis was primarily caused by right 
ventricular failure (Clowes, Jr., Farrington et al. 1970).  This has been validated and expanded upon by others: 
1. Thrombi that form in the pulmonary vasculature in patients with sepsis lead to increases in PVR, pulmonary 
hypertension, increased right ventricular stroke work and ultimately RV failure (Hoffman, Greenfield et al. 
1983; Guntheroth, Kawabori et al. 1978).  Survivors demonstrated increases in PVR (152 +/- 36%) and 
cardiac index (4.4 litres.min-1.m-2) that remained constant over time.  However, in non-survivors, PVR 
increased progressively to approximately 600% of control and cardiac index decreased to 2.2 litres.min-
1.m-2 before death (Sibbald and Driedger 1983; Clowes, Jr., Farrington et al. 1970). 
Central venous pressure (cm H2O) 
 
Onset Maximal response Convalescence / Pre-mortem 
Survivors 4 ± 3 9 ± 4 5 ± 2 
Non-survivors 4 ± 4 12 ± 5 19 ± 5 
Table 1.2.2.2.1  CVP values of patients with sepsis as reported by Clowes and colleagues, 1970.  Data 
presented as mean and standard deviation. 
 
2. The right, rather than the left ventricle, may be the limiting factor determining survival in sepsis (Hoffman, 
Greenfield et al. 1983).  Right ventricular dysfunction in sepsis has been reported to be worse and more 
consistently present than left ventricular dysfunction (Mitsuo, Shimazaki et al. 1992; Parker, McCarthy et al. 
1990; Reuse, Frank et al. 1988; Hoffman, Greenfield et al. 1983).  Circulating factors in sepsis induce 
biventricular myocardial depression and systemic vasodilatation (Grocott-Mason and Shah 1998; Parker, 
McCarthy et al. 1990; Reuse, Frank et al. 1988).  The resultant arterial hypotension adversely affects 
perfusion of the stressed right ventricle, which contributes to right ventricular dysfunction (Reuse, Frank et 
al. 1988; Hoffman, Greenfield et al. 1983).  Other investigators have demonstrated right ventricular 
dilatation (defined as an increased right ventricular end-diastolic volume normalized for body surface area) 
in sepsis (Mitsuo, Shimazaki et al. 1992; Dhainaut, Lanore et al. 1988; Hoffman, Greenfield et al. 1983).  
The resultant leftward shift of the interventricular septum would, at least in part, explain the observed 
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decrease in compliance of the left ventricle seen in sepsis (Mitsuo, Shimazaki et al. 1992; Dhainaut, 
Lanore et al. 1988).  Furthermore, many of these patients develop adult respiratory distress syndrome 
(ARDS), which has significant implications for RV-PA interaction.   
3. The prognostic value of right ventricular function in sepsis has been documented whereas no relationship 
between survival and left ventricular function was seen (Hoffman, Greenfield et al. 1983).  The initial right 
ventricular ejection fraction (RVEF) is significantly higher in survivors of sepsis (Reuse, Frank et al. 1988).  
Furthermore, an improvement of the RVEF over time is an indicator of survival (Hoffman, Greenfield et al. 
1983).  However, these factors may simply be related to the severity of the sepsis and the accompanying 
severe myocardial depression (Reuse, Frank et al. 1988).  
1.2.2.3 Right ventricular performance and pulmonary resection 
Resection of lung tissue results in the removal of both lung parenchyma and a portion of the pulmonary vasculature.  
Should the remaining vascular bed not allow further recruitment and dilation in response to an increase in cardiac 
output, PA pressure will then rise (Lewis, Bastanfar et al. 1994).  Depending on firstly the degree of rise in pulmonary 
artery pressure for a particular rise in the cardiac output and secondly the right ventricular reserve of the RV, the 
patient may either tolerate the new physiological status or exhibit various degrees of right ventricular dysfunction 
(Coetzee 2000; Bolliger, Jordan et al. 1995).  This dysfunction may span a spectrum from, on the one hand, allowing 
a sedentary lifestyle to, on the other hand, the development of acute right ventricular failure and death (Okada, Ota et 
al. 1994; Gass and Olsen 1986).  The amount of pulmonary vascular reserve and right ventricular function needs to 
be considered before pulmonary resection is undertaken (Okada, Ishii et al. 1996; Gass and Olsen 1986).   
 
Pneumonectomy after hemorrhagic shock carries a dismal prognosis in humans and animal models alike (Cryer, 
Mavroudis et al. 1990).  The reasons appear to be the development of acute pulmonary hypertension within 4 hours 
of the insult.   Pulmonary vascular resistance increase was shown to exceed 500% of baseline 4 hours after 
pneumonectomy.  This was followed by acute RV dysfunction and death of the organism.  Causes of this marked 
increase in PVR include the release of thromboxane and pulmonary leucostasis (Cryer, Mavroudis et al. 1990).  
Whatever the mechanisms suggested, it is most likely that these animals developed ARDS after this insult.   
1.2.2.4 Right ventricular infarction 
Cohn and colleagues (Cohn, Guiha et al. 1974) were the first to report on right ventricular failure complicating left 
ventricular infarction.  They suggested that the infarcted right ventricle could not generate enough pressure to fill the 
ischemic and non-compliant left ventricle.  In other words, when the ischemic right ventricle is faced with an acute 
rise in PA pressure with which it cannot cope, RV dysfunction becomes evident.  However, isolated RV infarction 
(without dysryhmias or LV extension) is usually a hemodynamically silent event. 
1.2.2.5 Right ventricular dysfunction after cardiopulmonary bypass 
Acute right ventricular dysfunction (Stein, Breisblatt et al. 1990) can be a cause of morbidity and mortality after 
cardiac surgery.  Causes for this include heparin-protamine reactions resulting in acute pulmonary hypertension and 
poorer protection of the RV especially by retrograde cardioplegia (Morel, Costabella et al. 1990). 
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1.2.2.6 Pulmonary embolism 
Acute pulmonary embolism, be the cause thrombi, air, carbon dioxide, or amniotic fluid may impose a strain on the 
right ventricle to a greater degree than that imposed by simple physical obstruction of the pulmonary vascular bed.  
This is the result of pulmonary vasoconstriction induced by the release of a number of vasoactive mediators 
(Goldhaber 1997; Moser 1990).  It is well described that such an acute rise in RV afterload is not well tolerated by the 
thin walled right ventricle and the resultant right ventricular dysfunction is the primary reason for the ensuing 
circulatory instability (Goldhaber 1997; Moser 1990). 
1.2.2.7 Lung and heart transplantation 
Right ventricular dysfunction may present problems after heart transplantation (Firestone 1991).  A pre-existing 
pulmonary vascular resistance of more than 480 to 640 dynes.sec.cm-5 is regarded as a contraindication to cardiac 
transplantation (Reichart, Reichenspurner et al. 1987). 
 
Right ventricular failure is often a problem during and early after, bilateral sequential lung transplantation and may be 
the cause of death (Myles, Weeks et al. 1997; Kendall, Bittner et al. 1997; Kirshbom, Tapson et al. 1996; Van Trigt, 
Bittner et al. 1995). 
1.2.2.8 Dynamic hyperinflation 
Dynamic hyperinflation is a clinically significant problem during one lung anesthesia (OLA) in patients with acute 
asthma, chronic obstructive pulmonary disease (COPD) and intrinsic positive end-expiratory pressure (PEEPi) or 
with malpositions and obstructions of a double lumen tube (DLT) (Levy, Kitch et al. 1998; Conacher 1998; Inomata, 
Nishikawa et al. 1997).  This will raise intra-alveolar pressure and PVR and eventually produce signs of right 
ventricular dysfunction, systemic hypotension and even cardiac arrest (Conacher 1998; Myles, Weeks et al. 1997; 
Conacher 1997; Naunheim and Ferguson 1996; Mercer 1995; Myles, Madder et al. 1995; Jardin, Dubourg et al. 
1987). 
 
Based on the above, it can justifiably be concluded that the right ventricle is not only a vital part of the cardiovascular 
system but may on occasion represent the physiologically dominant ventricle. 
 
Contributions from the left side of the circulation may support the failing right ventricle (Rittenhouse, Berger et al. 
1978; Raines, LeWinter et al. 1976).  However, when an increase in stroke work is needed (due to an increase in 
cardiac output as during exercise, or increase in right ventricular pressure), this mechanism may be inadequate to 
sustain an adequate circulation (Rittenhouse, Berger et al. 1978). 
1.3 Applied anatomy and physiology of the right ventricle 
Both right ventricular function and anatomy differ from that of its counterpart, the left ventricle.  However, the two 
ventricles are in intimate contact and their function and anatomy influence each other.  The anatomy of the right 
ventricle in relationship to its physiology will be addressed. 
 
The systolic function of the RV has similar determinants to those of the left ventricle namely preload, afterload and 
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contractility (Calvin, Jr. 1991; Sibbald and Driedger 1983).  The extent that the left and right ventricles differ in 
utilizing any one or a combination of these factors in their adaptive response to stress is unclear (Weber, Janicki et 
al. 1983; Sibbald, Paterson et al. 1978).  The right ventricle is exquisitely sensitive to afterload and this concept will 
be emphasized (Hurford and Zapol 1988). 
1.3.1 Anatomy 
In utero the right ventricle is the dominant ventricle.  It ejects 66% of 
the cardiac output and shares a similar preload and afterload with 
the left ventricle (Wiedemann and Matthay 1997; Hines and Barash 
1993; Weber, Janicki et al. 1983).  During the first three months of 
life, the RV has the greater mass and continues to be the dominant 
ventricle.  
 
On the one hand, pulmonary vascular resistance decreases and 
attains adult levels 2 weeks after birth (Hines and Barash 1993).  
Thereafter, even with a 200 to 300% increase in cardiac output 
during exercise, PA pressures do not rise much (Rigolin, Robiolio et 
al. 1995).  On the other hand, after birth the LV is faced with a 
significantly higher vascular resistance than it experienced in utero.  
The different load and wall stresses faced by the two ventricles in 
adult life causes remodelling to occur (Weber, Janicki et al. 1983).  
Wall thickness and muscle mass of the left ventricle exceeds that of 
the RV after the 24th month of life (Hennebry and Gerstenblith 2001). 
 
Normal adult right ventricular weight is less than 65 grams in men and 50 grams in women.  The relationship of LV 
including septal, to RV mass ranges between 2.3 and 3.3 to 1 (Wiedemann and Matthay 1997).  Normal right 
ventricular free wall thickness is less than or equal to 5 mm.  Therefore the adult RV is significantly thinner than the 
LV wall that is normally less than 9 to 11 mm in thickness (Hennebry and Gerstenblith 2001; Wiedemann and 
Matthay 1997).  The implications of being the “lightweight” ventricle with the thinner wall is that right ventricular 
compliance is much greater than that of the left ventricle, and the reserve to do work and generate pressure is much 
less than that of the LV (Rigolin, Robiolio et al. 1995).  
 
The RV lies anteromedial in relation to the LV.   It therefore forms most of the anterior surface of the heart (Figure 
1.3.1.1) (Rigolin, Robiolio et al. 1995; Hines and Barash 1993; Milnor 1982c).  The normal RV viewed in cross 
section is crescent shaped (Wiedemann and Matthay 1997; Dodson, Nathan et al. 1997; Hines and Barash 1993; 
Calvin, Jr. 1991).  Albeit this issue has elicited much discussion, the shape of the right ventricle has been described 
as a pyramid with a triangular base (Hennebry and Gerstenblith 2001; Rigolin, Robiolio et al. 1995). 
 
The muscle fascicles of the heart envelop both ventricles in one continuous sweep (Figure 1.3.1.2) (Thomas 1957; 
Bakos 1950).  Because of this arrangement, the interventricular septum is, during normal physiological states, 
considered as an anatomic and functional as part of the left ventricle (Hennebry and Gerstenblith 2001; Stoltzfus 
Figure 1.3.1.1. The anatomical 
relationship of the right ventricle showing 
the conical shape of the left ventricle, and 
half moon shape of the larger anterior right 
ventricle.  Wiedemann et al, 1997 
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1997; Dodson, Nathan et al. 1997; Rigolin, Robiolio et al. 1995). 
 
The RV is embryologically and functionally divided into antero-superior outflow and postero-inferior inflow regions 
that are separated by the crista supraventricularis (Dodson, Nathan et al. 1997; Rigolin, Robiolio et al. 1995; Calvin, 
Jr. 1991; Hurford and Zapol 1988; Armour, Pace et al. 1970).  The inflow region begins to contract 25 to 50 
milliseconds before the outflow region: a peristaltic type of contraction therefore exists in the RV (Hennebry and 
Gerstenblith 2001; Dodson, Nathan et al. 1997; Armour, Pace et al. 1970).  This sequence of contraction may be a 
result of the larger number of Purkinje fibres present in the inflow region and the paucity of thereof in the outflow 
tract.  The outflow tract also has greater contractile reserve partly due to a better (parallel) arrangement of the 
muscle fibres, and partly because contraction lasts longer than in the inflow tract (Dodson, Nathan et al. 1997; 
Armour, Pace et al. 1970).  Sympathetic nervous system stimulation has been shown to produce a pressure gradient 
of up to 40 mmHg between the inflow and outflow regions of the RV (Piene 1986; Raines, LeWinter et al. 1976; 
Pace, Keefe et al. 1969).  On the one hand, this gradient has been suggested to protect the pulmonary vasculature 
from high pressures developed by the inflow region.  Piene, on the other hand, has suggested that such stricture 
formation may be a disadvantage and result in considerable energy loss during right ventricular ejection (Piene 
1986). 
1.3.2 Right ventricular contraction 
The LV contracts by coaxial (radial) shortening of its fibres.  This action results in the interventricular septum being 
pulled leftward (Figure 1.3.2.1) (Rigolin, Robiolio et al. 1995).  In contradistinction to the simple radial shortening of 
the fibres in the LV, right ventricular ejection involves the co-ordinated contraction of three distinct components 
(Figure 1.3.2.1) (Hennebry and Gerstenblith 2001; Rigolin, Robiolio et al. 1995; Hines and Barash 1993).  These 
three components comprise the RV free wall, the septum and the conus.   
 
1. The spiral muscles initiate right ventricular contraction (Figure 1.3.1.2).  This results in shortening of the 
fibres of the free wall of the right ventricle.  This shortening causes RV free wall translation toward the 
septum (Figure 1.3.2.1).  This action comprises the major part of RV contraction.  RV free wall movement 
therefore acts as a bellows to expel blood from the right ventricle (Piene 1986).  The action of the crista 
supraventricularis, which is also contracting at this time, is to link the RV free wall to the LV (Hennebry 
and Gerstenblith 2001). 
2. At the time of maximal RV free wall contraction, the septum is only beginning to contract (Hennebry and 
Gerstenblith 2001).  The decrease in RV free wall surface area is assisted by the septal contraction in 2 
ways.  Firstly, septal stiffening prevents it bulging into the LV when the RV contracts.  Secondly, traction is 
applied by the septum at the point of its attachment of the RV.  RV free wall contraction is aided by this 
pulling action of septal contraction (Rigolin, Robiolio et al. 1995).  The conus (outflow region) is the last part 
of the RV to initiate contraction. 
 
RV ejection into the PA has been shown to continue even after the delayed contraction of the outflow tract has 
ceased and after the end-systolic pressure (Pes) has been reached.  This is unlike that of the LV ejection into the 
aorta, where ejection definitely ceases by the time Pes occurs (Hennebry and Gerstenblith 2001).   
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It has also been suggested that RV ejection is a dual process.  The first part is unequivocally a result of RV muscle 
contraction.  The second part is suggested to be due to the momentum of the blood that is being ejected into the low 
resistance pulmonary vasculature (Hennebry and Gerstenblith 2001).  However, this second phase of the RV 
ejection process is more likely a result of systolic ventricular interaction (Santamore, Lynch et al. 1976a). 
1.3.3   Preload 
1.3.3.1 Isolated muscle 
In an isolated muscle preparation, preload is the load imposed on the muscle before contraction and is obtained by 
stretching the muscle to a certain length (Braunwald, Ross, Jr. et al. 1967).  (See Figure 1.4.1 and the accompanying 
discussion).  The length that the muscle is stretched to at the end of diastole determines the force generated during 
the subsequent contraction.  The physiological basis of this is that as muscle length increases, greater actin-myosin 
overlap occurs resulting in optimal crossbridge formation with optimal tension generation (Leyton, Spotnitz et al. 
1971)  This optimal end-diastolic muscle length corresponds to a sarcomere length of 2.2 microns for left ventricular 
papillary muscle (Figures 1.3.3.1.1a, b and c) (Thys and Dauchot 1998; Braunwald, Ross, Jr. et al. 1967).  This 
corresponds closely to studies on sarcomere length done on the intact dog right ventricle.  This is an important 
observation as the RV has a larger end-diastolic volume than that of its counterpart (Leyton, Spotnitz et al. 1971). 
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Figure 1.3.2.1.    
 
A diagrammatic representation of 
the sequence of RV contraction.  
The RV contraction first begins at 
the inflow area and the RV free 
wall (arrows marked with “1”).   
Thereafter the outflow tract 
(conus, or area marked with a “2”) 
contracts.  
 
 Redrawn and adapted from 
Hennebry and Gerstenblith, 
2001 
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Figure 1.3.3.1.1a.    Top left hand figure: RVEDP versus 
sarcomere length for the canine RV.    
Figure 1.3.3.1.1b    Top right hand figure: RVEDV versus 
sarcomere length for the canine RV.  Adapted from Leyton, 
1971.   
Figure 1.3.3.1.1c.     Left hand figure: Left ventricular filling 
pressure and tension versus sarcomere length in intact dog 
ventricle.  Superimposed on these curves, the tension 
developed by isolated cat papillary muscles is plotted as a 
function of sarcomere length.  The apex of the length 
tension curve for papillary muscle corresponds to a filling 
pressure in the canine LV of 12 mmHg and in the RV of 7 
mmHg.  PM = Papillary muscle.  RV = Right ventricle.  LV = 
Left ventricle.   
 
Adapted from Braunwald et al, 1967 and. Leyton et al, 1971. 
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Figure 1.3.3.1.2. Simultaneous 
measurements of central venous 
pressure (CVP) and pulmonary artery 
wedge pressure (PAWP) made during 
preload changes in a normal hearts.   
Adapted from Benumof, 1998. 
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Figure 1.3.3.1.3. The relationship 
between central venous pressure 
(CVP) and pulmonary artery wedge 
pressure (PAWP) is normally based 
on the difference in compliance 
between the thick walled and relatively 
less compliant LV and the thinner 
walled RV.  Therefore, a small rise in 
CVP is accomplished by a much 
larger rise in pulmonary artery wedge 
pressure for a given rise in increase in 
cardiac output.  Adapted from 
Preload changes, Normal heart
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1.3.3.2 Intact ventricle 
For the intact left and right ventricles, preload is best defined as end-diastolic wall stress (the force per cm2) 
distending the ventricle at the end of diastole (Hennebry and Gerstenblith 2001; Jacobsohn, Chorn et al. 1997).  The 
determinants of diastolic wall stress are end-diastolic volume, end-diastolic pressure and wall thickness.  To be able 
to apply this to an intact ventricle, ventricular volumes may be substituted for wall stress, as both right and left 
ventricular volumes have been shown to correlate well with sarcomere length (Thys and Dauchot 1998; Leyton, 
Spotnitz et al. 1971). 
 
Leyton and colleagues studied the relationship of sarcomere length to right ventricular end-diastolic pressure and 
volume in the intact dog right ventricle (open pericardium) (Leyton, Spotnitz et al. 1971).  Right ventricular sarcomere 
length was linearly related to end-diastolic volume and a curvilinear relationship of sarcomere length to end-diastolic 
pressure was described (Figure 1.3.3.1.1).  Sarcomere length increased from 1.8 microns at a RVEDP of three 
mmHg, to 2.2 microns at 8 mmHg.  Further increases in sarcomere length were achieved only at the expense of very 
large increases in end-diastolic pressure: a length of 2.4 microns was achieved at a RVEDP of 20 mmHg. 
 
At a sarcomere length of 1.6 microns, wall tension is zero (Thys, Dauchot et al. 1999).  However, the sarcomere 
tension length relationship is very steep. Thus, the peak of the length-tension curve for papillary muscle corresponds 
to a sarcomere length of 2.2 microns.  This sarcomere length corresponds to “the normal upper limit of diastolic filling 
pressure” in both the right (8 mmHg) and the left ventricles (12 to 15 mmHg) (Leyton, Spotnitz et al. 1971).  This 
means that both the right and left ventricles function along the ascending limb of the length tension curve (Figure 
1.3.3.1.1c) and normally operate at end-diastolic sarcomere lengths of 2.24 microns or less (Leyton, Spotnitz et al. 
1971).  The lower pressure needed in the right versus the left ventricle to attain a similar sarcomere length is 
accounted for by the right ventricular wall being thinner and therefore more compliant than that of the left ventricle 
(Figure 1.3.3.1.3) (Leyton, Spotnitz et al. 1971).   
 
However, it is interesting to note that at high right ventricular end-diastolic pressures of 15 mmHg, longer sarcomeres 
were found in the right than the left ventricle.  This observation suggests greater potential for slippage of sarcomeres 
in the right ventricle.  This phenomenon can be observed in Figure 1.3.3.1.1c.  If left and right ventricular sarcomere 
length are compared at high filling pressures, maximal lengthening of sarcomeres first occurs in the middle of either 
ventricle at a pressure of 8 to 10 mmHg (Leyton, Spotnitz et al. 1971).  Further lengthening subsequently occurs at 
other points in the ventricle, this being a method of a recruiting further preload reserve (Thys and Dauchot 1998; 
Braunwald, Ross, Jr. et al. 1967). 
 
In a human study, RVEDVI correlated the best with cardiac index (r2 = 0.56) whereas RVEDP (r2 = 0.07) and 
pulmonary artery wedge pressure (PAWP) (r2 = 0.1) correlated poorly with cardiac output (Conrad 2001).  It must be 
emphasized that the right ventricle is a volume displacement pump and is highly dependent on being adequately 
filled (Boldt, Kling et al. 1990). 
 
Squara and colleagues (Squara, Journois et al. 1997) developed a novel approach to RV preload.  They evaluated 
end-diastolic RV elastic energy as an index of RV preload.  The advantages of using elastic energy as an index of 
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preload are: 
 
¾ Firstly, it integrates all the stretching effects of venous return and, 
¾ Secondly, it can be relatively easily measured from the area under the diastolic RV pressure-volume curve.  
 
This method involves measuring the RVDV and RVEDP changes on administration of a fluid bolus.  This information 
is then used to construct a diastolic pressure-volume curve.  From the laws of conservation of energy, the (elastic) 
energy distending the RV should equal the energy contained in the venous return. This may be expressed 
mathematically: 
Elastic energy = ∫end diastole P x dV ………………………… Equation 1.3.3.1 
This method was studied in patients who had just undergone cardiac surgery.  These investigators demonstrated that 
both RV end-diastolic elastic energy and RVEDV were linearly related to right ventricular ejection fraction (RVEF).  
However, RV filling pressures did not correlate with systolic indices of ejection (Hennebry and Gerstenblith 2001; 
Squara, Journois et al. 1997). 
 
The greater compliance of the RV results in the RV having a larger EDV than that of the LV (Wiedemann and 
Matthay 1997; Rigolin, Robiolio et al. 1995).  Since both ventricles eject a similar stroke volume, the RV normally has 
a lower ejection fraction than that of the LV (Rigolin, Robiolio et al. 1995).   
 
End-diastolic pressure of the ventricle is 
commonly substituted as an index of the end-
diastolic volume of the ventricle (Thys and 
Dauchot 1998).  The relationship of diastolic 
pressure to volume of the ventricle is governed 
by the diastolic compliance of the ventricle, 
pericardial and intrathoracic pressures, and 
the position of the interventricular septum 
(Table 1.3.3.1) (Dodson, Nathan et al. 1997; 
Rigolin, Robiolio et al. 1995; Hines and Barash 
1993; Weber, Janicki et al. 1983).  The 
resulting relationship between the filling 
pressures of the two ventricles in normal 
hearts is such that pulmonary artery wedge 
pressure is consistently found to be double 
central venous pressure, and the change in 
pulmonary artery wedge pressure is double 
that of the central venous pressure during fluid 
challenges (Figure 1.3.3.1.3) (Benumof 1998).  Thus, less stroke work (essentially the product of pressure and 
volume generated by a ventricle) can be generated for similar increases in right than left ventricular filling pressure 
(Figure 1.3.3.2.1) (Randall and Stacy 1956). 
Figure 1.3.3.2.1.   Comparative effects of increasing left and right 
atrial pressure on right and left ventricular stroke work. Wiedemann 
and Matthay, 1997 and Hines and Barash, 1993 
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Factors influencing diastolic ventricular properties 
Factors extrinsic to the ventricle Factors intrinsic to the ventricle 
1. Pericardium 1. Passive compliance of the ventricular wall 
(thickness, composition) 
2. Loading of the other ventricle and position of 
the septum 
2. Active relaxation (diastolic function) of the 
ventricular muscle due to residual cross 
bridging of actin and myosin.  Ischemia would 
deleteriously influence this factor 
3. Intrathoracic pressure 3. Elastic recoil (diastolic suction) 
Table 1.3.3.1 Adapted from Braunwald et al, 1998 
 
The compliance of the RV results in an end-diastolic pressure that hardly changes over the physiological range 
(Hennebry and Gerstenblith 2001).  This can be deduced from inspecting the initial flat part of the ventricular diastolic 
pressure-volume relationship (Figure 1.3.4.1#) (Braunwald, Sonneblick et al. 1998; Stoltzfus 1997).  The flat portion 
of the diastolic pressure-volume curve where the pressure doesn’t rise is analogous to the filling of a large rubber 
balloon.  The initial inflation does not stretch its floppy walls. It is only after the balloon has been inflated to the point 
that the walls start to stretch that a rise in distending pressure can be measured.  In other words, initial EDP of the 
RV is poorly related to its EDV (Diebel, Wilson et al. 1992; Dhainaut and Squara 1992; Martyn, Snider et al. 1981).  
Investigators consistently show that due to this poor correlation of EDP to EDV, the indices of forward flow are better 
related to right ventricular EDV than to EDP (Martyn, Snider et al. 1981).  Nevertheless some sources do report that 
CVP is a good indicator of RVEDV (Thys and Dauchot 1998). 
 
Filling of the right ventricle occurs in phases and is not purely passive.  In early diastole, the ventricle creates a mild 
suction that aids the inflow of blood (Shintani and Glantz 1994a).  However later in diastole, atrial contraction 
contributes up to 25 percent to filling in the normal ventricle (Stoltzfus 1997): this allows lower mean atrial and 
venous pressures than would be the case if the atrial contraction was not present (Braunwald, Sonneblick et al. 
1998).  Atrial contraction is of lesser importance in the presence of normal RV physiology.  However, the less 
compliant a ventricle becomes, the greater the atrial contribution to the EDV and the greater the contribution that 
atrial contraction makes to ventricular filling (Thys and Dauchot 1998; Braunwald, Sonneblick et al. 1998). 
 
Factors that govern the passive return of blood to each chamber are different.  The pressure gradient governing the 
                                                                
# Albeit Figure 1.3.4.1 depicts the LV, it illustrates the situation that would occur in the RV with and without the pericardium intact.   
The reader is pointed to LeWinter, Myhere et al. 1994 for examples of RV pressure-volume relationships with and without an intact 
pericardium that are similar to that illustrated in Figure 1.3.4.1. 
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passive flow of blood to the right ventricle is the difference between intra- and extra- thoracic pressures.  The venous 
return to the left ventricle is determined by the pulmonary venous drainage.  This process occurs within the thoracic 
pressure chamber.  That gradient is not deleteriously affected by increases in intrathoracic pressure, as is the 
situation with the RV. 
 
Preload is normally the major determinant of stroke volume in both ventricles (Hennebry and Gerstenblith 2001; 
Reuse, Vincent et al. 1990).  However, the importance of preload may eventually be overshadowed when the right 
ventricle experiences a significant increase in afterload. 
1.3.4 The pericardium 
The pericardial collagen bundles are wavy and stretch easily until tractional forces cause them to straighten.  At this 
point the pericardial tissue becomes relatively inelastic (Figure 1.3.4.1) (Shintani and Glantz 1994b).  Above the point 
that it is relatively non-elastic, the pericardium is stiffer than the myocardium and presents considerable resistance to 
attempts to increase its volume or the volume of the underlying ventricles (Shintani and Glantz 1994b).  Above this 
inflexion point, the pericardium will govern the diastolic pressure-volume relationship of the normal right ventricle.  
The inflexion point occurs at an end-diastolic pressure of between 3 to 8 mmHg for the right ventricle (Shintani and 
Glantz 1994b; Milnor 1982c) and 10 mmHg for the left ventricle (Shintani and Glantz 1994a).  
 
The magnitude of pericardial pressure is similar to right atrial and right ventricular EDP (Shintani and Glantz 1994b; 
Calvin 1991).  In other words, pericardial and RV end-diastolic pressures increase in approximately a one to one 
relationship (Shintani and Glantz 1994b; Calvin 1991).  Therefore pericardial constraint causes the upper limit of end-
diastolic volume (and hence stroke volume) of the normal right ventricle to be reached at an end-diastolic pressure of 
12 (Weber, Janicki et al. 1983) to 15 (Stoltzfus 1997) mmHg.  This underscores the importance of the pericardium on 
limitation of right ventricular filling in the normal heart (Shintani and Glantz 1994b).  This limitation is quantitatively 
different for the left and right ventricles because of the right ventricle being more compliant than its counterpart.  
Therefore, at any particular pericardial pressure, right ventricular filling will be influenced to a greater degree than left 
ventricular filling (Shintani and Glantz 1994b).   
 
Figure 1.3.4.1.   Pressure volume 
relationships of the heart and pericardium, 
together and alone.  The heart without the 
pericardium is far less stiff then the two 
together.  The two together is virtually the 
same as the pericardium alone, indicating 
that the stiffness of the pericardium 
dominates the curve for the ventricle alone, 
especially along the steeper part of the 
pressure volume curve.   Redrawn from  
Shintani and Glantz, 1994 
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Opening the pericardial sac during right ventricular infarction in dogs removes a major limitation on RV dilation.  This 
results in the ability to increase both the right and left ventricular end-diastolic volumes and permit the generation of 
larger stroke volumes (Shintani and Glantz 1994a; Calvin 1991).  Opening the pericardium has a further effect of 
causing the ventricular diastolic pressure-volume relationship to shift down and to the right (i.e. becomes more 
compliant – Figure 1.3.5.1):  This has a more marked effect on the right than on the left ventricular diastolic pressure-
volume relationship (Calvin 1991).   
 
The role of the pericardium on systolic pump function in man has been a subject of debate (Shintani and Glantz 
1994b).  Some studies have found that the pericardium does not influence the systolic function of either ventricle 
(Shintani and Glantz 1994b; Mangano 1980).  This differs from other studies where the pericardium has been 
demonstrated to limit ventricular expansion and subsequent generation of right ventricular stroke work.  The 
explanation for the difference in these studies may lie therein that cardiac dilatation takes a (short) period of time to 
occur, and only then tests the limits of pericardial expansion (Shintani and Glantz 1994b).  During the period before 
these limits are reached, the pericardium will play no role on filling of the RV.  Nonetheless, the situation during 
chronic ventricular dilation may be different.  The pericardium may stretch over time and accommodate a larger 
volume.  This stretch will result in loss of hemodynamic findings associated with subsequent volume loading or 
episodes of dilatation (Shintani and Glantz 1994b; Mangano 1980). 
1.3.5 Ventricular interaction  
The two ventricles are encircled by common muscle fibres, share a septal wall and are enclosed within the 
pericardium (Santamore and Gray, Jr. 1996).  This intimate anatomical association causes the ventricles to interact 
mechanically with each other (Santamore and Gray, Jr. 1996; Shintani and Glantz 1994a; Santamore, Lynch et al. 
1976a; Santamore, Lynch et al. 1976b; Taylor, Covell et al. 1967).  Santamore and Gray define this interaction as the 
forces that are transmitted from one ventricle to the other ventricle through the myocardium and pericardium, 
independent of neural, humoral or circulatory effects (Santamore and Gray, Jr. 1996).  The ventricle-ventricle 
interaction has been the most extensively studied relationship, albeit that inter-atrial and atrio-ventricular interactions 
also exist (Santamore and Gray, Jr. 1996; Shintani and Glantz 1994b).  Ventricular interaction is commonly divided 
into diastolic and systolic, or parallel and series interactions. 
 
The left and right ventricles are a set of pumps in series that eject the same cardiac output over a short period of time 
(Santamore, Lynch et al. 1976b).  The implications of this are twofold.  Firstly, the right provides at least part of the 
energy needed to fill the left ventricle during diastole (Piene 1986).  Secondly, right ventricular output becomes the 
left ventricular output after passing through the pulmonary circulation (Shintani and Glantz 1994a).  Should right 
ventricular output decrease, the left ventricle will become underfilled.  This consequence is termed a series 
interaction between the ventricles.   
 
The relationship of mechanical forces across the interventricular septum on ventricular function is termed parallel or 
direct ventricular interaction (Shintani and Glantz 1994b).  Diastolic ventricular ‘crosstalk’ is the best-studied 
interaction (Shintani and Glantz 1994b).  Ventricular-ventricular interaction is particularly dynamic in diastole when 
pressures and wall stresses are low (Shintani and Glantz 1994a).  Santamore and Gray (Santamore and Gray, Jr. 
1996) and others emphasize that the shape and position of the septum at the onset of systole is extremely sensitive 
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to small alterations in the end-diastolic transseptal pressure gradient (Dodson, Nathan et al. 1997; Rigolin, Robiolio 
et al. 1995; Hines and Barash 1993; Weber, Janicki et al. 1983; Kingma, Tyberg et al. 1983).  It has been stated 
“diastolic ventricular interdependence is present on a beat to beat, and moment to moment basis as part of the 
measured diastolic pressure of the ventricle is caused by the opposite ventricle.  However, ventricular 
interdependence is most apparent with sudden changes in ventricular volume” (Santamore and Gray, Jr. 1996). 
Thus, the interventricular septum normally bows convexly into the right ventricle.  This is dependent on a positive left 
to right diastolic pressure gradient (Figure 1.6.2.3) (Kingma, Tyberg et al. 1983).  If the normal gradient is reduced 
(e.g. an increase in RV end-diastolic volume or pressure) progressive flattening of the septal curvature occurs.  
When the gradient is reversed, the septum will bulge into the left ventricle, distort its geometry and reduce its 
compliance (Figure 1.3.5.1) (Shintani and Glantz 1994b; Kingma, Tyberg et al. 1983; Santamore, Lynch et al. 
1976a).  
 
Taylor et al. (Taylor, Covell et al. 1967), and Santamore et al. (Santamore, Lynch et al. 1976a) investigated diastolic 
ventricular interaction by varying right ventricular volume while keeping the left ventricle at various constant volumes.  
For a given right ventricular end-diastolic volume, the corresponding filling pressure was dependent on the left 
ventricular end-diastolic volume (Figure 1.3.5.2) (Wiedemann and Matthay 1997; Shintani and Glantz 1994a; Calvin, 
Jr. 1991; Weber, Janicki et al. 1983; Taylor, Covell et al. 1967).  These studies were performed without the 
pericardium.  It is however known that ventricular interaction is markedly amplified by the intact pericardium, because 
changes in ventricular pressure and volume are associated with similar trends in intrapericardial pressure (Shintani 
and Glantz 1994b).  These studies may therefore underestimate the magnitude of this effect.   
 
Figure 1.3.5.1.   The effect of RVEDP on LVED pressure-volume relationships is amplified by an intact pericardium.  RVEDP 
was raised in a stepwise fashion.  At each RVEDP, incremental increases in left ventricular volumes were made and the LV 
pressure-volume relationship measured at each incremental change.  When the pericardium is intact, the P-V relationships 
are shifted upward compared to when the pericardium is absent.  A further increase is seen when the pericardium is sutured.   
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The diastolic interventricular relationship has moreover been quantified (Shintani and Glantz 1994b).  The magnitude 
of the interaction can be expressed as the gain in RV pressure (ΔPRV) secondary to changes in LV pressure (ΔPLV) 
for an unchanged LV volume: 
 GRÎL = ΔPLV /ΔPRV 
 Where  GRÎL is the right to left ventricular crosstalk gain (Hennebry and Gerstenblith 2001). 
The change in LVEDP for a given change in RVEDP (GRÎL) is 0.33.  This value is independent of the absolute EDP, 
and implies that a linear relationship exists between the two ventricles (Shintani and Glantz 1994b).   
 
What are the implications of diastolic ventricular interaction on the systolic function of the other ventricle?  An 
increase in EDP or EDV of one ventricle results in the other ventricle having a reduced EDV with a decrease in 
stroke volume and systolic pressure for the same contractile state and afterload (Shintani and Glantz 1994b; 
Santamore, Lynch et al. 1976a; Santamore, Lynch et al. 1976b).  Furthermore, the changing compliance of the other 
ventricle means that its end-diastolic pressure is not a good reflection of either end-diastolic volume or sarcomere 
length (Taylor, Covell et al. 1967).  Santamore has also demonstrated that the left ventricular pressure-volume 
relationship is influenced not only by the volume of the opposite ventricle, but can be modified exclusively by 
changes in RV pressure and compliance (Shintani and Glantz 1994a; Santamore, Constantinescu et al. 1988a; 
Santamore, Constantinescu et al. 1988b). 
The relative importance of the parallel versus the series interaction between the ventricles has been difficult to study 
(Shintani and Glantz 1994a).  Nonetheless, it has been concluded that parallel interaction is about half as important 
as series interaction in determining LV end-diastolic volume when the pericardium is present.  Removing the 
pericardium decreases the importance of parallel interaction to about one fifth that of the series effect (Slinker and 
Glantz 1986). 
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Figure 1.3.5.2.   Left ventricular diastolic pressure-volume relationship at 
various levels of right ventricular filling in the dog with the pericardium 
removed.   Redrawn from Taylor, Covell et al, 1967 
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The relative importance of the parallel versus the series interaction depends also on the stiffness of the ventricular 
walls.  In hypertrophied hearts with an intact pericardium, parallel interaction is only one tenth as important as the 
series interaction in determining ventricular EDV.  This is understandable as the thick non-compliant ventricular walls 
and septum are resistant to external influences (Shintani and Glantz 1994a; Shintani and Glantz 1994b).  Removal of 
the pericardium in subjects with ventricular hypertrophy makes little difference to the relative importance of the series 
versus parallel interaction discussed above (Shintani and Glantz 1994a; Slinker, Chagas et al. 1987).   
 
LeWinter and colleagues have recently observed an interesting ventricular interaction whereby a small decrease in 
caval flow and RVEDV occurs when LVEDV increases suddenly (Shintani and Glantz 1994b).  This may be 
secondary to a decrease in the pressure gradient responsible for venous return to the RV.  
 
The left ventricle dominates the systolic interplay between the ventricles (Weber, Janicki et al. 1983; Elzinga, 
Piene et al. 1980).  The pressure generated by the left ventricle during systole has been shown to cause a double 
peak in the RV pressure waveform.  What is remarkable is that the transmission of force to the RV contributes 
significantly to pulmonary artery blood flow (Santamore and Gray, Jr. 1996; Shintani and Glantz 1994a; Damiano, Jr., 
La Follette, Jr. et al. 1991; Weber, Janicki et al. 1983; Elzinga, Piene et al. 1980; Santamore, Lynch et al. 1976a; 
Santamore, Lynch et al. 1976b).  Quantification of these components suggests that the left ventricular component is 
significantly greater than that of the right ventricle.  Thus, peak systolic pressures of 63.5% vs. 36.5%, root mean 
squared values of 65.5 vs. 34.8%; and pulmonary blood flow 67.5 vs. 32.5% were associated with the left and right 
ventricular components respectively (Table 4.3.3) (Santamore and Gray, Jr. 1996; Damiano, Jr., La Follette, Jr. et al. 
1991).  It follows that when right ventricular free wall performance is acutely depressed, the RV function of propelling 
blood through the pulmonary vasculature is even more dependent on left ventricular-septal contraction (Shintani and 
Glantz 1994a).  In addition, the maintenance of circulatory function after inactivation of the RV free wall is testimony 
of the left ventricle being operative in sustaining right ventricular performance (Sunagawa, Maughan et al. 1983; 
Santamore, Lynch et al. 1976b; Donald and Essex 1954; Kagan 1952; Starr, Jeffers et al. 1943). 
 
The mechanism of systolic ventricular interaction has been discussed in the literature.  The generation of transseptal 
pressure gradients has been suggested to play an important role in systolic ventricular interdependence (Santamore 
and Gray, Jr. 1996; Sunagawa, Maughan et al. 1983; Santamore, Lynch et al. 1976b).  However Santamore and 
Gray suggest that ventricular pressures and volumes are really the consequence of stress in the ventricular walls and 
that “ventricular interdependence should really be viewed as the balance of forces at the interventricular sulcus” 
(Figure 1.3.5.3) (Santamore and Gray, Jr. 1996). 
Figure 1.3.5.3. The diagram illustrates the balance of forces at the 
interventricular sulcus.  The summation of the forces at the sulcus is zero.  The 
tension in the LV free wall (T1) is balanced by tension in the septum (Ts) and the 
RV free wall (Tr).  The force in the LV free wall is balanced by forces in the RV 
free wall and interventricular septum.  Therefore changing one wall directly affects 
all three walls: i.e. a direct transfer of forces between the left and right ventricular 
free walls occurs.  If the LV volume changes, it will affect both LV free wall and 
septum, and the RV free wall dimensions.  Adapted from Santamore and Gray, 
1996 
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Weber and colleagues have suggested that the systolic function of the RV only affects left ventricular contraction 
when its RV systolic pressure approximates that in the left ventricle (Weber, Janicki et al. 1983).  Other work 
(Shintani and Glantz 1994b; Calvin, Jr. 1991) has quantified this interaction on left ventricular systolic function.  
Pulmonary artery constriction results in a small amount (4 to 10%) augmentation increase in LV pressure and stroke 
volume (Hennebry and Gerstenblith 2001; Shintani and Glantz 1994b). 
1.3.6 Myocardial blood supply to the right ventricle 
The RV is supplied predominantly by the right coronary artery (Stoltzfus 1997; Rigolin, Robiolio et al. 1995; Dries and 
Mathru 1992).  Various factors result in the right ventricle being better protected against ischemia than the left 
ventricle (Hines and Barash 1993): 
 
1. The right ventricle receives coronary supply in both systole and diastole, whereas the LV coronary blood 
flow occurs predominantly in diastole.  Faster heart rates with shorter diastolic filling times will interfere less 
with RV coronary blood flow.   
 
2. Autoregulation prevents the lion’s share of blood from going to the right ventricle as would happen if only 
hydraulic factors played a role in blood flow distribution between the ventricles.  Furthermore, the flow per 
gram of tissue in the RV is only two thirds of that of the left ventricle (Dries and Mathru 1992). 
 
3. The right ventricle is able to receive nutrient 
flow directly from the Thebesian veins, 
which is not possible on the left hand side of 
the heart (Stoltzfus 1997). 
 
4. Extensive collateral connections have been 
shown to develop when right coronary artery 
obstruction occurs.  The moderator band# 
artery is a branch of the LAD.  This artery is 
suggested to be an important source of 
blood to the RV papillary muscles and to 
part of the RV free wall during obstruction of 
the proximal RCA.  Collateral flow via the 
moderator band artery protects against right 
ventricular infarction (Hines and Barash 
1993; Sunagawa, Maughan et al. 1985). 
 
5. The systolic and end-diastolic pressures, 
and therefore the wall tension, are lower in 
                                                                
# The moderator band is one of the trabeculae that are better developed than the rest (Hurford and Zapol, 1988). 
Figure 1.3.6.1.  Coronary blood flow during one cardiac 
cycle.  The majority of LV CBF occurs during diastole and 
the majority of RV CBF occurs during systole.  Redrawn 
from Thys and Dauchot, 1998 
Left Coronary
Right Coronary
.2 .4 .6 .8 1.0
120
100
80
100
80
60
40
20
0
15
10
5
0
Time (sec)
Ph
as
ic 
co
ro
na
ry 
blo
od
 flo
w
(m
l / 
mi
n)
Ao
rtic
 pr
es
su
re
(m
mH
g)
Ph
as
ic 
co
ro
na
ry 
blo
od
 flo
w
(m
l / 
mi
n)
Ao
rtic
 pr
es
su
re
(m
mH
g)
Ph
as
ic 
co
ro
na
ry 
blo
od
 flo
w
(m
l / 
mi
n)
Ao
rtic
 pr
es
su
re
(m
mH
g)
 
Chapter 1.  Literature review
 
45 
the right than the left ventricle.  This results in lower oxygen requirements and oxygen extraction.  
Furthermore, RV subendocardial blood supply is relatively greater than that of the LV.  This is important in 
the prevention of RV ischemia, as the subendocardium is an especially vulnerable portion of both the left 
and right ventricles (Dries and Mathru 1992).  Nonetheless, the closer the RV pressure approximates 
systemic pressure, the more the RV behaves like the left ventricle in terms of coronary blood flow (Figure 
1.3.6.1) (Rigolin, Robiolio et al. 1995; Hines and Barash 1993; Dhainaut and Squara 1992; Milnor 1982). 
 
The relationship between ventricular work performed and myocardial oxygen consumption is termed myocardial 
efficiency (Hennebry and Gerstenblith 2001).  The RV normally operates at maximal efficiency, as does its 
counterpart, the LV.   
1.4 Afterload and the right ventricle 
The concept of afterload was introduced by Starling to distinguish phenomena relating to emptying from that of filling 
of the ventricle (Noordergraaf and Melbin 1978).  The right ventricle has been suggested to be very sensitive to 
afterload, much more so than the left ventricle (Hennebry and Gerstenblith 2001).   
 
Afterload is easy to define for an isolated muscle preparation, but is considerably more complex to define for the 
intact heart.  Braunwald defines afterload in isolated papillary muscle as being the force resisting muscle fibre 
shortening (Braunwald, Ross, Jr. et al. 1967).  From inspection of Figure 1.4.1, it can be seen that afterload is the 
tension that a contracting muscle must develop before shortening can occur (Hurford and Zapol 1988).  Furthermore, 
an inverse relationship exists between the velocity of myocardial fibre shortening and afterload  (Figure 1.4.1 c and d) 
(Thys and Dauchot 1998; Braunwald, Sonneblick et al. 1998; Milnor 1982a; Braunwald, Ross, Jr. et al. 1967).  The 
implication is that as the afterload on cardiac muscle increases, the ability of isolated muscle preparations to shorten 
and perform work decreases progressively (Figure 1.4.1 f).  
 
Afterload in the intact heart has been described in the following terms (Thys and Dauchot 1998; Hurford and Zapol 
1988): 
¾ Ventricular pressure, 
¾ Wall stress, 
¾ Vascular resistance, 
¾ Input impedance and, 
¾ Arterial elastance (Ea). 
 
Milnor suggests that there are two main schools of thought as to just what constitutes the afterload on the intact 
ventricle.  The first, which is derived from experiments using isolated muscle strips, suggests that afterload is the 
pressure (alternatively wall tension or stress) developed by the ventricle (Milnor 1982a).  This has been referred to 
the internal resistance of the ventricle. 
 
A second way of looking at afterload is that of forces external to the ventricle as being the load that opposes 
ventricular ejection (Thys and Dauchot 1998; Milnor 1982a).   
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Figure 1.4.1  The use of afterloaded isotonic contractions to obtain force-length relationships.  Adapted from 
Braunwald, Ross et al, 1967; Braunwald, Sonneblick et al, 1998; Milnor, 1982 and Thys and Dauchot 1998 
 
A. A papillary muscle is placed in a bath of Ringers solution and stimulated by electrodes.  The lower end of the muscle is 
attached to an extension from a tension (force) transducer.  The upper end is attached to the end of a lever system that 
is free to move.  The stop is not initially placed above the lever.  A small weight that constitutes preload stretches the 
muscle to its resting length.  The stop is now fixed above the tip of the lever; the result of fixing the stop is that the 
muscle does not sense any weight added to the counterbalance until it begins to contract.  Total load equals the sum of 
preload and afterload.  
 
B. A tracing of an afterloaded isotonic contraction.  The contraction is shown as a function of tension and shortening versus 
time.  After stimulation at time zero, there is a short latent period.  This latent period is followed by isometric contraction 
until the force (P) just exceeds the load when shortening begins.  Maximum velocity is reached soon after the shortening 
begins.   The tangent to the shortening slope (dl/dt) is the maximum velocity of shortening for that particular load.  
 
C. Muscle shortenings are shown for progressive increases in afterload with preload kept constant.  Increasing afterload 
decreases both the velocity of shortening (dl/dt), and the extent of the shortening. 
 
D. The velocity of shortening (dl/dt) is plotted as a function of afterload.  This is termed the force-velocity relationship.  As 
the afterload is increased, the velocity of shortening increases.  An inverse relationship exists between afterload (load) 
and the initial velocity of shortening of cat papillary muscle.  When the curve is extrapolated back to zero load, Vmax is 
obtained.  Increases in initial muscle load (preload) do not alter Vmax.  However, the maximal force that the papillary 
muscle can develop (Po) increases as the preload exerted on the muscle increases (not illustrated). 
 
E. When contractility is increased, the rate of tension development and the extent of shortening for a given afterload 
increases significantly.  The whole curve is shifted upwards and to the right and both Vmax and Po increased\.  (Vmax 
therefore is an index of the contractile state of the muscle.) 
 
F. The top graph illustrates the relationship between afterload and power (the product of load and velocity) done by the 
papillary muscle.  The bottom graph illustrates the relationship between afterload and work (the product of load and 
length) done by the papillary muscle.  For a particular pump and its load, maximum work is done at the summit of the 
curve. When the pump operates at that point, the pump is considered matched to its load. Should the working point 
move to the right or left, then less work is done and the pump and its load are not optimally matched. 
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The pressure generated by the ventricle comprises a component of each of the above definitions of afterload, and it 
will not be dealt with as a separate topic.  Similarly trends emerge in isolated muscle facing an increase in afterload 
and the RV facing an increase in afterload.   An inverse relationship exists between stroke volume and the pressure 
developed by the right ventricle (Figure 1.4.2.2.1).  At pulmonary artery pressures that were acutely raised to 63 and 
80 mm Hg systolic, the right ventricle was unable to eject blood (Weber, Janicki et al. 1983).  It has been suggested 
that the right ventricle is twice as sensitive as the left ventricle to similar percentage rises in the ejection pressure 
(Weber, Janicki et al. 1983; Stool, Mullins et al. 1974).  A similar inverse relationship was subsequently described 
between PVR and right ventricular stroke volume (Figure 1.4.2.2.1) (Piene and Sund 1979).  Qualitatively similar 
function and curves have been described for the left ventricle facing an increase in afterload (Thys and Dauchot 
1998). 
1.4.1 Wall stress (σ) as afterload 
The law of Laplace, when applied to the ventricle, states that the forces within the ventricular wall are functions of the 
intraventricular pressure and geometry (size and shape and thickness) of the chamber (Shintani and Glantz 1994a; 
Sandler and Dodge 1963).  The nature of these forces is illustrated in Figure 1.4.1.1.  If a hypothetical slit were made 
in the ventricular wall, the edges would pull apart with a certain force per centimetre per length of the slit.  The force 
per unit length of slit is defined as wall tension1 (Sandler and Dodge 
1963).  In other words, wall tension is the force per centimetre length in 
a circumferential strand of myocardium in a particular plane (Figures 
1.4.1.1) (Thys and Dauchot 1998).  The units of tension are grams.cm-
1 or dynes.cm –1 (Thys and Dauchot 1998).   
 
Because the wall has a thickness too, the hypothetical slit described 
above creates an area in the wall (Figure 1.4.1.2) (Sandler and Dodge 
1963).  Wall stress σ is defined as the force exerted per cross 
sectional area of ventricular wall (Thys and Dauchot 1998; Shintani 
and Glantz 1994a; Sandler and Dodge 1963).  Stress is expressed in 
units of grams.cm-2 or dynes.cm–2.  The mathematical relationship 
between stress and tension is that tension is the product of wall stress 
and wall thickness (Sandler and Dodge 1963). 
 
To model the concept of wall stress as afterload, the (left) ventricle can 
be viewed as a pressurized spherical shell (Shintani and Glantz 
1994a).  Three assumptions that allow us to derive an equation for wall 
stress are (Shintani and Glantz 1994a): 
                                                                
1 The word tension is often used to convey different meanings: Force per unit length as in surface tension (dynes.cm-1 or g.cm-1) 
or force per unit area as in stress (dynes.cm-2 or g.cm-2) or as another word for force (dynes or grams).  Note that 1 gram is equal 
to 981 dynes. 
 
Figure 1.4.1.1. Circumferential 
(σc), meridional (σm) and radial (σr) 
components of wall stress in an ellipsoid 
model of a ventricle.  The three 
components are mutually perpendicular 
and not significantly different from each 
other.   Redrawn from Thys and Dauchot, 
1998 and Lang, Borow et al, 1986 
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The ventricle is a sphere with a uniform wall thickness, h and inner radius r; 
1. The ventricle is stationary and, 
2. The wall is so thin that the stress is constant throughout the wall.   
 
To start with, we may cut the sphere into two halves to expose the internal forces.  The force tending to push the 
hemispheres away from each other is equal to the pressure within the sphere multiplied by the cross-sectional area, 
πr2 (Shintani and Glantz 1994a).  Alternatively, the total force in the wall holding the two halves together equals the 
wall stress (σ) multiplied by the cross-sectional area of the wall. 
 
 The force within the sphere pushing the two halves away is 
Pπr2     ………………………… Equation 1.4.1.1  
 
The force within the wall holding the two halves together can be considered to be 
σπ [(r+ h)2 – r2]    ………………………… Equation 1.4.1.2  
 
These two forces must balance, therefore  
Pπr2  = σπ [(r+ h)2 – r2]   ………………………… Equation 1.4.1.3 
 
Because we assumed a thin wall, the ratio of the thickness to the internal radius is very small (at least, much smaller 
than 2), we can ignore h/r.  If we then solve for stress, we get 
σ = Pr/2h    ………………………… Equation 1.4.1.4  
Where 
σ is the wall stress, 
Tension Tensioni
Stre
sse
sPressure
Figure 1.4.1.2.  Stress and tension in the ventricular wall.    Sandler and Dodge, 1963 
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P is the pressure in the ventricle, 
r is the radius of the ventricle and, 
h is the thickness of the ventricle 
 
It should be noted both wall stress and tension vary with time: this is because P, r, and h are dimensions that vary 
during the cardiac cycle (Sandler and Dodge 1963).  Different components of systolic wall stress have been 
identified, each of which has its own importance (Lang, Borow et al. 1986): 
1. Peak systolic wall stress: this is the most important stimulus for ventricular hypertrophy in the face of 
pressure overload faced by a ventricle. 
2. The integral of systolic wall stress over time (∫Tdt): ∫Tdt correlates closely with myocardial oxygen 
consumption (Lang, Borow et al. 1986; Sandler and Dodge 1963).  (i.e. both wall stress and the time over 
which this stress is exerted determine oxygen consumption).  Acute increases in wall stress faced by the 
right ventricle therefore play a role in inducing imbalances in its oxygen supply-demand ratio (Martyn, 
Snider et al. 1980).  
3. End systolic wall stress (σes): σes defines the force limiting ventricular fibre shortening.  Wall stress at the 
end of systole, and not the stress during the ejection phase, is inversely related to the velocity and extent of 
fibre shortening in the ventricle (Lang, Borow et al. 1986).  This is analogous to the inverse relationship that 
exists between the velocity of myocardial fibre shortening and afterload observed in isolated muscle 
preparations (Braunwald, Sonneblick et al. 1998).  It is reasonable to speculate that if similar relationships 
apply to the isolated cardiac muscle and left ventricle, that such a relationship would apply to the right 
ventricle. 
 
From the formulae derived above, it follows that P, r, and h play a significant role in influencing wall stress.  Wall 
stress reaches its peak during the first third of systole, a period when the ventricle still contains its end-diastolic 
volume.  This peak occurs despite the ventricular pressure rising throughout the ejection period.  This emphasizes 
the importance of the increase in wall thickness and the decrease in volume of the ventricle in limiting wall stress.  
The remodelling of the ventricles that occurs for example, after birth or in response to chronic increases in the 
pressure they need to generate, is an attempt to normalize peak systolic wall stress (Jackson and Thomas 1998; 
Lang, Borow et al. 1986; Sandler and Dodge 1963).  Left ventricular hypertrophy that occurs in association with aortic 
stenosis actually normalizes wall tension of the left ventricle (Jackson and Thomas 1998).  No such studies of 
right ventricular hypertrophy and wall stress could be found. 
 
The normal left ventricle is not spherical and approaches the shape of an ellipse.  Various radii are therefore present 
for which different vectors of wall stress (circumferential, meridional and radial) are described (Figure 1.4.1.1) (Thys 
and Dauchot 1998; Sandler and Dodge 1963).  It has been demonstrated that at the equator of the ellipse with radii r1 
and r2 that: 
σ1 /r1  + σ2 /r2  = P/h ………………………… Equation 1.4.1.5 (Sandler and Dodge 1963)  
Where  
σ1 and σ2  represent the wall stresses at the equator of each half of an ellipse.  
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Wall stress undoubtedly plays a similar role in both right and left ventricular function (Thys and Dauchot 1998).  The 
right ventricle is crescent shaped and is more difficult to model mathematically (Dhainaut and Squara 1992).  The 
factors determining wall stress have not been formally conceptualised for the RV.  Nonetheless, it has been 
suggested that the two curvatures of its walls may be considered as two separate radii as has been described for the 
left ventricle (Equation 1.4.1.5), but this concept has not been further discussed in the literature.   
 
When an acute increase in afterload is presented to the right ventricle, it utilizes preload reserve to maintain stroke 
volume (Calvin, Jr. 1991).  This results in both pressure and volume of the ventricle increasing.  An increase in end-
diastolic volume and therefore radius of the ventricle causes an increase in both wall tension and stress (Jackson 
and Thomas 1998; Sandler and Dodge 1963).  The decrease in wall thickness as the already thin right ventricle 
dilates, accentuates the rise in wall stress (Calvin, Jr. 1991; Martyn, Snider et al. 1980).  The increase in wall tension 
will lead to an increase in oxygen demand of the RV.   
 
The above discussion emphasizes that intraventricular pressure, radius and wall thickness all play a significant role 
in determining wall stress.  From this perspective, the following points regarding afterload need to be emphasized: 
1. The RV free wall is, at most, half the thickness of the LV and the RVEDV exceeds that of the LV.  This 
results in RV wall stress that tends to exceed that of the LV chamber.  However, the one factor limiting the 
development of RV chamber stress is the lower pressure that the RV normally has to generate.   
2. Intraventricular pressure is only one component of afterload.  If pressure is viewed in isolation, it may give 
an incorrect impression of afterload (Thys and Dauchot 1998; Lang, Borow et al. 1986).   
3. Preload has an effect on afterload.  However, the only indices of afterload that are available in the clinical 
scenario are RVEDV and RV ejection pressure. 
4. It is not possible to measure wall tension and stress in the human right ventricle.  However, the ability to 
measure both right ventricular volume and pressure present valuable clinical clues in the evaluation of wall 
tension and stress (Equation 1.4.1.4). 
1.4.2 The arterial system as afterload: pulmonary vascular resistance 
Poiseulle (1799-1869) first described the relationship between steady flow and pressure of fluid in cylindrical tubes 
(Milnor 1982b):  
Q = π r4 (P1 – P2) / 8 η L  ………………………… Equation 1.4.2.1   
Where 
Q   is flow in a vessel or tube, 
r  is radius of the vessel, 
P1 is the pressure at the beginning and  
P2 is the pressure at the end of a tube of length L, and 
η is the viscosity of the fluid. 
 
This equation applies to laminar type flow at a steady flow rate (Parbrook, Davis et al. 1985). 
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Poiseuille’s law may also be considered in the following way: the ratio of the pressure gradient to the flow is a 
function of the physical properties of the system (dimensions of the tube, and the viscosity of the fluid being moved) 
(Equation 1.4.2.2).  The ratio of pressure gradient to flow rate is therefore a measure of the extent to which the 
system opposes or resists flow (Milnor 1982b).  This ratio, when it is determined for the pulmonary or systemic 
arterial tree, is called vascular resistance (R).  This ratio can be formulated in the following equations: 
(P1 – P2) / Q = 8ηL / πr 4  ………………………… Equation 1.4.2.2   
 
R = 8ηL / πr 4    ………………………… Equation 1.4.2.3   
 
(P1 – P2) / Q = R   ………………………… Equation 1.4.2.4    
 
Vascular resistance (Equation 1.4.2.3) is analogous to electrical resistance as described by Ohm’s law (Equation 
1.4.2.5) (Parbrook, Davis et al. 1985; Milnor 1982b)  
Electrical resistance = E / I  ………………………… Equation 1.4.2.5    
Where  
E is the flow of current through a circuit component, and 
I  is the decrease in voltage across the system. 
  
If Equation 1.4.2.4 is applied to humans, it assumes that the cardiovascular system is a direct current circuit.  Thus, 
for steady flow in a system of smooth walled similar non-distensible tubes in which flow is laminar, resistance to flow 
will be constant.  The graph of pressure versus flow is linear and the gradient represents resistance.  A steep 
gradient indicates that the resistance is high and vice versa.  
 
Calculations of vascular resistances are easily done in clinical medicine (Equations 1.4.2.6 and 1.4.2.7).  This ease 
adds to the clinical appeal of this number.  However, flow (cardiac output) in clinical practice is usually measured as 
time averaged or mean flows (Nichols, Conti et al. 1977).  The values for pressure are also not instantaneous, but 
mean pressures.  These values do not reflect the fact that flow and pressure varies during the cardiac cycle.  The 
implication is that calculating resistances based on average values cannot be a truly representative index of 
opposition to flow in the vasculature. 
SVR = MAP – CVP / CO  ………………………… Equation 1.4.2.6   
 
PVR = PAP – PAWP / CO  ………………………… Equation 1.4.2.7   
Where  
 
SVR is systemic vascular resistance; 
PVR is pulmonary vascular resistance; 
CVP is central venous pressure; 
PAWP is pulmonary artery wedge pressure and, 
CO is cardiac output in litres per minute. 
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Figure 1.4.2.1.1. The effect of gravity on PVR is compared with a Starling resistor (left) and with a weir (right).   
 Redrawn from Nunn, 1988 
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Figure 1.4.2.1.2. Left: Pulmonary vascular resistance decreases as pulmonary arterial or venous pressures are raised.  
Right: Recruitment and dilation are the reasons given as to why PVR decreases as pulmonary vascular pressures decrease.   
West, 1985 
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 1.4.2.1 The factors determining normal pulmonary vascular resistance 
It is useful to consider the resistance met by the blood flowing through the lungs (PVR) as the difference between  
pulmonary artery and left atrial pressure divided by blood flow.  Nonetheless, it must be remembered that PVR is not 
a complete description either of the pressure-flow properties (resistance) of the system (West 1985), or of opposition 
to RV ejection. 
 
The mean drop in pressure from pulmonary artery to left atrium is only 10 mmHg.  This is very small compared to the 
100 mm Hg pressure gradient across the systemic circulation.  However the average amount of blood flowing 
through both systems over a measured period of time is the same.  The systemic circulation needs to pump blood to 
organs that are far above the level of the heart; this necessitates a higher pressure generation (West 1985).  One 
reason that pressure can be kept at a lower level in the pulmonary vascular system is that the blood has to be 
pumped is only the height (30 cm) of the lung (West 
1985).  Thus, the resistance (pressure-flow 
relationship) of the pulmonary circulation is about one 
tenth that of the systemic circulation.  Resting PVR# is 
reported to range from 56 +/- 24 (Zapol 1982), 100 
(West 1985) to 150 +/- 30 dynes.seconds.cm-5.  SVR 
is considerably greater at 1100 +/- 140 
dynes.seconds.cm-5 (West 1985; Milnor 1982). 
 
What is also remarkable is that the pulmonary 
vascular resistance has been reported to decrease as 
pressure and flow in the pulmonary circulation 
increases (Lake 1990; Nunn 1988; West 1985).  As 
the cardiac output and therefore the pulmonary blood 
flow increase from resting values of 5 litres per minute 
to 20 litres per minute, there is a only small rise in 
pulmonary artery pressure (Lake 1990; Nunn 1988).  
The pulmonary vascular resistance decreases 
concomitantly with this increase in flow.  Using 
Poiseuille’s formula, this decrease in resistance 
implies an increase in the radius of the pulmonary 
vessels.  (Figure 1.4.2.1.2) (Lake 1990; Nunn 1988). 
 
The mechanisms by which this decrease in PVR occurs are suggested to be recruitment and dilation of pulmonary 
capillaries (Figure 1.4.2.1.2) (Lake 1990; Nunn 1988).  Under normal circumstances, not all capillaries have blood 
                                                                
If pressure is expressed in units of dynes per cm2, and flow as cm3 per second, then from equation 2.7, the units for vascular 
resistance are dynes.sec.cm-5; the units mmHg.litre-1 minute-1 are also used to represent resistance and may be multiplied by a 
factor of approximately 80 to get dynes.sec.cm-5.  
Figure 1.4.2.1.3.  The effect of lung volume when the 
transmural pressure of the capillaries is held constant.  At 
low lung volumes resistance is high as the extra-alveolar 
vessels are not stretched open and at high volumes, 
narrowing of the capillaries occur.  Pulmonary vascular 
resistance is lowest at functional residual capacity. 
Adapted from West, 1985 and Lake, 1990 
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flowing through them.  Recruitment is the first process to occur.  It refers to the commencement of blood flow via 
certain capillaries as pressure and flow increase.  Dilatation occurs at a later stage.  It is a consequence of the 
pulmonary vasculature being thin walled without much musculature (West 1985). 
 
The site of the greatest pressure drop in the systemic circulation is at the level of the arterioles.  In the pulmonary 
circulation, the pressure drop along the arterioles is relatively smaller than that in the systemic circulation and the site 
of resistance is equally divided between arterioles, capillaries, and veins.  Half of the PVR is situated in the vessels of 
the pulmonary microcirculation (i.e. vessels that do not have musculature in their walls) that cannot actively contract 
or dilate (Nunn 1988). 
 
The vascular resistance (radius) of the pulmonary capillaries is determined by their transmural pressure gradient.  
The transmural pressure gradient is the difference between the intravascular capillary pressure and the pressure in 
the adjacent alveolus (Nunn 1988; West 1985).  Under the influence of gravity, pulmonary artery pressure increases 
from the top to the bottom of the lung.  However, intra-alveolar pressure, at the end of expiration, stays the same 
from the top to the bottom of the lung.  Thus, the transmural pressure gradient, vascular resistance of the alveolar 
capillaries and blood flow changes from the bottom to the top of the lung (West 1985).  When alveolar pressure 
exceeds the intravascular pressure, capillary size decreases, and resistance increases.  This is termed West zone 1.  
In this zone, the alveolar capillaries are compressed by alveolar pressure, and no blood flow occurs (Figure 
1.4.2.1.1).  This zone does not occur under normal conditions, as the pulmonary arterial pressure is usually sufficient 
to raise blood to the top of the lung (West 1985).  However, if alveolar pressures increase relative to pulmonary 
arterial pressure (e.g. IPPV, PEEP, or decreased blood volume), this zone may be present (Nunn 1988; West 1985). 
 
With progression down the lung, West zone 2 occurs.  This is where pulmonary artery pressure exceeds alveolar 
pressure.  However, venous pressure is still lower than alveolar pressure.  The downstream pressure resisting flow is 
therefore alveolar pressure and not the distal venous pressure (Nunn 1988; West 1985).  The behaviour of such a 
system where the distal pressure does not play a role in determining resistance is described by a vascular waterfall 
or weir (Figure 1.4.2.1.1) (Nunn 1988; West 1985).  West zone 2 is the predominant area of the lung where 
recruitment occurs when the critical opening pressure of the vessels is exceeded (Nunn 1988; West 1985). 
 
In West zone 3, the downstream pressure is higher than the alveolar pressure and the alveolar capillaries are kept 
dilated by the downstream pressure (Nunn 1988).  Flow and resistance are therefore determined by the arterial-
venous pressure difference and the calculation of resistance by dividing pressure by flow may legitimately be applied 
in this zone (Nunn 1988).   
 
A fourth zone at the most dependent part of the lung also exists (Nunn 1988; West 1985; West, Dollery et al. 1965).  
It is a zone of reduced flow due to the compression of the extra-alveolar vessels where the lung is poorly expanded 
and is more pronounced at small lung volumes (Nunn 1988; West 1985). 
.   
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Table 1.4.2.1.1 Effects of vasoactive mediators on pulmonary vascular tone.  Adapted from (Nunn 1988; 
McMurtry, Rodman et al. 1988; West 1985). 
 
 
The mechanism is analogous to the narrowing of a rubber pipe that occurs when stretched.  This narrowing of the 
alveolar capillaries is the factor dominating PVR at high lung volumes (Figure 1.4.2.1.3) (West 1985).Lung volume 
also affects pulmonary vascular resistance at the level of the extra-alveolar vessels.  Extra-alveolar vessels are 
pulled open by the radial traction of the lung parenchyma and their resistance decreases at large lung volumes (West 
1985).  However, the smooth muscle and elastic tissue in their walls tend to collapse these vessels and increase 
their resistance at low lung volumes (West 1985). 
 
The pressure at which flow commences in the pulmonary vasculature is termed the pressure at zero flow or the 
critical opening pressure (Lake 1990; Nunn 1988; West 1985).  At low lung volumes, when certain extra-alveolar 
vessels are completely collapsed, a higher than normal intravascular pressure needs to be presented to these 
Pulmonary vasoconstriction Pulmonary vasodilatation 
Alpha adrenoreceptor agonists (noradrenaline, 
adrenaline, and dopamine) 
Beta adrenoreceptor agonists 
Acetylcholine 
Parasympathetic innervation, acetylcholine (weak 
influence) 
Histamine type one receptor agonists Histamine type two receptor agonists 
Bradykinin Bradykinin 
Serotonin  
Angiotensin 2  
Vasopressin Vasopressin 
Prostaglandins: PGH2, PGF2 alpha, PGD2, PGE2, TXA2 
(thromboxane) 
Prostaglandins: PGE1 and PGE2 (prostacyclin) 
Leucotrines: LTC4, LTE4, LTD4 Adenosine 
Platelet activating factor Atrial natriuretic factor 
Adenosine triphosphate  
Low pH, excess of hydrogen ions, carbon dioxide Higher pH 
Potassium ions  
 Nitric oxide 
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vessels before flow commences (West 1985).  In the lung, critical closure can occur at many sites including alveolar, 
extra-alveolar vessels or pulmonary arterioles (Lake 1990).  When critical pressure is considered, the formula for 
PVR is the quotient of the difference between mean pulmonary artery pressure and critical opening pressure, and 
cardiac output.  
 
Autonomic nervous system influences on PVR exist.  The sympathetic nervous system innervates arterial vessels 
with a diameter of more than 30 microns.  These vessels possesses and beta-adrenergic receptors that, when 
stimulated, result in vasoconstriction and vasodilatation respectively, (Nunn 1988).  Maximal alpha-adrenergic 
stimulation causes a 25% increase in PVR (Kadowitz and Hyman 1973).  Active vasoconstriction and vasodilatation 
of smooth muscle in the pulmonary vasculature may occur in response to various mediators and stimuli (Table 
1.4.2.1.1).  However, vasoconstriction is only possible in approximately half the pulmonary vasculature, and is 
quantitatively and qualitatively is limited and does not have the same powerful effects as in the systemic circulation 
(Nunn 1988; McMurtry, Rodman et al. 1988)(Nunn 1988; Nimbkar and O'Neill 1973).   
 
It is important to note the following about vasomotion in the pulmonary vasculature: 
¾ The vasoconstrictor phenomena are influenced by lung volume and become more pronounced at low lung 
volumes (West 1985). 
¾ Both vasodilatation and constriction are caused by the same mediator depending on the route, dose and 
pre-existing tone of the pulmonary vasculature (McMurtry, Rodman et al. 1988). 
¾ Nitric oxide has been suggested to play an important role in maintenance of normal pulmonary vascular 
resistance.  Its release is impaired in the presence of hypoxia (Johns 1991; McMurtry, Rodman et al. 
1988).  Other substances, such as prostacyclin, may also have a role to play in the maintenance of the 
normal low pulmonary vascular tone (McMurtry, Rodman et al. 1988). 
 
Hypoxic pulmonary vasoconstriction (HPV) is initiated when alveolar partial pressures of oxygen are less than 70 
mmHg.  HPV is accentuated by a low mixed venous oxygen tension and a low pH (Nunn 1988; West 1985).  The 
physiological response is due to decrease in partial pressures of oxygen in the vessels less than 1 mm in diameter 
(Nunn 1988).  HPV is a powerful physiological phenomenon and can redirect blood flow away from hypoxic areas of 
the lung.  This phenomenon is clinically important as it preserves ventilation perfusion ratios (Nunn 1988).  
Hematocrit % Average PVR 
25 216 
33 268 
44 375 
 
Table 1.4.2.1.2.  PVR changes with changes 
in hematocrit.  Tyson and Fender, 1975 
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pH of the blood affects pulmonary vascular resistance and minimal PVR is found at pH of 7.6 (Hosking and Beynen 
1992; Lake 1990). 
 
Viscosity directly influences pulmonary vascular resistance.  As hematocrit increases, a pari passu increase in PVR 
occurs.  This is in keeping with Poiseuille’s law in which viscosity is a factor in the generation of pressure needed to 
generate a certain flow rate (Tyson and Fender 1975). 
1.4.2.2 The use of pulmonary vascular resistance# as an index of right 
ventricular afterload 
As discussed, the use of vascular resistance as an indicator of the physical properties of a vascular system and of 
ventricular afterload is commonplace in medicine.  There are similarities in the responses of isolated muscle 
preparations to increases in afterload, and the decrease in stroke volume in intact right ventricles facing an increase 
in PVR.  Nonetheless, it has been stated that caution should be applied especially when PVR is used to describe 
characteristics either of the pulmonary vasculature or of right ventricular afterload (Skimming, Cassin et al. 1997; 
Morpurgo 1995; Lang, Borow et al. 1986; McGregor and Sniderman 1985; Versprille 1984; Mitzner 1983; Milnor 
1982b): 
 
1. Pulmonary vascular resistance may not be an accurate expression of the physical properties of the system 
opposing flow.  As the length of blood vessels is constant and viscosity of blood does not ordinarily change, 
the variable that resistance represents is mainly vessel diameter.  If peripheral resistance changes, then it 
is safe to conclude that vessel diameter of at least some of the vessels in the vascular bed being studied 
has changed, but this does not necessarily adequately describe the afterload of the ventricle (Lang, Borow 
et al. 1986).  However, PVR has been shown to have little correlation with the change in diameter in the 
pulmonary capillaries (Morpurgo 1995). 
 
2. Poiseuille’s formula describes the ohmic resistance characteristics of steady laminar flow of a “Newtonian” 
fluid in a rigid cylindrical tube quite accurately (Hilgenberg 1983).  The limitations when studying pulsatile 
flow in living organisms using Poiseuille’s formula are apparent as it assumes that: 
i. The flow is constant.  It does not address the phasic or pulsatile nature of the circulation 
(Hilgenberg 1983; Milnor 1982b); 
ii. That blood behaves a Newtonian fluid, which it does not (Versprille 1984; Milnor 1982b); 
iii. The flow pattern is always laminar (Lang, Borow et al. 1986) and that, 
iv. The pulmonary vessels are rigid (Morpurgo 1995). 
 
3. Vascular resistance demonstrates poor correlation with other indices of afterload.  Lang et al. (Lang, Borow 
et al. 1986) have compared SVR and wall stress as indicators of afterload.  They demonstrated that SVR is 
a poor indicator of afterload as compared to wall stress.  No literature correlating PVR and right ventricular 
                                                                
# Resistance is considered as the opposition to steady flow whereas impedance is the opposition to pulsatile flow in 
the human cardiovascular system.  Resistance is one of the components of impedance. 
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wall stress could be found. 
 
In patients with pulmonary hypertension, (e.g. mitral stenosis or acute lung injury), PVR has been found to 
be normal; even though advanced pulmonary hypertension existed (Sandler and Dodge 1963).  It has been 
shown that impedance of the pulmonary circulation changes long before PVR changes: it has been 
suggested that impedance is a more sensitive indicator of opposition to flow in the pulmonary vasculature 
(Morpurgo 1995). 
 
4. Resistance as commonly calculated could appear to change due to artefacts in calculation.  Consider the 
pressure-flow curve of a system in which in which flow is laminar and the tube is non-distensible (i.e. it 
complies with the criteria necessary to apply Poiseuille’s formula).  Resistance to flow is constant, and the 
graph of pressure versus flow for this system will therefore describe a straight line (Figure 1.4.2.2.3 lines a 
and b) (McGregor and Sniderman 1985; Mitzner 1983).  The gradient of this line represents the ratio of 
pressure to flow i.e. resistance.  The resistance in this system remains constant, even if changes in flow 
and pressure occur (McGregor and Sniderman 1985).  A steep gradient implies high resistance and a 
shallow slope indicates low resistance (Figure 1.4.2.2.3 lines a or b) (McGregor and Sniderman 1985). 
 
However, in a system in which the walls are not rigid but compliant like a real vessel, radius will increase (dilatation) 
with increasing pressure (McGregor and Sniderman 1985; Mitzner 1983).  Therefore resistance will decrease as 
pressure increases (McGregor and Sniderman 1985; Mitzner 1983).  The graph of pressure versus flow will no longer 
be linear but the slope will decrease with increases in pressure (Figure 1.4.2.2.3 line c).  When the limits of the 
elasticity of the vessel are reached, the pressure flow relationship will again become linear.  Most textbooks conclude 
from this “as flow increases, pulmonary vascular resistance decreases” (McGregor and Sniderman 1985; Mitzner 
1983). 
 
However, the evidence available indicates that the slope of the pressure flow curve in the pulmonary vasculature is 
approximately linear with resistance being constant as flow and pressure change! (Figure 1.4.2.2.3 lines e and e1) 
(McGregor and Sniderman 1985; Mitzner 1983).  A decreasing resistance can therefore not be used to explain the 
absence of pulmonary hypertension at an increased cardiac output in normal subjects.  The conclusion in the 
preceding paragraph therefore needs to be needs to be carefully considered (McGregor and Sniderman 1985). 
 
An important factor that must be taken into account is that calculation of pulmonary vascular resistance differs for the 
various West zones (Gilbert, Hessler et al. 1972).  The outflow pressure (P2 in equation 1.4.2.4) in the PVR 
calculation is considered to be equivalent to left atrial pressure.  This is indeed true for West zone 3 conditions, 
where the vessels are held widely open and the venous pressure is the pressure opposing flow.  Calculations of 
resistance across the lung at this (Poiseuille’s) zone may legitimately use LAP as an accurate reflection of 
downstream pressure (Versprille 1984; Gilbert, Hessler et al. 1972). 
 
However, much of the normal lung vasculature falls in West zone 2 where resistance is determined by the forces that 
occur in a Starling resistor (Figure 1.4.2.1.1) (Versprille 1984; Mitzner 1983; Gilbert, Hessler et al. 1972).  If we 
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consider Equation 1.4.2.4, [(P1 – P2) / Q = R], the driving pressure, P1 is as is usual for the pulmonary circuit, mean 
pulmonary artery pressure.  The outflow or downstream pressure of the circuit does not however play a role in the 
resistance of such a circuit (Mitzner 1983; Gilbert, Hessler et al. 1972).  The distal pressure, P2, in the calculation of 
PVR, is therefore the pressure tending to collapse the Starling resistor (PSTARLING). 
 
When pulmonary artery pressure (P1) is less than PSTARLING, no flow will occur (West zone 1).  When P1 exceeds Ps, 
the vessel opens and flow commences (Mitzner 1983).  This is seen in Figure 1.4.2.2.3 as the pressure intercept of 
lines e and e1 not passing through the origin, but at a pressure equal to PSTARLING.  The pressure intercept (PSTARLING) 
at which flow first occurs is called the critical opening pressure (McGregor and Sniderman 1985; Mitzner 1983).  
The calculation of resistance for these zones where Starling resistors exist should use critical opening pressure as 
the downstream pressure (McGregor and Sniderman 1985).  It must also be remembered that the resistance 
described by the equation 1.4.2.4 is the resistance upstream of the critical opening pressure and does not describe 
trans-pulmonary resistance (Gilbert, Hessler et al. 1972).  
 
What happens if the critical pressure is ignored or not known and LAP is used as the downstream pressure?  The 
pressure versus flow plot will still be linear, albeit the slope will be altered (Figure 1.4.2.2.3 f1, f2, and f3) (McGregor 
and Sniderman 1985; Mitzner 1983).  This will however lead to the following interesting artefact: the resistance 
(P/Q) versus flow plot will decrease as the flow increases (Figures 1.4.2.2.3 d and 1.4.2.2.4 top) (McGregor and 
Sniderman 1985).  This error is greater in patients with a high critical opening pressure (McGregor and Sniderman 
1985).  This may lead to incorrect conclusions being made about the nature of the pulmonary bed i.e. that PVR 
decreases as flow increases.  
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Figure 1.4.2.2.2.  Outflow from the right ventricle 
decreases as the resistance of the pulmonary 
circulation increases.   
 
 
Adapted from Piene and Sund, 1979 
Figure 1.4.2.2.1.  Right ventricular stroke volume is 
determined by ejection pressure, end-diastolic volume 
(EDV) and contractile state.  In the left panel, EDV’s of 51 
and 63 ml representing filling pressures of 5 ad 10 mmHg 
for the normal canine right ventricle.  For either filling volume 
an inverse relationship exists between stroke volume and 
ejection pressure. The ventricle with the larger EDV was 
able to eject a larger stroke volume for any given ejection 
pressure.  In the right hand diagram, the filling pressure was 
kept constant.  An increase in contractility mediated by 
dobutamine resulted in a bigger stroke volume for any 
ejection pressure.  Adapted from Weber, Janicki et al, 1983 
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In summary, the practice of using LAP instead of critical opening pressure in the calculation of resistance in Zone 2 
can at times lead to false interpretation of data.  The ratio of “(mean pulmonary artery pressure – LAP) / flow” will 
change as flow changes without their being any change in the forces opposing flow (Figure 1.4.2.2.3 f) (McGregor 
and Sniderman 1985; Versprille 1984).  A manoeuvre causing an increase in cardiac output without rises in pressure 
would therefore seem to have induced vasodilatation (McGregor and Sniderman 1985; Versprille 1984).  
Vasodilatation can only be deemed to have taken place when the slope of the P/Q relationship becomes less steep, 
i.e. when pressure decreases or stays unchanged in the face of an increase in flow (McGregor and Sniderman 
1985).  If however, West zone 3 conditions exist where the distal (LA) pressure is the true downstream pressure, 
then accurate reflections of the opposition to pulmonary flow will be attained.  In other words, the true slope of the 
pressure-flow relationship (the true PVR) will be calculated.  
 
The slope of the true pressure-flow relationship in the lung is approximately 1.6 mmHg.litre-1.min-1.m-2, or 3.3 
mmHg.litre-1.min-1.m-2 per lung (West 1985).  Thus, the normal lung has a low resistance to flow and this will explain 
the very small increase in pressure as flow increases. 
 
Extrapolation of the pressure-flow relationship back to the point at which flow first commences allows us to determine 
the critical opening pressure which is widely considered to be in the order of 5 to 10 mmHg in the normal human lung 
(McGregor and Sniderman 1985; Lodato, Michael et al. 1985).  Both the slope of the pressure-flow relationship and 
the critical opening pressure should be included as part of the description of PVR (Figure 1.4.2.2.3, lines e1 and e2) 
(Versprille 1984). 
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Figure 1.4.2.2.3.  See text for details.  Adapted from Alvarez, Casa et al. 1990. 
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A true increase in resistance, elevation of critical opening pressure or LAP should all be considered in the generation 
of pulmonary hypertension.  Depending on which mechanism is operative, there will be a difference in how the 
pressure responds to an increase in cardiac output.  Therefore if the cause of pulmonary hypertension is due to: 
1. A true increase in resistance, any increase in flow will result in an increase in pressure (Figure 1.4.2.2.3, 
lines a and b) or, 
2. An increase in critical opening pressure, pulmonary flow could almost double before any significant 
increase in pressure occurred (Compare lines e1 and e in Figure 1.4.2.2.3) (McGregor and Sniderman 
1985). 
 
What is quantitatively known about critical opening pressure and pulmonary vascular resistance in patients with 
various causes of pulmonary hypertension is summarized in Table 1.4.2.1 below. 
Pathophysiology Resistance Critical Opening Pressure 
Normal 1.6 mmHg.litre-1.min-1.m-2 10 - 12 mmHg 
Chronic obstructive airways disease Normal > 30 mmHg 
Mitral stenosis Normal > 20 mmHg 
Left heart disease Increased 44 mmHg 
True increased PVR Increased Increased 
Table 1.4.2.1 Critical opening pressure and PVR in various pathophysiological states 
1.4.3 Pulmonary vascular impedance 
The heart is a pulsatile pump that generates repetitive changes in blood flow, pressure and afterload.  Between one 
half to one third of the hydraulic power produced by the right ventricle is needed solely to generate the pulsatile 
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Figure 1.4.2.2.4 
Top: resistance versus mean pulmonary artery 
pressure graph.  
Middle: LAP versus mean pulmonary artery pressure 
Bottom: Flow versus pressure relationship. 
 
True resistance (slope of the bottom flow versus 
pressure graph) is constant, but “resistance” as 
represented by the pressure-flow versus pressure 
relationship falls steeply as pulmonary artery pressure 
increases.  
 
McGregor and Sniderman, 1985 
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components of flow (Grant and Lieber 1996; Piene and Hauge 1976).  Vascular resistance expresses opposition to 
steady flow, and is not a comprehensive description of the opposition to pulsatile flow (Morpurgo 1995).  The factors 
that oppose pulsatile flow are best described in terms of vascular impedance (Morpurgo 1995; Milnor 1982).  The 
concept of impedance has been borrowed from electrical engineering.  This concept is analogous to the impedance 
concept that is used to describe the relationship between voltage and current in alternating current circuits (Fourie, 
Coetzee et al. 1992; Fourie, Coetzee et al. 1992a; Milnor 1982c). 
 
Consecutive branches of the vascular bed differ in their dimensions and elasticity.   These branches are responsible 
for the generation of reflected pressure and flow waves (Morpurgo 1995; Hijazi and Hellenbrand 1992; Bergel and 
Milnor 1965).  Thus, both flow and pressure measured in the main pulmonary arteries are composed of a mixture of 
the incident and reflected waves.  When the forward pressure waves collide with pressure waves reflected backward 
from the bifurcations, the proximal pressure increases. (This is assuming that both are positive waves at the point of 
incidence).  However, summation of the incident and reflected waves decreases the proximal flow rate.  This creates 
a lag between the peak of the flow and pressure waves and they become out of phase with each other.  The phase 
difference between flow and pressure is a part of the usual description of vascular impedance.   
 
Input impedance (Zin(ω)) expresses the opposition of the vascular system to pulsatile flow at a particular vascular 
cross section.  As the waves reflected from distal sites in the vasculature vary from point to point in a vascular bed, 
input impedance is specific to a particular vascular cross section and the vasculature distal to it.  Input impedance 
incorporates all the factors that oppose flow in that particular (pulmonary) vascular bed (Milnor 1982).  Theses factors 
can be divided into the following: 
 
1. Factors related to the properties of the fluid being moved, being 
a. The inertia and, 
b. Viscosity of blood and, 
2. Factors related to the vasculature, being:  
a. The resistance presented by the pulmonary vasculature, 
b. The compliance of the pulmonary arteries, and the 
c. Waves reflected from the peripheral vessels. 
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Figure 1.4.3.1.  A Fourier analysis illustrating the harmonics of the flow curve in the aorta.  Nichols, Conti et al, 1977 
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It is insightful to understand how input impedance is measured.  Accurate measurements of instantaneous flow and 
pressure are made just beyond the aortic or pulmonary valves (Equation 1.4.3.1) (Thys and Dauchot 1998).  These 
measurements are then subjected to Fourier analysis: this process identifies the sinusoidal waves that comprise the 
harmonics of flow and pressure of each arterial pulse wave  (Figure 1.4.3.1) (Piene 1986).  The ratio of the 
corresponding pressure and flow wave amplitudes are then calculated. 
 
Zin(ω) = P(ω) / Q(ω)  ………………………… Equation 1.4.3.1   
Where  
Zin(ω) = input impedance modulus 
P(ω) = pressure modulus  
Q(ω) = flow modulus, and  
(ω) indicates the phases of the pressure and flow waves. 
 
These amplitude ratios and the associated phase shift values are plotted against frequency to create an input 
impedance spectrum (Figure 1.4.3.2) (Thys and Dauchot 1998; Parbrook, Davis et al. 1985).  Input impedance 
cannot therefore be expressed as a single number as can resistance, but rather as two sets of numbers.  The first is 
Figure 1.4.3.2.  Input impedance spectra measured in A: the canine pulmonary artery (Milnor 1982) and B: the human aorta 
(Nichols 1977).  (No input impedance spectrum of a human pulmonary artery could be found).  The units on the y-axis are 
dynes.seconds.centimetres-5 and the x-axis units are frequency in hertz.  The bottom graphs indicate the phase changes that 
occur as the frequency changes.  Note that at high frequencies, input impedance approximates characteristic impedance and 
that at zero frequency, impedance approximates peripheral arterial resistance.  These diagrams were reproduced in Milnor, 
1982c.  The aortic impedance spectrum was originally published by Nichols et al 1977. 
A: Input impedance spectrum in the pulmonary artery B: Input impedance spectrum in the aorta
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the graph of impedance modulus# versus frequency, and the second, a graph of phase versus frequency (Grant 
and Lieber 1996).  The frequencies over which impedance is measured is typically up to 12 or even 25 Hertz: values 
above this are usually excluded as they represent noise in measuring systems (Milnor 1982c; Nichols, Conti et al. 
1977).  The units of both input impedance and vascular resistance are dynes.seconds.centimetres-5. 
 
At zero frequency the modulus of input impedance is maximal and the phase is zero (Z(0)) (Piene 1986).  
Conceptually, at constant flow, the modulus of input impedance in a three-element Windkessel model is determined 
by the sum of Zc and Rp, as compliance will be constant at a particular flow rate.  Z(0)  can be approximated from 
mean pressure divided by mean flow.   
 
Z(0) = MAP/CO  …………………………                Equation 1.4.3.2   (Fourie, Coetzee et al. 1992)  
 
If the distal vascular bed were a continuation of the proximal vessel with the same physical properties (i.e. if the 
vasculature were a uniform tube), no reflected waves would be present.  The opposition to flow under such 
circumstances would be called the characteristic impedance (Zc or Rc) and would not be different from input 
impedance (Zin(ω)) (Fourie 1989; Fitzpatrick and Grant 1989).  Under normal circumstances, the relationship 
between the two is such that the input impedance spectrum (Zin(ω)) oscillates around the numerical value of the 
characteristic impedance (Zc) because of waves reflected from the periphery (Figure 1.4.3.2) (Grant and Lieber 
1996; Morpurgo 1995; Milnor 1982c; Nichols, Conti et al. 1977; Nichols, Conti et al. 1977) 
 
Because of oscillations caused by waves reflected from the periphery, characteristic impedance cannot be 
measured in vivo but has to be estimated by averaging impedance moduli that occur over a range of frequencies.  
Wave reflection is minimal at higher frequencies due to attenuation by the vessel wall (Grant and Lieber 1996).  As a 
result, the pressure and flow are in phase.  Therefore the phase shift is close to zero and characteristic impedance 
(Zc) can be represented by a single number (Grant and Lieber 1996).  The steep portion of the input impedance 
spectrum (Zin(ϖ)) that occurs at lower frequencies is therefore omitted when calculating Zc.  The frequencies used to 
calculate characteristic impedance should be specified, for example ‘characteristic impedance (Zc) which is 
calculated between 8 and 18 hertz for the pulmonary circulation, is…’ (Milnor 1982c; Nichols, Conti et al. 1977).  
 
Womersley’s equation for characteristic impedance is instructive (Piene and Hauge 1976): 
 
Zc = ρco/√(1 - σ2) x 1/ (M10 x e-jε10) ………………………… Equation 1.4.3.3 
Where   
                                                                
# The use of complex numbers and the term “modulus” is discussed briefly in the appendix of this document.   
 
Note that the term “modulus” refers to the absolute value of input impedance (frequency dependent ratios of pressure to flow).  An 
increase in the modulus of the input impedance refers to an increase in the absolute value of the ratio of pressure to flow at a 
particular frequency or frequencies. In older (Bergel and Milnor 1965) and the more recent literature (Lowe, Hettrick et al. 1996; 
Hettrick, Pagel et al. 1995), the term “modulus” has been omitted and the term “magnitude” used instead when describing the 
absolute value of impedance.   
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ρ is density of the fluid 
co is wave velocity 
j is √-1 
σ is the Poisson ratio 
and the parameters M and ε10 are dependent on viscosity, density, frequency and vessel radius. 
 
Therefore characteristic impedance (Zc), like input impedance, depends on the physical properties of the vessel, the 
fluid it is conducting, and the velocity of the fluid.  Characteristic impedance (Zc) varies directly with the elasticity and 
indirectly with the compliance of the vessel and inversely with its cross-sectional area.  This means that the stiffer the 
tube and the smaller its radius, the higher the characteristic impedance will be (Milnor 1982c; Piene and Hauge 
1976). 
 
In models that were developed to represent the pulmonary circulation, Milnor has shown that the characteristic 
impedance (Zc) declines slightly in the first few branches of the pulmonary artery and then rises 10% per generation 
until the pulmonary capillaries are reached.  The initial drop in Zc is probably due to the increase in cross sectional 
area that occurs as the capillaries are approached (Milnor 1982c). 
 
The pulmonary input impedance spectrum (Zin(ϖ)) in both humans and animals typically falls steeply from a high 
value at zero hertz to a minimum at 2 to 6 hertz (Hijazi and Hellenbrand 1992; Piene 1986; Bergel and Milnor 1965; 
Milnor 1982c).  The exact value at which the impedance minima occur varies with the animal species studied (Figure 
1.4.3.2) (Piene 1986; Milnor 1982c). 
 
An interesting aspect of the input impedance is the phase versus frequency plot (Figure 1.4.3.2).  The plot of phase 
against frequency shows an initial negative phase: this indicates that, under normal circumstances, flow leads 
pressure.  Therefore at lower (physiological) heart rates, the high compliance of the pulmonary vessels allows blood 
to be ejected into the vasculature with little initial rise in pressure (Fourie, Coetzee et al. 1992; Fourie 1989; Piene 
1986; Bergel and Milnor 1965).  The positive phase evident at higher frequencies indicates that pressure leads flow 
due to the inertia of blood (Figure 1.4.3.2 and Figure 1.4.3.2.1) (Fourie, Coetzee et al. 1992; Piene 1986; Milnor 
1982c; Randall and Stacy 1956). 
 
Caro and McDonald conducted the first study of pulmonary input impedance in isolated rabbit lungs (Hijazi and 
Hellenbrand 1992).  Later studies, such as the classic one by Bergel and Milnor confirmed and extended this work by 
including the phase difference between corresponding harmonics of pressure and flow in their studies (Bergel and 
Milnor 1965).  Pulmonary vascular input impedance has been infrequently studied in humans due to technical 
demands and its study necessitating the placement of invasive measuring devices.  Milnor and colleagues however 
successfully studied pulmonary artery input impedance during cardiac catheterisation in humans being investigated 
for mitral stenosis (Milnor, Conti et al. 1969) and a close correlation was found with animal studies (Hijazi and 
Hellenbrand 1992; Bergel and Milnor 1965; Pouleur, Lefevre et al. 1978; Piene and Hauge 1976; Reuben, Swadling 
et al. 1971). 
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1.4.3.1 Windkessel models used in describing impedance 
Since impedance is difficult to measure in vivo, it is conceptually convenient to visualize the vascular system in terms 
of an electrical model: this has been an ongoing development since the 19th century (Milnor 1982; Randall and Stacy 
1956).  The approach has been to create an electrical circuit that has similar impedance to pulmonary arterial input 
impedance or other vascular beds being studied.  To mimic the impedance characteristics of the systemic or 
pulmonary vascular beds accurately, these so called ‘lumped element’ models need to incorporate resistive, elastic 
and inertial elements (Figure 1.4.3.1.1) (Randall and Stacy 1956). 
 
Noordegraaf developed a three-element Windkessel model that has been extensively used to describe the vascular 
system (Figure 1.4.3.1.1) (Westerhof, Elzinga et al. 1971).  The three elements Noordegraaf incorporates are a 
capacitor and two resistances.  The capacitor imitates the elastic behaviour of the arterial tree in which energy can 
be temporarily ‘stored’.  The rise in pressure for a particular stroke volume inputted into the vessel also represents a 
parameter of resistance that the ventricle has to overcome.  The resistances represent peripheral resistance (Rp) 
and characteristic impedance (Zc) (Fourie 1989; Westerhof, Elzinga et al. 1971).  This modified three-element 
Windkessel model has been shown to be able to closely estimate the input impedances of both the PA and aorta 
when appropriate pressures and flows are incorporated into it (Fourie 1989; Grant and Paradowski 1987; Sunagawa, 
Maughan et al. 1985; Westerhof, Elzinga et al. 1971).   
 
Various arrangements of the components in a Windkessel model have been systematically studied as to their ability 
to accurately describe PA input impedance (Grant and Paradowski 1987).  Noordegraaf’s model may be the one 
most commonly used, but is by no means the only arrangement that can accurately predict pulmonary input 
impedance (Grant and Paradowski 1987).  In fact, model F in Figure 1.4.3.1.1 better represents pulmonary input 
impedance than any of the other models tested. 
Figure 1.4.3.1.1.  8 ‘lumped element’ electrical analogues that 
have been tested to compare how they predicted pulmonary 
arterial input impedance.  The models that fitted the Zo of the 
pulmonary circulation best were models C to F.  Redrawn from 
Grant and Paradowski, 1987 
 
A: Two-element Windkessel model (1899). 
 
B: Inductance added to the two-element model.  The 
inductance represents the inertia of the blood. 
 
C: Westerhof’s three-element model (1971) in which the 
inductance is replaced by a resistor.  The resistor Ro 
represents Rc. 
 
D: A later version of C with an inductor introduced in series with 
the second resistor. 
ÍRpRo
A
B
C
D
E
F
G
H
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The modified three-element Windkessel model concept can be described in hydraulic terms that parallel the normal 
ventricular–arterial interaction as follows.  Flow from a phasic pump (the ventricle or AC generator) enters a chamber 
through a one-way valve (diode), distending the elastic wall (capacitance) of the Windkessel (German for ‘air 
compression chamber’).  A resistor is inserted here as it plays an important role in dictating flow at this point. (a 
simple resistor may be used as frequency plays little or no role in determining characteristic impedance).   When the 
inflow into the chamber stops, the elastic wall recoils and fluid exits the chamber through the resistance of the narrow 
outflow tube (Rp).  The elasticity of the arteries causes a phase shift between the pressure and flow waves (Hettrick, 
Pagel et al. 1995; Fourie, Coetzee et al. 1992a; Grant and Paradowski 1987; Milnor 1982; Pouleur, Lefevre et al. 
1978).   
 
Westerhof subsequently developed and verified the accuracy of a hydrodynamic model of the arterial vasculature 
that was derived from the earlier electrical model that he developed (Westerhof, Elzinga et al. 1971).  The purpose of 
developing such a model was to utilize it in studies in which the isolated heart pumps into a mock arterial system.  A 
further advantage of this hydrodynamic model is that reflected waves are present.  Their presence is an advantage 
over the electric analogue model (Grant and Lieber 1996).  A normal load is therefore presented to the ventricle and 
a normal arterial pressure (aorta or pulmonary artery) pattern is generated.  The hydrodynamic model can then be 
adjusted to study the effects of changing various parameters such as C, Zc or Rp on the ventricular-vascular 
interaction (Grant and Paradowski 1987; Milnor 1982).  That we need a complex model incorporating resistive, 
inductive, capacitances and reflective waves emphasizes that a simple resistive device (e.g. a constriction of the 
artery exiting the relevant ventricle) is inadequate to model the impedance presented by the circulation (Calvin, Jr., 
Baer et al. 1985; Milnor 1982).  
 
The input impedance spectrum may be mathematically expressed as a function of a 3 element modified Windkessel 
model (Sagawa, Maughan et al. 1988; Hettrick, Pagel et al. 1995) relatively simply as  
Zin(ω) = Zc + ((Rp / (1 + jωC Rp)  ………………………… Equation 1.4.3.1.1   
Where   
Zin(ω) = input impedance at a particular frequency ω, 
ω = frequency, 
Zc = characteristic impedance, 
Rp  = peripheral arterial resistance, 
C   = compliance, and 
j    =  χ-1 
 
The usefulness of the above equation is that it makes clinicians aware that impedance or opposition to flow in the 
pulmonary vasculature is directly proportional to the sum of Zc and Rp and inversely proportional to the compliance 
of the system.  Frequency and phase angle also play a role in determining impedance. 
1.4.3.2 Factors influencing pulmonary vascular impedance 
We will explore various factors affecting impedance to blood flow in the pulmonary vascular bed.  Changes in 
impedance can be brought about by three principal mechanisms (Morpurgo 1995): 
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1. Radius of peripheral vasculature affects the reflection of incident waves and thereby alters the magnitude 
of the impedance moduli; 
2. An increase in cross-sectional area of the large proximal pulmonary arteries decreases characteristic 
impedance and vice versa, and/or, 
3. Change in compliance: a decrease in compliance shifts the minima and maxima of the impedance 
spectrum to the right. 
 
The pulmonary input impedance spectrum is qualitatively similar in dogs, rabbits, cats and humans.  However, as 
impedance depends on the physical characteristics of the pulmonary bed, moduli of the impedance spectrum at 
similar frequencies may vary quantitatively between subjects of various sizes (Piene 1986).  The similarity in shape 
of the input impedance spectrum suggests that conclusions drawn from animal studies are applicable to the 
human pulmonary vasculature (Milnor, Conti et al. 1969).  Characteristic impedance falls from 1000 dynes.s.cm-5 in 
rabbit and cat lungs (Hijazi and Hellenbrand 1992; Piene 1986; Piene and Hauge 1976) to 200 dynes.s.cm-5 in dogs 
(Bergel and Milnor 1965; Pouleur, Lefevre et al. 1978; Pouleur, Lefevre et al. 1978) to approximately 30 dynes.s.cm-5 
in humans (Milnor, Conti et al. 1969).  This decrease in characteristic impedance with increases in body size is 
related to both increasing size and compliance of the larger PA’s, and also decreasing peripheral resistance (Piene 
1986). 
 
Similar to the species differences in impedance spectra, input impedance spectra in the main pulmonary artery and 
aorta are qualitatively similar.  Not surprisingly, the moduli of impedance at similar frequencies are much lower in the 
pulmonary artery than the aorta (Figure 1.4.3.2).  Typical characteristic impedance in the human pulmonary 
vasculature is 23 to 30 dynes.seconds.centimetres-5 and in the aorta is 74 dynes.seconds.centimetres-5 for 
frequencies above 2 hertz (Piene 1986; Milnor 1982c).  As the diameters of the aorta and the pulmonary artery are 
approximately equal and both carry the same average volume of blood per unit time, this difference may be attributed 
to a greater compliance of the PA (Piene 1986).  Pulmonary vascular resistance is only one fifth of the systemic 
vascular resistance, but characteristic impedance in the pulmonary circulation is half that in the systemic circulation.  
The ratio of peripheral resistance to characteristic impedance is two to three times higher in the pulmonary circulation 
than in the systemic circulation.  The implication is that input impedance plays a more important role in the pulmonary 
than the systemic afterload (Piene 1986).  It follows therefore that non-pulsatile work (the product of mean pressure 
and time averaged flow), accounts for the majority of the energy expenditure of both the left and right ventricles.  
However, pulsatile flow accounts for 30 to 50% of the energy expended by the right ventricle, but only 15% of that 
expended by the left ventricle (Figure 1.4.3.2.3) (Morpurgo 1995).   
 
PA input impedance is affected largely by the first five divisions of the pulmonary artery, in decreasing levels of 
importance.  Measurements of input impedance take into account both forward and reflected flow and pressure 
waves.  The reflections are predominantly caused by branching in the vasculature.  Different waves will be 
encountered at different points in the vasculature.  Thus, the site at which the measurement of input impedance was 
made must be specified, as the measurement is specific for a particular site in the vasculature.  Typically, 
measurements of pulmonary vascular impedance are made with a catheter in the main PA and aortic impedance in 
the ascending aorta.  Furthermore, the pulmonary vasculature behaves as if it has a single reflecting site generating 
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reflected waves that affect input impedance#.  It is interesting that the main site where reflection occurs can be 
determined as follows: the physical distance between the site of measurement of impedance and the main site of 
wave reflection in the peripheral pulmonary vasculature equals one quarter of a wavelength of the frequency at the 
first impedance minimum (Cohen, Kirschner et al. 1988; Bergel and Milnor 1965; Reuben, Swadling et al. 1971).  
This site is located in the vessels between the pulmonary arterioles and the capillary bed i.e. in the small (extra-
alveolar) arterioles of less than 0.5 to 1 mm in diameter (Hijazi and Hellenbrand 1992; Bergel and Milnor 1965; Piene 
and Hauge 1976; Milnor, Conti et al. 1969).  It is also known that the pulmonary capillaries are the sites of pulmonary 
vascular resistance (opposition to non-pulsatile or static flow), whereas the proximal PA is the first structure 
causing opposition to RV output beyond the pulmonary valve and plays a dominant role in determining 
characteristic impedance (Grant and Lieber 1996).  These relationships help to determine the effects of various 
manoeuvres and drugs on the reflection site in the pulmonary vasculature (Figure 1.4.3.2.5).   
 
Bergel and Milnor originally demonstrated that changes in capillary and arteriolar diameters have differing effects on 
resistance and impedance (Bergel and Milnor 1965).  They studied the effects of lung inflation (up to 20 cm H2O) on 
the impedance spectrum.  Lung inflation compresses alveolar capillaries but at the same time increases the radius of 
extra-alveolar vessels.  This degree of lung inflation therefore results predominantly in alveolar capillary compression 
and an increase in pulmonary vascular resistance (Piene 1986).  In keeping with these concepts, lung inflation has 
been consistently demonstrated to produce 
a significant increase in the input impedance 
modulus at 0 hertz (i.e. a predominant 
increase in resistance) (Piene 1986; Bergel 
and Milnor 1965; Calvin, Jr., Baer et al. 
1985; Pouleur, Lefevre et al. 1978).  Input 
impedance spectra above one to two hertz 
are little affected by alveolar vessel diameter 
if the pulmonary artery pressure is kept 
constant (Figure 1.4.3.2.4) (Piene 1986).  
Other influences on alveolar capillary size, 
such as compression by PEEP or capillary 
dilatation by increased left atrial pressure, 
similarly have little effect on the input 
impedance spectrum above two hertz 
(Piene 1986; Bergel and Milnor 1965; 
Calvin, Jr., Baer et al. 1985; Fitzpatrick and 
Grant 1989). 
                                                                
# The distance from the measuring site to reflecting site is a quarter of the wavelength of the frequency at the impedance 
minimum.  Therefore, from λ=f/c, (where λ is wavelength at a designated frequency, f is frequency at the first impedance 
minimum, and c is velocity of blood flow which, in the PA, is approximately 200 mm per second), the reflecting site can be 
anatomically located by the quotient of λ/4 as a measurement in centimeters from the point of measurement of impedance 
(Reuben, Swadling et al. 1971). 
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Figure 1.4.3.2.1.  The pressure and flow waves generated in the 
pulmonary artery.  Flow leads pressure with a phase angle of φ.  Fourie, 
1989 
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Apart from the effects on PVR, Bergel and Milnor found evidence of increased wave reflection with increasing airway 
pressure.  Lung inflation caused the moduli of input impedance between 3 to 6 hertz to increase (Figure 1.4.3.2.4) 
(Bergel and Milnor 1965).  They explain their finding in the following way.  Wave reflection occurs where the radius of 
vessel segments changes.  During lung inflation, greater reflection of waves is due to an increase in radius of the 
extra-alveolar vessels, rather than alveolar capillary compression (Piene 1986). 
 
As changes in the capillary bed predominantly affect pulmonary vascular resistance and contributes relatively little to 
changes in input impedance, it follows that changes of impedance and resistance may be dissociated from one 
another (Fourie and Coetzee 1993; Piene 1986; Bergel and Milnor 1965; Pouleur, Lefevre et al. 1978; Milnor, Conti 
et al. 1969).  This again emphasizes that PVR describes only one particular aspect of afterload.  That mean and 
pulsatile components of RV output are dependent on different portions of the pulmonary circulation, suggests that 
they can be controlled separately, and provides a hitherto unexplored therapeutic modality (Grant and Lieber 1996). 
 
Input impedance in the lung vasculature should be measured at similar phases of the respiratory cycle as respiration 
may significantly affect it (Morpurgo 1995).  Early studies however, found no effects of respiration on pulmonary input 
impedance (Hijazi and Hellenbrand 1992; Bergel and Milnor 1965); this was possibly due to insensitivity of older 
measuring equipment. 
 
Infusions of serotonin, and alveolar hypoxia produce similar effects on input impedance (Piene 1986; Bergel and 
Milnor 1965; Piene and Hauge 1976; Reuben, Swadling et al. 1971).  The main reflecting site moves to a more 
proximal position, an increase in the reflection coefficient# occurs, and the impedance minima shift to higher 
frequencies.  Alveolar hypoxia increases characteristic impedance (Morpurgo 1995; Piene 1986; Bergel and Milnor 
1965; Reuben, Swadling et al. 1971).  These observations seen during hypoxia are consistent with the development 
of generalized pulmonary vasoconstriction (Piene 1986). 
 
Sympathetic stimulation or infusions of adrenaline tend to stiffen the walls of the pulmonary vessels but have little 
effect on vessel calibre (Piene 1986; Reuben, Swadling et al. 1971).  Stiffening of the vessel walls leads to an 
increase in characteristic impedance, but the associated increase in pulmonary artery pressure and flow tends to 
dilate the vessels (Piene 1986).  Therefore stimulation of the sympathetic nervous system produces competing 
                                                                
# The reflection coefficient (also termed the arterial wave reflection factor) (ΔZ/Zc) is defined as the ratio of the difference between 
Zin (ω) at the impedance minimum and the following maximum of Zin(ω), and Zc.  This ratio is proportional to the magnitude of 
reflected waves (Hettrick, Pagel et al. 1995) 
Figure 1.4.3.2.2.   A model of a vascular tree to explain the 
Windkessel models of the circulation.  Flow enters the 
chamber through a one-way valve on the left and distends 
the elastic wall as shown by the dashed line. When inflow 
ceases, the wall recoils and the valve closes and fluid 
leaves through the narrow resistance on the right.  The 
model illustrated here would correspond to model A in 
Figure 1.4.3.1.1.  Redrawn from Milnor, 1982 
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effects that limit the impact of an increase in impedance.  This again emphasizes the multifactorial nature of factors 
that determine impedance (Piene 1986).  
 
Fitzpatrick and Grant compared the effects of three forms of vascular obstruction (PEEP, occlusion of the left 
pulmonary artery and pulmonary embolism) on pulmonary input impedance (Fitzpatrick and Grant 1989).  All three 
manoeuvres increased mean PAP.  PEEP produced no changes in characteristic impedance or compliance; 
occlusion of the left pulmonary artery increased characteristic impedance (24%) and decreased compliance (50%) of 
the PA. 
 
In Fitzpatrick and Grant’s study, one of the factors that were suggested to increase characteristic impedance after 
pulmonary artery clamping was active vasoconstriction of the main PA (Fitzpatrick and Grant 1989).  Fitzpatrick and 
Grant suggest that the mechanisms whereby vasoconstriction was induced upstream of the PA obstruction include 
either neural reflexes, or serotonin that reached the vasa vasorum of the main PA via the bronchial circulation 
(Fitzpatrick and Grant 1989).   
 
Fitzpatrick and Grant described that left PA clamping produced a new reflection site very close to the main 
pulmonary artery with a reflection coefficient close to one (Weber, Janicki et al. 1983).  Why did this increase in wave 
reflection combined with active pulmonary vasoconstriction, not produce greater increases in characteristic 
impedance? The explanation given is that the decrease in compliance due to vasoconstriction observed with PA 
clamping attenuates the increase in wave reflection associated with this manoeuvre (Grant and Lieber 1996; 
Fitzpatrick and Grant 1989).  The nett result is that left PA occlusion induces minimal effects on wave reflection 
(Grant and Lieber 1996; Fitzpatrick and Grant 1989). 
 
The above effects are in contrast to the increased 
wave reflection due to clots present in the pulmonary 
arterial tree that are present with thromboembolism.  
Pulmonary thromboembolism decreased characteristic 
impedance and pulse pressures.  The reflected waves 
are not attenuated as with PA clamping, but magnified 
by the decrease in characteristic impedance of the 
pulmonary circulation (Grant and Lieber 1996; 
Fitzpatrick and Grant 1989).  The reflected and 
forward waves summate and pulmonary artery 
pressure increases; the opposite happens with the 
flow waves and the forward flow rate decreases 
(Fitzpatrick and Grant 1989).  The non-attenuated 
increase in wave reflection reduces hydraulic power 
output by the RV and induces systemic hypotension 
(Grant and Lieber 1996). 
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Figure 1.4.3.2.3.  RV power output in the dog related to 
heart rate.  The power is reduced as the heart rate reaches 
the frequency of the impedance minimum at 3 Hz (180 beats 
per minute).  Redrawn from Piene, 1986 
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Figure 1.4.3.2.4.  Oscillatory power in rabbit lungs versus 
pulmonary arterial pressure as the vasculature is 
progressively constricted from a state of maximal 
vasodilatation.  Pulmonary input impedance attains a 
minimum at normal mean pulmonary arterial pressures of 15 
to 20 mm Hg.  “LA”P represents an increase in mean PAP 
due to increases in left atrial pressure and “vasoc.” 
represents increases in mean PAP secondary to 
vasoconstriction of the PA.  Redrawn from Piene, 1986. 
5 10 15 20 25 30
Pulmonary arterial pressure (cm H2O)
1.0
0.5
Os
cil
lat
or
y p
ow
er
 (m
illi
wa
tt)
LAP
Vasoc.
Os
cil
lat
or
y p
ow
er
 (m
illi
wa
tt)
 
Pouleur and colleagues (Pouleur, Lefevre et al. 1978) also studied the difference between lung inflation and clamping 
of the left pulmonary artery on pulmonary input impedance.  Clamping of the pulmonary artery and sustained lung 
inflation produced similar increases in the modulus of impedance at zero hertz.  However, lung inflation slightly 
decreased (– 10%) while pulmonary artery clamping significantly increased (+ 77%) the impedance moduli over the 1 
to 3 hertz range (Pouleur, Lefevre et al. 1978).  As the pulmonary beds are in parallel with each other, clamping of 
one pulmonary artery should double the impedance moduli without producing phase changes (Figure 1.4.3.2.5).  
Pouleur and his colleagues observed that the impedance moduli increased by on clamping the PA; however this 
increase was to slightly less than double the pre-clamp values.  They suggested that their findings concur with the 
aforementioned theoretical considerations if the pulmonary vascular adaptations of dilation and recruitment are taken 
into account (Pouleur, Lefevre et al. 1978). 
 
The effect of an increase in transmural pressure on vascular impedance is difficult to predict.  Arteries become stiffer 
as they distend.  Vascular impedance is directly 
proportional to the stiffness (indirectly proportional to 
compliance) of the vessel wall (Nichols, Conti et al. 
1977).  This is supported by Fourie and co-workers 
who showed that characteristic impedance is 
‘strongly influenced by the compliance’ of the 
pulmonary artery (Fourie 1989).  They induced 
pulmonary microvascular injury and pulmonary 
hypertension (PHPT) using glass beads (Fourie and 
Coetzee 1993; Fourie, Coetzee et al. 1992b; Fourie 
1989; Calvin, Jr., Baer et al. 1985).  Input impedance 
at zero frequency (PVR) increased (Fourie 1989; 
Calvin, Jr., Baer et al. 1985) but characteristic 
impedance was not changed by glass bead 
embolism (Calvin, Jr., Baer et al. 1985).  This is in 
keeping with the differing effects of various 
manoeuvres on aspects of the pulmonary input 
impedance spectrum. 
 
The normal pressure in the pulmonary vascular bed 
assures an optimal balance between the oppositely directed influences on input impedance by vessel compliance 
and vessel diameter (Morpurgo 1995; Piene and Hauge 1976).  Input impedance, as estimated by the oscillatory 
power generated to drive blood through rabbit lungs, has been shown to attain a minimum at normal mean 
pulmonary arterial pressures of 15 to 20 mmHg (Figure 1.4.3.2.4) (Piene 1986; Piene and Hauge 1976).  It is most 
likely that this phenomenon is related to increases in pulmonary artery diameter caused by the existing pressure, 
albeit that this is accompanied by a decrease in PA compliance (see Womersley’s equation (Equation 1.4.3.3)).  
However, above a mean PAP of 20 to 25 mmHg, the pulmonary artery approaches its elastic limit, PA compliance 
decreases exponentially (Fourie, Coetzee et al. 1992b; Fourie 1989; Reuben, Gersh et al. 1970) and consequently 
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the moduli of PA impedance increase (Milnor 1982c; Milnor, Conti et al. 1969) (Figure 1.5.4.3). 
 
The relationships between the various elements comprising impedance have important physiological implications 
when considering the pulmonary vascular bed.  The product of compliance and resistance is the time constant, tau 
(τ).  Tau has been shown not to change over a wide range of resistance values in the pulmonary vasculature 
(Reuben, Swadling et al. 1971; Reuben, Gersh et al. 1970).  Rueben et al. suggest that the uniformity of the time 
constant implies that compliance of the pulmonary arteries decreases to compensate for pre-capillary pulmonary 
vasoconstriction (Reuben, Swadling et al. 1971; Reuben, Gersh et al. 1970).  However, in severe PHPT, the time 
constant of the PA will eventually lengthen when PVR increases beyond the limit that can be compensated for by a 
decrease in PA compliance (Reuben, Gersh et al. 1970). 
 
The input impedance spectrum itself is independent of heart rate (Bergel and Milnor 1965; Reuben, Swadling et al. 
1971).  However, the fundamental harmonic for heart rate falls on the low frequency, steep part of the impedance 
versus frequency spectrum.  The impedance for the first harmonic is twice as great when the heart rate is 60 (one 
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Figure   1.4.3.2.5. 
 
Top: The pulmonary vascular 
impedance spectra in a dog at 
steady lung inflation of 0 to 25 
cmH2O and with IPPV to 5 cm H2O.  
The impedance spectrum is the 
same during cyclic respiration and 
steady inflation to 5 cmH2O. As 
pressure increases, impedance 
increases below 3 Hz and 
decreases between 3 to 6 Hz 
probably due to increased wave 
reflection from the compressed 
capillaries.  Phase data are omitted 
as no significant changes occurred. 
 
Bottom:  Pulmonary input 
impedance spectra in dogs during 
steady lung inflation at 18 cmH2O 
and during left PA clamping.   
 
Top:  Redrawn from Bergel and 
Milnor, 1965 
 
Bottom: Redrawn from Pouleur, 
Lefevre et al, 1978 
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hertz) than when it is 120 beats per minute (Milnor, Conti et al. 1969).  On the one end of the spectrum, the slower 
the heart rate is below one to two hertz, the greater the external cardiac work needed to eject a given stroke volume 
(Nichols, Conti et al. 1977; Milnor, Conti et al. 1969).  On the other end of the spectrum, Milnor has shown that the 
power delivery of the RV falls as heart rate increases (Figure 1.4.3.2.3) (Piene 1986).   
1.4.3.3 Is vascular impedance optimised in the normal lung? 
Certain observations lead us to believe that impedance of the normal pulmonary vasculature is the optimal load for 
the right ventricle: 
1. Physiological heart rates correlate with the impedance minima of various species (Piene 1986); 
2. Impedance reaches a minimum at normal pulmonary artery pressures of 15 to 20 mmHg (Piene and Hauge 
1976); 
3. The theoretically calculated parameters of impedance (compliance, Zc and Rp) correlate closely with the 
measured parameters for maximal stroke volume and efficiency (Piene and Sund 1979); 
4. The power output of the right ventricle is matched to the load presented by the pulmonary impedance or in 
other words, 
5. The normal state is where the elastance of the pulmonary vasculature is less than half that of the right 
ventricle and the RV functions as a flow pump. 
1.4.3.4 The use of pulmonary input impedance as an index of right 
ventricular afterload  
Noordegraaf and Melbin suggest that if the product of pressure and area constitutes force, and if pressure is what the 
ventricle experiences during ejection, then the pressure in the vessels determines the force opposing shortening of 
the ventricular muscle fibres (Noordegraaf and Melbin 1978).  However, as input impedance is a property of the 
arterial system that also takes the properties of the fluid being moved (i.e. viscosity and inertia) into account, it meets 
the requirements of a reliable index of arterial opposition to ventricular ejection external to the ventricle (Piene 1986; 
Parbrook, Davis et al. 1985; Milnor 1975).    Therefore, Noordegraaf and Melbin incorporated input impedance as a 
component in their comprehensive definition of afterload.  They suggest that the time varying increase in ventricular 
pressure ΔPv(t) be considered to be equal to the (time varying) ejection flow Q(t) convoluted# with input impedance 
Zin(ω): 
 
Δ Pv(t) = Q(t) ∗ Zin(ω)   ………………………… Equation 1.4.3.4.1 
Where 
 
Zin(ω)  is input impedance at a particular frequency (in other words a frequency domain index 
of afterload whereas the other terms in this equation represent time domain indices) 
and, 
∗ represents the mathematical process of convolution. 
                                                                
# “Convolution” is a mathematical procedure allowing multiplication of time dependent and frequency dependent quantities 
(Noordegraaf and Melbin, 1978).  It is represented by the symbol ∗ in section 1.4.3.4.  
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During the ejection phase, pulmonary arterial Pa(t) and right ventricular pressures Pv(t) can be expressed as  
 
Pa(t) = Pv(t) = PDiastole + Q(t) ∗ Zin(ω)  ………………………… Equation 1.4.3.4.2 
Where  
PDiastole is diastolic pressure in the PA. 
 
Equation 1.4.3.4.2 describes afterload as varying with time throughout systole. Until ejection occurs, afterload rises 
continuously with time and factors external to the ventricle do not play a role (flow is zero).  However, factors external 
to the ventricle (well described by input impedance) then play a role during ejection into the arterial system.  What is 
also incorporated in this concept of afterload is that during ventricular ejection, ventricular volume decreases.  If force 
is the product of pressure and area, and if pressure were constant during ejection, the forces opposing shortening of 
the ventricular muscle fibres would therefore decrease. This definition of afterload is noteworthy in three ways.  
Firstly, it incorporates input impedance as one element of its definition.  Secondly it emphasizes that afterload varies 
with time and ventricular volume throughout the period of systole.  It could be speculated that equation 1.4.3.4.2 
could be modified to incorporate a time dependent variable of afterload such as an index of resistance (Rp, Zc or 
RTOTAL) or, arterial elastance (Ea) (see section 1.4.4), which can be considered the time domain (Fourie 1989) 
representation of input impedance. Thirdly, this definition is applicable to both the right and left sides of the circulation 
(Noordergraaf and Melbin 1978). 
1.4.3.5 Pulmonary input impedance and right ventricular performance 
An increase in the moduli of input impedance can be reliably considered as an increase in afterload as it raises the 
external work done by the ventricle and influences ventricular performance.  Elzinga and Westerhof (Elzinga and 
Westerhof 1973) showed that when input impedance in the aorta increased, left ventricular pressure increased and 
ventricular stroke volume fell (Grant and Lieber 1996; Milnor 1982a; Elzinga and Westerhof 1973).  Calvin et al. 
(Calvin, Jr., Baer et al. 1985) have demonstrated that a similar inverse relationship between RV stroke volume and 
PA input impedance exists.  The cause of the increase in impedance did not make a difference to right ventricular 
performance.  
1.4.3.6 Limitations of input impedance as an index of right ventricular 
afterload  
Sagawa suggests that arterial impedance has not been widely used as a measure of ventricular afterload as its 
physiological meaning is hard to grasp without the proper background (Sagawa, Maughan et al. 1988).  Furthermore, 
measurement of arterial and pulmonary vascular impedance, particularly in humans, is difficult (Parbrook, Davis et al. 
1985). 
1.4.4 Effective arterial elastance as an index of afterload (Ea) 
Ea may be modelled mathematically in the following way.  From the concept of a direct current circuit, (Fourie, 
Coetzee et al. 1992a; Sagawa, Maughan et al. 1988; Sunagawa, Maughan et al. 1985; Sunagawa, Maughan et al. 
1983), where potential difference is equal to the product of mean flow multiplied by total resistance, we can see that   
Pmean = RTOTAL x Q  ………………………… Equation 1.4.4.1  
Where   
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Pmean is the mean pressure 
RTOTAL is the total resistance of the vascular circuit, the sum of Rp and Zc in the 3 element 
Windkessel model of the circulation, and 
Q is the mean (time averaged) flow in the circuit. 
 
Pmean approximates end systolic pressure (Pes).  Furthermore Q (ml.min-1) is equal to SV divided by the time per 
cardiac cycle length (T).  (T = seconds per beat / 60), i.e.: 
Q = SV / T   ………………………… Equation 1.4.4.2   
 
Then from Equations 1.4.4.1 and 1.4.4.2 
Pes ≈ RTOTAL x SV / T  ………………………… Equation 1.4.4.3   
  
Thus the slope of the Pes-stroke volume relationship, which is effective arterial elastance (Ea), is approximated by  
Ea ≈ RTOTAL / T   ………………………… Equation 1.4.4.4   
 
Another way of expressing Ea is in combination with the three parameters of the modified Windkessel model.  If the 
area under one arterial pressure cycle (AT) divided by the time of one cardiac cycle (T) is used to calculate Pmean, 
then from Equations 1.4.4.1 and 1.4.4.3 
RTOTAL = Pmean = AT / T   ………………………… Equation 1.4.4.5 
                Q       SV / T 
 
If we simplify the preceding equation, we get  
SV = AT / RTOTAL   ………………………… Equation 1.4.4.6 
 
By inspecting Figure 1.4.4.1, we can assume that the area under the systolic curve approximates a rectangle, thus 
As ≈ Pes x ts   ………………………… Equation 1.4.4.7 
 
The diastolic area Ad can be described by (Sagawa, Maughan et al. 1988) 
Ad = Pes x τ (1 – e -td/τ)  ………………………… Equation 1.4.4.8   
Where  
τ is the time constant of diastolic arterial pressure decay that equals compliance of the system 
multiplied by resistance.   The derivation of Equation 1.4.4.8 is given in the appendix of this 
document. 
 
We may add the last two equations together to describe the total area subtended by the arterial pressure curve (AT).  
This reveals that 
AT = Pes [ts + τ(1 - e -td/τ)]  ………………………… Equation 1.4.4.9   
 
If we substitute equation 1.4.4.9 into equation 1.4.4.6, then 
SV x RTOTAL = Pes [ts + τ(1 - e -td/τ)]  ………………………… Equation 1.4.4.10 
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Figure 1.4.4.1.  A schematic 
diagram of an arterial 
pressure curve.  The area 
subtended by systole is 
designated As, and diastole 
Ad.  ts and td designate 
systolic and diastolic times 
respectively.  T is the time of 
one cardiac cycle.  Redrawn 
from Sagawa, Maughan et al, 
1988. 
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Figure 1.4.4.2.  The correlation between pulmonary Ea as 
measured by Pes/SV and as calculated by Equation 
1.4.4.12 containing the elements of the modified windkessel 
model.  r = 0.997; n = 62; p <0.001.  Redrawn from Fourie 
and Coetzee, 1992 
Figure 1.4.4.3.  The correlation between Ea as measured 
by Rtotal/T and that measured by the relationship of R0/ T.  
r = 0.99; n = 33; p <0.0001 
 
Redrawn from Sunagawa, Maughan et al, 1988 
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Solving for Pes: 
 
Pes =   SV x RTOTAL    ………………………… Equation 1.4.4.11   
           ts + τ(1 - e -td/τ) 
If Ea is Pes /SV, then 
Ea = RTOTAL / (ts + τ(1 - e -td/τ)) ………………………… Equation 1.4.4.12   
Where in terms of the Windkessel model, the three elements are 
Tau (τ) which is RTOTAL x C and, 
RTOTAL, which is the sum of Rp and Zc (Fourie 1989). 
 
Another approach is to conceptualise the arterial tree as if it were an elastic chamber that accommodates a certain 
volume of blood during each beat (Sunagawa, Maughan et al. 1985).  Arterial elastance therefore represents the 
pressure change of the arterial tree in accommodating the stroke volume and can be derived from the slope of the 
relationship of end systolic pressure (Pes) to stroke volume (Coetzee and Fourie 1993; Fourie, Coetzee et al. 1992; 
Sagawa, Maughan et al. 1988).   
Ea = Pes / SV   ………………………… Equation 1.4.4.13 
Ea calculated by the above equation or measured by using Pes/SV or RTOTAL/T is highly linear.  Furthermore, a 
strong correlation exists between the various methods of determining Ea (Figures 1.4.4.2 and 1.4.4.3).  Therefore, 
although the slope is accurately described by the Pes/SV relationship, Ea contains more complex elements than 
simply the relationship of pressure to volume.  It also does not simply represent the inverse of compliance of an 
arterial system (Sagawa, Maughan et al. 1988).  From Equation 1.4.4.12 it can be seen that Ea includes components 
of resistance, compliance and time (heart rate), and is justifiably termed the ‘effective’ arterial elastance (Sagawa, 
Maughan et al. 1988).  A further illustration of the complex nature of Ea is illustrated in Figure 1.5.4.2: Ea is more 
affected by changes in peripheral resistance than by changes in compliance of the relevant arterial tree (Sunagawa, 
Maughan et al. 1983). 
 
Ea may also be considered as the time domain representation of the pulmonary artery input impedance.  Fourie 
(Fourie 1989) has confirmed that Ea incorporates the lumped parameters (Ro, Rp, and C) of the Windkessel model 
for the right side of the circulation (compare Equations 1.4.3.1.1 and 1.4.4.12). 
1.5 Coupling of the ventricle to its load 
In 1975 Milnor wrote: “Adopting arterial impedance as the operational definition of afterload may solve one problem, 
but it leaves another crucial question unanswered.  How can we put afterload and inotropic state into commensurate 
terms?  What is required is an expression of afterload that can be correlated with some description of contractile 
state; such an expression has not yet been developed (Milnor 1975).”  This problem may be addressed by utilizing 
the concept of ventricular-arterial coupling. 
 
The concept of ventricular-arterial coupling is analogous to that of two elastic “balloon” like structures, the one (the 
ventricle) periodically becomes stiffer than the other (the arterial system) and transfers a volume of blood into it 
(Maughan and Oikawa 1989).  If the elastances of each of the two chambers are known, then prediction of how much 
volume is transferred between the two is possible 
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The one balloon is the ventricle.  Ventricular stiffness is described by the end systolic elastance of the ventricle, Ees.  
Ees describes the slope of the ventricular Pes-SV relationship.  It is a linear and load independent descriptor of 
ventricular contractile function.  The other balloon is the arterial circulation.  Its stiffness is described by the effective 
arterial elastance, Ea (Sunagawa, Maughan et al. 1985).   
 
The stroke volume that results from the interaction (coupling) of various Ea and Ees values can be mathematically 
described from the pressure versus volume diagrams (Sunagawa, Maughan et al. 1983).  To mathematically 
describe the interaction between Ees and Ea, we need to define the lines Ees and Ea.  Ea has been defined already. 
From Figure 1.5.1 (Coetzee and Fourie 1993; Fourie, Coetzee et al. 1992a; Sagawa, Maughan et al. 1988; Piene 
and Myhre 1984; Sunagawa, Maughan et al. 1983; Sagawa 1978), 
Ees = Pes / (Ved – SV – Vo)   ………………………… Equation 1.5.1   
Where   
Ved is end-diastolic volume of the ventricle, and 
Vo is the volume intercept of Ees. 
 
From  Equation 1.4.4.3 (Pes ≈ R x SV / RTOTAL) and Equation 1.5.1 
Ved – SV – Vo = Pes/Ees = R x SV / T ………………………… Equation 1.5.2 
 
If  Ea ≈ R / T, then 
Ved – SV – Vo = Pes/Ees = Ea/Ees x SV ………………………… Equation 1.5.3 
 
Rearranging and solving for SV 
Ea/Ees x SV + SV = Ved – Vo  
 
Simplifying 
 SV (1 + Ea/Ees) = Ved – Vo 
 
∴  SV =  (Ved– Vo)  
          1 + Ea/Ees   ………………………… Equation 1.5.4  
 
Equation 1.5.4 has been verified to be valid and accurate in experimental models (Figures 1.4.4.2 and 1.4.4.2.3) 
(Coetzee and Fourie 1993; Maughan 1988; Sagawa, Maughan et al. 1988; Sunagawa, Maughan et al. 1983).  
Because the units of Ees (mmHg.ml-1) are the same as those of arterial elastance, the elastic properties of these 
structures and the interaction between the two can be depicted on one common set of axes (Figure 1.5.1).  Adding a 
representation of the pressure-volume relationship of the ventricle to the aforementioned graph gives a more 
complete picture of the interaction between Ea and Ees (Weber, Janicki et al. 1983).  This graphical representation 
can be useful as an intuitive tool to describe the effect of changes in various parameters (e.g. Ea, Ees, end-diastolic 
volume of the ventricle) on stroke volume (Figures 1.5.2 and 1.5.2.10) (Sagawa, Maughan et al. 1988; Burkhoff and 
Sagawa 1986; Sunagawa, Maughan et al. 1985; Sunagawa, Maughan et al. 1983).  These representations have 
been developed for the LV, however the concept has been demonstrated to also apply to the right ventricle (Fourie, 
Coetzee et al. 1992b; Fourie 1989). 
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Figure 1.5.1.   A diagrammatic representation of coupling of the ventricle to its load.  Mechanical characteristics of the 
ventricle are expressed in the left hand column as the relationship between pressure and volume generated by the ventricle, 
and those of the vasculature as the relationship of pressure in the arterial tree versus time.  However, the characteristics of 
the arterial tree can also be expressed as the relationship between the volume inputted into it and the resultant arterial 
pressure.  The ratio between pressure and volume in a chamber is termed its elastance.  If the elastances of these two 
chambers are expressed in terms of pressure and volume, then the properties of these two chambers can be expressed on 
the same axes.  The relationship between ventricular pressure and volume (i.e. ventricular elastance) is represented by the 
end-systolic elastance (Ees) line.    The relationship between vascular pressure and volume (i.e. arterial elastance) is 
represented by the arterial elastance  (Ea) line.  These relationships apply to the left ventricle and its vascular tree as well as 
the right ventricle and its vascular tree.  Ved is end-diastolic volume of the ventricle and Vo is the intercept of the Ees line with 
the axis representing ventricular volume.   Redrawn and adapted from Sunagawa, Maughan et al, 1985. 
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Figure 1.5.2   
 
These figures represent three ventricular 
pressure-volume relationships. 
 
 
Top: The top diagram represents the 
normal situation.  Ea and Ees are 
normal.  The various annotations in the 
top diagram are omitted in the bottom 
two for the sake of clarity. 
 
 
Middle: afterload (Ea) is increased at an 
Ees that is unchanged from baseline.  
An increase in Ea is represented by an 
increase in the slope of the line 
representing Ea.  It can be observed 
that, if the end-diastolic volume is kept 
the same, stroke volume decreases as 
Ea increases.  Systolic pressure 
generated by the ventricle increases. 
 
   
Bottom: The diagram at the bottom on 
the left represents the effects of 
increasing Ees in the face of an increase 
in Ea.  An increase in Ees is represented 
by an increase in the slope of the line 
representing Ees.  If end-diastolic 
volume is kept constant, the effect of 
increasing end-systolic elastance in the 
face of an increase in Ea is to increase 
both systolic pressure and stroke 
volume.  Furthermore, if stroke work is 
the product of mean arterial pressure 
and stroke index (i.e. the area under the 
pressure volume lop), it can be 
graphically seen that the area subtended 
by the pressure-volume loop increases 
in this scenario.  Therefore, an increase 
in Ees of a ventricle facing an increase 
in arterial elastance results in it being 
able to generate an increase in stroke 
work. 
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1.5.1 The relationship of coupling of the ventricle to its load, and heart rate 
Sagawa and colleagues (Sagawa, Maughan et al. 1988) mathematically relate coupling of the ventricle to its load, 
and heart rate in the following manner.  From Equation 1.5.4: 
 
SV = Ees (Ved – Vo)   ………………………… Equation 1.5.1.1 
              Ees + Ea 
Where 
Ees  = end-systolic elastance, 
Ved  = end-diastolic volume, 
Vo  = volume of the ventricle when the intracavitary pressure is zero and, 
Ea  = effective arterial elastance. 
 
Cardiac output is the product of stroke volume and heart rate.  Cardiac output may also be derived by dividing stroke 
volume by cardiac cycle length “T”.  Therefore dividing equation 1.5.1.1 by “T” to obtain cardiac output gives the 
following relationship: 
 
CO = Ees (Ved – Vo)   ………………………… Equation 1.5.1.2 
        T(Ees) + RTOTAL 
 
The pressure is generated by the numerator, “Ees x (Ved – Vo)”.  The arterial load becomes a simple resistance, 
RTOTAL.  The internal resistance of the ventricle is the product of T and Ees.#  Thus, any increase in contractility will 
on the one hand, increase the pressure generated but on the other hand, also increase the internal resistance in the 
generator.  Such an increase in the internal resistance limits the increase in cardiac output.  However, an increase in 
heart rate shortens T and decreases the internal resistance of the generator.  The effect of this increase in heart rate 
will be to increase cardiac output if the end-diastolic volume remains constant (Sagawa, Maughan et al. 1988).   
 
Piene has also suggested that the frequency at which the impedance minimum occurs correlates well with the 
physiological heart rates of various species (Piene 1986).  Therefore at physiological heart rates, opposition to 
ventricular ejection is significantly influenced by both heart rate (impedance) and the status of the peripheral 
vasculature (resistance) (Milnor, Conti et al. 1969).  It is interesting that the concepts both coupling of the ventricle to 
its load and impedance to pulmonary flow (see last two paragraphs of section 1.4.3.2) can be linked to heart rate. 
 
                                                                
# The products of “T and Ees” and “T and Ea” can be equated with resistance to flow if the following is considered.  “T” is time per 
beat and the elastances “Ees and Ea” are relationships of pressure to volume.  For example, for the product of Ees and T 
  T x Ees = Time x  (Pressure/Volume)  ………………………… Equation y 
Equation y simplifies to  
T x Ees = Pressure/Flow   ………………………… Equation z 
Pressure/Flow is analogous to resistance.  The same can be shown for Ea.   
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1.5.2 Use of coupling to study right ventricular efficiency and stroke work 
The ventricle can be considered as a pump that generates hydraulic# power (Asanoi, Sasayama et al. 1989; Piene 
and Sund 1982).  Power is transferred to the blood in the ventricle which is moved into the receiving system, the 
arterial load (Asanoi, Sasayama et al. 1989; Piene and Sund 1982). 
 
The term ‘matching’ is borrowed from electrical theory.  According to electrical theory, a generator and its load are 
optimally matched when the power delivered from the generator to the load is maximal (Asanoi, Sasayama et al. 
1989; Piene 1986; Myhre, Johansen et al. 1986).  The graph of work versus load typically describes a concave 
curve (Figure 1.5.2.1) (Myhre, Johansen et al. 1986).  Optimal matching of a pump occurs when the work done and 
load it has to operate against, correspond to a point at the summit of the curve.  This point corresponds to the 
relationship between a pump and its load where the energy transfer is maximal (Piene and Sund 1982).   
 
Sunagawa et al. (Sunagawa, Maughan et al. 1985) studied arterial resistance versus stroke work in the isolated left 
ventricle.  SW peaked at a certain arterial resistance: if resistance increased or decreased from this point, stroke 
work decreased (Figure 1.5.2.1).  As preload was increased, the maximal stroke work that could be delivered 
increased, but the arterial resistance at which it occurred did not increase concomitantly.  However at a particular 
preload, as contractility was increased, the optimal arterial resistance at which maximal stroke work occurred also 
increased.  This may be understood if one considers ventricular-arterial coupling (Figure 1.5.2).  An increase in Ees 
will enable the ventricle to cope with an increase in the slope of Ea (afterload).  However, an increase in end-diastolic 
volume will increase stroke volume and work but not change the slope of Ees, or the Ea that that ventricle can 
accommodate (Sunagawa, Maughan et al. 1985). 
 
The relationship between right ventricular ability to generate work and its afterload (i.e. the coupling of right ventricle 
and the pulmonary circulation) is similar to that of the left ventricle (Fourie, Coetzee et al. 1992b; Fourie 1989).  The 
difference between left and right ventricles lies in the more limited ability of the RV to generate work.  Right 
ventricular end-systolic elastance normally ranges between 1 to 2 mmHg.ml-1 and right ventricular stroke work peaks 
at an Ea of approximately 2 mmHg.ml-1 (Fourie, Coetzee et al. 1992b).  SW in the thicker left ventricle peaks at an 
Ees of approximately 7 mmHg.ml-1 (Sagawa, Maughan et al. 1988; Burkhoff and Sagawa 1986) (Figures 1.5.2.2 and 
1.5.2.3). 
 
Another criterion for the evaluation of coupling between a power source and its load is how efficiently the transfer of 
energy occurs i.e.: 
¾ The ratio of the energy supplied to the system and the usable energy delivered by the system (Sagawa, 
Maughan et al. 1988) i.e. the ratio of  energy expended  
       work delivered   or, 
¾ How efficient the fuel consumption is (Asanoi, Sasayama et al. 1989).   
                                                                
# Hydraulics: the branch of physics that deals with the actions of liquids in pipes (Chambers Dictionary, 1992; Dorland’s Medical 
Dictionary 25th Edition) 
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Figure 1.5.2.2.  Parabolas of work (mmHg.ml) versus 
stroke volume (ml) at three levels of right atrial pressure (5, 
10, 15 mmHg) before (dotted parabolas) and after 
depression of the ventricle.  Using the following two 
equations, 
• Pes = Ees (EDV-SV-Vd), and 
• W = Pes x SV   
Myhere, Johansen, et al. showed that if Ees and preload 
are constant, then the following equation describes a 
concave parabola relating work to stroke volume.   
W = Ees (EDV-Vd) x SV – (Ees x SV2) 
Triangles: maximum point; Circles: control point.  Axes 
are graded in terms of percentages of control observations 
at RAP 5 mmHg.    
 
Redrawn from Myhere, Johansen, et al. 1988 
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Figure 1.5.2.3.  The relationship between Ea and SW for 
the right ventricle is represented in this diagram on the left.  
Opposition to right ventricular ejection was increased b\y 
injecting glass beads into the pulmonary vascular bed. In 
this diagram, afterload is represented by pulmonary arterial 
elastance.     
 
 
Redrawn from Fourie, Coetzee et al, 1992 
Figure 1.5.2.1. Plot of SW versus arterial resistance for various end-diastolic volumes and contractile states of the 
isolated canine left ventricle.   Redrawn from Sunagawa, Maughan et al, 1985. 
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A system is considered efficient when minimal loss of energy occurs when transferred (Figure 1.5.2.4).  Only a small 
fraction of the total amount of energy generated by any specific pump system is usually actually transferred to the 
load (Piene and Sund 1982).  Maximal efficiency of the normal heart is reported to be only 25% to 30% and normally 
operates between 5 to 20% efficiency (Sagawa, Maughan et al. 1988). 
 
The mechanical work done on the blood in the ventricle can be considered the useful energy outputted by this 
system (Sagawa, Maughan et al. 1988).  Efficiency can therefore be defined as the ratio of external stroke work 
performed, to the total work done (or used by) a ventricle (van den Horn, Westerhof et al. 1985). 
 
The total amount of mechanical work done to move the stroke volume into its arterial load is the sum of  (Figures 
1.5.2.4 and 1.5.2.5): 
 
1. The external stroke work (SW) represented by the area “SW” in figure 1.5.2.5 and, 
2. Creation of the potential energy (PE) that remains in the ventricle at the end of ejection.  (Potential energy 
is represented by area PE in figure 1.5.2.5). The sum of the areas SW and PE are termed the pressure-
volume area (PVA).  Efficiency can therefore be considered the ratio of SW / PVA. 
 
Figure 1.5.2.4.  A diagram illustrating the concept of efficiency.  
 
Efficiency = E out /E total (Note that for the heart, E out is the external mechanical work performed.) 
E total = E out + (E heat +potential +chemical +sound etc.) 
Energy not expended on the output of the 
system e.g. heat + potential + chemical 
sound energy etc 
E out = The useful 
energy finally 
outputted by the 
system 
E total  = Total 
energy or work 
supplied to the system
 
Figure 1.5.2.5.  Pressure volume relationship 
superimposed upon a diagram of ventricular-arterial 
coupling.  Total mechanical work is represented by 
the area PVA.  
 
PVA = SW + PE. 
 
Modified from Asanoi, Sasayama et al, 1989 
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Furthermore, the energy used by the heart is represented by 
myocardial oxygen demand (MVO2#) (Sagawa, Maughan et al. 1988).  
Suga has shown that MVO2 is linearly related to PVA with a co-efficient 
of determination (r2) of 0.72 (Fourie, Coetzee et al. 1992b; Asanoi, 
Sasayama et al. 1989; Burkhoff and Sagawa 1986; Suga, Hayashi et al. 
1981).  The remaining 28% depends on factors not included by PVA 
and Emax (Burkhoff and Sagawa 1986).  However, mechanical 
efficiency of a ventricle may, with reasonable accuracy, also be 
considered as the ratio of the external stroke work to MVO2 (Asanoi, 
Sasayama et al. 1989; Sagawa, Maughan et al. 1988).  Fourie, Coetzee 
et al. have applied this to the right ventricle also (Fourie, Coetzee et al. 
1992b). 
 
As afterload increases, the efficiency of the ventricle reaches a peak: 
further increases in afterload result in a decline in efficiency.  This is 
applicable to both right (Figure 1.5.2.6) (Fourie, Coetzee et al. 1992b) 
and left (Figure 1.5.2.7) (Sunagawa, Maughan et al. 1985) ventricles 
facing increasing afterload.  However, as Ees increases, the load with 
which the ventricle can cope also increases and therefore the load that 
corresponds to maximum efficiency also increases.  Efficiency of the 
ventricle working against a particular load also increases with increases 
in Ees (Figure 1.5.2.9).  
 
A number of studies have been performed to answer questions pertaining to the coupling of the ventricle to its load.  
One important question is whether arterio-ventricular coupling, under normal circumstances in vivo, results in the 
system functioning at maximal efficiency or maximal stroke work (Asanoi, Sasayama et al. 1989; van den Horn, 
Westerhof et al. 1985). 
 
Sunagawa made one of the first attempts to answer this question.    He hypothesized that maximal energy transfer 
would occur from one elastic chamber to another (i.e., right or left ventricle to its respective arterial system) when 
their elastances are equal.  This hypothesis was subsequently verified to apply to both isolated left (Myhre, 
Johansen et al. 1986; Sunagawa, Maughan et al. 1985; van den Horn, Westerhof et al. 1985) and right (Piene and 
Sund 1982) ventricles for a variety of loading conditions, contractile states and heart rates.  The suggestion was then 
made that the isolated right (Fourie 1989; Piene 1986; Piene and Sund 1982; Piene and Sund 1979) and left 
ventricles (Myhre, Johansen et al. 1988; Myhre, Johansen et al. 1986; Sunagawa, Maughan et al. 1985; Sunagawa, 
Maughan et al. 1983) normally operate at the peak of the maximal stroke work versus load curve.  If this were true, it 
would predict that firstly ventricular and arterial elastances would normally be equal (Coetzee and Fourie 1993; 
                                                                
# Note that “VO2” is used throughout the thesis to indicate “oxygen consumption per unit time” instead of the more conventional 
“ O2”. 
Zo
Q
SV : 2.5
C   : 1501.0
0.5
Q
0 1.0 2.0  
Figure 1.5.2.6.  The relationship 
between pump efficiency (Q) and 
characteristic impedance (Zo) in the 
isolated cat right ventricle.  Adapted from 
Piene and Sund, 1982 
Chapter 1.  Literature review
 
87 
Fourie, Coetzee et al. 1992a; Asanoi, Sasayama et al. 1989; Maughan 1988; Sagawa, Maughan et al. 1988; 
Sunagawa, Maughan et al. 1985; van den Horn, Westerhof et al. 1985; Piene and Sund 1982; Sunagawa, Maughan 
et al. 1985) and secondly that the ejection fraction of a normal ventricle would be 50% (Sunagawa, Maughan et al. 
1985; Sunagawa, Maughan et al. 1983).  However, this is an underestimate of ejection fraction in the normal LV.  
 
This question was also addressed by Burkhoff and Sagawa (Burkhoff and Sagawa 1986).  Similar to the approach 
used by Sunagawa, Maughan and colleagues, they utilized a hypothetical model of the left ventricle# to examine 
whether work or efficiency was maximal during normal physiology (Figure 1.5.2.7).  They found that when Ea = Ees, 
the end-diastolic volume and the end-systolic pressure of the hypothetical ventricle would be much larger, and the 
ejection fraction less, than what actually occurred during normal physiology.  They concluded that in order to obtain 
physiological conditions, Ea must be smaller than Ees, and that this state represents normal physiology.  Their 
hypothesis was subsequently verified for the isolated left (Sunagawa, Maughan et al. 1985; van den Horn, Westerhof 
et al. 1985) and right ventricles (Coetzee and Fourie 1993; Fourie, Coetzee et al. 1992b; Fourie 1989; Piene and 
Sund 1982).  Asanoi et al. (Asanoi, Sasayama et al. 1989) subsequently confirmed the concept that Ea is less than 
Ees in the normal human left ventricle (in vivo) possessing an ejection fraction of more than 60%.  Asanoi showed 
                                                                
# Burkhoff and Sagawa (Burkhoff and Sagawa 1986) used the formulae derived above for Pes and Ea, using the lumped element 
Windkessel model, and the aforementioned concepts for stroke work and efficiency.  The constants assumed were Ees = 7 
mHg.ml-1, Ved = 45 ml, Vo = 5 ml and Ea was varied from 0 to 15 mmHg.ml-1. 
Ees = 9 mmHg • ml
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Figure 1.5.2.7.   The relationship between 
Ea and stroke work for a left ventricle with 
various levels of contractility as indicated by 
the various Ees levels.  Actual left 
ventricular Ees as measured in isolated 
canine ventricles (Sunagawa, Maughan et 
al. 1985) varied from 4,1 +/- 1.1 to 7,5 +/-
2.3 mmHg.ml-1.   The arrows in the top 
diagram indicate the point of maximal 
stroke work and efficiency in the top and 
bottom diagrams respectively.  When 
coupling moves beyond (to the right of) the 
maximal point of the relationship between 
SW and Ea for a particular Ees level, the 
ventricle is considered to be failing.  Note 
that increasing contractility shifts this 
relationship higher and to the right. In other 
words, the ventricle can better cope with its 
load.  Improving contractility improves the 
ventricles efficiency for a particular load. 
 
 Redrawn from Burkhoff and Sagawa, 1986 
-1 
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that in intact humans with ventricles having mildly depressed contractility, ventricular-arterial coupling was set to 
deliver maximal stroke work rather than maximal efficiency (compare scenario in the preceding paragraph) (Asanoi, 
Sasayama et al. 1989). 
 
The initial observations that lead up to the controversy as to whether the normal ventricle normally operates at the 
point of maximal efficiency or maximal SW merit explanation.  The initial studies describing the relationship between 
stroke work and afterload had been done either in anaesthetized open chest animals, or using an isolated (excised) 
ventricle.  In both of these preparations, the contractility is lower than in the normal physiological state (EF 
approximately 50% for the isolated ventricle versus normal in which EF exceeds 60%).  Circulating catecholamines 
are present in the in vivo situation, and the compensatory reflexes of the intact cardiovascular system are 
responsible for inducing rapid adaptation via the adrenergic system (Fourie, Coetzee et al. 1992; Burkhoff and 
Sagawa 1986; Piene and Sund 1982).  Furthermore, contractility may be decreased by anesthetic agents (Asanoi, 
Sasayama et al. 1989; Sagawa, Maughan et al. 1988). 
Therefore the relationship between Ea and Ees can be classified into three broad coupling patterns: 
1. Ees = 2Ea 
2. Ees = Ea 
3. Ees < Ea 
Ea “line” in 
Figure 1.5.2.10 
Ees/Ea 
Matched to 
deliver: 
Ejection Fraction: 
(LV) # 
Contractility 
1. Ees = 2Ea 
Maximum 
Efficiency 
> 60 % 
Normal state of left and right 
ventricles 
2. Ees = Ea 
Maximum Stroke 
Work 
59 to 40 % 
Moderately depressed 
ventricle 
3. Ees < Ea 
Neither efficiency 
nor stroke work 
< 40 % Failing ventricle 
Table 1.5.2.1. The relationship between Ea and Ees.  Adapted from (Fourie, Coetzee et al. 1992a; 
Fourie, Coetzee et al. 1992b; Asanoi, Sasayama et al. 1989; Kass and Maughan 1988; Sunagawa, 
Maughan et al. 1985).  # No EF data for the RV exists. 
 
1. The normal ventricle and loading conditions 
During normal physiology, the right (Coetzee and Fourie 1993) and left (Myhre, Johansen et al. 1986) ventricle and 
their respective afterloads are optimally matched with respect to efficiency.  Therefore, their working points lie on the 
peak of the efficiency versus afterload curve, and on the ascending limb of the stroke work versus afterload 
curve.  Ventricular elastance is at least double arterial elastance.  (This scenario corresponds to condition 1 in Table 
1.5.2.1 and in Figure 1.5.2.10). 
 
The normal ventricle operates at 90% of the maximal stroke work available for a particular Ees (Sagawa, Maughan et 
al. 1988).  This confers an advantage on the ventricles, in that there is normally some reserve in terms of work 
(Coetzee and Fourie 1993; Fourie, Coetzee et al. 1992b; Fourie 1989).  
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If the right and left ventricles are compared (Figures 1.5.2.7, 1.5.2.8 and 1.5.2.9), the shape of the curves of 
efficiency and work versus afterload are similar, but the absolute values of Ea and Ees are lower for the right 
ventricle than for the systemic side of the circulation.  Therefore the power that the right ventricle can generate is 
much lower than that able to be generated by the left ventricle.  Burkhoff and Sagawa indicate that stroke work and 
efficiency in a weaker ventricle are more sensitive to changes in afterload than in a stronger ventricle (Burkhoff and 
Sagawa 1986).  These last two statements imply that the right ventricle with its smaller muscle mass and inherently 
lower Ees, possesses less reserve to accommodate acute rises in Ea. 
 
2. The mildly depressed ventricle, or the ventricle facing an acute rise in arterial elastance 
The priority of the mildly depressed right or left ventricle is to generate maximal work, and such a ventricle has been 
shown to operate at the peak of the stroke work versus Ea curve (Asanoi, Sasayama et al. 1989).  This is at the cost 
of efficiency!  This scenario can also apply when the afterload to the right (Bolliger, Fourie et al. 1991) or left ventricle 
acutely increases so that Ea and Ees become equal.  Therefore when Ea = Ees, stroke work generated by the 
ventricle is maximal, and correlates with a LV ejection fraction of between 40 to 59% (Asanoi, Sasayama et al. 1989; 
Burkhoff and Sagawa 1986).  No data for RVEF in this situation have as yet been described. 
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2000
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0
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Efficiency
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Figure 1.5.2.8. (Left hand diagram)  Relationship between right ventricular stroke work and Ea for various values of Ees.    
Figure 1.5.2.9. (Right hand diagram)  Relationship between efficiency and Ea for various values of Ees for the right ventricle.    
 
Both of these diagrams represent theoretical plots constructed using equations 1.5.4 and 2.9.3 inputted into the equation that 
describes ventricular efficiency, Efficiency = PVA/MVO2.  PVA was calculated from the product of end systolic pressure and 
stroke volume.  To reconstruct these graphs, Ees was set in equation 1.5.4 as the independent variable at 1, 2 and 3 
mmHg.ml-1, and mean pulmonary artery pressure was varied between 0 to 50 mmHg.  Compliance, Rp and Ea were varied 
as a function of mean pulmonary artery pressure according to regression analysis with mean PAP as the independent 
variable.  Compliance = (-1.682 + 80.564)/mean PAP where r = 0.657, n =10. Rp = 0.646 + 0.06 mean PAP (r = 0.566, n 
=55).   Redrawn from Fourie, Coetzee et al, 1992 
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From inspection of Figures 1.5.2.8, 1.5.2.9 and 1.5.2.10, it is evident that: 
 
¾ Efficiency is more sensitive than stroke work to increases in Ea (Sagawa, Maughan et al. 1988; Burkhoff 
and Sagawa 1986) and decreases to 70% of maximal if Ea and Ees are equal (Coetzee and Fourie 1993; 
Fourie, Coetzee et al. 1992a; Maughan 1988; Sagawa, Maughan et al. 1988; van den Horn, Westerhof et 
al. 1985) and, 
¾ The afterload at which stroke work reaches its maximum occurs at about double the Ea value at which 
maximal efficiency occurs (Sagawa, Maughan et al. 1988). 
3. The failing ventricle 
Should either the load increase further, or the Ees decrease to the point where Ea > Ees, both efficiency and stroke 
work are on the declining slope of their curves: any further increase in Ea will cause them to decline markedly.  A 
mismatch now exists between ventricular and arterial elastances (Asanoi, Sasayama et al. 1989).  This is the 
definition of a failing pump, and corresponds to the right hand descending limbs in Figures 1.5.2.1, 1.5.2.2, 1.5.2.3, 
1.5.2.6, 1.5.2.7, 1.5.2.8, 1.5.2.9 and 1.5.4.4.  Ejection fraction for a left ventricle performing under such conditions is 
less than 40% (Asanoi, Sasayama et al. 1989). 
1.5.3 The coupling of the right ventricle to the pulmonary circulation 
 
Coupling of the RV to its load has only been described by Fourie at al (Fourie, Coetzee et al. 1992b).  Maximum RV 
efficiency in intact pigs anaesthetized with 0.5% halothane occurred at an Ea of 1 mmHg.ml-1 and RVSW peaked at 
an Ea of 2 mmHg.ml-1.  Any further increases in Ea resulted in a decrease in stroke work with the right ventricle 
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Figure 1.5.2.10.    
Schematic representation 
of ventricular-arterial 
coupling.  A pressure-
volume relationship is 
superimposed on the 
diagram.  Three Ees / Ea 
relationships are 
illustrated: 
 
1.  Ea = Ees/2 
2.  Ea = Ees 
3.  Ea > Ees 
 
 
Adapted from Asanoi, 
Sasayana et al, 1989 and 
Fourie, Coetzee et al, 
1992. 
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starting to operate as a pressure pump (Fourie, Coetzee et al. 1992b).  At the point of maximal efficiency, the Ees / 
Ea ratio was 1.7.  As discussed above, maximal efficiency has been shown to occur at an Ees/Ea ratio of 2.  Thus, 
the intact right ventricle subjected to 0.5% halothane anesthesia, operating against its normal load, operates close to 
optimal efficiency rather than as an optimally matched system operating at maximal SW (Fourie, Coetzee et al. 
1992b; Piene and Sund 1982).  That there is a move from 2 to 1.7 may reflect a decrease in Ees due to the 
depressant effects of halothane.  Furthermore, Ea in the pulmonary artery of normal intact pigs has been reported to 
be 0.6 mmHg.ml-1.  This confers considerable reserve on the normal RV: if Ees remains constant, Ea could double 
before stroke work decreased (Fourie, Coetzee et al. 1992b).   
 
Piene and Sundt investigated the coupling between the RV and the PA in an isolated preparation and concluded 
that the RV operates at maximal SW.  Again, the difference in the results between these studies may lie therein that 
the Ees of the intact preparation is higher due to intact sympathetic nervous system (Fourie, Coetzee et al. 1992b; 
Sagawa, Maughan et al. 1988; Piene and Sund 1982). 
Ea (mmHg.ml-1) Mean PAP (mmHg) Ees/Ea 
1 15-20 Maximal efficiency; Ees = 1.7 Ea 
1.6 20-30  
2 30-40 Maximal stroke work; Ees = Ea 
Table 1.5.3.1 Coupling of right ventricle with Ees approximately 2 mmHg.ml-1 and its load.  The 
pulmonary artery pressures associated with various Ea/Ees ratios (Fourie, Coetzee et al. 1992b).
 
1.5.4 Right ventricular-pulmonary artery interaction and compliance of the 
pulmonary vasculature 
An extreme way of looking at looking at of ventricular-
vascular interaction is that the heart could not function 
if the pulmonary artery were not compliant.  During 
systole, the mitral valve is shut and if the PA was not 
able to store the stroke volume, the right ventricle 
would not be able to eject (Grant and Lieber 1996).  
Thus, the very compliant pulmonary vasculature 
serves as an impedance-uncoupling element 
between the ventricle and the peripheral vasculature 
where the major part of the resistance is located.  
Uncoupling results in a reduction of both input 
impedance and of the work done by the ventricle to 
generate pulsatile flow (Piene and Hauge 1976).  
However, RV performance is not completely independent of the PVR, as the ventricle still has to overcome 
Figure 1.5.4.1.  The linear relationship between Ea and 
mean pulmonary artery pressure.  Redrawn from Fourie, 
Coetzee et al, 1992 
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pulmonary artery diastolic pressure for ejection to begin.  The diastolic decline in pressure is related to the time 
constant.  This time constant is governed by the product of peripheral resistance and compliance of the pulmonary 
vasculature (Fourie 1989).  
 
Furthermore, the end of RV ejection does not correlate well with maximal RV elastance (Emax), as is the case for the 
left ventricle.  This is a result of the balance between the compliant and resistive properties of the pulmonary 
vasculature (Piene 1986; Piene and Sund 1980).  At higher resistance and low compliance values, as is the case in 
the systemic circulation, the end of ejection coincides more closely with the end of systole.  At low resistance and 
high compliance as occurs in the pulmonary circulation, RV ejection is prolonged.  It may present a mechanical 
advantage to the right ventricle to continue to deliver its stroke volume during diastole (Piene 1986).  Nonetheless, 
Piene also commented that the optimal compliance of the PA might be lower than what is needed for the efficient 
systolic delivery of the stroke volume (Piene 1986).  Pulmonary artery compliance should not be too low.  A 
“moderate” compliance is the ideal.  A “moderate compliance” will prevent blood accumulating during systole, but 
also avoid the other extreme of excessive opposition to RV ejection.   
 
The relationship between the compliance of the 
pulmonary vasculature and RV-PA coupling has been 
described mathematically (Fourie, Coetzee et al. 1992b).  
From equation 1.4.4.12, it can be seen that both 
pulmonary vascular compliance and resistance affect 
impedance (Ea).  The influence of PA compliance on Ea 
is complex.  Fourie studied the interaction of compliance 
and resistance on RV-PA coupling (Fourie 1989).  He 
showed that increases in resistance resulting in an 
increase in pulmonary artery pressure from 5 to 45 
mmHg, caused a 56% decrease in stroke volume.  It 
could be determined that the decrease in compliance 
contributed only 12% to the decrease in stroke volume.  
Therefore the decrease in compliance had a lesser effect on stroke volume than resistance (Fourie 1989).  Studies 
conducted by both Piene and Sundt (Nozawa, Cheng et al. 1994) and Elzinga et al. (Piene and Sund 1979) are in 
accordance with these results.  They used an isolated cat heart preparations pumping into an artificial load (i.e. a 
windkessel hydrodynamic circulatory model).  They subjected the right ventricle of these preparations to increases in 
peripheral resistance and decreases in compliance.  Both the resistance and the compliance changes produced 
decreases in stroke volume.  However, the right ventricle appeared more sensitive to changes in resistance than 
compliance (Figure 1.5.4.2).  The relationship between PAP, compliance and coupling of the RV to its load has also 
been studied by Piene and Hague (Piene and Hauge 1976).   Working from a state of maximal vasodilatation, they 
demonstrated that moderate increases in pulmonary artery pressure produced by an increase in blood flow, caused 
dilation of the large pulmonary arteries.  The increase in radius and therefore decrease in resistance induced by this 
manoeuvre outweighed the decrease in compliance.  The nett result was a decrease in PA input impedance (Piene 
and Hauge 1976). 
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Figure 1.5.4.2    Pes-SV relationship.  The slope of the 
Ea line changes markedly with changes in resistance but 
little with changes in compliance.  Adapted from 
Sunagawa, Maughan et al, 1983 
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Figure 1.5.4.3 
 
The effects of vasoconstriction on PA compliance.  
 
Note the exponential decline in compliance that 
occurs as PVR and PAP increase. 
 
 
 
 
Redrawn from Piene and Hauge, 1976 
Figure 1.5.4.4.  Two diagrams illustrating the effect of changes in PA compliance on the power output or work performed by 
the RV as opposition to pulmonary flow changes.   
 
Left hand diagram: Redrawn from Fourie, 1989.  The RV power output of the isolated cat heart (top) and the intact pig 
heart (bottom) versus elastance at high and low compliances.  The relationship between SW and Ea where compliance is 
described as a function of mean PAP ((-1.682 + 80.564)/mean PAP) was derived from a non-linear regression model 
described for the porcine pulmonary vascular bed subjected to glass bead embolism by Fourie (Fourie 1989).  The plot 
illustrating this relationship would be representative of what happens in the normal pulmonary vascular bed of pigs as the Ea 
changes between approximately 0 to 3 mmHg.ml-1.  The other relationships in this diagram illustrate the effects of significant 
increases or decreases in compliance on the generation of SW for a range of elastances.    
 
Right hand diagram: Redrawn from Piene, 1987.  The bottom diagram is a simplified rendition of the relationship between 
hydraulic power generation and resistance in the feline pulmonary vascular bed as compliance is varied.  This diagram was 
published in a review entitled “Matching between right ventricle and the pulmonary bed” in the reference work, 
Ventricular/Vascular coupling edited by Frank Yin (Yin 1987).  In this diagram, Piene has simplified previous work by himself 
and Sundt (Piene and Sundt 1979) to illustrate only relationships at the extremes of compliance that he tested.   There is 10-
fold difference between the maximal and minimal compliance (5 to 0.5 x 105 dynes.cm-5) in this experiment.  Note that 
hydraulic power is the product of pressure and mean flow.   
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If compliance affects opposition to pulmonary flow, it must affect the relationship between the work versus load 
relationship.  A decrease in PA compliance has been shown to shift the relationship between stroke work and Ea down 
and to the left (Fourie, Coetzee et al. 1992b; Piene 1986) (Figure 1.5.4.4).  A shift the curve down and to the left will 
result in the RV prematurely changing from the normal flow generator to a pressure pump situation with a decrease in 
the work done against a particular load (Fourie 1989).  This is in keeping with the observations of Piene that the high 
compliance of the lung vasculature facilitates transfer of energy from the ventricle to the load (Piene 1986).  Therefore 
although compliance plays a lesser role in determining Ea and stroke volume than Rp, it plays an important role in 
determining the coupling of the right ventricle to its arterial load (Fourie 1989).   
1.5.5 Consequences of ventricular-arterial coupling on right ventricular pump 
characteristics 
The right ventricle normally operates on the ascending limb of the power-load curve (Fourie 1989; Piene 1986; 
Pouleur, Lefevre et al. 1978).  If the diagrams depicting the relationships between power and afterload are inspected 
(Figures 1.5.4.4 and 1.4.1-f), it is apparent that the ascending limbs of these relationships approximate a straight line 
and can be described by the equation that describes a “flow pump”:  
 
Power = “afterload” x flow2  ………………………… Equation 1.5.5.1 
Where 
“Afterload” is a variable describing opposition to pulmonary flow.  This opposition to pulmonary flow 
has been described by arterial elastance, characteristic impedance or resistive properties of the 
pulmonary vascular bed (Fourie 1989, Fourie, Coetzee et al. 1992, Piene 1986). 
 
That the RV normally operates as a flow pump was originally deduced by work done by Pouleur et al. (Piene and Sund 
1979).  They demonstrated that elevation of characteristic impedance due to clamping of the left pulmonary artery 
caused peak ventricular and pulmonary artery pressures to increase.  This manoeuvre resulted in an increase in the 
hydraulic power output of the right ventricle.  The increase in RV power output in the face of an increase in impedance 
led Pouleur to conclude that this ventricle operates, under normal circumstances, as a low-pressure high-volume flow 
pump.  This scenario is usually abbreviated to the term ”flow generator” (Fourie, Coetzee et al. 1992; Fourie 1989).   
 
The implication of the RV operating on the ascending part of the SW-elastance relationship is that it possesses 
sufficient reserve to overcome the small day-to-day physiological changes in opposition to RV ejection.  The reserve is 
such that the opposition to RV ejection must double before the right ventricle tops the summit of the work versus load 
curve and starts operating as a pressure pump (Fourie, Coetzee et al. 1992). 
 
However, the descending limb of the power-afterload relationships have a different form and are described by the 
following relationship:  
 
Power = P2 / “afterload”   ………………………… Equation 1.5.5.2 
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Where 
“Afterload” is a variable describing opposition to pulmonary flow, for example effective arterial 
elastance, characteristic impedance or resistance (Fourie 1989, Fourie, Coetzee et al. 1992, Piene 
1986). 
 
This equation describes a hyperbola with the slope equal to the inverse of the parameter describing afterload (Fourie 
1989; Piene 1986).  When the RV works on this part of the power versus afterload curve, it operates as a constant 
pressure, variable output generator.  In this situation, the pressure generated by the RV will be little altered by 
changes in resistance.  The reason for this is that if resistance decreases, pressure will be maintained by an increase 
in flow and vice versa (Fourie, Coetzee et al. 1992; Fourie 1989; Piene 1986).  
 
Before classifying the ventricle as a pressure pump or flow generator, it is important to know the working point on the 
power-load curve (Piene 1986, Fourie 1989).  The point of maximum power transfer occurs where the two curves 
described by equations 1.5.5.1 and 1.5.5.2 intersect on the power-afterload graph (Fourie, Coetzee et al. 1992; Fourie 
1989).  At this point, arterial and ventricular elastances are numerically equal and maximal SW is generated.  
Therefore when the ventricle and its afterload operate at a point where Ea is equal to or less than Ees, the right 
ventricle will operate as a flow generator.  When the load increases so that Ea exceeds Ees, the RV makes the 
transition from operating as a flow generator to now operating as a pressure pump.  A ventricle and its load operating 
on the latter position on the power-afterload relationship is, per definition, failing.  In a porcine model of pulmonary 
bead embolism, Fourie determined that the RV makes the transition from flow to pressure generator and fails as a 
pump when Ea reaches 2 mmHg.ml-1 (Fourie 1989).  An Ea of 2 mmHg.ml-1 corresponds to a mean pulmonary artery 
pressure of 30 to 40 mmHg in both humans and animals (Fourie, Coetzee et al. 1992b, Vlahakes, Turley et al. 1981, 
Sibbald and Driedger 1983).  The pathophysiological consequences of RV failure due to an increase in afterload will be 
dealt with in the next section. 
1.6 Pathophysiological consequences of an acute increase in right 
ventricular afterload 
As long ago as 1936, Fineberg and Wiggers while studying the consequences of pulmonary vascular obstruction, 
demonstrated insight by stating that “the right ventricle has only limited power of response to a drastic sudden increase 
in pulmonary vascular resistance, and that fatigue and failure easily supervene when aortic pressure, and with it 
coronary flow, is suddenly reduced….  It is easy to understand why a circulatory crisis may be brought about through 
failure of the right ventricle…” (Hurford and Zapol 1988). 
 
Right ventricular enlargement due to a sudden increase in afterload of pulmonary vascular origin is termed acute Cor 
Pulmonale (Wiedemann and Matthay 1997; Schulman and Matthay 1992).  This relatively thin-walled chamber 
possesses a limited reserve to cope with increases in afterload (Figure 1.6.1). When faced with even a modest (Dries 
and Mathru 1992) increase in afterload, many investigators have shown that right ventricular stroke volume and 
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ejection fraction decrease (Figure 1.6.2.1) (Dries and Mathru 1992; Calvin, Jr. 1991; Calvin, Jr., Baer et al. 1985; 
Weber, Janicki et al. 1983; Sutherland, Calvin et al. 1981; Piene and Sund 1979).  These decreases in RV output are 
inversely proportional to the increase in mean pulmonary artery pressure (Figure 1.6.2.1) (Brunet, Dhainaut et al. 1988; 
Sibbald, Driedger et al. 1983).  The normal right ventricle can generate maximum pulmonary artery pressures of 40 
mmHg mean or pressure of 60 to 70 mmHg systolic without pharmacological support (Reuse, Frank et al. 1988; 
Weber, Janicki et al. 1983).  A hypertrophied right ventricle may tolerate a larger rise in afterload, at the expense of a 
high end-diastolic pressure (Dries and Mathru 1992; Schulman and Matthay 1992).  The discussion that follows deals 
predominantly with an inexperienced and non-hypertrophied right ventricle facing an acute increase in afterload (Figure 
1.6.1). 
1.6.1 The increase in RVEDV 
An increase in RVEDV in the presence of an increased afterload is a part of the definition of cor pulmonale. An 
increase in EDV comprises an important compensatory mechanism of the afterloaded RV in order to maintain its stroke 
volume and increase its stroke work (Figure 1.6.2.2) (Hendry, Ascah et al. 1994; Mitsuo, Shimazaki et al. 1992; Dries 
and Mathru 1992; Schulman and Matthay 1992; Calvin, Jr. 1991; Dhainaut, Lanore et al. 1988; Brunet, Dhainaut et al. 
1988; Sibbald, Driedger et al. 1983; Milnor 1982c; Guyton, Lindsey et al. 1954; Schulman and Matthay 1992; Hendry, 
Ascah et al. 1994).  The increase in EDV is proportional to the rise in pulmonary artery pressure (Brunet, Dhainaut et 
al. 1988; Sibbald, Driedger et al. 1983) and may, within certain limits, be augmented by volume therapy (Dries and 
Mathru 1992; Guyton, Lindsey et al. 1954).  Because of the high diastolic compliance of the right ventricle, the RVEDP 
remains low and increases slowly until dilation of the right ventricle is limited by the pericardium (Hurford and Zapol 
1988; Janicki and Weber 1980; Maughan, Shoukas et al. 1979).  Therefore the initial right ventricular response to an 
increase in opposition to RV ejection is dilatation rather than an increase in EDP (Hurford and Zapol 1988).  For 
example, on embolization of the pulmonary microvasculature of dogs with glass beads during which the mean 
pulmonary artery pressure increased from 14 to 48 mmHg, RVEDV increased from 91+/- 8 to 131 +/- 15 ml, while 
RVEDP increased only from 4 to 8 mmHg (Hurford and Zapol 1988).  Stool et al. demonstrated another example of this 
great RV compliance (Stool, Mullins et al. 1974).  Their experimental model included the inflation of a balloon in the 
Figure 1.6.1.    Guyton described the events as the 
main pulmonary artery of the dog is progressively 
constricted over a 5-minute period.  Initially RV 
pressure progressively increased, and cardiac output 
was maintained.  However, when systemic pressure 
dropped below a mean of 40 to 60 mmHg, progressive 
and rapid collapse of the circulation occurred within 6 
to 10 minutes. The pulmonary artery constriction 
decreased filling of the LV via decreased right 
ventricular stroke volume.  Adapted from Guyton, 
Lindsey et al, 1954 
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PA.  At the point of maximal right ventricular pressure generation (100 mmHg systolic and 60 mmHg mean), RVEDP 
averaged only 10 mmHg (Stool, Mullins et al. 1974). 
 
Only when the limits imposed by the inelastic pericardium are reached do further increases in RVEDV than described 
above results in significant increases in RVEDP (Calvin 1991; Calvin, Jr. 1991; Vlahakes, Turley et al. 1981).  Glantz et 
al. (Glantz, Misbach et al. 1978) have demonstrated that with the pericardium open, the thin walled right ventricle can 
undergo substantial dilatation with only small increases in EDP.  Hurtford and Zapol suggest that the ability of the right 
ventricle to compensate for acute rises in pulmonary artery pressure may be physically limited by the surrounding 
pericardium (Hurford and Zapol 1988). 
1.6.2 Ventricular interaction during pulmonary hypertension  
The various forms of ventricular interaction play a major role in influencing global cardiac function when right 
ventricular afterload increases.  The rise in intrapericardial pressure that results, accentuates the normal parallel 
interaction between the ventricles (Vlahakes, Turley et al. 1981).  Firstly, external pressure is exerted on the left 
ventricle that affects its ability to distend.  This has been likened to intrapericardial tamponade of the LV by the right 
ventricle as they compete for space within the pericardial sac (Wiedemann and Matthay 1997; Calvin 1991; Milnor 
1982c; Spotnitz, Berman et al. 1971; Calvin 1991) 
 
A second effect is that marked septal shift occurs in the presence of pulmonary hypertension (Figures 1.6.2.3 and 
1.6.2.4) (Weber, Janicki et al. 1983; Kingma, Tyberg et al. 1983).  An increase in right ventricular diastolic pressures 
will result in a decrease or even reversal in the transseptal diastolic pressure gradient.  Kingma et al. (Kingma, Tyberg 
et al. 1983) have studied the relationship between the diastolic transseptal pressure gradient and the position of the 
septum.  When the gradient is low or reversed, the interventricular septum shifts leftward at the end of diastole.  
Diastolic septal shift is termed paradoxical motion of the septum (Kingma, Tyberg et al. 1983).   
 
 
Septal shift causes left ventricular geometry to become distorted.  Distortion of the LV results in a decrease in diastolic 
compliance with the left ventricular diastolic pressure-volume relationship being shifted upward and to the left (Figure 
1.3.5.1) (Calvin 1991; Calvin, Jr. 1991; Hurford and Zapol 1988; Weber, Janicki et al. 1983; Vlahakes, Turley et al. 
1981; Sutherland, Calvin et al. 1981).  Consequently there is a poor correlation between pulmonary artery wedge 
pressure and cardiac index in pulmonary hypertension (Martyn, Snider et al. 1981).  A decrease in LV compliance 
results in LV under-filling.  Stool et al. have showed that LV volume progressively decreased when mean pulmonary 
artery pressures were greater than 30 mmHg, and at 60 mmHg, LVEDV was reduced by 30% (Stool, Mullins et al. 
1974).  This under filling leads to a decrease in LV stroke volume.  A compensatory baroreceptor-mediated increase in 
sympathetic nervous system stimulation (SNS) occurs.  SNS activation increases left and right ventricular contractility 
and induces a tachycardia that initially compensates for the circulatory dysfunction (Stool, Mullins et al. 1974; Guyton, 
Lindsey et al. 1954).  When this compensatory mechanism is overwhelmed, systemic hypotension will worsen.  
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Hendry and colleagues propose an additional view of septal shift.  They suggest that the septal shift encountered in 
pulmonary artery hypertension may hold an adaptive advantage in that the right ventricle has a larger EDV and 
therefore will generate a larger stroke volume (Hendry, Ascah et al. 1994).   
 
In the face of a decreased right ventricular output, Calvin has repeatedly shown that the LV is underfilled.  This occurs 
even if no septal shift has taken place.  It is an example of a series interaction of the two ventricles (Calvin 1998; 
Calvin, Jr. 1991; Calvin and Quinn 1989). 
1.6.3 Right ventricular ischemia during acute pulmonary hypertension  
RV ischemia with ischemic dysfunction of the right ventricle completes the pathophysiological viscous circle illustrated 
in Figure 1.6.5.1 (Hurford and Zapol 1988; Vlahakes, Turley et al. 1981).  When faced with an increase in afterload, 
both pressure and volume of the ventricle increase, and the wall stress of the RV rises.  The reduction in wall thickness 
as the ventricle dilates, accentuates the rise in wall tension (Martyn, Snider et al. 1980).  Increased systolic 
compression of the intramural coronary vessels during right ventricular hypertension decreases the perfusion pressure 
gradient between the aorta and the right ventricle.  An increase in coronary blood flow can only then occur with 
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Figure 1.6.2.1 Graphs illustrating decreases in 
RV stroke volume that occur secondary to 
increases in indices of afterload (pressure or 
impedance).  In the top-right graph, Calvin and 
colleagues demonstrated that RV SV was 
inversely proportional to PA input impedance.  
Redrawn from Piene and Sund, 1979 and 
Calvin, Baer et al, 1985 
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concomitant decreases in coronary vascular resistance or increases in coronary perfusion pressure (Gold and Bache 
1982).  The closer the right ventricular pressures are to systemic, the more the RV behaves like the LV in terms of 
coronary blood flow with the bulk of right ventricular coronary blood flow occurring during diastole (Dries and Mathru 
1992; Gold and Bache 1982). 
 
With moderate increases in right ventricular pressure, it has been repeatedly demonstrated that the coronary vascular 
reserve is sufficient to meet the increase in demand for oxygen (Wiedemann and Matthay 1997; Dries and Mathru 
1992; Calvin, Jr. 1991; Calvin and Quinn 1989; Gold and Bache 1982; Vlahakes, Turley et al. 1981; Manohar, 
Tranquilli et al. 1981).  Manohar and colleagues have demonstrated that coronary blood flow increased by 91 % when 
the RV was faced with an increase in afterload, even if aortic pressure decreased by 15 mmHg (Manohar, Tranquilli et 
al. 1981).  Gold and Bache demonstrated that when right ventricular systolic pressure was increased to 92 mmHg, RV 
coronary blood flow increased by more than 200% (Gold and Bache 1982).  Even though mean aortic pressure was 
unchanged at this stage of the study, the transmural distribution of blood flow indicated right ventricular subendocardial 
hypoperfusion, albeit coronary vasodilator reserve had not yet been exhausted (Gold and Bache 1982).  The increase 
in work done by the RV plus the increase in RV wall stress lead to an increase in myocardial oxygen demand (Calvin, 
Jr. 1991).  Calvin has confirmed that the aforementioned increases in CBF are indeed sufficient to meet the increased 
demand.  He demonstrated the absence of biochemical evidence of ischemia at “moderate” levels of right ventricular 
pressure overload (Calvin 1998). 
 
In spite of the above work demonstrating absence of RV ischemia, other authors suggest that with acute and severe 
increases in right ventricular afterload, right ventricular blood supply eventually fails to increase in proportion to 
demand (Vlahakes, Turley et al. 1981).  When coronary vasodilatation is maximal and coronary vascular reserve is 
exhausted, any decrease in driving pressure will result in decreases in coronary blood flow.  The onset of rapid 
circulatory collapse in various models at this point has repeatedly been shown to be related to RV ischemic dysfunction 
(Calvin and Quinn 1989; Gold and Bache 1982; Milnor 1982c; Vlahakes, Turley et al. 1981; Manohar, Tranquilli et al. 
1981; Fixler, Archie et al. 1973; Spotnitz, Berman et al. 1971; Guyton, Lindsey et al. 1954).  However, other 
investigators indicate that ischemia may not be necessary for RV failure to occur when it is faced with an increase in 
afterload.   
 
Vlahakes, Turley and Hoffman described exhaustion of coronary vascular reserve during acute RV hypertension when 
the PA was constricted until maximal RV pressures (65 mmHg) were generated.  The exhaustion of coronary vascular 
reserve (no hyperemia) was associated with the development of right ventricular ischemia and the onset of circulatory 
collapse.  One question that has been asked is whether the point of circulatory collapse during acute pulmonary 
hypertension is associated with LV ischemia.  To answer this question, Vlahakes and colleagues elegantly studied  
biochemical indicators of ischemia and coronary hemodynamics in both ventricles before, during and after the point of 
collapse.  No evidence of LV ischemia could be elucidated at the point of circulatory collapse (Vlahakes, Turley et al. 
1981). 
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Figure 1.6.2.2.  This work was done in patients 
with ARDS using a modified pulmonary artery 
catheter that can measure RV ejection fraction.  
The top left hand figure is a “Frank–Starling” 
curve.  The top right figure illustrates 
ventricular stroke work versus end-diastolic 
volume.  These two graphs illustrate the point 
that stroke volume and SW increase with 
increases in EDV and, within limits, is an 
important compensatory mechanism of the 
right ventricle faced with increased afterload. 
 
The figure below left illustrates that the EDV of 
the ventricle increases as a compensatory 
mechanism when pulmonary artery pressure 
rises.  
 
Redrawn from Sibbald, Driedger et al, 1983 
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Figure 1.6.2.3  Left hand side represents the events during diastole; the right 
hand side represents the events during systole 
 
Top: Normal situation: LV pressure exceeds RV pressure throughout the 
cardiac cycle.  This causes the interventricular septum (IVS) to have a curvature 
similar to the LV in both systole and diastole. 
 
Middle: When RV pressure exceeds LV pressure at the end of diastole, the IVS 
is displaced leftward and may actually become convex toward the LV.  During 
systole, there is a rapid increase in LV pressure with restoration of a positive LV-
RV pressure gradient.  This causes the IVS to move toward the RV in a 
paradoxical direction as it resumes its normal convex curvature toward the LV. 
However, with severe rises in RV pressure, and large reductions in the normal 
systolic transseptal gradient, the IVS may remain deformed (shifted leftward) at 
the end of systole. 
 
Bottom: With reductions in the normal diastolic transseptal gradient, the septum 
moves toward a progressively more neutral position between the ventricles.  
Therefore, in situations where the right and left ventricular end-diastolic 
pressures are almost equal, IVS motion may be minimal, or move 
hypokinetically in any direction.  Redrawn from Kingma, Tyberg et al, 1983 
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Figure 1.6.2.4    LV diastolic pressure 
length relationship before and after 
pulmonary hypertension.  PHPT shifts the 
relationship up and to the left.   
 
 
 
Redrawn from Calvin, 1991 
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Figure 1.6.3.1  An integrated chronology of events leading to RV failure during RV pressure overload (RVPO) as formulated 
from a summary of the available evidence by Calvin and Quinn, 1989.  
 
The black bars on the top indicate severity of the PVPO.  The bars at the bottom indicate the RV endocardial to epicardial 
blood flow ratio.   
 
Point 1.  Moderate degrees of RV pressure overload are well tolerated without evidence of ischemia.  Cardiac output is well 
maintained by increased inotropicity, heart rate and preload reserve.  RV blood flow increases to meet the increased 
metabolic demands.  The increase in CBF occurs even though the driving pressure for RV CBF is decreasing because of 
autoregulation of CBF.  
 
Points 2 and 3.  As RV afterload increases further, mismatch of the ventricle and its load occur and right ventricular stroke 
volume and cardiac out put decreases. 
 
Point 4.  Right ventricular ischemia develops beyond this point as demand starts exceeding the ability to supply oxygen.  RV 
endocardial to epicardial ratio decreases at this point. 
 
Point 5.  When the right ventricle fails and systemic hypotension ensues, right ventricular ischemia leads to decreases in RV 
CBF, right ventricular systolic pressure generation, cardiac output and endocardial to epicardial ratios.  Aortic pressure 
decreases from a combination of decreased left ventricular preload secondary to a decreased RV stroke volume (series 
interaction) and decreased compliance of the left ventricle, (parallel interaction).  The decrease in aortic pressure further 
impairs right ventricular CBF by reducing the driving pressure: CBF is linearly dependent on the upstream pressure when the 
coronary bed is maximally dilated.  This explains why increasing the systemic pressure can increase RV coronary blood flow 
but not at an earlier phase when the coronary bed may not be maximally dilated.  
 
Calvin and Quinn, 1989 
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It is interesting to note the discrepancy between two investigations regarding right ventricular coronary vasodilator 
reserve.  In the study already quoted above by Gold and Bache, further constriction of the PA to produce pulmonary 
artery pressures of 92 mmHg decreased myocardial blood flow to approximately baseline levels and the ratio of 
subendocardial to epicardial blood flow was reduced (Gold and Bache 1982).  Albeit that mean aortic pressure at this 
point was 50 to 55 mmHg and the RVEDP had increased from 4 to 13 mmHg, they describe no exhaustion of the 
coronary vasodilator reserve (Hurford and Zapol 1988; Gold and Bache 1982).  Maximal RV CBF during acute 
systolic overload increased flow to 1.69 ml.min-1.gram-1, and adenosine administration allowed up to 2.25 ml.min-
1.gram-1 of tissue in the dog myocardium.  Vlahakes and co-workers described exhaustion of the coronary vasodilator 
reserve in acute PHPT; they suggest that the discrepancy is due to the differing definitions of right ventricular failure 
used in these studies (Vlahakes, Turley et al. 1981).  Vlahakes et al. defined right ventricular failure by changes in 
RV and systemic pressures that continued to progress without further increments of PA constriction, whereas Gold 
and Bache used a definition comprising a decrease in aortic pressure and an increase in RVEDP (Gold and Bache 
1982). 
 
When the severity of RV dysfunction causes a decrease in aortic pressure, coronary perfusion pressure decreases 
further (Calvin, Jr. 1991; Hurford and Zapol 1988; Gold and Bache 1982).  However, reversal of ischemic dysfunction 
has been demonstrated by improving RV coronary perfusion pressure, even if the increase in afterload is sustained 
(Hurford and Zapol 1988; Gold and Bache 1982; Milnor 1982c; Vlahakes, Turley et al. 1981; Guyton, Lindsey et al. 
1954).  In the study by Vlahakes et al, it is noteworthy that administration of adenosine increased CBF to even 
greater levels than did aortic constriction but adenosine did not restore function of the ventricle (Gold and Bache  
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Figure 1.6.4.1   The diagram illustrates several right ventricular 
pressure length loops recorded while the afterload is being 
increased.   
 
The slope end systolic pressure length relationship remains 
constant in the face of the increase in afterload.  Note also the 
compensatory increase in pressure and segment length (volume) 
at the end of diastole in an attempt to maintain stroke volume.   
 
Fourie, Coetzee et al, 1992. 
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Figure 1.6.4.2.  Peak ESPV points averaged from three groups of 
patients with pulmonary artery pressures in ARDS as indicated.  
The group with the highest PAP has its ESPV point shifted 
significantly over to the right.  Sibbald and co-workers suggest 
that this implies that right ventricular contractile performance is 
reduced in patients with a mean PAP of more than 30 mmHg.  
This may however simply demonstrate the non-linearity of the 
ESPVR at the extremes of its range. 
 
Sibbald, Driedger et al, 1983 
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Figure 1.6.5.1. The pathophysiological consequences of an acute rise in right ventricular afterload.
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1982).  The difference was suggested to be due to the difference in the distribution of CBF generated by the two 
methods (Gold and Bache 1982).  These authors do not discuss the influence that an increase in left ventricular 
pressure may have on ventricular-ventricular interaction, or on the LV contribution to RV pressure generation. Right 
ventricular contractility during acute pulmonary hypertension  
1.6.4 Right ventricular contractility during pulmonary hypertension 
The contractility of the right ventricle faced with an acute increase in afterload does not change.  The RV Ees has 
been reported to be unchanged when faced with an increase in right ventricular afterload (Figure 1.6.4.1) (Fourie, 
Coetzee et al. 1992b; Fourie 1989; Brunet, Dhainaut et al. 1988; Sibbald, Driedger et al. 1983).  LV contractility also 
appears unaffected by acute pulmonary hypertension (Hurford and Zapol 1988; Sibbald, Driedger et al. 1983).  
However, Sibbald and co-workers have suggested that patients with ARDS and mean pulmonary artery pressures of 
greater than 30 mmHg may exhibit a decrease in Ees (Figure 1.6.4.2) (Sibbald, Driedger et al. 1983). 
1.6.5 The atrium during pulmonary hypertension  
The interatrial septum may play a role in the pathophysiology of right ventricular afterload.  A “probe patent” foramen 
ovale exists in 50% of people up to 5 years of age and 25% of persons older than 20 years of age.  .   
 
A potential left to right communication exists in 25% of adults if left atrial pressure exceeds right atrial pressure.  
Because it is less compliant than the right atrium, left atrial pressure is normally greater than right atrial pressure 
throughout systole.  The pressure gradient and flow across a patent foramen ovale is greatly affected by factors that 
affect right ventricular compliance (Schwartzman, Attubato et al. 1993).  A decrease in right ventricular compliance 
will increase right atrial pressure relative to that of the left atrium.  This pressure gradient would facilitate shunting of 
deoxygenated blood across a patent foramen ovale.  This has been demonstrated to be a cause of arterial 
hypoxemia in patients with acute increases in pulmonary artery pressure, right ventricular infarction and after 
pneumonectomy (Schwartzman, Attubato et al. 1993; Dries and Mathru 1992).  The patent foramen ovale may 
provide a route for systemic embolization of other material during an increase in right ventricular afterload.  Dilation 
and / or ischemia of the right ventricle may lead to tricuspid incompetence that may further decrease forward stroke 
volume (Dries and Mathru 1992). 
1.7 One lung anesthesia and right ventricular function  
The paucity of information on the interaction of the right ventricle and its afterload during one lung anesthesia has 
been commented on in the literature (Cohen 1995; Lewis-JW, Bastanfar et al. 1994).  The effects of OLA on RV 
function will be examined. 
1.7.1   Increases in right ventricular afterload during one lung anesthesia 
  
1.7.1.1 Effects of one lung anesthesia (OLA) on right ventricular afterload 
¾ Boldt et al, (Boldt, Muller et al. 1996) described an increase in pulmonary artery pressure after initiation of 
one lung anesthesia in patients undergoing both lobectomy (20.8 ± 2.5 to 27.2 ± 4.1 mm Hg) and 
pneumonectomy (21.1 ± 3.4 to 27.9 ± 3 mm Hg).  They did not however, report any data describing 
pulmonary vascular resistance. 
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¾ Carlsson and colleagues (Carlsson, Bindslev et al. 1987; Carlsson, Hedenstierna et al. 1987; Carlsson, 
Bindslev et al. 1985) have investigated various aspects of one lung anesthesia (the use of various 
inhalation anesthetic agents (IAA’s) and the  effect of time on the HPV response) in humans.  They have 
consistently demonstrated a 37 to 50% increase in pulmonary artery pressure compared to control, a 
doubling of PVR in the non-dependent lung, but no change in PVR of the dependent lung.   
 
¾ Malmkvist and colleagues (Malmkvist, Fletcher et al. 1989; Werner, Malmkvist et al. 1984; Werner, 
Malmkvist et al. 1984) studied 17 patients with chest wall or small intrapulmonary lesions who had only 
minor abnormalities in lung function and would therefore have had normal perfusion to both lungs 
preoperatively.  They described an increase in mean pulmonary artery pressure during one lung 
anesthesia from 17 ± 5 to 19 ± 6 mm Hg.  No values for pulmonary vascular resistance were described.  
No significant relationship between cardiac index and pulmonary artery pressure was found.  However, a 
significant relationship between pulmonary artery pressure and pulmonary shunt fraction during one lung 
anesthesia was found (Figure 1.7.1.2). 
 
¾ Fujita and colleagues (Fujita, Yamasaki et al. 1993) studied the suitability of using sevoflurane for one lung 
anesthesia in healthy sheep.  During one lung anesthesia with ZEEP or PEEP5 to the dependent lung, 
pulmonary artery pressures did not change, but on the application of PEEP10 to the dependent lung, 
pulmonary artery pressures (systolic/diastolic) increased from baseline 23/13.6 to 24.5/15.6 mm Hg.  From 
their results, it can be calculated that PVR did not change during one lung anesthesia during ZEEP, PEEP5 
or PEEP10.  Increases in pulmonary artery pressure such as those described by Fujita and colleagues and 
Malmkvist and colleagues are clinically insignificant. 
 
¾ Inomata and colleagues studied humans with normal preoperative lung function tests (Inomata, Nishikawa 
et al. 1997).  They demonstrated that PVR did not change when ZEEP (208 ± 64 dynes.sec.cm-5.m-2) or up 
to 7.8 cm H2O PEEP (220 ± 58 dynes.sec.cm-5.m-2) was applied to their dependent lungs.  However, if an 
additional 6.5 cm H2O PEEP was applied to the dependent lung, pulmonary vascular resistance increased 
to 286 ± 109 dynes.sec.cm-5.m-2.  Although this rise in PVR is statistically significant, the clinical 
significance of this increase in PVR is uncertain.  Pulmonary artery pressures were however not reported in 
their study. 
 
¾ Cohen and co-workers (Cohen, Eisenkraft et al. 1988) conducted a systematic study of hemodynamics 
during one lung anesthesia while ZEEP or PEEP10 was applied to the dependent lung and/or CPAP10 to the 
non-dependent lung.  The 20 patients studied were chosen because they had no significant pulmonary or 
cardiovascular disease.  Neither mean PAP nor PVR differed during any measurement epoch (2 lungs on 
side, one lung anesthesia, PEEP10, PEEP10/CPAP10 or CPAP10).  In other studies conducted by Cohen’s 
group (Cohen and Eisenkraft 1996; Cohen, Thys et al. 1985a), no change in mean PAP (or PVR where 
reported) was described on initiation of one lung ventilation.  
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¾ Aalto-Setala and colleagues (Aalto, Heinonen et al. 1975) studied 11 patients with mild COPD undergoing 
surgery for pulmonary malignancy.  No change in pulmonary artery pressure was found between two and 
one lung anesthesia, or with the application of PEEP5 to the dependent lung. 
 
¾ In a study in chronically instrumented dogs, Morgan and Guntheroth (Morgan and Guntheroth 1970) 
demonstrated that one lung anesthesia in the supine position induced a sixteen percent rise in PVR in the  
atelectatic lung.  Such a rise in PVR in the atelectatic lung is expected, but the 8% rise in PVR in the 
ventilated lung was explained as being secondary to a decrease in lung volume.  Mean PAP increased 
significantly albeit that the rise averaged only three mm Hg (Morgan and Guntheroth 1970). 
 
¾ Pagel et al, (Pagel, Fu et al. 1998) have demonstrated that during one lung anesthesia with isoflurane, 
PAP, PVR and CVP rose.  This did not happen with desflurane anesthesia.  Mean PAP was 19 ± 5 mmHg 
at baseline and 25 ± 6 mm Hg while anesthetised before one lung ventilation commenced. Mean PAP rose 
to 27 ± 6 mmHg after initiation of OLA. This rise is unlikely to be of clinical significance. 
 
Figure 1.7.1.1.  Changes in systolic PAP from awake to after clamping of the PA during pneumonectomy.  Solid lines and 
circles indicate those subjects who had pulmonary hypertension, while dashed lines and open circles indicate those with 
normal PA, before PA clamping.  The error bars indicate mean and one standard deviation of the two groups.  No differences 
in PAP occurred from before to after PA clamping in either the group as a whole or in the subset of patients with pre-existing 
pulmonary hypertension.  Lewis, Bastanfar et al, 1994 
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Satoh, Sato et al. 1998; 
Fujita, Yamasaki et al. 1993; 
Cohen, Eisenkraft et al. 
1988; Rogers and Benumof 
1985; Aalto, Heinonen et al. 
1975; Benumof and 
Wahrenbrock 1975 
Werner, Malmkvist et al. 
1984b; Malmkvist, Fletcher 
et al. 1989; Carlsson, 
Bindslev et al. 1987; 
Carlsson, Hedenstierna et 
al. 1987; Carlsson, Bindslev 
et al. 1985; Werner, 
Malmkvist et al. 1984; Pagel, 
Fu et al. 1998; Morgan and 
Guntheroth 1970  
Lewis-JW, Bastanfar et al. 
1994 
Lewis-JW, Bastanfar 
et al. 1994 in 70% of 
patients; Carlsson, 
Bindslev et al. 1987 
and Carlsson, 
Hedenstierna et al. 
1987 and Carlsson, 
Bindslev et al. 1985 
found no change in 
dependent lung 
PVR; Fujita, 
Yamasaki et al. 
1993; Cohen, 
Eisenkraft et al. 
1988;  
Lewis-JW, Bastanfar 
et al. 1994 in 30% of 
patients; Morgan 
and Guntheroth 
1970; Pagel, Fu et 
al. 1998 
PEEP5 
Fujita, Yamasaki et al. 1993; 
Aalto, Heinonen et al. 1975 
  Fujita, Yamasaki et 
al. 1993; Inomata, 
Nishikawa et al. 
1997 
 
PEEP≥10 
Cohen, Eisenkraft et al. 
1988 
 Fujita, Yamasaki et al. 1993  Fujita, Yamasaki et 
al. 1993; Cohen, 
Eisenkraft et al. 
1988 
Inomata, Nishikawa 
et al. 1997 
CPAP10 
Cohen, Eisenkraft et al. 
1988 
    
CPAP10 / 
PEEP10 
Cohen, Eisenkraft et al. 
1988 
    
Table 1.7.1.1.1 The effects of one lung anesthesia on pulmonary artery pressures and pulmonary vascular 
resistance 
 
¾ Lewis et al, (Lewis-JW, Bastanfar et al. 1994) investigated twenty patients with moderately severe chronic 
obstructive pulmonary disease undergoing pneumonectomy (Figure 1.7.1.1).  They studied the interaction 
between the RV and the pulmonary vasculature on clamping the PA.  They utilised a fast response 
thermodilution catheter capable of measuring RV ejection fractions and RV end-diastolic volumes.  They 
reported the following results:   
i. Preoperatively, 76.5% of these patients had pulmonary hypertension.  54% of this group 
demonstrated either a mean decrease of 8 mm Hg or no change in systolic and mean pulmonary 
artery pressure on clamping of the pulmonary artery.  The other subjects in this group exhibited a 
mean 12 mm Hg rise in pulmonary artery systolic or diastolic pressures on PA clamping. 
However, when compared to the preoperative period, systolic (41 ± 7 vs. 41 ± 7 mm Hg) and 
mean (28 ± 5 vs. 30 ± 6 mm Hg) PA pressures did not differ on PA clamping.   
ii. On the other hand, patients with normal pulmonary artery pressures exhibited only a 4 mm Hg 
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rise in mean PAP on clamping of the pulmonary artery (Figure 1.7.1.1).  
iii. 94% of Lewis et al’s (Lewis-JW, Bastanfar et al. 1994) patients had normal pulmonary vascular 
resistance preoperatively.  Lewis and Bastanafar state that 30% of these patients demonstrated 
a rise in PVR on PA clamping to greater than 200 dynes.sec.cm-5.  However, the rise is clinically 
and statistically insignificant.  The lack of difference also exists if data for the patients with 
pulmonary hypertension alone is analysed.  Furthermore, PA clamping did not appear to increase 
opposition to RV ejection.   
iv. Although this article does not study only the period of OLA, it is noteworthy for the following 
reasons; 
i. It is one of only a few articles to studying RV coupling to its load using a fast response 
thermistor that involves pulmonary surgery, 
ii. Data on RVEF during OLA are also tabulated in this study, albeit they are not 
commented on in the results or the discussion.  They indicate that both opposition to 
pulmonary flow and RV performance did not change during OLA and,  
iii. It emphasizes that the situation during OLA with and without PA clamping not always 
be comparable. 
 
In summary, the studies reported in humans or animals subject to OLA suggest that: 
1. During OLA, in animals and humans with normal lungs and when IPPV is performed at zero end expiratory 
pressure, PVR does not change.  Furthermore, pulmonary artery pressure does appear to increase, but 
by a clinically insignificant amount (Pagel, Fu et al. 1998; Inomata, Nishikawa et al. 1997; Wilson, 
Kapelanski et al. 1997; Chen, Lee et al. 1996; Cohen and Eisenkraft 1996; Fujita, Yamasaki et al. 1993; 
Fujita, Yamasaki et al. 1993; Cohen, Eisenkraft et al. 1988; Rogers and Benumof 1985; Aalto, Heinonen et 
al. 1975; Benumof and Wahrenbrock 1975). 
2. If pulmonary hypertension pre-exists and one lung anesthesia is initiated, Lewis and colleagues suggest 
that indices of right ventricular afterload increase on PA ligation (Lewis-JW, Bastanfar et al. 1994).   
However, inspection of the data in the article reveals unconvincing evidence of these increases. 
Figure 1.7.1.2.  The relationship between pulmonary artery pressure and 
shunt is illustrated.  Note that the data point in brackets represents a 
patient with partial obstruction of the lumen of the endobronchial tube.  
Redrawn from Malmkvist, Fletcher et al, 1989 
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3. Some studies have however demonstrated clinically significant increases in mean PAP after initiation of 
one lung ventilation both at ZEEP, and with the application of PEEP or PEEP/CPAP (Pagel, Fu et al. 1998; 
Boldt, Papsdorf et al. 1997; Boldt, Muller et al. 1996; Malmkvist, Fletcher et al. 1989; Werner, Malmkvist et 
al. 1984; Werner, Malmkvist et al. 1984).  Inomata suggested that the increase in PVR seen on application 
of 14 cm H2O PEEP was an indication that the lung volume exceeded FRC. 
Figure 1.7.1.3.  The decrease in FRC of the dependent lung in the lateral decubitus position: cause and effect.  The effects of 
sub-optimal positioning with chest wall (PCW) splinting, the weight of the mediastinum and abdominal contents (PAB) on the 
paralyzed diaphragm is illustrated in decreasing lung volume of the dependent lung.  The effect of this on the position of the 
dependent lung and on the pressure volume relationship of the lung is illustrated.  Adapted from Cohen, 1995 and Benumof, 
1991 
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Figure 1.7.1.4.  The Effect of pulmonary 
interstitial pressure on extra-alveolar vessels: 
The creation of zone 4 conditions.  
A: in normal lungs, the negative interstitial 
pressure (PISF) maintains patency of the extra-
alveolar vessels. 
 
B: If PISF exceeds venous and alveolar 
pressures, the extra-alveolar vessels will be 
less expanded and their resistance will 
increase.  This creates zone 4 conditions. 
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Figure 1.7.1.6.  The predicted PaO2 if different percentages of the lung are made hypoxic. With HPV, the PaO2 is reflected by 
the solid line, and in the absence of HPV, by the dashed line.  HPV is most effective when approximately half of the lung is 
hypoxic or atelectatic.  Redrawn from Domino, 1997 
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Figure 1.7.1.5.  Benumof and Wahrenbrock selectively induced hypoxia in the left lower lobe of open-chested dogs.  This 
resulted in a 51% decrease in electromagnetically measured blood flow to the lobe and to an increase in the pulmonary 
vascular resistance of 132% of that lobe.  PAO2 is measured in mm Hg.  Redrawn from Benumof and Wahrenbrock, 1975 
20 40 60 80 100 120 140 20 40 60 80 100 120 140
PAO2
9000
8000
7000
6000
5000
4000
3000
Pulmonary vascular resistance
left lower lobe (dynes • sec • cm
-3)
%
 of
 ca
rd
iac
 ou
tpu
t
pe
rfu
sin
g l
eft
 lo
we
r lo
be
18
16
14
12
10
8
6
A B
PAO2
Pulmonary vascular resistance
left lower lobe (dynes • sec • cm
-3)
%
 of
 ca
rd
iac
 ou
tpu
t
pe
rfu
sin
g l
eft
 lo
we
r lo
be
 
Chapter 1.  Literature review
 
112 
600
500
400
300
200
100
0
Ar
ter
ial
 P
O 2
(m
m 
Hg
)
20 30 40 50 60 70 80 90 100
Inspired Oxygen Concentration (%)
5%
10%
15%
20%
25%
30%
50%
Zer
o S
hun
t
Virtual Shunt
Lines
Hb               = 10 – 14 g.100 ml-1
PACO2 =  25 – 40 mmHg
C(a – v)O2 =    5 ml.100 ml-1
Ar
ter
ial
 P
O 2
(m
m 
Hg
)
 
Figure 1.7.1.7.  Isoshunt lines.  A 40 to 50% shunt will result in severe hypoxemia even with the administration of 100% 
oxygen and with effective ventilation.  However, the typical 20 to 35% shunt that is induced by HPV is addressable with 100% 
oxygen.    
 
Redrawn from Nunn, 1987 
Chapter 1.  Literature review
 
113 
Figure 1.7.1.8     The influence of isoflurane dose on the 
HPV response in animals.  For each dog, the maximal HPV 
response was identified as the difference between the 
shunt in the left lung during normoxia and the shunt during 
left lung hypoxia.  The reduction of HPV response when 
isoflurane was administered was calculated as a percent of 
this maximum and is plotted on the ordinate of this figure.  
The left lung isoflurane concentration is represented in % 
on the abscissa. The linear regression and correlation is 
indicated.  Redrawn from Domino, Borowec and colleagues, 
1986 
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Figure 1.7.1.9.  Diagrammatic representation of the effect of an alveolar concentration of 1 MAC isoflurane on blood flow 
distribution during one lung ventilation.  See text for explanation.  (1LV = one lung ventilation; HPV = hypoxic pulmonary 
vasoconstriction; MAC = minimum alveolar concentration; Qs/Qt = shunt fraction).  Redrawn from Benumof, 1986 
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Figure 1.7.1.10.  Dose response curves for inhibition of HPV by IAA’s in vitro isolated rat lungs.  Note that the 
curves for various anesthetic agents do not differ in slope, position or ED50.  (r > 0.82).  Domino, 1997 
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Figure 1.7.1.11.  The effects of IAA’s 
on the relationship between the 
observed changes in HPV with 
changes in cardiac output.  The 
baseline cardiac output on the x-axis 
without the administration of IAA is 
designated as one.  The effect of the 
IAA on HPV is indicated by the 
percentage flow to the atelectatic 
segment with IAA / Without IAA on the 
y-axis: A ratio of more than one 
indicates inhibition of HPV.  There is a 
linear relationship between cardiac 
output and attenuation of HPV (c.f. 
Figure 1.7.1.2).  The different shapes 
represent different IAA’s: halothane, 
isoflurane, methoxyflurane, nitrous 
oxide, trichlorethylene, diethyl ether 
and enflurane.  Redrawn from 
Domino, 1997 
Figure 1.7.1.12.  A diagram of the 
effect of IAA on the observed 
response to HPV.  Relative cardiac 
output (x axis) is plotted against the 
apparent HPV effect as in diagram 
1.7.1.11.  The dashed line represents 
the change in blood flow to the 
hypoxic lung as predicted by changes 
in cardiac output.  The solid line 
parallel to it represents the same 
relationship, but in the presence of 
IAA’s.  The vertical arrow indicates the 
true reduction of HPV by IAA when the 
cardiac output does not change.  The 
horizontal arrow represents the 
apparent effect when a decrease in 
cardiac output leads to a decrease in 
PvO2, which on the one hand, 
potentiates HPV.  On the other hand, 
the IAA contributes to direct 
depression of HPV. When these two 
effects act in combination, the result is 
an unchanged blood flow to the 
hypoxic lung.  Redrawn from Domino, 
1997 
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1.7.1.2 Causes of an increase in PVR and PA pressure during one lung 
anesthesia 
 
1.7.1.2.1 The decrease in lung volume of the dependent lung 
Lung volume (at end expiration this is represented by the functional residual capacity) decreases: 
 
¾ By 20 to 25% on assuming the supine position when awake (Wahba 1991) with 
¾ A further decrease of approximately 20% on induction of anesthesia in the supine position (Rothen 1997; 
Wahba 1991; Nunn 1987).  Greater decreases occur in obese patients (Wahba 1991). 
 
Dependent lung volume may be decreased by pre-existing damage.  This may occur secondary to similar processes 
as occurred in the lung being operated on.  This is especially important in the Western Cape with the high incidence 
of pulmonary tuberculosis (Cohen 1995; Benumof 1991; Katz, Laverne et al. 1982).  Causative factors include: 
 
1. A decrease in chest wall compliance of the of the dependent lung due to the weight of the chest (splinting); 
2. The weight of the mediastinum and the non-dependent lung; 
3. Surgical manipulation of the non-dependent lung; 
4. The abdominal contents exert greater pressure on the diaphragm of the dependent lung which aggravates 
the decrease in functional residual capacity; 
5. Use of 100% oxygen leads to absorption atelectasis; 
6. The development of atelectasis may be aggravated by airway obstruction from secretions, blood or pus 
from the non-dependent lung, poor muco-ciliary clearance during anesthesia and an incorrectly placed 
double lumen endotracheal tube (DLT).  
7. Zone 4 conditions may occur at the bottom of the non-dependent lung.  This zone is created either when a 
very low lung volume exists or transudation of fluid into the interstitial compartment occurs.  These 
situations produce a positive interstitial pressure that results in an increase in extra-alveolar vessel 
compression and resistance with subsequent decrease in pulmonary blood flow to this zone (Figure 
1.7.1.4); i.e. in zone 4 conditions, pulmonary arterial pressure > interstitial pressure > pulmonary venous 
pressure > alveolar pressure.  The patency of the extra-alveolar vessels, and therefore the blood flow 
through this area, is governed by the difference between pulmonary arterial and interstitial pressure. 
 
The decrease in lung volume leads to an increase in pulmonary vascular resistance because of the decrease in size 
of the extra-alveolar vessels.  This may impact adversely on right ventricular function (Lewis-JW, Bastanfar et al. 
1994).  Furthermore, the decrease in lung volume leads to the dependent lung being in a worse position on the 
pressure-volume relationship with a decrease in its compliance (Figure 1.7.1.3) (Cohen 1995).  This decrease in 
compliance may result in higher airway pressures during one lung anesthesia with adverse effects on right ventricular 
pre– and afterload (Aalto, Heinonen et al. 1975). 
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1.7.1.2.2 Hypoxic pulmonary vasoconstriction 
Barer and colleagues were some of the first people to study the effects of alveolar hypoxia on pulmonary blood flow.   
They elegantly described hypoxic pulmonary vasoconstriction (HPV) in the following words:  “The effects of bronchial 
occlusion on the pulmonary circulation were studied.  …  Blood flow fell rapidly at normal PAP, … and in constant 
flow experiments, PAP rose.  We conclude that an active … increase in vasomotor tone was involved” (Barer, 
Howard et al. 1969). 
 
Hypoxic pulmonary vasoconstriction is the principal mechanism whereby the resistance of hypoxic areas of the lung 
increases and blood flow is redirected.  This results in limitation of the shunt fraction (Figure 1.7.1.5) (Benumof 1991; 
Siegel and Brodsky 1991; Benumof 1985; Pirlo, Benumof et al. 1981; Bjertnaes, Mundal et al. 1980; Benumof 1979; 
Benumof and Wahrenbrock 1975).  Without HPV, 40 to 50% of the cardiac output would flow through the non-
dependent lung during OLA.  As a result of HPV, only 20 to 40% of the cardiac output is shunted through the non-
dependent lung (Benumof 1991; Rogers and Benumof 1985; Glasser, Domino et al. 1983; Fiser, Friday et al. 1982; 
Khanam and Branthwaite 1973; Tarhan and Lundborg 1970; Tarhan and Lundborg 1968).  This represents a 
decrease in the shunt to more manageable proportions (manageable in terms of arterial oxygenation) during one 
lung anesthesia (Figures 1.7.1.6 and 1.7.1.7) (Glasser, Domino et al. 1983).  HPV is therefore of importance in 
regulating the relative pulmonary vascular resistances, the distribution of flow between the dependent and non-
dependent lungs, and the shunt which plays a pivotal role in arterial oxygenation during one lung anesthesia.   
 
Factors relevant to this study that affect HPV during one lung anesthesia will be examined.  The relative magnitude 
of the collapse and tortuosity of the pulmonary vessels compared to the effects of HPV in decreasing flow to an 
atelectatic area has been quantified (Benumof 1991; Benumof 1985).  Whereas two studies from the same laboratory 
conducted in dogs report that limitation of flow is entirely due to hypoxic pulmonary vasoconstriction (Figure 1.7.1.5) 
(Pirlo, Benumof et al. 1981; Bjertnaes, Mundal et al. 1980; Benumof 1979), other work has demonstrated that 
mechanical obstruction accounts for approximately 6% of the rise in PVR during atelectasis (Bjertnaes, Mundal et al. 
1980).  Furthermore, it appears that P O2 also plays an important role in the initiation of HPV (Siegel and Brodsky 
1991).  A deviation from normal P O2 affects hypoxic pulmonary vasoconstriction due to diffusion of oxygen to or 
from the intravascular space.  An increase in the P O2 inhibits HPV in hypoxic areas of the lung, and a decrease 
therein promotes HPV in otherwise normoxic areas of the lung (Pease, Benumof et al. 1982; Benumof, Pirlo et al. 
1981).   
 
Intravenous anesthetic agents, including opioids, do not appear to have measurable effects on hypoxic pulmonary 
vasoconstriction, pulmonary vascular resistance and arterial oxygenation (Domino 1997; Reid, Slinger et al. 1996; 
Chen and Marshall 1995; Siegel and Brodsky 1991; Steegers and Backx 1990; Benumof, Augustine et al. 1987; 
Carlsson, Bindslev et al. 1987; Carlsson, Hedenstierna et al. 1987; Rogers and Benumof 1985; Rees and Gaines 
1984).  However, the inhalation anesthetic agents have been demonstrated to inhibit HPV in a dose dependent 
manner secondary to their effects on smooth muscle (Figures 1.7.1.8, 1.7.1.9 and 1.7.1.12) (Pagel, Fu et al. 1998; 
Domino 1997; Groh, Kuhnle et al. 1995; Mathers, Benumof et al. 1977).  Domino and her colleagues (Domino, 
Borowec et al. 1986) have quantified the dose dependent inhibitory effects of isoflurane on hypoxic pulmonary 
vasoconstriction in dogs independent of its effects on cardiac output or P O2 (Figure 1.7.1.8 and 1.7.1.9).  The 
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relationship between percentage inhibition by isoflurane on HPV was calculated as: 22.8 x % alveolar isoflurane 5.3♣ 
(Domino, Borowec et al. 1986).  Thus, a 0.5 x and a 1 x MAC end tidal partial pressure of isoflurane would inhibit 
hypoxic pulmonary vasoconstriction by 10.5% and 21% respectively.  This would consequently increase shunt from 
20%, to 22% and 24%, and decrease PaO2 from 37.3 kPa to 27.3 kPa while administering 100% oxygen (Figures 
1.7.1.7 and 1.7.1.9) (Benumof 1991; Benumof, Augustine et al. 1987; Bergel and Milnor 1965). 
 
The depressant effects of the inhalation agents on the circulation might counteract their direct inhibition of HPV 
(Benumof 1986; Domino, Borowec et al. 1986; Rees and Gaines 1984).  If the IAA’s decrease cardiac output, the 
resultant decrease in P O2 will potentiate HPV and thereby decrease shunt (Domino 1997; Siegel and Brodsky 
1991; Benumof 1986; Mathers, Benumof et al. 1977) (Figures 1.7.1.11 and 1.7.1.12).  This decrease in P O2 
coupled with a decrease in pulmonary artery pressure are suggested to be major reasons why inhalation agents 
produce minimal effects on PaO2 and shunt fraction and are well tolerated during one lung anesthesia despite 
directly inhibiting HPV (Figure 1.7.1.9) (Domino 1997; Siegel and Brodsky 1991; Benumof, Augustine et al. 1987; 
Carlsson, Bindslev et al. 1987; Benumof 1986; Domino, Borowec et al. 1986; Benumof and Wahrenbrock 1975). 
What is of concern however is that a change in P O2 will affect the PVR of both lungs.  A decrease in P O2 will 
cause an increase in the PVR in the ventilated, dependent lung.  This will act to redirect blood to the non-dependent 
lung and result in an increase shunt fraction (Siegel and Brodsky 1991). 
 
Factors other than anesthetic drugs may have an influence on HPV during one lung anesthesia (Benumof 1986):  
¾ Shunt fraction has shown to be higher in surgical patients due to local inhibition of HPV by the manipulation 
of the lung (Benumof 1991; Siegel and Brodsky 1991; Benumof 1986). Surgical stimulation may be cause 
the release of vasodilators such as prostaglandins (Boldt, Papsdorf et al. 1997; Scherer, Van Aken et al. 
1984).  This may contribute to an increase in shunt fraction. 
¾ Hyper– and hypocapnia have direct (via their effects on pH) and indirect effects on HPV (Benumof 1991).  
Hypercapnia promotes HPV.   However, hypercapnia will concomitantly increase PVR of the ventilated 
dependent lung, which will promote shunting of blood via the non-dependent lung.  The indirect effects of 
hypercapnia are related to the concomitant hypoventilation of the dependent lung, with a decrease in lung 
volume, development of low V/Q units and an increase in PVR (Benumof 1991).  Hypocapnia on the one 
                                                                
♣ In the study conducted by Domino and her colleagues (Domino, Borowec et al. 1986), the alveolar isoflurane concentration was 
calculated using a modification of the alveolar gas equation:   
 FAISO = [FIISO] – [[(FACO2 –FICO2)]/(FECO2-FICO2)] x [FIISO – FEISO]] 
 Where 
FIISO  is the mixed inspired isoflurane concentration expressed as fractional concentration of the 
inspired mixture, 
FEISO  is the mixed expired isoflurane concentration expressed as fractional concentration of the expired 
mixture, 
FACO2 is the alveolar carbon dioxide concentration.  This is estimated from the arterial carbon dioxide 
partial pressure, 
FICO2 is the inspired carbon dioxide concentration and, 
FECO2 is the mixed expired carbon dioxide concentration.   
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hand, inhibits hypoxic pulmonary vasoconstriction (Benumof, Mathers et al. 1976; Benumof and 
Wahrenbrock 1975).  On the other hand, the increase in tidal volume and respiratory rate required to 
induce hypocapnia may cause an increase in lung volume and pulmonary vascular resistance resulting in 
diversion of blood flow away from the dependent lung and to wards the non-dependent lung.  This shift 
may aggravate the shunt fraction during OLA.  
¾ The presence of pre-existing disease in the dependent lung limits the ability of its vascular bed to 
undergo recruitment and dilation and accept the increase in the percentage of the cardiac output that is 
distributed to it during one lung anesthesia (Benumof 1986).  This may increase the shunt flow directed via 
the non-dependent lung (Benumof 1986; Scanlon, Benumof et al. 1978). 
¾ Furthermore, pre-existing disease in the non-dependent lung may limit the ability of the lung to initiate 
hypoxic pulmonary vasoconstriction (Benumof 1991; Benumof 1986; Zapol and Snider 1977).  However 
pre-existing disease in the non-dependent lung may significantly limit flow to that side with favourable 
effects on shunt during one lung anesthesia (Benumof 1986).(Benumof 1991; Benumof 1985) 
¾ Both high and low pulmonary artery pressures affect hypoxic pulmonary vasoconstriction.  High 
pulmonary artery pressures compete with the smooth muscle in the vessel walls: as the normal pulmonary 
arteries have poor musculature, high pulmonary artery pressure will force the vasoconstricted channels 
open.  Low pulmonary artery pressure would enable zone one conditions in the “upper” part of the lung 
resulting in an increase in resistance (Benumof 1991; Scanlon, Benumof et al. 1978; Colley, Cheney et al. 
1977; Benumof and Wahrenbrock 1975).  
¾ When the percentage of the lung that is hypoxic is between 30 to 70% (typically the amount of lung that 
is hypoxic during one lung anesthesia), HPV is maximal and will positively influence PaO2 (Figure 1.7.1.6) 
(Benumof 1991).  When greater amounts of the lung are hypoxic, the ability to redistribute more blood 
away from the hypoxic area becomes proportionally less (Scanlon, Benumof et al. 1978).  
1.7.1.2.3 An increase in lung volume  
Should the volume of the dependent lung exceed functional residual capacity, compression of alveolar capillaries 
and stretching of the extra-alveolar vessels with an increase in pulmonary vascular resistance will result (West 1985).  
Furthermore, compromise of venous return due to the increase in intrathoracic pressure and direct compression of 
the heart, a situation analogous to tension pneumothorax, may occur (Conacher 1998; Myles, Weeks et al. 1997).  
Causes of an increase in lung volume of the dependent lung during one lung anesthesia include: 
1. Excessive intrinsic or extrinsic PEEP.  Even modern plastic double lumen tubes with better inner diameter 
to wall thickness ratios than their older rubber counterparts have been shown to result in significant amount 
of intrinsic PEEP (Inomata, Nishikawa et al. 1997).  This may be compounded by lung units with slow time 
constants (i.e. high airway resistance due to secretions (Conacher 1998; Myles, Weeks et al. 1997; 
Raffin, Michel-Cherqui et al. 1992), bronchospasm, low lung volumes, kinked, poorly positioned or 
inappropriately small double lumen tubes and high pulmonary compliance in patients with COPD).  If this 
is additionally combined with a relatively short time in which expiration is allowed to occur (high respiratory 
rate as usually recommended during one lung ventilation), dynamic hyperinflation may ensue (Conacher 
1998; Inomata, Nishikawa et al. 1997; Slinger, Hickey et al. 1989). 
2. Excessive tidal volumes, especially when combined with factors that aggravate dynamic hyperinflation 
and intrinsic PEEP (Ranieri, Mascia et al. 1995). 
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3. A pneumothorax, or bullus on the ipsilateral side as the dependent lung that has greatly distended during 
one lung ventilation, will produce similar effects as those described above. 
 
Excessive CPAP to the non-dependent lung, in the presence of an open chest that does not limit lung distension, 
may increase pulmonary vascular resistance of that lung.  
1.7.2   The performance of the right ventricle during one lung anesthesia 
1.7.2.1 Studies emphasizing right ventricular function during one lung 
anesthesia 
Only very few studies (Fujita, Yamasaki et al. 1993) have specifically studied the function of the right ventricle during 
one lung anesthesia: 
¾ Fujita and colleagues (Fujita, Yamasaki et al. 1993) used sonomicrometers to study the effect of 
sevoflurane on right ventricular function during one lung anesthesia in healthy sheep.  The aims of their 
study were “to examine the effect of sevoflurane on right ventricular function, the safety of sevoflurane for 
one lung ventilation and the effects of PEEP to the dependent lung”.  They found no difference on the 
Figure 1.7.2.1.  The changes in RVEF during pneumonectomy.    Lewis, Bastanfar et al, 1994 
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shortening fraction in these two areas when comparing ZEEP, PEEP5, and PEEP10.  They did not report on 
Ea or Ees data. 
Other studies (Inomata, Nishikawa et al. 1997; Lewis-JW, Bastanfar et al. 1994) have studied global 
hemodynamics and/or right ventricular function after PA clamping and/or lung resection: 
¾ Inomata and colleagues (Inomata, Nishikawa et al. 1997) investigated the level of PEEP that would 
optimise both hemodynamics and oxygenation during one lung anesthesia.  They studied eight patients 
without COPD scheduled for lobectomy.  The anesthetic regimen comprised fentanyl, isoflurane and 
nitrous oxide.  Up to 7.8 cm H2O PEEP applied to the dependent lung resulted in an increase in RVEF from 
30 ± 11% to 38 ± 8%, but PVR was unchanged when compared to ZEEP.  On applying a further 6.5 cm 
H2O PEEP to the dependent lung, a decrease in RVEF to 33 ± 9% and cardiac index (from 3.14 ± 0.74 to 
2.75 ± 0.86 litres.min-1.m-2) was detected (Inomata, Nishikawa et al. 1997).  Inomata et al, suggest that at 
these levels of PEEP, alveolar capillary compression was induced as reflected by the increase in 
pulmonary vascular resistance (Figures 1.7.3.1 and 1.7.3.2) (Inomata, Nishikawa et al. 1997). 
 
¾ Boldt and colleagues (Boldt, Muller et al. 1996) designed a study to investigate “cardiopulmonary 
alterations in patients undergoing pulmonary resection under standardized conditions, whether the kind of 
anesthetic management technique affects hemodynamics, and whether early or late extubation has any 
negative consequences”.  Hemodynamics were recorded after induction of anesthesia, before initiation of 
surgery, 30 minutes after initiating one lung anesthesia, at the end of surgery and postoperatively.  
Pneumonectomy, but not lobectomy, was associated with a deterioration in right ventricular function (a 
decrease in RVEF from 40.6 ± 3.4%) to 28.8 ± 4.3%, and increases in RVEDVI (85 ± 16) to 116 ± 21 
ml.m-2, CVP (10 ± 3.6 to 14.8 ± 3.1 mm Hg) and PAWP (12.2 ± 2.9 to 18.3 ± 3.8 mm Hg).  Boldt and his 
colleagues comment on their findings as follows: “an increase in right ventricular afterload associated 
initially with one lung anesthesia and subsequent pneumonectomy may lead to an increase in right 
ventricular end-diastolic volume, a decrease in EF with septal shift and reduced left ventricular filling but 
increased LVEDP”.  
 
¾ Lewis et al, (Lewis-JW, Bastanfar et al. 1994) also studied patients who had mild COPD undergoing 
pneumonectomy.  Their aims were to determine predictors of late cardiopulmonary function.  RVEF was 
normal (> 45%) preoperatively in 59% of the patients.  On clamping of the pulmonary artery, two types of 
response were observed: 70% of the patients demonstrated a decrease in RVEF to less than 45%, and in 
25% of patients, RVEF fell below 35%.  RVEF was closely related to right ventricular stroke work index and 
inversely to right ventricular end-diastolic volume index (Figure 1.7.2.1).  There were no changes in 
RVEDVI, central venous pressure or PAWP and no correlation between pulmonary vascular resistance, 
pulmonary artery pressure and RVEF.  
 
¾ The intraoperative decrease in EF and increase in RVEDV has been shown to continue postoperatively 
(Okada, Ishii et al. 1996; Okada, Ota et al. 1994; Lewis-JW, Bastanfar et al. 1994; Reed, Spinale et al. 
1992).  In the study by Lewis et al, (Lewis-JW, Bastanfar et al. 1994), a RVEF of less than 35% on 
pulmonary artery clamping accurately identified patients in whom limitation of exercise capacity (NYHA 
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class 3 or 4) was evident 9.7 ± 6.3 months after surgery.  It is interesting to note that a preoperative 
PVR/RVEF ratio greater than five predicted long-term exercise limitation (a NYHA classification of 3 or 4) 
in 5 out of 6 patients undergoing pneumonectomy (Lewis-JW, Bastanfar et al. 1994).  No other 
preoperative tests predicted this deterioration in postoperative cardiopulmonary status (Lewis-JW, 
Bastanfar et al. 1994).  Amar and colleagues also studied perioperative RV function in patients undergoing 
both lobectomy and pneumonectomy.  The tool that these investigators used was echocardiography (Amar, 
Burt et al. 1996).  They found that pneumonectomy, but not lobectomy, was associated with a 
postoperative increase in systolic pulmonary artery pressure (31 ± 15 versus 25 ± 10 mmHg respectively).  
Nonetheless, this moderate degree of increase in pulmonary artery pressure was not associated with any 
evidence of RV dysfunction.  However, two of the three patients who developed acute respiratory distress 
syndrome postoperatively also developed RV dilation.  These two patients with two-organ dysfunction died 
postoperatively (Amar, Burt et al. 1996). 
 
¾ Okada et al, (Okada, Ota et al. 1994) suggested that the RV adapts to increases in afterload by dilation, 
which may only be evident on exercise.  They subsequently investigated this hypothesis in candidates 
scheduled for lung resection by studying the preoperative predictive value of RVEF during exercise 
(Okada, Ishii et al. 1996).  A decrease in RVEF on exercise predicted a decrease in postoperative RVEF, 
and was found to be a better predictor of complications (e.g. arrhythmias, pneumonia) than the absolute 
value of this parameter.  
 
¾ The increase in RVEDV and decrease in RVEF have been related to the development of atrial fibrillation 
after lung resection (Backlund, Laasonen et al. 1998; Okada, Ota et al. 1994).  A study by Backlund and 
colleagues was not able to demonstrate a relationship between the above, albeit that immediate 
postoperative right ventricular pressure, greater volumes of intraoperative fluid and preoperative increased 
PVR was associated with the subsequent development of atrial fibrillation (Backlund, Laasonen et al. 
1998). 
 
Thus, in summary, right ventricular dysfunction during one lung anesthesia appears to occur: 
1. At too small or large lung volumes, but is not often associated with a measured increase in PVR,  
2. During pneumonectomy rather than lobectomy, 
3. Is predicted by a preoperative decrease in RVEF on exercise and by a PVR/RVEF ratio > 5,  
4. It is noteworthy that the deterioration in right ventricular function is not always associated with a 
measurable increase in total pulmonary vascular resistance or pulmonary artery pressure (Backlund, 
Laasonen et al. 1998; Freden, Wei et al. 1995) and,  
5. Dysfunction may continue for months postoperatively and be responsible for the subsequent limitation of 
exercise capacity 
1.7.2.2 One lung anesthesia, systemic hemodynamics and oxygen delivery 
Few studies have specifically addressed the effect of initiating one lung ventilation on hemodynamics and oxygen 
flux: most of the studies discussed below have addressed the effects of various manoeuvres on shunt and have 
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serendipitously included hemodynamic values in their tables of data.   
 
Many studies have reported that no change in cardiac output occurs during one lung ventilation (Wilson, Kapelanski 
et al. 1997; Boldt, Muller et al. 1996; Chen, Lee et al. 1996; Malmkvist, Fletcher et al. 1989; Carlsson, Bindslev et al. 
1987; Carlsson, Hedenstierna et al. 1987; Jenkins, Cameron et al. 1987; Carlsson, Bindslev et al. 1985; Rogers and 
Benumof 1985; Katz, Laverne et al. 1982; Rees and Wansbrough 1982a; Bachand, Audet et al. 1975; Morgan and 
Guntheroth 1970; Morgan and Guntheroth 1970; Morgan and Guntheroth 1970).  However there are a number of 
studies that have demonstrated an increase in cardiac output, VO2 and DO2 and a decrease in SVR on initiation of 
one lung anesthesia (Zaune, Knarr et al. 1990).(Pagel, Fu et al. 1998; Cohen, Eisenkraft et al. 1988; Thys, Cohen et 
al. 1988; Aalto-Setala and Heinonen 1982; Aalto, Heinonen et al. 1975): 
¾ Aalto-Setala and colleagues (Aalto-Setala, Heinonen et al. 1975) compared hemodynamics during one and 
two-lung ventilation.  They described a greater than 10% decrease in two, and an increase in another two 
of the 11 patients studied, of both cardiac output and oxygen delivery.  In a subsequent study, the same 
group described a small increase in stroke volume, cardiac output and oxygen delivery on initiation of one 
lung anesthesia (Aalto-Setala and Heinonen 1982).  What is also interesting that they described an inverse 
relationship between cardiac index and plateau airway pressure during one lung ventilation (Figure 
1.7.2.2). 
¾ On initiation of one lung anesthesia, Cohen and co-workers (Cohen, Eisenkraft et al. 1988) described an 
increase in cardiac output from 3.57 ± 0.17 to 4.5 ± 0.26 l.min-1.  Anesthesia was maintained with 
isoflurane and 50% nitrous oxide and the authors suggest that the increase in cardiac output could be 
attributed to a “fairly light level of anesthesia” or an autonomic reflex on initiation of one lung anesthesia 
(Cohen, Eisenkraft et al. 1988). 
Therefore, it appears that anesthetic agents used may have an influence on cardiac output and delivery of oxygen 
during one lung anesthesia (Boldt, Muller et al. 1996; Cohen, Eisenkraft et al. 1988; Rees and Wansbrough 1982a). 
 
Variable effects of PEEP and CPAP on hemodynamics during one lung anesthesia have been described, but many 
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Figure 1.7.2.2.  Relationship between plateau inspiratory airway pressure 
and cardiac index during one lung anesthesia.   r  = - 0.5894, p < 0.001.   
Redrawn from Aalto-Setala, Heinonen and colleagues, 1975 
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of the studies have reported a decrease in cardiac output:  
¾ Cohen and co-workers (Cohen, Eisenkraft et al. 1988) found no changes in hemodynamics when PEEP10 
compared to ZEEP was applied to the dependent lung.  However on application of PEEP10/CPAP10 to the 
dependent and non-dependent lungs respectively, cardiac output decreased. 
¾ In a subsequent study, Cohen and colleagues (Cohen, Thys et al. 1985a) compared the effect of a 
combination of CPAP and PEEP to the dependent and non-dependent lungs respectively during right and 
left thoracotomy.  They described a decrease in cardiac output (4.8 ± 1.3 to 3.79 ± 0.8 l.min-1) only when 
PEEP10/CPAP10 was administered which they suggested was due to the “increase in positive pressure in 
both lungs”.  No other differences in hemodynamics were elicited by the manoeuvres applied to either lung 
during one lung anesthesia. 
¾ Cohen and colleagues (Cohen, Thys et al. 1985b) also reported on the effects of applying PEEP10 to the 
dependent lung during one lung anesthesia during isoflurane and 50% nitrous oxide anesthesia in humans.  
Cardiac output decreased significantly from 5 ± 1.1 to 3.9 l ± 1.0 litres.min-1.     
¾ Cohen et al, (Cohen and Eisenkraft 1996) have differentiated between the effects of PEEP10 to the 
dependent lung in patients who are or are not hypoxic during one lung anesthesia.  Administration of 
PEEP10 elicited no difference on the cardiac output between these two groups.  They suggest that 
dependent lung volume and PVR were favourably affected in the hypoxic group, but this had no effect on 
total cardiac output (Cohen and Eisenkraft 1996).  
¾ Inomata et al, (Inomata, Nishikawa et al. 1997) demonstrated no change in cardiac index or delivery of 
oxygen during one lung anesthesia when ZEEP or an amount of PEEPe equal to the PEEPi present (up to 
7.8 cm H2O PEEP) was applied to the dependent lung.  However when an additional 6.5 cm H2O PEEP 
was applied to the dependent lung, both cardiac index and oxygen delivery decreased. 
¾ Capan et al, (Capan, Turndorf et al. 1980) systematically studied the effects of PEEP and/or insufflation of 
oxygen to the non-dependent lung with or without positive airway pressure on arterial oxygenation during 
one lung anesthesia.  Cardiac output was unchanged during application of CPAP or insufflation of oxygen 
to the non-dependent lung.  However PEEP10 to the dependent lung resulted in a 9% decrease in cardiac 
output (Capan, Turndorf et al. 1980).   
¾ Merridew and colleagues (Merridew and Jones 1985) studied the effects of non-dependent lung CPAP5 on 
arterial oxygenation.  No change in cardiac output was demonstrated in the 3 patients in whom it was 
measured.  No values for cardiac output were given in the article. 
¾ Alfery and colleagues (Alfery, Benumof et al. 1981) found no difference in cardiac output if up to 15 cm H2O 
of PEEP is applied to the non-dependent lung during one lung anesthesia in previously healthy dogs.  
¾ Fujita and colleagues (Fujita, Yamasaki et al. 1993) demonstrated that during one lung anesthesia with 
ZEEP, PEEP5 or PEEP10 administered to the dependent lung, systemic hemodynamics were not altered 
from baseline.   
 
The effects of initiation of one lung anesthesia on cardiac output and oxygen flux (where reported) can be 
summarized as follows:  
1. At ZEEP either  
¾ No change in cardiac output occurs, or  
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¾ An increase in cardiac output, VO2 and DO2 and a decrease in SVR are seen. 
2. On application of PEEP to the dependent lung  
¾ With up to 15 cm H2O, no change in cardiac output has on occasion been measured; 
¾ However, these levels of PEEP are usually associated with a decrease cardiac output. 
3. The combination of PEEP10 /CPAP10 consistently decreases cardiac output (Cohen, Eisenkraft et al. 1988; 
Cohen, Thys et al. 1985a).   
Cardiac output during OLA 
 No change Decrease Increase 
ZEEP 
Boldt, Muller et al. 1996; Fujita, Yamasaki et al. 1993; Malmkvist, Fletcher et al. 
1989; Carlsson, Bindslev et al. 1987; Carlsson, Hedenstierna et al. 1987; 
Jenkins, Cameron et al. 1987; Carlsson, Bindslev et al. 1985; Rogers and 
Benumof 1985; Katz, Laverne et al. 1982; Rees and Wansbrough 1982a; 
Bachand, Audet et al. 1975; Bachand, Audet et al. 1975 
 Cohen, 
Eisenkraft et 
al. 1988  
PEEP5 
Fujita, Yamasaki et al. 1993; Alfery, Benumof et al. 1981 Merridew and 
Jones 1985 
 
PEEP10 
Fujita, Yamasaki et al. 1993; Alfery, Benumof et al. 1981 Capan, Turndorf et 
al. 1980 
 
PEEP15 
Alfery, Benumof et al. 1981 Inomata, 
Nishikawa et al. 
1997 
 
CPAP10 
Capan, Turndorf et al. 1980 Cohen, Thys et al. 
1985b 
Cohen, 
Eisenkraft et 
al. 1988 
PEEP10 / 
CPAP10  
 Cohen, Eisenkraft 
et al. 1988; Cohen, 
Thys et al. 1985a 
 
Table 1.7.2.2.1  The effects of one lung anesthesia on cardiac output 
1.7.3   Management of an acute increase in RV afterload during one lung 
anesthesia 
1.7.3.1 Introduction 
How is it possible to optimise the work of, and ultimately restore the efficiency of a right ventricle that is faced with an 
acute increase in afterload?  On inspection of the diagram of ventricular-arterial coupling (Figure 1.5.2.10), it can be 
intuitively understood that improving the ratio of Ea to Ees (restoring the ratio to 1 to generate maximal stroke work 
or, optimally, restoring it to 0.5 to achieve maximal efficiency) will optimise the matching between the ventricle and its 
load.  The theory of coupling defines the factors determining SV as being (Sagawa, Maughan et al. 1988): 
SV = (Ees (Ved – Vo)) / (Ees + Ea) ………………………… Equation 1.7.3.1.1 
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Utilizing this approach, maximal SV may be achieved either by facilitating (Calvin, Jr. 1991): 
1. A reduction of Ea and/or 
2. An increase in Ees 
Either of these manoeuvres will move the ventricle from a failing position on the SW or efficiency versus Ea curves, 
at least to a point where SW is maximal and the ventricle is better matched to its afterload.  These variables may be 
addressed either singly or together.  However, addressing one variable may influence another.  For example, Fourie 
and co-workers have suggested that improving Ees of the right ventricle will be beneficial in optimising right 
ventricular coupling in acute pulmonary hypertension, not necessarily because of the increase in Ees, but because 
the improvement in ventricular elastance will match the new loading conditions (Fourie, Coetzee et al, 1992).  An 
increase in stroke volume may be also, within limits, be facilitated by: 
3. Optimising preload (Ved). 
1.7.3.2 Optimising afterload during one lung anesthesia 
During one lung anesthesia, the relative resistances of the dependent and non-dependent lung pulmonary vascular 
beds are of importance in determining shunt fraction and arterial oxygenation (Cohen, Eisenkraft et al. 1988).  
Minimizing the PVR of the dependent lung while minimally interfering with HPV in the non-dependent lung will 
optimise the total PVR.  Optimising the PVR will further optimise distribution of blood between the lungs (Benumof 
1991; Katz, Laverne et al. 1982; Benumof, Rogers et al. 1979).  Little to no information is directly available in the 
literature regarding the factors that affect PVR to the dependent lung during one lung anesthesia.  Conclusions 
regarding PVR have been derived from the reasoning that the degree of shunt and hypoxemia during one lung 
anesthesia is mostly related to the relative vascular resistances of the two pulmonary beds (Cohen, Eisenkraft et al. 
1988).  
 
The effects of various factors on PVR have been discussed previously, and only factors that are of relevance during 
one lung anesthesia will be discussed in this section. 
1.7.3.2.1 Optimising lung volume during one lung anesthesia 
Optimisation of dependent lung volume should minimize PVR and result in less of the cardiac output being shunted 
via the non-dependent lung (Cohen and Eisenkraft 1996; Benumof 1991; Katz, Laverne et al. 1982).  Atelectasis may 
be due to an increased closure of small airways caused by a decrease in the FRC (Cohen and Eisenkraft 1996). 
 
Ventilating the dependent lung with a tidal volume that is too small (less than 10 ml.kg-1) may predispose to 
atelectasis and an increase in PVR (Benumof 1991; Kerr, Smith et al. 1974).  Therefore, using large tidal volumes 
comprising either 16% of the total lung capacity, or 15 to 20 ml.kg-1, have been suggested to recruit alveoli, increase 
the FRC and prevent closing capacity from exceeding the FRC  (Cohen and Eisenkraft, 1996; Inomata, Nishikawa et 
al, 1997; Benumof, 1991).  However, the use of such large tidal volumes to ventilate the dependent lung has not 
been shown to have major beneficial effects on either oxygenation or PVR (Cohen and Eisenkraft 1996; Benumof 
1991; Katz, Laverne et al. 1982).  On the other hand, the use of an excessively large tidal volume has been 
associated with an increase in FRC and PVR that may increase diversion of blood to the non-dependent lung (Cohen 
and Eisenkraft 1996; Benumof 1991): 
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Figure 1.7.3.1.  The effect of PEEP on the dependent lung during one lung anesthesia in the lateral decubitus position.  See 
text for details.  Adapted from Cohen, 1995 
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Figure 1.7.3.2.  The effect of different levels of PEEPi and PEEPe applied to the dependent lung (see text for details) The 
correct level of PEEP may benefit the FRC with beneficial effects on shunt, oxygenation, and cardiac output.  However the 
therapeutic window is narrow, and excessive levels may prove deleterious. ZEEP indicates one lung ventilation with no added 
PEEPe, PEEP I indicates IPPV with PEEPe equivalent to PEEP1, and PEEPi + 5 indicates that 5 mm Hg of PEEP was added 
to the previous level of PEEPi that was being used too ventilate the DL.  Redrawn from Inomata et al, 1997 
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¾ The application of PEEP to the dependent lung is a logical manoeuvre in an attempt to ensure that FRC 
and PVR are maintained within normal limits and prevent alveolar and small airway closure (Cohen and 
Eisenkraft 1996; Benumof 1991; Cohen, Eisenkraft et al. 1988; Cohen, Thys et al. 1985b; Katz, Laverne et 
al. 1982; Tarhan and Lundborg 1970).  The application of PEEP10 to the dependent lung has however 
produced variable results on oxygenation, frequently resulting in an increase (Cohen and Eisenkraft 1996; 
Cohen, Thys et al. 1985b; Katz, Laverne et al. 1982; Capan, Turndorf et al. 1980; Tarhan and Lundborg 
1970) but also no change  (Cohen and Eisenkraft 1996; Cohen, Eisenkraft et al. 1988; Lowenstein, 
Johnston et al. 1983; Katz, Laverne et al. 1982; Aalto, Heinonen et al. 1975) in the shunt fraction during 
one lung ventilation.  The question arises therefore, as to the level of PEEP that needs be applied to 
optimise lung volumes and maintain PVR at its lowest level in the dependent lung?  Cohen and Eisenkraft, 
(Cohen and Eisenkraft 1996), and Inomata and colleagues (Inomata, Nishikawa et al. 1997) have 
addressed this problem.   
 
¾ Inomata and colleagues (Inomata, Nishikawa et al. 1997) studied the effect of intrinsic PEEP and externally 
applied PEEP to the dependent lung on right ventricular function.  The patients had normal preoperative 
lung function tests.  Their dependent lungs were ventilated via a 37 French gauge left sided Mallinckrodt ® 
DLT with a tidal volume of 8 ml.kg-1 at a rate of 16 breaths per minute with an ratio of inspiratory to 
expiratory time (I.E. ratio) of 1:2.   At first, the DL’s were ventilated with ZEEP while PEEPi was measured.  
PEEPi was measured as being 4 ± 2 mm Hg during OLA.  Thereafter, external PEEP equal to the patients 
individually measured PEEP was delivered to the DL.  This manoeuvre resulted in an increase in RVEF, 
cardiac index, and oxygen delivery and was accompanied by a decrease in shunt and improvement in 
arterial oxygenation, compared to when only PEEPi was present.  However, application of a further 5 mm 
Hg of PEEP to the dependent lung resulted in an increase PVR to values greater than those observed with 
ZEEP (from 208 ± 64 to 286 ± 109 dynes.sec.cm-5.m-2), and decreases in cardiac index, delivery of oxygen 
and RVEF.  Shunt increased to values close to those seen at ZEEP.  The patients studied by Inomata had 
no clinical evidence of COPD or restrictive lung disease, and unfortunately does not provide us with a 
blanket answer to the problem of how to optimise lung volume and minimize PVR in the individual patient.  
It does however emphasize the narrow therapeutic window seen with PEEP and the need to individualize 
therapy (Conacher 1998; Inomata, Nishikawa et al. 1997). 
 
¾ Cohen and Eisenkraft, demonstrated that PEEP10 improved oxygenation only in patients with low a PaO2 
during one lung anesthesia (Cohen and Eisenkraft 1996; Cohen 1995; Cohen, Thys et al. 1985b).  They 
“postulate that the patient who’s PaO2 is low while on one lung ventilation has an end-expiratory lung 
volume that is less than ideal and a high PVR.  The application of PEEP10 increases lung volume, restores 
FRC to normal, decreases PVR, and improves blood flow through (the dependent lung), all of which result 
in an increase in PaO2 (Cohen and Eisenkraft 1996).  Conversely, in a patient whose PaO2 on one lung 
ventilation is greater than 80 mm Hg (i.e. not hypoxic), the application of PEEP10 increases the existing 
favourable ventilation perfusion ratio, and the increase in FRC causes a decrease in PaO2 because of 
increases in PVR and shunt” (Figure 1.7.3.1) (Cohen and Eisenkraft 1996).  
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¾ Slinger and colleagues studied whether improved oxygenation occurs when the application of external 
PEEP causes the plateau end-expiratory pressure to move towards the lower inflexion point of the 
compliance curve (Slinger, Kruger et al. 2001).  They showed that on the application of PEEP5, if the 
plateau end-expiratory pressure moved toward the lower inflexion point, oxygenation improved.  Lung 
volume can be inferred from the lower inflexion point on the compliance curve (Nunn 1987; Slinger, Kruger 
et al. 2001).  Therefore, if PEEP5 increases lung volume towards FRC during OLA, oxygenation will 
increase.  However, if on the application of PEEP5, the plateau end-expiratory pressure moved away from 
the lower inflexion point, then oxygenation decreased.  This may be explained as follows: if PEEP5 
increases lung volume above FRC, PVR may increase and blood will be diverted to the NDL with a 
resultant increase in shunt fraction.  It is suggested that the discrepancy in results between various studies 
following on the application of PEEP5 to the DL is because PEEP5 may have different effects on lung 
volume in different patients.  Intrinsic PEEP and externally applied PEEP interact in an unpredictable 
fashion during OLA to produce increases in lung volume (Slinger, Kruger et al. 2001). 
 
The efficacy of adjustments to tidal volume and PEEP in restoring and maintaining dependent lung FRC and 
minimizing PVR may depend on the initial DL FRC (Figure 1.7.3.1).  Nonetheless, the variable results of these 
manoeuvres leads to the consensus that the therapeutic window to maintain dependent lung volume, minimize PVR 
and reduce shunting during one lung ventilation, is narrow (Figure 1.7.3.2) (Inomata, Nishikawa et al. 1997; Cohen 
and Eisenkraft 1996; Benumof 1991). 
 
Another method of favourably diverting blood between the two pulmonary beds is to compress or occlude the 
pulmonary flow through the NDL vascular bed (Ishikawa, Nakazawa et al. 2003).   
 
Application of PEEP10/CPAP10 has been shown to improve arterial oxygenation but at the same time decrease both 
cardiac output and oxygen delivery (Cohen, Eisenkraft et al. 1988).  It is noteworthy that the beneficial effect of 
PEEP10/CPAP10 on oxygenation is not because it increases PVR and thereby diverts blood flow away from the non-
dependent lung as it has been demonstrated not to affect total PVR (Cohen and Eisenkraft 1996; Alfery, Benumof et 
al. 1981).  There are no reports of its influence on right ventricular function. 
1.7.3.2.2 Hypoxic pulmonary vasoconstriction  
Factors affecting HPV in the non-dependent lung during one lung anesthesia have already been addressed.  A low 
PAO2 will induce HPV in the dependent lung, which is most undesirable.  The individual factors on which PAO2 is 
dependent are summarized in the alveolar gas equation: 
 
PAO2  = (PBO2 – PH2O) FiO2 – (PACO2 / respiratory quotient) …….…………….. Equation 1.7.3.2.2.1 
 
Administering 100% oxygen at sea level may optimise FiO2.  Ventilation of the dependent lung may be optimised by: 
¾ Maintaining an ideal position on the pressure-volume relationship, thereby optimising lung compliance and, 
¾ Decreasing airway resistance (removing secretions, optimal placement of the correct size DLT, optimising 
reversible airway resistance components of obstructive airways disease). 
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Additionally, maintaining ideal lung volume will optimise factors preventing the deleterious effects of HPV in the 
dependent lung:  
¾ Optimal ventilation perfusion matching will be maintained.  Lung units with low V/Q ratios will have a low 
PAO2.  Low alveolar oxygen partial pressures will induce HPV that limit the shunt fraction.  The effect of this 
on dependent lung PVR will depend on the rate of flow of blood through, and the vascular reserve of that 
lung. 
¾ Excessive increases in lung volume may lead to both increases in PVR and decreases in venous return.  
Both may lead to a decrease in cardiac output.  A decrease in cardiac output may lead to greater tissue 
extraction of oxygen and a lower P O2 with generalized HPV in the dependent lung. 
 
Rees and Wansbrough have demonstrated that no change in total PVR or mean PAP occurred if oxygen was 
insufflated down the non-dependent lung (Rees and Wansbrough 1982a).  Nonetheless, shunt was less and PaO2 
greater in the patients in which oxygen was insufflated down the non-dependent lung (Cohen 1995; Rees and 
Wansbrough 1982a). 
1.7.3.2.3 Pulmonary vasodilator drugs during lung surgery 
The multiple attempts to use various non-selective pulmonary vasodilators during pulmonary hypertension 
(prostaglandins, hydralazine, nitrates, sodium nitroprusside, adenosine, captopril, non-steroidal anti-inflammatory 
agents, prostacyclin, calcium channel blockers) attest to the problems involved in their use (Stoltzfus 1997; 
Haraldsson, Kieler Jensen et al. 1996; Pearl and Siegel 1992; Bolliger, Fourie et al. 1991; Lake 1990; Melot, Lejeune 
et al. 1989; Prielipp, Rosenthal et al. 1988; Packer, Medina et al. 1985; D'Ambra, LaRaia et al. 1985; Hasselstrom, 
Eliasen et al. 1985; Parsons and Wetzel 1985; Weigelt, Gewertz et al. 1982): 
¾ Use of these drugs, except for aminophyline and hydralazine, will lead to inhibition of HPV and hypoxemia.  
Therefore their use during one lung anesthesia may present problems (Myles, Weeks et al. 1997). 
¾ Vasodilators may decrease RVEDV that may result in decreases in RVSWI and cardiac output (Parsons 
and Wetzel 1985).(Sibbald, Short et al. 1985) 
¾ In ALI, fixed anatomical lesions (thrombi) in the pulmonary vasculature may be unresponsive to 
vasodilators (Troncy, Francoeur et al. 1997). 
¾ Even the nitric oxide donors (nitroglycerine and sodium nitroprusside) are not selective at higher dosages 
for the pulmonary vasculature and cause systemic hypotension.  A decrease in coronary perfusion 
pressure is deleterious to the right ventricle facing an increase in afterload.  Adenosine and prostaglandin 
E1, when compared to the other pulmonary vasodilators, appear to elicit the greatest decrease in PVR 
relative to the decrease in SVR (Prielipp, Rosenthal et al. 1988).  However, adenosine and prostaglandin 
E1 also give rise to systemic hypotension (Bolliger, Fourie et al. 1991)(Fullerton, Jones et al. 1996) 
 
Nevertheless, inhaled nitric oxide is a selective pulmonary vasodilator that has little effect on systemic 
hemodynamics. In response to an editorial by Zapol in 1994 in which he suggested that that the use of nitric oxide be 
investigated during one lung anesthesia, Wilson, Kapelanski et al, (Wilson, Kapelanski et al. 1997) administered 40 
parts per million of nitric oxide to 6 patients with a variety of lung pathologies undergoing OLA.  No difference in PVR, 
PAP, cardiac output or oxygenation was found whether nitric oxide was administered or not during one lung 
anesthesia.  The function of the right ventricle during nitric oxide administration while OLV was being conducted was 
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not specifically studied.  As the pulmonary vasodilator potency of inhaled nitric oxide is directly proportional to the 
PVR before administration of the drug, their findings are not unexpected as the patients that were studied had normal 
PVR before and during OLA.  Based on their study, Wilson and colleagues did not advocate the use of nitric oxide 
during one lung anesthesia in subjects who experience hypoxia and in whom PVR is not elevated (Wilson, 
Kapelanski et al. 1997). 
1.7.3.2.4 The effect of anesthesia and surgery on pulmonary vascular resistance 
Individual anesthetic agents and the interaction of anesthesia, surgery and the sympathetic nervous system may 
affect the pulmonary vasculature.  The effect of anesthesia on HPV has already been addressed.  Albeit that 
anesthetic agents minimally affect PVR during two-lung ventilation, isoflurane has been shown to cause pulmonary 
vasodilatation (Wilson, Kapelanski et al. 1997; Burrows, Klinck et al. 1986; Mathers, Benumof et al. 1977).  Large 
dosages of alfentanil and other opioids do not appear to have an effect on the pulmonary vasculature (Armstrong 
1992; Burrows, Klinck et al. 1986).  A high dose opioid technique administered in combination with IAA has been 
shown to decrease sympathetic nervous system tone.  Decreased sympathetic nervous system stimulation 
decreases baseline PVR whereas stimulation of sympathetic nerves has been demonstrated to increase PVR (Pagel, 
Fu et al. 1998; Wilson, Kapelanski et al. 1997; Armstrong 1992; Burrows, Klinck et al. 1986; Nimbkar and O'Neill 
1973; Kadowitz and Hyman 1973).  
1.7.3.3 Optimising right ventricular preload 
Augmenting EDV will potentially maximize the stroke work outputted by a ventricle with decreased contractility 
(Sibbald and Driedger 1983).  Animal experiments on right ventricular infarction conducted between 1974 and 1985 
(Dell'Italia, Starling et al. 1985; Guiha, Limas et al. 1974; Cohn, Guiha et al. 1974) lead to the recommendations that 
the first response to a decrease in right ventricular SV should be to administer fluid intravenously, thereby increasing 
RVEDV and sarcomere length (Jacobsohn, Chorn et al. 1997; Stoltzfus 1997; Hines and Barash 1993; Dhainaut and 
Squara 1992; Calvin, Jr. 1991; Dell'Italia, Starling et al. 1985; Sibbald and Driedger 1983).  
 
However, volume expansion in patients with a decrease in right ventricular SV due to an increase in RV afterload has 
not been shown to produce uniformly beneficial effects (Dell'Italia, Starling et al. 1985).  One the one hand, 
intravascular volume expansion has been shown to maintain cardiac output in acute pulmonary hypertension 
(Wiedemann and Matthay 1997; Sibbald and Driedger 1983).  On the other hand, various studies have echoed the 
fact that volume loading of the right ventricle faced with an increase in afterload may not only be unsuccessful but 
injurious (Goldhaber 1997; Stoltzfus 1997; Schreuder, Schneider et al. 1988; Ghignone, Girling et al. 1984; Prewitt 
and Ghignone 1983; Milnor 1982c).  Ghignone and colleagues demonstrated that volume-loading patients with right 
ventricular dysfunction resulted in marked deterioration of RV performance, and RV stroke volume and systemic 
mean arterial pressure were shown to decrease (Ghignone, Girling et al. 1984).  Canine pulmonary embolism 
resulting in circulatory insufficiency, when treated with volume therapy alone, resulted in the death of all dogs 
(Stoltzfus 1997).  A differentiating factor as to when volume loading may or may not be successful has been 
suggested to be the resistance faced by the right ventricle.  When PVR was less than 12 mm Hg.litre-1.minute-1, 
volume therapy usually increased cardiac output.  However when PVR was greater than 12 mm Hg.litre1.minute-1, 
volume infusion usually resulted in a decrease in cardiac output.  The RVEDP’s at which this decrease in cardiac 
output has been reported to occur, 7 mm Hg (Prewitt and Ghignone 1983) or 11.9 mm Hg (Ghignone, Girling et al. 
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1984), were surprisingly low.  This differentiation does not however consider the contractility of the right ventricle.   
 
The mechanism whereby cardiac output does not increase in response to fluid therapy is suggested to be due to:  
¾ The damaged right ventricle operating on the flat part of its ventricular function curve (Dell'Italia, Starling et 
al. 1985):  volume loading will not increase cardiac output or RVSWI (Stoltzfus 1997; Dell'Italia, Starling et 
al. 1985) and may even position the ventricle on the descending part of the ventricular function curve 
(Prewitt and Ghignone 1983). 
¾ The increase in right ventricular cavity size and pressure may produce extremes of the so-called “parallel” 
ventricular interaction (Dell'Italia, Starling et al. 1985; Ghignone, Girling et al. 1984; Milnor 1982c).  This 
leads to impairment of the left ventricular performance (Dell'Italia, Starling et al. 1985). 
¾ Increases in intracavitary pressure and radius will increase wall stress of the right ventricle (Wiedemann 
and Matthay 1997; Stoltzfus 1997; Ghignone, Girling et al. 1984; Prewitt and Ghignone 1983; Sibbald and 
Driedger 1983; Korr, Gandsman et al. 1982; Milnor 1982c).  This leads to two deleterious effects.  Firstly, 
the acute rise in right ventricular afterload due to the increase in radius will decrease right ventricular stroke 
volume (Korr, Gandsman et al. 1982).  This has been shown through series diastolic ventricular interaction, 
to decrease systemic arterial pressure (Dell'Italia, Starling et al. 1985).  Secondly, decreases in RV 
subendocardial blood flow (Figure 1.3.3.1) (Dyke, Brunsting et al. 1987) followed by frank RV myocardial 
Figure 1.7.3.3.1  Decrease in RV subendocardial blood flow and coronary vascular reserve as preload is increased from 
a low to a low level.  Note that “low level” means 3 mm Hg and “high level” of preload means 10 mm Hg.  Both high and low 
levels are considered relatively moderate filling pressures in acute RV failure.  Reproduced from Dyke, Brunsting et al. 1987.  
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ischemia may be induced by rapid increases in preload (Wiedemann and Matthay 1997; Stoltzfus 1997; 
Ghignone, Girling et al. 1984; Prewitt and Ghignone 1983; Sibbald and Driedger 1983; Milnor 1982c). 
¾ The development of tricuspid incompetence will limit forward stroke volume especially in the presence of 
an increase in opposition to RV ejection (Wiedemann and Matthay 1997). 
 
Because right ventricular performance has been shown to deteriorate with volume administration at relatively low RV 
end-diastolic pressures (7 to 12 mm Hg), RV filling pressures may be a poor predictor of the response to volume 
loading when a low cardiac output is caused by an increase in RV afterload (Calvin, Jr. 1991; Ghignone, Girling et al. 
1984). The great compliance of the right ventricle allows large volume increases which are accompanied by 
unimpressive rises in end-diastolic pressure until the elastic limits set by the pericardium are reached (Milnor 1982c).  
Guidelines as to fluid administration utilizing right-sided filling pressures are therefore problematic in the face of acute 
PHPT.  Some authors suggest that fluid administration should be started if CVP is less than 10 mm Hg (Dodson, 
Nathan et al. 1997); others suggest that the volume administration is used to increase end-diastolic pressure by at 
least 5 mm Hg and RVEDP should not exceed 20 mm Hg (Dell'Italia, Starling et al. 1985). 
 
Volume therapy during pulmonary hypertension is best guided by monitoring RVEDV, indices of RVEDP, position of 
the interventricular septum, cardiac output and P O2 utilizing both a pulmonary artery catheter (PAC) and 
echocardiography (Stoltzfus 1997; Lichtwarck-Aschoff, Leucht et al. 1994; Rafferty, Durkin et al. 1993; Vincent, 
Thirion et al. 1986).  Volume therapy should be aimed to increase cardiac output rather than filling pressures as: 
¾ Excessive volume administration may cause a decrease in cardiac output. 
¾ Indices of left ventricular filling such as LVEDP or PAWP, because of ventricular interdependence, may not 
reflect true volume of the LV during right ventricular dysfunction (Dell'Italia, Starling et al. 1985; Prewitt and 
Ghignone 1983; Laver, Strauss et al. 1979).  
¾ CVP values are also not considered by some to be useful as a guide to volume therapy in the presence of 
an increase in right ventricular afterload (Stoltzfus 1997). 
 
It is apparent that caution needs to be applied when utilizing fluid loading in the approach to therapy of RV 
dysfunction.  A clear difference in approach to maximizing preload exists, based on the origin of the decrease in RV 
stroke volume (Fourie, Coetzee et al. 1992b; Prewitt and Ghignone 1983).  Most studies would support the initial 
moderate use of volume therapy in the face of pulmonary hypertension but it should be much more cautiously titrated 
in those subjects with greater increases in right ventricular afterload than those with myocardial problems and normal 
afterload.  The difference appears to occur at a PVR of more than 12 mm Hg.litre1.minute-1 (Stoltzfus 1997; Prewitt 
and Ghignone 1983). 
  
Furthermore during one lung anesthesia, additional factors need to be considered with regard to fluid therapy: 
¾ Vasodilatation and myocardial depression on induction of anesthesia may necessitate fluid administration; 
¾ Third space and blood loss; 
¾ The deleterious effects of IPPV and PEEP on venous return and, 
¾ The risk of postoperative pulmonary edema that carries a high mortality (Slinger 1995). 
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1.7.3.4 Optimising the inotropic state of the right ventricle 
1.7.3.4.1  Avoidance of excessive myocardial depression by anesthesia 
It is prudent to avoid excessive myocardial depression, as this will inhibit the ability of the right ventricle to generate a 
greater stroke work in the face of an increase in afterload.  A high dose opioid technique in addition to judicious 
dosages of inhalation agent (< 1 MAC isoflurane) should avoid this problem in hearts with reasonable ventricular 
function (Heerdt, Gandhi et al. 1998). 
 
1.7.3.4.2  Inotropic support 
Optimising preload alone may prove inadequate or inappropriate in optimising RV performance in the face of an 
increase in afterload (Hines and Barash 1993).  Optimising coupling of the right ventricular and its afterload may 
therefore involve increasing contractility.  The advantages of increasing contractility are as follows: 
1. An increase in Ees will increase the load with which the ventricle can cope before it fails (Figures 1.5.2.8, 
1.5.2.9 and 1.5.2.10).   
2. Using Equation 1.7.3.1.1, the relationship between stroke volume and end-systolic elastance at constant 
values of end-diastolic volume, Vo and end-systolic pressure of the ventricle can be plotted (Figure 
1.7.3.4.2). If Pes and preload are unchanged, stroke volume and ejection fraction increase hyperbolically 
with increases in Ees.  Note that on the one hand, a reduction in end-systolic elastance from the normal 
value causes a dramatic decreases in stroke volume and ejection fraction.  On the other hand, increases in 
end-systolic elastance do not result in significant increases in stroke volume or ejection fraction (Sagawa, 
Maughan et al. 1988).  
3. Increases in stroke volume and cardiac output will result in an increase in oxygen delivery and increase in 
P O2 that may have advantages in the presence of the significant shunt that exists during one lung 
anesthesia.  Suitable positive inotropic agents in the scenario of one lung anesthesia should not possess 
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Figure 1.7.3.4.2 
Relationship of RV stroke 
volume and RV ejection 
fraction to end-systolic 
elastance at a constant 
RVEDV (100 ml), Vo (5 
ml), and Pes (20 mm Hg).  
This relationship was 
constructed using 
Equation 1.7.3.1.1 and EF 
= 1 – 
((Vo+Pes/Ees)/RVEDV)).    
 
Adapted from Sunagawa, 
Maughan et al. 1988 
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adverse and even possess favourable effects on PVR (Mathru, Dries et al. 1990).   
Few systematic studies of the use of inotropes during increases in right ventricular afterload or OLA have been 
conducted. 
 
1.7.3.4.3 Inodilators   
Zapol and Snider originally described the use of isoprotenolol infusions in patients with ALI and acute pulmonary 
hypertension in the hope that it would cause pulmonary vasodilatation while providing inotropic support (Prewitt and 
Ghignone 1983; Aalto-Setala, Heinonen et al. 1975).  Canine studies of pulmonary embolism have shown the failure 
of isoprotenolol to improve RV function.  Human literature describing the use of isoprotenolol has mostly consisted of 
anecdotal reports of the use of the drug for right ventricular failure after cardiopulmonary bypass (CPB).  The 
problems of systemic vasodilatation, hypotension, tachycardia and hypoxemia associated with the use of this drug 
may lead to a decrease in CPP and ischemia of the stressed right ventricle (Hines and Barash 1993). 
 
The phosphodiesterase inhibitors are described as having both vasodilator and inotropic properties and have 
been suggested to be of use during acute right ventricular dysfunction and pulmonary hypertension (Chen, Bittner et 
al. 1997; Stoltzfus 1997; Lee and Hou 1995; Petry and Dutschke 1994; Deeb, Bolling et al. 1989; Konstam, Cohen et 
al. 1986).  An increase in cardiac index and a decrease in PVR typically occurs with the use of these agents (Chen, 
Bittner et al. 1997; Stoltzfus 1997; Konstam, Cohen et al. 1986).  Furthermore, they have been shown to potentiate 
the inotropic effects of the beta-adrenergic agonists (Doyle, Dhir et al. 1995).  On their own they do not produce 
much decrease in systemic arterial pressure, an important consideration in the presence of right ventricular 
dysfunction (Doyle, Dhir et al. 1995).   
 
The beneficial effect of amrinone and milrinone on RV function has been suggested to be secondary to their 
powerful pulmonary vasodilator effects (Chen, Bittner et al. 1997; Lee and Hou 1995; Doyle, Dhir et al. 1995; Petry 
and Dutschke 1994; Lake 1990; Deeb, Bolling et al. 1989; Konstam, Cohen et al. 1986).  Other authors (Chen, 
Bittner et al. 1997; Doyle, Dhir et al. 1995; Petry and Dutschke 1994) attribute the increase in cardiac output seen 
with the phosphodiesterase inhibitors to increases in contractility and do not attribute any effect to reduction in 
afterload (Chen, Bittner et al. 1997; Petry and Dutschke 1994).  The discrepancy for the reasons given why right 
ventricular function improves with these drugs may lie therein that they decrease PVR to a greater degree in those 
patients with the highest baseline PVR (Stoltzfus 1997; Doyle, Dhir et al. 1995; Petry and Dutschke 1994).  
Phosphodiesterase inhibitors have been shown to improve coupling of the RV to its load (Chen, Bittner et al. 1997). 
 
Dobutamine has shown to improve RV-PA matching, and may prove to be more useful than volume loading during 
states of acute pulmonary hypertension (Calvin 1998; Dell'Italia, Starling et al. 1985; Ghignone, Girling et al. 1984).  
Dobutamine does not however appear to be a selective pulmonary vasodilator: much of the decrease in calculated 
PVR is secondary to an increase in cardiac output accompanied by little increase in PA pressure due to pulmonary 
vascular recruitment and dilatation that occurs in relatively normal pulmonary vascular beds (Wolfer, Krasna et al. 
1994; Dell'Italia, Starling et al. 1985).  Coddens and colleagues (Coddens, Delooft et al. 1993) have demonstrated a 
decrease in pulmonary Ea, but not pulmonary vascular resistance during dobutamine administration.  They found 
that RVEF correlated best with Ea and PAWP and suggest that this underscores the importance of LV function in 
Chapter 1.  Literature review
 
136 
determining right ventricular afterload (Coddens, Delooft et al. 1993).  Furthermore, concerns regarding an increase 
in shunt fraction with the administration of dobutamine during OLA have recently been questioned (Mathru, Dries et 
al. 1990).  On this point, Domino emphasizes that PaO2 is often well preserved when dobutamine is administered to 
critically ill patients because of the improvement in cardiac output (Domino 1997; Renard, Jacobs et al. 1984).  
Stolftzfus pointed out another aspect of the use of dobutamine in RV dysfunction.  He suggests that a more marked 
increase in heart rate is seen when utilizing dobutamine for primary right ventricular dysfunction than when it is used 
for left ventricular dysfunction (Stoltzfus 1997; Imai, Saitoh et al. 1992). 
 
1.7.3.4.4 Inoconstrictors and vasoconstrictors 
One of the final pathways in right ventricular decompensation is right ventricular ischemia.  Restoration of aortic 
pressure and thereby maintenance of coronary perfusion pressure is necessary for preservation of RV function 
(Coyle, Carlin et al. 1990; Schreuder, Schneider et al. 1989; Ghignone, Girling et al. 1984; Prewitt and Ghignone 
1983; Vlahakes, Turley et al. 1981).  The inoconstrictors comprise drugs with both inotropic and vasoconstrictor (α 
adrenergic agonist) properties.  An increase in inotropicity will benefit the RV faced with an increase in afterload.  
However, two questions need to be examined when using agents with vasoconstrictor properties.  Firstly, do 
inoconstrictors benefit RV function by virtue of their increase in coronary perfusion pressure (systemic aortic 
pressure) and secondly, are the benefits of an increase in Ees offset by a deleterious increase in PVR (Coyle, Carlin 
et al. 1990)? 
 
Right ventricular (RV) function and pulmonary hemodynamics were studied in burned patients while administering up 
to 9.0 micrograms.kg-1.min-1 of dopamine (Martyn, Wilson et al. 1986).  No significant improvement in RV 
performance (RVEDV, RVEF) was observed.  However, with the infusion of dopamine, elevations in mean pulmonary 
artery pressures were noted, particularly in patients with pre-existing pulmonary artery hypertension (Martyn, Wilson 
et al. 1986).  Concern about these deleterious effects on pulmonary vascular resistance, prompted studies 
comparing the effects of dobutamine and dopamine on the pulmonary circulation (Stoltzfus 1997).  Imai and 
colleagues (Imai, Saitoh et al. 1992) demonstrated lower PVR with dobutamine than with similar dosages of 
dopamine (10 to 20 ug.kg-1.min-1), whereas Vincent et al, (Vincent, Reuse et al. 1988) found no difference at a dose 
of 5 ug.kg-1.min-1. However, even at dosages of dopamine (5 ug.kg-1.min-1) that did not increase PVR, similar 
dosages of dobutamine resulted in more favourable effects on right ventricular function (Table 1.7.3.4.4.1) (Stoltzfus 
1997; Vincent, Reuse et al. 1988).  It appears that patients with pre-existing pulmonary hypertension who received 
higher dosages of dopamine, experience greater increases in PVR.  The explanations brought forward are:  
¾ In equipotent dosages, dopamine has more prominent alpha adrenergic effects while dobutamine has 
stronger beta adrenergic effects, 
¾ Coronary blood flow has been shown to be greater with dobutamine than dopamine (Vincent, Reuse et al. 
1988).  Furthermore, dopamine has been suggested to have unfavourable effects on right ventricular 
oxygen supply-demand relationship with decreases in RVEF in spite of the restoration of right ventricular 
perfusion pressure (Schreuder, Schneider et al. 1989) and, 
¾ The use of dopamine has been associated with an increase in LV filling pressures.  LV filling pressures 
either do not change or decrease with dobutamine administration (Vincent, Reuse et al. 1988).  PAWP may 
play an important role in determining pulmonary vascular resistance (Coddens, Delooft et al. 1993). 
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No studies have been conducted as to the effects of adrenaline on right ventricular function in the face of an 
increased afterload (Stoltzfus 1997).  Lowenstein and colleagues published a case report of the beneficial effect of 
adrenaline in 5 patients with heparin-protamine reactions (Lowenstein, Johnston et al. 1983).  In a study of patients in 
severe septic shock, adrenaline administration proved beneficial in patients with right ventricular failure unresponsive 
to fluid, dopamine and dobutamine (Le Tulzo, Seguin et al. 1997).  Right ventricular function improved in spite of an 
11% increase in pulmonary artery pressure (Le Tulzo, Seguin et al. 1997). 
 
 Dopamine Dobutamine Significance 
Stroke index (ml.m-2) 28.1 ± 3.6 31.0 ± 3.8 p<0.01 
PAWP (mm Hg) 15.1 ± 1.0 13.9 ± 1.2 p<0.05 
RAP (mm Hg) 14 ± 1.3 12.2 ± 1.1 p<0.05 
RVEF % 21.5 ± 2.7 23.7 ± 2.9 p<0.01 
RVEDVI (ml) 140 ± 12 141 ± 12 not significant 
MAP (mm Hg) 88 85 not significant 
PAP (mean) (mm Hg) 29.4 ± 8.8 28.4 ± 9.3 not significant 
Table 1.7.3.4.4.1    Effects on RV function of a change from dopamine to dobutamine in critically ill 
patients without hypotension.  15 subjects were included in the study.  (Vincent, Reuse et al. 1988). 
 
The use of noradrenaline has been shown to markedly improve function of the failing RV in the presence of an 
increase in RV afterload (Stoltzfus 1997; Myles, Weeks et al. 1997; Raffin, Michel-Cherqui et al. 1992; Coyle, Carlin 
et al. 1990; Schreuder, Schneider et al. 1989; Schneider, Groeneveld et al. 1987; Ghignone, Girling et al. 1984).  In 
some studies, noradrenaline has resulted in a decrease in PVR; however in other studies PVR did not increase, 
albeit that there was an increase in mean PAP secondary to an increase in cardiac output (Kwak, Lee et al, 2002; 
Stoltzfus 1997; Ghignone, Girling et al. 1984; Angle, Molloy et al. 1989).  Schreuder and colleagues suggested that 
the increase in PVR in their study was offset by a concomitant improvement in right ventricular myocardial oxygen 
demand–supply relationship (Schreuder, Schneider et al. 1989).  Furthermore, they described a positive correlation 
between RVEF and RV coronary perfusion pressure with the use of noradrenaline (Schreuder, Schneider et al. 
1989).  An interesting approach to the problem of pulmonary vasoconstriction associated with noradrenaline 
administration is to infuse the drug into the left atrium (Coyle, Carlin et al. 1990).  The peripheral vasculature clears 
40% of the infused noradrenaline, compared to the 84% cleared by the pulmonary circulation.  This results in 
significantly less pulmonary vasoconstriction. 
 
Phenylephrine will induce peripheral vasoconstriction and increase right ventricular coronary perfusion pressure.  In 
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a landmark study, Vlahakes and colleagues (Vlahakes, Turley et al. 1981) demonstrated that an increasing coronary 
perfusion pressure using phenylephrine reversed right ventricular failure in an animal model of pulmonary 
hypertension. Other sources also suggest that PVR may not be greatly affected by phenylephrine (Kozhevnikov, 
Glonti et al. 1992; Meadow, Rudinsky et al. 1986) (abstracts only).  A study done in humans with chronic pulmonary 
hypertension (mean PAP 58 mm Hg) who were administered phenylephrine, demonstrated an increase in RV 
perfusion pressure but worsening of right ventricular function secondary to pulmonary vasoconstriction (Stoltzfus 
1997; Rich, Gubin et al. 1990).  Their conclusion was that phenylephrine might not be of benefit in this scenario: 
however it must be noted that these patients did not have pre-existing hypotension (Rich, Gubin et al. 1990). Lake 
suggests that albeit phenylephrine and other alpha agonists increase PVR, they are useful in restoring right 
ventricular perfusion pressure (Lake 1990).  Differences in PVR recorded in various studies when vasopressors are 
administered, may be due to differences in: 
¾ The pre-existing pulmonary vascular tone (Kozhevnikov, Glonti et al. 1992; Coyle, Carlin et al. 1990; 
McMurtry, Rodman et al. 1988); 
¾ Differences between species (McMurtry, Rodman et al. 1988); 
¾ Down regulation of pulmonary alpha receptors (Coyle, Carlin et al. 1990) and, 
¾ Dose and route of administration (Coyle, Carlin et al. 1990; McMurtry, Rodman et al. 1988). 
 
It should be noted that sympathetic nervous system stimulation has been demonstrated to induce pressure gradients 
of 20 to 40 mm Hg across the normal right ventricular outflow tract (Pace, Keefe et al. 1969).  The influence of this on 
right ventricular function has not been described.  
 
Left ventricular contraction via ventricular systolic interaction is considered to play an important role in right 
ventricular function (Santamore and Gray, Jr. 1996).  Therefore the effect of inotropes on the left ventricle may have 
significant effects on right ventricular function (Santamore and Gray, Jr. 1996; Coddens, Delooft et al. 1993). 
1.8 Mixed venous oxygen saturation and one lung anesthesia 
1.8.1 Descriptions of P O2 during one lung anesthesia 
If the Fick equation is solved for C O2, then   
C O2 = CaO2 – VO2/CO  ………………………… Equation 1.8.1  
Where   
 C O2 is mixed venous oxygen content 
CaO2 is arterial oxygen content 
VO2 is oxygen consumption 
CO is cardiac output 
 
If the oxygen dissolved in blood is ignored, and both sides of equation 1.8.1 are divided by hemoglobin concentration 
[Hb], the following equation can be derived: 
S O2 = SaO2 – VO2/(CO x [Hb] x 1.36) ………………………… Equation 1.8.2 
Where 
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 S O2 is venous oxygen saturation 
 SaO2 is arterial oxygen saturation and  
CO x Hb approximates oxygen delivery to the tissues.  
 
The implications of Equation 1.8.1 are that C O2 will increase as CaO2 increases, provided the relationship of VO2 to 
cardiac output remains unchanged. The factors predominantly affecting CaO2 are oxygen saturation and hemoglobin 
concentration.  Oxygen saturation normally approximates 100%.  However, CaO2 and therefore C O2 decrease and 
increase in parallel with changes in hemoglobin concentration.   
 
As the term on the right hand side of Equation 1.8.1 (the quotient of oxygen consumption and cardiac output) 
increases, mixed venous oxygenation decreases.  The reason is that a greater percentage of oxygen is extracted 
from the arterial blood.  It is not important whether increase in the relationship is due to an increase in oxygen 
consumption or a decrease in cardiac output.  The result is the same.  The converse of this relationship also applies.  
 
The implications of equation 1.8.2 are similar to those for equation 1.8.1.  The usefulness of Equation 1.8.2 lies 
therein that in the clinical setting, anesthesiologists commonly measure and are familiar with its components, arterial 
and venous saturation, hemoglobin concentration and cardiac output.  Therefore, the components of equation 1.8.2 
are more familiar to clinicians than the equation containing oxygen content.   
 
Only two studies have specifically studied what happens to P O2 during one lung anesthesia (Zaune, Knarr et al. 
1990; Thys, Cohen et al. 1988).  Thys et al, (Thys, Cohen et al. 1988) and Zuane and colleagues (Zaune, Knarr et al. 
1990) demonstrated a decrease in P O2 and an increase in both oxygen delivery and consumption after initiation of 
one lung ventilation. The ratio of DO2 to VO2 did not change and P O2 did not correlate with cardiac output or 
oxygen consumption.  If the relationship of DO2 to VO2 is unchanged, we may conclude that the decrease in P O2 is 
attributable to a decrease in the PaO2.   
 
Various other studies have reported data obtained during one lung anesthesia that include P O2 or S O2.  A full 
picture of hemodynamics including oxygen flux data is not always given in these studies.  This makes their 
interpretation difficult. 
¾ Malmkvist and colleagues (Malmkvist, Fletcher et al. 1989; Werner, Malmkvist et al. 1984) described a 
decrease in P O2 from 5.1 ± 0.6 kPa before pleurectomy to 4.2 ± 0.6 kPa during one lung anesthesia.  
They used pethidine (350 to 850 mg) and 50% nitrous oxide for anesthesia.  Cardiac index did not change 
and no further oxygen flux data are available.  
 
¾ Various studies by Cohen et al, during one lung anesthesia have reported data on P O2: 
a. S O2 decreased on administration of PEEP10 or PEEP10/CPAP10 from 83.8 ± 1.4% to 78.6 ± 
1.7%.  These investigators did not attempt to make an association between S O2, 
hemodynamics and oxygenation (Cohen, Eisenkraft et al. 1988). 
b. CPAP10 applied to the non-dependent lung was associated with an increase in S O2 from 78 ± 
7.5% to 82 ± 6.8% and in PaO2 from 80 ± 26 mm Hg to 126 ± 59 mm Hg (Cohen, Thys et al. 
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1985a).  During this study, an important observation was made.  It was noted that if the tip of the 
pulmonary artery catheter is located in the collapsed lung, the measured P O2 is lower than, and 
is not a reflection of the true mixed venous saturation (Cohen, Thys et al. 1985a). 
c. PEEP10 was applied to the dependent lung during isoflurane and 50% nitrous oxide anesthesia.  
PaO2 increased whereas no difference in the S O2 (77% ± 5) was described on administration of 
PEEP, despite an associated decrease in cardiac output (Cohen, Thys et al. 1985b). 
d. The effect of PEEP in hypoxic patients during one lung anesthesia was studied.  Anesthesia was 
maintained with an unspecified dosage of fentanyl, pancuronium and 1 to 1.5% isoflurane.  P O2 
did not differ between one and two-lung ventilation, nor did it differ between hypoxic and 
normoxic patients.  No oxygen flux data is reported (Cohen and Eisenkraft 1996). 
 
¾ Mathru and colleagues (Mathru, Dries et al. 1990) studied the effect of cardiac output on gas exchange 
during one lung anesthesia using enflurane.  They described an S O2 of 60 ± 6.9% during one lung 
anesthesia that increased to 74.6 ± 2.8% on administration of dobutamine.  Dobutamine administration 
was also associated with an increase in PaO2 and DO2 and a decrease in shunt and C(a-v)O2. No 
explanation for the decrease in shunt is given and neither is the influence of P O2 on PaO2 mentioned in 
the discussion.  That increases in P O2 may favourably influence PaO2 during one lung anesthesia is an 
interesting avenue to explore. 
 
¾ Pagel et al, (Pagel, Fu et al. 1998) describe a decrease in P O2 on initiation of one lung ventilation with 
desflurane and isoflurane albeit that no change in VO2 and an increase in cardiac output occurred. 
1.8.2 The increase in shunt fraction during one lung ventilation 
The shunt fraction has been shown to increase during one lung ventilation to 36% (Cohen, Eisenkraft et al. 1988), 
38% (Torda, McCulloch et al. 1974) or 25% (Weinreich, Silvay et al. 1980) at an FiO2 of 0.5, or 38% (Capan, 
Turndorf et al. 1980), 39% (Torda, McCulloch et al. 1974) or 36% (Weinreich, Silvay et al. 1980) if an FiO2 of 1.0 is 
used to ventilate the dependent lung. 
1.8.3 The effect of P O2 on arterial oxygen tension in the presence of a shunt 
P O2 may significantly influence PaO2 in the presence of a shunt or alveolar hypoxemia as induced by low V/Q units 
(West 1990; Domino, Borowec et al. 1986; West 1985).  In the presence of a decrease in PAO2, blood entering the 
capillary is subjected to a low driving pressure of oxygen across the alveolar capillary membrane and therefore the 
rate of movement of oxygen across the capillary is slower.  A significant difference between PAO2 and PcO2 may 
occur under these circumstances.  The PAO2-PcO2 difference may be further exaggerated when the time that blood 
spends in the pulmonary capillary is shortened as may happen during exercise or the administration of positive 
inotropic drugs (West 1990; West 1985) (Figure 1.8.3.1). 
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An increase in cardiac output has been associated with an increase in PaO2 during one lung anesthesia (Mathru, 
Dries et al. 1990).  On the other hand, if cardiac output decreases due to a rise in right ventricular afterload or the 
deleterious effects of anesthesia, both P O2 and arterial oxygenation will decrease if VO2 remains unchanged 
(Domino, Borowec et al. 1986; Mathers, Benumof et al. 1977).  Thus, the interaction of cardiac output, P O2 in the 
presence of the large shunt that exists during OLA, has not yet been clarified (Domino, Borowec et al. 1986). 
 
Furthermore, P O2 exercises significant influence on the hypoxic pulmonary vasoconstriction response (Benumof 
1985).  This may have a significant effect on the opposition to pulmonary blood flow in the non-hypoxic ventilated 
lung (Pease, Benumof et al. 1982). 
1.9 Hypothesis 
The right ventricle is a thin walled structure that can generate considerably less power than the thicker walled LV.  It 
possesses little reserve to deal with an acute rise in afterload as may occur during acute lung injury or after lung 
resection (Reed, Spinale et al. 1992).  As afterload progressively increases and the pulmonary vascular and right 
ventricular elastance become equal, the coupling of the RV and its load changes from operating at maximal 
efficiency to working at maximal SW.  Eventually, when pulmonary elastance exceeds RV elastance, the RV makes 
the transition from pressure to a flow pump and may fail.  Thus, the RV may be the limiting factor in the circulation 
and determine survival of the organism. (Calvin, Jr. 1991) During intrathoracic surgery, it is common to ventilate only 
one lung while the other lung is operated on.  This gives rise to 3 problems:   
1. Loss in lung volume 
The usual reduction in FRC during anesthesia is exaggerated in the dependent lung when the patient is 
positioned in the lateral decubitus position.  This can contribute to an increase in PVR especially if PHPT 
pre-exists. 
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Figure 1.8.3.1 The rise in PO2 as blood flows along the pulmonary capillary.  Blood enters the capillary at a PvO2 of 
5.3 kPa.  The PO2 rises rapidly until it approaches the alveolar partial pressure of oxygen.  The equilibration is almost 
complete after a third of the time that the blood spends in the capillary is complete.  If the alveolar partial pressure of oxygen 
is low which reduces the gradient driving blood across the alveolar capillary, the resultant rise in capillary PO2 is slower.  
There may be a significant difference between the alveolar and capillary partial pressure of oxygen at the end of the capillary.  
This process will be aggravated by any decrease in the transit time of the blood in the capillary, such as occurs with an 
increase in cardiac output.  Adapted from West, 1985 
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2. Acute increase in RV afterload 
An increase in PA pressure and PVR may result in an acute increase in RV afterload and impair matching 
between the RV and its afterload.  How exactly the right ventricle performs during OLA has not been well 
studied.  
3. Arterial hypoxia 
Arterial hypoxemia, due mainly to pulmonary shunt, may present a clinical problem during one lung 
ventilation.  The relative resistances of the pulmonary vascular beds of the dependent and non-dependent 
lungs are an important factor governing arterial oxygenation during one lung anesthesia.  A poorly 
performing right ventricle as a cause of circulatory impairment, may lead to mixed venous desaturation 
which will contribute significantly to the hypoxemia in the presence of a large shunt (West 1985).  Venous 
desaturation as a cause of hypoxemia during one lung anesthesia has not as yet been systematically 
addressed in the literature (Cohen 1995; Benumof 1991).  
 
The hypotheses that will be examined, state:  
1. RV performance and coupling with its afterload is adversely affected during one lung anesthesia by the 
increase in pulmonary vascular resistance.   
2. The following therapeutic modalities will prove to benefit RV-PA coupling: 
a. Inotropic support will favourably readjust the relationship between right ventricular stroke work 
and the load faced by the RV.  This will improve the ability of the RV to cope with an increase in 
afterload during OLA.   
b. The application of positive end expiratory pressure (PEEP) to the dependent lung will restore the 
decrease in lung volume usually seen during OLA.  This should reduce indices of RV afterload, 
minimize RV-afterload mismatch and enhance arterial oxygenation. 
3. Furthermore, in the presence of the large shunt that occurs during OLA, mixed venous oxygenation will 
most likely play an important role in arterial oxygenation.  Mixed venous oxygenation reflects the balance of 
systemic oxygen supply to oxygen demand, which will be affected by RV performance and the factors 
influencing it.  Therefore optimising RV performance and thereby PvO2 will improve arterial oxygenation 
during OLA.  
 
 
 2. Methods 
2.1 Consent, inclusion and exclusion criteria 
Institutional research committee approval was obtained for the study (Research Committee Study 97/028).  The 
ethical standards used conformed to the Declaration of Helsinki#.  A copy of the patient information and consent form 
that was used to recruit patients is included in the appendix to this document.    
 
Inclusion criteria to qualify for enrolment in this study were: 
¾ Patients who were scheduled for thoracotomy and pulmonary surgery utilizing one lung anaesthesia, 
¾ The ability to obtain informed consent preoperatively (see informed consent document: section 5.2) and, 
¾ Patients above 18 years of age. 
 
Patients that were excluded from this study were those that: 
¾ Did not qualify for pulmonary surgery according to the criteria used at our institution (Coetzee, 2000),  
¾ In whom there was preoperative evidence of left ventricular pathology (e.g. ischemic heart disease, 
systemic hypertension, left ventricular hypertrophy, left ventricular systolic or diastolic dysfunction or 
valvular disease), 
¾ Exhibited any clinical evidence of functional hemodynamic disturbances due to acute blood loss, fever, 
pregnancy, arteriovenous fistulae, heart failure, 
¾ Exhibited biochemical evidence of renal disease (urea > 7 mmol.l-1 or creatinine > 150 umol.l-1), 
¾ Had hemoglobin concentrations of less than 10 grams per 100 millilitres of blood, 
¾ Were scheduled for lung volume reduction surgery, 
¾ In whom the duration of surgery was expected to be less than 60 minutes and, 
¾ Had a family or personal history of metabolic muscle disease (e.g. malignant hyperthermia, myasthenia 
gravis or Eaton Lambert syndrome). 
2.2 Preoperative assessment of patients 
In addition to clinical assessment and chest roentgenology of all the patients, the investigations delineated in the 
section below were obtained as frequently as was possible, even if not indicated for selection for suitability for lung 
resection.  Brief descriptions of the methods and laboratory quality control protocols are included in this section. 
2.2.1 Pulmonary function tests  
The pulmonary function tests described in this section were conducted by the clinical technologists of the lung 
function laboratory of the respiratory unit of the department of internal medicine of the University of Stellenbosch 
                                                                
# Recommendations Guiding Medical Physicians in Biomedical Research Involving Human Subjects: Adopted by the 18th World 
Medical Assembly, Helsinki, Finland, June 1964 and most recently amended by the World Medical Assembly in the year 2000 CE 
(Edinburgh, Scotland).  See appendix to this thesis for the most current version of this document. 
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located at Tygerberg Academic Hospital.  
2.2.2 Flow-volume loops 
The flow-volume loops were recorded from a wedge spirometer (Med Science Corporation, Model 570, United States 
of America).  Quality control included daily calibration of the spirometer for both volume and flow by the injection of 3 
litres of air from a calibrated syringe.  Furthermore, three successive maximal effort flow-volume loops were obtained 
from each subject.   
 
Spirometry was performed with the patient in the sitting position and while wearing a nose clip.  A period of quiet 
breathing was maintained until a similar tidal volume was measured for three consecutive breaths. The subject was 
then instructed to exhale slowly and maximally from resting, end-expiration to residual volume.  Once residual 
volume was reached, the subject was exhorted to inhale as fast, forcefully and deeply as possible to total lung 
capacity, then to hold inspiratory effort at total lung capacity for 1-2 seconds, and thereafter to exhale as rapidly, 
forcefully and completely as possible for at least 6 seconds or until no more gas could be exhaled (Van Schalkwyk, 
Schultz et al. 2001; Basson 1996).   The flow-volume curve with the greatest sum of FEV1 and FVC was used for 
analysis (Van Schalkwyk, Schultz et al. 2001; Basson 1996).   
 
The following variables were recorded:   
¾ Forced expiratory vital capacity (FVC), forced expiratory volume in 1.0 second (FEV1),  
¾ Forced expiratory volume in 1 second expressed as a percentage of the FVC (FEV1/FVC) and, 
¾ Peak inspiratory flow rate (PIFR), and peak expiratory flow rate (PEFR).   
 
Those variables influenced by height or weight were expressed as a percentage of predicted normal values obtained 
from the combined regression equations of Schoenberg et al. (Schoenberg, Beck et al. 1978) and Grimby and 
Soderholm (Grimby and Sonderholm 1967). 
2.2.2.1 Lung volumes determined by whole body plethysmography  
Lung volumes were measured with a plethysmograph, (Jaeger Masterlab, Erich Jaeger, Wurzburg, Federal Republic 
of Germany).  The principles of the plethysmograph are based on Boyle's law.  This law relates pressure to volume..  
Boyle's law states that if a given mass of gas is compressed at a constant temperature, the product of pressure (P) 
and volume (V) is constant (Ruppel 1998; Basson 1996). 
P1V1 = k    ………………………… Equation 2.2.2.1.1 
Pressure fluctuations result from the compression and decompression of gas within both the subjects’ thorax and the 
body-box.  These pressure changes are then related to volume changes by calibration.  The calibration is done by 
measuring pressure changes that occur in response to a known volume of air that is added to the body-box.  
Measurement of lung volumes is performed with the patient in the sitting position while wearing a nose clip.  After 
explanation of the manoeuvre, tidal breathing was maintained while the plethysmograph was completely sealed off to 
atmosphere.  To measure intrathoracic gas volume, the patient is asked to perform rapid shallow breathing (panting) 
manoeuvres against a closed shutter with an open glottis.   
 
First consider the gas inside the body-box.  The pressure (P1) and volume (V1) are known from the prior calibration 
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manoeuvre.   The patient is asked to pant.  A pressure transducer monitors pressure changes in the plethysmograph.  
P2 represents the pressure after an inspiratory effort and ΔV represents the change in the body-box (or lung) volume.  
Therefore  
P1V1 = P2 (V1-ΔV)   ………………………… Equation 2.2.2.1.2 
 
Next consider the gas in the thorax.  A mouth pressure transducer is coupled to an electronic shutter mechanism.  
The transducer records mouth pressures when the airway is occluded.  It is assumed that mouth pressure reflects 
alveolar pressure when the shutter blocks the airway.  The following relationship then applies to the pressure and 
volume at the mouth during panting: 
P2V2 = (P2 + Δ P)(V2+ Δ V)   ………………………… Equation 2.2.2.1.3 
Where    
P2  =  alveolar pressure as reflected by mouth pressure 
ΔP =  change in pressure during panting against the shutter 
V2 = intrathoracic gas volume (FRC) 
ΔV = change in volume due to compression of the chest by the respiratory muscles 
when the airway is obstructed.   
 
The final step in determination of lung volumes using the plethysmograph is the performance of a vital capacity 
manoeuvre.  The other lung volumes are then determined mathematically using the following equations: 
TLC  =  VC + RV ………………………… Equation 2.2.2.1.4 
VC  =  IRV + Vt + ERV ………………………… Equation 2.2.2.1.5 
FRC (ITGV) =  ERV + RV ………………………… Equation 2.2.2.1.6 
Where VC  =  vital capacity 
IRV  = inspiratory reserve volume 
ERV = expiratory reserve volume 
FRC  =  functional residual capacity 
TLC  = total lung capacity 
ITGV = intrathoracic gas volume. 
RV = residual volume 
Vt = tidal volume 
 
ITGV, RV, and TLC were expressed as a percentage of predicted normal values obtained from the combined 
regression equations of Schoenberg et al. (Schoenberg, Beck et al. 1978) and Grimby and Soderholm (Grimby and 
Sonderholm 1967). 
2.2.2.2 Determination of FRC using helium dilution 
FRC was also measured using helium dilution technique (Jaeger Masterlab, Erich Jaeger, Wurzburg, Federal 
Republic of Germany).  This technique measures the volume of the FRC but excludes the volume of gas distal to 
occluded airways.  The volume of gas distal to occluded airways (the intrathoracic gas volume) is included in 
measurements made using plethysmography.   
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The principles of helium dilution technique are as follows (Ruppel 1998; Basson 1996; West 1985).  The subject 
breathes in helium gas of a known concentration.  Helium is nearly insoluble in blood and is therefore not rapidly 
taken up from the alveoli.  After a number of breaths, the helium is diluted equally in both the FRC and the breathing 
system. The minimal amount of helium that is lost from the system allows FRC to be determined using the principle 
of conservation of matter.  In other words, the amount of helium in the breathing system present before equilibration 
(the product of concentration and volume or C1 x V1) is a known quantity.  The same amount of helium is present in 
the system after equilibration (C2 x (V1+V2)).  V2 is the desired and unknown quantity and represents FRC.  C2 
represents the new concentration of helium after dilution with the FRC (V2) has occurred.  C2 is therefore measured 
and is therefore used to calculate the unknown variable V2 (FRC) using the following formula: 
C1 x V1 = (C2 x (V1+V2))  ………………………… Equation 2.2.2.2.1 
2.2.2.3 Pulmonary diffusion capacity  
Diffusion capacity is the rate of transfer of gas across a membrane at a particular partial pressure gradient across the 
membrane.   
DL = VGAS / (P1-P2)    ………………………… Equation  2.2.2.3.1 
Where 
 DL = Diffusion capacity for carbon monoxide 
VGAS = volume of gas transferred per unit time 
P1 = the partial pressure of the indicator gas proximal to the membrane over which the gas has to 
diffuse  (in this case the partial pressure of carbon monoxide in the alveoli). 
P2 = the partial pressure of the indicator gas distal to the membrane over which the gas has 
diffused  (in this case the partial pressure of carbon monoxide in the pulmonary capillary blood). 
In practice, we are concerned with oxygen transfer across the alveolar capillary membrane.  However, the 
measurement of diffusion capacity using oxygen is difficult.  Pulmonary diffusion capacity is therefore measured 
using the single-breath, carbon monoxide diffusion (DLCO) method introduced by Krogh (Jaeger Masterlab, Erich 
Jaeger, Wurzburg, Federal Republic of Germany).  The advantage of using carbon monoxide is that the size of the 
carbon monoxide molecule is similar to that of oxygen and therefore their diffusion capacities are similar.  
Furthermore, as the blood carbon monoxide concentration is usually zero, P2 in equation 2.2.2.3.1 does not have to 
be measured.  The following equation has to be used to calculate diffusing capacity for carbon monoxide: 
DL CARBON MONOXIDE = VCARBON MONOXIDE / (PA CARBON MONOXIDE) …… Equation  2.2.2.3.2 
The amount of carbon monoxide transferred across the membrane per minute is calculated using the following 
principles.   
1. Alveolar volume is calculated using helium dilution. 
2. The patient exhales to residual volume.  They then inhale rapidly to TLC from a reservoir that 
contains a mixture containing 0.2 to 0.3% carbon monoxide.  This breath is held for 
approximately 10 seconds.  The subject then exhales to RV.  During this exhalation, a sample of 
alveolar gas is obtained after the dead space gas has been discarded.  The fractional 
concentration of carbon monoxide is measured in the inhaled gas and exhaled sample.   
3. VGAS is calculated as the product of alveolar volume and the difference between the 
concentration in the alveoli at the start and end of the breathold, divided by the breathold time. 
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4. DLCO is expressed as a proportion of the alveolar gas volume.  DLCO is therefore reported in 
units of millilitres per minute per mm Hg alveolar partial pressure per litre of the FRC.   
 
DLCO was measured three times for each subject.  It was ensured that the inspired volume was within 5% of the 
inspired vital capacity obtained in the flow-volume loop.  To ensure reproducibility, the three DLCO values had to be 
within 5% of one another.   
2.2.2.4 Exercise testing to determine maximum oxygen consumption 
Continuous progressive exercise testing on a treadmill was utilised for the determination of maximum oxygen 
consumption (VO2 max).   
 
The treadmill (Trackmaster, ETL testing laboratories, New York, USA) was linked to a computer running a dedicated 
software program (Cardio2 Combined VO2 ECG Exercise System, Medical Graphics Corporation, St. Paul, 
Minnesota, USA).  The modified Balke protocol was used.  This protocol accommodates individual patient needs by 
allowing a walking or running speed that is comfortable for the patients.  The speed is increased by 1 km/h every 
minute up to a maximum.  After the maximum is attained, speed is kept constant while elevation is increased by 2% 
every minute.  Patients were exhorted to attain at least 85% of their predicted heart rate.  Predicted maximum heart 
rate was determined by using following equation (Basson 1996): 
 Maximal predicted heart rate = 210 - 0.65 x age   ……………… Equation 2.2.2.4.1 
The exercise study was terminated when either symptoms of fatigue, myocardial ischemia, or signs suggestive of 
myocardial ischemia on the 12 lead ECG system or a decrease in blood pressure below the resting value occurred 
(Basson 1996). 
 
An infrared analyser was used for the analysis of CO2.  A fuel cell oxygen analyser measured mixed expired oxygen 
concentration.  A breath-by-breath system provided gas exchange data for each individual breath. To determine 
oxygen consumption, the following equation was used: 
VO2 = (VI x FIO2) - (VE x FEO2) ………………………… Equation 2.2.2.4.2 
Where  FIO2 = Mixed inspired oxygen concentration 
FEO2 = Mixed expired oxygen concentration 
 VE = Expired minute volume 
 VI = Inspired minute volume  
 VO2 = Oxygen consumption in milliliters per minute 
To determine desaturation during exercise, a pulse oximeter (Ohmeda Biox 3700, Louisville, CO, USA) was attached 
to an earlobe and stabilized with adhesive tape.  The lead connecting the patient sensor to the monitor was affixed to 
a headband for additional stabilization. 
2.2.3 Differential ventilation and perfusion radioisotope scintigram 
Pre-operatively, as many of the patients as possible underwent differential ventilation-perfusion lung scanning.  This 
was conducted at the Department of Nuclear Medicine of Tygerberg Academic Hospital and the University of 
Stellenbosch. 
Chapter 2.  Methods
 
148 
To evaluate lung perfusion, Technetium 99 labelled microspheres were injected intravenously.  95% of the 
microspheres are removed from the circulation on their first pass through the pulmonary capillary bed (Basson 1996).  
Ventilation studies are conducted using inhalation of radioactive Krypton 81 gas.  The differential distribution of both 
these isotopes was studied with an Opscon gamma scintillation camera (Searle, Radiographics, Scintiview) 
connected to a computer.  To ensure quality control of the gamma camera, a source of cobalt 67 was counted and 
imaged daily.  Linearity of the system was checked weekly. 
2.3 Preparation of patients 
2.3.1 Premedication and preoperative sedation 
Premedication comprising 0.05 mg.kg-1 of lorazepam was administered orally in two divided dosages.  The first dose 
was administered the evening before surgery and the second dose was administered two hours pre-operatively. On 
arrival in the operating room, additional sedation (up to 2 mg of lorazepam intravenously) was administered if 
considered necessary by the investigator.   
2.3.2 Randomisation 
Patients were randomly assigned to either the control or intervention groups.  This was done by blind card draw on 
the morning of surgery. 
2.3.3 Temporal description of preoperative preparation, intraoperative 
management and monitoring of patients in the operating theatre in all groups 
While the patient was awake and following the infiltration of local anesthetic (2% lignocaine), a thoracic epidural 
catheter and the following vascular lines were placed: a peripheral venous cannula, a 20 gauge radial arterial 
cannula and an internal jugular vein 8.5 French gauge introducer sheath.  The sheath was always placed on the 
same side as the hemithorax that was going to be surgically opened.  A balloon tipped thermodilution pulmonary 
artery catheter (PAC) with either a standard thermistor (response time 1200 milliseconds) (Arrow®, Reading, PA, 
USA) or a fast response thermistor (response time 95 milliseconds) (REF-1®, Baxter Edwards, Santa Ana, 
California) was placed via the introducer sheath (Lichtwarck-Aschoff, Leucht et al. 1994; Vincent, Thirion et al. 1986).   
 
Radial and pulmonary arterial pressures were transduced (Medex Medical® MX9504, Rossendale, Lancashire, Great 
Britain) and displayed continuously on a multichannel monitor (Siemens® Sirecust 1281, Erlangen, Germany or 
Datex®, Helsinki, Finland).  In the supine position, the transducers were zeroed at the level of the midaxillary line.  
On turning the patient into the lateral decubitus position (LDP), transducers were zeroed at the level of the sternum.  
A calibration of 100 mmHg was applied to the transducers using the built in calibration feature of the Medex MX9504 
transducer.  Care was taken to optimise the frequency response of the catheter system by elimination of all air 
bubbles and blood clots.  To further ensure optimal dynamic response of the catheter-transducer system, the 
proximal lumen of the PAC was connected directly to the pressure transducer without any added connecting tubing.  
 
Cardiac output was measured by thermodilution (REF-1 cardiac output computer, Baxter Edwards, Santa Ana, 
California).  Three measurements of cardiac output were made per step.  The average of the three measurements 
was taken as being the cardiac output for that step.  Each measurement was made at the end of expiration.  The 
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indicator for determining cardiac output comprised iced normal saline injected at approximately 4O Celsius.  An inline 
sensor was used to measure the temperature of the injectate.  The injectate port of the fast response catheter was 
positioned in the right atrium 1 cm proximal to the tricuspid valve.  This was accomplished by inspection of the 
pressure waveform transduced from the injectate port of the catheter (Rafferty, Durkin et al. 1993).  Mixed venous 
samples were obtained by withdrawing blood from the distal lumen of the pulmonary artery catheter after it had been 
withdrawn into the right ventricle.  Before and after sampling of mixed venous blood, a right ventricular position of the 
catheter tip was confirmed by identifying a RV waveform.   
 
Further monitoring included ECG, inspired oxygen partial pressure, pulse oximetry, end tidal isoflurane and carbon 
dioxide partial pressures (Datex®, Helsinki, Finland), blood temperature and airway pressure.  Arterial and venous 
blood gases, pH, hemoglobin, hematocrit and bicarbonate levels were measured at each step (Nova 1 or Nova 5 
blood gas analyser, Massachusetts, USA).   
2.4 Induction and maintenance of anesthesia, ventilation and fluid 
management strategies 
Prior to induction of anesthesia, patients were administered up to 7 ml.kg-1 of 6% hydroxyethyl starch.  The aim of 
this manoeuvre was to raise the central venous pressure by 2 to 4 mmHg above their baseline value.  Thereafter, 
while the patients breathed 100% oxygen at 8 litres per minute delivered via a facemask attached to a circle-
absorber breathing circuit, a computer-controlled alfentanil infusion2 targeted to achieve and maintain a plasma 
concentration of 280 ng.ml-1 throughout surgery, was commenced.  When the patient became apnoeic or 
unresponsive to verbal stimuli, etomidate 0.1 to 0.3 mg.kg-1 was titrated intravenously to further induce 
unconsciousness.  Thereafter, pancuronium 0.1 mg.kg-1 was administered intravenously.  Manual intermittent 
positive pressure ventilation with a mask was then commenced.  The anesthetic mixture during mask ventilation 
comprised 100% oxygen at 4 litres per minute and an inspired concentration of 1 kPa isoflurane (Heerdt, Gandhi et 
al. 1998).   
 
Approximately 5 minutes after commencement of facemask ventilation, endobronchial intubation with an 
appropriately sized left sided double lumen tube (DLT) was performed (Hannallah, Benumof et al. 1997; Brodsky, 
Macario et al. 1996; Slinger 1995).  The position of the DLT was confirmed clinically (auscultation, chest movement).  
When the patient was turned into the LDP, the DLT position was confirmed with both auscultation and, when 
considered necessary, with a flexible fibreoptic bronchoscope (Cohen, Neustein et al. 1995; Brodsky 1994; Benumof 
1993; Benumof 1986).  A right-sided DLT was only to be used if anatomical or pathophysiological considerations 
(tumour in left main bronchus, tortuous and narrow left main bronchus) precluded the use of a left sided tube.  
Intermittent positive pressure ventilation (Ohmeda 7000 anesthesia ventilator, Madison, USA) was continued at a 
fresh gas flow of 2 litres per minute utilizing 100% oxygen.  An inspired partial pressure of 1 kPa of isoflurane was 
administered until the end of the study.  Tidal volume and respiratory rate during both two and one lung anesthesia 
were 7 ml.kg-1 and 12 breaths per minute respectively.  Permissive hypercapnia was to be permitted so that arterial 
                                                                
2 Stelpump version 1.2 (University of Stellenbosch, South Africa), controlling a Baxter Flo-Guard 6201 volumetric infusion pump 
(Deerfield, IL, USA). 
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partial pressures of carbon dioxide of up to 8 to 10 kPa were to be allowed.  
 
Patients were then turned into the lateral decubitus position.  A forced air warmer (Bair hugger, Augustine Medical, 
Minnesota, USA) operating at 38o C was sited over the lower half of the patient’s body.  From the commencement of 
one lung ventilation in all patients in all groups, oxygen at 2 litres per minute was insufflated via an 8 French gauge 
catheter down the non-dependent lung lumen of the DLT.  Prior to commencement of surgery, 100 ug of preservative 
free fentanyl diluted in 10 ml of 0.9% saline was injected into the epidural space.  No local anesthetic or other drug 
was administered via the epidural catheter before the termination of the study period.  
 
The goal of intraoperative fluid management was to maintain central venous pressure and pulmonary artery wedge 
pressure at pre-induction levels.  Fluids used were 6% hydroxyethyl starch (mean molecular weight 200 000 Daltons, 
substitution ratio 0.5) and packed red blood cells to maintain a hematocrit of 30%. 
2.5 Differential management of patients in each of the three groups 
The exact sequence of events in the control group is indicated in Table 2.5.1.  The intervention groups were 
designated as the “dobutamine” and “PEEP” groups (Table 2.5.2 and Table 2.5.3).  Variables were recorded at each 
of the times depicted in the three tables in this section.  The labels that were used to identify each step were shown 
in the middle column of the tables.  Note that the time of commencement of OLA was considered to be only after 
thoracotomy had been performed, the pleural cavity had been opened and confirmation of NDL collapse was 
assured.  Surgery was not paused during the measurement of hemodynamic data. 
 
Dobutamine was administered by adding 25 mg of dobutamine to a 200 ml bag of 0.9% saline.  The infusion rate 
equivalent to 3, 5 and 7 ug.kg-1.min-1 was calculated.  A volumetric infusion pump (Infusomat, B Braun, Federal 
Republic of Germany) was used to administer the dobutamine at the calculated rate. 
 
Extrinsic PEEP was administered by adding a PEEP value (Ambu ®, USA) between the ventilator and the circle 
system.  The level of extensive PEEP was measured on the pressure gauge of the circle breathing system.  PEEPi 
was measured in this study by employing the end expiratory occlusion (EEO) method (Slinger and Hickey 1998; 
Rossi, Polese et al. 1995; Simbruner 1986).  A clamp was applied just before the end of expiration to the connection 
between the breathing circuit and the DLT and a connection with a manometer was placed between the clamp and 
the DLT.  A minimum period of one second is required for pressure to equalize between lung units with differing time 
constants; as long as 5 seconds may be needed to complete this process (Yokota, Toriumi et al. 1996; Rossi, Polese 
et al. 1995).  Allowing sufficient time for lung units with differing (slow) time constants to equilibrate provides a 
measure of PEEPi that reflects the mean amount of intrinsic PEEP present in the system (Rossi, Polese et al. 1995).  
PEEPi measured using rapid occlusion of the airway by a shutter at the end of expiration has the disadvantage that it 
predominantly reflects the intrinsic PEEP present in those lung units with fast time constants (Rossi, Polese et al. 
1995).  Thus, in the current study, at least 5 seconds were allowed to pass before PEEPi was measured.  This 
method of EEO measures the end-expiratory elastic recoil of the respiratory system under static conditions.   
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Tables 2.5.1 (above) and 2.5.2 (below) The sequence of events in the control and dobutamine 
groups respectively. 
 
Control group 
Description of steps in control group patients Step label 
Conduct of 
surgery 
Prior to induction of anaesthesia, and before fluid pre-loading 
commenced 
S1: Awake  
In the lateral decubitus position while ventilating 2 lungs S2: 2 LA No surgery 
15 minutes after commencing one lung ventilation S3: OLA 15 mins 
Surgery 
commences 
5 minutes after step 3 data had been recorded S4: OLA Control 1 Surgery continues 
5 minutes after step 4 data had been recorded  S5: OLA Control 2 Surgery continues 
5 minutes after step 5 data had been recorded  S6: OLA Control 3 Surgery continues 
5 minutes after step 6 data had been recorded  S7: OLA Control 4 Surgery continues 
Dobutamine group 
Description of steps in patients administered dobutamine  Step label 
Conduct of 
surgery 
Prior to induction of anaesthesia, and before fluid pre-loading 
commenced 
S1: Awake  
In the lateral decubitus position while ventilating 2 lungs S2: 2 LA No surgery 
15 minutes after commencing one lung ventilation S3: OLA 15 mins 
Surgery 
commences 
5 minutes after an infusion of dobutamine 3 ug.kg-1.min-1 had 
commenced 
S4: Dobutamine 3 Surgery continues 
5 minutes after an infusion of dobutamine 5 ug.kg-1.min-1 had 
commenced 
S5: Dobutamine 5 Surgery continues 
5 minutes after an infusion of dobutamine 7 ug.kg-1.min-1 had 
commenced 
S6: Dobutamine 7 Surgery continues 
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Table 2.5.3 The sequence of events in the PEEP group. 
2.6 Data collection 
Baseline hemodynamic values were recorded once the monitors had been calibrated.  Hemodynamic data was 
collected both on a dedicated form and using a personal computer running “Alab” (Stellenbosch University and 
Cirrlus Development Systems, South Africa).  Electronic data collection consisted of a 30 second recording of ECG, 
pulmonary arterial, right ventricular and peripheral arterial waveforms.  This data was recorded at 100 hertz on “Alab” 
while intermittent positive pressure ventilation (IPPV) continued. 
 
Values that were recorded included: heart rate, arterial and pulmonary arterial blood pressures, pulmonary artery 
wedge and central venous pressure, right ventricular pressures at the beginning and end of diastole, peak right 
ventricular pressure, cardiac outputψ, right ventricular ejection fraction (RVEF)ψ, right ventricular end-diastolic volume 
(RVEDV)ψ, PA and systemic end systolic pressures (Pes), arterial and mixed venous blood gases, hematocrit, 
hemoglobin concentration, blood temperature as measured at the distal thermistor of the pulmonary artery catheter, 
partial pressure of carbon dioxide at the end of expiration, the partial pressure of isoflurane at end of expiration, peak 
airway pressure, intrinsic and externally applied PEEP, expired tidal volume and respiratory rate.   Blood for 
determination of arterial and venous gases were immediately placed on ice inside the refrigerator in the anteroom of 
the theatre and analysed within 10 minutes of being collected. 
 
All data collected (demographic data (age, weight, sex, operation, operation side, underlying pathology) as well as 
the data from the preoperative pulmonary function tests and differential ventilation perfusion scans and the 
intraoperative data) was transcribed to an Excel® spreadsheet (Microsoft Corporation, USA). 
 
If the surgery terminated before all steps could be performed, the data collected up to that point were to be used.   
                                                                
ψ The Baxter cardiac output computer was used to determine cardiac output, right ventricular ejection fraction and right ventricular 
end-diastolic volume. 
PEEP group 
Description of steps in patients administered PEEP  Step label 
Conduct of 
surgery 
Prior to induction of anaesthesia, and before fluid pre-loading 
commenced 
S1: Awake  
In the lateral decubitus position while ventilating 2 lungs S2: 2 LA No surgery 
15 minutes after commencing one lung ventilation S3: OLA 15 mins 
Surgery 
commences 
10 minutes after PEEP5 was applied to the dependent lung, S4: PEEP5 Surgery continues 
5 minutes after PEEP10 was applied to the dependent lung,  S5: PEEP10 Surgery continues 
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Figure 2.6.1.  A “screenshot” of part of a 30 second recording epoch made in “Alab”.  The “Y” axis represents 
pressure in mm Hg and the X-axis represents time in seconds.  The top tracing is a recording of arterial pressure.  The 
bottom tracing is a recording of pulmonary arterial pressure versus time and then right ventricular pressure versus time. The 
two middle beats of the 4 represented in the bottom trace occur during changeover of the recording from PA to RV.  These 
beats adjacent to the changeover were not used for measurement of pressure.  Note the cursor function in “Alab” used to 
measure pressures.  The crosshairs are moved by using the mouse and the pressure and time values at the crosshairs are 
indicated in the information bar at the bottom of the screen.  For instance, the systolic arterial pressure at the 4th beat of the 
above window measured at 124.984 mm Hg using the crosshairs.  Such values were rounded off to the nearest mm Hg. 
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2.7 The formulae for derived parameters 
Table 2.7.1  Derived hemodynamic parameters were calculated using the above formulae (Mark, 
Slaughter et al. 2000; Reich, Moskowirz et al. 1999). 
 Abbreviation Units Formula 
Body surface area BSA m2 (lengthcm0.725) (weightkg0.425) (0.007184) 
Cardiac index CI ml.m-2.minute-1 CO/BSA 
Stroke volume SV ml.beat-1 CO/HR 
Stroke index SI ml.beat-1.m-2 SV/BSA 
Mean arterial pressure MAP mm Hg 
((Systolic arterial pressure-diastolic 
arterial pressure)/3) + (diastolic 
arterial pressure) 
Mean pulmonary arterial 
pressure 
mean PAP mm Hg 
((Systolic pulmonary arterial 
pressure-diastolic pulmonary arterial 
pressure)/3) + (diastolic pulmonary 
arterial pressure) 
Left ventricular stroke work index LVSWI g.m.m-2 (MAP – PAWP)(CI/HR) x 0.0136 
Right ventricular stroke work 
index 
RVSWI g.m.m-2 (mean PAP – CVP)(CI/HR) x 0.0136 
Systemic vascular resistance SVR dynes.secs.cm-5 (MAP – CVP)/CO 
Pulmonary vascular resistance PVR dynes.secs.cm-5 
(PAP-LAP)/CO where PAWP is 
considered an indication of LAP 
Right ventricular coronary 
perfusion pressure 
RV CPP mm Hg 
The difference between mean systemic 
arterial and mean PA pressure 
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 Abbreviation Units Formula 
Dynamic lung compliance  ml.cm H2O-1 
Vt/(Peak airway pressure – 
PEEPEXTRINSIC) 
Alveolar oxygen tension PAO2 kPa (Pb – PH2O)-(PaCO2/RQ) 
Arterial oxygen content CaO2 ml.100ml-1 
([Hb] x SaO2 x 1.39)+(PaO2 x 
0.0031) 
Mixed venous oxygen content C O2 ml.100ml-1 ([Hb] x S O2 x 1.39)+(P O2 x 
0.0031) 
Pulmonary capillary oxygen 
content 
CcO2 ml.100ml-1 
([Hb] x ScO2 x 1.39)+(PcO2 x 
0.0031) 
Intrapulmonary shunt  Qs/Qt % (CcO2-CaO2)/(CcO2-C O2) 
Table 2.7.2  Respiratory parameters were calculated using the following formulae (Moon and 
Camporesi 2000; Reich, Moskowirz et al. 1999; Costarino and Marshall 1995). 
 
 
 
 
 
 
Table 2.7.4 Formulae were used to determine parameters of oxygen delivery and consumption 
(Reich, Moskowirz et al. 1999). 
 
 Abbreviation Units Formula 
Oxygen delivery DO2 ml.minute-1 CO x CaO2 x 10 
Oxygen delivery index DO2I ml.minute-1.m-2 DO2/BSA 
Oxygen consumption VO2 ml.minute-1 CO(CaO2-C O2) 
Oxygen consumption index VO2I ml.minute-1.m-2 VO2/BSA 
Oxygen extraction ratio OER Ratio (CaO2-C O2)/CaO2 
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 Abbreviation Units Formula 
Aortic elastance Ea aorta mm Hg.ml-1 Aortic Pes/SV or MAP/SV 
Pulmonary arterial elastance Ea PA mm Hg.ml-1 PA Pes/SV or mean PAP/SV 
PA characteristic impedance  Rc PA dynes.secs.cm-5 
See section 2.9 below and/or Rc = 
Rp – (Ea/total cardiac cycle time) 
Total pulmonary vascular 
resistance 
RTOTAL PA dynes.secs.cm-5 
Method 1:  Calculated using the sum 
of PVR and Ro.  Rc is determined as 
in section 2.9.  It is assumed that 
PVR approximates Rp. 
Method 2:  RTOTAL = Ea PA  . total 
cardiac cycle time. (Sagawa, 
Maughan et al. 1988. Page 238.  See 
also Equation 1.4.4.12)  
Total cardiac cycle time was 
physically measured from the 
recordings made in “Alab”. 
Pulmonary arterial compliance PA compliance ml.cm H2O-1 
Calculated using the formula, 
Compliance = Tau/RTOTAL,  where “tau” 
is the diastolic time constant of the 
pulmonary vasculature.  RTOTAL can be 
determined by using either of the 
methods described above. 
Table 2.7.3  Parameters of the Windkessel model were calculated using the above formulae 
(Tanaka, Oshita et al. 1998; Senzaki, Chen et al. 1996; Fourie, Coetzee et al. 1992b; Dahlgren, 
Veintemilla et al. 1991; Sagawa, Maughan et al. 1988: Cardiac contraction and the pressure volume loop.  
Chapter 5, page 238).  As there was ringing in the PA catheter-transducer system, using Pes was not 
considered to be an accurate representation of PA end-systolic pressure.  Tanaka, Oshita et al. 1998, 
Senzaki, Chen et al. 1996 and Sagawa, Maughan et al. 1988 consider that Pes and mean arterial and 
pulmonary arterial pressures approximate each other.  Therefore, mean PAP was used to calculate PA 
elastance in this study.  Note that the formula for Rc = Rp – (Ea/total cardiac cycle time) is derived from 
Sagawa, Maughan et al. 1988. 
 
 
 
In the above formulae the following assumptions were considered reasonable: 
1. For the determination of the alveolar partial pressure of oxygen: 
a. That PB was 101.3 kPa  
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b. That PH2O was 6.2 kPa 
c. That the respiratory quotient (RQ) was 0.8 
 
2. To determine the amount of oxygen in pulmonary capillary blood, the following assumptions were 
considered reasonable: 
a. That the partial pressure of oxygen in the pulmonary capillary (PcO2) was equal to PAO2, 
b. That the hemoglobin of pulmonary capillary blood (ScO2) is fully saturated with oxygen and, 
c. The pulmonary capillary hemoglobin concentration was equal to that of the arterial hemoglobin 
concentration. 
 
3. In the above formulae, the partial pressure of oxygen used to calculate dissolved oxygen content is 
measured in mmHg.  One kPa equals 7.55 mmHg. 
2.8 Reasons to terminate the study  
Reasons for removing patients and their associated data from the study: 
¾ Inability to separate the lungs because of an inability to correctly place, or subsequent malposition of, the 
double lumen tube,  
¾ Failure to adhere to the study protocol because of clinical necessity and, 
¾ Massive hemorrhage (defined for the purposes of this study to be greater than 500 ml of blood loss over a 
period of 10 minutes). 
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Figure  2.9.1.1. The method of obtaining the time constant of the 
pulmonary circulation.  The exponential decline of the pressure 
curve during diastole is selected and typically, 15 to 35 data points 
are imported into the spreadsheet.  The inverse of the absolute 
value of the slope of the semi logarithmic plot is the time constant. 
PAP 
mm Hg 
Time 
seconds 
ln 
PAP 
28.57 0 3.352357 
26.67 0.01 3.283539 
26.67 0.02 3.283539 
24.76 0.03 3.209229 
23.81 0.04 3.170106 
22.86 0.05 3.129389 
20.95 0.06 3.042139 
20.95 0.07 3.042139 
20.95 0.08 3.042139 
20.95 0.09 3.042139 
20.95 0.1 3.042139 
20 0.11 2.995732 
20 0.12 2.995732 
19.05 0.13 2.947067 
20 0.11 2.995732 
20 0.12 2.995732 
19.05 0.13 2.947067 
 
 
Blood Pressure
BP2 BP3 BP5
76.956.96.856.86.756.76.656.66.556.56.456.46.35
50
48
46
44
42
40
38
36
34
32
30
28
26
24
22
20
18
  
Chapter 2.  Methods
 
159 
 
2.9 Derivation of a method for calculating characteristic impedance 
(Rc)#  
Ea may be calculated from the following two formulae with good agreement between the two (Sagawa, Maughan et 
al. 1988: Cardiac contraction and the pressure volume loop.  Chapter 5, page 239; Fourie, Coetzee 1992, Figures 
1.4.4.2 and 1.4.4.3): 
Ea = Rtotal / (ts + τ(1 - e -td/τ))  ………………………… Equation 2.9.1 
 
Ea = Pes/SV   ………………………… Equation 2.9.2 
 From Windkessel models of the pulmonary circulation, RTOTAL is comprised of the sum of Rc and Rp.  Therefore  
 
Ea = (Rc + Rp) / (ts + τ(1 - e -td/τ)) ………………………… Equation 2.9.3 
Solving for Rc  
(Rc + Rp) = Ea / [(ts + τ(1 - e -td/τ)]  
     
               ……………   Equation 2.9.4 
 
Where the units of equation 2.9.4 are: 
Resistance:  mmHg.seconds.ml-1 (1 mmHg.second.ml-1 equals 79.9 dynes.seconds.cm-5) 
Pes:  mmHg 
SV:  ml 
ts and td:  seconds 
τ:  seconds 
e -td/τ:  no units 
 
If it is assumed that Rp ≡ PVR, the parameter τ is required to calculate a value for Rc.  τ may be derived from the 
exponential decline in PA pressure after closure of the pulmonary valve (Fourie, Coetzee et al. 1992b; Westerhof and 
Elzinga 1991; Laskey, Parker et al. 1990).  Thus 
PAPt = PAPo e-t/τ   ………………………… Equation 2.9.5 
Where  PAPt = pulmonary artery pressure at time t 
 PAPo = pulmonary artery pressure at the beginning of the function 
 
Taking natural logarithms on both sides of the equation: 
                                                                
# Note that the author developed this particular method of deriving characteristic impedance.  The method was mathematically 
verified by Dr Toit Mouton of the department of applied engineering of the University of Stellenbosch.  Subsequent to this, a 
number of articles (Westerhof and Elzinga, 1991; Yin, Liu et al. 1987) using similar methods of deriving characteristic impedance 
(albeit in the systemic circulation) were discovered using a Medline search.  Note also that PVR and Rp are both used to describe 
pulmonary vascular resistance.   
Rc =           Pes                         
                          SV  ((ts + τ(1 - e -td/τ)) 
Rc =    – Rp 
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LnPAPt = -t/τ + lnPAPo   ………………………… Equation 2.9.6 
 
The data points of the exponential decline in pulmonary artery pressure after closure of the pulmonary valve 
(pressure and the corresponding time points) were inputted into an Excel® spreadsheet (Figure 2.9.1.1).  The natural 
logarithm of the pressure points were calculated, a semi-logarithmic plot of lnP(t) versus time constructed and a 
regression in the form of equation 2.9.6 was calculated.  The inverse of the absolute value of the slope of the semi-
logarithmic plot is the time constant.  This method was applied to 5 beats per epoch.  The average of these 5 
determinations of tau were used to solve for Rc in equation 2.9.3.   
2.10 Determination of the frequency response of the transducer-
catheter systems 
 
The flush method as described by Gardner and employed by Schwid was used to determine the natural frequency 
and damping coefficient of the arterial and pulmonary arterial catheter and transducer systems (Schwid 1988).  The 
high-pressure flush valve was opened and then rapidly released with the catheters still connected to the patient.  This 
has shown to provide reliable testing of the transducer, connecting tubing and the intravascular catheter (Schwid 
1988).  The tracing was recorded using “Alab”. To ensure accuracy of the measurements, the tracing was amplified 
in Alab.  This results in the problem that the “paper speed” is not known.  The natural frequency response is given by 
the inverse of the wavelength in millimetres as illustrated in Figure 2.10.1 (Mark, Slaughter et al. 2000; Sykes, 
Vickers et al. 1994; Schwid 1988; Foster and Roelofse 1987; Fourie, Badenhorst et al. 1987).  The damping 
coefficient was determined by measuring the amplitude ratio of subsequent oscillations (A1 and A2) after the flush 
had been terminated.  This ratio was then related to the table 2.10.1 to determine the damping coefficient of the 
system (Foster and Roelofse 1987; Gardner 1981).  These measurements were conducted for both systemic and 
pulmonary arterial transducer systems. 
 
Amplitude 
Ratio A1/A2 
1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.05 0.02 
Damping 
coefficient 
0 0.03 0.07 0.11 0.16 0.22 0.28 0.36 0.46 0.6 0.7 0.9 
 
Table 2.10.1 A table relating amplitude ratios and damping coefficients.  Reproduced from “Databook of 
anaesthesia and critical care”, Foster and Roelofse, Springer-Verlag, Berlin, 1987 
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Blood Pressure
Aorta MV C lose(Start ) AV Open AV C Lose MV Open MV C lose(End) AV Open(N ex tC y c le)
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A1 
A2 
Blood Pressure
Aorta MV C lose(Start ) AV Open AV C Lose MV Open MV C lose(End) AV Open(N extC y c le)
23.2523.223.1523.123.052322.9522.922.8522.822.7522.722.6522.622.5522.522.4522.422.3522.3
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Figure 2.10.1  A diagram illustrating the principles of determination of frequency response of an arterial 
system.  The traces have been imported from Alab and expanded to allow accurate measurements to be made.    
The natural frequency response is given by the inverse of the wavelength in millimetres.  The damping coefficient 
was determined by measuring the amplitude ratio of subsequent oscillations (A1 and A2) after the flush had been 
terminated.  This ratio was then related to Table 2.10.1 to determine the damping coefficient of the system. 
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2.11 Models used to study right ventricular performance  
The following models of right ventricular performance and afterload during OLA will be studied: 
¾ The components of the Windkessel model of the pulmonary circulation (Ro, Rp and C) will be calculated. 
¾ The coupling of the RV to its load: i.e. indices of right ventricular performance e.g. RVSWI, RVEF, SV 
related to indices of afterload (PVR, PA Ea, PAP, pulmonary vascular Rc and compliance). 
¾ Indices of right ventricular preload (RVEDV and RVEDP). 
¾ Pulmonary and systemic hemodynamics and oxygen flux data, including P O2 will be studied. 
¾ The influence of P O2 on arterial oxygenation in the presence of the shunt that exists during OLA will be 
studied. 
2.12 Statistical analysis 
Statistical analysis was performed in collaboration with Professor J.F. Coetzee of the Department of Anesthesiology 
and Critical Care, University of Stellenbosch.  The sample size that would be needed was calculated before 
commencement of the study.  For the purposes of the calculation of sample size, it was decided that a 20% change 
in cardiac output would represent a clinically significant change.  Using this value, it was estimated that that five 
patients per group would be needed for the study to have a power of 80% to detect a 5% difference between the 
various steps.  
 
The data collected was inputted into an Excel® spreadsheet and each data point was checked before analysis.  
Sigmastat for Windows® version 2.03 (SPSS Incorporated, San Rafael, California) was used to perform statistical 
analysis.   
 
Data was tested for normality of distribution (Kolmogorov Smirnov test; p < 0.05) and equality of variance (Levene 
Median test; p < 0.05) 
 
Analysis of whether differences existed between different epochs within a particular group was performed using 
analysis of variance (ANOVA) for repeated measures (RM).  Between groups analyses for the first three steps of 
the 3 different groups was conducted using one way ANOVA.  If differences existed, these were identified using 
multiple comparisons were made (Student-Newman-Keuls test).  Analysis of whether differences existed between 
the first three steps of the groups was done using one-way ANOVA.  An alpha value equal to or less than 0.05 was 
regarded as indicating a significant difference. 
 
Nominal and ordinal data were compared using the Chi-squared test.  The strength of associations was measured 
using the Pearson product moment correlation for data that was normally distributed and exhibited a constant 
variance.  For data that was not normally distributed and/or did not exhibit constant variance, Spearman rank order 
correlation was used to measure the strength of associations.    
 
 3. Results 
3.1 Demographics 
Gr
ou
p 
Pa
tie
nt Operation Pathology 
Control Ca Left pneumonectomy 
Destroyed lung for completion pneumonectomy, large bullous right 
upper lobe 
Control Cb Right lower lobe lobectomy Carcinoma bronchus, COPD, smoker 
Control Cc Left upper lobe lobectomy Left upper lobe mass 
Control Cd Left lower lobe lobectomy Pulmonary tuberculosis, hemoptysis 
Control Ce Left pneumonectomy Pulmonary tuberculosis, destroyed left lung 
Control Cf Right upper lobe lobectomy Mass of unknown etiology 
Control Cg Right pneumonectomy Empyema, previous lobectomy 
Control Ch Left upper lobe lobectomy Pulmonary tuberculosis, mycetoma 
Control Ci Right upper lobe lobectomy Carcinoma bronchus 
Control Cj Left pneumonectomy Giant bullous, COPD 
Control Ck Right pneumonectomy Carcinoma bronchus 
Control Cl Left upper lobe cystectomy Echinococcus cyst 
Control Cm Left upper lobe lobectomy Carcinoma bronchus 
Control Cn Right upper lobe lobectomy Pulmonary tuberculosis, mycetoma 
Control Co Right upper lobe lobectomy Bullous lung disease 
Control Cp Left upper lobe lobectomy Carcinoma bronchus 
Control Cq Right pneumonectomy Pulmonary tuberculosis, aspergilloma 
Control Cr Left pleurectomy Spontaneous pneumothorax, COPD 
Control Cs Right pneumonectomy Pulmonary tuberculosis, destroyed  lung 
Control Ct Left upper lobe lobectomy Pulmonary tuberculosis, hemoptysis 
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Gr
ou
p 
Pa
tie
nt Operation Pathology 
Control Cu Right pleurectomy Spontaneous pneumothorax, COPD 
Control Cv Right pneumonectomy Pulmonary tuberculosis, hemoptysis 
Control Cw Left lower lobe lobectomy Carcinoma bronchus 
Control Cx Right upper lobe lobectomy Pulmonary tuberculosis, mycetoma 
Control Cy Left pneumonectomy Carcinoma bronchus 
Control Cz Right upper lobe lobectomy Pulmonary tuberculosis 
Dobutamine Da Left pneumonectomy Pulmonary tuberculosis 
Dobutamine Db Right pneumonectomy Carcinoma bronchus 
Dobutamine Dc Right pleurectomy Pulmonary tuberculosis 
Dobutamine Dd Diaphragmatic plication Normal lung parenchyma 
Dobutamine De Left pneumonectomy Tumour left main bronchus 
Dobutamine Df Right pneumonectomy Post tuberculosis destroyed lung 
Dobutamine Dg Right pneumonectomy Cystic fibrosis 
Dobutamine Dh Right upper lobe lobectomy Right upper lobe bullous 
Dobutamine Di Left upper lobe bullectomy COPD, bullous lung disease 
Dobutamine Dj Left upper lobe lobectomy Pulmonary tuberculosis, mycetoma 
Dobutamine Dk 
Right upper lobe wedge 
resection 
Tumour unknown origin 
Dobutamine Dl Right pneumonectomy Post tuberculous bronchiectasis, hemoptysis 
Dobutamine Dm Right pneumonectomy Bullous disease 
Dobutamine Dn Left pneumonectomy Post tuberculosis destroyed lung 
Dobutamine Do Right pneumonectomy Undifferentiated carcinoma bronchus 
Dobutamine Dp Left lower lobe lobectomy Bronchiectasis 
Dobutamine Dq Right upper lobe bullectomy Bullous lung disease 
Dobutamine Dr Right cystectomy Very large echinococcus cyst 
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Gr
ou
p 
Pa
tie
nt Operation Pathology 
Dobutamine Ds Right upper lobe lobectomy Tumour of unknown origin, COPD, pulmonary tuberculosis 
Dobutamine Dt Right pneumonectomy Post tuberculous bronchiectasis 
Dobutamine Du Left pneumonectomy Post tuberculous destroyed lung 
Dobutamine Dv Right pneumonectomy Destroyed right lung, hemoptysis 
Dobutamine Dw Right upper lobe lobectomy Previous pulmonary tuberculosis, hemoptysis 
Dobutamine Dx 
Right upper lobe wedge 
resection 
Tumour of unknown origin for frozen section 
PEEP Pa Left upper lobe lobectomy Unknown pathology 
PEEP Pb Right pneumonectomy Carcinoma bronchus 
PEEP Pc Right pleurectomy Pulmonary tuberculosis, fibrosis in other lung 
PEEP Pd Right pneumonectomy Post tuberculous lung destruction 
PEEP Pe Right lower lobe lobectomy Carcinoma bronchus 
PEEP Pf Left upper lobe lobectomy Pulmonary tuberculosis, mycetoma 
PEEP Pg Right pneumonectomy Post tuberculous bronchiectasis and hemoptysis 
PEEP Ph Left pneumonectomy Post tuberculous lung destruction 
PEEP Pi Left lower lobe lobectomy Bronchiectasis, cause unknown 
PEEP Pj Left segmentectomy Tumour, possibly lymphoma 
PEEP Pk Right upper lobe bullectomy COPD, bullous lung disease 
Table 3.1.1 A list of the diagnoses and operations performed.  Male subjects comprised 55.5%, 54% 
and 64% respectively for the control, dobutamine and PEEP groups.  Post tuberculous disease was 
present in 45% of the patients and 40% of subjects had chronic obstructive pulmonary disease and/or 
carcinoma of the bronchus. 
 
 
Table 3.1.2 (On following page)  The demographics of the 3 groups.  Data is presented as the mean 
(standard deviation) for each parameter.  No differences were found between the groups.   
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Demographics 
 Control Dobutamine PEEP 
 Units   SD.   SD.   SD. 
Age Years 47.6 14.5 40.8 13.7 45.6 16.1 
Weight Kg 59.8 12.1 59.4 18.3 63.8 15.0 
Length m 162 8 164 10 170 10 
Body surface area m2 1.63 0.2 1.63 0.3 1.73 0.2 
Forced vital capacity % predicted 95 26 80 26 92 24 
Forced expiratory volume in one 
second 
% predicted 83 23 69 22 76 24 
FEV1/FVC % predicted 74 14 76 14 69 8.5 
Peak expiratory flow rate % predicted 89 24.5 84 27 89 26 
Peak inspiratory flow rate % predicted 68 16 61 25 67 20 
Intrathoracic gas volume  
(plethysmography) 
% predicted 151 66 138 46 168 57 
Residual volume (plethysmography) % predicted 123 50 146 42 194 74 
RV (Helium dilution) % predicted 98 40 107 38 107.5 45 
TLC (Helium dilution) % predicted 119 40 104 27 106 32.5 
DLCO/Va % predicted 76 25 81 24 80 12 
VO2MAX ml.kg-1.min-1 17 4 20 5 20 4 
Oxyhemoglobin saturation on 
exercise 
% 93 4 89 5.5 89 9 
Preoperative ventilation to right lung % total 52 20.5 50.5 23 47 26 
Preoperative ventilation to left lung % total 47.5 20 49 22 53 26 
Preoperative perfusion to left lung % total 47 24 52 28 64 25 
Preoperative perfusion to right lung % total 52.5 24 45 30 36 25 
Perfusion to lung to be collapsed 
(i.e. NDL) 
% total 36 19 25.5 16.5 33 21 
New York Heart Association Dyspnoea   2 1 2 1 2 1.6 
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3.2 Between group comparisons  
Between groups comparison of the variables recorded during the first 3 steps (i.e. while the patients were awake, 
subjected to 2 and one lung anesthesia in the LDP) was done.  The only difference between the groups was that 
body temperature was lower in the PEEP than the dobutamine group when the patients awake (Table 3.2.1).  This 
difference did not persist once the patients were anesthetised.  The 0.8 OC difference in temperature was an isolated 
finding and is not regarded as a clinically significant difference for the purposes of this study.  . 
 
Temperature OC 
Measured while subjects were awake   SD. 
Control group 36.7 0.6 
Dobutamine group ## 37.0 0.5 
PEEP group ## 36.2 0.7 
Table 3.2.1  Between group analyses of first three steps revealed that the only difference was that 
temperature differed while the patients were awake.  ## PEEP and dobutamine groups differ, p = 0.035. 
3.3 Within group comparisons (Tabulated) 
Explanatory note to the tables in section 3.3 
Each group’s data is presented in a separate set of tables (control group is presented in section 3.3.1, dobutamine 
group in section 3.3.2 and PEEP group in section 3.3.3).  Each results table contains within it two separate sets of 
tables.   
1. The data table:   
i. The top two rows of the data table identify which parameters data is contained in the table.   
ii. The steps are identified on the left of the table.   
iii. Each parameter spans three columns: 
a. The number of patients in which a particular parameter was observed is noted in the    
column marked “n”,   
b. The arithmetic mean is noted by the column marked “ ”, 
c. The column marked “SD” notes the standard deviation. 
2. The “intragroup differences” tables:  Repeated measures analysis of variance was employed to do 
within group comparisons of individual parameters.  Any differences that existed were analysed using the 
Student-Newman-Keuls post hoc test.  The intragroup differences that were identified are noted in tabular 
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form in the tables with solid black table headings situated below the data table.  The p values for each 
difference are included in this table.     
3.3.1 Control group tables 
Control group 
Expired tidal volume  
(ml.kg-1) 
Expired minute volume  
(litres)  
n   SD. n   SD. 
S1: Awake - - - - - - 
S2: Two-lung Anesthesia, LDP 16 7.8 2.1 16 4.8 1.3 
S3: After 15 minutes of OLA 17 6.7 2.2 17 4.2 1.2 
S4: OLA, Control step 1 18 6.7 2.0 18 4.3 0.8 
S5: OLA, Control step 2 16 6.7 1.7 16 4.2 0.9 
S6: OLA, Control step 3 11 6.1 1.9 11 4.4 0.9 
S7: OLA, Control step 4 5 6.2 1.4 5 4.2 0.7 
 
Table 3.3.1.1 
No changes in expired tidal volume or minute volume occurred on initiation of OLA.  No further changes 
tidal volume or expired minute volume occurred as OLA progressed. 
Chapter 3.  Results 
 
169 
 
Control group 
End tidal isoflurane 
partial pressure 
(kPa)  
n   SD. 
S1: Awake - - - 
S2: Two-lung Anesthesia, LDP 11 0.4 0.2 
S3: After 15 minutes of OLA 12 0.5 0.2 
S4: OLA, Control step 1 12 0.5 0.1 
S5: OLA, Control step 2 10 0.4 0.2 
S6: OLA, Control step 3 9 0.5 0.2 
S7: OLA, Control step 4 4 0.5 0.2 
 
Table 3.3.1.2 
No differences in the end tidal partial pressure of isoflurane occurred between any of the steps in the 
control group.   
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Control group 
Peak airway pressure 
(cm H20) 
Dynamic compliance  
(ml.cm H20-1) 
Intrinsic PEEP 
(cm H20)  
n   SD. n   SD. n   SD. 
S1: Awake - - - - - - - - - 
S2: Two-lung Anesthesia, LDP 16 21 6.6 16 24 9.5 7 3 2.5 
S3: After 15 minutes of OLA 17 27 8.2 17 15 5.1 11 3 2.7 
S4: OLA, Control step 1 18 28 6.8 18 15 5.4 10 3 2.7 
S5: OLA, Control step 2 16 28 7.8 16 15 5.6 8 5 3.1 
S6: OLA, Control step 3 11 27 7.6 11 15 4.9 8 3 1.6 
S7: OLA, Control step 4 5 25 5.5 5 16 5.6 4 3 2.6 
 
Peak 
airway 
pressure 
p 
S2 < S3 0.05 
S2 < S4 0.003 
S2 < S5 0.003 
S2 < S6 0.008 
Dynamic 
compliance 
p 
S2  > S3 <0.001 
S2 > S4 <0.001 
S2 > S5 <0.001 
S2 > S6 <0.001 
S2 > S7 <0.001 
 
Table 3.3.1.3 
Peak airway pressure increased and dynamic compliance decreased on initiation of OLA compared to when two-lungs 
were being ventilated.  These changes in peak airway pressure and dynamic compliance were sustained as OLA 
progressed in the control group.  The amount of intrinsic PEEP present did not differ between two-lung and OLA, or 
change as OLA progressed. 
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Control group 
PaCO2    
(kPa) 
PeCO2    
(kPa) 
pH arterial  
 
HCO3 
(mmol.litre-1) 
BE    
(mmol.litre-1)  
n   SD. n   SD. n   SD. n   SD. n   SD. 
S1: Awake 20 5.0 0.6    20 7.42 0.02 20 21 2.9 20 1.7 2.5 
S2: Two-lung Anesthesia, LDP 16 5.7 1.1 16 4.6 0.5 16 7.36 0.05 16 26 2.1 16 0.0 1.5 
S3: After 15 minutes of OLA 17 6.0 1.7 17 5.3 1.1 17 7.34 0.06 17 26 1.5 17 -0.8 1.4 
S4: OLA, Control step 1 18 6.2 1.4 18 5.4 1.0 18 7.33 0.06 18 26 2.9 18 -1.2 2.4 
S5: OLA, Control step 2 15 6.5 1.8 16 5.7 1.2 15 7.31 0.08 15 26 2.5 15 -1.1 2.1 
S6: OLA, Control step 3 9 6.3 0.7 11 5.9 1.2 9 7.31 0.04 9 26 1.8 9 -1.6 2.1 
S7: OLA, Control step 4 5 6.9 1.1 5 6.0 1.0 5 7.30 0.08 5 27 1.5 5 -0.2 2.6 
 
BE p 
S1 > S2 0.015 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 0.002 
S2 > S4 0.002 
S2 > S5 0.002 
S2 > S6 0.024 
pH arterial p 
S1 > S2 0.007 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
S2 vs. S3 0.053 
S2 > S4 0.002 
S2 > S5 <0.001 
S2 > S6 0.004 
S2 > S7 0.003 
PaCO2 p 
S1  < S4 <0.001 
S1  < S5 <0.001 
S1  < S6 <0.001 
S1  < S7 <0.001 
S2   < S5 0.03 
S2   < S7. 0.032 
PeCO2 p 
S2 < S3 <0.001 
S2 < S4 0.001 
S2 < S5 <0.001 
S2 < S6 <0.001 
S2 < S7 <0.001 
 
Table 3.3.1.4 
Arterial carbon dioxide tension increased during the first OLA control step (S4) compared to when the patients were awake 
(S1).  Arterial carbon dioxide tensions continued to exceed awake levels during the rest of the OLA control steps.  During 
OLA control steps 5 and 7, arterial carbon dioxide tensions also exceeded those observed during two-lung anesthesia. 
 
During all OLA steps, expired carbon dioxide tensions exceeded those seen during two-lung anesthesia.  Arterial pH was 
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also lower during all the OLA control steps (S4 to S7) than when two-lungs were being ventilated.  No intragroup 
differences in bicarbonate concentrations were observed in the control group.  When the patients were awake, base 
excess exceeded that measured during all other steps in the control group.  Base excess was also lower during all the 
OLA control steps (S4 to S7) compared with the two-lung anesthesia step.   
Control group 
PaO2   
(kPa) 
SaO2   
(%) 
P O2   
(kPa) 
S O2   
(%)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 20 11.2 1.9 20 96.3 2.4 20 5.5 0.5 20 74.9 5.5 
S2: Two-lung Anesthesia, LDP 16 58.9 8.8 16 99.9 0.04 16 9.3 1.4 16 91.8 2.3 
S3: After 15 minutes of OLA 17 38.4 17.3 17 99.1 2.1 17 8.5 1.8 17 88.4 5.1 
S4: OLA, Control step 1 18 34.8 15.4 18 99.1 2.4 18 8.3 1.6 18 87.5 4.8 
S5: OLA, Control step 2 15 35.4 13.3 15 99.1 2.7 15 8.3 1.9 15 86.8 5.2 
S6: OLA, Control step 3 9 36.9 14.2 9 99.4 1.2 9 8.8 2.9 9 86.8 6.3 
S7: OLA, Control step 4 5 32.5 10.3 5 99.6 0.6 5 8.1 0.8 5 86.8 1.6 
 
S O2 p 
S1 < S2 <0.001 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S2 > S6 0.011 
PaO2 p 
S1 < S2 <0.001 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S2 > S3 <0.001 
S2 > S4 <0.001 
S2 > S5 <0.001 
S2 > S6 <0.001 
S2 > S7 <0.001 
SaO2 p 
S1 < S2 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 0.047 
S1 < S7 0.006 
P O2 p 
S1 < S2  <0.001 
S1 < S3  <0.001 
S1 < S6  <0.001 
S1 < S7  <0.001 
 
Table 3.3.1.5 
During two-lung anesthesia, the PaO2 exceeded that seen during all other steps in the control group.  During the first 3 
steps of OLA (S3,4,5), PaO2 also exceeded that seen when the patients were awake.  However, during the last two OLA 
control steps (S6 and S7), PaO2 was not statistically different from those seen during the awake state.  Arterial oxygen 
saturation was less during the awake state than during steps S2,4,5,6 and 7 in the control group.  
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Mixed venous oxygen tension and mixed venous oxygen saturation increased by 70% and 23% respectively after induction 
of anesthesia compared with when the patients were awake.  Similar increases in the venous oxygen tension and 
saturation were sustained during steps 3, 6, and 7 of OLA.  During two-lung anesthesia, S O2 also exceeded that 
measured during OLA control group step 3. 
 
Control group 
CaO2   
(ml.100ml-1)  
C O2 
(ml.100ml-1)  
n   SD. n   SD. 
S1: Awake 20 17.84 2.2 20 13.81 2.0 
S2: Two-lung Anesthesia, LDP 16 17.07 2.1 16 14.69 2.1 
S3: After 15 minutes of OLA 17 16.17 2.5 17 13.89 2.4 
S4: OLA, Control step 1 18 16.20 2.4 18 13.82 2.3 
S5: OLA, Control step 2 15 16.23 2.2 15 13.72 2.2 
S6: OLA, Control step 3 9 16.18 1.8 9 13.60 1.9 
S7: OLA, Control step 4 5 17.25 3.3 5 14.58 2.8 
 
CaO2 p 
S2 < S1 0.043 
S3 < S1 0.010 
S4 < S1 0.003 
S5 < S1 0.012 
S6 < S1 <0.001 
   
Table 3.3.1.6 
CaO2 was higher when the patients were awake than in steps 2,3,4,5 and 7.  No intragroup differences in mixed venous 
oxygen content occurred.   
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Control group 
Shunt Qs/Qt   
(%) 
D(A-a)O2    
(kPa) 
PaO2/FiO2   
  
n   SD. n   SD. n   SD. 
S1: Awake 18 17.3 8.4 18 7.7 1.9 18 53.1 9.2 
S2: Two-lung Anesthesia, LDP 14 26.0 8.6 14 36.3 9.3 14 58.6 9.3 
S3: After 15 minutes of OLA 15 36.3 11.8 15 54.2 17.0 15 40.8 17.0 
S4: OLA, Control step 1 16 37.1 10.8 16 58.6 15.6 16 36.3 15.5 
S5: OLA, Control step 2 14 36.5 8.3 14 59.1 13.6 14 35.8 13.6 
S6: OLA, Control step 3 8 35.8 13.2 8 55.0 11.5 8 40.0 11.5 
S7: OLA, Control step 4 5 35.6 6.6 5 62.5 10.3 5 32.5 10.3 
 
PaO2/FiO2 p 
S1 > S3 0.016 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 0.001 
S1 > S7 0.008 
S2 > S3 <0.001 
S2 > S4 <0.001 
S2 > S5 <0.001 
S2 > S6 <0.001 
S2 > S7 <0.001 
Shunt Qs/Qt p 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
S1 < S7 <0.001 
S2 < S4 <0.001 
S2 < S5 <0.001 
S2 < S6 0.002 
S2 vs. S7 0.054 
D(A-a)O2 p 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
S1 < S7 <0.001 
S2 < S4 <0.001 
S2 < S5 <0.001 
S2 < S6 <0.001 
S2 < S7 <0.001 
 
Table 3.3.1.7 
The shunt fraction was greater during OLA steps 4,5 and 6 than during the first two steps in the control group.  However, 
during step 7, the shunt did not differ statistically from that calculated for step 2.  No progressive increase in the shunt 
fraction occurred as OLA progressed.  The cost of oxygenation, as indicated by the so-called non-invasive indicator of 
shunt, the D(A-a)O2 and the ratio of PaO2/FiO2, was greater during OLA compared with the awake and two-lung 
anesthesia steps. 
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Control group 
MAP    
(mmHg) 
Systemic Pes    
(mmHg) 
SAP    
(mmHg) 
DAP    
(mmHg)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 19 100 16 19 99 20 19 149 26 19 76 12 
S2: Two-lung Anesthesia, LDP 15 79 17 15 79 17 15 112 25 15 64 14 
S3: After 15 minutes of OLA 16 88 14 16 84 123 16 125 23 16 69 10 
S4: OLA, Control step 1 17 79 20 17 76 20 17 113 32 17 62 15 
S5: OLA, Control step 2 15 77 17 15 75 17 15 109 25 15 61 13 
S6: OLA, Control step 3 10 81 15 10 77 17 10 115 22 10 64 12 
S7: OLA, Control step 4 5 69 17 5 67 19 5 98 27 5 54 12 
 
MAP p 
S1 > S2 <0.001 
S1 > S3 0.002 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
Systemic 
Pes 
p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
SAP p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
DAP p 
S1 > S2 0.003 
S1 > S3 0.019 
S1 > S4 0.002 
S1 > S5 0.002 
S1 > S6 0.007 
S1 > S7 0.004 
 
Table 3.3.1.8 
Systolic, diastolic, mean and end systolic systemic arterial pressures were higher when the patients were awake then 
during all other control group steps. 
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Table 3.3.1.9 
Mean pulmonary arterial pressure did not change from when the patients were awake to when 2 lungs were being 
ventilated in the LDP.  However, during all OLA steps except for step 4, mean pulmonary artery pressure exceeded that 
measured when the patients were awake.  Mean pulmonary arterial pressure during OLA in steps 3, 5 and 7 also 
exceeded that seen when two-lungs were being ventilated.  Mean PAP in S3 escaped being statistically different from S2. 
 
Neither PA systolic nor diastolic pulmonary arterial pressures differed between the various steps in the control group.  
 
Control group 
PAP (mean)    
(mmHg) 
SPAP 
(mmHg) 
DPAP 
(mmHg)  
n   SD. n   SD. n   SD. 
S1: Awake 19 19 5.1 19 33 6.7 19 12 4.9 
S2: Two-lung Anesthesia, LDP 15 21 5.9 15 34 9.7 15 14 4.3 
S3: After 15 minutes of OLA 16 24 7.7 16 40 12.1 16 16 6.0 
S4: OLA, Control step 1 17 22 5.3 17 37 9.4 17 15 5.0 
S5: OLA, Control step 2 15 23 6.1 15 37 10.3 15 16 4.6 
S6: OLA, Control step 3 10 21 4.3 10 34 6.9 10 14 3.5 
S7: OLA, Control step 4 5 25 4.8 5 39 6.2 5 17 4.6 
 
PAP (mean) p 
S1 < S3 0.001 
S1 < S5 0.007 
S1 < S6 0.04 
S1 < S7 0.002 
S2 < S3 0.050 
S2 < S5 0.004 
S2 < S7 0.006 
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Control group 
Cardiac index    
(litres.min-1.m-2) 
Stroke index 
(ml.m-2) 
Heart rate    
(beats.min-1)  
n   SD. n   SD. n   SD. 
S1: Awake 20 3.6 0.7 10 44 15 19 82 17 
S2: Two-lung Anesthesia, LDP 16 3.4 0.9 15 39 7 15 83 19 
S3: After 15 minutes of OLA 17 4.4 1.1 5 43 10 16 98 16 
S4: OLA, Control step 1 18 4.0 1.0 17 41 9 17 97 18 
S5: OLA, Control step 2 16 4.2 1.6 15 42 11 15 94 16 
S6: OLA, Control step 3 11 4.1 1.9 19 41 12 10 93 19 
S7: OLA, Control step 4 5 3.6 1.2 16 40 10 5 93 13 
 
Cardiac index p 
S1 < S3 0.02 
S2 < S3 0.001 
S2 < S4 0.01 
S2 < S5 0.006 
S2 < S6 0.05 
Heart rate p 
S1 < S3 0.001 
S1 < S4 0.01 
S1 < S5 0.04 
S1 < S6 0.01 
S2 < S5 0.03 
S2 < S6 0.01 
 
Table 3.3.1.10 
Cardiac index did not change from when the patients were awake to after induction of anesthesia while two-lungs were 
being ventilated awake.  However, cardiac index did rise on initiation of OLA when compared with both the two-lung 
anesthesia and awake steps.  This increase in cardiac index was sustained until all but the very last step of OLA (S7) at 
which point cardiac index returned to baseline awake values.   
 
No intragroup changes in stroke index occurred.  During steps 4, 5 and 6, heart rate was higher than when the patients 
were awake.  During steps 5 and 6, heart rate was also greater than when two-lungs were being ventilated.    
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Table 3.3.1.11 
No intragroup changes in the indices of right or left ventricular preload occurred. 
 
Control group 
CVP 
(mmHg) 
RVEDP 
(mmHg) 
RVEDVI 
(ml.m-2) 
PAWP 
(mmHg)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 20 5.1 3.2 6 4.8 3.5 4 97 28 20 8.7 4.7 
S2: Two-lung Anesthesia, LDP 16 6.7 3.5 6 8.7 4.7 10 111 35 16 10.4 4.1 
S3: After 15 minutes of OLA 17 6.5 4.8 6 9.2 3.9 9 106 37 17 11.4 4.9 
S4: OLA, Control step 1 18 6.0 3.2 4 7.3 2.9 12 114 32 18 10.3 4.6 
S5: OLA, Control step 2 16 6.2 3.6 5 9.2 2.9 13 117 30 16 11.3 4.3 
S6: OLA, Control step 3 11 6.2 3.9 2 14.0 1.4 11 117 24 11 9.6 3.8 
S7: OLA, Control step 4 5 8.0 2.7 1 13.0 0 12 114 32 5 11.6 3.7 
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Table 3.3.2.12 
PA elastance was greater during OLA control steps 4, 5 6 and 7 compared to when patients were awake.  In the last OLA 
control step (S7), PA elastance also exceeded that seen during both two-lung anesthesia (S2) and the first OLA step (S3).  
No intragroup changes were observed in any of the other indices of pulmonary vascular resistance or impedance. 
 
                                                                
3.  Calculated using Ro as derived using the Windkessel equation 
4.  Calculated using Ea = RTOTAL/time of the beat 
Control group 
Ea PA 
(mmHg.ml-1 ) 
PVR 
(dynes.secs.cm-5) 
Rc PA3 
(dynes.secs.cm-5) 
Rc PA4  
(dynes.secs.cm-5) 
R TOTAL 
(dynes.secs.cm-5)  
n   SD. n   SD. n   SD. n   SD. n   SD. 
S1: Awake 25 0.28 0.1 25 160 77 11 78 99 13 108 93 13 201 74 
S2: Two-lung Anesthesia, LDP 21 0.32 0.1 21 156 78 10 64 53 11 92 55 11 200 51 
S3: After 15 minutes of OLA 22 0.33 0.03 22 131 59 11 61 53 12 90 63 12 189 58 
S4: OLA, Control step 1 24 0.33 0.03 24 153 77 11 70 78 10 92 121 12 207 83 
S5: OLA, Control step 2 19 0.35 0.03 19 149 70 9 78 39 9 106 102 9 219 76 
S6: OLA, Control step 3 11 0.33 0.03 11 151 40 8 79 99 9 118 132 8 232 86 
S7: OLA, Control step 4 6 0.38 0.04 6 173 26 5 43 49 5 67 80 5 194 64 
 
Ea PA p 
S4 > S1 0.035 
S5 > S1 0.039 
S6 > S1 0.015 
S7 > S1 0.001 
S7 > S2 0.007 
S7 > S3 0.020 
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Control group 
Compliance PA5 
(ml.mmHg-1) 
Compliance PA6 
(ml.mmHg-1) 
Tau PA 
(secs)  
n   SD. n   SD. n   SD. 
S1: Awake 13 2.5 1.0 13 2.2 1.00 9 0.40 0.25 
S2: Two-lung Anesthesia, LDP 11 3.8 3.0 11 3.3 2.7 11 0.51 0.45 
S3: After 15 minutes of OLA 12 3.1 2.1 12 2.8 2.0 11 0.45 0.30 
S4: OLA, Control step 1 10 2.2 1.0 10 2.0 1.0 12 0.41 0.21 
S5: OLA, Control step 2 9 2.3 1.8 9 2.3 1.8 10 0.51 0.40 
S6: OLA, Control step 3 5 3.3 2.1 5 2.9 2.00 8 0.43 0.16 
S7: OLA, Control step 4 5 2.7 1.4 5 2.4 1.3 4 0.39 0.21 
 
Table 3.3.1.13 
No intragroup changes in PA compliance or the time constant of the pulmonary circulation were observed.    
                                                                
5.  Calculated using Ro as derived using the Windkessel equation 
6.  Calculated using Rt/time of the beat 
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Control group 
SVR 
(dynes.secs.cm-5) 
Ea aorta 
(mmHg.ml-1)  
n   SD. n   SD. 
S1: Awake 10 1104 515 24 1.5 0.2 
S2: Two-lung Anesthesia, LDP 15 1002 483 20 1.2 0.2 
S3: After 15 minutes of OLA 5 951 640 22 1.2 0.4 
S4: OLA, Control step 1 17 993 445 23 1.2 0.5 
S5: OLA, Control step 2 15 1126 315 19 1.5 0.5 
S6: OLA, Control step 3 19 1392 351 11 1.2 0.6 
S7: OLA, Control step 4 16 993 276 6 1.1 0.6 
 
SVR p 
S1 > S2 0.019 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 < S5 <0.001 
S1 < S6 0.005 
S1 > S7 0.015 
 
Table 3.3.1.14 
Systemic vascular resistance was less during steps 2,3,4 and 7 than when the patients were awake.  However, during 
steps 5 and 6, systemic vascular resistance exceeded the SVR when the patients were awake.   
 
Aortic elastance did not change from when the patients were awake to the last OLA control step. 
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Control group 
RVSWI 
(g.m.m-2) 
LVSWI    
(g.m.m-2) 
RVEF 
(%)  
n   SD. n   SD. n   SD. 
S1: Awake 10 9.29 5.0 10 54.6 10.6 11 35.5 6.2 
S2: Two-lung Anesthesia, LDP 15 7.36 2.48 15 36.3 15.3 12 35.8 7.1 
S3: After 15 minutes of OLA 5 10.8 4.32 5 43.1 15.6 10 35.9 6.6 
S4: OLA, Control step 1 17 9.96 4.79 17 37.0 15.8 12 38.9 7.9 
S5: OLA, Control step 2 15 10.6 5.36 15 33.1 15.5 13 36.2 8.5 
S6: OLA, Control step 3 19 9.48 4.44 19 35.1 15.7 9 38.7 3.7 
S7: OLA, Control step 4 16 10.73 5.69 16 31.3 6.1 4 36.8 1.7 
 
LVSWI p 
S1 > S2 <0.001 
S1 > S3 0.006 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
 
Table 3.3.1.15 
No intragroup changes in either RVSWI or RVEF were observed in the control group.   
 
Left ventricular stroke work index decreased by 33% on induction of anesthesia compared with the awake state.  
Throughout OLA, LVSWI remained lower relative to the awake step.    
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Control group 
VO2 index   
(ml.min-1.m-2) 
DO2 index   
(ml.min-1.m-2) 
HKT    
(%) 
Temperature    
(oC)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 20 141 28 20 641 149 20 39.4 4.7 20 36.7 0.6 
S2: Two-lung Anesthesia, LDP 16 78 13 16 582 155 16 34.0 4.5 16 35.8 0.6 
S3: After 15 minutes of OLA 17 98 26 17 695 183 17 33.3 4.8 17 35.8 0.5 
S4: OLA, Control step 1 18 93 26 18 643 169 18 33.5 4.5 18 35.7 0.5 
S5: OLA, Control step 2 15 94 23 15 615 157 15 33.6 4.6 15 35.6 0.5 
S6: OLA, Control step 3 9 88 29 9 586 168 9 33.3 4.2 9 35.8 0.6 
S7: OLA, Control step 4 5 96 33 5 623 232 5 35.8 7.0 5 35.6 0.8 
 
VO2 index p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
Temperature p 
S1> S2 <0.001 
S1> S3 <0.001 
S1> S4 <0.001 
S1> S5 <0.001 
S1> S6 <0.001 
S1> S7 <0.001 
DO2 index p 
S2 <. S3 0.020 
HKT p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1> S5 <0.001 
S1> S6 <0.001 
S1> S7 0.003 
 
Table 3.3.1.16 
Oxygen consumption decreased by 45% after induction of anesthesia compared with when the patients were awake.  
During the OLA steps, oxygen consumption was also less (on average 34%) than when the patients were awake. 
 
The only intragroup difference in oxygen delivery was a lower DO2 during the step when two-lungs were being ventilated 
(S2) compared with when OLA and surgery commenced (S3). 
 
Both hematocrit and temperature decreased after induction of anesthesia compared with when the patients were awake.  
No further changes in hematocrit and temperature occurred as OLA progressed. 
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Control group 
CaO2 – C O2   
(ml.100ml-1)   
OER    
 
n   SD. n   SD. 
S1: Awake 20 4.0 1.0 18 0.23 0.05 
S2: Two-lung Anesthesia, LDP 16 2.4 0.45 14 0.14 0.03 
S3: After 15 minutes of OLA 17 2.3 0.45 15 0.14 0.03 
S4: OLA, Control step 1 18 2.4 0.52 16 0.15 0.03 
S5: OLA, Control step 2 15 2.5 0.47 14 0.16 0.03 
S6: OLA, Control step 3 9 2.6 0.95 8 0.16 0.06 
S7: OLA, Control step 4 5 2.7 0.47 5 0.16 0.01 
 
CaO2 – C O2 p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
OER p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S1 > S7 <0.001 
 
Table 3.3.1.17 
The arterial-venous oxygen content difference and the oxygen extraction ratio both decreased by 40% after 
induction of anesthesia compared with when the patients were awake.  These decreases in the arterial-
venous oxygen content difference and the oxygen extraction ratio were sustained throughout OLA. 
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3.3.2 Dobutamine group tables 
 
 
 
Dobutamine group 
Tidal volume expired 
(ml.kg-1) 
Minute volume expired 
(litres)  
n   SD. n   SD. 
S1: Awake    - - - 
S2: Two-lung Anesthesia 24 7.1 1.8 24 4.7 1.6 
S3: One Lung Anesthesia 23 6.7 2.1 23 4.8 1.3 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 5.9 1.4 18 4.4 1.4 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 6.5 2.2 15 4.3 1.4 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 5.8 1.4 15 4.5 1.3 
 
Table 3.3.2.1 
No changes in expired tidal volume or minute volume occurred on initiation of OLA.  No further changes in 
tidal volume or expired minute volume occurred while any of the 3 dosages of dobutamine were being 
administered. 
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Table 3.3.2.2 
Peak airway pressure increased while dynamic compliance decreased on induction of OLA.  These 
changes were sustained during the OLA steps while dobutamine was being administered.   
 
Intrinsic PEEP was present during all the OLA steps; however, no intragroup differences were observed. 
Dobutamine group 
Peak airway pressure 
(cmH20) 
Dynamic compliance 
(ml.cmH20-1) 
Intrinsic PEEP 
(cm H20)  
n   SD. n   SD. n   SD. 
S1: Awake - - - - - - - - - 
S2: Two-lung Anesthesia 24 22 7 24 21 8 0 - - 
S3: One Lung Anesthesia 24 26 6 24 15 4 2 3 3 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 26 5 18 14 4 2 4 4 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 29 5 16 13 5 2 5 6 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 27 6 15 12 4 1 9 0 
 
Peak airway 
pressure 
p 
S2 < S3 <0.001 
S2 < S4 <0.001 
S2 < S5 <0.001 
S2 < S6 <0.001 
Dynamic 
compliance 
p 
S2 > S3 <0.001 
S2 > S4 <0.001 
S2 > S5 <0.001 
S2 > S6 <0.001 
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Table 3.3.2.3 
No differences end tidal isoflurane partial pressures between the various steps in the dobutamine group 
occurred. 
  
Dobutamine group 
End tidal isoflurane 
concentration 
(kPa)  
n   SD. 
S1: Awake - - - 
S2: Two-lung Anesthesia 7 0.4 0.2 
S3: One Lung Anesthesia 7 0.5 0.2 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 6 0.4 0.2 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 7 0.4 0.2 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 4 0.5 0.1 
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Table 3.3.2.4 
Arterial carbon dioxide tensions increased after induction of anesthesia, and increased progressively as OLA continued.  
During all dobutamine administration steps, the expired carbon dioxide tensions exceeded those seen during two-lung 
anesthesia.  During the administration of 7μg per kg of dobutamine (S6), PeCO2 also exceeded that seen during OLA 
when no intervention was applied (S3).   
 
Arterial pH was less during all steps in the dobutamine group compared with when the patients were awake.  When 
dobutamine 5 and 7 μg per kg were administered, arterial pH was less than during the two-lung anesthesia step.   
Dobutamine group 
PaCO2  
(kPa) 
PeCO2  
(kPa) 
pH arterial 
 
HCO3 
(mmol.litre-1) 
BE 
(mmol.litre-1)  
n   SD. n   SD. N   SD. n   SD. n   SD. 
S1: Awake 24 5.3 0.7 - - - 24 7.43 0.02 24 27.7 2.7 24 2.7 2.0 
S2: Two-lung Anesthesia 23 5.8 1.0 24 4.8 1.0 23 7.38 0.05 23 27.3 2.7 23 1.1 2.0 
S3: One Lung Anesthesia 23 6.0 0.9 24 5.1 1.1 23 7.35 0.09 23 27.1 2.5 23 0.7 2.2 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 6.7 1.2 18 5.6 1.1 18 7.32 0.06 18 27.2 2.7 18 -0.3 2.4 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 6.9 1.3 16 5.7 1.3 16 7.31 0.07 16 27.5 3.2 16 -0.3 2.9 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 6.5 1.1 15 5.7 1.1 15 7.30 0.07 15 26.3 3.8 15 -1.3 3.7 
 
PaCO2 p 
S1 < S2. 0.006 
S1 < S3 0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
S2 < S4 0.022 
S2 < S5. 0.009 
S2 < S6 0.024 
S3 vs. S4 0.065 
S3 < S5 0.034 
S3 < S6 0.042 
BE p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S2 > S4 0.004 
S2 > S5 0.003 
S2 > S6 <0.001 
S3 > S4 0.018 
S3 > S5 0.023 
S3 > S6 <0.001 
PeCO2 p 
S2 < S4 0.005 
S2 < S5 0.001 
S2 < S6 <0.001 
S6 < S3 0.02 
pH arterial p 
S1 > S2 0.002 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S2 > S5 0.007 
S2 > S6 0.008 
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No differences in bicarbonate concentrations were seen between any of the steps in the dobutamine group.  Base excess 
was greater in the awake state relative to all the other steps in the dobutamine group.  Base excess was also greater in  
 steps 2 and 3 compared with steps 4,5 and 6. 
 
 
Table 3.3.2.5 
Arterial oxygen tensions and saturations were greater than awake values during all steps after induction of anesthesia.  
While both lungs were being ventilated, arterial oxygen tension also exceeded that measured both during the OLA steps 
and when the patients were awake. 
 
Dobutamine group 
PaO2 
(kPa) 
SaO2 
(%) 
P O2 
(kPa) 
S O2 
(%)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 24 11.2 1.9 24 96.0 3.1 24 5.4 0.5 24 75.1 5.7 
S2: Two-lung Anesthesia 23 53.4 13.5 23 99.9 0.1 23 8.6 1.7 23 89.9 4.7 
S3: One Lung Anesthesia 23 45.4 17.7 23 99.7 0.6 23 9.0 1.7 23 90.6 4.7 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 37.9 19.3 18 98.8 2.6 18 9.0 2.1 18 89.0 5.5 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 38.1 19.6 16 98.5 4.2 16 8.5 2.2 16 85.5 11.9 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 37.7 15.9 15 99.3 1.9 15 9.3 1.6 15 89.9 5.8 
 
PaO2 p 
S1 < S2 <0.001 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
S2 > S3 0.013 
S2 > S4 <0.001 
S2 > S5 <0.001 
S2 > S6 0.001 
SaO2 p 
S1 < S2. <0.001 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
PvO2 p 
S1 < S2 <0.001 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
SvO2 p 
S1 < S2 <0.001 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
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Immediately after induction of anesthesia, venous oxygen tension and saturation increased by 60 and 20% respectively 
relative to the awake values.  These increases in venous oxygen tension and saturation were sustained at similar levels 
during OLA both with and without dobutamine administration. 
 
Dobutamine group 
CaO2 
(ml.100ml-1)   
C O2 
(ml.100ml-1)  
n   SD. n   SD. 
S1: Awake 24 18.35 2.19 24 14.27 1.91 
S2: Two-lung Anesthesia 23 17.98 2.28 23 15.28 2.18 
S3: One Lung Anesthesia 23 17.54 3.00 23 15.21 2.86 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 17.35 2.97 18 15.12 3.15 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 16.49 2.21 16 13.70 2.43 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 16.35 2.62 15 14.29 2.60 
 
CaO2 p 
S1 > S5 0.013 
S1 > S6 0.013 
 
Table 3.3.2.6 
No intragroup differences in mixed venous oxygen content occurred.  However, arterial oxygen content was decreased 
during the dobutamine 5 and 7 ug.kg-1.min-1 steps relative to when the patients were awake.   
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Dobutamine group 
Shunt Qs/Qt  
% 
D(A-a)O2  
kPa 
PaO2/FiO2 
  
n   SD. n   SD. n   SD. 
S1: Awake 23 18.0 11.2 24 7.7 2 24 53.1 9 
S2: Two-lung Anesthesia 23 26.2 7.2 23 41.7 14 23 53.3 13 
S3: One Lung Anesthesia 23 32.5 8.3 23 49.6 18 23 45.3 17 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 38.5 13.9 18 57.2 19 18 37.8 19 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 34.2 7.8 16 56.9 20 16 38.0 19 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 39.6 7.5 15 57.3 16 15 37.7 15 
 
Shunt Qs/Qt p 
S1 < S2 0.003 
S1 < S3 <0.001 
S1 < S4 <0.001 
S1 < S5 <0.001 
S1 < S6 <0.001 
S2 < S3 0.012 
S2 < S4 <0.001 
S2 < S5 0.010 
S2 < S6 <0.001 
PaO2/FiO2 p 
S1 > S3 0.021 
S1 > S4 0.002 
S1 > S5 0.003 
S1 > S6 0.003 
S2 > S3 0.039 
S2 > S4 0.003 
S2 > S5 0.001 
S2 > S6 0.004 
D(A-a)O2 p 
S2 > S1 <0.001 
S3 > S1 <0.001 
S4 > S1 <0.001 
S5 > S1 <0.001 
S6 > S1 <0.001 
S3 > S2 0.013 
S4 > S2 <0.001 
S5 > S2 <0.001 
S6 > S2 0.001 
 
Table 3.3.2.7 
The shunt fraction increased by 46% while two-lungs were being ventilated compared with that seen when the patients 
were awake.  A further 24% increase in shunt fraction was noted on institution of OLA (S3) relative to the shunt seen 
during two-lung anesthesia.  Compared with the two-lung anesthesia step, this increase in shunt fraction was sustained 
during all steps (S4, 5 and 6) during which dobutamine was administered.  The increase in D(A-a)O2 during step 2 
indicated an increased cost of arterial oxygenation compared with the awake state.  The D(A-a)O2  increased further during 
OLA (S3) compared with both the awake and two-lung anesthesia steps.  The PaO2/FiO2 ratio also indicated that the cost 
of arterial oxygenation increased after institution of OLA compared with the first two steps; this difference was sustained in 
the rest of the control group steps. 
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Table 3.3.2.8 
After induction of anesthesia and while two-lungs were being ventilated (S2), an approximately 27% decrease in both MAP 
and systemic Pes occurred compared with awake values.  During two-lung anesthesia, MAP was also lower than that 
measured during all the other steps in the dobutamine group.  Pes was lower during two-lung anesthesia than in steps 3 
and 5.  After initiation of OLA (S3), MAP was only 12% less than the when the patients were awake.  However, on 
administration of dobutamine, the MAP was not different from when the patients were awake.   
 
SAP and DAP decreased during two-lung anesthesia compared with all other steps.  SAP was also less than baseline 
awake during OLA (S3) and when dobutamine 3 ug.kg-1.min-1 was administered.  However, during administration of 
dobutamine (both 5 and 7 ug.kg-1.min-1), any difference from baseline was no longer apparent. 
  
 
Dobutamine group 
MAP   
(mmHg) 
Systemic Pes   
(mmHg) 
SAP  
(mmHg) 
DAP  
(mmHg)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 25 95 13 25 95 14 25 136 18 25 75 12 
S2: Two-lung Anesthesia 24 70 16 24 70 15 24 96 19 24 57 14 
S3: One Lung Anesthesia 24 84 19 24 81 16 24 116 24 24 68 16 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 84 20 18 79 19 18 121 30 18 65 16 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 88 19 16 82 20 16 127 28 16 68 16 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 88 17 15 81 20 15 133 27 15 64 14 
 
MAP p 
S1 > S2 <0.001 
S1 > S3 0.030 
S1 vs. S4 0.056 
S2 < S3 <0.001 
S2 < S4 0.003 
S2 < S5 0.001 
S2 < S6 0.001 
SAP p 
S1 < S2 <0.001 
S1 < S3 0.002 
S1 < S4 0.039 
S2 < S3 <0.001 
S2 < S4 <0.001 
S2 < S5 <0.001 
S2 < S6 <0.001 
S6 vs. S3 0.061 
DAP p 
S2 < S1 <0.001 
S2 < S3 0.008 
S2 < S4 0.022 
S2 < S5 0.024 
S2 < S6 0.018 
Systemic 
Pes 
p 
S1 > S2 <0.001 
S1 > S3 0.006 
S1 > S4 0.016 
S1 > S5 0.019 
S1 > S6 0.014 
S2 < S3 0.026 
S2 < S5 0.039 
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Table 3.3.2.9 
Compared with when the patients were awake, no differences in PA pressures occurred after induction of either two or one 
lung anesthesia (S2 and S3).  The two higher dosages of dobutamine increased mean pulmonary arterial pressure above 
those seen both while the patient was awake and when both lungs were being ventilated.   
 
No intragroup changes in diastolic PAP were observed in the dobutamine group.   
 
As the dosage of dobutamine was being increased, systolic pulmonary arterial pressure rose progressively.   
Dobutamine group 
PAP   (mean) 
(mmHg) 
SPAP  
(mmHg) 
DPAP  
(mmHg)  
n   SD. n   SD. n   SD. 
S1: Awake 25 19 5 25 32 8 25 12 5 
S2: Two-lung Anesthesia 24 19 5 24 31 7 24 13 4 
S3: One Lung Anesthesia 24 22 6 24 35 10 24 15 6 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 23 6 18 40 10 18 15 5 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 25 7 16 42 12 16 16 5 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 25 6 15 43 12 15 16 5 
 
PAP (mean) p 
S5 > S1 0.002 
S5 > S2 0.013 
S6 > S1 0.002 
S6 > S2 0.014 
SPAP p 
S6 > S1 <0.001 
S6 > S2 <0.001 
S6 > S3 0.042 
S5 > S1 <0.001 
S5 > S2 <0.001 
S5 > S3 0.031 
S4 > S1 0.038 
S4 > S2 0.024 
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Dobutamine group 
Cardiac index 
(litres.min-1.m-2) 
Stroke index  
(ml.min-1.m-2) 
Heart rate  
(beats.min-1)  
n   SD. n   SD. n   SD. 
S1: Awake 24 3.6 0.8 24 46 11 25 85 25 
S2: Two-lung Anesthesia 24 3.4 0.9 24 41 12 24 82 13 
S3: One Lung Anesthesia 23 4.4 1.1 23 45 15 24 94 14 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 5.2 1.1 18 52 12 18 103 21 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 4.9 1.2 16 46 11 16 108 21 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 5.5 1.2 15 47 12 15 114 23 
 
Cardiac index P 
S6 > S1 <0.001 
S6 > S2 <0.001 
S6 > S3 <0.001 
S6 > S5 0.054 
S5 > S1 <0.001 
S5 > S2 <0.001 
S5 > S3 0.0012 
S4 > S1 <0.001 
S4 > S2 <0.001 
S4 > S3 0.008 
S3 > S1 <0.001 
S3 > S2 <0.001 
Stroke index  P 
S2 < S4 0.017 
Heart rate P 
S6 > S1 <0.001 
S6 > S2 <0.001 
S6 > S3 0.002 
S5 > S1 <0.001 
S5 > S2 <0.001 
S5 > S3 0.01 
S4 > S1 0.003 
S4 > S2 <0.001 
S3 > S1 0.050 
S3 > S2 0.010 
 
Table 3.3.2.10 
Cardiac index did not change from when the patients were awake  to the step after induction of anesthesia when two-lungs 
were being ventilated.  However, cardiac index rose after initiation of OLA (S3) compared with both S1 and S2.  
Administration of all three dosages of dobutamine (S4,5 and 6) further increased cardiac output above values seen when 
the patients were awake (S1), above the cardiac index seen when two-lungs were being ventilated (S2), and above those 
levels seen during OLA when dobutamine was not being administered (S3).   
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Stroke index decreased during the step following initiation of anesthesia relative to steps 4.  After initiation of OLA, this 
decrease in stroke index was restored to baseline awake state.  No further changes in stroke index were seen while any of 
the dosages of dobutamine was being administered.  However, heart rate increased on initiation of OLA and increased 
progressively as the dose of dobutamine was increased. 
 
 
 
Table 3.3.2.11 
No intragroup changes in the indices of right or left ventricular preload occurred. 
Dobutamine group 
CVP 
(mmHg) 
RVEDP 
(mmHg) 
RVEDVI 
(ml.m-2) 
PAWP 
(mmHg)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 25 5.1 4.4 11 5.1 3.6 11 110 27 25 9.1 4.5 
S2: Two-lung Anesthesia 24 6.5 4.1 12 7.0 3.4 9 100 25 24 9.8 4.2 
S3: One Lung Anesthesia 24 7.0 37 10 7.4 3.0 12 112 23 24 11.3 4.1 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 6.5 3.8 9 7.1 2.8 8 101 20 18 10.4 3.6 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 7.2 3.5 10 8.7 3.7 10 116 42 16 8.6 5.3 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 6.8 3.8 5 8.4 4.2 11 114 19 15 10.6 4.0 
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Table 3.3.2.12 
During OLA while dobutamine 5 ug.kg-1.min-1 was being administered, PVR exceeded that observed during all other OLA 
steps.  During OLA while dobutamine 7 ug.kg-1.min-1 was being administered, pulmonary elastance (PA Ea) exceeded that 
observed when the patients were awake.  No further intragroup changes in any of the other indices of pulmonary vascular 
resistance or impedance were observed in the dobutamine group. 
                                                                
7 Calculated using Ro as derived using the Windkessel equation 
8 Calculated using Ea = RTOTAL/time of the beat 
Dobutamine group 
Ea PA 
(mmHg.ml-1) 
PVR 
(dynes.secs.cm-5) 
Rc PA7 
(dynes.secs.cm-5) 
Rc PA8 
(dynes.secs.cm-5) 
R TOTAL 
(dynes.secs.cm-5)  
n   SD. n   SD. n   SD. n   SD. n   SD. 
S1: Awake 24 0.27 0.1 25 134 73 7 119 141 7 167 152 7 185 56 
S2: Two-lung Anesthesia 24 0.31 0.1 24 145 77 7 115 100 7 143 117 7 254 146 
S3: One Lung Anesthesia 23 0.29 0.07 23 119 54 7 57 49 7 84 52 7 185 21 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 0.28 0.1 18 117 50 8 66 39 8 61 66 8 138 58 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 17 0.34 0.09 16 162 52 5 66 96 5 108 98 5 202 61 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 20 0.35 0.1 15 125 48 6 76 55 6 76 80 6 154 48 
Ea PA p 
   S6 > S1 0.022 
     
 
PVR p 
S5 > S3 0.043 
S5 > S4 0.042 
S5 > S6 0.045 
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Dobutamine group 
Compliance PA9 
(ml.mmHg-1) 
Compliance PA 10 
(ml.mmHg-1) 
Tau PA 
(secs)  
n   SD. n   SD. n   SD. 
S1: Awake 6 2.8 2.3 6 2.2 1.6 7 0.52 0.36 
S2: Two-lung Anesthesia 6 3.3 1.6 6 3.0 1.3 6 0.65 0.34 
S3: One Lung Anesthesia 6 3.5 2.1 6 3.1 1.9 6 0.49 0.26 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 7 3.7 2.9 7 4.1 2.5 6 0.46 0.23 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 5 2.1 0.8 5 2.1 0.5 5 0.34 0.14 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 5 1.1 0.5 5 1.2 0.5 5 0.19 0.09 
 
Compliance 
PA  using  
Rt/time 
p 
S5<S3  0.027 
S6<S3  0.050 
Tau p 
S6<S2 0.036 
 
Table 3.3.2.13 
During administration of dobutamine 7μg.kg-1.min-1, both PA compliance and the time constant of the pulmonary 
vasculature decreased.  During the administration of 5 and 7μg.kg-1.min-1 of dobutamine, PA compliance decreased 
significantly from that calculated during OLA when no dobutamine was being administered (S3). 
 
 
                                                                
9 Calculated using Ro as derived using the Windkessel equation 
10 Calculated using Ea = RTOTAL/time of the beat 
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Dobutamine group 
SVR 
(dynes.secs.cm-5) 
Ea Aorta 
(mmHg.ml-1)  
n   SD. n   SD. 
S1: Awake 24 1282 345 24 1.4 0.5 
S2: Two-lung Anesthesia 24 986 319 24 1.1 0.4 
S3: One Lung Anesthesia 23 912 239 23 1.1 0.3 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 761 279 18 1.0 0.4 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 842 241 16 1.2 0.4 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 787 318 15 1.2 0.5 
 
SVR p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
 
Table 3.3.2.14 
Both after induction of anesthesia and throughout OLA, systemic vascular resistance was less than that during the awake 
step.   
 
No intragroup differences in aortic elastance were noted in the dobutamine group.    
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Dobutamine group 
RVSWI 
(g.m.m-2) 
LVSWI 
(g.m.m-2) 
RVEF 
(%)  
n   SD. n   SD. n   SD. 
S1: Awake 24 9.1 3.8 25 52.4 18.7 12 41.2 6.7 
S2: Two-lung Anesthesia 24 8.4 4.7 24 35.2 15.2 10 39.5 6.7 
S3: One Lung Anesthesia 25 9.1 3.7 25 48.8 14.5 9 47.1 6.8 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 13.0 5.5 18 52.4 22 12 44.8 6.4 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 11.4 6.3 16 50.1 22.0 11 45.7 5.8 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 13.3 6.8 15 50.0 16.3 9 45.9 4.6 
 
RVSWI p 
S4 > S1 0.039 
S4 > S2 0.024 
S6 > S1 0.013 
S6 > S2 0.022 
LVSWI p 
S2 < S1 <0.001 
S2 < S3 0.002 
S2 < S4 <0.001 
S2 < S5 0.004 
S2 < S6 0.001 
RVEF  p 
S3 > S2 0.014 
S4 > S2 0.020 
S5 > S2 0.009 
S6 > S2 0.012 
 
Table 3.3.2.15 
When compared with the awake step, no change in right ventricular stroke work index was seen either during the two-lung 
anesthesia (S2) or after the initiation of OLA (S3) steps.  Dobutamine, at infusion rates of both 3 and 7 μg.kg-1.min-1, 
increased right ventricular stroke work index relative to steps 1 and 2.  On administration of dobutamine 5 μg.kg-1.min-1, 
RVSWI did not differ from that seen during steps 1,2 or 3. 
Left ventricular stroke work index decreased during the two-lung anesthesia step (S2) compared with the awake values.  
However, on commencement of surgery during the OLA step without administration of dobutamine (S3) and on 
administration of all 3 dosages of dobutamine, left ventricular stroke work index was restored to baseline levels.   
No difference in right ventricular ejection fraction was seen on induction of anesthesia compared with the pre-induction 
levels.  During both the baseline OLA step (S3) and during administration of all 3 dosages of dobutamine (S4,5 and 6), 
right ventricular ejection fraction increased compared with that seen during two-lung anesthesia (S2).   
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Table 3.3.2.16 
Oxygen consumption decreased by 39% after induction of anesthesia compared with when the patients were awake.  
Compared with awake levels, smaller decreases (23 to 32%) in oxygen consumption occurred on initiation of OLA (S3) and 
while dobutamine 3, 5 and 7 μg.kg-1.min-1 were administered.     
 
After induction of anesthesia (S2), oxygen delivery was less than that seen during steps 3, 4, 5 and 6.  However, the 
commencement of surgery and the initiation of OLA (S3), restored oxygen delivery to levels seen when the patients were 
awake.  During the administration of dobutamine 3 and 7 μg.kg-1.min-1, oxygen delivery exceeded that seen during steps 1, 
2 and 3.  Dobutamine 5 μg.kg-1.min-1 increased oxygen delivery to levels that exceeded those observed when the patients 
were awake.   
Dobutamine group 
VO2 index 
(ml.min-1.m-2) 
DO2 index 
(ml.min-1.m-2) 
HKT 
(%) 
Temperature   
(oC)  
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 24 147 49 24 660 127 24 40.7 4.9 23 36.9 0.5 
S2: Two-lung Anesthesia 23 90 28 23 613 169 23 36.2 4.9 21 36.0 0.6 
S3: One Lung Anesthesia 23 100 30 23 759 206 23 35.7 6.4 23 35.9 0.6 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 119 32 18 896 199 18 36.1 7.1 18 35.9 0.6 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 121 27 16 803 195 16 34.3 5.3 16 35.9 0.6 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 113 31 15 892 217 15 33.7 6.0 14 35.9 0.7 
   
VO2 index p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S5 > S2 <0.002 
DO2 index p 
S2 < S3 0.001 
S4 > S1 <0.001 
S4 > S2 <0.001 
S4 > S3 0.023 
S5 > S1 0.007 
S5 > S2  <0.001 
S6 > S1 <0.001 
S6 > S2 <0.001 
S6 > S3 0.012 
HKT p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
Temperature p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
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Compared with when the patients were awake, both hematocrit and temperature decreased after induction of anesthesia.  
These changes in hematocrit and temperature were sustained at similar levels as OLA progressed. 
 
Dobutamine group 
CaO2 – C O2 
(ml.100ml-1)   
OER 
  
n   SD. n   SD. 
S1: Awake 24 4.07 1.20 24 0.22 0.06 
S2: Two-lung Anesthesia 23 2.70 0.74 23 0.15 0.04 
S3: One Lung Anesthesia 23 2.33 0.49 23 0.13 0.03 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 18 2.23 0.55 18 0.13 0.04 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 16 2.79 1.30 16 0.17 0.08 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 15 2.06 0.41 14 0.13 0.04 
 
OER p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
CaO2 – C O2 p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S1 > S6 <0.001 
S2 > S6 0.033 
S5 > S6 0.048 
 
Table 3.3.2.17 
The arterial-venous oxygen content difference was decreased during the two-lung anesthesia step (S2) compared with 
when the patient was awake.  This decrease was sustained on initiation of OLA (S3) and during administration of 
dobutamine 3μg.kg-1.min-1.  However, on administration of dobutamine 7 μg.kg-1.min-1, the arterial-venous oxygen content 
difference was less than that seen during the infusion of dobutamine 5μg.kg-1.min-1, during two-lung anesthesia and while 
the patients were awake.  The oxygen extraction ratio decreased by 30% after induction of anesthesia while two-lungs 
were being ventilated (S2) compared with when the patients were awake.  Similar decreases in extraction ratio were seen 
during OLA (S3) and during administration of all dosages of dobutamine (S4, 5 and 6).   
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3.3.3 PEEP group tables 
 
 
 
PEEP group 
Tidal volume expired 
(ml.kg-1) 
Minute volume expired 
(litres) 
 
n   SD. n   SD. 
S1: Awake - - - - - - 
S2: Two Lung Anesthesia, LDP 11 7.3 1.3 11 5.7 0.9 
S3: After 15 minutes of OLA 11 6.2 1.5 11 4.8 0.9 
S4: OLA, DL PEEP5 11 6.2 1.4 11 4.7 1.3 
S5: OLA, DL PEEP10 6 5.8 0.4 6 4.9 1.2 
 
Minute 
volume 
p 
S2 > S3 0.014 
S2 > S4 0.009 
S2 > S5 0.060 
 
Table 3.3.3.1 
No changes in expired tidal volume were seen on institution of OLA.  No changes in tidal volume were 
observed during OLA when either 5 or 10 cm H2O PEEP was applied to the dependant lung.   
 
However, expired minute volume decreased on institution of OLA compared with that measured during 
two-lung anesthesia.  This decrease was sustained during administration of PEEP5 to the dependant lung. 
 
However, the expired minute volume during the PEEP10 step did not differ statistically from that measured 
during S2, S3 or S5. 
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PEEP group 
Peak airway pressure 
(cm H20) 
Dynamic compliance 
(ml.cm H20-1) 
Intrinsic PEEP 
 (cm H20) 
 
n   SD. n   SD. n   SD. 
S1: Awake - - - - - - - - - 
S2: Two Lung Anesthesia, LDP 11 21 6.4 11 25 9.0 2 1 1 
S3: After 15 minutes of OLA 11 31 8.3 11 15 6.5 2 2.5 2.5 
S4: OLA, DL PEEP5 11 34 8.1 11 14 4.7 1 11 0 
S5: OLA, DL PEEP10 6 40 7.2 6 12 3.4 1 10 0 
 
Peak airway 
pressure 
p 
S3 > S2  <0.001 
S4 > S2 <0.001 
S5 > S2  <0.001 
S5 < S3 0.062 
Dynamic 
compliance 
p 
S3 < S2 <0.001 
S4 < S2 <0.001 
S5 < S2 <0.001 
 
Table 3.3.3.2 
Peak airway pressure increased by 48% and dynamic compliance decreased by 40% on initiation of OLA 
compared with when two lungs were being ventilated.  Administration of both PEEP5 (S4) and PEEP10 (S5) 
also resulted in an increased peak airway pressure and decreased dynamic compliance compared with 
that seen during two-lung anesthesia (S2). 
No intragroup differences in PEEPi were observed. 
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PEEP group 
End tidal isoflurane  
(kPa) 
 
n   SD. 
S1: Awake - - - 
S2: Two Lung Anesthesia, LDP 4 0.4 0.1 
S3: After 15 minutes of OLA 4 0.5 0.1 
S4: OLA, DL PEEP5 3 0.6 0.2 
S5: OLA, DL PEEP10 4 0.5 0.1 
 
Table 3.3.3.3 
No differences in the end tidal partial pressure of isoflurane occurred between the various steps of the 
PEEP group. 
Chapter 3.  Results 
 
205 
 
PEEP group 
PaCO2  
(kPa)  
PeCO2  
(kPa) 
pH arterial  
 
HCO37 
(mmol.litre-1) 
B.E.  
(mmol.litre-1) 
 
n   SD. n   SD. n   SD. n   SD. n   SD. 
S1: Awake 10 4.9 0.3 - - - 10 7.43 0.02 10 25.8 2.4 10 1.2 2.4 
S2: Two Lung Anesthesia, LDP 11 5.2 0.5 11 4.2 0.9 11 7.41 0.05 11 26.1 2.4 11 0.9 2.7 
S3: After 15 minutes of OLA 11 5.5 0.7 11 4.7 1.0 11 7.39 0.06 11 25.9 1.9 11 0.2 2.6 
S4: OLA, DL PEEP5 11 5.7 0.8 11 4.9 1.2 11 7.35 0.06 11 24.9 2.2 11 -1.4 2.5 
S5: OLA, DL PEEP10 6 6.0 0.8 6 5.0 0.8 6 7.35 0.06 6 26.2 1.6 6 -0.5 1.8 
 
B.E. p 
S1 > S4 <0.001 
S1 > S5 0.003 
S2 > S4 0.001 
S2 > S5 0.006 
S3 > S5 0.034 
S3 > S4 0.034 
PeCO2 p 
S2 < S4 0.016 
pH 
arterial 
p 
S1 > S3 0.006 
S1 > S4 <0.001 
S1 > S5 <0.001 
S2 > S4 <0.001 
S2 > S5 0.002 
S3 > S4 0.011 
S3 > S5 0.054 
PaCO2 p 
S1 < S3 0.024 
S1 < S4 0.003 
S1 < S5 0.009 
S2 < S4 0.050 
 
Table 3.3.3.4 
Arterial carbon dioxide tension did not differ between when the patients were awake (S1) and two-lung 
anesthesia (S2).  However, arterial carbon dioxide tension increased on initiation of OLA (S3) compared 
with when the patients were awake (S1).  This increase was sustained during application of both PEEP5 
and PEEP10 to the dependant lung.  During the PEEP5 (S4) step, PeCO2 was also greater than during the 
two-lung anesthesia step (S2).   
 
Arterial pH decreased on institution of OLA (S3) compared to the awake state (S1).  Progressive decreases 
in arterial pH occurred during steps 3,4 and 5 of the PEEP group.  No differences between bicarbonate 
concentrations occurred between any steps in the PEEP group.  Base excess decreased on administration 
of both levels of PEEP compared to all of the first 3 steps of the PEEP group.   
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PEEP group 
PaO2 
(kPa) 
SaO2 
(%) 
P O2 
(kPa) 
S O2 
(%) 
 
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 10 11.6 2.2 10 97.0 2.1 10 5.4 0.4 10 74.6 4.5 
S2: Two Lung Anesthesia, LDP 11 54.4 13.5 11 99.9 0.04 11 8.3 1.3 11 89.9 4.0 
S3: After 15 minutes of OLA 11 43.2 21.8 11 97.9 4.0 11 8.4 1.7 11 88.9 7.1 
S4: OLA, DL PEEP5 11 39.5 21.9 11 97.8 4.0 11 8.3 2.2 11 86.8 7.9 
S5: OLA, DL PEEP10 6 25.3 16.1 6 95.7 7.7 6 6.6 1.3 6 79.0 9.4 
 
P O2 p 
S1 < S2  <0.001 
S1 < S3  <0.001 
S1 < S4  <0.001 
S1 < S5  0.001 
PaO2 p 
S2> S1  <0.001 
S1 < S3  <0.001 
S1 < S4  <0.001 
S1 < S5  0.004 
S2 > S3 0.024 
S2 > S4  0.009 
S2 > S5  0.005 
S O2 p 
S1 < S2  <0.001 
S1 < S3 <0.001 
S1 < S4  <0.001 
S1 < S5 0.005 
S2 > S5  0.010 
S3 > S5  0.017 
 
Table 3.3.3.5 
Arterial oxygen tension was less when the patients were awake than in all other steps.  During two-lung 
anesthesia, arterial oxygen tension exceeded that in all other steps.  However, no intragroup differences in 
arterial oxygen saturation were observed.   
 
Both mixed venous oxygen tension and saturation increased after induction of anesthesia (S2).  This 
increase was sustained on initiation of OLA (S3) and when PEEP5 (S4) was administered.  However, mixed 
venous oxygen saturation decreased to levels not different from baseline when PEEP10 (S5) was 
administered compared with both OLA without PEEP (S3) and two-lung anesthesia (S2).   
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PEEP group 
CaO2 
(ml.100ml-1)  
C O2  
(ml.100ml-1) 
 
n   SD. n   SD. 
S1: Awake 10 17.7 2.0 10 13.5 1.9 
S2: Two Lung Anesthesia, LDP 11 17.0 1.6 11 14.3 1.3 
S3: After 15 minutes of OLA 11 16.8 1.6 11 14.5 1.4 
S4: OLA, DL PEEP5 11 15.5 2.1 11 13.0 1.7 
S5: OLA, DL PEEP10 6 16.4 1.8 6 13.1 1.4 
 
CaO2 p 
S1 > S4  0.014 
S2 > S4  0.061 
S3 > S4  0.061 
 
Table 3.3.3.6 
No intragroup difference in mixed venous oxygen content occurred.  However, arterial oxygen content was 
decreased compared to the awake baseline state while PEEP5 (S4) was being administered.   
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PEEP group 
Shunt Qs/Qt  
% 
D(A-a)O2  
 
PaO2/FiO2  
 
 
n   SD. n   SD. n   SD. 
S1: Awake 10 14.2 8.1 10 7.4 2.2 10 55.0 10.6 
S2: Two Lung Anesthesia, LDP 11 26.2 8.5 11 40.7 13.5 11 54.4 13.5 
S3: After 15 minutes of OLA 11 36.1 14.8 11 51.8 21.8 11 43.2 21.8 
S4: OLA, DL PEEP5 11 36.4 12.6 11 55.5 21.9 11 39.5 21.9 
S5: OLA, DL PEEP10 6 39.0 12.7 6 69.7 16.1 6 25.3 16.1 
 
Shunt p 
S1 < S2  0.002 
S1 < S3  <0.001 
S1 < S4 <0.001 
S1 < S5  <0.001 
S3 > S2  0.032 
S4 > S2  0.047 
S5 vs. S2  0.059 
D(A-a)O2 p 
S2 > S1 <0.001 
S3 > S1  <0.001 
S4 > S1 <0.001 
S5 > S1  <0.001 
S3 > S2  0.024 
S4 > S2  0.009 
S5 > S2  0.005 
PaO2/FiO2 p 
S1 > S2 <0.001 
S1 > S3  0.001 
S1 > S4  0.012 
S1 > S5  0.003 
S2 > S3 0.003 
S2 > S4  0.009 
S2 > S5  0.008 
 
Table 3.3.3.7 
The shunt fraction increased after induction of anesthesia while 2 lungs were being ventilated (S2) 
compared with the awake state (S1).  Shunt fraction further increased on initiation of OLA (S3) compared 
with the preceding two steps (S1 and S2).  A similar increase in shunt fraction was also apparent while 
PEEP5 was applied to the dependent lung (S4) compared with both the awake and two lung anesthesia 
steps (S1 and S2).  Shunt during PEEP10 (S5) was also greater than when the patients were awake (S1), 
but did not differ from that measured during the two lung anesthesia step (S2). 
 
The D(A-a)O2 increased while the PaO2/FiO2 ratio decreased after induction of anesthesia.  The cost of 
oxygenation increased even further as indicated by further increases in the D(A-a)O2 and decreases in the 
PaO2/FiO2 ratio during OLA (S3), or when PEEP5 (S4) or PEEP10 (S5) were applied to the dependant lung, 
compared with both the awake (S1) and two lung anesthesia steps (S2). 
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PEEP group 
MAP 
 (mmHg) 
Systemic Pes 
(mmHg) 
SAP 
(mmHg) 
DAP 
(mmHg) 
 
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 10 98.5 7.8 9 98.4 9.1 10 144.4 13.7 10 75.6 6.6 
S2: Two Lung Anesthesia, LDP 11 80.5 19.5 10 80.6 14.9 11 111.3 26.4 11 65.1 16.3 
S3: After 15 minutes of OLA 11 86.9 17.7 10 87.8 17.3 11 122.5 26.9 11 69.2 13.4 
S4: OLA, DL PEEP5 10 70.9 15.1 10 69.3 16.6 10 100.7 24.2 10 56.1 10.9 
S5: OLA, DL PEEP10 5 74.3 12.9 5 72.8 14.4 5 104.6 19.7 5 59.2 9.7 
 
MAP p 
S1 > S5 0.016 
S1 > S4 0.002 
Systemic 
Pes 
p 
S1 > S4 <0.001 
S1 > S5 0.004 
S1 > S2 0.022 
S3 > S4 0.013 
S3 > S5  0.044 
SAP p 
S1 > S5 0.003 
S1 > S4 <0.001 
S1 > S2 0.008 
DAP p 
S1 > S4 0.005 
 
Table 3.3.3.8 
During both steps during which PEEP was administered, MAP, Pes and SAP decreased compared to when 
the patients were awake.  Both SAP and Pes were less during the two-lung anesthesia step than during the 
awake step.  DAP was less during the PEEP5 step than when the patients were awake. 
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PEEP group 
 
PAP  (mean) 
(mmHg) 
SPAP  
(mmHg) 
DPAP  
(mmHg) 
 n   SD. n   SD. n   SD. 
S1: Awake 10 20.2 4.3 10 34.8 6.9 10 12.9 3.6 
S2: Two Lung Anesthesia, LDP 11 18.6 4.4 11 28.4 6.7 11 13.7 3.9 
S3: After 15 minutes of OLA 11 20.3 10.1 11 35.3 12.6 11 15.9 5.9 
S4: OLA, DL PEEP5 10 22.0 4.0 10 35.5 6.8 10 15.3 3.2 
S5: OLA, DL PEEP10 5 24.9 2.4 5 40.6 6.1 5 17.0 2.3 
 
Table 3.3.3.9 
No intragroup changes in mean, systolic or diastolic pulmonary arterial pressures were noted in the PEEP 
group.  
PEEP group 
Cardiac index  
(litres.min-1.m-2) 
Stroke index  
(ml.min-1.m-2) 
Heart rate  
(beats.min-1) 
 
n   SD. n   SD. n   SD. 
S1: Awake 10 3.7 0.7 10 48 14 10 80 23.4 
S2: Two Lung Anesthesia, LDP 11 3.1 0.9 11 38 7 11 81 18.8 
S3: After 15 minutes of OLA 11 4.1 1.2 11 47 13 11 89 17.8 
S4: OLA, DL PEEP5 11 4.0 1.2 11 42 9 10 95 14.0 
S5: OLA, DL PEEP10 6 3.0 0.9 5 34 8 5 90 9.7 
 
Stroke index p 
S5 < S1 0.018 
S5 < S3 0.031 
S2 < S1 0.029 
Cardiac index p 
S2 < S3  0.020 
S2 < S4   0.031 
S5 vs. S4 0.089 
 
Table 3.3.3.10 
Cardiac index did not differ during two-lung anesthesia compared with when the patients were awake.  
Cardiac index increased on initiation of OLA (S3) compared with when two lungs were being ventilated 
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(S2).  This rise was sustained while PEEP5 (S4) was being administered.  Cardiac index did not differ 
statistically from step one while PEEP10 (S5) was being administered.   On administration of PEEP10, (S5) 
cardiac index did not differ from that measured during steps 1 or 2. 
 
Stroke index decreased during two-lung anesthesia (S2) compared with when the patients were awake 
(S1).  On initiation of OLA (S3), and while PEEP5 (S4) was being administered, stroke index did not differ 
from when the patients were awake.  However, the administration of DL PEEP10 (S5) decreased stroke 
index compared with both when the patients were awake (S1) and that calculated for the OLA (S3) step.  
During administration of PEEP10 (S5), stroke index did not differ from that seen during S2, S3 or S4. 
 
No intragroup changes in heart rate were observed.    
 
PEEP group 
CVP  
(mmHg) 
RVEDP  
(mmHg) 
RVEDVI 
(ml.m-2) 
PAWP 
(mmHg) 
 
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 10 5.3 2.3 6 6.7 3.2 10 112 26.0 10 10.2 4.3 
S2: Two Lung Anesthesia, LDP 11 5.0 2.6 7 9.3 2.7 11 107 18.6 9 9.2 4.3 
S3: After 15 minutes of OLA 11 6.3 3.0 7 11.3 4.2 11 109 28.0 10 10.3 3.6 
S4: OLA, DL PEEP5 10 6.4 3.7 8 8.1 2.2 10 97 21.5 10 11.4 2.7 
S5: OLA, DL PEEP10 5 5.4 2.6 4 10.3 3.6 6 83 22.6 5 9.4 2.2 
 
RVEDVI p 
S5 < S1 0.008 
S5 < S2 0.024 
S5 < S3 0.014 
 
Table 3.3.3.11 
No intragroup changes in filling pressures of either the right or left ventricle occurred in the PEEP group.  
However, compared to steps 1, 2 and 3, a significant decrease in right ventricular end-diastolic volume 
index occurred when PEEP10 was administered to the dependant lung. 
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PEEP group 
Ea PA 
(mmHg.ml-1) 
PVR 
(dynes.secs.cm-5) 
Rc PA11 
(dynes.secs.cm-5) 
Rc PA12 
(dynes.secs.cm-5) 
R TOTAL 
(dynes.secs.cm-5) 
 
n   SD. n   SD. n   SD. n   SD. n   SD. 
S1: Awake 10 0.27 0.1 10 133 63 10 167 52 10 151 128 10 244 178 
S2: Two Lung Anesthesia, LDP 11 0.30 0.1 9 147 70 9 143 77 9 130 112 9 250 129 
S3: After 15 minutes of OLA 11 0.29 0.08 9 124 52 9 104 49 9 74 50 9 176 52 
S4: OLA, DL PEEP5 10 0.34 0.10 10  155 60 10 104 57 10 65 41 10 200 66 
S5: OLA, DL PEEP10 7 0.36 0.08 7 177 57 7 135 69 7 80 45 7 206 60 
 
Rc PA = 
Rt/time 
p 
S1 > S4 0.048 
Ea PA p 
S4 > S1 0.03 
S5 > S1 0.002 
S5 > S2 0.047 
S5 > S3 0.030 
PVR p 
S5 > S1 0.018 
S5 > S3 0.030 
 
Table 3.3.3.12 
During steps 2 and 3, PA elastance did not differ from the awake step.  However, administration of PEEP5 
to the dependant lung (S4) increased PA elastance, but at the same time decreased characteristic 
impedance compared to baseline awake levels (S1).  The administration of 10 cm of water of PEEP to the 
dependant lung (S5) also increased PA elastance compared to the awake (S1), two lung anesthesia (S2) 
and OLA steps when PEEP was not applied (S3).  PEEP10 (S5) also increased pulmonary vascular 
resistance during OLA compared to both the awake (S1) and OLA step when PEEP was not applied (S3). 
                                                                
11  Calculated using Ro as derived using the Windkessel equation 
12.  Calculated using Ea = RTOTAL/time of the beat 
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PEEP group 
Compliance PA13 
(ml.mmHg-1) 
Compliance PA 
14(ml.mmHg-1) 
Tau PA 
(secs)  
n   SD. n   SD. n   SD. 
S1: Awake 9 2.8 1.9 9 2.2 1.4 13 0.46 0.3 
S2: Two Lung Anesthesia, LDP 8 2.7 1.3 8 2.4 1.1 10 0.52 0.29 
S3: After 15 minutes of OLA 8 3.4 2.4 8 2.9 2.2 11 0.43 0.24 
S4: OLA, DL PEEP5 9 2.5 1.0 9 2.5 0.6 9 0.35 0.12 
S5: OLA, DL PEEP10 7 2.1 1.1 7 1.9 1.0 7 0.36 0.16 
 
Table 3.3.3.13 
No intragroup changes in PA compliance or the time constant of the pulmonary circulation were observed 
in the PEEP group.    
                                                                
13 Calculated using Ro as derived using the Windkessel equation 
14 Calculated using Ea = RTOTAL/time of the beat 
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PEEP group 
SVR  
(dynes.secs.cm-5) 
Ea Aorta  
(mmHg.ml-1) 
 
n   SD. n   SD. 
S1: Awake 10 1251 414 10 1.4 0.5 
S2: Two Lung Anesthesia, LDP 11 1221 271 11 1.1 0.3 
S3: After 15 minutes of OLA 11 1047 478 11 1.1 0.3 
S4: OLA, DL PEEP5 11 693 322 11 1.1 0.5 
S5: OLA, DL PEEP10 5 960 124 5 1.1 0.3 
 
SVR p 
S4 < S1 0.003 
S4 < S2 0.003 
S5 < S1  0.004 
S5 < S2  0.036 
 
Table 3.3.3.14 
Systemic vascular resistance showed no decrease after induction of anesthesia or initiation of OLA 
compared to the awake state.  However, administration of both DL PEEP5 (S4) and DL PEEP10 (S5) 
decreased systemic vascular resistance compared to values calculated for the baseline awake (S1) and 
two lung anesthesia steps (S2). 
 
No intragroup changes in aortic elastance were observed in the PEEP group. 
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PEEP group 
RVSWI 
(g.m.m-2) 
LVSWI 
(g.m.m-2) 
RVEF  
(%) 
 
n   SD. n   SD. n   SD. 
S1: Awake 10 10.5 .2 10 47 12 4 41.7 8.1 
S2: Two Lung Anesthesia, LDP 11 7.7 2.6 11 45 12 4 43.5 7.7 
S3: After 15 minutes of OLA 11 10.8 4.7 11 43 12 4 36.0 7.0 
S4: OLA, DL PEEP5 11 9.8 4.4 11 45 19 4 41.0 4.2 
S5: OLA, DL PEEP10 5 9.5 2.7 5 31 17 3 35.9 8.7 
 
LVSWI p 
S5 < S1 0.010 
S5 < S2 0.034 
S5 < S4 0.020 
S5 < S2 0.031 
 
Table 3.3.3.15 
No intragroup changes in either right ventricular stroke work index or right ventricular ejection fraction were 
observed.   
 
Left ventricular stroke work index did not change either during two-lung ventilation or after initiation of OLA 
or on application of DL PEEP5.  However, administration of DL PEEP10 decreased left ventricular stroke 
work index compared with that calculated for the step when two lungs were being ventilated (S2). 
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PEEP group 
VO2 index 
(ml.min-1.m-2) 
DO2 index 
(ml.min-1.m-2) 
HKT 
(%)  
Temperature 
(oC) 
 
n   SD. n   SD. n   SD. n   SD. 
S1: Awake 10 151 34.4 10 645 126 10 38.7 4.4 9 36.7 0.8 
S2: Two Lung Anesthesia, LDP 11 78 19.4 11 526 201 11 34.0 3.9 10 36.1 0.8 
S3: After 15 minutes of OLA 11 94 31.6 11 690 201 11 35.1 5.2 11 35.8 0.7 
S4: OLA, DL PEEP5 11 97 28.9 11 621 177 11 32.4 6.7 11 35.8 1.2 
S5: OLA, DL PEEP10 6 102 39.3 6 511 183 6 36.0 6.4 6 36.0 1.0 
 
VO2 index p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4  <0.001 
S1 > S5  <0.001 
HKT p 
S1 > S2 0.021 
S1 > S3 0.031 
S1 > S4  0.002 
DO2 index p 
S5 < S3  0.049 
S2 < S3 0.008 
Temperature p 
S1 > S2 0.025 
S1 > S3 0.007 
S1 > S4 0.021 
 
Table 3.3.3.16 
Compared with the awake state (S1), oxygen consumption was decreased after induction of anesthesia 
(S2).  After initiation of OLA (S3) and during application of both levels of PEEP to the DL (S4 and S5), 
oxygen consumption was less than when the patients were awake (S1). 
 
Delivery of oxygen was less while two lungs were being ventilated (S2) than after initiation of OLA (S3).  
On administration of DL PEEP10, oxygen delivery also decreased to values less than those observed 
during OLA when PEEP was not being applied (S3). 
 
Hematocrit and temperature was greater when the patients were awake than in all but the last step (S5) of 
the PEEP group. 
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PEEP group 
CaO2 – C O2 
(ml.100ml-1)  
OER 
 
RV CPP 
(mmHg) 
 
n   SD. n   SD. n   SD. 
S1: Awake 10 4.1 0.7 10 0.24 0.04 10 76 13 
S2: Two Lung Anesthesia, LDP 11 2.7 0.8 11 0.16 0.04 11 53 15 
S3: After 15 minutes of OLA 11 2.3 0.5 11 0.14 0.03 11 62 17 
S4: OLA, DL PEEP5 11 2.5 0.5 11 0.16 0.02 11 46 16 
S5: OLA, DL PEEP10 6 3.3 0.8 6 0.20 0.03 6 43 15 
 
RV CPP 
during OLA 
p 
S5 < S1 <0.001 
S5 < S3 <0.001 
S5 < S4 <0.001 
S4 < S1 <0.001 
CaO2 – C O2 p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4 <0.001 
S1 > S5 <0.001 
S5 vs. S3 0.085 
OER p 
S1 > S2 <0.001 
S1 > S3 <0.001 
S1 > S4  <0.001 
S1 > S5  0.004 
S5 > S3 0.013 
S5 vs. S3 0.066 
 
Table 3.3.3.17 
The arterial-venous oxygen content difference decreased after induction of anesthesia (S2) and during 
both OLA (S3) and administration of DL PEEP5 (S4) compared to when the patients were awake (S1).  
Administration of PEEP10 increased the numerical value of the arterial-venous oxygen content difference to 
its highest level observed during anesthesia in any of the groups.  This increase however was not 
statistically significant.   
 
The oxygen extraction ratio was decreased after induction of anesthesia (S2) compared with when the 
patients were awake.  This decrease was sustained during both OLA (S3), and during the OLA DL PEEP5 
step (S4).  However on application of PEEP10 to the dependant lung (S5), the oxygen extraction ratio did 
not differ from the awake state. 
 
On application of DL PEEP10, RV coronary perfusion pressure decreased when compared to the awake, 
OLA and DL PEEP5 steps.  PEEP5 decreased RV coronary perfusion pressure compared to when the 
patients were awake. 
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3.4 Within group comparisons (graphically represented)  
Data is presented as the mean value for that step.  The error bars represent the 95% confidence intervals.  Any 
differences between the steps determined by RM ANOVA and utilizing Student-Neuman-Keuls’ test for 
post hoc analysis are annotated in the caption of the figure. 
3.4.1 Control group  
Steps in control group patients Label 
Prior to induction of anaesthesia, and before fluid pre-loading commenced S1: Awake 
In the lateral decubitus position while ventilating 2 lungs S2: 2 LA 
15 minutes after commencing one lung ventilation S3: OLA 15 mins 
5 minutes after step 3 data had been recorded S4: OLA Control 1 
5 minutes after step 4 data had been recorded  S5: OLA Control 2 
5 minutes after step 5 data had been recorded  S6: OLA Control 3 
5 minutes after step 6 data had been recorded  S7: OLA Control 4 
Table 3.4.1.1 The sequence of the steps and abbreviations used in the control group graphs.  
Figure 3.4.1.1     Airway pressure, Control group
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Figure 3.4.1.3      PaCO2, Control group
S1 < S4, 5, 6, 7    S2 < S5, 7
S1
: A
wa
ke
S2
: 2
 LA
S3
: O
LA
 15
 m
ins
S4
: C
on
tro
l 1
S5
: C
on
tro
l 2
S6
: C
on
tro
l 3
S7
: C
on
tro
l 4
 
Pa
CO
2 (
kP
a)
0
2
4
6
8
10
 
S2
: 2
 LA
S3
: O
LA
 15
 m
ins
S4
: C
on
tro
l 1
S5
: C
on
tro
l 2
S6
: C
on
tro
l 3
S7
: C
on
tro
l 4
 
Dy
na
mi
c c
om
pli
an
ce
 (m
l.c
mH
2O
-1
)
0
10
20
30
40
50
Figure 3.4.1.2     Dynamic compliance, Control group
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Figure 3.4.1.5     Arterial oxygen saturation, Control group
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Figure 3.4.1.4     PaO2, Control group
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Figure 3.4.1.7     SvO2, Control group
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Figure 3.4.1.6     PvO2, Control group
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Figure 3.4.1.9     Shunt, Control group
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Figure 3.4.1.8     CaO2-CvO2, Control group
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Figure 3.4.1.10     Mean PAP, Control group
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Figure 3.4.1.11     Cardiac index, Control group
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Figure 3.4.1.13     RVSWI, Control group
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Figure 3.4.1.12     CVP, Control group
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Note that the “y” axis ranges from 0 to 25 mm Hg to allow both left and right-
sided filling pressures (i.e.  PAWP and CVP) to be illustrated on the same scale.  
Note that the “y” axis ranges from 0 to 60 g.m.m-2  to give the perspective of how much less stroke work the RV 
generates compared with its counterpart, the LV.  LVSWI ranges from 45 to 60 g.m.m-2 whereas RVSWI is 
approximately 8 to 10 g.m.m-2. 
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Figure 3.4.1.14     PAWP, Control group
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Figure 3.4.1.15     PA elastance, Control group
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Note that the scale of the PA elastance ranges from 0 to 1 mm Hg.ml-1.  The normal RV end-systolic elastance is 
approximately 1.7 to 2 mm Hg.ml-1.  Therefore, PA elastance would have to rise to 1 mm Hg.ml-1  before Ea/Ees 
approaches 0.5.    
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Figure 3.4.1.17     Oxygen consumption, Control group
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Figure 3.4.1.16     RVEF, Control group
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3.4.2 Dobutamine group  
Description of steps in patients administered dobutamine Label 
Prior to induction of anaesthesia, and before fluid pre-loading commenced S1: Awake 
In the lateral decubitus position while ventilating 2 lungs S2: 2 LA 
15 minutes after commencing one lung ventilation S3: OLA 15 mins 
5 minutes after an infusion of dobutamine 3 ug.kg-1.min-1 was commenced S4: Dobutamine 3 
5 minutes after an infusion of dobutamine 5 ug.kg-1.min-1 was commenced S5: Dobutamine 5 
5 minutes after an infusion of dobutamine 7 ug.kg-1.min-1 was commenced S6: Dobutamine 7 
Table 3.4.2.1 The sequence of the steps and the abbreviations used in the dobutamine group graphs. 
 
 
Figure 3.4.2.1     PaO2, Dobutamine group
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Figure 3.4.2.3     PvO2, Dobutamine group  
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Figure 3.4.2.2     SaO2, Dobutamine group
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Figure 3.4.2.5     CaO2, Dobutamine group
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Figure 3.4.2.4     SvO2, Dobutamine group
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Figure 3.4.2.7     PAP, Dobutamine group
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Figure 3.4.2.6     CvO2, Dobutamine group
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Figure 3.4.2.9     Cardiac index, Dobutamine group
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Figure 3.4.2.8     Heart rate, Dobutamine group
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Figure 3.4.2.11     PVR, Dobutamine group
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Figure 3.4.2.10     RVEF, Dobutamine group
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Figure 3.4.2.13     PA Compliance, Dobutamine group
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Figure 3.4.2.12     RVSWI, Dobutamine group
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Figure 3.4.2.15     Oxygen delivery, Dobutamine group
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Figure 3.4.2.14     Shunt, Dobutamine group
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Figure 3.4.2.17     Effective PA elastance, Dobutamine group
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F igure 3.4.2.16     O xygen consum ption, Dobutam ine group
S1 < S2,3,4,5,6    S2 < S1,5
S1
: A
wa
ke
S2
: 2
 LA
S3
: O
LA
 15
 m
ins
S4
: D
ob
uta
mi
ne
 3
S5
: D
ob
uta
mi
ne
 5
S6
: D
ob
uta
mi
ne
 7
VO
2 i
nd
ex
 (m
l.m
in-
1 .m
-2
)
0
50
100
150
200
250
300
Chapter 3.  Results 
 
236 
 
3.4.3 PEEP group 
 
Description of Steps in patients administered PEEP Label 
Prior to induction of anaesthesia, and before fluid pre-loading commenced S1: Awake 
In the lateral decubitus position while ventilating 2 lungs S2: 2 LA 
15 minutes after commencing one lung ventilation S3: OLA 15 mins 
10 minutes after PEEP5 was applied to the dependent lung, S4: PEEP5 
5 minutes after PEEP10 was applied to the dependent lung, S5: PEEP10 
 
Table 3.4.3.1 The sequence of the steps and the abbreviations used in the PEEP group graphs. 
Figure 3.4.3.1     Peak airway pressure, PEEP group
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3.5 
Figure 3.4.3.3     PaO2, PEEP group
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Figure 3.4.3.2     Dynamic compliance, PEEP group
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Figure 3.4.3.5     PvO2, PEEP group
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Figure 3.4.3.4
SaO2, PEEP group
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Figure 3.4.3.7     Oxygen delivery, PEEP group
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Figure 3.4.3.6     SvO2, PEEP group
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Figure 3.4.3.8     Oxygen consumption, PEEP group
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3.5  Relationships  
Figure 3.5.1    Relationship between PAP and Shunt
Control group, OLA steps
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Figure 3.5.2:     PAP vs. Shunt
Dobutamine group, OLA steps only
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p < 0.0001, 
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Figure 3.5.4     Relationship between cardiac index and mean PAP
Dobutamine group, OLA steps
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Figure 3.5.3     Relationship between cardiac index and mean PAP
Control group, OLA steps 
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Figure 3.5.5     Relationship between PAP and RVSWI
Control group, OLA steps
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Figure 3.5.6     Oxygen delivery vs. oxygen consumption
Control Group, all anesthetised steps
The grey bars represent the 95% confidence intervals
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Figure 3.5.7     Relationship between oxygen delivery & oxygen consumption
Dobutamine group, all OLA steps
The grey bars represent the 95% confidence intervals
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Figure 3.5.8      Relationship between PaCO2 and mean PAP
Control Group, all steps
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Figure 3.5.9     Relationship between PaCO2 and pHa
Control group, all steps
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Using Sigmaplot, the best description of this relationship is
PA compliance = 10.(0.01Heart rate)
 n = 35, p< 0.015; r2 = 0.30
PA compliance (mmHg.ml-1)
PA compliance (mmHg.ml-1)
Figure 3.5.10    Relationship between heart rate and PA compliance
Dobutamine group, all OLA steps 
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Using Sigmastat, the relationship that best fitted these data points was: 
PA Compliance = 113/PAP - 2  
n = 33, p < 0.001, r2 = 0.57
Figure 3.5.11  Relationship between PA compliance and mean PAP 
Dobutamine Group, all OLA steps
PAP (mmHg)
 
Figure 3.5.12     Relationship between FEV1 and PEEPi,1 vs. PEEPi
Control group, OLA steps only
The gray bars represent the 95% confidence intervals for the regression
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Figure 3.5.13     Relationship between ITGVplethpredicted vs PEEPi 
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Figure 3.5.14      Relationship between FEV1/FVC & PEEPi
Control group, OLA steps only
The grey bars represent the 95% confidence intervals
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Control group 
OLA steps only 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
PAP (mean) and shunt  < 0.0001 0.52 0.27 80 3.5.1 
PAP (mean) and PVR  < 0.0001 0.50 0.25 82  
PAP (mean) and 
cardiac index 
< 0.001 0.56 0.32 105 3.5.3 
PAP (mean) and 
RVSWI 
< 0.0001 0.50 0.25 82 3.5.5 
Table 3.5.1. Relationships between mean PAP and shunt, PVR cardiac index and RVSWI, in the 
control group during OLA. 
 
 
Figure 3.5.15     Relationship between RVEDVI and cardiac index
All groups and all data points
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Control group 
All anesthetised steps 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
DO2I and VO2I < 0.001 0.73 0.54 109 3.5.6 
DO2I and LVSWI < 0.0001 0.55 0.3 103  
DO2I and heart rate < 0.0001 0.54 0.3 104  
VO2I and LVSWI < 0.001 0.36 0.13 103  
VO2I and heart rate < 0.0001 0.39 0.15 104  
Table 3.5.2 Relationships between oxygen delivery, oxygen consumption, LVSWI and heart rate for 
all steps while the patient was anesthetised. 
 
Control group 
All steps 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
CI and DO2I <0.0001 0.80 0.64 137  
CI and heart rate <0.0001 0.54 0.3 132  
DO2I and heart rate <0.0001 0.46 0.2 131  
PAWP and RVEDVI 0.52 0.07 0.005 78  
CVP and RVEDVI 0.711 0.02 0.0004 83  
Table 3.5.3 Relationships between cardiac index, heart rate and delivery of oxygen for all steps in 
the control group. 
 
Control group 
All steps 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
PaCO2 and pHa <0.0001 -0.86 0.74 135 3.5.9 
PaCO2 and pHv <0.0001 -0.85 0.72 135  
PaCO2 and PvCO2 <0.0001 0.92 0.85 135  
PaCO2 and CI 0.0011 0.278 0.08 135  
PaCO2 and SI 0.70 -0.034 0.001 131  
PaCO2 and heart rate <0.0001 0.40 0.16 131  
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Control group 
All steps 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
PaCO2 and PAP <0.0001 0.51 0.26 129 3.5.8 
PaCO2 and MAP 0.52 -0.06 0.0036 131  
PaCO2 and PVR <0.0001 0.33 0.11 129  
PaCO2 and SVR 0.04 -0.25 0.06 70  
PaCO2 and pulmonary 
Ro 
0.63 -0.06 0.0036 69  
PaCO2 and RVSWI <0.0001 0.34 0.11 129  
PaCO2 and LVSWI 0.17 0.168 0.028 70  
PaCO2 and VO2I 0.955 0.005 0.000025 132  
PaCO2 and DO2I <0.005 0.52 0.26 132  
DO2 and pHa < 0.0001 0.34 0.12 132  
Table 3.5.4 Correlations of PaCO2 with acid base and hemodynamic parameters for all steps in the 
control group. 
 
 
Dobutamine group p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
PAP (mean) and Shunt, 
OLA steps only 
0.27 0.12 0.015 84 3.5.2 
PAP (mean) and CI,  
OLA steps only 
< 0.001 0.52 0.27 83 3.5.4 
DO2I and VO2I,  
OLA steps only 
< 0.0000001 0.55 0.18 82 3.5.7 
PAP (mean) and PVR,  
all steps 
< 0.0001 0.37 0.14 131  
Table 3.5.5 The strength of relationships between mean PAP and shunt, PVR and CI, and oxygen 
delivery and oxygen consumption in the dobutamine group. 
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Control group 
OLA steps only 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
PEEPi and ITGV 
(plethysmography) as % 
predicted 
0.048 0.36 0.13 31 3.2.13 
PEEPi and FEV1/FVC as 
% predicted 
0.032 - 0.39 0.15 31 3.2.14 
PEEPi and FEV1 as % 
predicted 
< 0.0001 - 0.60 0.36 31 3.5.12 
Table 3.5.6 Relationships between preoperative pulmonary function testing and PEEPi during OLA.  
Note that ITGV, FEV1/FVC and FEV1 were expressed as a percentage of predicted normal for that 
patient’s height, weight and sex. 
 
 
PEEP group p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
The decrease in MAP 
(%) and the 
preoperative ITGV 
during all PEEP steps 
0.6 -- -- 36  
Table 3.5.7  The relationship between the percentage decrease in MAP and the preoperative ITGV 
during all PEEP steps. 
 
 
All groups 
All patients data 
p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
Shunt during OLA and 
preoperative Q to 
collapsed lung (%) 
0.83 -- -- 63  
Table 3.5.8 Correlation between the proportions of blood flowing to the NDL determined by 
preoperative V/Q scan, and the shunt during OLA.  Data from all available patients and groups used. 
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 p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
Control group OLA <0.0001 0.983 0.97 86  
Dobutamine 3 ug.kg-
1.min-1 OLA 
<0.0001 0.962 0.93 19  
Dobutamine 5 ug.kg-
1.min-1 OLA 
<0.0001 0.891 0.79 16  
Dobutamine 7 ug.kg-
1.min-1 OLA 
<0.0001 0.966 0.93 25  
Table 3.5.9 The relationship between calculated CaO2 and CaO2 predicted by the Kelman, Nunn et 
al. equation for the control and dobutamine groups during OLA. 
Table 3.5.10 Correlation between mean PAP while subjects were awake and preoperative VO2max.  
Analysis used data for all patients in the study. 
Control group:  r2 
   SD. 
S1: Awake 0.92 0.05 
S2: Two-lung Anesthesia, LDP 0.78 0.21 
S3: After 15 minutes of OLA 0.75 0.25 
S4: OLA, Control step 1 0.83 0.15 
S5: OLA, Control step 2 0.75 0.26 
S6: OLA, Control step 3 0.85 0.11 
S7: OLA, Control step 4 0.71 0.22 
Table 3.5.11 (On previous page). The strength of the correlation (r2) (± standard deviation) between 
All patients in study p value 
Correlation 
coefficient, r 
r2 
Number of 
data pairs 
Figure 
PAP (mean) while 
subjects were awake 
and preoperative VO2 
max 
0.062 - 0.31 0.10 36 3.5.7 
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the actual PA diastolic curve and the exponential curve fit for the control group.   
 
Dobutamine Group: r2 
   SD. 
S1: Awake 0.91 0.09 
S2: Two-lung Anesthesia 0.84 0.06 
S3: One Lung Anesthesia 0.87 0.09 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 0.81 0.19 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 0.90 0.11 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 0.91 0.07 
Table 3.5.12 The strength of the correlation (r2) (standard deviation) between the actual PA diastolic 
curve and the exponential curve fit for the dobutamine group.   
 
PEEP Group: r2 
   SD. 
S1: Awake 0.80 0.22 
S2: Two-lung Anesthesia, LDP 0.81 0.14 
S3: After 15 minutes of OLA 0.66 0.21 
S4: OLA, DL PEEP5 0.86 0.11 
S5: OLA, DL PEEP10 0.97 0 
Table 3.5.13 The strength of the correlation (r2) (standard deviation) between the actual PA diastolic 
curve and the exponential curve fit for the PEEP group.  
  
Chapter 3.  Results 
 
254 
3.6 The natural frequency and damping coefficients of transducer -
catheter systems 
 
 
 
Systemic Pulmonary 
Subject 
Frequency 
Response Hz 
Damping 
coefficient 
Frequency 
Response Hz 
Damping factor 
A 19.4 0.27 7.65 0.5 
B 15.95 0.21 9.45 0.37 
C 25.2 0.17 8.88 0.37 
D 47.1 0.11 14.2 0.36 
E 25.0 0.2 13.1 0.26 
F 28.7 0.4 10.0 0.4 
G 22.0 0.53 8.25 0.4 
H 16.7 0.21 9.82 0.38 
I 50.7 0.28 14.3 0.48 
J 33.59 0.32 10.11 0.38 
Mean (SD.) 28.4 (12.0) 0.27 (0.12) 10.6 (2.4) 0.39 (0.07) 
 
Table 3.6.1 Data of the natural frequency and damping coefficients for systemic and arterial catheter 
systems.  The frequency response of the arterial catheter system is higher than that of the pulmonary 
arterial system (p = <0.0002).   
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3.7 The venous - arterial carbon dioxide tension difference 
Control Group: PvCO2-PaCO2 (kPa) 
Steps   S.D. 
S1: Awake 0.7 0.5 
S2: Two-lung Anesthesia, LDP 0.8 0.3 
S3: After 15 minutes of OLA 0.9 0.3 
S4: OLA, Control step 1 0.9 0.5 
S5: OLA, Control step 2 0.7 0.5 
S6: OLA, Control step 3 1.0 0.5 
S7: OLA, Control step 4 0.5 0.4 
Table 3.7.1 The difference between the mixed venous and arterial carbon dioxide tensions at each 
measurement step for the control group.   
Dobutamine Group: PvCO2-PaCO2 (kPa) 
Steps   S.D. 
S1: Awake 0.6 0.4 
S2: Two-lung Anesthesia 0.6 0.5 
S3: One Lung Anesthesia 0.6 0.5 
S4: OLA & Dobutamine 3 ug.kg-1.min-1 0.7 0.5 
S5: OLA & Dobutamine 5 ug.kg-1.min-1 0.6 0.4 
S6: OLA & Dobutamine 7 ug.kg-1.min-1 0.8 0.6 
Table 3.7.2 The difference between the mixed venous and arterial carbon dioxide tensions at each 
measurement step for the dobutamine group.   
 
Chapter 3.  Results 
 
256 
PEEP Group: PvCO2-PaCO2 (kPa) 
Steps   S.D. 
S1: Awake 0.7 0.4 
S2: Two-lung Anesthesia, LDP 0.9 0.3 
S3: After 15 minutes of OLA 0.7 0.4 
S4: OLA, DL PEEP5 0.8 0.6 
S5: OLA, DL PEEP10 0.8 0.4 
Table 3.7.3 The difference between the mixed venous and arterial carbon dioxide tensions at each 
measurement step for the PEEP group.  
 4. Discussion 
The following sequence is used to discuss the hypothesis relevant to each of the groups in turn.  The discussion of 
each group begins by studying the opposition to pulmonary flow and the effects thereof on RV performance during 
OLA.  Thereafter, the relationship of oxygen consumption to oxygen delivery and the effects of this relationship on 
mixed venous and arterial oxygenation are considered. 
4.1 Discussion of methods  
4.1.1 Demographics 
No differences in demographic parameters were found between the different groups.  It can therefore be concluded 
that the randomisation of the groups was adequate.  From inspection of the demographic data, it is apparent that the 
population studied included patients with both restrictive and obstructive disease.  The high prevalence of pulmonary 
tuberculosis in the Western Cape Province was largely responsible for a number of the patients having restrictive 
disease.  This is interesting, as the majority of current studies during OLA in the literature involve the study of 
subjects with chronic obstructive pulmonary disease (Ducros, Moutafis et al. 1999; Bardoczky, d'Hollander et al. 
1998; Abe, Mashimo et al. 1998; Bardoczky, Yernault et al. 1996).  It must also be noted that the population studied 
was a selected one, the selection being related to suitability for toleration of lung resection.  Particularly, this section 
would have excluded patients with a predicted postoperative VO2max of less than 10 to 15 ml.kg-1 (Coetzee 2000; 
Bolliger, Jordan et al. 1995). 
4.1.2 The conduct of a human study 
The study of human subjects is subject to a host of interesting problems.  One aspect was that many load 
independent and dependent indices of RV contractility could not be studied (Burger, Jockwig et al. 2001; Karunanithi, 
Michniewicz et al. 1992; Fourie, Coetzee et al. 1992b).  Furthermore, the pulmonary vasculature could only be 
accessed by using a long thin catheter that often resulted in less than hi-fidelity recordings of PA pressure (Gardner 
1981).  On the other hand, observations made while patients are operated on provide a reliable reflection of what 
actually happens during pulmonary surgery.  This is unlike other studies where surgery was stopped before and 
during recording of the variables (Cohen, Eisenkraft et al. 1988).  The real time nature of the study also meant that 
not all the planned steps could be conducted in a particular patient.  The decreasing numbers of patients observed 
as steps progressed attests to this problem.  The reasons for the drop-out of subjects were: 
¾ The procedure finished more quickly than expected, 
¾ Massive hemorrhage occurred due to tears of the pulmonary artery in 3 cases where extensive fibrosis 
secondary to tuberculosis was present, 
¾ The DLT could not be correctly placed, was moved out of position by surgical manipulation or its position 
could not be confirmed and, 
¾ Technical problems resulted in data from part or complete patient studies being lost on four occasions.   
Recruitment of subjects was slower than expected.  Patients who declined to be included or expressed reservations 
had their wishes respected.  Other patients did not fulfil the inclusion criteria because of the presence of co-morbid 
disease such as coronary artery disease, hypertension, cardiac valve lesions, sepsis and pregnancy.  Inclusion of 
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subjects with these diseases would have influenced hemodynamics.  Furthermore, a number of patients who had 
undergone the lengthy recruitment process were not included due to lack of theatre time. 
 
Conducting a study of this nature on animals is feasible. However, an animal study would not necessarily advance 
knowledge of how to improve the care of patients undergoing OLA.  The presence pulmonary disease results 
frequently results in a decrease in blood blow to the lung to be operated on, as seen on preoperative V/Q scintigram 
(Table 3.1.2). In this respect, it is noteworthy that disparate results of similar manoeuvres have been observed in 
patients (with and without lung disease) and animals.  For example, Inomata and colleagues, Cohen and colleagues 
and Abe and colleagues applied various amounts of PEEP to patients with normal preoperative lung function tests 
(Abe, Mashimo et al. 1998; Inomata, Nishikawa et al. 1997; Cohen, Eisenkraft et al. 1988).  Alfery and colleagues 
studied the effect of PEEP in dogs during OLA (Alfery, Benumof et al. 1981).  These studies came to different 
conclusions.  The same problem applies to studies conducted to investigate the effects of an increase in oxygen 
delivery on arterial oxygenation both in humans (with lung disease) and in animals (without lung disease) (Russell 
and James 2000; Mathru, Dries et al. 1990).  All things considered, the current study is a trade-off between greater 
clinical relevance versus the measurement of load independent indices of RV contractility and pulmonary impedance 
that could have been made in the laboratory. 
4.1.3 Quality control:  the pulmonary artery catheter during OLA 
Both Benumof and Cohen highlight important considerations that apply to pulmonary artery catheters in the LDP 
(Benumof and Alfery 2000; Reich and Thys 1995).  When inserted in the supine position, 90% of pulmonary artery 
catheters float into the right lung (Benumof and Alfery 2000; Reich and Thys 1995).  When the patient is 
subsequently placed in the left LDP, the PAC will be in the NDL.  These positional influences on the PAC position 
mean that mixed venous oxygen tensions, PAP, PAWP and cardiac output measurements could differ during two 
versus one lung ventilation, or in the right versus the left LDP.  These considerations have been investigated.  
Simultaneous measurements of cardiac output were done using thermistors located in both the non-dependent and 
dependent lungs.  The results indicate that measurement of cardiac output is not influenced by the PAC position 
during OLA in the LDP (Benumof and Alfery 2000; Reich and Thys 1995).  
 
It is important to note that, in the current study, sampling of mixed venous blood was done after the PA catheter tip 
had been withdrawn into the RV.  Pressure waveforms were checked before and after sampling to confirm the 
correct position of the catheter tip.  This precaution ensured that mixed venous oxygen tension was an actual 
reflection of whole body oxygenation.  Failure to do this could have led to two possible errors:   
If the PAC tip had been located in the NDL, S O2 would have been decreased (Reich and Thys 1995).  This 
decrease in S O2 would most likely have been the result of “stagnant blood flow”.   
The PAC tip could have been located deep in the DL close to the pulmonary capillary bed.  This would have resulted 
in “mixed venous” specimens drawn from the catheter tip being representative of alveolar capillary oxygen and 
carbon dioxide tensions (Shapiro, Smith et al. 1974).  Even if the catheter’s tip was not located too deeply in the PA, 
too rapid withdrawal of blood from the catheter (reportedly at a rate of more than 3 ml per 60 seconds) may result in 
the gas tensions being representative of alveolar capillary blood, especially in patients ventilated with high partial 
pressures of oxygen (Wiedeman, Matthay et al. 1984).  Withdrawing the catheter into the RV for mixed venous blood 
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sampling eliminated these concerns.  The absence of a PvCO2 – PaCO2 difference is considered indicative of a 
sample representative of pulmonary capilliary blood (Shapiro, Smith et al. 1974).  However, in the current study, at 
least a 0.3 kPa difference between arterial and venous carbon dioxide tensions was observed.  This is in spite of the 
decreased metabolic rate induced by anesthesia that would tend to decrease the PvCO2 – PaCO2 difference.  This 
PvCO2 – PaCO2 difference confirms that the potential problem of aspiration of pulmonary capillary blood was 
eliminated.  This is an important consideration, as the venous oxygen tensions in the current study were unusually 
high.  The abovementioned sources of error must be excluded as reasons for these high venous oxygen tensions.  A 
further advantage of reinsertion would have been that the catheters would most likely have floated back into the lung 
via which the majority of blood was flowing, this being the dependent lung (Reich and Thys 1995).  Thus, if the 
pulmonary artery catheter is in the dependent lung, it is most likely that it is in a West zone 3 region.  The importance 
of this is that in zone 3, PAWP will accurately reflect left atrial pressure, even in the face of DL PEEP (Mark, 
Slaughter et al. 2000).  
4.1.4 Quality control: dynamic response of transducers 
Care was taken to ensure the dynamic response of the catheter-transducer systems were adequate.  The arterial 
systems tested in the current study had a mean resonant frequency of 28.4 ± 12.0 hertz and a damping coefficient 
0.27 ± 0.12.  This represents an adequate frequency response (Gardner 1981).  This frequency response will also 
ensure relatively accurate reproduction of the arterial pressures (Sykes, Vickers et al. 1994; Gardner 1981).  The 
frequency responses in the arterial catheter-transducer system are slightly higher than those seen in other studies 
reporting on the characteristics of invasive arterial measuring systems in clinical practice (Gardner 1981).   
 
Care was also taken to position the systemic, pulmonary arterial and airway pressure measurement transducers at 
the correct height.  In the supine position, the reference point was mid-axillary level.  In the LDP, the reference point 
used was the mid-thoracic height; this usually coincided with the lower horizontal border of the sternum.  Adopting a 
similar reference point was especially important as pulmonary arterial, wedge, central venous and airway pressures 
are sensitive to small changes in their transducer position.   
4.1.5 Quality control: the measurement of impedance  
Impedance was estimated using Equation 1.4.4.12 by assuming that the PA pressure diastolic decay is a 
monoexponential function described by the equation P(t) = Po e–t/τ (Fourie, Coetzee et al. 1992b; Westerhof and 
Elzinga 1991; Laskey, Parker et al. 1990).  This method has previously been used successfully both in the systemic 
(Westerhof and Elzinga 1991; Yin, Liu et al. 1987) and pulmonary vasculature (Fourie, Coetzee et al. 1992b) to 
determine elements of the Windkessel model.   
 
In the current study, characteristic impedance (Ro) was measured using Equations 2.9.4 and 1.4.4.12.  Both of these 
equations solve for pulmonary arterial elastance, Ea.  The former uses the pressure/SV method and the latter the 
Windkessel method to solve for Ea.  The assumption that Ea could be determined by either of these equations is 
based on the excellent correlations (r = 0.997) between the Windkessel and the pressure/SV method that was 
achieved in Fourie’s doctoral study for the RV (Fourie 1989) and also by Sagawa’s group (r = 0.999) for the systemic 
circulation (Sagawa, Maughan et al. 1988).   
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To solve Equation 2.9.4, the variables, stroke volume, PA pressure, systolic and diastolic times and PVR could all be 
directly measured in this study.  This however left the problem of two unknown variables, one that was desired (Ro), 
and the other being the time constant of the pulmonary arterial system.  The time constant was measured by 
employing the above assumption that the diastolic decay of the arterial pressure waveform has a monoexponential 
form (Westerhof and Elzinga 1991; Laskey, Parker et al. 1990).  Five beats taken from a 20 second PA pressure 
versus time recording were analysed per patient for each step (Laskey, Parker et al. 1990).  The time constant for 
that particular epoch was then determined by the method described in the “Results” section.   The average of 5 
values was taken as the time constant of the pulmonary circulation for that epoch. 
 
This method should therefore have provided a relatively simple method of determining characteristic impedance in 
the human pulmonary vasculature without having to resort to the use of high fidelity catheter tip transducers.  
Nonetheless, data with a wide scatter was generated.  This method is therefore poorly suited to determine 
impedance with great accuracy.  The reasons for this are outlined below.     
 
1. Liu and colleagues state that the above method of estimating the time constant is typically associated with 
coefficients of determination greater than 0.95 (Liu, Brin et al. 1986).  In the current study, the coefficient of 
determination between the actual PA diastolic curves and the exponential curve fit predicted by Microsoft 
Excel® was good and ranged from 0.82 to 0.97 (Tables 3.5.11, 3.5.12 and 3.5.13).  Nonetheless, 
coefficients of determination between the recorded PA diastolic pressure decline and the regression line 
(P(t) = Po e–t/τ) did not always approach the excellent values (0.95 to 0.99) that have been seen before in 
the arterial system (Liu, Brin et al. 1986).  The reasons were that the frequency response of the PA 
catheter-transducer system was low in the current study.  The mean resonant frequency was 10.6 ± 2.4 Hz 
with a damping coefficient of 0.39 ± 0.07.  This is below the desired requirements for accurate reproduction 
of the PA waveform#.  Too low a frequency response and damping coefficient can lead to ringing 
(resonance) around the natural frequency of the system (Mark, Slaughter et al. 2000; Sykes, Vickers et al. 
1994; Schwid 1988; Gardner 1981).  The result is that harmonics of the pressure trace close to the 
resonant frequency will be amplified.  As emphasized, this was not due to negligence of the part of the 
investigator as great care was taken to exclude all bubbles from the system and to connect the PA catheter 
directly to the transducer housing without any added connecting tubing.  Rather, the problem can be 
attributed to the physical properties of the equipment used in these human subjects.  The low frequency 
response is most likely because of the thinness of the lumen of the PAC, its great length and the slight 
elasticity of the material from which it is constructed (Sykes, Vickers et al. 1994; Fourie, Badenhorst et al. 
1987).  It is noteworthy that the resonant frequencies and damping factors in the current study are better 
than those obtained in other studies with similar sized PAC’s (Fourie, Badenhorst et al. 1987).   
The result of the low resonant frequency was that the diastolic decline of the PA tracing recorded in Alab at 200 Hz 
was frequently not smooth but showed a jagged response; in contrast, the systemic arterial trace appeared smooth 
                                                                
#The best option to achieve accurate reproduction of the PA waveform is for the catheter-transducer system to have as high a 
resonant frequency as possible.  At a natural frequency above 25 hertz, damping will have minimal effect on PA waveform and the 
waverform will be accurately reproduced.  (Mark, Slaughter et al. 2000). 
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(Mark, Slaughter et al. 2000).  These artefacts occurred at a frequency of close to the resonant frequency of the 
system (Figure 4.1.5.1).  This interference would have had two effects.  Firstly and most importantly, the time 
constant could have been less accurately recorded.  Secondly, the correlations between the curve fit in Microsoft 
Excel® and the exponential diastolic declines where less than those recorded previously by other authors (Liu, Brin 
et al. 1986).   
Whereas diastolic and systolic times could be measured accurately, there are 5 to 10% errors in measurement of 
cardiac output and stroke volume using a PAC (Mark, Slaughter et al. 2000).  The calculation of Ea using the 
Figure 4.1.5.1 An illustration of resonance in an underdamped PA pressure vs. time recording.  In the example above, 
oscillation on the down slope of the PA diastolic curve occur at between 16.7 and 18.18 Hz (indicated by “hz”), close to the 
resonant frequency of the PA catheter – transducer system.  The trough indicated by “Pes” indicates the end-systolic 
pressure for that beat. 
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Windkessel model involves small numbers and many calculations.  Small initial errors could lead to larger errors in 
the final calculation.   
 
Another calculation needed to determine characteristic impedance is PVR.  This is done by using the equation PVR = 
(PAP-LAP)/cardiac output.  The method of measuring PVR in this study is a commonly used, but potentially flawed, 
method.  The problem is that downstream pressure (LAP) is not known with accuracy.  This problem of not knowing 
the downstream pressure also creeps into the assumptions governing the determination of pulmonary impedance 
using P(t) = Po e–t/τ as the downstream pressure is ignored in this simplified formula (Liu, Brin et al. 1986).  What 
arguments can be used in defence of the use of PAWP as a surrogate measure of downstream pressure this study?  
Firstly, it is likely that if the PAC had been located in the DL during OLA, it would have been subjected to zone 3 
conditions.  In zone 3, PAWP is an accurate reflection of LAP.  Furthermore, LAP is the correct downstream pressure 
for zone 3 conditions.  Secondly, the validity and accuracy of one-point PVR calculations have been seriously 
questioned (Skimming, Cassin et al. 1997).  The potential error of not using a multiple pressure and flow plot is 
noted.  In defence of not using a multiple pressure-flow plot, it is difficult to construct such a plot in humans.  Albeit 
flawed, PVR is a commonly used clinical indicator of opposition to flow in the pulmonary circulation.  Should zone 3 
conditions have prevailed in the NDL (a reasonable assumption), then a pressure flow plot is not needed to 
determine PVR as the downstream pressure is known with reasonable accuracy.   
In spite of the excellent correlation coefficients observed in their study, Yin suggests that this association is not 
necessarily conclusive evidence that the pressure decay declines monoexponentially (Yin, Liu et al. 1987; Liu, Brin et 
al. 1986).  Whether this is of importance in the current study, is doubtful. 
Another drawback of this method is that the calculation of the PA time constant required copying and pasting by hand 
of 5 pulmonary arterial diastolic tracings per patient per step from Alab into Microsoft Excel®.  This is an extremely 
time-consuming task.   
 
In conclusion, the physical characteristics of the PA catheter currently used in adult humans are not ideal for 
accurate determination of impedance.  This technique for determining characteristic impedance is valid.  However, 
only gross changes of characteristic impedance could be determined because of limitation in data collection.  
Possibly the method of using the area under the PA diastolic curve# could provide an answer to the problem of more 
accurate determination of characteristic impedance in human subjects using a standard PAC (Liu, Brin et al. 1986). 
4.2 Control group:  OLA and the opposition to pulmonary flow  
The relevant part of the hypothesis to be examined in this section was that OLA increases RV afterload and thereby 
impairs coupling to its load.  It was hypothesised that this increase in afterload would have had deleterious effects on 
RV performance.  The parameters that were used to study the opposition to flow in the pulmonary vasculature were 
                                                                
# Liu, Brin and colleague (Liu, Brin et al. 1986), using the concept of a two element Windkessel model, developed a method of 
determining vascular compliance using the area under the pressure tracing rather than the waveform itself.  This eliminates the 
problem of the waveform not being monoexponential in form.  The formula that they derived is: RC = td/[Ln (Ps – Po) – Ln(Pd - 
Po)] where td is the total duration of diastole, R is total vascular resistance, C is vascular compliance, Ps is the pressure at the 
dicrotic notch, Po is the venous pressure (or better the pressure at zero flow in the vascular bed) and Pd is the diastolic pressure.  
Please see the original article for the relatively simple derivation of this formula. 
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pulmonary arterial pressure, elastance, resistance, compliance, and characteristic impedance.  It is noteworthy that 
mean PAP increased from 19 ± 5.1 mm Hg to a maximum of 25 ± 4.8 mm Hg during OLA.  This represented a 32% 
rise in mean PAP observed in the current study after initiation of OLA   This increase in mean PAP on initiation of 
OLA is greater than that observed by certain investigators (Pagel, Fu et al. 1998; Malmkvist, Fletcher et al. 1989; 
Malmkvist, Fletcher et al. 1989; Carlsson, Bindslev et al. 1987; Carlsson, Hedenstierna et al. 1987; Werner, 
Malmkvist et al. 1984) but similar to that seen previously in patients with damaged lungs (Boldt, Muller et al. 1996; 
Flacke, Thompson et al. 1976).   
 
Why does pulmonary artery pressure rise during OLA?  From consideration of Ohm’s law, pressure may be regarded 
as the product of flow and resistance (Mark, Slaughter et al. 2000).  In the current study, the relationship between 
pulmonary artery pressure and PVR demonstrated that the increase in PVR accounts for 25% of the increase in 
mean PAP (Table 3.5.1).  This is a surprising observation as it is commonly stated that as flow and pressure increase 
in the pulmonary vascular bed, PVR is reduced by vasodilatation and recruitment (Domino 1997; Rodman and 
Voelkel 1997; Basson 1996; West 1985).  In other words, as flow and pressure increase, recruitment and 
vasodilatation should limit the increase in pulmonary artery pressure.  This should result in a decrease in PA 
elastance.  It is apparent that the aforementioned concept does not hold true for this group of patients during OLA, as 
indicated by the rise in PA elastance when PA flow and pressure increase.  If the relationship does not hold, it may 
well indicate that pulmonary vascular recruitment and dilatation are more limited in scope for these patients than is 
usual (Cryer, Mavroudis et al. 1990; Crouch, Lucas et al. 1987).  The reason for the limited pulmonary vascular 
reserve is probably because the pulmonary vascular bed of patients subjected to OLA is frequently abnormal.  A 
number of reasons for an abnormal pulmonary vascular bed might be the following: 
¾ Similar disease processes as in the lung being operated on frequently affect the dependent lung.   
¾ During OLA in the lateral decubitus position, lung volume decreases to a greater degree than during two-
lung anesthesia (Klingstedt, Hedenstierna et al. 1990).  This will lead to an increase in PVR.  The 
consequence of a low lung volume is also an increased number of low V/Q units in the DL.  This will result 
in DL HPV.  The mechanical obstruction and vasoconstriction will both contribute to an increase in PVR 
(Capan, Turndorf et al. 1990).   
¾ This decrease in lung volume will be further aggravated by DLT malpositions, secretions and blood, and 
absorption atelectasis due to the use of high concentrations of oxygen (Hedenstierna 1998; Krucylak, 
Naunheim et al. 1996).  
¾ Excessive amounts of extrinsic or intrinsic PEEP during OLA can compress the intra-alveolar capillaries 
and deleteriously affect the pulmonary vascular resistance (Ducros, Moutafis et al. 1999; Inomata, 
Nishikawa et al. 1997; Bardoczky, Yernault et al. 1996; Yokota, Toriumi et al. 1996).  
 
The aforementioned processes will result in a steeper relationship between flow and pressure in the pulmonary 
vasculature and most likely account for the increase in pulmonary artery pressure during OLA.  A problem 
aggravating this rise in resistance is that it is likely that flow through the DL vascular bed increased during OLA in the 
current study.  The increase in DL flow is due to two factors peculiar to OLA:  
1. Approximately 50% of the cardiac output usually flows through each lung.  During OLA a significantly 
greater portion of the cardiac output typically courses through the vascular bed of the dependent lung. 
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2. The 30% increase in cardiac index observed on initiation of OLA in this and other studies (Abe, Mashimo et 
al. 1998; Boldt, Papsdorf et al. 1997; Cohen, Eisenkraft et al. 1988) will also aggravate the increase in 
PAP.  The greater portion of this increase in cardiac output will flow via the DL.  This will further increase 
DL lung flow. 
If it is likely that in these patients, recruitment and dilation was exhausted, the relationship between pulmonary blood 
flow and pulmonary artery pressure is a straight line (Figure 1.4.2.2.3).  Therefore, an increase in pulmonary blood 
flow would have resulted in an increase in PAP.  This contention is supported by an examination of the relationship 
between flow (cardiac index) and mean PAP during OLA in the current study.  It can be seen that the increase in flow 
accounts for 25% of the rise in mean PAP (Figure 3.5.3).  Therefore in summary, the rise in mean PAP during OLA is 
due to two reasons.  Firstly, the pressure versus flow curve is steeper during OLA.  Secondly, there is greater flow 
through this vascular bed that possesses a higher resistance.   
 
It is remarkable that in spite of the increase in PAP, no increases in PVR were measured during OLA in the control 
group of the current study.  The explanation may again lie in considering pulmonary vascular resistance as the slope 
of the relationship between flow and pressure (Figure 1.4.2.2.3) (McGregor and Sniderman 1985; Mitzner 1983).  
Thus, the greater the damage to the pulmonary vasculature, the higher will be the PVR as reflected by a steeper 
gradient of the pressure versus flow relationship.  In a normal lung, this relationship is such that for every litre per 
minute increase in cardiac index, mean PAP rises by 1 mm Hg.  A higher resistance in a damaged pulmonary 
vascular bed will contribute to the reasons why mean PAP but not PVR increased when the cardiac output and flow 
to the NDL rose during OLA. 
 
As PA pressure increases during OLA, the forces producing hypoxic vasoconstriction of the vasculature in the NDL 
are progressively opposed with eventual elimination of HPV at PA pressures greater than 25 mm Hg (Benumof 1991; 
Benumof and Wahrenbrock 1975).  The strength of the relationship between increases in mean PAP and shunt 
fraction in this study is not strong.  The increases in mean PAP account for only 26% of the increase in shunt fraction 
occurring during OLA (Figure 3.5.1).  However, the strength of the relationship between mean PAP and shunt 
fraction is similar in magnitude to that described by Malmkvist and colleagues (Figure 1.7.1.2) (Malmkvist, Fletcher et 
al. 1989; Malmkvist, Fletcher et al. 1989).  
 
It is noteworthy that the rise in mean PAP did not exceed a value of 25 mm Hg during OLA, even though cardiac 
output increased by 30%.  However, in studies conducted in patients with “damaged lungs”, greater increases in PA 
pressure accompanied by a decrease in RVEF have been reported to occur on PA ligation (Lewis-JW, Bastanfar et 
al. 1994; Cryer, Mavroudis et al. 1990; Pouleur, Lefevre et al. 1978).  A question arises as to why differences exist 
between PA clamping and OLA?  The answers may well be that  
1. It can be speculated that the observed plateau in the rise of PA pressure during OLA is as a result of 
progressive diversion of flow to the NDL as PA pressure increases.  Support for such a suggestion comes 
from the observation of progressive inhibition of HPV and an increase in shunt fraction during OLA seen 
with increases in PA pressure during OLA (Benumof 1991; Malmkvist, Fletcher et al. 1989; Malmkvist, 
Fletcher et al. 1989; Benumof and Wahrenbrock 1975)  This increase in shunt fraction as PA pressure 
rises reflects an increase in diversion of pulmonary blood flow to the NDL.  The impact of diversion of this 
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blood to the NDL is that it possibly acts as a safety mechanism limiting increases in PA pressure and other 
indices of opposition to pulmonary flow during OLA.  This “blow-off effect” will protect the RV until PA 
clamping occurs.    
2. The increases in mean PAP on PA clamping probably reflect the limited vascular reserve of the DL 
because of pre-existing pulmonary damage and loss of volume during OLA (Inomata, Nishikawa et al. 
1997; Cohen and Eisenkraft 1996; Cohen 1995) This may be reflected by the large increases in PA 
pressure and PVR that are sometimes seen during PA clamping and pneumonectomy (Cryer, Mavroudis et 
al. 1990; Crouch, Lucas et al. 1987) as this “blow off effect” cannot occur.   
 
Pulmonary arterial elastance rose by between 18 to 36% during OLA.  This is further indicative that the opposition to 
pulmonary flow increased.   It is also interesting that it appears that this increase in resistance was progressive as 
OLA continued (Table 3.3.1.12).  However, no progressive increases in mean PAP were observed during the course 
of OLA.   
 
Therefore, it can be concluded that the RV afterload did increase during OLA.  The rise in PA pressures observed 
during OLA in the current study has been so commonly described before, that it is quoted in textbooks discussing the 
‘pathophysiology of OLA’ (Chang, Black et al. 1996).  This increase in afterload was accompanied by an increase in 
pulmonary artery impedance, (predominantly an increase in PA elastance).  However, the purely resistive 
measurement of opposition to pulmonary flow, PVR, did not change.  The current study represents the opportunity to 
investigate the significance of these increases in PA pressures and PA elastance on RV performance during OLA. 
4.3 Control group:  OLA and RV function  
Stroke volume did not change from when the patients were awake to when OLA was instituted.  This lack of change 
in stroke volume was observed in spite of the increase in cardiac index seen on initiation of OLA.  No further 
differences in SV were observed during the course of OLA.  Each factor determining stroke volume will be examined 
using the concept of coupling between a ventricle and its load i.e.  
SV = (Ved-Vo) – Pes/Ees ………………      Equation 4.3.1 (Sagawa, Maughan et al. 1988)  or 
SV = (Ved – Vo)/(1 + Ea/Ees)  ………………      Equation 4.3.2 (Fourie, Coetzee et al. 1992b). 
 
The term Ved-Vo represents ventricular preload.  Fluid management policy was to administer hydroxyethyl starch 
prior to induction of anesthesia to raise CVP by 3 mmHg.  Intraoperative management was aimed at maintaining 
CVP at pre-induction levels.  This policy resulted in no difference in either RV end-diastolic volume or filling pressure 
being recorded during any epoch in the control group (Table 3.3.1.11).  This was in spite of potential decreases in 
venous return due to anesthesia induced vasodilatation (Thys, Dauchot et al. 1999), IPPV and hemorrhage that 
occurred in several patients.  It must be stressed that RV preload has been shown to be the major determinant of 
right ventricular SV provided mean PAP does not exceed 35 mm Hg (Reuse, Vincent et al. 1990; Martyn, Snider et 
al. 1981).  The mean PAP did not increase to greater than 25 mm Hg in the current study.  This leads to the 
conclusion that the right ventricle operates during OLA in the current study, as a volume displacement or preload 
dependent pump (Hennebry and Gerstenblith 2001; Boldt, Kling et al. 1990).  The corollary of the aforementioned 
statement is also important: that had preload not been constant, it would not have been possible to attribute changes 
Chapter 4.  Discussion
 
266 
seen in RV performance purely to changes in RV afterload.  Another observation is that preload forms part of the 
definition of wall stress, which in turn is one of the definitions of afterload intrinsic to the ventricle (Figure 1.4.1A and 
Equation 1.4.1.4).  Had preload increased, it would have represented another form of increase of afterload for the 
RV. 
 
The absence of a significant relationship between RVEDVI and either CVP or PAWP has been described in other 
studies (Table 3.5.3) (Reuse, Vincent et al. 1990).  This is interesting as it was predetermined that fluid 
administration be titrated against cardiac filling pressures.  It appears that using this method succeeded in 
maintaining a constant preload throughout the study period, despite the poor correlation between end-diastolic 
pressure and end-diastolic volume.  It is possible that the clinician, who was not blinded to the happenings in theatre, 
titrated fluid against other parameters such as the MAP, heart rate, arterial pressure fluctuations associated with 
ventilation and ongoing blood losses.  It is also possible that grouping all the RVEDVI and CVP data into one scatter 
plot is not a useful exercise as this hides the responses of individual patients (Thys and Dauchot 1998). 
 
Neither RVEDVI nor SV changed on initiation of OLA or as OLA progressed.  Thus, if equations 4.3.1 and 4.3.2 are 
studied, it is likely that Ees did not change from baseline.  This conclusion could only apply if Vo and Pes did not 
change.  Pes, as represented by mean PAP did however increase by 30% during OLA.  In addition, Vo cannot be 
measured using the techniques currently available in theatre.  Furthermore, although end-diastolic volume could be 
measured directly in this study, neither load independent variables of RV contractility such as Ees or preload 
recruitable stroke work (Karunanithi, Michniewicz et al. 1992) nor load dependent variables such as preload adjusted 
maximal power or dP/dt adjusted for RVEDV (Leather, Segers et al. 2000) could be measured in these studies.  
Instead, RVSWI, RVEF, and the relationship between right ventricular stroke work and indices of opposition to RV 
output were utilised as indices of contractility (Fourie, Coetzee et al. 1992b).  The results of the current study indicate 
that, at these levels of increase (30%) in PAP, neither RVEF nor RVSWI differed from baseline.  Ejection fraction is a 
load dependent parameter (Robotham, Takata et al. 1991).  At constant RVEDV and with a 30% rise in mean PAP, 
as was seen in this study, an unchanged EF would represent an unchanged contractility compared to the baseline 
awake state (Robotham, Takata et al. 1991). 
 
In essence, stroke work is the product of the (stroke) volume and pressure generated by the ventricle.  Therefore 
when the LV is faced with increases in opposition to its ejection but stroke volume is maintained, the result is that 
stroke work will increase but at the cost of efficiency (Sagawa, Maughan et al. 1988).  This relationship has been 
shown to hold for the RV as well (Fourie, Coetzee et al. 1992b).  In a pig model utilizing glass bead embolism to 
induce pulmonary hypertension (Fourie, Coetzee et al. 1992b), it has been demonstrated that maximal RV efficiency 
occurred at a pulmonary elastance of 1 mm Hg.ml-1.  A pulmonary elastance of 1 mm Hg.ml-1 corresponds to a mean 
PAP of 15 to 20 mm Hg.  In the same model, maximal stroke work occurred at a pulmonary elastance of 1.8 to 2 mm 
Hg.ml-1.  A pulmonary elastance of 1.8 to 2 mm Hg.ml-1 corresponds to a mean PAP of 30 to 40 mm Hg.  When 
pulmonary elastance increased beyond this point, stroke work declined, the RV failed and began operating as a 
pressure pump (Fourie, Coetzee et al. 1992b; Sagawa, Maughan et al. 1988).  Thus, RV performance usually only 
begins to deteriorate when indices of opposition to RV ejection reach 200 to 250% of baseline (Figure 4.3.1) (Fourie, 
Coetzee et al. 1992b).  However, the exact relationship between SW and load will vary depending on the contractile 
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reserve of the ventricle (Figures 1.5.2.8 and 1.5.2.9). 
 
If data from animal studies is applicable to humans, it is apparent that parameters of opposition to pulmonary flow 
indicating a transition from a flow to a pressure pump (i.e. pulmonary vascular elastance and mean PAP doubling 
and exceeding 1.8 mm Hg.ml-1 or 30 to 40 mm Hg respectively) were never reached in patients included in the 
control group of this study.  Furthermore, the observation that RV stroke work index did not change with the 
increases in mean PAP during OLA implies that the right ventricle, at the levels of contractility exhibited by these 
patients, was not deleteriously affected by the 30% rise in mean PAP during OLA and continued to operate as a flow 
pump.  It can therefore be concluded that during OLA, the right ventricle was still acting as a flow pump and never 
even approached the transition where it would function as a pressure pump (Fourie, Coetzee et al. 1992b).  This 
implies that during OLA, the RV operates on the upward limb of the SW load relationship and there is RV reserve in 
terms of ability to generate more SW, should load increase.   
 
There is a problem with the above view of RV function during OLA.  There was a statistically significant increase in 
PAP during OLA.  However, this rise in PAP was not accompanied by an increase in RV stroke work index.  The 
question that needs to be addressed is whether the lack of change in RVSWI is explained by the RV operating on the 
flat part of the RVSWI-PA Ea relationship (see Figure 1.5.2.8).  In other words, the RV was generating maximal 
stroke work during OLA.  It has been suggested before that myocardial depression attributable to anesthesia per se 
resulted in both right and left ventricles operating on the peak of the SW-Ea relationship (Fourie 1989; Piene 1986; 
Piene and Sund 1982; Piene and Sund 1979).   Can we be sure that RV function did not deteriorate during OLA?  
This question was addressed in two ways:   
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Figure 4.3.1   The effects of an increase in PAP on right ventricular performance and the consequences on systemic oxygen 
delivery.  Note the large reserve and that deterioration of RV performance does not occur until PAP has increased by 250% of 
baseline. [PAP (%) is as a % of baseline mean PAP, where baseline mean PAP = 13.76 + 3.02 mm Hg].  Fourie and 
Coetzee, 1992 
Chapter 4.  Discussion
 
268 
1. A significant relationship (Figure 3.5.5) (r = 0.5, p < 0.0001, n = 82) exists between mean PAP and RVSWI 
during OLA in the control group.  This indicates that while RVSWI did not increase during OLA for the 
whole group, increases in mean PAP did result in increases in RVSWI in individual patients.  Why then did 
these rises in mean PAP during OLA not result in increases in RVSWI?  The answer may lie therein that 
only a small percentage (25%) of RVSWI is accounted for by the increase in PAP.  Furthermore, mean 
PAP only rose by 30%.  It is entirely possible that the power of the current study was not sufficient to detect 
small changes in RVSWI.  Using Sigmastat for Windows and the data in the current study, it can be 
calculated that between 21 and 25 patients are need to be studied to detect a significant increase in 
RVSWI.  This is more than the number of patients enrolled in the control group of the current study. 
2. To further address this question, individual patient changes in the RVSWI – Ea relationship were 
investigated.  Firstly, the differences in RVSWI between the OLA and the awake steps were calculated for 
each patient.  Secondly the differences between pulmonary elastance during the OLA and the awake steps 
were calculated for each patient.  Thereafter, the RVSWI differences obtained for each individual patient 
were divided by the elastance differences for that patient.  In this manner the slope of (i.e. the change in) 
the RVSWI-PA Ea relationship could be calculated for each patient.  The mean slope of this relationship 
was +10.8 (95% confidence interval +2.3 to +19.3; 66 data points).  The gradient is positive and the 
confidence interval does not include zero.  This indicates that a positive gradient exists for the RVSWI-PA 
elastance relationship between the awake state and OLA. The conclusion can be made that in the majority 
of patients in the current study, the RV was operating on the upslope of the RVSWI versus Ea relationship.  
It supports the observation that RV function is well preserved during OLA. 
 
In conclusion, regarding the indices of opposition to pulmonary flow and RV performance during OLA, it can be 
concluded that: 
1. Opposition to RV ejection increases.  This is evidenced by a 30% rise in mean PAP and 18 to 36% 
increase in pulmonary arterial elastance. 
2. RVSWI, RVEF and stroke volume do not change during OLA compared with when the patients are awake 
or subjected to two-lung anesthesia.  The conclusion is that coupling between the RV and its load is well 
preserved during OLA.  It is likely that RV stroke work reserve is present during OLA.  This would imply that 
the RV operates at close to maximal efficiency during OLA.  (Figure 4.3.1).   
3. PA elastance seems to deteriorate (i.e. increase) with time as OLA progresses.  However, no evidence of 
time related changes in RV performance accompanied this progressive increase in elastance. 
 
Thus, the hypothesis that the opposition to pulmonary flow increases during OLA has to be accepted.  However, the 
sequitur that RV performance deteriorates when the indices of opposition to pulmonary flow increase during OLA is 
rejected.  The alternative hypothesis, that RV performance is well maintained in the face of a moderate increase in 
PA pressure and PA elastance during OLA, is hence accepted.     
 
Acceptance of the above conclusions must take into account the conditions prevailing in this study, which were as 
follows: 
a. The patients included in this study represent a selected group of patients with pulmonary disease 
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and VO2max greater than 11 ml.kg-1.min-1 with no clinical evidence of pulmonary hypertension, 
b. These subjects had no clinical abnormalities of LV function, systemic hypertension or myocardial 
ischemia.  LV abnormalities would have interfered with the normal force transmission between 
the left and right ventricles, 
c. They had acceptable RV coronary perfusion pressures, 
d. RV preload was kept constant, 
e. A moderately high dose of opioid and low dose of inhalation anesthetic agent was employed to 
provide anesthesia.  This would have caused little myocardial depression,  
f. A moderate sympathetic nervous system response to surgical stress accompanied OLA (see 
section 4.4.3), 
g. The DLT’s were correctly placed,  
h. Limited tidal volumes were used to avoid excessive DL dynamic inflation and permissive 
hypercapnia was allowed.  Approximately 5 cm intrinsic PEEP was present during OLA and, 
i. A FiO2 of 1 to the DL and oxygen insufflation into the NDL. 
Table 4.3.1 Factors contributing to preserving a low PVR during OLA in this study.  
 
 
This observation of preserved RV function with plenty of reserve is remarkable as one would expect that the effects 
of pulmonary disease, one lung anesthesia, positioning and IPPV would deleteriously affect the RV and its load.   
 
Factor Lung Influenced 
Inspired oxygen concentration of anesthetic mixture 100% (Domino 1997) DL 
Preservation of lung volume by intrinsic PEEP during OLA (Myles 1996) DL 
P O2 increase during anesthesia (West 1985) DL and NDL 
Decrease in temperature with inhibition of HPV (Benumof and Wahrenbrock 1977) DL and NDL 
Blow off effect of the pulmonary vasculature of the NDL (see section 4.2 for 
explanation) 
NDL 
Selection of patients with sufficient pulmonary vascular reserve to undergo lung 
resection 
DL and NDL 
Inhibition of HPV by Isoflurane (Domino 1997; Benumof 1986) DL and NDL 
Adequate anesthesia levels with minimal catecholamine releases and little effect on 
PVR 
DL and NDL 
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Why does the frequently reported decrease in lung volume, lateral decubitus position and the onset of OLA, as 
demonstrated in the first group in Inomata and colleagues’ study (Inomata, Nishikawa et al. 1997), not result in 
greater increases in any of the indices of opposition to pulmonary flow?  Possible reasons for this phenomenon are 
outlined in Table 4.3.1.  It may be concluded that conditions prevailing in this particular human model resulted in a 
low opposition to pulmonary flow compared with baseline levels.  Therefore, the techniques used in this study are 
suitable for use in patients in whom further increases in opposition to RV ejection could compromise right ventricular 
performance.  
4.3.1 Control group:  factors affecting RV performance during OLA 
The anesthetic agents in this study were maintained at constant levels for the duration of the period that the patients 
were observed.  Isoflurane was administered at a relatively low end tidal partial pressure of 0.4 ± 0.2 to 0.5 ± 0.2 
kPa, in combination with a moderately high targeted blood level 280 ng.ml-1 using a target-controlled infusion of 
alfentanil.  This particular combination of anesthetic agents (isoflurane and alfentanil) was chosen for the following 
reasons: 
¾ The two agents act synergistically to produce “anesthesia” at concentrations used in this study (Glass, 
Shafer et al. 2000),  
¾ The targeted plasma concentrations of alfentanil used in this study agree with those quoted by Glass, 
Shafer and Reves in a current textbook of anesthesia (Glass, Shafer et al. 2000) as being adequate to 
produce anesthesia in combination with a low level of inhalation agent (Table 4.3.2), 
¾ It was unlikely that, in this selected group of patients, any individuals would have contraindications to this 
combination of drugs.  Therefore, all patients could be exposed to the same combination of anesthetic 
drugs and hemodynamic effects should be similar in all patients, 
¾ The effects of isoflurane on HPV during OLA have been well described and quantified.  Furthermore, in the 
clinical setting of OLA, PaO2 has been shown not to differ from agents (e.g. propofol) that do not inhibit 
HPV (Reid, Slinger et al. 1996) and, 
¾ The moderately high dose opioid technique would hopefully avoid the confounding issue of sympathetic 
nervous system stimulation in response to the surgical assault and produce little myocardial depression 
(Coetzee 1993; Frostell, Blomqvist et al. 1993).  This would enable comparability between the epochs. 
 
The computer controlled infusion employed the model described by Maitre and colleagues to maintain the 
predetermined alfentanil plasma concentrations (Maitre, Ausems et al. 1988; Maitre, Vozeh et al. 1987).  Actual 
plasma concentrations that are achieved using computer controlled infusions of alfentanil may vary by 20 to 30% of 
predicted and Maitre and colleagues’ model has been reported to have a median performance error of approximately 
53% (Figure 4.3.1.1) (Glass, Shafer et al. 2000; Westmoreland, Sebel et al. 1994; Coetzee 1993).  These variations 
are considered to be within a clinically acceptable range (Glass, Shafer et al. 2000; Coetzee 1993).   
 
Isoflurane has been reported to produce a dose dependent negative inotropic effect (Frostell, Blomqvist et al. 1993; 
Coetzee, Fourie et al. 1987b).  It is however apparent that the anesthetic agents employed in this study, in 
combination with surgical stimulation and fluid loading, exhibited no clinically measurable deleterious effects on right 
ventricular performance.  This observation must be contrasted with reports in which inhalation anesthetic agents 
compromised RV stroke work and efficiency (Piene 1987; Priebe 1987; Elzinga, Piene et al. 1980; Piene and Sund 
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1979).  
Table 4.3.2 Adapted from Glass, Shafer et al. 2000 
 
As discussed in the literature review, early studies indicated that, in its normal state and facing a normal opposition to 
ejection, the RV generates maximal stroke work (Piene 1987; Elzinga, Piene et al. 1980; Piene and Sund 1979).  
This contention was subsequently refuted, when it was demonstrated that the normal RV, like the LV, works at 
maximal efficiency and possesses a significant stroke work reserve (Hennebry and Gerstenblith 2001; Coetzee and 
Fourie 1993; Fourie, Coetzee et al. 1992; Fourie 1989; Piene and Sund 1982).  The reasons for the discrepancy 
between early and later studies were hypothesized to be that the anesthetic techniques used in these animal models 
(e.g. high concentrations of halothane or barbiturate infusions) (Asanoi, Sasayama et al. 1989; Sagawa, Maughan et 
al. 1988), combined with the effects of cardiac denervation (Fourie, Coetzee et al. 1992a; Burkhoff and Sagawa 
1986; Piene and Sund 1982), deleteriously affected RV performance.  The preservation of SW reserve of the RV 
under the balanced anesthesia technique and loading conditions employed in this study is therefore an important 
observation. 
 
Boyd and colleagues compared the effects of propofol and isoflurane on RV function in patients with peripheral 
vascular disease undergoing lower limb bypass surgery (Boyd, Murdoch et al. 1994).  They concluded that right 
ventricular performance as measured by cardiac output (4.0 vs. 4.5 l.min-1), RVEF (35.1 vs. 39.4%), stroke volume 
(35.4 vs. 39.6 ml) and RVEDVI (102 vs. 110 ml.m-2) was better preserved with propofol than isoflurane.  They 
observed no difference in MAP or heart rate between the groups.  From this observation they concluded firstly that 
sympathetic nervous system stimulation was not a factor that differentiated the cardiac effects of either technique, 
and secondly that their anesthetic techniques were of similar depth.  They suggested that propofol might be more 
suitable than isoflurane in patients who may already have impaired right ventricular function and in whom maintaining 
a high cardiac output may be beneficial.  This conclusion would be of relevance to patients undergoing OLA.  
However, their conclusion that one anesthetic technique (propofol infusion) is superior to another (isoflurane) in 
patients with depressed RVF is probably an overstatement of fact for the following reasons: 
Depth of anesthesia 
Plasma concentration 
of alfentanil 
The steady state plasma concentration that causes 50% reduction in MAC of 
isoflurane in 50% of patients 
50 ng.ml-1 
The steady state plasma concentration that prevents somatic or autonomic 
response to skin incision in 50% of patients  
200 – 300 ng.ml-1 
Recommended levels for minor surgery when combined with 67% nitrous oxide  100 – 300 ng.ml-1 
Recommended levels for skin incision when combined with 67% nitrous oxide  200 – 300 ng.ml-1 
Recommended levels for major surgery when combined with 67% nitrous oxide 250 – 400 ng.ml-1 
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¾ Isoflurane and propofol resulted in only a 10% difference in cardiac index, SI and RVEF.  Albeit these 
changes were statistically different, it is questionable as to whether they are of clinical significance, and 
whether their firm conclusion is justified based on the strength of the differences they observed.  One 
concern is that the variation in cardiac output with thermodilution is approximately 10 %.  This difference is 
within the observed 10% measurement error of the thermodilution method used in their study. 
¾ These authors claim to have used equipotent anesthetic dosages (Boyd and Grounds 1996).  This may not 
in fact be the case as the dosage of anesthetic agent was titrated to unsophisticated endpoints.  The 
method they used to determine equivalent levels of anesthetic agent was that the end tidal isoflurane 
concentration was adjusted within a range of 0.5 to 1.0 MAC and computer controlled infusion of propofol 
concentration was adjusted  “until satisfactory anesthesia was achieved. …  Anesthesia was judged to be 
satisfactory on the basis of an aggregate of clinical signs used daily to control and monitor the depth of 
anesthesia.  The patients had to have a heart rate less than 15% above control and a systolic blood 
pressure less than 15% above control, as well as no evidence of sweating or tears.“   
¾ Although relative MAC and MIR for each agent was similar, the presence of cardiac disease and the use of 
cardiovascular medication by the vascular surgery patients involved in this study could also account for the 
different responses of the two anesthetic regimes.  
¾ Isoflurane produces a dose dependent decrease in contractility of both ventricles (Pagel, Farber et al. 
2000).  However, the negative inotropic effects of propofol exhibit hysteresis with myocardial function failing 
to return to baseline as plasma levels decrease (i.e. myocardial depressant effect prolonged beyond the 
decay in propofol concentrations) (Coetzee 1993; Coetzee, Fourie et al. 1989).  Albeit propofol is perceived 
by these authors to be less deleterious for RV function, the administration of constant infusions or 
additional boluses may result in plasma propofol concentrations reaching levels that compromise 
ventricular function.  In contrast to these risks posed by propofol boluses, one safety mechanism of 
inhalation anesthetic agents is that their partial pressures in plasma cannot increase above that of the 
dialled in concentration (Coetzee 1993).  
¾ Propofol appears to have profound effects on the pulmonary circulation, predominantly causing or 
potentiating pulmonary vasoconstriction: 
o It has been shown to cause pulmonary hypertension in pigs (Coetzee 1993), 
o Propofol increases the myofilament calcium sensitivity of dog PA smooth muscle.  This led to increases 
in the tension developed by propofol treated PA muscle strips compared with control (Tanaka, Kanaya 
et al. 2002), 
o Propofol has been shown to increase the tension in response to phenylephrine produced by canine PA 
rings (Ogawa, Tanaka et al. 2001), 
o This anesthetic drug has also been demonstrated to potentiate the effects of sympathomimetics on the 
pulmonary circulation (Kondo, Kim et al. 2001),  
o Propofol has been shown to attenuate endothelium-dependent pulmonary vasodilatation (Kondo, Kim 
and Murray 2000) and, 
o Propofol has also been demonstrated to potentiate HPV (Nakayama and Murray 1999), 
Therefore propofol may well increase PA pressure and concomitantly decrease RV contractility. This is a 
potentially dangerous combination in patients with severe pulmonary disease. 
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In subsequent correspondence in the British Journal of Anaestheia, Boyd and colleagues stated that they “took 
considerable care to compare similar anesthetic dosages of propofol and isoflurane” (Boyd and Grounds 1996).  
They comment furthermore, “observations of cardiac function should be made during periods of steady state 
anesthesia.”  These principles are applicable to a study conducted by Boldt and colleagues (Boldt, Muller et al. 
1996).  In both the Boldt and the Boyd studies, an RVEF catheter was used to compare the effects of two anesthetic 
techniques in patients undergoing pneumonectomy and lobectomy.  In the Boldt study, one anesthetic technique 
used was fentanyl, nitrous oxide, propofol and vecuronium.  The other technique comprised fentanyl, midazolam and 
vecuronium.  The results of the Boldt study indicated that the anesthetic regimen itself did not result in any 
differences in hemodynamics or RV function.  Rather it was the procedure (pneumonectomy or lobectomy) that 
played the key role in determining hemodynamics.  However, certain deficiencies in methodology are apparent in 
Boldt’s study.  Albeit “one size does not fit all”, one wonders if the anesthetic techniques of titration against clinical 
effect fulfil the criterion of comparability in terms of depth of anesthesia as mentioned by Boyd.  For example, 
significantly different dosages of fentanyl were used in two of the groups and there was a significantly lower heart 
rate in the propofol-nitrous oxide than in the midazolam-fentanyl group.  These observations suggest the presence of 
different anesthetic depths in the groups.  The difference in depth of anesthesia may have resulted in differing 
autonomic responses to surgery.  These differences make it difficult to compare RV function and other hemodynamic 
parameters between the groups.   
 
Kellow and colleagues (Kellow, Scott et al. 1995) compared the hemodynamic and right ventricular effects of 
isoflurane with propofol.  The isoflurane was administered at an inspired concentration of 1 to 1.5% but neither fresh 
gas flow nor end tidal isoflurane concentrations were reported in the paper.  The propofol infusion was administered 
initially at 10 mg.kg-1.hour-1 and was progressively reduced at 10 minute intervals to 8 and finally to 6 mg.kg-1.hour-1.  
50% nitrous oxide in oxygen was co-administered during OLA.   In contrast to the Boyd study, this study by Kellow 
and colleagues came to a different conclusion, namely that RV systolic function, as judged by RVEDVI, RVEF, and 
CI, was more deleteriously affected by propofol and nitrous oxide mixture than isoflurane.  The reductions in systolic 
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Figure 4.3.1.1 Relationship 
between of end tidal isoflurane 
concentration and mean alfentanil 
concentrations for each patient.  
Each point represents the 
move/no move response for an 
individual patient.  The line 
represents the 50% likelihood of 
movement to skin incision.  The 
patients in the current study are 
represented by the star*.  
Redrawn from Westmoreland, 
Sebel et al, 1994. 
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function also persisted in the propofol group after the infusion was stopped.  Similar observations have also been 
demonstrated for the LV (Coetzee 1993; Coetzee, Fourie et al. 1989).  Thus, Kellow’s study confirms that RV 
function is also deleteriously affected by propofol and this effect lingers after terminating the infusion.  As mentioned 
previously, this raises questions regarding the suitability of propofol anesthesia in patients whose RV systolic 
performance is at risk.  Furthermore in the Kellow study, hemodynamics during OLA when anesthesia was 
conducted with isoflurane did not differ from baseline.  This is contrary to the findings in the Boyd study but similar to 
observations made in the current study.  Again, as in the Boldt and Boyd studies, the anesthetic depth in the two 
groups in the Kellow study may not be comparable, a factor which may confound their findings. 
 
There are other points of interest in the Kellow study: 
¾ In both the Kellow study’s isoflurane group and in the current study, surgical stimulation during OLA 
restored the cardiac index to baseline.  Similar increases in cardiac output on initiation of OLA have been 
reported in other studies (Pagel, Fu et al. 1998; Abe, Mashimo et al. 1998; Zaune, Knarr et al. 1990; 
Cohen, Eisenkraft et al. 1988; Thys, Cohen et al. 1988; Aalto-Setala and Heinonen 1982; Aalto-Setala, 
Figure 4.3.1.2  Isoflurane induced changes in RV and LV function.  The parameters are standardized as a percentage 
change from baseline.  PRSW = preload recruitable stroke work.  n  = 6.  * Indicates RV and LV differ, p < 0.05.  Modified 
from Heerdt, Gandi and colleagues, 1998 
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Heinonen et al. 1975).  In the light of these increases in cardiac output, could it be that the sympathetic 
nervous system activity counterbalanced the negative inotropic effects of the inhalation agent but not those 
attributable to propofol?   
¾ Another point to note in the Kellow study is that shunt fraction was threefold greater in the isoflurane group 
than in the propofol group during OLA.  Kellow and colleagues’ study therefore highlights the divergent 
influences on hemodynamics and oxygenation, aggravated by propofol and isoflurane respectively, during 
thoracic anesthesia.  These problems led these investigators to conclude that neither propofol nor 
isoflurane are ideal anesthetic agents during OLA.  This conclusion opens the possibility that the balanced 
anesthetic techniques used in the current study may result in less depression of both RV function and HPV 
than when using a single agent in higher dose during OLA.  Albeit isoflurane and other inhalation agents 
have been shown to produce progressive myocardial depression, low dosages of isoflurane in the order of 
magnitude used in the current study have been demonstrated to produce little myocardial depression 
(Coetzee, Fourie et al. 1987b).  Dosages of alfentanil have been demonstrated to produce decreases of 
sympathetic nervous system tone but little or no myocardial depression (Bailey, Egan et al. 2000; Heerdt, 
Gandhi et al. 1998; Coetzee 1993).  However, a report of the effects of the combination of alfentanil and 
isoflurane on hemodynamics and oxygenation could not be found using a Medline search of the literature. 
 
¾ Decreases in systemic arterial pressure of up to 30%, and LVSWI of between 21 to 43% occurred after 
induction of anesthesia in our patients.  However, indices of RV afterload increased moderately while 
RVSWI did not change after induction of anesthesia or during OLA.  Therefore the anesthetic technique in 
the current study resulted in a decrease in the parameters of left ventricular afterload and stroke work.  
This is in contrast to the moderate increase in RV afterload and absence of change in the indices of RV 
performance during both two and one lung anesthesia.  The differing effects of similar dosages of 
anesthetic agents on coupling of the two ventricles and their respective loads were elegantly studied by 
Heerdt and co-workers (Heerdt, Gandhi et al. 1998).  They described disparate effects of increasing 
dosages of isoflurane on afterload and work performed by the right and left ventricles of pentobarbital 
anesthetised swine.  Heerdt et al. observed that progressively increasing partial pressures of isoflurane 
produced similar effects on contractility of both ventricles.  However, left and right ventricular afterload was 
affected very differently by increasing dosages of isoflurane.  LV afterload and work decreased in a dose 
dependent manner while indices of RV afterload and RV work per unit time (power output) actually 
increased as the partial pressure of isoflurane progressively increased.  The result of this was to impair the 
coupling between the RV and its load.  Usually, the vasodilatation induced by clinically useful 
concentrations of isoflurane more than compensates for its negative inotropic effects on LV. The usual 
result is that the LV stroke work and the effectiveness circulation as a whole, is well preserved.  Heerdt 
however suggests that reports in which isoflurane have been shown to decrease cardiac output by as 
much as equipotent dosages of halothane may be due to the deleterious effects of inhalation anesthetic 
agents on RV-PA coupling.   
 
Therefore, as demonstrated again in the Heerdt study, the anesthetic technique used has significant effects on RV 
function and coupling to its load.  This consideration may be of special relevance in circumstances where RV function 
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is compromised.  It emphasizes that the anesthetic technique used in the current study avoids deleteriously 
influencing RV performance.  However, care should be taken when the results of the current study are extrapolated 
outside the particular “human model” that was used. 
 
Heerdt’s study raises the issue of the influence of left ventricular function on that of its counterpart.  Mean arterial 
blood pressure decreased by 20% after induction of anesthesia in the current study.  This decrease in aortic pressure 
was accompanied by a greater than 30% rise in PAP.  This had the effect of decreasing RV coronary perfusion 
pressure (CPP) by 30% from 80.3 when awake, to 56.5 mm Hg while anesthetised (p < 0.001).  Vlahakes and 
colleagues (Vlahakes, Turley et al. 1981) demonstrated that after greater rises in right-sided pressures than were 
observed in the present study (RV systolic pressure 54 ± 13 mm Hg and RV coronary perfusion pressure 41 mm 
Hg), coronary vascular reserve was well preserved.  Only at the point of circulatory collapse (RV systolic pressure of 
61 ± 10 mm Hg and coronary perfusion pressure 23 ± 9 mm Hg), did RV ischemia become an issue in their dog 
model (Vlahakes, Turley et al. 1981).  However, during OLA, the RV in the control group of the current study was not 
stressed by severe increases in afterload or an increase in RVEDVI, as was the case in the Vlahakes study.  
Therefore, it is unlikely that this small decrease in coronary perfusion pressure represented a clinically significant 
decrease in RV perfusion pressure in these patients. 
 
A dual inflexion was observed in 83.5% of the electronically recorded RV and PA pressure tracing (Figure 4.3.1.3).  
This raises the contention that LV systolic interaction between the ventricles may play a significant role in right heart 
performance.  This double hump in the RV and PA pressure versus time recordings has been observed and 
investigated by Santamore’s group (Santamore and Gray, Jr. 1996; Damiano, Jr., La Follette, Jr. et al. 1991).  
Damiano and colleagues (Damiano, Jr., La Follette, Jr. et al. 1991) demonstrated that the first component of the 
pressure wave is directly related to RV contraction, whereas the second part is related to left ventricular contraction.  
It is remarkable that the LV component comprised the dominant fraction of both the PA and RV contraction (Table 
4.3.3) (Santamore and Gray, Jr. 1996; Santamore, Constantinescu et al. 1988a; Santamore, Lynch et al. 1976b).  
Although the percentage contribution of each component of the double hump was not measured in this study as was 
done by Damiano and colleagues, we have no reason to suspect that this form of systolic interaction is not the 
reason behind the double inflexion in the PA and RV pressure-time tracings in this study.  The implication is that the 
LV contributes a significant portion of the energy to the forces propelling blood through the pulmonary vasculature 
(Woodard, Chow et al. 1992; Slinker and Glantz 1986; Elzinga, Piene et al. 1980; Pool, Piggott et al. 1976).  Because 
of the aforementioned consideration, exclusion criteria for our patients included the presence of clinical abnormalities 
of LV function.  The implications for the current study are that RV performance is well preserved during OLA 
when LV function is intact.  The corollary is that impairment of LV function may significantly impair RV function 
during OLA because of both decreased systolic interaction between the ventricles and a raised LVEDP that 
frequently accompanies LV systolic and diastolic dysfunction (Marshall and Marshall 1997).    
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Figure 4.3.1.3a Six RV pressure versus time recordings.  These recordings were imported from Alab.  They 
demonstrate the “double hump” in the pressure trace.  Electronic recordings were made in 24 subjects and comprised 396 
tracings, 200 of the PA and 196 of the RV.  In 32 RV and 33 PA tracings, which comprise 16.5% of the total of the tracings, 
double peaks did not appear or were obscured by ringing.  Solid white arrows represent the RV and solid black arrows 
represent the LV part of the recordings. 
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Figure 4.3.1.3b Six PA pressure versus time recordings.  These recordings were imported from Alab.  They 
demonstrate the “double hump” in the pressure trace.  Electronic recordings were made in 24 subjects and comprised 396 
tracings, 200 of the PA and 196 of the RV.  In 32 RV and 33 PA tracings, which comprise 16.5% of the total of the tracings, 
double peaks did not appear or were obscured by ringing.  Solid white arrows represent the RV and solid black arrows 
represent the LV part of the recordings. 
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Another explanation as to why this double hump may occur relates to the dual embryonic origins of the RV outflow 
tract (Raines, LeWinter et al. 1976; Armour, Pace et al. 1970).  The RV inflow tract contracts 25 to 50 milliseconds 
before the outflow tract.  The effect is that RV contraction occurs in a peristaltic manner (Heerdt and Pleimann 1996; 
Meier, Bove et al. 1980; Raines, LeWinter et al. 1976).  This results in intraventricular pressure gradients occurring 
within the RV (Heerdt and Pleimann 1996; Raines, LeWinter et al. 1976; Armour, Pace et al. 1970).  Furthermore, the 
RV outflow tract exhibits a greater response to inotropic agents with elevation of the normal intraventricular pressure 
gradient (Heerdt and Pleimann 1996; Armour, Pace et al. 1970).  However, as the partial pressure of halothane 
(Heerdt and Pleimann 1996) or isoflurane (Priebe 1987) is increased, this gradient is firstly minimized and eventually 
abolished at 2 MAC halothane.  Heerdt and Pleimann (Heerdt and Pleimann 1996) showed that the normal 
disconcordance of RV contraction is abolished because inhalation anesthetic agents delay the inflow tract contraction 
to be synchronous with that of the outflow tract.  This results in the abolition of the RV intraventricular pressure 
gradient on administration of even low dosages of inhalation anesthetic agents (Meier, Bove et al. 1980).  
Furthermore, the differences in time between contraction of the inflow and outflow regions of the RV are significantly 
shorter than that seen between the double peak (90 to 120 milliseconds) of the RV and PA tracings (Hennebry and 
Gerstenblith 2001).  Thus, for the reasons outlined above, it is unlikely that these double pressure peaks are due to 
disconcordance of RV inflow and outflow tract contraction.   
 
 
LV component 
% 
RV component 
% 
PA: Peak to Peak 67.5 32.5 
PA: Root-mean-square value 68.3 31.8 
RV: Peak to Peak 63.5 36.5 
RV: Root-mean-square value 65.2 34.8 
Table 4.3.3  The relative left and right ventricular contributions to pressures driving blood across the 
pulmonary vasculature.  Data reproduced from Santamore (Santamore and Gray, Jr. 1996). 
 
Murgo and Westerhof (Murgo and Westerhof 1987) describe a midsystolic inflexion followed by a late systolic 
pressure rise in both the LV, aortic, and RV and PA pressure tracings when significant wave reflection is present.  
Beats demonstrating such a phenomenon are termed type A beats.  The input impedance spectrums of type A beats 
demonstrate large oscillations around the characteristic impedance.  These oscillations indicate that significant wave 
reflection is present.  Murgo and Westerhof termed beats without the double pressure peak, that are associated with 
low peripheral vascular resistance and a nonoscillatory input impedance spectrum, type C beats.  During normal 
circumstances, the pulmonary circulation produces little wave reflection and the beats do not demonstrate a double 
peak, and are typical of type C beats.  Using a catheter with multiple sensors, they concluded that the systemic 
vascular reflection originates primarily around the renal arteries, but there has been no such study of the origins of 
wave reflection in the pulmonary circulation during PHPT (Murgo and Westerhof 1987).  No conclusions for or 
against this particular cause of the dual inflexion can be made in the present study. 
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One last possibility is that the low resonant frequencies of the PA catheter-transducer system produced artefacts in 
the PA waveform.  It is unlikely that amplification due to ringing was the sole reason for these double peaks.  The 
reason why this explanation is unlikely to provide the sole reason is that these double peaks occur with great 
consistency.  Furthermore, too many other plausible explanations exist for them to be considered purely artefactual. 
 
Cardiac index and oxygen delivery both decreased during two-lung anesthesia compared to the measurements 
made when the patients were awake (Tables 3.3.1.10 and 3.3.1.16).  Similar observations were made in Kellow’s 
study (Kellow, Scott et al. 1995).  Attenuation of sympathetic nervous system tone can occur after administration of 
any of the synthetic opioids currently in use (Bailey, Egan et al. 2000; Thys, Dauchot et al. 1999; Coetzee 1993).  
This will explain the decreases in cardiac output and oxygen delivery seen in the current study. 
 
However, moderately high dose opioid administration combined with inhalation anesthetic agents, at partial 
pressures that exceed MAC awake, do not necessarily achieve the levels needed to block autonomic responses to 
surgical stimulation (MAC BAR) (Bailey, Egan et al. 2000; Stanski 2000).  In the presence of 70% nitrous oxide, the 
plasma concentration of alfentanil needed to produce a 50% chance of suppressing increases of heart rate and blood 
pressure in response to skin incision (Cp50) is 279 ± 20 ng.ml-1 (Stanski 2000).  For intraoperative manipulation, Cp50 
varied between 270 ± 63 to 412 ± 135 ng.ml-1 for breast and upper abdominal surgery respectively (Stanski 2000).  
The targeted concentrations of alfentanil used in the current study were 280 ng.ml-1, in combination with a partial 
pressure of 0.5 ± 0.2 kPa isoflurane.  This represents a depth of anesthesia less than in Stanksi’s study (Stanski 
2000).  It is therefore possible that approximately 50% of patients in the current study could have exhibited 
endogenous catecholamine release in response to surgical manipulation.  Surgical stimulation was permitted only 
after the “2 lung anesthesia” measurements had been completed.  The decreases in cardiac index and oxygen 
delivery observed immediately after induction of anesthesia were restored to baseline once surgery commenced, as 
observed in other studies (Abe, Mashimo et al. 1998; Boldt, Papsdorf et al. 1997; Cohen, Eisenkraft et al. 1988).  
Furthermore, an increase in heart rate was observed once surgical manipulation commenced.  This constitutes 
evidence that the levels of anesthesia employed in this study were able to blunt but was inadequate to abolish the 
autonomic response to surgical incision.  However, the partial pressure of isoflurane exceeded MAC awake and was 
sufficient to prevent explicit recall and movement in response to surgical stimulation (only the initial dose of muscle 
relaxant was given and not repeated) (Stanski 2000). 
 
Endogenous catecholamine release in response to surgical stimulation may however provide an advantage by 
increasing RV contractility.  This may result in an improvement in coupling between the ventricle and its load, if 
concomitant increases in RV afterload do not occur.  Thus, the possible positive inotropic stimulation that occurred 
concurrently with OLA in this study, may have further counteracted the already minimal cardiac depressant effects of 
the anesthetic agents and contributed to the preservation of RV function.  The cardiovascular effects of anesthesia 
are frequently the result of a balance between on the one hand, myocardial depression, vasodilatation, and 
sympathetic nervous system depression induced by the anesthetic agents and, on the other hand, the sympathetic 
response to surgical stimulation (Pagel and Warltier 1997).   
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Although increases in sympathetic nervous system stimulation undoubtedly play a role in the increased oxygen 
delivery, cardiac index and heart rate on initiation of OLA, is this mechanism solely responsible for such powerful and 
immediate restoration of hemodynamics to baseline (Abe, Mashimo et al. 1998; Boldt, Papsdorf et al. 1997; Cohen, 
Eisenkraft et al. 1988)?  Could it be that release of neurohumoral factors induced by the onset of OLA are also 
responsible for this phenomenon?  The lung is an active metabolic organ that renders inactive the circulating 
vasoconstrictory substances that bombard its vast vascular endothelium (Taylor and Lausch 2001; Boldt, Papsdorf et 
al. 1997; Rodman and Voelkel 1997; Scherer, Van Aken et al. 1984).  Pre-existing lung disease and collapse during 
one lung anesthesia may affect the way circulatory mediators are metabolised (Taylor and Lausch 2001; Boldt, 
Papsdorf et al. 1997).  In addition, the increase in pulmonary blood flow such as occurs in the DL during OLA, will 
induce vasodilatation mediated by nitric oxide, prostaglandins, and acetylcholine.  These mediators may spill over 
into the circulation and influence systemic hemodynamics (Scherer, Van Aken et al. 1984).  It has also been 
suggested that the collapsed ischemic NDL may produce vasoconstrictory substances such as endothelin (Rodman 
and Voelkel 1997).  Boldt and colleagues (Boldt, Papsdorf et al. 1997) therefore studied the concentrations of a 
number of vasoconstrictors, noradrenaline, vasopressin and endothelin, during OLA.  Of these, only noradrenaline 
levels were raised during OLA.  It is however notable that higher levels of noradrenaline were observed in the 
pneumonectomy group.  In the same study, Boldt and colleagues also described increases in vasodilatory 
substances during OLA.  Atrial natriuretic peptide and 6-keto-prostaglandin F1∝ showed tendencies to rise during 
OLA.  Scherer and co-workers (Scherer, Van Aken et al. 1984) also demonstrated raised vasodilatory prostaglandin 
E2 and decreased vasoconstrictor F2 during both one and two-lung ventilation.  Scherer commented that increased 
levels of vasodilatory substances could result in inhibition of HPV during OLA, although he himself could not 
demonstrate a relationship between shunt fraction and an increase in PGE2 levels (Scherer, Van Aken et al. 1984).  
In the current study, hormonal levels were not measured, but the indices of systemic vascular resistance did not 
decrease during OLA compared to 2-lung anesthesia.   Even though the changes in the abovementioned vasoactive 
mediators do occur during OLA, I suspect that the hemodynamic changes seen in the current study are mainly 
attributable to stress related to the surgical stimulation, as the rapid changes seen are so typical of sympathetic 
nervous system stimulation.   
 
It is also possible that the catecholamines released in response to surgical stimulation contributed to increases in PA 
pressure and decreases in PA compliance (Liu and Barnes 1997).  Marshall and Marshall point out that such 
catecholamine-induced changes are not sustained.  This is because the lungs’ possess many mechanisms to 
prevent vasoconstriction: these mechanisms eventually predominate over the vasoconstrictory stimuli (Marshall and 
Marshall 1997).  This override of vasoconstrictory influences does not occur if vasoconstriction is due to hypoxia, an 
issue that was certainly not the case in this study (Marshall and Marshall 1997).  Furthermore, West suggests that if 
PVR is already low further insults such as sympathetic nervous system stimulation will have less effect on pulmonary 
vascular tone (West 1985). Thus, the endogenous release of catecholamines most likely had minimal effect on the 
already low PA tone in this study.   
 
In the face of an increased afterload, both right and left ventricles have been reported to be capable of generating 
either homeometric and/or heterometric autoregulatory responses (Calvin, Jr. 1991).  As long ago as 1912, Von 
Anrep first suggested that a ventricle facing an increase in afterload would exhibit an increase in contractility (Calvin, 
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Jr. 1991; Coetzee, Fourie et al. 1987a).  This phenomenon was described as homeometric autoregulation because 
the increase in contractility occurred without an increase in ventricular end-diastolic volume (Calvin, Jr. 1991).  
Homeometric autoregulation may however be the result of a very steep Ees relationship and very small increases in 
EDV of the ventricle, which easily compensate for an increase in afterload (Coetzee, Fourie et al. 1987a).  This 
phenomenon therefore depends to a large degree on the state of contractility of the ventricle (Coetzee, Fourie et al. 
1987a).  The Anrep effect has also been associated with increases in heart rate, the so-called Bodwitch effect.  The 
mechanism underlying the Bodwitch effect has been attributed to increased sarcolemmal calcium concentrations.  A 
further mechanism, that of increased coronary blood flow induced by systemic hypertension, has also been 
suggested to underlie this phenomenon (Calvin, Jr. 1991).   
 
Does this phenomenon occur in ventricles with lesser contractile reserve such as the RV or those depressed by 
anesthetic agents?  Homeometric autoregulation has been shown to exist in the right ventricle of newborn lambs.  
This was demonstrated by an increase in Ees during infant respiratory distress syndrome (Lopes, Steendijk et al. 
2000).  However, the neonatal RV is a much thicker walled chamber than that of its adult equivalent and may 
possess greater contractile reserve, hence explaining the aforementioned observation.  Calvin has however also 
reported the existence of homeometric autoregulation in the RV facing pulmonary glass bead embolism (Calvin, Jr. 
1991).  He could however not distinguish this phenomenon from metabolic effects secondary to the vascular damage 
caused by embolism (Calvin, Jr. 1991).  In the current study, load independent indices of contractility such as Ees or 
PRSW were not measured; however, indirect indices of RV contractility (such as RV ejection fraction and RVSWI) 
and stroke work did not change as PA pressure and elastance increased on initiation of OLA.  Thus, there is no 
evidence of homeometric autoregulation in this study.  The reasons may be that: 
¾ Increased coronary blood flow is a prerequisite for the Anrep effect.  In the current study, this did not 
increase because RV perfusion pressure did not increase during OLA (Calvin, Jr. 1991),  
¾ The moderate increases in PA pressures seen in this study are of insufficient consequence to the RV to 
induce such a phenomenon,  
¾ The indices representing contractility in the current study were not sensitive enough to detect this 
phenomenon,  
¾ Homeometric autoregulation is impaired or even abolished by anesthesia (Coetzee, Fourie et al. 1987a) or, 
¾ Neither ventricle actually exhibits homeometric autoregulation, and alternative explanations account for the 
phenomenon (Coetzee, Fourie et al. 1987a). 
 
Coetzee and colleagues (Coetzee, Fourie et al. 1987a) found no evidence of Anrep’s effect and questioned the 
existence of homeometric autoregulation under anesthesia.  They did however demonstrate that in response to a 
40% increase in MAP, under similar levels of anesthesia (0.7% inspired isoflurane) to those used in the current 
study, that heterometric autoregulation (also termed preload reserve or Frank Starling mechanism) preserved left 
ventricular stroke work of anesthetised dogs.  Calvin has also demonstrated that heterometric autoregulation is a 
relevant concept in the right ventricle of dogs subjected to an increase in afterload by pulmonary glass bead 
embolism (Calvin, Jr. 1991).  However, no such increases in RVEDVI were observed in the current study albeit mean 
PAP and PA Ea rose by 30%.  Under anesthetic conditions during which RV contractile function is well preserved, it 
may be difficult to determine the small changes in EDP and volume that are expected to occur consequent to 
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increases in afterload that do not exceed 200% of baseline (Fourie, Coetzee et al. 1992b; Fourie 1989).  
Furthermore, the RVEF catheter has at least a 10 to 15% variation in measurement of RV volume (Conrad 2001).  
Should afterload have increased further (Calvin, Jr. 1991; Sarnoff and Berglund 1954) or RV contractility be further 
depressed, it is most likely that the RV would have been forced to utilise its preload reserve in an attempt to generate 
stroke work (Coetzee, Fourie et al. 1987a).   
 
Another important factor to take into account when considering the well-preserved ventricular function is that the 
subjects enrolled in the present study formed part of a select group of patients.  Normal adult mean PAP, measured 
in the supine position, at rest, and while breathing air at sea level, has been described as being 14.3 ± 3 mm Hg 
(Marshall and Marshall 1997).  From this observation, a mean PAP of more than 25 mm Hg will occur in less than 1% 
of the population.  Marshall and Marshall therefore consider the definition of pulmonary hypertension to be a mean 
PAP of greater than or equal to 25 mm Hg (Marshall and Marshall 1997).  Only one of 52 subjects in whom baseline 
PA pressure was measured in this study had a mean PAP pressure exceeding 25 mm Hg.  The patient with the 
highest resting mean PAP (30 mm Hg) also had the lowest VO2max (11.1 ml.kg-1.min-1) of any patient in the current 
study.  A limited pulmonary vascular reserve would be unmasked by a limited ability of the RV to increase cardiac 
output in the face of severe rises in PA pressure on exercise (Okada, Ishii et al. 1996; Basson 1996; Sue and 
Wasserman 1991).  This would be unmasked during preoperative exercise testing (Okada, Ishii et al. 1996).  
However, not all patients underwent preoperative exercise testing.  If mean PAP is considered to be the product of 
PVR and cardiac output, a low cardiac output at rest may indicate a very limited pulmonary vascular reserve but still 
have resting pulmonary artery pressures that are high but do not qualify to be designated as “pulmonary 
hypertension” (Marshall and Marshall 1997; Okada, Ishii et al. 1996).  Low resting cardiac outputs were not however 
observed during the awake step in the current study.   
 
Preoperative exercise capacity was severely limited in 19% of the patients.  In other words, 7 out of 36 patients in 
whom preoperative exercise capacity was measured had a VO2max of less than 15 ml.kg-1.min-1.  However, no 
relationship could be demonstrated between mean PAP measured before induction of anesthesia and preoperative 
exercise capacity as measured by VO2max in this study (Table 3.5.10).  An important factor pointed out by Marshall 
and Marshall is that in the presence of a diminished pulmonary vascular reserve, significant increases of PA pressure 
occur on exercise.  The increases in PA pressure will lead to RV hypertrophy (RVH) (Stoltzfus 1997; Marshall and 
Marshall 1997; Okada, Ishii et al. 1996).  Moderate amounts of RVH are difficult to diagnose without extensive 
cardiac investigations (Wiedemann and Matthay 1997) but the increase in stroke work induced by mild RVH would 
have facilitated coupling between the RV and its load intraoperatively (Marshall and Marshall 1997). 
 
It is also noteworthy that the 3 subjects in the control group with a VO2max of between 11 to 15 ml.kg-1.min-1 did not 
exhibit signs of RV dysfunction or failure during OLA.  This implies that although VO2max is in this low range, it 
should probably not be considered a contra-indication for patients to be subjected to OLA when a balanced 
anesthetic technique as used in the current study is employed and surgical resection (when done) is carefully 
considered with reference to prediction of how much pulmonary function will remain (Coetzee 2000; Basson 1996; 
Bolliger, Wyser et al. 1995; Bolliger, Jordan et al. 1995). 
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In summary with respect to RV performance during OLA (continued from previous summary on page 268) 
1. The anesthetic technique used in the present study had a minimal effect on RV function immediately after 
induction of anesthesia.  Nonetheless, LVSWI decreased during this step.     
2. Sympathetic nervous system stimulation during surgical stimulation was not completely obtunded by the 
anesthetic technique employed in this study.  As suggested by Cohen, the catecholamine release aids 
maintenance of the circulation during OLA (Cohen, Eisenkraft et al. 1988).  The differential effect of the 
inhalation anesthetic agents on the ventricles, and the RV in particular, has threatened the integrity of the 
circulation in certain studies (Heerdt, Gandhi et al. 1998; Coetzee 1993).  The use of a single anesthetic 
agent at high partial pressures or plasma concentrations may not provide optimal conditions for either the 
circulation or arterial oxygenation during OLA (Abe, Mashimo et al. 1998; Fourie, Coetzee et al. 1992b; 
Piene 1987; Piene and Sund 1982; Piene and Sund 1979) 
3. Well-preserved LV function may be crucial for the transmission of blood via the pulmonary vasculature. 
4. Above a preoperative VO2max of 11 ml.kg-1.min-1, RV performance is well preserved during OLA. 
4.4 Control group: oxygenation during OLA 
4.4.1 Overview 
One of the major concerns of anesthesiologists during OLA has been to maintain adequate arterial oxygenation 
(Table 4.4.1) (Slinger and Scott 1995; Barker, Clarke et al. 1993; Benumof 1991).  This concern is seen by the cost 
of oxygenating patients (as judged by the alveolar-arterial oxygen tension difference, PaO2/FiO2 ratio, and the shunt 
fraction) in the current study increased during OLA compared to both the awake and two-lung anesthesia steps.  The 
shunt fraction doubled to 36% during OLA compared with awake values.  This increase in shunt fraction was 
accompanied by a 40% decrease in the PaO2/ FiO2 ratio and a 7 to 8 fold increase in the alveolar-arterial oxygen 
difference in the OLA step compared to the baseline awake step.  The shunt fractions and indices of arterial 
oxygenation observed during OLA in the current study are comparable to those seen in other studies (Pagel, Fu et al. 
1998; Cohen, Eisenkraft et al. 1988; Domino, Borowec et al. 1986; Katz, Laverne et al. 1982; Capan, Turndorf et al. 
1980; Jarmakani, Nakazawa et al. 1976).  The shunt equation calculates an “as if” shunt.  In other words, the shunt 
equation calculates the shunt assuming that (“as if”) the depression of arterial PaO2 is entirely due to the addition of 
mixed venous blood.  The shunt equation does not consider the decrease in PaO2 that results from the presence of 
low V/Q units (West 1985).  However breathing 100% oxygen, as was used in this study, eliminates the contribution 
of low ventilation perfusion units to measurement of shunt because any V/Q unit that is not zero will fully saturate 
with oxygen (Moon and Camporesi 2000).  Therefore, estimation of shunt fraction during the use of 100% oxygen 
accurately measures the actual degree of shunt present (Moon and Camporesi 2000; West 1985).   
 
In the current study, in spite of the increase in shunt and cost of oxygenation, both arterial oxygen tension and 
saturation increased during OLA compared to when the patients were awake.  This belies the fact that oxygenation 
is a problem during OLA as is usually reported (Slinger and Scott 1995; Barker, Clarke et al. 1993; Benumof 1991; 
Capan, Turndorf et al. 1990).  This also underscores the power of the manoeuvres detailed below which were 
employed in this study to address oxygenation during OLA. 
 
Chapter 4.  Discussion
 
285 
The incidence of hypoxia during one lung anesthesia 
Authors 
Incidence of 
hypoxia  % 
*  PaO2 < 10.6 kPa 
**  PaO2 < 13.3 kPa 
Tarhan and Lundborg, 1970 35 * 
Kerr, Smith et al, 1974 25 * 
Das, Fenstermacher et al, 1970 40 ** 
Aalto, Heinonen et al, 1975 27 * 
Flacke, Thompson et al, 1976 15 * 
Capan, Turndorf et al, 1980 27 * 
Katz, Laverne et al, 1982 30 * 
Rees and Wansbrough, 1982 50 ** 
Table 4.4.1 Adapted from (Capan, Turndorf et al. 1990). 
 
When discussing arterial oxygenation it is important to consider the following factors (Coetzee 1987): 
1. Inspired oxygen concentration, 
2. Alveolar ventilation.  (1 and 2, and the prevailing barometric pressure of the atmosphere, determine the 
alveolar partial pressure of oxygen of ventilated alveoli), 
3. Venous admixture, 
4. Shunt fraction and, 
5. The mixed venous oxygen tension in the light of the prevailing shunt fraction. 
 
It would be useful to write the discussion regarding oxygenation in a circular fashion, as the various factors are 
interdependent on one another.  A particular focus of the current study was to investigate the influence of right 
ventricular function on systemic oxygen delivery and consumption:  Mixed venous oxygenation reflects the balance of 
systemic oxygen supply to oxygen demand (Marino 2003; Mark, Slaughter et al. 2000).  In turn, P O2 will 
significantly influence arterial oxygenation in the presence of a large shunt (Amsel, Rodrigus et al. 1995; West 1985).  
Recent review articles on thoracic anesthesia have failed to consider the influence of mixed venous oxygen tension 
on arterial oxygenation during OLA (Benumof and Alfery 2000; Cohen 1995; Cohen 1995; Benumof 1991; Siegel and 
Brodsky 1991).  Nonetheless, Benumof (Benumof 1986) and Capan and colleagues did address the issue in 1990 
(Capan, Turndorf et al. 1990).   
4.4.2 Control group: mixed venous oxygenation 
Mixed venous saturation recorded when the subjects were awake was 74.9 ± 5.5%.  These values fall within a range 
of values (68 to 77%) that are regarded as being normal for humans (Marino 2003).  However, a clinically significant 
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rise in mixed venous oxygen tension and saturation was observed during both two and one lung anesthesia.  This 
differs significantly from that observed in other studies (Zaune, Knarr et al. 1990; Thys, Cohen et al. 1988).  This rise 
was so significant that it frequently approached levels that are considered respectable arterial oxygen tensions 
(average P O2 8.4 ± 1.8 kPa and S O2 87.2 ± 4.6 %) during all OLA steps.  In fact, during OLA in the control group, 
37% of measurements of venous saturation were greater than or equal to 90% and 46% of venous oxygen tensions 
exceeded 8 kPa.  These rises mean that the relationship between P O2 and S O2 was now functioning on the flat 
part of the oxygen dissociation curve (ODC).  The respiratory acidosis present during OLA would have increased the 
P50 and had the effect of shifting the oxygen dissociation curve to the right (figure 4.8.1).  This rightward shift of the 
ODC during OLA would have increased the possibility that the relationship between venous oxygen tension and 
saturation was operating on the flat part of the oxygen dissociation curve (West 1985).   
 
The Fick equation (Equation 4.4.1) can be re-arranged (Equations 4.4.2 and 4.4.3) to elucidate how venous oxygen 
content and saturation are influenced by cardiac output, oxygen consumption and arterial oxygen content (Marino 
2003; Mark, Slaughter et al. 2000).   
VO2 = CO (CaO2 – C O2)       ………………………… Equation 4.4.1  
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Figure 4.4.2.1  The theoretical relationships between cardiac output on mixed venous and arterial oxygenation in the 
presence of various shunt fractions.    Redrawn from Kellman, Nunn et al, 1967. 
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C O2 = CaO2 – VO2/CO  ………………………… Equation 4.4.2 
S O2 = SaO2 – (VO2/(CO x 1.36 x [Hb]))………………………… Equation 4.4.3 
 
In the control group, arterial oxygen tension rose from an average of 11.2 ± 1.9 kPa while the patients were awake to 
58.9 ± 8.8 kPa on initiation of anesthesia.  PaO2 varied between 32.5 ± 10.3 and 38.4 ± 17.3 kPa during OLA.  
However, because of the “flat” relationship between arterial oxygen saturation and tension at the high values at which 
these patients were functioning, the statistically significant rise in oxygen saturation between the awake and OLA 
steps had minimal clinical implications.  Furthermore, the effect of this moderate rise in arterial saturation was offset 
by a decrease in hematocrit due to fluid administration.  This is reflected by an 18% decrease in arterial oxygen 
content (CaO2) measured after induction of anesthesia.  CaO2 remained at these levels throughout OLA except for 
the last step in the control group.  Therefore, the reason for the increase in venous oxygenation was not an increase 
in CaO2.  Therefore, the mechanisms for the increase in C O2 should be sought by considering oxygen consumption 
and cardiac output. 
 
Cardiac output, normalized for body surface area, increased 35% on initiation of OLA.  This was due to an increase 
in heart rate and not an increase in stroke volume.  As discussed above, a temporal relationship existed between the 
increase in cardiac output and the surgical stimulation; the increase in cardiac output is most likely attributed to 
sympathetic nervous system activity secondary to surgical stimulation.  The product of oxygen content and cardiac 
output determines tissue oxygen delivery.  The net result of the increase in cardiac output and the small decrease in 
CaO2 was a DO2 during OLA that did not differ from baseline values.  Therefore, the increases in P O2 and S O2 
cannot be explained by an increase in cardiac output that resulted in a greater delivery of oxygen to the tissues.  
 
The only remaining possibility for the increased C O2 during OLA is that the oxygen consumption decreased 
during anesthesia.  Compared with the awake state, oxygen consumption decreased by 45% during two-lung 
anesthesia and by up to 38% during OLA compared with awake controls.  The oxygen extraction ratio (OER) and the 
arterial-venous oxygen content difference also decreased by approximately 40% after induction of anesthesia and 
during OLA.  In other words, the decrease in oxygen consumption during anesthesia combined with an unchanged 
oxygen delivery was reflected by a significant decrease in the proportion of the delivered oxygen being extracted by 
the tissues.     
 
Oxygen consumption in humans under nitrous oxide and fentanyl anesthesia has been reported to be 109 ± 16 
ml.min-1.m-2 (Shibutani, Komatsu et al. 1983) and 110 to 130 ml.min-1.m-2 (Noe, Whitty et al. 1980).  Albeit anesthesia 
techniques were not the same in these and the current study, these values for oxygen consumption appear to be 
greater than the 78 ± 13 to 98 ± 26 ml.min-1.m-2 observed in the current study.  Carli and co-workers also 
demonstrated a 20% decrease in VO2 at one MAC of both halothane and isoflurane in non-surgically stimulated 
patients (Carli, Ronzoni et al. 1993).  Theye and Michenfelder previously demonstrated in dogs that inhalation 
anesthetic agents (halothane, isoflurane and enflurane) produce dose dependent decreases in whole body oxygen 
consumption (Theye and Michenfelder 1975).  The decrease in oxygen consumption was maximal when the highest 
partial pressures of the inhalation anesthetic agent were administered, i.e. 29% decrease at 2,2 MAC enflurane, 27% 
at 2 MAC halothane and 22% at 2.3% isoflurane.  Scheeren and colleagues studied sevoflurane and desflurane, in 
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addition to all the inhalation anesthetic agents investigated in the aforementioned studies (Scheeren, Schwarte et al. 
1999).  They observed similar 30% decreases in VO2 at 2 MAC of all the inhalation anesthetic agents examined.  
 
Theye and Michenfelder also demonstrated that inhalation anesthetic agents do not cause significant depression of 
sphlancnic, skeletal and renal oxygen consumption.  The decrease in oxygen consumption that they observed was 
primarily due to a decrease in myocardial oxygen consumption because of a decrease in cardiac stroke work (lower 
MAP and cardiac output) (Theye and Michenfelder 1975).  Michenfelder and Theye concurred with Mikat and co-
workers (Mikat, Peters et al. 1984) that “the inhalation anesthetic agents are not generalized metabolic depressants” 
(Theye and Michenfelder 1975; Theye and Michenfelder 1975; Theye and Sessler 1967).   
 
It is noteworthy that in the current study, oxygen consumption was decreased by up to 55% more than in other 
studies (Scheeren, Schwarte et al. 1999; Carli, Ronzoni et al. 1993; Mikat, Peters et al. 1984; Noe, Whitty et al. 1980; 
Theye and Michenfelder 1975).  Nonetheless, the dose of inhalation anesthetic agent was less in the current study 
than in the aforementioned studies.  The question may be posed as to whether other balanced anesthetic techniques 
comprising a combination of high dosages of opioid and relatively low dose inhalation anesthetic agent (as was used 
in our study), decrease oxygen consumption to a greater degree than that of an inhalation anesthetic agent 
administered as a lone drug?  The answer to this question has not been widely studied.  However, in a yet 
unpublished study entitled “Sevoflurane compared with halothane to supplement computer controlled sufentanil 
infusions during anesthesia for coronary artery bypass surgery,” (Levin, Coetzer et al. 2002) significant decreases in 
oxygen consumption were found.  This study provided anesthesia utilising a computer-controlled infusion of 
sufentanil at 2 ng.ml-1 in addition to 0.35 MAC of either halothane or sevoflurane.  This decrease in oxygen 
consumption occurred in spite of the differences between the current and the unpublished study.  In the 
aforementioned study, both lungs were ventilated, and furthermore, the circulation was threatened by patient 
pathology (severe coronary artery disease), drug usage (beta adrenoreceptor blocking agents and/or phenylephrine).  
However, the relevant issue is that oxygen consumption decreased significantly in both these studies.  The common 
thread was the use of balanced anesthesia that employed relatively high levels of opioid at constant blood 
concentration in combination with small dosages of inhalation anesthetic agent at concentrations that just exceeded 
MAC aware.  Furthermore, in both studies, administration of anesthesia resulted in an improved efficacy of the 
circulation as judged by an increase in P O2.  The following hypotheses can therefore be generated.  Firstly, that 
balanced anesthesia provides a greater margin of safety to patients in whom systemic and arterial oxygenation is 
threatened.  Secondly, that many combinations of high dose opioid with low dose inhalation anesthetic agent provide 
similar benefits.  Which combination and concentrations of these agents would provide the best safety margin in 
terms of the reduction of VO2, is unknown at present.  One concern is that prolonged infusions of opioid may result in 
a long context sensitive decrement time resulting in delayed recovery.  Prolonged postoperative ventilation may be 
inappropriate after thoracic surgery.  One solution to this problem is to utilise remifentanil in combination with one of 
the more insoluble inhalation anesthetic agents.  The context sensitive half-life of remifentanil does not increase with 
time (Bailey, Egan et al. 2000).  The hypothesis put forward is that remifentanil in combination with one of the more 
insoluble inhalation anesthetic agents will demonstrate similar beneficial reductions in oxygen consumption as other 
opioid-inhalation anesthetic agent combinations, without prolonging wakeup time.  
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Figure 4.4.2.2.  The top diagram illustrates that the greater the venous oxygen saturation, the lesser the effect that this 
will have on arterial saturation at a particular shunt fraction, and vice versa.  The above set of isosaturation lines are plotted 
assuming a constant cardiac output, hemoglobin concentration of 11g%, FiO2 of 1.0, and PaCO2 6.0 kPa.  These values are 
representative of the mean control group data during OLA in the current study.  For each isosaturation line plot, the CaO2 was 
calculated using equation 4.4.2.6 over a range of shunt fractions form 0 to 100% using Microsoft Excel®.   The above set of 
relationships was then constructed using Sigmaplot® version 5, SPSS, USA.  The concept used to construct these 
relationships was originally published by Coetzee in The Southern African Journal of Critical Care, 1987.  The bottom diagram 
includes only values illustrative of the values observed during OLA in the control group.   It appears as if the values for arterial 
oxygen content correspond with the values actually obtained in the study patients (Table 3.3.1.6) 
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The influence of oxygen delivery and P O2 on arterial oxygenation in the presence of the significant shunt that 
occurs during OLA has been studied by Mathru et al. (Mathru, Dries et al. 1990), and Kelman and colleagues 
(Kelman, Nunn et al. 1967) 
 
Kelman and colleagues theoretically “explored the quantitative relationship between cardiac output and arterial PO2 
because … the admixture of venous blood with a lower oxygen content must inevitably lower the oxygen content of 
… arterial blood” (Kelman, Nunn et al. 1967).  For this purpose, they utilised a modified version of the Fick equation.  
Their formula was derived in the following way. 
 
If the Fick equation, is solved for C O2, then 
C O2 = CaO2  - VO2/Qt   ………………………… Equation 4.4.2.1 
 
If Equation 4.4.2.1 is inserted the following equation#  
VO2 = (Qt – Qs) x (CcO2 – C O2)  ………………………… Equation 4.4.2.2 
 
Then  
VO2 = (Qt – Qs) x (CcO2 – CaO2 + VO2 /Qt) ………………………… Equation 4.4.2.3 
 
This can be rearranged as: 
   VO2 (Qs/Qt)  ………………………… Equation 4.4.2.4∇ 
        10[1- (Qs/Qt)] Qt 
 
 
To construct the graphs in figure 4.4.2.1, Kelman and colleagues assumed that VO2 was 200 ml.min-1, and remained 
                                                                
# The origin of equation 4.4.2.2 can be deduced as follows: 
CaO2.Qt  = CcO2 (Qt – Qs) + C O2.Qs  ……………………. Equation a  (West, Pulmonary physiology, 
Chapter5, page 53, 1985) 
Expanding equation a: 
CaO2.Qt  = CcO2.Qt - CcO2.Qs + C O2.Qs  ……………….. Equation b 
The Fick equation (West, 1985): 
VO2 = Qt (CaO2 - C O2) …………………………… Equation c  
Solving equation c for CaO2.Qt:   
CaO2.Qt  = VO2 + Qt. C O2 …………………………… Equation d 
Substituting equation d into equation a 
VO2 + Qt. C O2 = CcO2 (Qt – Qs) + C O2.Qs  …………….. Equation e 
Simplifying equation e results in equation 4.4.2.2 
VO2 = (Qt – Qs) x (CcO2 – C O2)  
 
     
∇ Note that the occurrence of the number “10” in Equation 4.4.2.4 is because oxygen content is normally expressed in units of ml 
per 100 ml of blood, whereas cardiac index is expressed in units of liters per minute.  
CaO2 = CcO2  - 
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constant as cardiac output changed.  Hemoglobin concentration was assumed to be 15 g.100ml-1 of blood.   Their 
results are reproduced graphically in figure 4.4.2.1.  They concluded that moderate decreases in cardiac output, 
when combined with an increased shunt, resulted in striking decreases in venous oxygen tension with resultant 
decreases in arterial oxygen tension.  Both of these effects will occur more rapidly when hemoglobin concentration 
declines to 10 g.100ml-1 because of a concomitant decrease in the oxygen content of blood.  The differences 
between their theoretical study and the current one are that: 
 
¾ Oxygen consumption in our anesthetised patients was lower than that assumed in their study, 
¾ They did not consider shunt fractions of the magnitude seen during OLA and, 
¾ Hemoglobin concentrations were approximately 11 g.100ml-1 in the present study. 
 
To make their concepts more applicable to the current study, values representative of the control group during OLA 
were entered into a spreadsheet (Microsoft Excel®) and were modelled using Kelman and colleagues’ formula 
(Equation 4.4.2.4).  These graphs are reproduced in Figure 4.4.2.3.  Data used to construct this graph reflected 
average results obtained in the control group of this study during OLA i.e. shunt 36.5%, oxygen consumption 95 
ml.min-1.m-2, hematocrit 33.5% and CcO2 17.5 ml.100ml-1.  A family of curves were obtained for various rates of 
oxygen consumption, representative of when the patients were awake, during two-lung anesthesia and at the 
extremes of what were seen during OLA.  For illustrative purposes, CaO2 is plotted against a wider range of cardiac 
indices than the 3.6 to 4.4 l.min-1.m-2 ranges that was observed during OLA in the current study.  The resultant 
relationships accurately agree with the arterial oxygen contents seen at the values of VO2, cardiac indices, 
hematocrit and shunt fractions at which these patients were operating during OLA.  It is apparent that the relationship 
between oxygen content and cardiac output is “flat” at the levels of oxygen consumed and at the levels of cardiac 
output that these patients were generating.  Below the cardiac outputs seen in the current study and particularly 
when less than 3 l.min-1.m-2, arterial oxygen content and therefore oxygen saturation will decrease much more 
rapidly.  The decrease in CaO2 will be aggravated when VO2 is increased.  On the other hand, decreases in VO2 shift 
this curve upward and to the left and provide a large safety net in terms of arterial oxygenation.  Increasing 
hemoglobin concentrations has an even greater influence on shifting the relationship between cardiac output and 
CaO2 to a more favourable position (see Figures 4.4.2.1 and 4.4.2.3). It can therefore be concluded that the 
decrease in oxygen consumption, that resulted in very high venous oxygen tensions and saturations, significantly 
improved arterial oxygenation in spite of the large 36% shunt observed during OLA.  This is a seldom-reported 
consequence of adequate levels of balanced anesthesia and a decrease in VO2 during OLA.   Coetzee has published 
an approach to aid the understanding how mixed venous oxygenation influences arterial oxygenation in the presence 
of a shunt (Coetzee 1987).  In this approach, (Figure 4.4.2.2), shunt and arterial oxygen content are linked by lines of 
equal venous saturations (venous isosaturation lines).  For each isosaturation line plot, CaO2 is calculated using 
equation 4.4.2.6 and plotted over a range of shunt fractions.  The relationship elegantly demonstrates the influence of 
different levels of venous oxygen saturation on arterial oxygen content as shunt fraction increases.  The relationship 
is derived using the following mathematical equations (West, Pulmonary physiology, Chapter 5, page 53, 1985):  
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Figure 4.4.2.3 Influence of CO in arterial oxygenation for various levels of oxygen 
consumption during OLA using data gathered in the control group of the study. Hb = 11g.100 ml-
1; pulmonary shunt = 36.5%; CcO2 17.5 ml.100 ml-1.  The effect of an Hb of 15 g.100ml-1 at an 
oxygen consumption of 96 ml.min-1 is included for comparison.  The patients in Mathru, Dries and 
colleagues 1990 study are also included for comparison.  
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CaO2.Qt  = CcO2 (Qt – Qs) + C O2.Qs ………………………… Equation 4.4.2.5 
Where   
CaO2.Qt   = amount of oxygen delivered to the tissues per minute,   
CcO2 (Qt – Qs)  = amount of oxygen emanating from the ventilated alveoli per minute and,   
C O2.Qs   = amount of oxygen passing via the shunt per minute. 
 
Equation 4.4.2.5 may be described in the following conceptual way.  The amount of arterial oxygen delivered to the 
tissues each minute is the sum of the quantities of oxygen contributed to the arterial circulation per minute firstly, by 
deoxygenated blood coursing via the shunt and secondly, by the blood that flowed past ventilated alveoli (assumed 
to be perfectly oxygenated).  The amount of deoxygenated blood that flows via the shunt per minute is determined by 
the product of the volume of blood flowing via the shunt every minute (Qs) and the mixed venous oxygen content 
(C O2) of that blood.  It is important to note that both Qs and C O2 determine the “size of a shunt” in terms of its 
effect on arterial oxygenation.  Furthermore, the venous oxygen content is largely determined by the hemoglobin 
concentration and the venous oxygen saturation.  The size of the shunt (Qs) itself may be influenced by the cardiac 
output.  Therefore, at a particular hemoglobin concentration and cardiac output, a lesser amount of deoxygenated 
blood flows via a shunt (Qs) of a particular magnitude if the venous oxygen saturation increases.  The implication of 
this is that higher venous oxygen saturation limits the “size of the shunt” in terms of its effect on depression of arterial 
oxygenation for a particular Qs/Qt ratio. Figure 4.2.2.2 was constructed using Equation 4.4.2.6 (a modification of 
Equation 4.4.2.5) and represents a graphic illustration of this concept.   
 
If Equation 4.4.2.5 is expanded, it results in the following expression: 
CaO2.Qt  = CcO2.Qt - CcO2.Qs + C O2.Qs   
 
The relationship between CaO2 and shunt in figure 4.4.2.2 is obtained using equation 4.4.2.5 solved for CaO2: 
CaO2 = CcO2 - Qs/Qt(CcO2 - C O2) ………………. Equation 4.4.2.6 
 
The implications of Equation 4.4.2.6 (as illustrated in Figure 4.4.2.2.) are 
1. The equation describes a straight line of slope (CcO2 - C O2) and intercept CcO2,   
2. At a constant hemoglobin concentration, FiO2 and alveolar ventilation, CcO2 will be constant, and therefore 
the intercept on the CaO2 axis will be constant.   
3. As there is a linear relationship between C O2 and S O2 at a constant hemoglobin concentration, it is 
valid to label the lines in the figure using S O2.   
4. It also follows that, if CcO2 and hemoglobin are constant, the slope of the line relating CaO2 and shunt 
fraction depends entirely on the venous oxygen saturation.  The lower the venous saturation, the greater 
the difference between CcO2 and C O2 and therefore the greater the negative slope of the line relating 
CaO2 and shunt fraction.   
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The effect that the anesthetic technique has 
on the mixed venous oxygen tension is not 
often considered when investigating the 
effects of anesthesia during OLA (Pagel, Fu et 
al. 1998; Abe, Mashimo et al. 1998; Shimizu, 
Abe et al. 1997; Chen, Lee et al. 1996; Slinger 
and Scott 1995; Slinger and Scott 1995; 
Benumof, Augustine et al. 1987; Rogers and 
Benumof 1985; Bjertnaes, Mundal et al. 
1980).  Many studies have compared the 
effects of two inhalation anesthetic agents on 
HPV and arterial oxygenation during OLA.  In 
order to do this they generally used relatively 
high partial pressures of a single anesthetic 
agent.  However, these high partial pressures 
of inhalation anesthetic agent depress cardiac 
function without necessarily producing the 
same degree of decrease in oxygen 
consumption when using the balanced 
anesthesia technique employed in this study 
(Bailey, Egan et al. 2000).  It is therefore not surprising that most studies report a decrease in P O2 during OLA that 
aggravates arterial hypoxemia in the presence of a large shunt.  Furthermore, many studies focus attention on the 
inhibition of HPV by the inhalation anesthetic agent as being the major cause of worsening arterial hypoxemia during 
OLA (Abe, Shimizu et al. 1998; Pagel, Fu et al. 1998; Abe, Mashimo et al. 1998; Slinger and Scott 1995). 
 
A decrease in temperature of approximately 1O Celsius was recorded in the epoch immediately after induction of 
anesthesia.  This initial 1O Celsius decrease in temperature is attributable to redistribution of heat between the 
periphery and the core (Sessler 2000; Kurz, Kurz et al. 1993; Parbrook, Davis et al. 1985).  Whereas this 
redistribution cannot be prevented, further losses were counteracted by using a forced air warmer positioned over the 
lower half of the body to create an artificial microenvironment around the patient.  Convection and radiation of heat to 
the environment account for a further 70% of the decreases in temperature (Parbrook, Davis et al. 1985).  This 
decrease in temperature is relevant to this discussion because decreases in temperature result in a 7 to 8% 
decrease in VO2 per degree Celsius (Schubert 1992).  If delivery of oxygen is unchanged, this will contribute to 
increases in P O2 and therefore improve arterial oxygenation (Bacher, Illievich et al. 1997).   
  
 
Bacher and colleagues’ studied the influence of progressive hypothermia on VO2 during anesthesia (Bacher, Illievich 
et al. 1997).  They anesthetised their patients by administering a propofol infusion of 6 mg.kg-1.hr-1 and 5 ug.kg-1 of 
fentanyl every 30 minutes. During anesthesia and surgery, at 35.5 OC, VO2 was 100 ± 13 ml.min-1.m-2.  This level of 
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Figure 4.4.4.4 The sigmoid relationship between PsO2 and 
HPV.  Redrawn from Domino: Anesthetic modulation of vascular 
tone. Chapter 76 in Anesthesia: Biologic Foundations.  Editors: 
Yakash et al, Lippincott – Raven publishers, Philadelphia, New York, 
USA, 1997. 
Chapter 4.  Discussion
 
295 
VO2 does not appear to be different to measurements made during OLA during the present investigation.  At 32 OC, 
VO2 was 77 ± 11 ml.min-1.m-2.  Again this does not appear different from values observed in the anesthetised and 
non-surgically stimulated patients in the current study.  However, the aim of decreasing temperature is to decrease 
VO2; this would increase P O2 and benefit PaO2 during OLA.  In the Bacher study, albeit P O2 rose from 4.9 ± 0.3 
kPa at 35.5 OC to 5.6 ± 0.9 kPa at 32 OC, it is surprising that these P O2 values are lower than those seen in the 
current study.  The difference between the studies is not that hemoglobin concentrations differed from those in the 
current study.  Neither does the difference rest therein that Bacher’s patients were shivering (which would increase 
oxygen consumption) as vecuronium was repeatedly administered during hypothermia.  The answer is that oxygen 
delivery at approximately 350 ml.min-1.m-2 at 2.4 l. min-1.m-2 is almost half of that in the current study.  Thus, the 
comparison of the studies of Bacher and colleagues’ and the present one emphasizes that if the benefits of a 
decrease in VO2, associated with a decrease in temperature, are to be realized with a beneficial improvement in 
P O2, then DO2 has to be optimised.  The clinical implication of the aforementioned statement predominantly rests 
with the maintenance of a high-normal cardiac index and an adequate hemoglobin concentration.   
 
An important consideration is that the large increase in P O2 observed in the current study would inhibit HPV 
(Capan, Turndorf et al. 1990; Benumof 1985; Katz, Laverne et al. 1982).  The amount of HPV present at any time is 
governed by the partial pressure of oxygen (PsO2) at the so-called “sensor site.”  The PsO2 is governed by diffusion 
of oxygen from both the alveoli and the mixed venous blood (Benumof, Pirlo et al. 1981).  The mathematical 
relationship for the oxygen tension at the sensor site (PsO2 = P O2 0.4 x PAO20.6) was originally determined by 
Marshall and Marshall (Marshall and Marshall 1997; Marshall and Marshall 1988).  This relationship implies that the 
alveolar oxygen tension plays a more important role in determining PsO2 than P O2.  However, the rise in P O2 
seen in this study will also have a significant influence on HPV.   
 
Domino and colleagues used a dog model to study the influence of P O2 on HPV in the collapsed left lung of dogs.  
The dose response curve indicated that at a P O2 of 2.6 to 4 kPa, 50% of blood flow was diverted away from the 
atelectatic lung and HPV was abolished at a P O2 of more than 13.3 kPa (Domino, Wetstein et al. 1983).  Thus, the 
raised mixed venous oxygen tension of 8.5 kPa during OLA would have resulted in significant inhibition of HPV in the 
NDL in the patients included in the current study. 
 
The above influence of P O2 on HPV during OLA has to be contrasted with the classic approach to the relationship 
between HPV and cardiac output as described in figure 1.7.1.11.  It essentially describes the mechanisms why 
inhalation anesthetic agents do not affect PaO2 during OLA.  It is assumed that both cardiac output and P O2 
decrease under anesthesia.  This assumed decrease in P O2 potentiates HPV and thereby counterbalances the 
inhibition of HPV by the inhalation agent.  The logic of this explanation is based on the assumption that anesthetic 
agents predominantly produce a depressant effect on the circulation.  These assumptions do not apply to the effects 
of the anesthetic technique used in the current study that resulted in increases in PAP, cardiac output and P O2.   
 
Chapter 4.  Discussion
 
296 
At least three other factors could have inhibited HPV during OLA in the current study.  Firstly, Benumof has 
demonstrated that hypothermia progressively 
inhibits HPV while increases in temperature to 42 
oC progressively potentiate HPV (Figure 4.4.4.5) 
(Benumof and Wahrenbrock 1977).  However, 
Benumof and Wahrenbrock did not separate the 
effects of temperature and P O2 on HPV.  Thus, 
the effects of temperature on HPV that were 
demonstrated by heating and cooling the dogs 
could possibly have been due to the effects of 
changes in oxygen consumption and the 
concomitant effects on P O2.  Therefore, in the 
current study, it is difficult to separate the effects of 
the 1O Celsius decrease in temperature on HPV 
from those of the increase in P O2.  However, as 
similar decreases in temperature occurred in all 
patients, this is not an issue in the current study.  Secondly, the end tidal isoflurane concentration of 0.5 kPa would 
have contributed to a further 6% inhibition of HPV (Domino 1997; Benumof 1986).  Thirdly, the increase in PA 
pressure would have had a deleterious effect on HPV in the NDL (Malmkvist, Fletcher et al. 1989; Benumof and 
Wahrenbrock 1975).  Therefore, for all the reasons discussed, it is doubtful whether, in this particular model, NDL 
HPV was of as much significance in determining oxygenation during OLA as is commonly suggested (Benumof 1986; 
Benumof 1985).   
 
In conclusion, the hypothesis that in the presence of the large shunt that occurs during OLA, the factors determining 
mixed venous oxygenation play an important role in determining arterial oxygenation, must be accepted (Amsel, 
Rodrigus et al. 1995; West 1985).  Cohen and co-workers succinctly stated that the current approach to arterial 
oxygenation during OLA has been concentrated on minimizing DL PVR while maximizing PVR in the NDL.  The aim 
of this approach is therefore to minimize NDL shunt (Cohen 1995; Cohen, Eisenkraft et al. 1988).  The current 
approach to prevention of arterial hypoxemia during OLA includes using intravenous rather than inhalation 
anesthetics to minimize deleterious effects on NDL HPV, using pulmonary vasoconstrictors (almitrine, phenylephrine, 
prostaglandin F2α) to maximize NDL HPV and DL pulmonary vasodilators (nitric oxide) (Doering, Hanson et al. 1997; 
Capan, Turndorf et al. 1990).  That the decrease in oxygen consumption induced predominantly by balanced 
anesthesia, but also by moderate hypothermia, aids arterial oxygenation during OLA, is a concept that is neglected in 
the literature and textbooks (Cohen 1995; Benumof 1991).  The maintenance of the adequacy of delivery of oxygen 
must also be emphasized.  The emphasis to date on minimizing the deleterious effects of inhalation anesthetic 
agents on HPV may well change in the light of the findings of the current study.  Certain considerations now arise: 
1. From Kelman and co-workers’ data, it is apparent is that a cardiac output greater than 3 litres.min-1.m-2 
increase P O2, thereby improving arterial oxygenation (Kelman, Nunn et al. 1967).  Will even greater 
increases in oxygen delivery with further rises in mixed venous oxygen tension progressively improve 
arterial oxygen tension during OLA?  This issue will be addressed by the administration of dobutamine as 
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Figure 4.4.4.5 The effect of temperature on HPV. 
Redrawn from Benumof and Wahrenbrock, 1978. 
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part of the current study. 
2. Would further decreases in oxygen consumption that occur during more profound hypothermia result in 
even greater rises in P O2 benefit and further oxygenation during OLA?   
3. What is the optimal and minimum oxygen carrying capacity (i.e. hemoglobin concentration) during OLA? 
4. Do other balanced anesthetic techniques have similar beneficial effects on venous oxygen tension? 
5. Will this balanced anesthesia technique benefit oxygenation during OLA in the supine position when gravity 
does not assist in minimizing shunt (Pinsky, Desmet et al. 1992)? 
6. Are these principles of maintaining high levels of P O2 of importance during other clinical situations when 
right to left shunts occur?  An example of an appropriate clinical situation would be a child with an 
intracardiac shunt due to congenital heart disease that is presented for corrective or palliative surgery. 
4.4.3 Control group: Relationship between oxygen consumption and delivery 
Once the patients were anesthetised, but before surgical stimulation occurred, both oxygen consumption and 
delivery decreased.  However, oxygen delivery was always greater than the critical level under anesthesia of 330 
ml.min-1.m-2 (Shibutani, Komatsu et al. 1983).  Partial restoration of oxygen consumption and complete restoration of 
oxygen delivery to values observed before induction of anesthesia occurred after surgical incision.  Furthermore, a 
significant relationship and linear correlation exists between DO2I and VO2I under anesthesia in the control group of 
the current study (Figure 3.5.6 and Table 3.5.2.).  The implication of this relationship is that the more oxygen that is 
delivered to the tissues, the greater the amount of oxygen used.  Does this constitute evidence that supply 
dependency existed in these patients under anesthesia?  Supply dependency has been described before during 
anesthesia (Rock, Beattie et al. 1990).  However, this dependency of oxygen consumption on oxygen demand during 
anesthesia is reported to be different in mechanism and much less in degree than the similar phenomenon that 
occurs during sepsis and systemic inflammatory response syndrome (Dantzker and Guiterrez 2002).   
 
Theye and Michenfelder demonstrated that a large percentage of the decrease in total body oxygen consumption 
seen during anesthesia is attributable to the decrease in myocardial oxygen consumption (Theye and Michenfelder 
1975; Theye and Sessler 1967).  Coetzee et al’s observations using various anesthetic agents that myocardial work 
decreases as depth of anesthesia is increased, is in agreement with Theye and Michenfelder’s study (Coetzee, 
Fourie et al. 1987).  Theye and Sessler similarly postulated that at least part of the supply dependency phenomenon 
represents changes in myocardial oxygen consumption that accompany anesthesia (Theye and Sessler 1967).  
Thus, it can be hypothesized that the decrease in total body VO2 seen in these patients is due to the decrease in LV 
stroke work induced by anesthesia.  This hypothesis cannot be directly tested in the current study, but the significant 
relationship that exists between LVSWI and whole body VO2 may be considered as support for it (Table 3.5.2).  
However, examination of the relationship between LVSWI and VO2 reveals only very weak relationships between the 
variables (Table 3.5.2).  It is likely that two factors confound the ability to discover the aforementioned relationship: 
 
1. Myocardial oxygen consumption is only a fraction of the total body VO2.  Thus, if myocardial oxygen 
consumption is not measured, it will be difficult to differentiate the increases directly attributed to 
myocardial oxygen consumption by studying whole body VO2.  This is indicated by the small 8% rise in VO2 
associated with increases in LVSWI, and, 
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2. Increases in sympathetic nervous system stimulation may increase peripheral oxygen consumption 
(Karzai, Lotte et al. 1996; Karzai, Gunnicker et al. 1996; Karzai, Gunnicker et al. 1994). 
 
The relationship observed between VO2 and LVSWI raises a question.  Will the increase in oxygen consumption that 
accompanies the increase in oxygen delivery deleteriously affect P O2 and therefore arterial oxygenation during 
OLA?  The answer is probably that because of the small (8%) increase in VO2 that accompanies the rise in oxygen 
delivery, P O2 will not be much depressed.  Furthermore, any increase in VO2 that accompanies an increase in 
LVSWI will start from a low baseline.  It is also likely that any increase in LVSWI and therefore oxygen consumption 
will be more than compensated for by a greater increase in cardiac output.  This will maintain the VO2/DO2 
relationship with minimal effect on venous and therefore arterial oxygenation. 
4.5 Ventilation during OLA 
4.5.1 Ventilation during OLA:  The maintenance of DL volume 
OLA in the LDP is reported to result in a decrease in DL volume.  This decrease in DL volume after induction of 
anesthesia exceeds that which occurs in the supine position when both lungs are being ventilated (Benumof and 
Figure 4.4.3.1 In previous work, Theye and Michenfelder showed that one of the main reasons 
for the decrease in systemic oxygen consumption under anesthesia is the decrease in LV work.  In this 
graph, they demonstrate that it is not the partial pressure of isoflurane per se that is related to the 
myocardial oxygen consumption. However, myocardial oxygen consumption is directly related to left 
ventricular work.  Redrawn from Theye and Michenfelder, 1975.
External work. LV. (kg. Min-1)
0 2 4 6 8
16
12
8
4
0
Y = 3.21 + 1.78 x
My
oc
ar
dia
l o
xy
ge
n c
on
su
mp
tio
n
ml
.m
in-
1 .1
00
g-1
End tidal isoflurane partial 
pressure (kPa)
< 0.3
1.4
2.6
My
oc
ar
dia
l o
xy
ge
n c
on
su
mp
tio
n
ml
.m
in-
1 .1
00
g-1
 
 
Chapter 4.  Discussion
 
299 
Alfery 2000; Cohen 1995; Siegel and Brodsky 1991; Klingstedt, Hedenstierna et al. 1990).  The implication is that low 
V/Q ratios will develop in the DL.  This decrease in lung volume will therefore contribute to arterial hypoxia during 
OLA (Hedenstierna 1998).  The mechanisms causing this reduction in lung volume are attributed not only to DL 
compression by mediastinal weight and abdominal contents, but also to the presence of pre-existing lung disease, 
and the use of high concentrations of oxygen intraoperatively (Benumof and Alfery 2000; Cohen 1995; Benumof 
1991; Siegel and Brodsky 1991; Capan, Turndorf et al. 1990).  Splinting of the chest wall also contributes to the 
41.9% lower static DL compliance described during OLA in the LDP (Szegedi, Bardoczky et al. 1997).   
 
To maintain DL volume during OLA, most textbooks encourage DL ventilation with tidal volumes of 10 to 15 ml.kg-1 
(Cohen 2001; Szegedi 2001; Cohen 1995; Benumof 1991).  In the current study however, tidal volumes of only 6 to 7 
ml.kg-1 were employed during OLA.  The reasons why the decision was made to employ smaller tidal volumes and 
disregard the basis of these aforementioned recommendations, during this study needs to be discussed.   
 
Research has been published indicating that the use of larger tidal volumes improves oxygenation during OLA (Katz, 
Laverne et al. 1982; Flacke, Thompson et al. 1976; Kerr, Smith et al. 1974; Khanam and Branthwaite 1973).  Katz 
and his colleagues demonstrated that ventilation of the DL with larger tidal volumes (7 vs. 16 ml.kg-1, i.e. 8 versus 
16% of lung volume) during OLA improved both lung compliance and PaO2 and was accompanied by beneficial 
decreases in shunt fraction from 39 ± 2 to 35 ± 2% (p < 0.01) (Katz, Laverne et al. 1982).  An earlier study by Kerr 
and colleagues demonstrated that maintaining the same tidal volume (10–15 ml.kg-1) during OLA as was used during 
two-lung anesthesia prevented the progressive 10% increase in shunt seen when lower (unspecified) tidal volumes 
were used (Kerr, Smith et al. 1974).  Both these papers suggested that the reason oxygenation was better when 
greater tidal volumes were employed during OLA, was because of recruitment of DL atelectatic areas.  A contrary 
view was however expressed by Khanam and Branthwaite who determined that smaller tidal volumes provided 
optimal arterial oxygenation and carbon dioxide 
tensions during OLA (Khanam and Branthwaite 
1973).  They first conducted a pilot study in which a 
smaller tidal volume of 7 ml.kg-1 at a rate of 20 
breaths per minute was found to be “optimal” during 
OLA as judged by a PaCO2 of 4.0 to 5.3 kPa 
(Khanam and Branthwaite 1973).  In their study, 
they showed that deviation from a tidal volume of 7 
ml.kg-1 to one of either 5 or 9 ml.kg-1, decreased 
arterial oxygenation (Khanam and Branthwaite 
1973).  However, both Cohen and Benumof’s 
textbooks and even an excellent article by Capan 
and associates, all quote an article by Flacke and 
colleagues as being the reason they recommend DL 
tidal volumes of 10 to 12 ml.kg-1 during OLA.  They 
both suggest that this is the midpoint between 
extremes of tidal volume not affecting arterial 
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Figure 4.5.1  The advantage of larger tidal volumes on 
lung mechanics and oxygenation during OLA is illustrated in this 
diagram reproduced from Katz, Laverne et al, 1982.  At the 
larger tidal volume, all values are more favorable  (p < 0.05, n = 
16). 
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oxygenation during OLA in the Flacke study (Cohen 1995; Benumof 1991; Capan, Turndorf et al. 1990; Flacke, 
Thompson et al. 1976).  Scrutiny of the Flacke study indicates that part of their aims were to compare blood gases 
and shunt fraction when tidal volumes of 15 ml.kg-1 and 8 ml.kg-1 were used during one lung ventilation (Flacke, 
Thompson et al. 1976).  However, the conclusion that the Flacke paper reached was that PaO2 during one-lung 
ventilation was directly related to patients' preoperative oxygen tensions.  They could demonstrate no relationship 
between PaO2 and tidal volume.  What they did recommend, however, in the light of the disparate results of tidal 
volume on PaO2, was that an FIO2 of 1.0 should be used during one-lung ventilation. 
 
Does this article by Flacke and colleagues really provide a solid foundation on which to base ventilation strategies for 
the majority of patients undergoing OLA?  Surely Katz and colleagues, and Kerr and colleagues and others (Inomata, 
Nishikawa et al. 1997; Cohen and Eisenkraft 1996; Katz, Laverne et al. 1982; Kerr, Smith et al. 1974) have validly 
demonstrated that optimisation of DL FRC using larger tidal volumes minimizes PVR, decreases venous admixture in 
the DL and shunt to the NDL with optimisation of arterial oxygenation.  The validity of basing ventilatory 
recommendations on the Flacke study is undermined by the observation made by these authors themselves.  The 
abstract of this paper states that  “When VT was reduced, patients who had had low oxygen tensions (< 150 mm Hg) 
at the higher volume, showed an increase in PaO2, and conversely.  Shunts changed accordingly.”  This observation 
implies that the use of a greater tidal volume improves a low DL FRC and thereby arterial oxygenation, whereas 
patients with a well-maintained or even high DL FRC are deleteriously affected by higher tidal volumes during OLA 
(Flacke, Thompson et al. 1976).  This concurs with observations made in an interesting study conducted by Cohen 
(Cohen, Thys et al. 1985b).  He demonstrated that a select group of patients who were hypoxic during OLA, 
benefited by application of PEEP to the DL.  Those patients who had a well-maintained PaO2, however, did not 
demonstrate an increase in oxygenation during DL PEEP (Cohen, Thys et al. 1985b).  This paper suggested that 
patients with a low DL volume had their DL volumes increased by 10 cm H2O PEEP.  Therefore, rather than the aim 
of a specific tidal volume or PaCO2 level, (Benumof and Alfery 2000; Cohen 1995), it appears a more important 
consideration is maintaining a relatively normal dependent lung volume.   
 
While the aforementioned discussion serves as justification for utilizing larger tidal volumes during OLA, it raises 
another question.  Does the use of smaller tidal volumes during OLA as employed in the current study, lead to 
decreases in DL volume and, with time, worsening hypoxia during OLA (Benumof 1991; Capan, Turndorf et al. 1990; 
Flacke, Thompson et al. 1976; Kerr, Smith et al. 1974; Khanam and Branthwaite 1973; Das, Fenstermacher et al. 
1970; Newnan, Finer et al. 1961)?  In the current study, unlike other studies (Kerr, Smith et al. 1974; Das, 
Fenstermacher et al. 1970), no evidence of progressively decreasing arterial oxygenation became apparent as OLA 
progressed.  This observation is a further justification to raise questions about the literature demonstrating that large 
tidal volumes are needed to maintain DL volume.  The question why these parameters did not deteriorate during OLA 
with the use of low tidal volumes is commented upon in the PEEP section of this discussion.   
4.5.2 Ventilation during OLA:  avoidance of volotrauma 
Another issue that may justify the use of smaller tidal volumes is the recent recognition that certain ventilatory 
strategies used in the ICU (The Acute Respiratory Distress Syndrome Network Study 2000; Amato, Barbas et al. 
1998) may be harmful to the lung parenchyma (Slinger 1999; Williams, Evans et al. 1996; Quinlan and Buffington 
1993).  Furthermore, volotrauma has recently been recognized as a factor determining morbidity and even mortality 
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during OLA (Connery, Deignan et al. 1999; Conacher 1998; Myles, Madder et al. 1995; Myles and Weeks 1992).  
Post pneumonectomy pulmonary edema (PPE) occurs in 4 to 5% of patients and carries with it a high (50 to 80%) 
mortality.  According to both Williams et al. (Williams, Evans et al. 1996) and Alvarez and co-workers (Alvarez, 
Bairstow et al. 1998), PPE presents as acute respiratory distress after lung resection.  Progressive and refractory 
hypoxemia is followed by infiltrates on chest roentgenology.  The causes originally associated with PPE were fluid 
overload and right pneumonectomy.  These causes have recently become contentious as the main etiological factor.  
As Alvarez et al. state, “there must be more to the answer of the PPE puzzle than withholding fluids” (Slinger 1999; 
Alvarez, Bairstow et al. 1998; Slinger 1995).  It appears that this condition is histologically and clinically 
indistinguishable from ALI with its hallmark of altered capillary permeability (Slinger 1999; Alvarez, Bairstow et al. 
1998; Williams, Evans et al. 1996; Marini, Culver et al. 1985).  The suggested etiological reasons are multiple 
(Slinger 1999; Williams, Evans et al. 1996; Slinger 1995; Slinger 1995; Eger 1994; Waller and Turner 1989; Marini, 
Culver et al. 1985).  However, volotrauma is at present considered to play a key role in the etiology of PPE and ALI 
after OLA.  The importance of volotrauma as an etiological factor lies therein that the anesthesiologist may be to 
blame by applying excessive tidal volumes or permitting the development of excessive levels of intrinsic PEEP during 
OLA (Slinger 1999). 
 
Albeit the underlying pathologies are not the same, Myles suggests that the Acute Respiratory Distress Syndrome 
Network (ARDSnet) study may be of relevance for patients undergoing OLA that have pulmonary disease (Myles 
2001).  In the ARDSnet study, patients with acute lung injury who were ventilated with lower tidal volumes (6.2 ± 0.8 
vs. 11.8 ± 0.8 ml.kg-1; p < 0.001) and lower plateau airway pressures (25 ± 6 vs. 33 ± 8 cm H2O; p < 0.001) had a 
lower mortality (31.0 vs. 39.8%; p < 0.007) and spent fewer days on a ventilator (The Acute Respiratory Distress 
Syndrome Network Study 2000).  Support for Myles’s suggestion, and of more relevance to the OLA situation, comes 
from a study by van der Werff and colleagues (van der Werff, van der Houwen et al. 1997).  In 35 patients subjected 
to pneumonectomy, 11 developed respiratory distress and radiographic infiltrates.  In all 11 patients, peak inspiratory 
pressures of more than 40 cm H2O were used during OLA (van der Werff, van der Houwen et al. 1997).   
 
Szegedi and colleagues demonstrated that plateau pressures (the correct pulmonary distending pressure) are only 
70% of peak airway pressures during OLA (Szegedi, Bardoczky et al. 1997).  (The difference between peak and 
plateau pressures can be understood if the resistance presented to the ventilator by the endotracheal tube and the 
patient’s airways are taken into account). Considering both Van der Werff and Szegedi and colleagues’ studies, 
Slinger suggested that it is advisable to limit plateau pressures to 25 cm H2O and peak pressures to 35 cm H2O to 
avoid lung damage during OLA (Slinger 1999; Szegedi, Bardoczky et al. 1997).  Attention must be drawn to the fact 
that that transpulmonary pressure per se is not the major etiological factor causing trauma.  Administering large tidal 
volumes during IPPV at low airway pressures is more damaging than IPPV at high airway pressures and normal tidal 
volumes in animals with their chests’ bound (Slinger 1999; Hachenberg and Rettig 1998).  Therefore although the 
current evidence points to the limitation of volume rather than the limitation of pressure to prevent lung damage, the 
importance of excessive inflation pressures lies therein that it may herald the use of excessive tidal volumes.     
 
While there are concerns that utilizing tidal volumes of less than 8 ml.kg-1 can have deleterious effects on DL volume 
(Cohen 2001), in the current study DL tidal volumes were limited to between 5.7 ± 1.4 and 6.7 ± 2.1 ml.kg-1 (Tables 
Chapter 4.  Discussion
 
302 
3.3.1.1, 3.3.2.1 and 3.3.3.1). Using these tidal volumes, rises in peak airway pressures were limited to between 25 ± 
5.5 and 29 ± 5.4 cm H2O during OLA except when extrinsic PEEP was applied 1 (Tables 3.3.1.3, 3.3.2.3 and 3.3.3.3).  
These tidal volumes and peak inspiratory pressures fall within the recommended ranges suggested to avoid the risk 
of volotrauma both during OLV and in patients with ALI (The Acute Respiratory Distress Syndrome Network Study 
2000; Slinger 1999).  Measurement of plateau airway pressures was not possible using the ventilating system 
currently available in the theatre.  Plateau pressures are a better indication of transpulmonary distending pressures 
than the peak pressure used in this study (Moon and Camporesi 2000; Szegedi, Bardoczky et al. 1997).  Using the 
principle described by Szegedi that only 70% of peak airway pressure is transmitted to the parenchyma, the plateau 
pressures were most likely within the aforementioned safe range recommended by Slinger (Slinger 1999). 
 
One other consequence of using lower tidal volumes during OLA is that there is a significant negative relationship 
between cardiac index and plateau inspiratory pressures (Figure 1.7.2.2) (Aalto-Setala, Heinonen et al. 1975).  In the 
current study, the avoidance of using large tidal volumes and excessive plateau airway pressures prevented 
decreases in cardiac output.  Avoidance of this cause of a decrease in cardiac output is important in the light of the 
relationship between cardiac index and CaO2 seen in the current study.   
4.5.3 Ventilation during OLA:  permissive hypercapnia 
Currently, most authorities recommend titration of alveolar ventilation to a particular carbon dioxide tension during 
OLA (Benumof and Alfery 2000; Cohen 1995; Benumof 1991).  However, blindly applying this strategy may cause 
damage to the lung if excessively high tidal volumes and respiratory rates are used.  The problem is that volotrauma 
may be caused by either the excessive tidal volume and/or air trapping that occurs during OLV as expiratory time 
decreases (see PEEP section).  Therefore, an aspect of a protective ventilation strategy during OLA involves 
avoiding titration of alveolar ventilation to a particular carbon dioxide tension (Morisaki, Serita et al. 1999; Tuxen 
1994; Quinlan and Buffington 1993; Myles and Weeks 1992).  As a consequence, a progressively increasing 
hypercarbia and respiratory acidosis was seen in the current study. 
 
The highest PaCO2 levels (6.9 ± 1.1 kPa) occurred in the last control group steps.  A consequence of this was a 
decrease in pH to 7.3 ± 0.07 in the last steps of the control group.  This pH was not due to a decrease in serum 
bicarbonate levels, as they remained unchanged from baseline in both the control and dobutamine groups 
(Figure 3.5.9).  Base excess decreased as time progressed from 1.7 to – 0.2 mmol.l-1 (control group), 2.7 to – 1.2 
mmol.l-1 (dobutamine group) and 1.2 to – 0.5 mmol.l-1 (PEEP group). This statistical difference occurs because the 
sample size was large enough and contains data with little scatter.  It is considered however of no clinical 
consequence.   
 
The possible influence of this moderate respiratory acidosis on cardiac function is relevant to the current study 
(Morisaki, Serita et al. 1999; Quinlan and Buffington 1993).  On the one hand, an acidosis of this degree could impair 
ventricular performance due to myocardial depression and/or the development of pulmonary hypertension (Solaro, 
Lee et al. 1988; Steinhart, Permutt et al. 1983).  On the other hand, the increase in carbon dioxide tension may 
induce mild sympathetic nervous system stimulation and vasodilatation and improve cardiac output (Walley, Lewis et 
al. 1990).  It is also important to consider the venous carbon dioxide tensions as this rapidly diffuses intracellularly, 
decreases tissue pH, and has been related to depression of cardiac function (Morisaki, Serita et al. 1999).   
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Nonetheless, no significant relationships between PaCO2 and MAP, LVSWI, SVR, VO2, characteristic impedance or 
stroke index were demonstrable.  Furthermore, albeit statistically significant correlations do exist between PaCO2 and 
cardiac index, heart rate, PVR and RVSWI, the strength of the relationships between these variables is weak and 
clinically insignificant (Table 3.5.4).  One of the “stronger” associations noted is that 26% of the increases in both 
oxygen delivery and mean PAP is associated with the increase in PaCO2.  Therefore, as hypercarbia increases, it is 
possible that sympathetic nervous system stimulation induced by the increased carbon dioxide tension, accounts for 
a degree of the increase in oxygen delivery.  However, a significant correlation does not imply a cause, only an 
association.  Two variables may be related via their association with a third variable (Van der Linden, Schmartz et al. 
2000).  As was discussed earlier, the initiation of OLA coincided with the initiation of the surgical stimulus.  Surgical 
stimulation may have resulted in an increase in sympathetic nervous system activity that was heralded by an 
increase in heart rate.  Is it possible to separate the relative roles of surgical stimulation and hypercarbia on the 
increase in heart rate, cardiac index, and oxygen delivery during OLA?  On studying the relationships between 
various factors, hypercarbia can only be associated with a small and clinically insignificant percentage (16 and 8%) of 
the increases in heart rate and cardiac index respectively.  On the other hand, the increase in heart rate accounts for 
30% of the increase in cardiac index.  Therefore, the most probable conclusion is that the sympathetic nervous 
system stimulation associated with the surgical insult played the more important role in determining the increase in 
cardiac index with hypercarbia playing a lesser role in this process.    
 
The other side of the coin is that no evidence of compromise of either left or right ventricular function exists nor was 
any significant degree of pulmonary vasoconstriction or systemic vasodilatation associated with the moderate 
respiratory acidosis that was permitted during OLA.  The implication is that in this group of patients, hypercarbia to 
these levels was a safe event with respect to cardiac function.  Hypercarbia may even have stimulated heart rate and 
cardiac output.  Permissive hypercapnia has long been employed in the ICU to limit volotrauma during ventilation of 
patients with ALI and bronchospasm and also those with severe loss of elastic recoil during both two and one lung 
ventilation (Connery, Deignan et al. 1999; Morisaki, Serita et al. 1999; Conacher 1998; Myles, Madder et al. 1995; 
Myles, Madder et al. 1995; Tuxen 1994; Quinlan and Buffington 1993).  Albeit permissive hypercapnia has been 
advocated during OLA, no studies have described the effects of moderate hypercapnia on hemodynamics during 
OLA.   
 
The advantages of permissive hypercarbia during OLA are the limitation or prevention of air trapping and 
concomitant increases in FRC.  Avoidance of air trapping will prevent the deleterious consequences of a decrease in 
venous return and an increase in RV afterload, which may result in severe hypotension or even cardiac arrest 
(Connery, Deignan et al. 1999; Conacher 1998; Myles, Madder et al. 1995).  Tuxen describes that in severe airflow 
limitation due to asthma, an intrathoracic gas volume at the end of inspiration of less than 20 ml.kg-1 reduces the risk 
of both hypotension and volotrauma (Tuxen 1994).  As discussed in the literature review, the smaller the rise in 
airway pressure during OLA, the fewer deleterious effects that ventilation has on cardiac output.  Therefore, smaller 
tidal volumes are associated for many reasons with a better cardiac output, as well as improved mixed venous and 
arterial oxygenation during OLA. 
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These beneficial effects must be balanced against the myocardial depression seen in experimental models when 
hypercarbia is induced (Solaro, Lee et al. 1988).  The acidosis induced by the increase in carbon dioxide tension is 
suggested to be the major problem (Walley, Lewis et al. 1990; Solaro, Lee et al. 1988).  Solaro and colleagues have 
suggested that the myocardial depression seen during hypercarbia is a result of the antagonism of calcium ion fluxes 
by the excess of hydrogen ions (Solaro, Lee et al. 1988).  Because carbon dioxide readily diffuses intracellularly, it 
may result in the rapid onset of severe intracellular acidosis and myocardial cellular dysfunction (Walley, Lewis et al. 
1990).  Levels of respiratory acidosis slightly greater than in the current study (PaCO2 12 kPa and pH 7.09) have 
been shown to decrease end-systolic elastance by 20% in a dog model (Walley, Lewis et al. 1990).  Furthermore, 
isolated strips of ventricular muscle demonstrated a 70% decrease in developed tension when exposed to a pH of 
6.9 that was purely the result of hypercarbia (Solaro, Lee et al. 1988).  The levels of hypercarbia and acidosis in 
these studies were greater than in the current study.  It is of concern that during thoracic anesthesia, deleterious 
effects on canine RV function were observed at levels of PaCO2 and pH (PaCO2 6.5 and pH 7.27) similar to those in 
the current study.  The RV dysfunction was demonstrated by a fourfold increase in RV filling pressures in right 
ventricles facing an increase in afterload (Quinlan and Buffington 1993; Rose, Van Benthuysen et al. 1983).   
 
It is remarkable however, that although myocardial depression was seen in the abovementioned dog model, cardiac 
output actually increased (Walley, Lewis et al. 1990).  This was because hypercarbia induced an increase in preload, 
a decrease in afterload and catecholamine release.  This underscores the divergent effects that respiratory acidosis 
has on circulatory function.  One of the main factors underlying the increase in cardiac output is that respiratory 
acidosis does not inhibit the ventricular response to beta-adrenoreceptor agonists (Walley, Lewis et al. 1990; 
Steinhart, Permutt et al. 1983).  In fact, Steinhart and colleagues demonstrated that B-adrenergic stimulation 
prevented cardiac failure associated with severe hypercarbia in a dog model (PaCO2 66 kPa and pH 6.39) (Steinhart, 
Permutt et al. 1983).  This observation is supported by a report by Morisaki and colleagues (Morisaki, Serita et al. 
1999).  They retrospectively reviewed the records of patients with severe COPD during OLA and assessed the 
implications of permissive hypercapnia of a much greater degree than what was permitted in the current study.  
Mean PaCO2 was 13.0 ± 3.0 kPa.  All of the patients in Morisaki et al’s study required inotropic support with 3 to 5 
ug.kg-1.min-1 of dopamine and intermittent boluses of phenylephrine to maintain the circulation.  Therefore, there 
appears to be a difference between the consequences of these higher carbon dioxide tensions in Morisaki’s study 
and the lack of consequence of moderate hypercarbia in the current study.  This lack of consequence supports the 
tolerance of moderate levels of respiratory acidosis in thoracic surgery. 
 
Hypoxemia is a potential concern during OLA in which hypercapnia is permitted.  Hypercarbia facilitates HPV 
(Benumof, Mathers et al. 1976), and avoids DL dynamic hyperinflation that would increase diversion of blood flow via 
the NDL shunt (Ishibe, Shiokawa et al. 1996).  This will offset the deleterious effects of hypoventilation on alveolar 
and arterial oxygen tensions.  Furthermore, utilizing high concentrations of oxygen while employing alveolar 
hypoventilation will result in the maintenance of an adequate alveolar oxygen tension.  The simplified alveolar gas 
equation is PAO2 = PB-PH2O – PaCO2/RQ.  If RQ is 0.8, then for every kPa increase in PaCO2, there is a 1.25 fold 
decrease in PAO2 (Coetzee 1987).  However, the corollary of this statement is that increasing the inspired oxygen 
concentrations easily compensates for decreases in PAO2 due to hypoventilation.  This benefit will apply even to 
carbon dioxide concentrations at the extremes of physiological abnormality.   
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4.5.4 Inspired oxygen concentration:  dependent lung, all groups 
An additional advantage of using higher concentrations of oxygen is that the movement of gas across the blood gas 
barrier is dependent on the partial pressure gradient of oxygen between the alveolus and pulmonary capillary (West 
1985).  The higher the alveolar oxygen partial pressure, the greater the transfer rate.  The normal difference at the 
beginning of the capillary is approximately 8 kPa (West 1985).  Increasing the fraction of inspired oxygen to 1 would 
have resulted in a DL alveolar oxygen tension of 95.03 kPa during OLA.  The lowest P O2 during one lung 
anesthesia in this study was 8.1 ± 0.8 kPa.  Therefore the gradient that resulted between the alveolus and pulmonary 
capillary would have been at least 87 kPa in the current study.  This almost 10 fold rise in the gradient compared with 
breathing air, would have increased the rate of oxygen transfer across the alveolar capillary membrane (West 1985).  
This adds an additional compensatory mechanism for hypoventilation.  For the short periods of time that these high 
concentrations of oxygen are used, oxygen toxicity is not considered a problem (Nunn 1987).  Dantzker and 
colleagues theoretically determined the critical V/Q ratio of an alveolus to be 0.08 to 0.1 when using 100% oxygen 
(Dantzker, Wagner et al. 2002).  This FiO2 has been shown to result in absorption atelectasis with a consequent 10% 
decrease in FRC (Baker, McGinn et al. 1993).  This will potentially contribute to an increase in shunt fraction (West 
1985).  However, in the current study no increase in shunt fraction was observed as OLA progressed.  This may be 
because intrinsic PEEP maintained patency of some of the lower V/Q units (Klingstedt, Hedenstierna et al. 1990). 
4.6 NDL insufflation of oxygen during OLA, all groups 
Oxygen, at a flow rate of 2 l.min-1 was insufflated with an 8 French catheter gauge down the lumen of the NDL.  The 
reason for the use of oxygen insufflation was to minimize the incidence of hypoxia during OLA (Capan, Turndorf et al. 
1980).  Furthermore, reports in the literature express concern regarding hypoxia during administration of dobutamine 
and other beta-adrenoreceptor stimulants (Voelkel 1986).     
 
Insufflation of oxygen down the NDL lumen of the DLT at an airway pressure of zero was not effective in improving 
arterial oxygenation during OLA in either Capan et al’s or Alfery and colleagues’ studies, whereas it was effective in 
Rees and Wansbrough’s study (Rees and Wansbrough 1982a; Alfery, Benumof et al. 1981; Capan, Turndorf et al. 
1980).  Benumof criticizes the Rees and Wansbrough study because they did not use patients as their own controls 
as done by Alfery in their dog study (Alfery, Benumof et al. 1981); rather Rees and Wansbrough used a separate 
control group with which to compare the effects of NDL insufflation on oxygenation (Benumof 1991).  Whether this is 
valid criticism is uncertain.  What is not clear is why these conflicting reports appear in the literature on the efficacy of 
NDL oxygen insufflation.  The conflicting reports on the use of oxygen insufflation stand in contrast to the consistent 
improvement brought about by low levels of NDL CPAP (Hogue 1994).  For instance, administration of NDL CPAP at 
values as low as 2 cm H2O is reported to benefit arterial oxygenation during OLA in the LDP (Hogue 1994).  The 
differences between CPAP and oxygen insufflation in their efficiency in improving oxygenation may be related to the 
mechanisms whereby they work.  In the absence of ventilation, both of these techniques rely on the mass diffusion of 
oxygen into the alveoli.  This requires a patent airway, denitrogenation, and the presence of high partial pressures of 
oxygen in the airway (Cohen 2001; Sue and Wasserman 1991).  It is suggested that all the aforementioned 
conditions may not be met by oxygen insufflation (Rees and Wansbrough 1982a).  However Rothen and colleagues 
describe that the pressure needed to expand virtually all atelectatic areas that develop under anesthesia is an 
inflation to vital capacity accompanied by an airway pressure (transpulmonary pressure) of 40 cm H2O (Rothen, 
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Sporre et al. 1993).  These observations underscore the questionable effects of insufflated oxygen into the NDL as 
treatment of hypoxemia during OLA.  Nonetheless, a number of authors suggest that the CPAP induced 
transpulmonary pressure gradient possibly exceeds the critical opening pressure in a large percentage of NDL alveoli 
(Benumof and Alfery 2000; Hogue 1994; Benumof 1991; Alfery, Benumof et al. 1981).  This will maintain a degree of 
alveolar patency in the “collapsed lung”.   
  
The use of the large 14 French gauge catheter in Rees and Wansbrough’s study could have partially occluded the 
Robertshaw DLT lumen and created NDL CPAP.  However, these authors specifically state in their methods that the 
large catheter introduced into the DLT’s did not occlude the lumen of the DLT in their study.  In the current study a 
smaller 8 French gauge catheter was used for oxygen insufflation.  The use of the thin catheter was in order to 
prevent NDL CPAP from developing as a result of the catheter completely or partially occluding the airway. 
 
Another possible explanation for the difference between Rees and Wansbrough, and Alfery and colleagues’ studies 
is that the former authors started administering oxygen when OLA was first initiated, whereas the latter authors first 
conducted various manoeuvres and only later started insufflating oxygen down the NDL lumen of the DLT.  In the 
Rees and Wansbrough study, the NDL oxygen insufflation catheter was introduced immediately after two-lung 
ventilation with 100% oxygen had ceased.  The effect of ventilation with 100% oxygen would have meant that two of 
the criteria mentioned above (the presence of oxygen and denitrogenation) would most likely have been fulfilled in 
Rees and Wansbrough’s study.  This would have facilitated movement via mass diffusion of oxygen down the 
airways to the alveoli.  However, it is possible that in the Capan study, by the time oxygen was insufflated down the 
NDL airway, any oxygen remaining in the airways after the cessation of two-lung ventilation would have been 
absorbed (Rees and Wansbrough 1982a; Capan, Turndorf et al. 1980).  This discussion introduces a hypothesis that 
would be interesting to test.   
 
It is also important to consider the importance of NDL oxygen insufflation in the light of the very high mixed venous 
oxygen saturations approaching and frequently exceeding 90% in the current study.  Thus, even in the presence of a 
large shunt, the high mixed venous oxygen tensions ensured that arterial hypoxia was unlikely to occur.  Therefore 
any potential benefit of NDL oxygen insufflation becomes of lesser importance.  It is also unclear whether oxygen 
insufflation benefited the patients in our study because there was no control group in which this technique was not 
used.   
 
In retrospect, in the light of the inconsistencies in the literature regarding the effectiveness of NDL oxygen 
insufflation, the use of low levels of NDL CPAP could have been considered instead.  The counterarguments to this 
contention are firstly, similar amounts of CPAP would have differing effects on NDL volume because of different NDL 
compliances.  Secondly, NDL CPAP may have interfered with the surgical field.  This would however have introduced 
another confounding factor in determining the effect of venous oxygenation on arterial oxygenation during OLA.  
Possibly, oxygen insufflation should have been avoided altogether in the conduct of this study. 
4.7 Dobutamine during OLA 
The part of the hypothesis relevant to this section is that RV afterload will increase during OLA.  Such an increase in 
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afterload will deleteriously affect RV-PA coupling, and therefore RV performance.  Dobutamine is an inotropic agent 
that has salutary effects on RV afterload.  It is therefore considered to be a particularly suitable drug to use in 
circumstances where RV afterload is increased (Wolfer, Krasna et al. 1994; Coddens, Delooft et al. 1993; Mathru, 
Dries et al. 1990; Dell'Italia, Starling et al. 1985; Jardin, Gueret et al. 1985; Dell'Italia, Starling et al. 1985).  It was 
therefore hypothesized that inotropic support with dobutamine would favorably readjust RV coupling to its load during 
OLA. 
4.7.1 Dobutamine during OLA: opposition to pulmonary flow  
During the administration of dobutamine 5 and 7 ug.kg-1.min-1, mean PA pressure increased by 33% compared to the 
steps when the patients were awake and when two-lungs were being ventilated.  Systolic PA pressure increased by 
between 23 and 33% during the steps when dobutamine was administered (i.e. OLA plus dobutamine 3, 5 and 7 
ug.kg-1.min-1) compared to the steps when dobutamine was not administered (i.e.the steps when patients were 
awake, when two-lungs were being ventilated and during the OLA step during which dobutamine was not 
administered) (Table 3.3.2.9).  PA elastance increased by 30% during administration of dobutamine 5 ug.kg-1.min-1 
compared to when the patients were awake (Table 3.3.2.12).   PVR increased by up to 39% during administration of 
dobutamine 5 ug.kg-1.min-1 compared to either OLA without dobutamine, or when either dobutamine 3 or 7 ug.kg-
1.min-1 was administered (Table 3.3.2.12).   The PA time constant decreased by 70% during infusion of dobutamine 7 
ug.kg-1.min-1 compared to the two-lung anesthesia step (Table 3.3.2.13).  PA compliance was decreased by up to 
61% when dobutamine 5 and 7 ug.kg-1.min-1 were infused compared to the OLA step when dobutamine was not 
administered (Table 3.3.2.13).    
 
While dobutamine was being administered during OLA, mean PAP increased to a maximum of 24.9 ± 6.2 mm Hg at 
a cardiac index of 5.5 ± 1.2 l.min-1.m-2.  However during OLA, in the control group, mean PAP was 24.0 ± 7.7 mm Hg 
at the maximum cardiac index of 4.4 ± 1.1 l.min-1.m-2.  This represents a relatively limited rise in PA pressure on 
administration of dobutamine compared to the increease in mean PAP observed during OLA alone.  Three possible 
reasons exist as to why there may have been a limited increase in mean PAP while dobutamine was being 
administered:  
1. The “blow off” effect via the NDL vasculature may have limited the rise in PA pressure (See discussion on 
3rd last paragraph of section 4.2 for discussion of the “blow-off effect”).   
2. The lung tissue could have been less damaged in this than in the other two groups. The implication of the 
preceding statement is that the pulmonary vascular reserve of patients in this group may have been better 
preserved so that the increase in cardiac output on administration of dobutamine did not exhaust their 
pulmonary vascular recruitment and dilation reserve.  However, demographic data does not reveal 
differences between the groups in terms of preoperative pulmonary function.  This reason is therefore 
unlikely to be a valid explanation for this phenomenon.  
3. The possibility exists that dobutamine administration induced pulmonary vasodilatation (Lejeune, Naeije et 
al. 1987; Lejeune, Leeman et al. 1987).  This issue will be discussed under the heading of “dobutamine 
and arterial oxygenation”. 
 
During the infusion of dobutamine 5 ug.kg-1.min-1, PVR exceeded that observed during the OLA, dobutamine 3 and 7 
ug.kg-1.min-1 steps.  However, this increase in PVR does not represent a clinically significant increase in PVR. 
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Further evidence that this increase in PVR is not significant, is the observation that this “increase in PVR” did not 
differ statistically or clinically from the baseline awake, or two lung anesthesia steps.   
 
PA compliance represents one of the factors determining vascular impedance in the 3-element Windkessel model of 
the circulation (Fourie, Coetzee et al. 1992; Fourie, Coetzee et al. 1992b).  Why then did PA compliance decrease 
with the administration of dobutamine?  To answer this question, the factors deteremining compliance can be 
studied.  In the current study, PA compliance was derived from the quotient of the PA time constant and total 
pulmonary vascular resistance (Laskey, Parker et al. 1990; Visser 1989).  Total pulmonary vascular resistance did 
not change, whereas the PA time constant decreased by 70% on administration of dobutamine 7 ug.kg-1.min-1 
compared with one lung anesthesia when dobutamine was not administered.  Heart rate also plays a role in 
determining the PA time constant.  In this respect, it must be noted that increases in dobutamine dosage iwere 
assosiated with progressive increases in heart rate in the current study.  Such increases in heart rate are associated 
with decreases in diastolic time and therefore decreases in the PA time constant (Thys, Dauchot et al. 1999).  This 
decrease in the time constant explains mathematically why the increase in PA compliance occurred.   
 
The conceptual reasons for the decrease in PA compliance can be explained as follows.  The implication of the 
administration of dobutamine was to increase the amount of blood residing in the PA for the following reasons: 
1. Firstly, the administration of dobutamine was associated with an unchanged stroke volume; however its 
administration resulted in an increase in heart rate compared to OLA alone.  Therefore, more blood was 
ejected into the PA per unit time and,  
2. Secondly, because of the decrease in diastolic time associated with the increase in heart rate on 
administration of dobutamine, runoff of blood into the left atrium may not have been complete by the time 
the next systole occurred.   
This greater volume of blood remaining in the PA means that the increase in pressure for a certain stroke volume will 
be greater than if the PA were emptier and more compliant.  In simple words, the PA is stiffer, like a car tyre that has 
been inflated from a floppy structure to one with stiff walls.  This “inflation” is observed as a decrease in PA 
compliance.   
 
Other factors that could possibly have played a role in the decrease in PA compliance include: 
¾ The effect of a decreased runoff time will be further aggravated by a higher PVR, 
¾ Sympathetic nervous system stimulation has been shown to decrease pulmonary vascular compliance 
(Hennebry and Gerstenblith 2001) and, 
¾ A stiffer PA with lower compliance will increase elastic recoil.  This increase in PA elastic recoil will cause 
the diastolic pressure decline in the pulmonary artery to be more rapid.  In other words, the PA will tend to 
empty in a shorter time. This is reflected by a decrease in the time constant of the PA diastolic delay curve.   
4.7.2 Dobutamine during OLA: RV performance 
All dosages of dobutamine administered during OLA increased cardiac output compared to OLA when dobutamine 
was not administered, and the baseline awake state and when two lungs were being ventilated (Table 3.3.2.10).  
However, no progressive increase in cardiac output was seen as the dose of dobutamine was increased (Table 
3.3.2.10).  The only change in stroke volume in this group was observed during administration of dobutamine 3 
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ug.kg-1.min-1, when stroke volume was greater than that measured during two lung anesthesia (Table 3.3.2.10).  
Further increases in the dobutamine dose were not assosiated with increases in stroke volume (Table 3.3.2.10).  
Nonetheless, dobutamine infusions did raise cardiac output by increasing heart rate (Table 3.3.2.10).  RVSWI 
increased during administration of dobutamine 3 and 7 ug.kg-1.min-1 compared to the baseline awake and two-lung 
anesthesia steps (Table 3.3.2.15).  However, administration of dobutamine did not improve RVEF or decrease 
RVEDVI or CVP (Tables 3.3.2.10, 3.3.2.3.3.2.11 and 3.3.2.15).   
 
The lack of increase in stroke volume at higher dosages of dobutamine necessitates comment.  Reasons include: 
¾ It is likely that the increases in opposition to pulmonary flow observed to occur concomitantly with the 
infusion of dobutamine, (predominantly an increase in PA elastance and a decrease in PA compliance), 
deleteriously affected RV performance. 
¾ Both Piene and Sundt, and Fourie and Coetzee and colleagues have studied the effect of PA compliance 
on coupling of the RV to the pulmonary vasculature (Fourie, Coetzee et al. 1992b; Piene and Sund 1979).  
Piene and Sundt suggested that the normal (high) PA compliance enhances power transmission between 
the RV and the pulmonary vasculature (Piene and Sund 1979).  If impedance is low and PA compliance 
high, less energy is wasted on pulsatile flow in the pulmonary vasculature (Hennebry and Gerstenblith 
2001).  Under circumstances of low impedance and high compliance, the blood flow in the PA takes on a 
more continuous pattern.  Fourie and Coetzee and colleagues demonstrated that decreases in compliance 
impair the delivery of RV stroke volume (Fourie, Coetzee et al. 1992b; Piene and Sund 1979).  This is 
because a decrease in PA compliance will increase peak pressures and amplify the oscillatory nature of 
the movement of blood through the lungs.  The increased energy expended does not benefit forward flow 
and is therefore wasted energy (Hennebry and Gerstenblith 2001).   
¾ As animal ventricles are paced at faster and faster rates, stroke volume has been observed to decrease 
progressively (West 1989).  The explanation given for this observation is that increases in heart rate 
decreases diastolic filling time that limits further increases in stroke volume.  In the current study, as higher 
dosages of dobutamine were administered, heart rate increased progressively.  This decrease in filling time 
may have contributed to the lack of increase in stroke volume as the dose of inotrope was increased.    
¾ The effect of ventricular interdependence on RV function can be speculated on.  Opposition to RV ejection 
increased with the administration of dobutamine.  However, systemic pressures did not increase above 
baseline.  It could be speculated that if systemic pressures had increased because of the administration of 
an inotrope, greater transseptal transmission of force (pressure) from the left to the right ventricle could 
have occurred.  This may have assisted RV function in the face of an increase in opposition to RV ejection.   
¾ It must be noted that an increase in heart rate to near the usual impedance minimum at 2 hertz (Hennebry 
and Gerstenblith 2001) accompanied the administration of dobutamine.  As the impedance spectrum per 
se was not measured in this study, it is difficult to comment as to whether this increase in heart rate had 
either a beneficial or deleterious effect on RV performance.   
 
In summary, regarding the effects of dobutamine infusions on opposition to pulmonary flow and RV performance 
during OLA: 
1. Low rates of dobutamine infusion (3 ug.kg-1.min-1) increase in cardiac output, stroke volume, and RVSWI.  
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The administration of dobutamine 3 ug.kg-1.min-1 was not accompanied by increases in RV afterload.  
Therefore, low infusion rates of dobutamine did benefit RV-PA coupling during OLA as evidenced by 
increases in cardiac output, stroke volume, and RVSWI. 
2. However, administration of higher dosages of dobutamine (5 and 7 ug.kg-1.min-1) during OLA increased the 
opposition to pulmonary blood flow.  There were increases in mean PAP and PVR: both these increases 
are considered to have limited clinical significance.  However, the decrease in PA compliance during the 
infusion of the highest dosage of dobutamine appears to be clinically significant.  The increases in 
opposition to pulmonary flow and lack of progressive increase in indices of RV performance are in contrast 
to what is expected to occur on administration of the inotrope and pulmonary vasodilator, dobutamine.  It is 
likely that the pulmonary vascular reserve during OLA was exhausted at the high cardiac indices of 5 to 5.5 
l.min-1.m-2 and this overshadowed the expected pulmonary vasodilator effects of dobutamine.  Moreover, it 
is probable that the increase in RV afterload was significant enough to prevent its performance 
increasing as would be expected with the administration of progressively higher dosages of inotrope 
(Domino 1997).   
 
The hypothesis relevant to section 4.7 was that the combined inotropic and pulmonary vasodilatory properties of 
dobutamine would improve impaired RV performance during OLA.  Low dosages of dobutamine administration did, 
whereas higher dosages did not, improve the coupling between the RV and its afterload during OLA.  The hypothesis 
for this section can therefore not be accepted without qualification. 
4.8 Dobutamine during OLA:  oxygenation  
The relevant part of the hypothesis for this section was that the impairment of RV performance secondary to the 
increase in RV afterload imposed by OLA would be improved by administration of dobutamine.  Inotropic support will 
restore oxygen delivery to normal.  The increase in the DO2/VO2 ratio will improve P O2, and in the presence of the 
large shunt present during OLA, improve arterial oxygenation (Kelman, Nunn et al. 1967). 
 
The patients in the present study did not become hypoxic during OLA when the cardiac output increased 
concomitantly with the administration of dobutamine (Russell and James 2000; Lejeune, Naeije et al. 1987; Lejeune, 
Leeman et al. 1987; Bishop and Cheney 1983; Marin, Orchard et al. 1979).  However, dobutamine administration did 
not decrease PaO2 or arterial oxygen saturation (Tables 3.3.2.5), and neither did it increase the cost of oxygenation 
(i.e. shunt fraction, alveolar-arterial oxygen partial pressure gradient, or PaO2/FiO2 ratio (Tables 3.3.2.7)) during OLA 
compared to when OLA was conducted without dobutamine administration.  These observations differ from other 
studies demonstrating hypoxemia when vasodilatory amines are administered during both two (Lejeune, Naeije et al. 
1987; Lejeune, Leeman et al. 1987; Bishop and Cheney 1983; Marin, Orchard et al. 1979) and one lung ventilation 
(Russell and James 2000).  Theoretically, the influence of dobutamine on arterial oxygenation during OLA may be 
related to the balance of the following divergent effects (Mathru, Dries et al. 1990; Lejeune, Naeije et al. 1987; 
Lejeune, Leeman et al. 1987; Marin, Orchard et al. 1979): 
1. By improving the relationship between oxygen delivery and consumption, dobutamine increases P O2.  
This increase will benefit arterial oxygenation in the presence of a large shunt, 
2. The above has to be weighed against possible increases in VO2 induced by dobutamine, the consequence 
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of which will be a decrease in P O2 (Karzai, Lotte et al. 1996; Karzai, Gunnicker et al. 1996; Karzai, 
Gunnicker et al. 1994), 
3. Increased PA pressure accompanying the increased cardiac output will inhibit HPV and increase shunt 
(Benumof 1985; Benumof and Wahrenbrock 1975), 
4. Direct inhibition of HPV by dobutamine (Lejeune, Naeije et al. 1987; Marin, Orchard et al. 1979) and, 
5. The influence of P O2 on HPV (i.e. high levels of venous oxygenation will inhibit and low levels will 
potentiate HPV) (Benumof 1985; Domino, Wetstein et al. 1983; Marshall and Marshall 1983; Benumof, 
Pirlo et al. 1981). 
 
As discussed already, Kelman and co-workers were the first to report on the theoretical influence of mixed venous 
oxygenation on arterial oxygenation during anesthesia (Kelman, Nunn et al. 1967).  During OLA, only two studies, 
one in humans (Mathru, Dries et al. 1990) and the other in an animal model (Russell and James 2000) have directly 
attempted to address arterial oxygenation by administering inotropes to increase oxygen delivery.  These studies 
have produced inconsistent results (Mathru, Dries et al. 1990).  Mathru and colleagues administered 5 ug.kg-1.min-1 
of dobutamine to patients undergoing pneumonectomy during OLA in the LDP (Mathru, Dries et al. 1990).  The 
details of their methodology deserve comment when considering their results or on making comparisons with the 
present study.  Many aspects of the basic study design are comparable to those of the current study: 
1. Premedication, non-depolarising muscle-relaxant usage, monitoring techniques, methods of measuring 
oxygenation and both the type and determination of the position of the DLT were similar in the Mathru and 
the current studies.  Furthermore, ventilation was titrated so that peak airway pressures were limited to 20 
cm H20 (which were lower than in the current study) (Table 3.3.2.2) and no DL PEEP was applied.  
However, ventilation was titrated to an unspecified value of “normocapnia”.  This ventilatory technique 
resulted in PaCO2 values of 5.2 ± 0.7 and 5.3 ± 0.5 kPa in the control and dobutamine steps respectively.  
As in the current study, their patients were also ventilated with 100% oxygen.  Mathru et al. state they 
maintained normovolemia, although details of how this was achieved were not specified. 
2. The patients had carcinoma of the “lung.”  Mathru and colleagues state that preoperative pulmonary 
function was within normal limits. This is different from the majority of the lung function test results obtained 
in the current study. 
3. As in the current study, they also compared hemodynamics, venous and arterial oxygenation with and 
without the administration of dobutamine.  Furthermore, their observations were obtained 15 minutes after 
thoracotomy and OLA had commenced.  A similar time period and sequence of events was used in the 
current study. 
4. Albeit only one dose of dobutamine was used, this was infused at the same rate as one of the dosages 
used in the current study. 
 
Certain differences in study design and results are apparent.  Oxygen was not insufflated down the NDL lumen of the 
DLT in the Mathru study.  Mathru and colleagues used enflurane alone to provide anesthesia.  They did not specify 
the partial pressure used.  Furthermore, cardiac output was only 2.37 ± 0.2 l.min-1.m-2 during OLA.  This appears to 
be lower than the cardiac output in the current study under OLA.  This is possibly the result of depression by the 
unspecified concentration of enflurane.  Additionally, oxygen consumption in their patients was higher than in the 
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current study (see table 4.8.1).  They do not report body temperature, neither do they normalize VO2 for body weight 
and body surface area, nor do they give the relevant demographic data.  This means that that the patients in the 
current and Mathru studies cannot be compared.  However, if it is assumed that normal BSA is approximately 1.73 
m2, the oxygen consumption in their patients was 158.3 ± 38.0 and 164.5 ± 15.9 ml.min-1.m-2 respectively during 
OLA at baseline and when dobutamine 5 ug.kg-1.min-1 was being administered.  Therefore, if the current and the 
Mathru studies are compared, it is likely that the balance between a greater oxygen demand and a diminished supply 
during OLA in the Mathru study resulted in an S O2 of only 60% during baseline OLA.  In the current study, mixed 
venous saturations during baseline OLA in the dobutamine group were 90.6 ± 4.7 kPa.  It is probably reasonable to 
conclude that, compared with the current study, systemic oxygenation in Mathru and co-workers’ patients started 
from a lower baseline (i.e. a lower ratio of oxygen delivery to consumption) before the administration of dobutamine 
commenced.  
 
On administration of dobutamine during OLA in Mathru and colleagues’ study, cardiac output and oxygen delivery 
increased by 23% and 35% respectively compared with baseline, whereas no increase in oxygen consumption was 
seen.  The result was a 24% increase in S O2 to 74.6 ± 2.8 %.  Concomitantly, PaO2 increased from 10 ± 1.8 kPa to 
33.3 ± 6 kPa.  In other words, the administration of dobutamine normalized the mixed venous oxygen tension and 
thereby significantly improved arterial oxygenation.  In spite of the administration of dobutamine and the increase in 
cardiac output, the shunt fraction decreased from 33.2 ± 6.2 to 20.2 ± 2.9 %.  It is noteworthy that mean PAP 
actually decreased when they administered dobutamine (Table 4.8.1).  It implies that their patients, who had normal 
preoperative lung function tests, had adequate pulmonary vascular reserve at the flows generated.  Furthermore, in 
spite of the increase in cardiac output, the decreased PA pressure would have had minimal deleterious influences on 
HPV and shunt during OLA.  Therefore, in contrast to the current study, Mathru and colleagues were successful in 
employing the increased delivery and unchanged consumption of oxygen to improve (normalise) mixed venous 
oxygenation and thereby arterial oxygenation during OLA. 
 
 
Figure 4.8.1 ODC’s for patients with normal 
and lower pHs. The initial position of mixed venous 
oxygenation in the current and Mathru study are 
indicated.  The benefit of increasing cardiac output for 
Mathru’s normocarbic# and the current study’s 
hypercarbic* patients is shown.   
 
Redrawn from Chapter 35 “Gas transport between the 
lungs and the tissues” in WF Ganong. Review of 
medical physiology, 19th edition. Appelton & Lange, 
Stamford, Connecticut, 1999. 
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Table 4.8.1 Data from Mathru’s study (Mathru, Dries et al. 1990).  Anesthesia was maintained with 
enflurane (partial pressure not reported) in 100% oxygen.  Dobutamine 5 ug.kg-1.min-1 was administered 
during OLA with favourable effects on cardiac output, mixed venous and arterial oxygenation.  Oxygen 
consumption did not change during administration of dobutamine.  Note the low starting mixed venous 
oxygen saturation and its improvement with the administration of dobutamine.  7 subjects were included in 
the study and Student’s-t test was used to compare the groups.  
 
 
 
OLA 
OLA and 
Dobutamine 
 
  SD.   SD. 
p 
Heart rate (beats.min-1) 73.8 8.1 80.0 7.1 p < 0.01 
Stroke index (ml.m-2) 32.4 4.1 36.6 5.0 p < 0.01 
Cardiac index (litres.min-1.m-2) 2.4 0.2 2.9 0.5 p < 0.01 
LVSWI (g.m.m-2) 34.9 5.4 41.8 6.7 p < 0.01 
RVSWI (g.m.m-2) 8.6 1.8 8.2 1.8 Not significant 
MAP (mm Hg) 89.9 5.9 93.6 4.3 p < 0.01 
PAP (mean) (mm Hg) 18.7 3.3 17.4 2.5 p < 0.05 
PAWP (mm Hg) 11.1 1.4 10.4 1.6 Not significant 
PVR (mm Hg.litres-1.min-1) 1.7 0.7 1.3 0.5 p < 0.01 
PaO2 (kPa) 9.97 1.8 33.5 5.9 p < 0.01 
S O2 (%) 60.0 8.9 74.6 2.8 p < 0.01 
Shunt fraction (%) 33.2 6.3 20.2 2.9 p < 0.01 
CaO2 (ml.100 ml-1) 16.0 0.9 17.7 1.1 p < 0.01 
C O2 (ml.100 ml-1) 10.2 1.6 12.7 0.8 p < 0.01 
CcO2 (ml.100 ml-1) 18.9 1.0 18.9 1.0 Not significant 
Oxygen delivery (ml.min-1) 755.4 66.4 1021.8 106.1 p < 0.01 
VO2 (ml.min-1) 273.9 65.8 284.5 27.5 Not significant 
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The decrease in shunt in Mathru’s and colleagues study is interesting.  The Mathru paper find it “difficult to explain” 
the decrease in shunt fraction.  The shunt equation, Qs/Qt = (CcO2 – CaO2)/(CcO2 – C O2), considers the ratio of 
the difference between pulmonary capillary and arterial oxygen content to the difference between pulmonary capillary 
and mixed venous blood.  In the Mathru study, because of the steep part of the oxygen dissociation curve on which 
they are operating, the increase in cardiac output raised venous saturation and content by 2½ times as much as the 
rise in arterial content.  However, because of the shape of the ODC, the increase in arterial oxygen tension had a 
much smaller effect on SaO2 and CaO2.  CcO2 would not be affected by the administration of dobutamine.  Therefore 
the different starting positions on the ODC of these parameters and how they were influenced by the greater increase 
in oxygen delivery relative to VO2, explains this phenomenon of “a decrease in shunt fraction”.   
 
Table 4.8.2 Data adapted from (Nomoto and Kawamura 1989).  Dobutamine 5 ug.kg-1.min-1 was 
administered during OLA with favourable effects on cardiac output and arterial oxygenation.  Venous 
oxygenation data is not reported in their study. Inspired oxygen fraction was varied between 0.5 to 1.0 in 
this study.  7 subjects were included in the study and Student’s-t test was used to compare the groups. 
 
 
Thus, from consideration of Mathru’s work, it appears that not only is the ratio of VO2 to DO2 important in determining 
P O2, but the initial position of the ODC also plays an important role.  Thus, if the P O2 starts from a low position on 
the steep part of the ODC and then increases because the DO2/VO2 ratio improves because of administration of 
dobutamine, significant benefits on venous oxygenation will be seen.  Furthermore, whereas Mathru’s patients were 
OLA 
OLA and 
Dobutamine 
 
  SD.   SD. 
p 
Heart rate (beats.min-1) 99.0 8.0 109.0 12.0 p < 0.05 
MAP (mm Hg) 87.0 15.0 95.0 9.0 Not significant 
Cardiac index (litres.min-1.m-2) 3.3 0.3 4.1 0.4 p < 0.05 
PAP (mean) (mm Hg) 18.0 3.0 21.0 3.0 p < 0.05 
PAWP (mm Hg) 9.1 2.4 10.0 2.5 Not significant 
PVRI (dynes.s.cm-5.m-2) 215 68 212 55 Not significant 
Qs/Qt (%) 29.2 7.0 26.0 6.2 p < 0.05 
pH 7.39 0.03 7.38 0.04 Not significant 
PaCO2  (kPa) 4.9 0.4 5.0 0.4 Not significant 
PaO2 (kPa) 22.3 6.1 26.6 6.9 p < 0.01 
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normocarbic, the patients in our study were hypercarbic.  The ODC is shifted to the right by hypercarbia (West 1985).  
This rightward shift of the ODC in the current study would have ensured that the working position of the very high 
venous saturations would have been on the flat part of the curve.  Therefore, in the current study, increasing the 
DO2/VO2 ratio did not benefit arterial oxygenation because of the starting position of P O2 on the ODC.  
Furthermore, the initial position on the ODC of C O2 plays a role in determining the effect of an increase in cardiac 
output on the calculation of the “virtual” shunt. 
 
 The differences and similarities between Mathru and colleagues’ and the current study also highlight other important 
points.  As mentioned, with respect to cellular oxygenation, the patients in the Mathru study started from a low 
baseline position on the steep part of the ODC and improved with dobutamine administration.  However, 
administration of the inotrope did not improve the already high P O2 in the current study.  The difference between 
these studies lies not only in the higher cardiac index and presumably higher oxygen delivery of the current study, 
but also the lower oxygen consumption seen during OLA in the present study.  It is likely that the anesthetic 
techniques used in these two studies were responsible for the different cardiac indices observed.  The decrease in 
VO2 in the current study is most likely the result of the anesthetic technique used; the small decrease in temperature 
on induction would also have contributed to this phenomenon.   
 
Table 4.8.3 Data adapted from (Nomoto and Kawamura 1989).  Nitroglycerine 1 ug.kg-1.min-1 was 
administered during OLA with deleterious effects on cardiac output and arterial oxygenation. Inspired 
oxygen fraction was varied between 0.5 to 1.0 in this study.  7 subjects were included in the study and 
Student’s-t test was used to compare the groups. 
 
To illustrate the effects of the increase in oxygen delivery and decrease of VO2 on arterial oxygenation, values 
representative of oxygen consumption and cardiac index typically seen during OLA in the current and Mathru and 
colleagues’ studies were entered into the modified Fick formula described by Kelman and colleagues (Equation 
4.4.2.4).  The discrepancy between the Mathru and the current studies is apparent in the graphs that result (Figure 
4.4.2.3).  The cardiac outputs of the patients in the current study place them on the flat portion of the relationship 
OLA 
OLA and 
Nitroglycerine 
 
  SD.   SD. 
p 
Cardiac index (litres.min-1.m-2) 3.4 0.6 2.9 0.7 p < 0.05 
PAP (mean) (mm Hg) 19.0 4.0 17.0 3.0 p < 0.05 
PAWP (mm Hg) 10.0 2.7 9.8 2.8 Not significant 
Qs/Qt (%) 29.2 4.9 34.6 5.0 p < 0.01 
PaO2 (kPa) 24.6 4.0 19.1 3.8 p < 0.01 
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between CaO2 and cardiac index where further increases in flow do not provide better arterial oxygenation.  A patient 
in Mathru’s study with a starting cardiac index of 2.37 l.min-1.m-2, would experience an improvement in arterial 
oxygen content when cardiac output increased from 2.4 ± 0.2 to 2.91 ± 0.5 kPa at an unchanged VO2 of 164 ml.min-
1.m-2.   
 
A limitation of the use of the Kelman curves is that other effects such as the influence of PA pressure and 
dobutamine on the shunt and the changing P O2 as VO2 increases with inotrope administration during OLA, are not 
taken into account in these graphs.   However, graphic relationships between cardiac index and arterial oxygen 
content  are still useful tools with which to understand both Mathru’s and the current study, as in neither study was 
oxygen consumption affected by the administration of dobutamine. 
 
Nomoto and Kawamura investigated the effects of dobutamine and nitroglycerine on oxygenation during OLA 
(Nomoto and Kawamura 1989).  Inspection of their results reveals that their patients had close to normal 
preoperative lung function tests.  Anesthesia was maintained with enflurane (partial pressures also unspecified) and 
nitrous oxide.  Pancuronium was administered as the non-depolarising muscle-relaxant.  Lung separation was 
achieved by using a Robertshaw DLT.  A tidal volume of 12 ml.kg-1 was delivered at a respiratory rate of 12 breaths 
per minute during OLA.  The resultant PaCO2 was 5.0 ± 0.04 kPa.  On the one hand, the administration of 
nitroglycerine during OLA decreased both cardiac index and arterial oxygenation (Tables 4.8.2 and 4.8.3).  On the 
other hand, dobutamine 5 ug.kg-1.min-1 improved cardiac index, but only to values that were similar to those 
observed in our patients during OLA before inotrope was administered.  This improvement in cardiac index was 
associated with an increase in arterial oxygenation and a decrease in shunt fraction during OLA.  These changes in 
arterial oxygenation could have occurred as a result of changes in mixed venous oxygenation that accompanied the 
opposing effects of these two drugs on cardiac 
output.  The aforementioned statement is based 
on the assumption that, in Nomoto and 
Kawamura’s study, as in the current and the 
Mathru study, the ratio of oxygen delivery to 
oxygen consumption increased with increases in 
cardiac output, and vice versa.  It is unfortunate 
that Nomoto and Kawamura did not report mixed 
venous oxygenation or oxygen consumption 
values in their paper so that we could test the 
validity of these suppositions.  However, 
additional support for the contention that 
improvement in arterial oxygenation was induced 
by increases in cardiac index and P O2 comes 
from similar directional changes in shunt fraction 
as seen in the Mathru study.  This observation 
again supports the assumption made above that 
mixed venous oxygen tension and cardiac index changes occurred in similar directions in this study.  In this respect, 
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Figure 4.8.2  The pressure vs. flow plots while 
dobutamine was administered to 8 dogs experiencing alveolar 
hypoxia (FiO2 0.125) or while a FiO2 of 0.4 was administered.  
Dobutamine did not decrease PVR in the hyperoxic group unlike 
the decrease in PVR seen in the hypoxic group.  Data 
represented as mean and SEM.  The groups differ significantly p < 
0.05. The graph has been redrawn from Lejeune et al, 1987. 
Chapter 4.  Discussion
 
317 
it is noteworthy that the administration of dopamine failed to improve cardiac index and arterial oxygenation in this 
study.  This absence of change again supports the hypothesis that the main reason for the improvement or 
worsening of arterial oxygenation seen by Nomoto and Kawamura was the influence of cardiac output on the 
DO2/VO2 ratio.  As in Mathru’s study, Nomoto and Kawamura’s patients had normal lung function tests and probably 
had normal pulmonary vascular reserve.  The subsequent lack of increase in mean PAP and PVRI during 
administration of dobutamine also implies that these factors did not influence HPV during OLA.  This emphasises that 
increases in P O2 were mainly responsible for the improvements in PaO2 seen with dobutamine. 
 
Table 4.8.4 Adapted from Slinger and Scott 1995.  Data obtained after 30 minutes of OLA during 
which period an end tidal partial pressure of 1 MAC of either anesthetic had been administered.  7 
subjects were included in the study and Student’s-t test was used to compare the groups. 
 
Previous studies have shown that at similar MAC values, isoflurane produces a better PaO2 during OLA than 
halothane (Benumof, Augustine et al. 1987).  Slinger and Scott compared the effect of equipotent dosages of 
isoflurane and enflurane on PaO2 during OLA in the LDP.  They were also interested in investigating whether the 
different hemodynamic effects of these agents influenced arterial oxygenation during OLA (Slinger and Scott 1995).  
After induction of anesthesia, patients were administered 1 MAC of either isoflurane or enflurane.  Muscle relaxation 
was attained using pancuronium.  Tidal volumes of 10 ml.kg-1 were administered during OLA and the respiratory rate 
was adjusted to keep the PaCO2 between 4.6 to 6.0 kPa.  Their results demonstrated a linear relationship between 
cardiac output and PaO2 (Figure 4.8.3).  Furthermore, isoflurane anesthesia resulted in a higher PaO2 than enflurane 
during OLA.  However, there were only a small number of patients in whom pulmonary artery catheterisation could 
be justified on clinical grounds.  There was no statistically significant difference between the cardiac outputs 
generated when anesthesia was conducted with either of these two anesthetic agents.  Thus, in that study, they 
demonstrated that PaO2 could be improved by increasing cardiac output.  Nonetheless, they failed to demonstrate 
that an anesthetic technique related improvement in cardiac output actually resulted in better arterial oxygenation 
(Pagel, Farber et al. 2000; Eger 1994). 
  
Enflurane Isoflurane 
 
  SD.   SD. 
Differences, if any, 
between the two 
groups 
Cardiac index (litres. min-1.m-2) 2.7 1.0 3.0 0.9 Not significant 
PaO2 (kPa) 16.4 6.0 21.2 7.0 p = 0.002 
P O2 (kPa) 6.2 1.0 6.8 1.0 p = 0.003 
Qs/Qt (%) 41.0 3.0 39.0 4.0 Not significant 
Oxygen consumption (ml.min-1.m-2) 71.9 11.0 75.8 14.0 Not significant 
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From the data presented in Slinger and Scott’s paper, their patients mean body surface area can be calculated to be 
1.78 m2. This enables comparisons to be made with other studies (Table 4.8.4).  Shunt, VO2 and cardiac output did 
not differ between the groups.  However, the difference in P O2 between the groups suggests that these 
normocarbic patients were located on the steep part of the ODC.  However, hemoglobin concentrations (and 
temperatures) were not published in the study.  This prevents the calculation of CaO2 and the location of these 
patients on the correct part of the Kelman curve.  However, the strong relationship between cardiac output and PaO2 
in Slinger and Scott’s study raises suspicion that at the cardiac indices at which these patients were operating, they 
were on a relatively steep part of ODC.  Administering inotrope to these patients would have probably improved 
oxygenation further. 
 
Russell and James also administered inotropes in an attempt to improve cardiac output and mixed venous 
oxygenation and thereby arterial oxygenation (Russell and James 2000).  The subjects of their study were healthy 
pigs.  Anesthesia was maintained with an inspired partial pressure of 1% halothane, while an FiO2 of 1 was 
administered.  Ventilation was aimed at maintaining a PaCO2 of between 4 to 6 kPa.  Forced air warming was used 
to keep nasopharyngeal temperatures between 35.5 to 37.5 oC.  The temperatures of individual pigs were not 
reported.  The sequence of events in the study was as follows.  Firstly, baseline hemodynamics and oxygenation 
were measured.  Thereafter, either an adrenaline or an isoprenaline infusion was administered with the stated aim of 
increasing cardiac output by at least 30%.  Hemodynamics and oxygenation were again measured once the goal had 
been achieved.  The catecholamine infusion was terminated.  The pig was then allowed to “settle usually to within ± 
10% of baseline values.”  15 minutes thereafter, “the second infusion (the other catecholamine) was then 
commenced to achieve the same target increase in cardiac output.”   
 
The inotropes resulted in an increase in cardiac output.  This increase varied from 54 to 87% with adrenaline and 
from 31 to 110% with isoprenaline compared to baseline.  The factors affecting oxygenation reported in their paper 
are summarized in Tables 4.8.5 and 4.8.6. 
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Figure 4.8.3   The 
relationship of arterial 
oxygenation and cardiac 
output during OLA with 
either isoflurane or 
enflurane.  A significant 
relationship exists 
between PaO2 and 
cardiac output (p < 
0.001, r = 0.81, n = 7).   
Redrawn from Slinger 
and Scott, 1995. 
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 Units 
Baseline 
Mean ± SD. 
Adrenaline 
Mean ± SD. 
% Change 
Mean ± SD. 
p 
Cardiac Output  l.min-1 1.3 to 4.3 
(SD. not reported) 
Not reported 54 to 87% increase Not reported 
C O2 ml.100ml-1 Not reported Increased by 
1.66 ± 1.03 
Not reported 0.003 
SaO2 % 86.9 ± 7.9 82.5 ± 10.6 4.4 ± 3.5 <0.001 
Shunt % 48.1 ± 6.9 64.9 ± 7.8 16.8 ± 5.9 < 0.0001 
VO2 ml.min-1 126.2 ± 30.2 133.8 ± 43.7 7.7 ± 25.6 0.42 
 
Table 4.8.5 Information obtained from Russell and James's study (adrenaline administration) 
presented in tabular form.  Significant p values indicate a change from baseline.
 
 Units 
Baseline 
Mean ± SD. 
Isoprenaline 
Mean ± SD 
% Change 
Mean ± SD. 
p 
Cardiac Output  l.min-1 Not reported 31 to 110 % Not reported Not reported 
C O2 ml.100ml-1 Not reported Increased by 
0.64 ± 0.43 
Not reported 0.004 
SaO2 % 89.5 84.7 ± 7.7 4.8 ± 3.6 0.0071 
Shunt % 44.9 ± 7.4 59.3 ± 3.7 14.3 ± 4.7 < 0.0001 
VO2 ml.min-1 120.5 ± 15.9 137.0 ± 26.6 16.6 v 18.4 0.038 
 
Table 4.8.6 Information obtained from Russell and James's study (isoprenaline administration) 
presented in tabular form.  Significant p values indicate a change from baseline. 
 
Certain questions can be raised concerning this study: 
¾ The final dose of inotrope administered was not reported.  Furthermore, the endpoint of titration of the 
inotrope, the cardiac index, was not increased in a uniform manner.  The disparate endpoints of both 
catecholamine infusion and cardiac output make it questionable whether comparisons can be made 
between the groups. 
¾ It would be useful to know if these large increase in cardiac output increased PA pressure and thereby 
increased shunt fraction.   
¾ The conduct of the study was such that after the administration of one drug had been completed, and once 
hemodynamics had returned to approximately 10% of baseline values, the alternative drug was 
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administered.  Using this sequence of events, it would be expected that measurements would not differ 
between control epochs.  However, Russell and James report a progressive increase in oxygen 
consumption during successive control periods.  In the light of this unstable baseline, it is unclear whether 
the administration of isoprenaline was the only reason for the increase in VO2.  This problem could have 
been addressed if there had been a control group.  
¾ The temperature of the animals is not recorded at each step.  What is reported is that temperature ranged 
between 35.5 and 37.5O C.  Could the increase in VO2 have been because of a progressive increase in 
body temperature induced by the forced air-warming blanket in a subject without an open body cavity?   
¾ The study concludes that the decrease in oxygen saturation and increase in shunt on inotrope 
administration is attributed to “the effects of sympathomimetic stimulation on intrapulmonary shunting and 
oxygen consumption.”  On closer inspection of their data, the increase in VO2 associated with the 
administration of the inotrope does not appear to be the cause of the arterial desaturation.  If the increase 
in VO2 was responsible for an increase in arterial saturation, a decrease in venous oxygenation would have 
been expected.  However, the C O2 did not decrease as would be expected if their conclusions were 
correct, but actually increased by 1.66 ± 1.03 ml.100ml-1.  This rise in venous oxygenation is not 
unexpected as the increase in VO2 (Figure 4.8.4) was minimal compared with the 54 to 87% increase in 
cardiac output.  Therefore, it was not the catecholamine induced increase in VO2 that played a role in the 
worsening hypoxia seen in these pigs.  It is more likely that the deleterious effects of catecholamines on 
intrapulmonary shunting played the dominant role in the worsening hypoxia.  It would have been useful to 
report the baseline venous saturations in this study.  Significant differences exist between one the one 
hand, the Mathru, Nomoto and Kawamura, Slinger and Scott and current studies, and on the other hand, 
the Russell and James study.  These pigs had normal lungs and were not in the LDP.   Arterial oxygenation 
is worse in the supine position during OLA as the beneficial effects of gravity in limiting blood flow to the 
NDL and limiting shunt are not operative (Pinsky, Desmet et al. 1992).  Furthermore, the experimental 
design resulted in a larger starting shunt fraction during OLA than is commonly seen during OLA in the 
LDP.   
 
Thus, it is doubtful whether the Russell and James and the human studies are comparable.  It does not help solve 
the question whether increasing arterial oxygenation in humans in the LDP subjected to OLA will be achieved by 
administering inotropes that increase cardiac output.  What this study does say is that catecholamine administration 
increases shunt and worsens arterial hypoxemia in subjects with normal lungs in the supine position during OLA. 
 
The Russell and James study emphasises one of the great concerns regarding the administration of inotropes during 
OLA, this being that the administration of inotropes to increase in cardiac output may increase shunt fraction and 
decrease arterial oxygenation during OLA.  Nonetheless, in the current study, dobutamine administration was not 
associated with a statistically significant increase shunt fraction during OLA.  There are two possible broad 
mechanisms why dobutamine could cause pulmonary vasodilatation and hypoxemia during OLA.   
1. Firstly it may be due to direct vasodilatation caused by the drug.   
2. Secondly, pulmonary vasodilatation can be secondary to the effects of dobutamine on the circulation.  In 
other words, the effects on PAP, mixed venous oxygenation and possibly pulmonary blood flow may cause 
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inhibition of HPV and thereby and increases in the shunt fraction.   
 
It is not apparent which of the above 
mechanisms could be responsible for an 
increase in shunt during OLA.  Albeit 
dobutamine has been suggested to inhibit 
HPV, this is an inconsistent finding (Capan, 
Turndorf et al. 1990).  Lejeune and colleagues 
published two studies investigating the 
aforementioned interaction of dobutamine on 
HPV (Lejeune, Naeije et al. 1987; Lejeune, 
Leeman et al. 1987).  In their one study, they 
determined PVR while cardiac output was 
varied independently of the dosage of inotrope 
infused.  Thus, while a certain dobutamine 
dosage was infused, a plot of mean PAP 
versus cardiac index was constructed by 
varying cardiac output utilizing inferior vena 
cava occlusion or the opening of an arteriovenous fistula.  The mean PAP versus flow plot is considered a more 
reliable method of determining PVR than one-point determinations thereof (Lejeune, Naeije et al. 1987).  Their 
conclusions indicate that dobutamine does not inhibit HPV at dosages below 10 ug.kg-1.min-1, but does do so at 
levels greater than this (Capan, Turndorf et al. 1990; Lejeune, Naeije et al. 1987).  In their other study on this topic, 
they discriminate between the effects of dobutamine in “hypoxic” (FiO2 0.125) and “hyperoxic” (FiO2 0.4) lungs.  
When the alveolar oxygen tension was low (as it was in the NDL in the current study), Lejeune and colleagues 
describe that dobutamine induces a progressive dose dependent decrease in pulmonary vascular resistance.  
However, no pulmonary vasodilatation was observed when the FiO2 was 0.4 (hyperoxic lungs) (Figure 4.8.2) 
(Lejeune, Leeman et al. 1987).  An increase in PA pressure would have diverted more blood to the NDL.  This could 
have increased shunt fraction and decreased arterial oxygenation (Pagel and Warltier 1997; Slinger and Scott 1995; 
Benumof 1991; Capan, Turndorf et al. 1990).  Mean PAP rose to its highest level (24.9 ± 6.2 mm Hg) when 
dobutamine 7 ug.kg-1.min-1 was administered but shunt fraction did not rise during OLA during this step.   
 
It must be noted that in the current study, even if the administration of dobutamine had resulted in an increase in 
shunt fraction, the very high levels of venous oxygenation would have ensured that arterial oxygenation would not 
have been deleteriously affected.  However, the studies by Mathru and colleagues, Nomoto and Kawamura and the 
current study demonstrate that under usual clinical conditions and low-nornal levels of venous oxygenation during 
OLA in the LDP, the administration of low dosages of dobutamine do not increase shunt fraction.  In fact, the 
beneficial effect of the increase in cardiac output on venous oxygenation uniformly resulted in a benefit in arterial 
oxygenation in the study by Mathru and colleagues, and probably in the Nomoto and Kawamura study.   Although 
pulmonary vasodilatation caused by dobutamine remains an area of concern, there is no evidence that its 
administration worsens arterial oxygenation in humans subjected to OLA in the LDP.  The effects of dobutamine on 
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Figure 4.8.4 The increase in oxygen consumption 
during OLA in pigs administered isoprenaline.  “Overall, there 
was an increase in oxygen consumption (mean 16.6 ± 18.4 
ml.min-1, p = 0.038)”.  Redrawn from Russell and James, 1999 
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shunt fraction are not the only factors to consider.  It is of more relevance to be concerned about the effects of 
dobutamine on all the components of shunt (i.e. both the amount of blood passing via the shunt and the venous 
oxygen content) when considering the effects of an inotrope on arterial oxygenation.   
 
Oxygen insufflation down the NDL would have ensured that at least a proportion of the NDL’s alveoli would have 
been oxygenated (Rees and Wansbrough 1982b).  Increases in cardiac output and PA pressure due to dobutamine 
and subsequent diversion of blood to the NDL could possibly have resulted in the shunted blood being exposed to 
alveoli that contained oxygen.  Therefore, the effects of the increase in “shunt” may have been limited by this 
manoeuvre.  If this manoeuvre had not been conducted, patients may have experienced a decrease in oxygenation 
as is observed when patients with low V/Q units who are administered dobutamine (Russell and James 2000).   
 
In the current study, infusions of dobutamine did not increase oxygen consumption.  The question as to whether 
catecholamines increase oxygen consumption by both positive inotropic effects and effects on peripheral tissues has 
been investigated by Kazai and colleagues.  In two of the three studies he and his colleagues have published on the 
topic, 6 ug.kg-1.min-1 of either dopamine or dobutamine were administered during cardiopulmonary bypass while the 
heart was cross clamped and cardiopleged (Karzai, Lotte et al. 1996; Karzai, Gunnicker et al. 1996).  Dobutamine, 
but not dopamine, increased oxygen consumption by 11%.  Bhatt and co-workers studied healthy awake physician 
volunteers (Bhatt, Hutchinson et al. 1992).  Administration of dobutamine 2.5, 5 and 7.5 ug.kg-1.min-1 produced an 
increase in oxygen consumption from 128 ± 6.1 to 159 ± 8 ml.min-1.m-2 (p < 0.05).  It is noteworthy that a linear 
relationship between oxygen consumption and delivery was seen in this study (Bhatt, Hutchinson et al. 1992).  A 
similar, relationship was observed in the current study (Figure 3.5.6 and 3.5.7).  However, the reasons why VO2 did 
not increase during the administration of dobutamine during OLA in the present study are unclear. 
 
In summary, with regard to oxygen flux during OLA in the dobutamine group, the following results were produced: 
6. Induction of anesthesia and the approximately 1O Celsius decrease in temperature induced a 39% 
decrease in VO2.  However, both cardiac output and oxygen delivery were unchanged during two-lung 
anesthesia when compared to the awake baseline state.  The consequence was an increase in S O2 from 
75.1% ± 5.7 to 89.9% ± 4.7 and P O2 from 5.4 ± 0.5 to 8.6 ± 1.7 kPa during two-lung anesthesia.   
7. Initiation of OLA resulted in an increase in cardiac output even before dobutamine was administered.  
However, no change in VO2 was noted.  This improved the DO2/VO2 ratio but resulted in no change in the 
already high P O2 (9.0 ± 1.7 kPa) and S O2 (90.6 ± 4.7 %) compared with the values observed during 
two-lung anesthesia. 
8. Dobutamine caused pulmonary vasodilatation. 
9. Arterial oxygenation was not improved and neither was shunt worsened by dobutamine administration. 
 
In conclusion, under conditions in the present study, dobutamine administration during OLA did not improve, but 
maintained the already high venous and arterial oxygenation compared with OLA alone.  Therefore the study 
hypothesis, that dobutamine would induce improvement in RVF and the increase in cardiac output during OLA 
would improve arterial oxygenation, does not hold in the current study.  The hypothesis must therefore be rejected.   
This is in contrast to the findings of Mathru et al, and Nomoto and Kawamura who demonstrated that inotrope 
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administration resulted in an increase in arterial oxygenation.    
 
The different results are not at odds with each other.  The differences can be explained in the following way.  
Conditions in the current study resulted in a favourable DO2/VO2 ratio and a high starting P O2.  Therefore the 
venous saturations were on the flat part of the oxygen dissociation curve and on the flat part of the Kelman curve.  
Further increases in cardiac output and the DO2/VO2 ratio would not be expected to, and did not, increase P O2, 
S O2, or C O2.  Thus, arterial oxygenation content and saturation did not change on the increase in cardiac output 
associated with the administration of dobutamine.  In contrast, in the Mathru study, the low starting venous 
saturations and tensions were improved by increases in the DO2/VO2 ratio.  As the venous starting point on the 
oxygen dissociation curve was “low,” significant benefit in arterial oxygenation was obtained on increasing cardiac 
output.  These observations are confirmed by Kelman’s graphs (Figures 4.4.2.1 and 4.4.2.3). 
 
Another area of concern is that pulmonary vasodilatation caused by dobutamine may result in arterial hypoxemia as 
exemplified in Russell and James’ animal study.  However, there is currently no evidence that the administration of 
dobutamine in dosages of up to 7 ug.kg-1.min-1 increases shunt and worsens arterial oxygenation in humans 
subjected to OLA in the LDP.  The vasodilatory effects of dobutamine resulting in a possible increase in shunt 
fraction are not the only factor to consider when studying its effects on arterial oxygenation.  It is of more relevance to 
be concerned about the effects of a drug on all aspects of the shunt that affect arterial oxygenation (i.e. the shunt 
fraction and the venous oxygen content) when considering the effects of an inotrope on arterial oxygenation.   
4.9 Extrinsic and intrinsic PEEP and OLA 
The hypothesis to be examined states that PEEP applied to the DL will restore FRC during OLA.  This will not only 
return low V/Q units towards normal with an improvement in arterial oxygenation, but also have salutary effects on 
PVR and cardiac output (Cohen and Eisenkraft 1996; Cohen, Eisenkraft et al. 1988; Cohen, Thys et al. 1985a; 
Baehrendtz, Bindslev et al. 1983).  PEEP will therefore improve RV performance.  Thus, the application of DL PEEP 
will increase cardiac output and the improved DO2/VO2 ratio will advantage tissue, and thereby arterial oxygenation.  
This concern expressed for both circulation and restoration of low pulmonary V/Q ratios respects the concept of “best 
PEEP” (Inomata, Nishikawa et al. 1997; Benumof 1991).  It was further hypothesised that the decrease in DL PVR 
induced by PEEP will decrease diversion of blood to the NDL, decrease shunt and improve arterial oxygenation.  
4.9.1 NDL PEEP5:  hemodynamics, oxygenation and intrinsic PEEP 
Surprisingly few studies have concerned themselves with the effect of “small” amounts of PEEP on either 
hemodynamics or oxygenation during OLA (Capan, Turndorf et al. 1990; Alfery, Benumof et al. 1981; Aalto, 
Heinonen et al. 1975).  Alfery and colleagues demonstrated that in dogs undergoing OLA, the administration of DL 
PEEP5 compared with ZEEP, favourably influenced both shunt and arterial oxygenation (Alfery, Benumof et al. 
1981).  Abe and colleagues also demonstrated a beneficial effect on PaO2 of 4 cm H2O of PEEP applied to DL.  This 
was unaccompanied by changes in cardiac output or venous oxygen saturation (Abe, Mashimo et al. 1998). 
 
In the current study, the application of 5 cm H2O PEEPe to the DL did not result in a uniform decrease in the indices 
of opposition to pulmonary blood flow.  There was a 57% decrease in characteristic impedance on administration of 
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PEEP5 compared to baseline values when the patients were awake.  Another index of opposition to pulmonary flow, 
PA elastance, increased by 25% on application of DL PEEP5 compared to when the patients were awake.  However, 
the application of PEEP5 did not change the indices of opposition to pulmonary flow compared to when OLA alone 
was being conducted.  Neither did the application of PEEP5 improve the indices of RV performance or the 
parameters of oxygenation compared to the OLA step when external PEEP was not applied.  These findings do not 
support the stated hypothesis of this section.  Aalto-Setala and colleagues (Aalto, Heinonen et al. 1975) similarly 
demonstrated the failure of PEEP5 compared with ZEEP to increase oxygenation or change hemodynamics during 
OLA in humans undergoing lobectomy.  Surely, the application of 5 cm H2O of PEEP to the DL during OLA would 
have restored lung volume to close to baseline levels, decreased PVR and resulted in an improved cardiac output 
and venous and arterial oxygenation in our patients (Cohen 1995; Benumof 1991).  In addition, the question needs to 
be asked why hemodynamics and oxygenation in the PEEP5 step did not differ from OLA when PEEPe was not 
applied?  The answer probably lies therein that intrinsic PEEP exercises a ubiquitous presence during OLA (Ducros, 
Moutafis et al. 1999; Inomata, Nishikawa et al. 1997; Bardoczky, Yernault et al. 1996; Yokota, Toriumi et al. 1996; 
Bardoczky, d'Hollander et al. 1994; Slinger, Hickey et al. 1989).   Levels of PEEPi in the current and other studies 
were similar in degree to that which was produced by applying 5 cm H2O PEEPe during OLA. 
Figure 4.9.1.1 
The effects of varying expiratory time on the amount of intrinsic PEEP (indicated by the “total PEEP on the “y axis” in the 
diagram above) during OLA. Data represented as means and the error bars represent one standard deviation from the mean.  
Tidal volume was 10 milliliters per kilogram body weight and respiratory rate was 10 breaths per minute during both two and 
one lung ventilation (OLV) with and without the addition of extrinsic PEEP (OLA + 5 cm PEEP).  Measurements were made at 
expiratory times of 2.4, 3.9 and 4.5 seconds, which correspond, with I:E ratios of 1.5:1, 1:2 and 1:3.  The intrinsic PEEP was 
higher during OLA without extrinsically applied PEEP than during two-lung ventilation (p = 0.001).  Furthermore, intrinsic 
PEEP increased as expiratory time decreased (p = 0.001).   
 
Redrawn from Slinger, Hickey et al, 1998. 
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Intrinsic PEEP ranged between 3 ± 2.7 to 5 ± 3.1 cm H2O during OLA in the control group.  The development of 
PEEPi is governed by the ability of the dependent lung to empty the delivered tidal volume by the end of expiration 
(Rossi, Polese et al. 1995; Tobin and Lodato 1989; Marini, Culver et al. 1985). The factors to be taken into account 
are:  
¾ Inspired tidal volume, 
¾ The pulmonary time constant which is determined by the product of compliance of the lung and chest wall 
and resistance to expiration (Slinger and Hickey 1998; Rossi, Polese et al. 1995; Bardoczky, d'Hollander et 
al. 1994; Simbruner 1986) and, 
¾ The time available for expiration (Slinger, Hickey et al. 1989; Tobin and Lodato 1989). 
 
Each factor needs to be independently addressed.  The functioning of the constant flow generator type ventilator 
employed in the current study (Ohmeda 7700) would not have been significantly impaired by the increased airway 
resistance attributable to ventilation being conducted via a relatively narrow lumen endotracheal tube during OLA.  
Thus, the set tidal volume would have been delivered during inspiration irrespective of this increased resistance 
(Mushin, Rendell-Baker et al. 1980).  However, the whole of the delivered tidal volume needs to be expired by the 
end of expiration to prevent gas retention from occurring (Myles 1996).  The tidal volumes delivered in this study 
were 6 to 7 ml.kg-1.  These are relatively small compared to conventionally used tidal volumes.  This relatively small 
volume would have limited the development of excessive amounts of PEEPi during OLA (Myles 1996).  Yokata and 
colleagues delivered a tidal volume of 8 ml.kg-1 at a breath rate of 12 per minute to the DL (Yokota, Toriumi et al. 
1996).  These ventilatory settings were close to those that were used to ventilate our patients.  They demonstrated 
similar values of PEEPi (3.2 ± 3.3 cm H2O) as were observed in the current study.  In Inomata’s study a tidal volume 
of 8 ml.kg-1 via a left sided 37 French Mallinckrodt® DLT resulted in PEEPi of 4 ± 2 mm Hg (5.32 ± 2.7 cm H2O).  
However, this relatively small tidal volume was delivered at a frequency of 16 breaths per minute, which would have 
limited time available for expiration (Inomata, Nishikawa et al. 1997). 
 
In the current study, the patients were administered a non-depolarising muscle relaxant and moderately high 
dosages of alfentanil.  The patients did not breathe spontaneously and expiration was purely a passive process.  
Therefore the elastic recoil of the lung and chest wall was the driving force for expiration.  The decrease in FRC on 
induction of anesthesia and the additional decrease in DL volume imposed by the LDP decreases lung compliance 
(Benumof 1991; Nunn 1990; Klingstedt, Hedenstierna et al. 1990).  Such decreases in lung and chest wall 
compliance will facilitate passive expiration.   
 
On the other hand, in severe COPD, significant destruction of pulmonary elastic tissue occurs.   This results in a 
decrease in the elastic recoil of the lung (Rossi, Polese et al. 1995).  Szegedi points out that patients with COPD do 
not develop decreases in FRC or atelectasis during anesthesia that would decrease compliance and aid lung 
emptying (Szegedi 2001).  It is not surprising therefore, that the amount of PEEPi in this and other studies was 
inversely related to the severity of COPD (Ducros, Moutafis et al. 1999; Bardoczky, Yernault et al. 1996; Yokota, 
Toriumi et al. 1996).   
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Significant relationships between the extent of preoperative lung function impairment and the amount of PEEPi exist 
in this study.  The strongest of these is that between preoperative FEV1 and intrinsic PEEP during OLA (Table 3.5.6 
and Figures 3.5.12, 3.5.13 and 3.5.14).  Albeit the strengths of these relationships were relatively weak, they are 
comparable with those described in other studies (Bardoczky, Yernault et al. 1996; Yokota, Toriumi et al. 1996). #  
 
What can be established from the above discussion is that 3 to 5 cm H2O PEEPi occurred in our patients.  This 
amount of PEEPi was related to the preoperative severity of obstructive lung disease.  It is not possible to draw 
conclusions about PEEPi in the dobutamine and PEEP groups because of the small number of subjects (2 in each 
group) that were studied.  There is however no reason to suspect that similar amounts of PEEPi did not occur during 
OLA in the other groups of the current study. 
 
The poor elastic recoil forces governing expiration in patients with COPD are aggravated by their increased 
expiratory resistance (Rossi, Polese et al. 1995; Tobin and Lodato 1989).  Bardoczky and associates demonstrated 
that airway resistance was significantly higher during OLA in patients who exhibited PEEPi (2.4 cm H2O.l-1.s) than 
those who did not (1.7 cm H2O.l-1.s) (Bardoczky, d'Hollander et al. 1994).  Factors influencing airway resistance 
during OLA include the patient’s own airway, DLT lumen, DLT connectors and breathing circuit resistance.  These 
factors explain the presence of PEEPi that occurs even in patients with normal lung function during OLA (Inomata, 
Nishikawa et al. 1997; Bardoczky, d'Hollander et al. 1994).  It is also important to note that a certain amount of PEEP 
is attributable to the expiratory valve on the Ohmeda 7700 ventilator that was used in the current study.  Further 
investigations indicated that a constant pressure gradient of 2 cm H2O over the Ohmeda expiratory valve exists at a 
range of flows from 1 to 10 litres per minute. 
 
An increase pulmonary resistance in the presence of an increased lung compliance will increase the amount of time 
needed to empty a tidal volume delivered to the DL.  When delivering a tidal volume of 10 ml.kg-1 and while varying 
the expiratory time during OLV, Slinger demonstrated that the time available for expiration largely determined the 
amount of intrinsic PEEP present (Slinger, Hickey et al. 1989) (Figure 4.9.1.1).  Tidal volumes of 6 to 7 ml.kg-1 at 
                                                                
# It is noteworthy that a PEEPi of 9.5 cm H2O was measured on two occasions during OLA in one of the patients in 
the dobutamine group who demonstrated severe obstructive airway disease on his preoperative LFT’s.  FEV1 was 
48% of predicted, FEV1/FVC 61%, FEF50 18%, FEF75 8% and ITGV determined by pletysmography 184% of 
predicted for the patient’s age, weight and sex. 
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Figure 4.9.1.2  The analogy of a waterfall over a dam wall is used to explain the effect of external PEEP (the 
downstream pressure) on PEEPi (the upstream pressure) during expiration.  Redrawn from Tobin and Lodato, 1989. 
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respiratory rates of 12 breaths per minute and an I:E ratio of 1:2 were typically employed in the current study.  These 
ventilatory settings resulted in an expiratory time of 3.3 seconds.  The resultant levels of PEEPi do not differ from 
those observed during similar expiratory times in Slinger’s study (Slinger, Hickey et al. 1989).   
 
It is remarkable that neither hemodynamics nor oxygenation differed between the PEEP5 step and the OLA step 
when external PEEP was not applied. The question that arises is what is the relationship between PEEPe and 
PEEPi?  Tobin and Lodato discuss the interaction of PEEPi and PEEPe in terms of a waterfall effect (Figure 4.9.1.2) 
(Tobin and Lodato 1989).  They suggest that externally applied PEEP less than or equal to intrinsic PEEP has no 
effect on intrinsic PEEP.  Only when externally applied PEEP exceeds intrinsic PEEP, is there an effect on the lung 
itself.  However, Rossi and colleagues caution that until a “critical value of somewhat lower than the PEEPi,” is 
reached, external PEEP will not add to intrinsic PEEP (Rossi, Polese et al. 1995).  This means that application of 
PEEPe equal to the initial PEEPi will induce a moderate increase in FRC.  Only values of PEEPe less than 75 to 
85% of PEEPi will not significantly increase the end-expiratory volume (Rossi, Polese et al. 1995).  Therefore Slinger 
and Hickey applied external PEEP in similar amounts to the PEEPi observed during OLA.  This resulted in an 
increase in PEEPi of 1 to 2 cm H2O (Slinger and Hickey 1998; Slinger, Hickey et al. 1989).  Inomata and colleagues 
studied humans in the lateral decubitus position undergoing OLA.  They first determined PEEPi and then applied 
external PEEP equal to PEEPi.  This should, if Tobin and Lodato’s “waterfall theory’ is correct, not have made any 
difference to shunt, PVR, oxygen delivery, or arterial oxygenation (Tobin and Lodato 1989).  However, application of 
the equivalent amount of PEEP to the PEEPi present resulted in these parameters improving to the best levels 
observed in their study.  Application of a further 5 cm H2O PEEP above PEEPi impacted unfavourably on these 
parameters.  Their study is interesting and needs to be viewed in the light that the critical end-expiratory pressure 
below which PEEPe would not increase FRC was probably exceeded in the Inomata study. 
 
The aforementioned observations contain the reasons why no difference in oxygenation or hemodynamics was seen 
with PEEP5 during OLA.  A significant amount of intrinsic PEEP is universally present during OLA (Slinger, Kruger et 
al. 2001; Ducros, Moutafis et al. 1999; Bardoczky, d'Hollander et al. 1998; Inomata, Nishikawa et al. 1997; 
Bardoczky, Yernault et al. 1996; Yokota, Toriumi et al. 1996; Bardoczky, d'Hollander et al. 1994; Slinger, Hickey et al. 
1989).  The levels of extrinsic PEEP in the PEEP5 step do not differ from the levels of PEEPi during OLA in the 
current or other studies (Rossi, Polese et al. 1995; Slinger, Hickey et al. 1989; Tobin and Lodato 1989).  Therefore, 
the presence of intrinsic PEEP will limit the effects of similar amounts of externally applied PEEP: small differences 
between PEEPe and PEEPi will have modest if any impact on oxygenation or hemodynamics 
 
The concern that the use of small tidal volumes may however lead to progressive decreases in lung volume during 
OLA is expressed by various authorities and demonstrated by Khanam and Branthwaite (Cohen 1995; Benumof 
1991; Capan, Turndorf et al. 1990; Flacke, Thompson et al. 1976; Khanam and Branthwaite 1973).  Such decreases 
in FRC and the subsequent development of low V/Q units may be counteracted by the presence of either intrinsic 
PEEP or the application of PEEPe (Inomata, Nishikawa et al. 1997; Myles 1996; Capan, Turndorf et al. 1990).  
Hedenstierna and colleagues studied patients subjected to OLA in the LDP using a tidal volume of 10 ml.kg-1 when 
ZEEP or PEEP10 was applied to the DL (Klingstedt, Hedenstierna et al. 1990).  Using computerized tomography, they 
demonstrated that PEEP10 results in complete (3 of 8 patients) or partial (5 of 8 patients) elimination of DL 
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atelectasis.  Therefore the presence of PEEPi is a likely reason why the small tidal volumes employed in the current 
study did not result in progressive decreases in arterial oxygenation (Benumof 1991; Capan, Turndorf et al. 1980; 
Kerr, Smith et al. 1974; Das, Fenstermacher et al. 1970).   
 
Evidence of the benefit of intrinsic PEEP is contained in Myles’s analysis of Yokota and colleagues’ study (Myles 
1996). This analysis indicated that PEEPi maintains DL volumes and benefits arterial oxygenation during OLA.   
Nonetheless, Bardoczky and colleagues have demonstrated an inverse relationship between intrinsic PEEP and 
PaO2 during OLA.  This emphasises that too much of a good thing can be problematic (Bardoczky, d'Hollander et al. 
1998).  Deleterious effects of intrinsic PEEP are also seen in patients with very low levels of lung elastic recoil.  They 
tend to develop dynamic hyperinflation during OLA.  This may lead to volotrauma (Sivalingam and Tio 1999; Slinger 
1999; Williams, Evans et al. 1996) or life threatening hemodynamic compromise (Sivalingam and Tio 1999; 
Conacher 1998; Myles, Ryder et al. 1997; Myles, Madder et al. 1995; Quinlan and Buffington 1993; Myles and 
Weeks 1992). 
 
Another issue of importance is whether PEEP5 during OLA will be effective in restoring lung volume to preoperative 
levels.   Slinger and colleagues have demonstrated that on the application of PEEP5 to the DL, if the difference 
between the lower inflexion point and the end-expiratory pressure plateau becomes negative, lung volume probably 
increases (Slinger, Kruger et al. 2001).  The aforementioned scenario was associated with an increase in arterial 
oxygenation during OLA.  However, from Slinger and colleagues’ data, it is apparent that the effect of PEEP5 on lung 
volume is unpredictable in individual patients.  In other words, in other subjects in the same study, the application of 
PEEP5 did not result in increases in lung volume or arterial oxygenation during OLA (Slinger, Kruger et al. 2001).  
Rothen and colleagues have demonstrated that an airway pressure of 20 cm H20 sustained for 15 seconds was 
necessary to start recruitment of lung that had become atelectatic during two-lung anesthesia in the supine position 
(Rothen, Sporre et al. 1993).  A sustained airway pressure of 40 cm H20 was needed to almost completely reverse 
the atelectasis associated with anesthesia (Rothen, Sporre et al. 1993).  Tusman and colleagues attempted to 
restore lung volume and arterial oxygenation during OLA by administering a peak airway pressure of up to 40 cm H20 
and PEEP of 20 cm H2O for 10 respiratory cycles (Tusman, Bohm et al. 2002).  A tidal volume of 8ml.kg-1 and 100% 
oxygen was administered during the recruitment manoeuvre.  The recruitment manoeuvre was administered after the 
PA to the lobe being resected had been clamped.  Both DL and the remaining NDL segments were included in the 
recruitment manoeuvre.  The patients were thereafter returned to the OLA state and arterial oxygenation measured 
15 minutes later.  The blood gas during the second period of OLA demonstrated a PaO2 similar to that seen during 
two-lung anesthesia that was significantly higher than that seen during OLA.  The conclusion of this study was that a 
recruitment manoeuvre improves arterial oxygenation during OLA (Tusman, Bohm et al. 2002).  However, this study 
does not unequivocally answer the question whether recruitment manoeuvres are successful to restore arterial 
oxygenation during OLA.  Firstly, both lungs were recruited in the Tusman study.  The authors defend this problem 
by suggesting that recruitment of the NDL would not helpful in restoring arterial oxygenation as all oxygen in the NDL 
alveoli would have been absorbed within 5 to 7 minutes and quote an article authored by Rothen and colleagues to 
support their argument (Rothen, Sporre et al. 1995).   It may also be speculated that similar amount of atelectasis 
would have occurred in the DL within the same period of time (Rothen, Sporre et al. 1995; Rothen, Sporre et al. 
1995a).  However, this study does not convincingly answer the question whether recruitment of the DL alone 
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improves arterial oxygenation.  Secondly, Tusman and colleagues also suggest that a more pronounced HPV 
response may occur after repeated periods of hypoxia.  This argument detracts from their contention that recruitment 
itself improves oxygenation during OLA.  Therefore, it appears as if the methodology used in this study does not 
conclusively address the question of whether a recruitment manoeuvre improves arterial oxygenation during OLA.   
 
In summary, when PEEP5 was applied to the DL during OLA in the current study: 
4. Right ventricular function, hemodynamics, oxygen flux nor arterial oxygenation was affected by the 
application of PEEP5 compared to the step when no external PEEP was applied. 
5. Significant amounts of intrinsic PEEP were present during OLA in the control group patients.  The degree 
of intrinsic PEEP was weakly related to the derangement in preoperative LFT’s.   
6. The most likely reason why PEEP5 did not make a difference to oxygenation or hemodynamics is the 
existence of similar amounts of intrinsic PEEP during OLA.  These findings confirm Myles’s contention that 
low levels of intrinsic PEEP may have salutary effects on oxygenation during OLA (Myles 1996). 
 
Therefore the study hypothesis that administration of PEEP to the DL improves its FRC, that restores low V/Q ratios 
and PVR thereby improving RV function and systemic and arterial oxygenation has to be rejected with regard to the 
administration of PEEP5 to the NDL 
4.9.2 NDL PEEP10 during OLA 
Unfortunately, only 7 subjects were enrolled in the PEEP10 step.  Consequently, intragroup comparisons at times 
approached, but did not reach, statistical significance.  This was in spite of a clinical difference being suspected. 
Therefore, because of the small number of subjects included in the PEEP10 step, real differences may have been 
missed, or in other words, a beta error may have been incurred (Coetzee 2001). 
 
 ZEEP 
DL 
PEEP9 
DL 
PEEP10 
DL 
PEEP16 
Blood flow to NDL as % of total cardiac output 43 50 55 65 
Blood flow to DL as % of total cardiac output 57 50 45 35 
 
Table 4.9.2.1 Data from Hedenstierna and colleagues study (Hedenstierna, Baehrendtz et al. 1984).  
PEEPe is measured in cm H2O. 
 
During the application of 10 cm H2O PEEP to the DL, pulmonary arterial elastance and resistance was greater than 
values calculated for two-lung anesthesia and one lung anesthesia without application of extrinsic PEEP (Table 
3.3.3.12).  Inomata also observed increases in PVR when higher levels of PEEP are delivered to the DL (Inomata, 
Nishikawa et al. 1997).  Hedenstierna and colleagues conducted an elegant study in patients without clinical, ECG or 
roentographic signs of cardiopulmonary disease comparing the effects of PEEPe and ZEEP during one and two-lung 
anesthesia in the lateral decubitus position (Hedenstierna, Baehrendtz et al. 1984).  They described the distribution 
of pulmonary perfusion when varying amounts of PEEP were applied to the DL.  During IPPV to both lungs without 
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PEEPe, the cardiac output was distributed so that 57% went to the DL and 43% to the NDL.  On application of 9 cm 
H2O PEEP to the DL, the distribution of pulmonary blood flow to each lung did not differ.  However, on application of 
10 and 16 cm H2O PEEP to the DL, perfusion to that lung decreased to 45 and 35% respectively.  The mechanism 
involves an increase in lung volume of the DL to such a degree that lung volume exceeds FRC and alveolar vessel 
compression occurs which increases pulmonary vascular resistance.   
 
The indices of RV performance (RVSWI, RVEF) were unchanged during OLA in the PEEP10 step (Table 3.3.3.15).  
However, stroke volume decreased during PEEP10.  This is remarkable as only one other change in SV was 
recorded in either the control or the dobutamine groups.  The 25% decrease in cardiac index from the PEEP5 to the 
PEEP10 epochs creates the suspicion that PEEP10 decreased cardiac output: nonetheless, statistical analysis 
indicated that this was not statistically significant.  This lack of a significant difference is most likely due to a type 2 or 
beta error referred to at the beginning of this section.  The question can be asked whether this decrease in stroke 
volume is clinically significant?  The answer is that the cardiac indices and stroke volumes in this study were 
relatively “high”.  “High” here indicates that these cardiac indices and stroke volumes at baseline were significantly 
above the inflexion point of the “Kelman and Nunn” curve (Figure 4.4.2.3).  A PEEP10 induced 25% decrease in 
stroke index (or cardiac index if it had occurred) would not have resulted in circulatory or oxygenation on the basis of 
a decrease in venous oxygenation.  However, in another group of patients, with hemodynamics that are more 
marginal, a 25% decrease in cardiac output may cause problems with venous and thus arterial oxygenation.   
 
RVEDVI did not change from baseline during the control, dobutamine, or PEEP5 groups.  However, administration of 
10 cm H20 PEEP to the DL resulted in RVEDVI decreasing by 25% from baseline (Table 3.3.3.11).  Similar 
magnitudes of decreases in RVEDVI with PEEP10, have been reported during two-lung ventilation (Groeneveld, 
Schreuder et al. 1990; Assmann and Falke 1988; Eddy, Rice et al. 1988; Biondi, Schulman et al. 1988; Baehrendtz, 
Bindslev et al. 1983).   
 
It is apparent that right ventricular SV was deleteriously affected by these excessive levels of PEEP for two reasons: 
firstly the increase in PVR and secondly the decrease in end-diastolic volume of the RV.  Which of these two factors 
dominated this scenario?  Albeit PVR increased by 33% during the administration of PEEP10 and attained the highest 
levels recorded in this study, similar orders of magnitude of increase in opposition to pulmonary flow have been 
shown not to impair RV performance.  Fourie demonstrated that PA pressure has to increase to more than 250% of 
baseline before RV performance even begins to be compromised (Fourie 1989).  In conclusion, the significant finding 
of this study is that PEEP10 results in a decrease in right ventricular preload.  The normal RV acts as a preload 
dependent flow pump (Conrad 2001; Hennebry and Gerstenblith 2001; Nelson, Safcsak et al. 2001; Boldt, Kling et al. 
1990) and PEEP10 impairs its ability to deliver a stroke volume.  Only at higher levels of PEEP (15 to 20 cm H2O) do 
severe increases in PVR result to the extent that RV afterload is significantly affected (Rossi, Polese et al. 1995). 
 
The decrease in SV with the application of PEEP was accompanied by a decrease in oxygen delivery.  Oxygen 
delivery achieved its minimum and maximum levels respectively during OLA with PEEP10 and without PEEPe (Table 
3.3.3.16).  The administration of PEEP5 or PEEP10 did not affect oxygen consumption.  Thus, the ratio of oxygen 
delivery to consumption decreased.  This resulted in both mixed venous saturation and tension decreasing to their 
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lowest levels (79.0 ± 9.4 % and 7.0 ± 1.9 kPa respectively) during OLA.  The consequence was that the proportion of 
oxygen extracted by the tissues rose to the highest fraction (OER = 0.20) seen in any group during anesthesia albeit, 
statistical significance was not achieved (p = 0.066).  The arterio-venous oxygen content difference also increased to 
its highest level during OLA with the application of PEEP10.  This implies that systemic oxygenation declined to its 
lowest margin of safety during OLA, albeit these levels of oxygenation were still far in excess of the human metabolic 
requirements during anesthesia.  The decrease in PaO2 to 25.3 ± 16.1 kPa with administration of PEEP10 was of 
minimal clinical significance, as oxygen saturation never decreased below 95.7 ± 7.7 %.  However, if the large safety 
margin induced by the decrease in VO2 produced by this particular anesthetic technique had not been present, and 
these patients had not been operating from a baseline that had plenty of reserve, PEEP10 could conceivably have 
threatened both tissue and arterial oxygenation. This decrease in oxygenation during the PEEP10 epoch is reflected 
by the relationship between cardiac index and CaO2 now being on a much steeper part on the Kelman curve (Figure 
4.4.2.3). 
 
A further contribution to decreased arterial oxygenation with the application of PEEP10 to the DL could be an increase 
in DL PVR.  This would have had the effect of diverting blood to the NDL (Hedenstierna, Baehrendtz et al. 1984).  
That arterial oxygenation decreased during PEEP10 with potential increase in diversion of blood to the NDL, lends 
support to observations that oxygen insufflation to the NDL did not improve oxygenation.  Capan and colleagues 
observed that oxygen insufflation down the NDL while PEEP10 was administered to the DL did not benefit arterial 
oxygenation (Capan, Turndorf et al. 1980).  
 
This deleterious effect of PEEP10 on the RV also had a spill over effect on the systemic circulation.  Mean arterial 
blood pressure (MAP) deteriorated during OLA when both 5 and 10 cm H2O DL PEEP was applied (Table 3.3.3.17).  
This decrease in MAP did not exceed 25% during either level of PEEP.  This is a clinically tolerable decrease.  
However, hypotension presented a clinical problem in individual patients in whom systolic pressure decreased by as 
much as 55 to 65% in the PEEP5 and PEEP10 groups respectively.  For example, in one of the patients who 
demonstrated a severe decrease in MAP, RVEDVI fell to 69 ml.m-2 and PVR was 180 dynes.secs.cm-5.  In another 
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Figure 4.9.2.1 The therapeutic index for PEEP during OLA is illustrated by juxtaposition of pulmonary compliance and 
PVR-lung volume curves.  A. If the FRC of the DL is low, addition of PEEP will decrease PVR.  B.  If the DL volume is 
however increased by the application of PEEP, this may start having deleterious effects on lung volume and PVR.  This 
emphasizes the need for a measure of DL volume during OLA.  Redrawn from Capan, Turndorf and Miller, 1990. 
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individual who became severely hypotensive, severe preoperative hyperinflation was present on preoperative LFT’s 
(intrathoracic gas volume measured by body plethysmography was 180% of predicted).  This observation prompted 
an investigation of the relationship between intraoperative hypotension and the preoperative ITGV.  However, no 
relationship was evident between these two variables (Table 3.5.7).  The 25% decrease in MAP during PEEP 
administration could also elicit concern about RV coronary perfusion pressure.  RV coronary perfusion pressure# was 
78.3 mm Hg when the patients were awake and 66.6 mm Hg during OLA without PEEP.  These values fell to 48.9 
and 49.4 mm Hg with PEEP5 and PEEP10 cm H2O respectively (Table 3.3.3.17).  In spite of this decrease in RV 
coronary perfusion pressure, no evidence of ischemic RV dysfunction was present as evidenced by a lack of 
changes in the ECG or hemodynamic parameters (CVP, RVEDVI or RVEF).  These levels of RV coronary perfusion 
pressure are higher than the pressures at which circulatory collapse occurred in experimentally produced increases 
in PVR (Vlahakes, Turley et al. 1981).  Furthermore, the predominant reason for the circulatory impairment in the 
patients enrolled in the current study was a decrease in preload.  This decrease in RVEDV probably decreases wall 
tension so that RV myocardial oxygen demand did not increase. 
 
DL PEEP10 has been shown to produce divergent effects on oxygenation (Capan, Turndorf et al. 1990).  Most studies 
demonstrated a decrease or no change in arterial oxygenation on administration of PEEP10 (Cohen, Eisenkraft et al. 
1988; Katz, Laverne et al. 1982; Capan, Turndorf et al. 1980; Aalto, Heinonen et al. 1975; Tarhan and Lundborg 
1970).  Why, in the current and other studies, do increasing levels of PEEP not produce uniform and progressive 
effects on parameters of circulation and oxygenation as demonstrated by Inomata and colleagues?  One of the 
inclusion criteria in the Inomata study was that their patients had to have ‘normal’ lungs preoperatively.  An important 
factor that is often not considered is the diversity of pre-and intraoperative lung pathology to which a uniform mode of 
therapy is applied.  Cohen and co-workers shed light on this when they demonstrated that DL PEEP10 improved 
oxygenation in patients with PaO2 values of less than 10.6 kPa (Cohen and Eisenkraft 1996; Cohen 1995; Cohen, 
Thys et al. 1985b).  They attributed this to restoration of the DL FRC in those patients in whom intraoperative DL 
volume was low (Figure 4.9.2.1).  They postulated that this had the effect of optimising DL PVR and thereby less 
blood was diverted to the NDL (Cohen and Eisenkraft 1996; Cohen, Thys et al. 1985a; Cohen, Thys et al. 1985b).  
This can be seen by the shunt fraction decreasing from 42 ± 8 to 31 ± 17 % on application of PEEP10 to the DL in 
Cohen et al’s study.   
 
One aspect that Cohen did not highlight in his paper was the influence of PEEP on cardiac output and cellular 
oxygenation during OLA.  On inspection of the data in their paper (Table 4.9.2.2), the decrease in cardiac output that 
they observed with DL PEEP10 was not accompanied by a decrease in S O2 as occurred in our study.  Kelman and 
colleagues predict that the deleterious effects of PEEP on cardiac output will negatively affect CaO2 in the presence 
of a large shunt (Kelman, Nunn et al. 1967).   
 
                                                                
# RV coronary perfusion pressure was shown by Cross to be “ the planimetrically measured difference between the pressure in 
the ascending aorta and the RV pressure” (Cross 1961).  He demonstrated, using this method in the non-distended canine RV 
with a pressure of less than 5 mm Hg, that “right coronary flow was linearly related to the mean right coronary driving (perfusion) 
pressure”.  In the absence of the ability to do planimetry, it was considered reasonable to use the difference between mean 
systemic arterial and mean PA pressures as an index of RV coronary perfusion pressure. 
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Thus, the hypothesis that administration of PEEP to the DL improves its FRC, restores low V/Q ratios and PVR and 
thereby improves RV function and systemic and arterial oxygenation is rejected.  
 
The effects of PEEP on hemodynamics and oxygenation during OLA may be summarised as follows: 
1. In patients with a significant decrease in DL volume during OLA, the application of the ideal amount of 
PEEP will lead to the optimisation of FRC.  This will decrease venous admixture occurring in the DL.  
Furthermore, optimisation of DL volume will decrease PVR and PAP, and less blood will be diverted to the 
NDL.  These mechanisms will decrease shunt in the subgroup of patients experiencing a decrease in DL 
volume.  This has been seen in both the Cohen and Inomata studies (Inomata, Nishikawa et al. 1997; 
Cohen and Eisenkraft 1996).  In the current study, intrinsic PEEP (3 ± 3 cm H2O) appears to result in a 
lung volume that had no deleterious effects on PVR, the RV and the circulation.  PEEP5 was almost 
indistinguishable from OLA without external PEEP in these regards. 
2. However, greater (excessive) amounts of PEEP may have deleterious cardio-respiratory effects.  PEEP10 
commonly leads to decreases in stroke volume, as seen in our study, and cardiac output, as seen in Cohen 
and colleagues’ study (Cohen and Eisenkraft 1996).  This decrease in cardiac output is predominantly due 
to a decrease in preload, as PVR does not increase to levels that are known to impair RV performance.  
The decrease in the DO2/VO2 ratio that is induced by excessive PEEP, predictably decreases P O2 and 
can potentially lead to impairment of arterial oxygenation.   
3. Increases in DL PVR will divert pulmonary blood flow to the NDL and increase shunt. Oxygen insufflation 
down the NDL during DL PEEP10 does not appear to oxygenate this diverted blood (Capan, Turndorf et al. 
1980). 
 
The take home message is that optimising DL volume will play a crucial role in determining arterial oxygenation 
(Conacher 1997; Cohen, Eisenkraft et al. 1988).  The therapeutic index for PEEP is narrow and the anesthesiologist 
needs to know firstly when the lung volume of the DL approaches FRC and secondly, how to avoid dynamic 
hyperinflation of that lung (Inomata, Nishikawa et al. 1997).  There are multiple ways to address this problem: 
 
1. From the beginning of OLA, ventilation practices need to be adapted according to the pathology of the lung 
that is being ventilated (Bardoczky, d'Hollander et al. 1998; Bardoczky, Yernault et al. 1996).  The 
physician should study the characteristics of the lung to be ventilated during OLA before surgery 
commences.  Optimal levels of DL PEEP during OLA for patients with normal lungs most likely lie between 
3 to 8 cm H2O (Abe, Shimizu et al. 1998; Inomata, Nishikawa et al. 1997). 
 
2. However, “correct approaches” to the problem do not guarantee that DL volume will be normalised.  The 
interaction of different lung pathologies and intrinsic PEEP during OLA result in small safety margins for 
both PEEPe and PEEPi (Benumof and Alfery 2000; Benumof 1991).  Monitoring methods need to be 
developed to determine how much PEEPe needs to be applied to restore lung volume.  The same 
monitoring should inform decisions whether excessive amounts of PEEPi are developing that require 
lengthening of the expiratory time, a decrease in inspired tidal volume and the allowance of (further) 
hypercapnia.  Monitoring could take one or more of the following forms 
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a. The ideal would be if lung volume could be measured continuously during OLA.  Options include: 
i. Stenqvist, Olegard and colleagues have described a method for FRC monitoring based 
on quantification of oxygen consumption and carbon dioxide production during a short 
apnea.  End-tidal (approximately alveolar) oxygen and carbon dioxide concentrations 
were measured before and after a short apnea of 8 to 12 seconds.  FRC was 
calculated according to standard washin/washout formulas (Stenqvist, Olegard et al.  
2002). 
ii. Fretchner and colleagues have described a method of using washin and washout of 
nitrogen to determine FRC in mechanically ventilated patients in the intensive care unit 
(Fretschner, Deusch et al. 1993).   
b. The continued occurrence of dependent lung flow just before the next inspiration commences 
indicates that not enough time has elapsed to allow for the completion of expiration.  This can be 
determined in one of two ways: 
i. The display of flow-volume loops to determine whether expiration is complete before a 
new breath is delivered has recently been reported during OLA (Szegedi 2001; 
Bardoczky, d'Hollander et al. 1994) and, 
ii. The display of a graph of flow versus time can also determine that expiratory flow is sill 
occurring at the time the next inspiration starts. 
c. Measuring intrinsic PEEP using pressures at the distal (patient) end of the DLT could provide an 
indication of whether PEEP was present at the end of expiration.   
d. Pressure-volume loops could indicate autoPEEP in the following ways: 
i. The pressure in the airways at the end of expiration did not return to zero.   
ii. Either a flattening of the slope at the top end of the pressure-volume loop or a 
decrease in the slope of the pressure-volume loop as bigger tidal volumes are 
administered indicate that compliance is decreasing due to over distension of the 
ventilated lung.   
iii. Titrating PEEP to a value at or slightly above the inflexion point on the pressure-volume 
loop (the so-called “open-lung” approach to ventilation) has been suggested to optimise 
low lung volumes (Mergio, Volpi et al.  2001).   
e. Ventilatory rate can be adjusted by measuring the (average) time constant of expiration.  (This 
measurement would assume that expiration was a monoexponential process and that expiration 
of most lung units is represented by the dominant time constant).  Using this time constant, the 
time needed to empty the lung of a predetermined percentage of the inspired volume could be 
calculated.  For instance, in Slinger and Hickeys study of PEEP and intrinsic PEEP during OLA 
(Slinger and Hickey 1998), they reported that the time constant during OLA was 0.8 ± 0.5 
seconds.  Using such information, the anesthesiologist could then determine the expiratory time 
period needed to permit a certain percentage of the tidal volume that is expired.  After a period of 
time equal to three or four time constants, expiration of the previous breath (if inspiration 
occurred from FRC) would be 95% or 98.2% complete.  Using data from the Slinger study, 3.2 ± 
2 seconds would need to be permitted during OLA for 98.2% of the previous breath to be 
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exhaled.  The problem with this approach is that the “air-trapping” would be progressive and the 
amount of gas above FRC in the ventilated lung would be difficult to determine.   
f. Static compliance can be measured pre- and intraoperatively.  Maintaining similar static 
compliance levels intraoperatively by adjusting ventilation to develop or prevent PEEPi, or 
applying PEEPe, may provide some answers to this vexing problem.   
g. The difference between arterial and end-tidal carbon dioxide partial pressures (a-ET PCO2) has 
been used to determine optimal levels of PEEP.  At optimal PEEP levels, lung volumes and, 
oxygenation were optimal; the lung was ventilating at the inflexion point of the pressure-volume 
curve.  It was demonstrated that at this level of PEEP, the a-ET PCO2 difference reaches its 
lowest level.  This approach has been used to titrate PEEP with the aim of optimising lung 
volume in patients with ARDS (Blanch, Fernandez et al.  1987).   
 
Table 4.9.2.2 Oxygenation and hemodynamic data for patients with PaO2 < 10.6 kPa on OLA.  Adapted from 
(Cohen and Eisenkraft 1996).  Data has been normalized for BSA.  BSA was calculated from length and weight data 
presented in the paper.  Values are mean ( ) and ± standard deviation).  In this select group of patients, PEEP10 
improved DL FRC and decreased venous admixture with beneficial effects on shunt and arterial oxygenation.  
PEEP10 decreases cardiac output but does not deleteriously affect S O2.  11 subjects were included in the study and 
Student’s-t test was used to compare the groups. 
 
3. Occult sources of PEEP need to be considered such as  
a. Patient airway resistance due to bronchospasm and dynamic airway collapse, 
b. Resistance from DLT tube and, 
c. PEEP from the ventilator expiratory valve.  
4. Furthermore, the normality of the PaCO2 is not the aim of the game during OLA.  Maintaining acceptable 
lung volume with acceptable oxygenation and hemodynamics while permitting hypercapnia if needed are 
the important considerations during OLA.   
 
2LA OLA OLA + PEEP10 
 
  SD.   SD.   SD. 
Differences, if 
any, between 
OLA 
PaO2 (kPa) 26.5 9.0 8.6 0.9 11.5 4.0 p < 0.05 
Qs/Qt (%) 11.0 6.0 42 8.0 31 17 p < 0.05 
CO (litres.min-1) 3.2 0.6 4.6 1.0 3.9 1.0 p < 0.01 
MAP (mm Hg) 87.0 11.0 81.0 14.0 84.0 10.0 Not significant 
S O2 (%) 83.0 8.0 78.0 9.0 77.0 7.0 Not significant 
 5. Appendices  
5.1 Abbreviations 
σ   wall stress 
   (pronounced “x – bar”), the mean of a sample 
τ  time constant, tau 
2 Lung Anes anesthesia while two-lungs are being ventilated 
AC  alternating current 
ALI   acute lung injury 
Anes  anesthesia 
ANOVA  analysis of variance 
Ao  aortic or aorta 
ARDS  adult respiratory distress syndrome 
B.E.  base excess (a negative value represents a base deficit) 
BSA  body surface area 
C(a- )O2  arterio-venous oxygen content difference 
C O2  oxygen content of mixed venous blood 
CaO2   oxygen content of arterial blood 
CBF  coronary blood flow 
CcO2  oxygen content of pulmonary capillary blood 
CI  cardiac index (l.min-1.m-2) 
Cm H2O   centimetres of water 
CO  cardiac output (l.min-1) 
Control  control group 
COPD  chronic obstructive pulmonary disease 
Cp50 plasma concentration needed to provide a 50% chance of suppressing increases of heart rate 
and blood pressure in response to skin incision (compare to MAC BAR) 
CPP  coronary perfusion pressure 
CVP  central venous pressure 
DAP  diastolic arterial pressure (systemic) 
DC  direct current 
DL  dependent lung 
DLCO  diffusion capacity for carbon monoxide 
DLCO/Va  diffusion capacity for carbon monoxide corrected for alveolar volume 
DLT  double lumen tube 
DO2   oxygen delivery 
DO2I  oxygen delivery indexed for body surface area 
DPAP  diastolic pulmonary artery pressure 
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dPdt  maximum positive rate of rise of left ventricular pressure (mmHg.sec-1) 
dPdt –  maximum negative rate of decline of left ventricular pressure (mmHg.sec-1) 
E(t)  elastance at a particular time, t 
Ea  effective arterial elastance 
ECG  electrocardiograph or electrocardiogram 
EDP  end-diastolic pressure 
EDV   end-diastolic volume 
EEO  end expiratory occlusion 
Ees  ventricular end systolic elastance 
EF  ejection fraction 
Emax  maximal ventricular elastance 
ERV  expiratory reserve volume 
ESPVR  end-systolic pressure-volume relationship 
FEF25  forced expiratory flow rate at the time of the FVC is 25 % complete 
FEF75  forced expiratory flow rate at the time of the FVC is 75 % complete 
FEO2  fractional concentration of oxygen (expired) 
FEV1  forced expiratory volume in one second 
FEV1/FVC the ratio of forced expiratory volume in one second to the forced vital capacity 
FiO2  fractional concentration of oxygen (inspired) 
FRC  functional residual capacity 
FRC   functional residual capacity 
FVC  forced vital capacity 
g  gram 
HCO3-  bicarbonate concentration 
HKT  hematocrit 
HPV  hypoxic pulmonary vasoconstriction 
HR  heart rate 
IAA  inhalation anesthetic agent 
IPPV  intermittent positive pressure ventilation 
IRV   inspiratory reserve volume 
ITGV  intrathoracic gas volume 
ITGV  intrathoracic gas volume. 
kg  kilogram 
kPa  kilopascal(s) 
LAP  left atrial pressure 
LDP  lateral decubitus position 
LFT  lung function test 
LV  left ventricle 
LVEDP  left ventricular end-diastolic pressure 
LVEDV   left ventricular end-diastolic volume 
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LVSW  left ventricular stroke work 
LVSWI  left ventricular stroke work index 
m  metre 
MAC  minimal alveolar concentration 
MAC (BAR) minimal alveolar concentration needed to obtund the hemodynamic response to a noxious 
stimulus   
MAP  mean arterial pressure (mmHg) 
min  minute 
ml  millilitre 
mmHg  millimetres of mercury 
MPAP  mean pulmonary artery pressure 
MVO2  myocardial oxygen consumption 
n  number of subjects 
NDL  non-dependent lung  
NO  nitric oxide 
NYHA  New York Heart Association 
OC  degrees Celsius 
oC  degrees Celsius 
ODC   oxygen dissociation curve 
OER  oxygen extraction ratio 
OLA  one lung anesthesia 
OLV  one lung ventilation 
P  pressure 
p  probability 
P  CO2   partial pressure of carbon dioxide in mixed venous blood 
P O2  mixed venous oxygen tension 
P O2  partial pressure of oxygen in mixed venous blood 
P50  the partial pressure of oxygen at which hemoglobin is 50% saturated 
PA  alveolar pressure 
PA  pulmonary artery 
PA Pes  pulmonary artery pressure at end systole 
PAC  pulmonary artery catheter 
PACO2   partial pressure of carbon dioxide in alveoli 
PACO2  partial pressure of carbon dioxide in alveoli 
PaCO2  partial pressure of carbon dioxide in arterial blood 
PaO2   partial pressure of oxygen in arterial blood 
PAO2  partial pressure of oxygen in alveoli 
PAP  mean pulmonary artery pressure 
PAWP  pulmonary artery wedge pressure 
PB  barometric pressure of atmosphere 
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PcO2  pressure of oxygen in the pulmonary capillary 
PcO2  partial pressure of oxygen in pulmonary venous capillaries 
PEEP10  positive end expiratory pressure of 10 cm H2O 
PEEP10/CPAP10 positive end expiratory pressure of 10 cmH2O to the dependent lung, and constant positive 
airway pressure of 10 cmH2O to the non- dependent lung 
PEEP5  positive end expiratory pressure of 5 cmH2O 
PEEPe  extrinsically applied positive end expiratory pressure 
PEEPi  intrinsic positive end expiratory pressure 
PEFR  peak expiratory flow rate 
Pes  end systolic pressure 
PH2O  partial pressure of water vapour 
pHa  the negative logarithm of the hydrogen ion concentration in arterial blood 
PHPT  pulmonary hypertension 
pHv  the negative logarithm of the hydrogen ion concentration in venous blood 
PiO2  partial pressure of inspired oxygen 
PPE  post pneumonectomy pulmonary edema 
ppm  parts per million 
PsO2  partial pressure of oxygen at the sensor for hypoxic pulmonary vasoconstriction  
PSTARLING  pressure tending to collapse the starling resistor 
Pv  pulmonary venous pressure 
PVA  pressure-volume area 
PVR  pulmonary vascular resistance 
PVRI   pulmonary vascular resistance normalised for body surface area 
Qs/Qt  shunt as a fraction of cardiac output 
Qt  cardiac output 
R  resistance 
RA  right atrium 
Rc the resistor representing characteristic impedance: as this is not frequency dependent, it is 
represented by a simple resistor in the Windkessel model of the circulation. 
Rc characteristic impedance 
RCA  right coronary artery 
Ro  characteristic impedance 
Rp  peripheral resistance 
RQ  respiratory quotient 
RV  right ventricle, or right ventricular 
RV  residual volume 
RVEDP  right ventricular end-diastolic pressure 
RVEDV  right ventricular end-diastolic volume 
RVEDVI  right ventricular end-diastolic volume index 
RVEF  right ventricular ejection fraction 
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RVH  right ventricular hypertrophy 
RVSW  right ventricular stroke work 
RVSWI  right ventricular stroke work index 
S O2  mixed venous oxygen saturation 
S1, S2, S3 … step one, step two, step 3 etc 
SaO2  arterial oxygen saturation 
SAP  systolic arterial pressure (systemic) 
ScO2  saturation of hemoglobin of pulmonary capillary blood 
SD.  standard deviation 
secs  seconds 
SI  stroke index (ml.m-2) 
SIRS  systemic inflammatory response syndrome  
SNS  sympathetic nervous system 
SPAP  systolic pulmonary artery pressure 
SV  stroke volume 
SVR   systemic vascular resistance 
SW  stroke work 
td  duration of diastole  
TLC   total lung capacity 
ts   duration of systole 
ug  microgram 
V/Q  ventilation-perfusion… 
VC    vital capacity 
VC  vital capacity 
Vd  dead volume of the ventricle; similar to the unstressed volume of the ventricle 
VE  expired minute volume 
Ved  end diastolic volume of the ventricle 
VI  inspired minute volume 
Vo  volume of the ventricle when the intra-cavitary pressure is zero 
VO2  oxygen consumption per unit time 
VO2I  oxygen consumption per unit time indexed for body surface area 
VO2max  maximal consumption of oxygen 
vs.  versus 
Vt  tidal volume 
Zc characteristic impedance 
ZEEP  zero end expiratory pressure 
Zin(ω)  input impedance at frequency ω 
 
 5.2 Information and consent document used in current study 
 
A study of right ventricular function during one lung anesthesia 
Patient information and consent document 
 
 
A BACKGROUND TO THE STUDY/INFORMATION 
 
1. This clinical study has been approved by the Ethical Committee of the University of Stellenbosch. 
2. One lung anesthesia is a standard and normal part of intrathoracic surgery that is well tolerated.  It is 
essential to use it during your surgery.  The aim of the study is to observe the function of the right side of 
the heart (which pumps blood through the lungs) during one lung anesthesia.  In addition, the effect of right 
ventricular function on the effectiveness of the circulation as a whole will be studied.  The influence of low 
dosage of dobutamine and/or nitric oxide will be studied.   
 The use of dobutamine and/or nitric oxide# may in fact benefit the function of the right ventricle and improve 
circulation and oxygenation as a whole during one lung anesthesia.  The data so gathered would be used 
to further the understanding of heart function during one lung anesthesia.  A total of 30 to 60 patients over 
a period of 2 years will be studied.   
3. The intraoperative conduct of this project is similar to the standard anesthetic protocol and risk for one lung 
anesthesia and compared to the normal clinical practice of one lung anesthesia. 
4. All personal information will be treated as highly confidential, but the data gathered will be used in a 
doctoral thesis or publication. 
5. If any of the information gathered should be pertinent to your health, you will be informed accordingly. 
6. We wish to make it clear that your participation in this study is voluntary and that should you refuse to take 
part, your decision will not place you at a disadvantage in any way.  Your participation in this study may 
also be discontinued without your consent by the Investigator if the Investigator feels that it is in your best 
interest.  You may withdraw your consent at any time prior to surgery without prejudice to your future 
treatment.   
7. You will not be subjected to clinically unproven or risky manoeuvres. 
                                                                
# Albeit that it was intended that patients were to be exposed to nitric oxideduring OLA, all the investigators attepts over a period 
of 2 years to obtain nitric oxide met with no success.  No patient was thus ever exposed to nitric oxide.   
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B CONSENT 
 
 
Patient Name:  ................................................................................................. 
 
 
 
Hospital Number:  ....................................................................... 
I, the abovementioned confirm that I understand the information that is contained in this document and voluntarily 
agree to 
1. Participation in the research project with the title:  A study of right ventricular function during one lung 
anesthesia.  The information and procedures have been satisfactory explained to me by Dr. 
.........................................., and 
2. The administration of general anesthesia, and epidural analgesia, and 
3. The use of nitric oxide and/or dobutamine which is well established therapy for the treatment of pulmonary 
hypertension, and 
4. The use of devices (that are commonly used in the hospital during lung surgery) for monitoring of the 
circulation. 
 
Signed at Tygerberg on ............................................................................................... 
 
 
 
.............................................................................................................. 
Patient signature or right thumbprint 
 
 
 
.......................................................................................... 
Witness 
 
 
 
IMPORTANT INFORMATION 
Dear patient.  Many thanks for your participation in the study.  If at any time during the project you require further 
information about the project, please contact Dr. Levin at 938-9231 
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C DECLARATION BY/FOR THE RESEARCHER 
 
 
I, ..............................................................................................., declare that I: 
1. Explained the information contained in this document to the patient; and 
2. He/she was given an opportunity to ask questions should anything not be clearly understood. 
 
 
Signed Tygerberg on ................................................................................ 
 
 
.................................................................................................. 
Researcher or Researcher's representative 
 
 
.......................................................................... 
Witness 
 
 
D DECLARATION BY TRANSLATOR 
 
 
I, ....................................................................................................... confirm that I 
1. Have translated this document from English/Afrikaans to the patient, as well as the questions put by the 
patient to the researcher and subsequently translated this person's answers. 
2. That the information so exchanged was a factually accurate version of what was actually explained to me. 
 
 
Signed at Tygerberg on .............................................................................................. 
 
 
............................................................................................... 
Signature of Translator 
 
 
............................................................................................... 
Signature of Witness 
 5.3 World Medical Association Declaration of Helsinki# 
5.3.1 Ethical principles for medical research involving human subjects 
5.3.1.1 Introduction 
1. The World Medical Association has developed the Declaration of Helsinki as a statement of ethical 
principles to provide guidance to physicians and other participants in medical research involving human 
subjects.  Medical research involving human subjects includes research on identifiable human material or 
identifiable data.  
2. It is the duty of the physician to promote and safeguard the health of the people.  The physician’s 
knowledge and conscience are dedicated to the fulfillment of this duty. 
3. The Declaration of Geneva of the World Medical Association binds the physician with the words, "The 
health of my patient will be my first consideration," and the International Code of Medical Ethics declares 
that, "A physician shall act only in the patient's interest when providing medical care which might have the 
effect of weakening the physical and mental condition of the patient." 
4. Medical progress is based on research, which ultimately must rest in part on experimentation involving 
human subjects. 
5. In medical research on human subjects, considerations related to the well being of the human subject 
should take precedence over the interests of science and society. 
6. The primary purpose of medical research involving human subjects is to improve prophylactic, diagnostic, 
and therapeutic procedures and the understanding of the etiology and pathogenesis of disease.  Even the 
best-proven prophylactic, diagnostic, and therapeutic methods must continuously be challenged through 
research for their effectiveness, efficiency, accessibility, and quality. 
7. In current medical practice and in medical research, most prophylactic, diagnostic, and therapeutic 
procedures involve risks and burdens. 
8. Medical research is subject to ethical standards that promote respect for all human beings and protect their 
health and rights.  Some research populations are vulnerable and need special protection.  The particular 
needs of the economically and medically disadvantaged must be recognized.  Special attention is also 
required for those who cannot give or refuse consent for themselves, for those who may be subject to 
giving consent under duress, for those who will not benefit personally from the research and for those for 
whom the research is combined with care. 
9. Research Investigators should be aware of the ethical, legal, and regulatory requirements for research on 
human subjects in their own countries as well as applicable international requirements.  No national ethical, 
legal or regulatory requirement should be allowed to reduce or eliminate any of the protections for human 
subjects set forth in this Declaration. 
                                                                
# The Declaration of Helsinki (Document 17.C) is an official policy document of the World Medical Association, the global 
representative body for physicians.  It was first adopted in 1964 (Helsinki, Finland) and revised in 1975 (Tokyo, Japan), 1983 
(Venice, Italy), 1989 (Hong Kong), 1996 (Somerset-West, South Africa) and 2000 (Edinburgh, Scotland).  Note of clarification on 
Paragraph 29 added by the WMA General Assembly, Washington 2002. 
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5.3.1.2 Basic principles for all medical research 
10. It is the duty of the physician in medical research to protect the life, health, privacy, and dignity of the 
human subject. 
11. Medical research involving human subjects must conform to generally accepted scientific principles, be 
based on a thorough knowledge of the scientific literature, other relevant sources of information, and on 
adequate laboratory and, where appropriate, animal experimentation. 
12. Appropriate caution must be exercised in the conduct of research, which may affect the environment, and 
the welfare of animals used for research must be respected. 
13. The design and performance of each experimental procedure involving human subjects should be clearly 
formulated in an experimental protocol.  This protocol should be submitted for consideration, comment, 
guidance, and where appropriate, approval to a specially appointed ethical review committee, which must 
be independent of the investigator, the sponsor or any other kind of undue influence.  This independent 
committee should be in conformity with the laws and regulations of the country in which the research 
experiment is performed.  The committee has the right to monitor ongoing trials.  The researcher has the 
obligation to provide monitoring information to the committee, especially any serious adverse events.  The 
researcher should also submit to the committee, for review, information regarding funding, sponsors, 
institutional affiliations, other potential conflicts of interest and incentives for subjects. 
14. The research protocol should always contain a statement of the ethical considerations involved and should 
indicate that there is compliance with the principles enunciated in this Declaration. 
15. Medical research involving human subjects should be conducted only by scientifically qualified persons and 
under the supervision of a clinically competent medical person.  The responsibility for the human subject 
must always rest with a medically qualified person and never rest on the subject of the research, even 
though the subject has given consent. 
16. Every medical research project involving human subjects should be preceded by careful assessment of 
predictable risks and burdens in comparison with foreseeable benefits to the subject or to others. This does 
not preclude the participation of healthy volunteers in medical research.  The design of all studies should 
be publicly available. 
17. Physicians should abstain from engaging in research projects involving human subjects unless they are 
confident that the risks involved have been adequately assessed and can be satisfactorily managed.  
Physicians should cease any investigation if the risks are found to outweigh the potential benefits or if there 
is conclusive proof of positive and beneficial results. 
18. Medical research involving human subjects should only be conducted if the importance of the objective 
outweighs the inherent risks and burdens to the subject.  This is especially important when the human 
subjects are healthy volunteers. 
19. Medical research is only justified if there is a reasonable likelihood that the populations in which the 
research is carried out stand to benefit from the results of the research. 
20. The subjects must be volunteers and informed participants in the research project. 
21. The right of research subjects to safeguard their integrity must always be respected.  Every precaution 
should be taken to respect the privacy of the subject, the confidentiality of the patient’s information and to 
minimize the impact of the study on the subject's physical and mental integrity and on the personality of the 
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subject. 
22. In any research on human beings, each potential subject must be adequately informed of the aims, 
methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the 
anticipated benefits and potential risks of the study and the discomfort it may entail.  The subject should be 
informed of the right to abstain from participation in the study or to withdraw consent to participate at any 
time without reprisal.  After ensuring that the subject has understood the information, the physician should 
then obtain the subject's freely given informed consent, preferably in writing.  If the consent cannot be 
obtained in writing, the non-written consent must be formally documented and witnessed.  
23. When obtaining informed consent for the research project the physician should be particularly cautious if 
the subject is in a dependent relationship with the physician or may consent under duress.  In that case, 
the informed consent should be obtained by a well-informed physician who is not engaged in the 
investigation and who is completely independent of this relationship. 
24. For a research subject who is legally incompetent, physically or mentally incapable of giving consent or is a 
legally incompetent minor, the investigator must obtain informed consent from the legally authorized 
representative in accordance with applicable law.  These groups should not be included in research unless 
the research is necessary to promote the health of the population represented and this research cannot 
instead be performed on legally competent persons. 
25. When a subject deemed legally incompetent, such as a minor child, is able to give assent to decisions 
about participation in research, the investigator must obtain that assent in addition to the consent of the 
legally authorized representative. 
26. Research on individuals from whom it is not possible to obtain consent, including proxy or advance 
consent, should be done only if the physical/mental condition that prevents obtaining informed consent is a 
necessary characteristic of the research population.  The specific reasons for involving research subjects 
with a condition that renders them unable to give informed consent should be stated in the experimental 
protocol for consideration and approval of the review committee.  The protocol should state that consent to 
remain in the research should be obtained as soon as possible from the individual or a legally authorized 
surrogate. 
27. Both authors and publishers have ethical obligations.  In publication of the results of research, the 
investigators are obliged to preserve the accuracy of the results.  Negative as well as positive results 
should be published or otherwise publicly available.  Sources of funding, institutional affiliations and any 
possible conflicts of interest should be declared in the publication.  Reports of experimentation not in 
accordance with the principles laid down in this Declaration should not be accepted for publication. 
5.3.1.3 Additional principles for medical research combined with medical 
care 
28. The physician may combine medical research with medical care, only to the extent that the research is 
justified by its potential prophylactic, diagnostic, or therapeutic value.  When medical research is combined 
with medical care, additional standards apply to protect the patients who are research subjects.  
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29. ♣The benefits, risks, burdens and effectiveness of a new method should be tested against those of the best 
current prophylactic, diagnostic, and therapeutic methods. This does not exclude the use of placebo, or no 
treatment, in studies where no proven prophylactic, diagnostic or therapeutic method exists.  
30. At the conclusion of the study, every patient entered into the study should be assured of access to the 
best-proven prophylactic, diagnostic and therapeutic methods identified by the study. 
31. The physician should fully inform the patient which aspects of the care are related to the research.  The 
refusal of a patient to participate in a study must never interfere with the patient-physician relationship. 
32. In the treatment of a patient, where proven prophylactic, diagnostic and therapeutic methods do not exist or 
have been ineffective, the physician, with informed consent from the patient, must be free to use unproven 
or new prophylactic, diagnostic and therapeutic measures, if in the physician’s judgment it offers hope of 
saving life, reestablishing health or alleviating suffering.  Where possible, these measures should be made 
the object of research, designed to evaluate their safety and efficacy.  In all cases, new information should 
be recorded and, where appropriate, published.  The other relevant guidelines of this Declaration should be 
followed. 
                                                                
♣ Note of Clarification on Paragraph 29 of the WMA Declaration of Helsinki.   
The WMA hereby reaffirms its position that extreme care must be taken in making use of a placebo-controlled trial and that in 
general this methodology should only be used in the absence of existing proven therapy. However, a placebo-controlled trial may 
be ethically acceptable, even if proven therapy is available, under the following circumstances: 
1. Where for compelling and scientifically sound methodological reasons its use is necessary to determine the efficacy or 
safety of a prophylactic, diagnostic or therapeutic method; or 
2. Where a prophylactic, diagnostic or therapeutic method is being investigated for a minor condition and the patients who 
receive placebo will not be subject to any additional risk of serious or irreversible harm. 
All other provisions of the Declaration of Helsinki must be adhered to, especially the need for appropriate ethical and scientific 
review. 
 5.4 Complex numbers (including discussion of imaginary numbers and 
the modulus of a complex number)# 
5.4.1 History: Quadratic and cubic equations or “Are real numbers not sufficient?” 
The earliest fleeting reference to square roots of negative numbers occurred in the 1st century of the common era, in 
the work of the Greek mathematician and inventor, Heron of Alexandria, when he considered the volume of an 
impossible frustum# of a pyramid.  During the mathematical reawakening in Western Europe in the 13th century, 
works in mathematics were translated from the Arabic into Latin allowing Western European scholars to learn about 
the medieval Arabic-language mathematics and the older Greek mathematics, such as “Euclid’s Elements”.  In all 
this mathematics, only positive numbers were considered numbers.  Negative numbers were not yet accepted as 
entities.  (Some ancient cultures, including that of China and India, accepted negative numbers, but not yet, 
imaginary numbers).  Negative numbers became more prominent when, in the 16th century, Italian mathematicians, 
Tartaglia and Cardano, discovered unsolvable formulae for the roots of third and fourth degree polynomial equations.  
However, no one likes a result that states, “the solution is impossible” (Batschelet, 1975).  It was soon realized that 
these formulae, even if one was only interested in real solutions, sometimes required the manipulation of square 
roots of negative numbers.  This was unsettling since negative numbers were not considered to be on firm ground at 
the time.  Descartes (1596–1650) also studied the solution to polynomial equations.  He called negative solutions 
"false" and treated other solutions (that is, complex numbers) as "imaginary".  Descartes used the term “imaginary” in 
a derogatory sense.  The existence of complex numbers was not completely accepted until Caspar Wessel described 
the geometrical interpretation thereof in 1799.  This definition was rediscovered several years later and popularized 
by Carl Friedrich Gauss.  The formal and correct definition, using pairs of real numbers, was eventually given in the 
19th century.  
                                                                
# The information on complex numbers was adapted from the following sources: 
 
1. Batschelet E.  “Introduction to mathematics for life sciences”.  Second edition, 1975.  Springer-Verlag, 
Berlin, Heidelberg, New York.  
 
2. Claeys J.  “An introduction to complex numbers”.  These webpages are located at 
http://home.scarlet.be/math Copyright 1997.  Contact address of author is Johan.Claeys@ping.be  
 
 
3.  Joyce DE.  “Dave's Short Course on complex numbers”.  Department of Mathematics and Computer 
Science.  Clark University, Worcester, Massachusetts.  These pages are located at 
http://www.clarku.edu/~djoyce/complex/  
 
4. Wikipedia, the free encyclopedia.  These pages are located at http://www.wikipedia.org 
 
# Frustum is defined as a slice of a solid body (Chambers Maxi Dictionary, W and R Chambers, 1992) 
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5.4.2 Definition of a complex number 
From the time that Gauss proved the Fundamental Theorem of Algebra, it was known that all complex numbers are 
constructed as an ordered pair of real numbers, each real numberψ being associated with a second real number.  A 
complex number (x,y) is written in the form:  
x + yi    ………………………… Equation 5.4.2.1 
Where the '+' and the i are just symbols for now, and x and y are real numbers. We call 'x' the real part and 'yi' the 
imaginary part of the complex number. 
For example:  
(2, 4.6) can also be written as  2 + 4.6i, 
(0, 5) can also be written as  0 + 5i and, 
(-5, 36/7) can also be written as  -5 + (36/7)i  
Note that  
Instead of 0 + yi, we write 5i, 
Instead of x + 0i, we write x and, 
Instead of 0 + 1i, we write i. 
 
C denotes the standard symbol for the set of all complex numbers.  If the real number x is associated with an 
imaginary number (x, yi), R becomes a subset of C.   
5.4.3 Geometric representation of a complex number 
To provide complex numbers of the form x + yi with some kind of “reality”, these numbers can also be displayed as a 
point or a vector on the two dimensional xy-plane (also referred to as the Gaussian or complex plane C) (Figure 
5.4.1).  This provides a second way to approach complex numbers, the first way being algebraically as in the 
expression x + yi.   
 
The Gaussian or complex plane is constructed by drawing a horizontal x-axis indicating real numbers.  This plane 
corresponds to the x-axis in a conventional xy-coordinate system.  Then another vertical axis is drawn through the 
point representing the number zero.  The vertical axis has the same unit of length as the horizontal axis.  When the 
xy-plane is used as a representation of the complex plane, the x-axis is called by the name “real axis”, and the y-axis 
is called the “imaginary axis”.  Using this graphical representation, it can also be appreciated that real numbers are to 
be considered as special cases (subsets) of complex numbers; real numbers are just the numbers x + yi when y is 0.  
For instance, the real number 2 is 2 + 0i.  On the other hand, imaginary numbers are a special case too, namely the 
numbers when x is zero i.e. 0 + yi. 
  
The complex number x + yi can be simply represented on the Gaussian or complex plane by vector P or OP with 
coordinates (x,y) (Figure 5.4.1).    Complex numbers are also sometimes referred to by a single symbol, for example 
z = x + yi.   
 
                                                                
ψ Real numbers are all those numbers that are positive, negative, or zero.  The symbol for real numbers is “R”. 
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The addition of two complex numbers is just the vector addition of two vectors, and the multiplication with a fixed 
complex number can be seen as a simultaneous rotation and stretching (see Figure 5.4.3). 
5.4.4 Modulus of a complex number 
The modulus or absolute value of x + yi is defined as the square root of (x2 + y2).  This modulus of x + yi is written as 
|x + yi|.  Furthermore, if P is the representation of x + yi in the Gauss-plane, the distance from the origin O to P is the 
modulus of x + yi.  For example, |3 + 4i| = 5 (Figure 5.4.2). 
5.4.5 Polar co-ordinates of complex numbers 
It is convenient and useful to introduce polar co-ordinates for complex numbers.  The distance from the origin to P is 
represented by r, and α is the angle between the positive x-axis and the line OP measured in a counterclockwise 
direction.  Let x and y be the rectangular co-ordinates of P (Figure 5.4.2).  Then  
x = rcosα    ………………………… Equation 5.4.5.1 and  
y = rsinα    ………………………… Equation 5.4.5.2 
We may rewrite z = x + iy using Equation 5.4.5.1 and Equation 5.4.5.2 as  
z = r (cos α + i sin α)  ………………………… Equation 5.4.5.3 
 
Note that r(cosα + i sinα) is called the polar representation of a+bi.  
 
Figure 5.4.1.  The geometric representation of a complex number in the Gaussian or complex plane.  See text for details.  
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Note also that the polar angle α, is also called the argument or phase angle of a + bi.  It can be represented in 
degrees or a number that is the angle represented in radians.   
5.4.6 Addition and subtraction of complex numbers  
The operations of addition and subtraction are now easily understood.  To add or subtract two complex numbers, just 
add or subtract the corresponding real and imaginary parts.  Therefore, if  
z1 = x1 + iy1 and z2 = x2 + iy2  represent two imaginary numbers, 
Then 
z1 + z2 = (x1 + x2) + i(y1 + y2)  ………………………… Equation 5.4.6.1 
z1 - z2 = (x1 - x2) + i(y1 - y2)  ………………………… Equation 5.4.6.2 
 
For instance, the sum of 5 + 3i and 4 + 2i is 9 + 5i.  For another, the sum of 3 + i and –1 + 2i is 2 + 3i.  
 
As mentioned above, the addition of two complex numbers is just the algebraeic addition of two vectors (Figure 
5.4.3).  “Addition” can therefore be represented graphically on the complex plane C. Take the last example.  The 
complex number x1,y1 = 3 + i is located 3 units to the right of the imaginary axis and 1 unit above the real axis, while 
x2,y2 = –1 + 2i is located 1 unit left and 2 units up. So the sum (x1,y1) + (x2,y2) = 2 + 3i is 2 units right and 3 units up.  
So z1 + z2 is the vector corresponding with the sum of the two complex numbers.  The addition of complex numbers 
corresponds with the addition of the corresponding vectors in the Gaussian-plane.  
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Figure 5.4.2.  The modulus of a complex number, z = x + yi  is represented as the distance from the origin O, to the point P.  
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5.4.7 Multiplication of complex numbers 
To define multiplication, two steps are needed.  First, the imaginary number i is managed as if it were a real number.  
For example,  
(3 + 2i) (4 – 5i) = 12 – 15i + 8i –10i2   ………………………… Equation 5.4.7.1 
Secondly, if i2 = -1, we can simplify Equation 5.4.7.1 to  
 (3 + 2i) (4 – 5i) = 12 – 15i + 8i –10(-1) = (22 – 7i) 
Therefore, if  
z1 = x1 + iy1 and z2 = x2 + iy2  represent two imaginary numbers, 
Then 
z1 z2 = (x1 + iy1) (x2 + iy2) 
z1 z2 = (x1x2 -  y1y2) + i(x1y1 + x2y2)  ………………………… Equation 5.4.7.2 
 
Multiplication with i corresponds to a counter clockwise rotation by 90 degrees (see Figure 5.4.4). The geometric 
content of the equation i2 = -1 is that a sequence of two 90 degree rotations results in a 180 degree rotation.  Even 
the fact (-1)(-1) = +1 from arithmetic can be understood geometrically as the combination of two 180 degree turns.  
5.4.8 Applications of complex numbers 
Complex numbers are used in signal analysis and other fields as a convenient description for periodically varying 
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Figure 5.4.3.  The addition of two complex numbers can be represented simply by vector addition. 
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signals. The absolute value |z| is interpreted as the amplitude and the argument arg(z) as the phase of a sine wave 
of given frequency. If Fourier analysis is employed to write a given real-valued signal as a sum of periodic functions, 
these periodic functions are often written as the real part of complex valued functions of the form  
f(t) = z eiωt    ………………………… Equation 5.4.8.1 
Where ω represents the angular frequency and the complex number z encodes the phase and amplitude as 
explained above.  In electrical engineering, this is done for varying voltages and currents.  The treatment of resistors, 
capacitors and inductors can then be unified by introducing imaginary frequency-dependent resistances for the latter 
two and combining all three in a single complex number called the impedance. (Electrical engineers and some 
physicists use the letter j for the imaginary unit since i is typically reserved for varying currents.) 
Figure 5.4.4.  The multiplication of a complex number by i results in its counter clockwise rotation by 90O. 
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5.4.9  Proof that area under the diastolic curve, Ad = Po.τ(1 – e –td/τ)  
In Sunagawa, Maughan et al. 1988, it is assumed that the area under the diastolic curve, Ad = Po.τ(1 – e –td/τ).  The 
following is proof thereof. 
          Ad = ∫O Po e–td/
τdt  
 = Po ∫ O  e–td/
τdt 
 = -τ.Ps ∫ e–td/τdt 
= -τ.Ps. e–td/τdt/  
= -τ.Ps. (e–td/τ - e–0/τ) 
= -τ.Ps. (e–td/τ - 1) 
= τ.Ps. (1 - e–td/τ) 
This proof is attributed to Pieter de Kock, Faculty of Electrical and Electronic Engineering, University of 
Strellenbosch. 
P0 P(t) = P0. e–td/τ
Ad
td  
Figure 5.5.1.  The area under the diastolic portion of the pulmonary or systemic arterial curve is depicted.  It is assumed that 
the decline in pressure in diastole follows a mono-exponential curve.  “τ” is the time-constant.  The area under the curve is 
given by Po.τ(1 – e –td/τ).   
 td 
 td 
0 
 td 
 6. Referencesψ 
Aalto-Setala M and Heinonen J. One-lumen versus double-lumen endobronchial tubes in thoracic anaesthesia: a 
comparison of blood-gas tensions. Ann. Chir. Gynaecol. Fenn. 63: 276-283, 1974.   
Aalto-Setala M, Heinonen J, and Salorinne Y. Cardiorespiratory function during thoracic anaesthesia: a comparison 
of two-lung ventilation and one-lung ventilation with and without PEEP5. Acta Anaesthesiol. Scand. 19: 287-295, 
1975. 
Aalto-Setala M and Heinonen J. Oxygen delivery during endobronchial anaesthesia: a comparison of halothane-
oxygen and nitrous oxide-oxygen. Acta Anaesthesiol. Scand. 26: 550-553, 1982. 
Abe K, Mashimo T, and Yoshiya I. Arterial oxygenation and shunt fraction during one-lung ventilation: a comparison 
of isoflurane and sevoflurane. Anesth. Analg. 86: 1266-1270, 1998. 
Abe K, Shimizu T, Takashina M, Shiozaki H, and Yoshiya I. The effects of propofol, isoflurane, and sevoflurane on 
oxygenation and shunt fraction during one-lung ventilation. Anesth. Analg. 87: 1164-1169, 1998. 
Alfery DD, Benumof JL, and Trousdale FR. Improving oxygenation during one-lung ventilation in dogs: the effects of 
positive end-expiratory pressure and blood flow restriction to the nonventilated lung. Anesthesiology 55: 381-385, 
1981. 
Alvarez JM, Bairstow BM, Tang C, and Newman MA. Post-lung resection pulmonary edema: a case for aggressive 
management. J. Cardiothorac. Vasc. Anesth. 12: 199-205, 1998. 
Amar D, Burt ME, Roistacher N, Reinsel RA, Ginsberg RJ, and Wilson RS. Value of perioperative Doppler 
echocardiography in patients undergoing major lung resection. Ann. Thorac. Surg. 61: 516-520, 1996. 
Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, 
Munoz C, Oliveira R, Takagaki TY, and Carvalho CR. Effect of a protective-ventilation strategy on mortality in the 
acute respiratory distress syndrome. N. Engl. J. Med. 338: 347-354, 1998. 
Amsel BJ, Rodrigus I, De Paep R, De Raedt H, and Moulijn AC. Right-to-left flow through a patent foramen ovale in 
acute right ventricular infarction. Two case reports and a proposal for management. Chest 108: 1468-1471, 1995. 
                                                                
ψ References were organized using Reference Manager for Windows, version 8.5.  Wherever possible, references were imported 
from Medline directly into Reference Manager to ensure accuracy. 
References 
 
356 
Angle MR, Molloy DW, Penner B, Jones D, and Prewitt RM. The cardiopulmonary and renal hemodynamic effects of 
norepinephrine in canine pulmonary embolism. Chest  95: 1333-1337, 1989. 
Armour JA, Pace JB, and Randall WC. Interrelationship of architecture and function of the right ventricle. Am. J. 
Physiol. 218: 174-179, 1970. 
Armstrong P. Thoracic epidural anaesthesia and primary pulmonary hypertension. Anaesthesia 47: 496-499, 1992. 
Asanoi H, Sasayama S, and Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans 
[published erratum appears in Circ Res 1990 Apr;66(4):1170]. Circ. Res. 65: 483-493, 1989. 
Assmann R and Falke KJ. Pressure and volume assessment of right ventricular function during mechanical 
ventilation. Intensive. Care Med. 14 Suppl 2: 467-470, 1988. 
Bachand R, Audet J, Meloche R, and Denis R. Physiological changes associated with unilateral pulmonary 
ventilation during operations on the lung. Can. Anaesth. Soc. J. 22: 659-664, 1975. 
Bacher A, Illievich UM, Fitzgerald R, Ihra G, and Spiss CK. Changes in oxygenation variables during progressive 
hypothermia in anesthetized patients. J. Neurosurg. Anesthesiol. 9: 205-210, 1997. 
Backlund M, Laasonen L, Lepantalo M, Metsarinne K, Tikkanen I, and Lindgren L. Effect of oxygen on pulmonary 
hemodynamics and incidence of atrial fibrillation after noncardiac thoracotomy. J. Cardiothorac. Vasc. Anesth. 12: 
422-428, 1998. 
Baehrendtz S, Bindslev L, Hedenstierna G, and Santesson J. Selective PEEP in acute bilateral lung disease. Effect 
on patients in the lateral posture. Acta Anaesthesiol. Scand. 27: 311-317, 1983. 
Bailey PL, Egan TD, and Stanley TH. Chapter 10. Intravenous opioid anesthetics. In: Anesthesia 5th edition. 2000. 
Churchill Livingstone, Philadelphia. 
Baker AB, McGinn A, and Joyce C. Effect on lung volumes of oxygen concentration when breathing is restricted. Br. 
J. Anaesth. 70: 259-266, 1993. 
Bakos ACP. The question of the function of the right ventricular myocardium: an experimental study. Circulation 1: 
724-732, 1950. 
Bardoczky G, d'Hollander A, Yernault JC, Van Meuylem A, Moures JM, and Rocmans P. On-line expiratory flow-
volume curves during thoracic surgery: occurrence of auto-PEEP. Br. J. Anaesth. 72: 25-28, 1994. 
References 
 
357 
Bardoczky GI, d'Hollander AA, Rocmans P, Estenne M, and Yernault JC. Respiratory mechanics and gas exchange 
during one-lung ventilation for thoracic surgery: the effects of end-inspiratory pause in stable COPD patients. J. 
Cardiothorac. Vasc. Anesth. 12: 137-141, 1998. 
Bardoczky GI, Yernault JC, Engelman EE, Velghe CE, Cappello M, and Hollander AA. Intrinsic positive end-
expiratory pressure during one-lung ventilation for thoracic surgery. The influence of preoperative pulmonary 
function. Chest 110: 180-184, 1996. 
Barer GR, Howard P, McCurrie JR, and Shaw JW. Changes in the pulmonary circulation after bronchial occlusion in 
anesthetized dogs and cats. Circ. Res. 25: 747-764, 1969. 
Barker SJ, Clarke C, Trivedi N, Hyatt J, Fynes M, and Roessler P. Anesthesia for thoracoscopic laser ablation of 
bullous emphysema. Anesthesiology 78: 44-50, 1993. 
Basson E. Lung resection and the cardiopulmonary reserve.  PhD, 1996, University of Stellenbosch.  Promotor: 
Coetzee, AR. 
Batschelet E.  “Introduction to mathematics for life sciences”.  Second edition, 1975.  Springer-Verlag, Berlin, 
Heidelberg, New York.  
 
Benumof JL. Mechanism of decreased blood flow to atelectatic lung. J. Appl. Physiol. 46: 1047-1048, 1979. 
Benumof JL. One-lung ventilation and hypoxic pulmonary vasoconstriction: implications for anesthetic management. 
Anesth. Analg. 64: 821-833, 1985. 
Benumof JL. Fiberoptic bronchoscopy and double-lumen tube position [letter]. Anesthesiology 65: 117-118, 1986. 
Benumof JL. Isoflurane anesthesia and arterial oxygenation during one-lung ventilation. Anesthesiology 64: 419-422, 
1986. 
Benumof JL. Chapter 8. Physiology of the lateral decubitus position, the open chest and one lung ventilation. In: 
Thoracic anesthesia, 2nd edition. 1991. Churchill Livingstone, New York. 
Benumof JL. The position of a double-lumen tube should be routinely determined by fiberoptic bronchoscopy 
[editorial] [see comments]. J Cardiothorac. Vasc. Anesth. 7: 513-514, 1993. 
Benumof JL. Chapter 7. Monitoring. In: Thoracic Anesthesia, 2nd edition. 1991. Churchill Livingstone, New York.  
Benumof JL and Alfery DD. Chapter 45. Anesthesia for thoracic surgery. In: Anesthesia, 5th edition. 2000. Churchill 
Livingstone, Philadelphia. 
References 
 
358 
Benumof JL, Augustine SD, and Gibbons JA. Halothane and isoflurane only slightly impair arterial oxygenation 
during one-lung ventilation in patients undergoing thoracotomy. Anesthesiology 67: 910-915, 1987. 
Benumof JL, Mathers JM, and Wahrenbrock EA. Cyclic hypoxic pulmonary vasoconstriction induced by concomitant 
carbon dioxide changes. J. Appl. Physiol. 41: 466-469, 1976. 
Benumof JL, Pirlo AF, Johanson I, and Trousdale FR. Interaction of PvO2 with PAO2 on hypoxic pulmonary 
vasoconstriction. J. Appl. Physiol. 51: 871-874, 1981. 
Benumof JL, Rogers SN, Moyce PR, Berryhill RE, Wahrenbrock EA, and Saidman LJ. Hypoxic pulmonary 
vasoconstriction and regional and whole-lung PEEP in the dog. Anesthesiology 51: 503-507, 1979. 
Benumof JL and Wahrenbrock EA. Blunted hypoxic pulmonary vasoconstriction by increased lung vascular 
pressures. J. Appl. Physiol. 38: 846-850, 1975. 
Benumof JL and Wahrenbrock EA. Dependency of hypoxic pulmonary vasoconstriction on temperature. J. Appl. 
Physiol. 42: 56-58, 1977. 
Bergel DH and Milnor WR.  Pulmonary vascular impedance in the dog.  Circ Res16: 401-415, 1965. 
Bhatt SB, Hutchinson RC, Tomlinson B, Oh TE, and Mak M. Effect of dobutamine on oxygen supply and uptake in 
healthy volunteers. Br. J. Anaesth. 69: 298-303, 1992. 
Biondi JW, Schulman DS, Soufer R, Matthay RA, Hines RL, Kay HR, and Barash PG. The effect of incremental 
positive end-expiratory pressure on right ventricular hemodynamics and ejection fraction. Anesth. Analg. 67: 144-
151, 1988. 
Bishop MJ and Cheney FW. Effects of pulmonary blood flow and mixed venous O2 tension on gas exchange in dogs. 
Anesthesiology 58: 130-135, 1983. 
Bjertnaes L, Mundal R, Hauge A, and Nicolaysen A. Vascular resistance in atelectatic lungs: effects of inhalation 
anesthetics. Acta Anaesthesiol. Scand. 24: 109-118, 1980. 
Blanch L, Fernandez R, Benito S, Mancebo J, and Net A. Effect of PEEP on the arterial minus end-tidal carbon 
dioxide gradient. Chest  92: 451-454, 1987. 
Boldt J, Kling D, Dapper F, and Hempelmann G. Myocardial temperature during cardiac operations: influence on right 
ventricular function. J. Thorac. Cardiovasc. Surg. 100: 562-568, 1990. 
References 
 
359 
Boldt J, Muller M, Uphus D, Padberg W, and Hempelmann G. Cardiorespiratory changes in patients undergoing 
pulmonary resection using different anesthetic management techniques. J. Cardiothorac. Vasc. Anesth. 10: 854-859, 
1996. 
Boldt J, Papsdorf M, Uphus D, Muller M, and Hempelmann G. Changes in regulators of the circulation in patients 
undergoing lung surgery. Br. J. Anaesth. 79: 733-739, 1997. 
Bolliger C, Fourie P, and Coetzee A. The effect of prostaglandin E1 on acute pulmonary artery hypertension during 
oleic acid-induced respiratory dysfunction. Chest 99: 1501-1506, 1991. 
Bolliger CT, Jordan P, Soler M, Stulz P, Gradel E, Skarvan K, Elsasser S, Gonon M, Wyser C, and Tamm M. 
Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am. J. Respir. Crit. 
Care Med. 151: 1472-1480, 1995. 
Bolliger CT, Wyser C, Roser H, Soler M, and Perruchoud AP. Lung scanning and exercise testing for the prediction 
of postoperative performance in lung resection candidates at increased risk for complications. Chest 108: 341-348, 
1995. 
Boyd O and Grounds RM. Effects of propofol and isoflurane on right ventricular function [letter]. Br. J. Anaesth. 76: 
598-598, 1996. 
Boyd O, Murdoch LJ, Mackay CJ, Bennett ED, and Grounds RM. The cardiovascular changes associated with 
equipotent anaesthesia with either propofol or isoflurane. Particular emphasis on right ventricular function. Acta 
Anaesthesiol. Scand. 38: 357-362, 1994. 
Braunwald E, Ross J, Jr., and Sonnenblick EH. Mechanisms of contraction of the normal and failing heart. N. Engl. J. 
Med. 277: 853-863, 1967. 
Braunwald E, Sonneblick EH, and Ross J. Chapter 13. Mechanisms of Cardiac Contraction and Relaxation. In: 
Braunwald Textbook of cardiology. 1998.  
Brodsky JB. Fiberoptic bronchoscopy should not be a standard of care when positioning double-lumen endobronchial 
tubes [letter; comment]. J Cardiothorac. Vasc. Anesth. 8: 373-375, 1994. 
Brodsky JB, Macario A, and Mark JB. Tracheal diameter predicts double-lumen tube size: a method for selecting left 
double-lumen tubes. Anesth. Analg. 82: 861-864, 1996. 
Brunet F, Dhainaut JF, Devaux JY, Huyghebaert MF, Villemant D, and Monsallier JF. Right ventricular performance 
in patients with acute respiratory failure. Intensive. Care Med. 14 Suppl 2: 474-477, 1988. 
References 
 
360 
Burger W, Jockwig B, Rucker G, and Kober G. Influence of right ventricular pre- and afterload on right ventricular 
ejection fraction and preload recruitable stroke work relation. Clin. Physiol. 2001. Jan. ;21. (1. ):85. -92. 21: 85-92, 
2001. 
Burkhoff D and Sagawa K. Ventricular efficiency predicted by an analytical model. Am. J. Physiol. 250: R1021-7, 
1986. 
Burrows FA, Klinck JR, Rabinovitch M, and Bohn DJ. Pulmonary hypertension in children: perioperative 
management. Can. Anaesth. Soc. J. 33: 606-628, 1986. 
Calvin JE. Optimal right ventricular filling pressures and the role of pericardial constraint in right ventricular infarction 
in dogs. Circulation 84: 852-861, 1991. 
Calvin JE. Right ventricular mismatch during acute pulmonary hypertension and its treatment with dobutamine: a 
pressure segment length analysis in a canine model. Journal Of Critical Care 4: 239-250, 1998. 
Calvin JE and Quinn B. Right ventricular pressure overload during acute lung injury: cardiac mechanics and the 
pathophysiology of right ventricular systolic function. Journal Of Critical Care 4: 251-265, 1989. 
Calvin JE, Jr. Acute Right heart Failure: pathophysiology, Recognition, and Pharmacological Management. Journal of 
Cardiothoracic and Vascular Anesthesia 5: 507-513, 1991. 
Calvin JE, Jr. Pressure segment length analysis of right ventricular function: influence of loading conditions. 
American Journal of Physiology 260: H1087-H1097, 1991. 
Calvin JE, Jr., Baer RW, and Glantz SA. Pulmonary artery constriction produces a greater right ventricular dynamic 
afterload than lung microvascular injury in the open chest dog. Circ. Res. 56: 40-56, 1985. 
Capan LM, Turndorf H, and Miller S. Maximising oxygenation during one lung anesthesia. Problems in 
Anesthesiology 4: 282-304, 1990. 
Capan LM, Turndorf H, Patel C, Ramanathan S, Acinapura A, and Chalon J. Optimization of arterial oxygenation 
during one-lung anesthesia. Anesth. Analg. 59: 847-851, 1980. 
Carli F, Ronzoni G, Webster J, Khan K, and Elia M. The independent metabolic effects of halothane and isoflurane 
anaesthesia. Acta Anaesthesiol. Scand. 37: 672-678, 1993. 
Carlsson AJ, Bindslev L, and Hedenstierna G. Hypoxia-induced pulmonary vasoconstriction in the human lung. The 
effect of isoflurane anesthesia. Anesthesiology 66: 312-316, 1987. 
References 
 
361 
Carlsson AJ, Bindslev L, Santesson J, Gottlieb I, and Hedenstierna G. Hypoxic pulmonary vasoconstriction in the 
human lung: the effect of prolonged unilateral hypoxic challenge during anaesthesia. Acta Anaesthesiol. Scand. 29: 
346-351, 1985. 
Carlsson AJ, Hedenstierna G, and Bindslev L. Hypoxia-induced vasoconstriction in human lung exposed to enflurane 
anaesthesia. Acta Anaesthesiol. Scand. 31: 57-62, 1987. 
Chang MC, Black CS, and Meredith JW. Volumetric assessment of preload in trauma patients: addressing the 
problem of mathematical coupling. Shock 6: 326-329, 1996. 
Chen EP, Bittner HB, Davis RD, and Van Trigt P. Right ventricular failure--insights provided by a new model of 
chronic pulmonary hypertension. Transplantation 63: 209-216, 1997. 
Chen L and Marshall BE. Chapter 4. Hypoxic pulmonary vasoconstriction and the choice of anesthesia. In: The 
practice of thoracic anesthesia1995. J.B. Lippincott Company, Philadelphia. 
Chen TL, Lee YT, Wang MJ, Lee JM, Lee YC, and Chu SH. Endothelin-1 concentrations and optimisation of arterial 
oxygenation and venous admixture by selective pulmonary artery infusion of prostaglandin E1 during thoracotomy. 
Anaesthesia 51: 422-426, 1996. 
Claeys J.  “An introduction to complex numbers”.  These webpages are located at http://home.scarlet.be/math 
Copyright 1997.  Contact address of author is Johan.Claeys@ping.be 
Clowes GH, Jr., Farrington GH, Zuschneid W, Cossette GR, and Saravis C. Circulating factors in the etiology of 
pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis). Ann. Surg. 171: 663-678, 
1970. 
Coddens J, Delooft T, and Vandenbroucke G. Effects of dobutamine and/or nitroprusside on the pulmonary 
circulation in patients with pulmonary hypertension secondary to end-stage heart failure. J. Cardiothorac. Vasc. 
Anesth. 7: 321-325, 1993. 
Coetzee A. Hipoksie: Die agtergrond vir die interpretasie van moontlike oorsake. [Hypoxia: the background for the 
interpretation of possible causes]. The Southern African Journal of Critical Care 3: 28-30, 1987. 
Coetzee A and Fourie P. Ventricular-arterial coupling. Cardiovascular Journal of Southern Africa 4: 53-55, 1993. 
Coetzee A, Fourie P, and Badenhorst E. Effect of halothane, enflurane and isoflurane on the end- systolic pressure-
length relationship. Can. J. Anaesth. 34: 351-357, 1987b. 
References 
 
362 
Coetzee A, Fourie P, and Badenhorst E. Response of the heart to acute hypertension during halothane, enflurane, 
and isoflurane anesthesia. Anesth. Analg. 66: 1219-1226, 1987a. 
Coetzee A, Fourie P, Coetzee J, Badenhorst E, Rebel A, Bolliger C, Uebel R, Wium C, and Lombard C. Effect of 
various propofol plasma concentrations on regional myocardial contractility and left ventricular afterload. Anesth. 
Analg. 69: 473-483, 1989. 
Coetzee AR. 'n Sistematiese benadering tot patiente geskeduleer vir long reseksie chirurgie. (A systematic approach 
to patients scheduled for lung resection.). 2000. Department of Anesthesiology and Critical Care, Faculty of Health 
Sciences, University of Stellenbosch, 
Coetzee JF. An investigation into the cardiovascular effects of propofol and alfentanil for total intravenous 
anesthesia.  PhD, 1993, University of Stellenbosch.  Promotor: Coetzee, AR. 
Coetzee JF. Introduction to biostatistics. Based on the interactive computer tutorial program by R Cody, S just, And C 
de la Motte; Adapted and expanded by J.F. Coetzee. 2nd edition. 2001. Department of Anesthesiology and Critical 
Care, Faculty of Health Sciences, University of Stellenbosch, Cape Town, South Africa. 
Cohen E. Chapter 13. Anesthetic management of one-lung ventilation. In: The practice of thoracic anesthesia. Editor: 
Cohen E. 1995. J.B. Lippincott Company, Philadelphia. 
Cohen E. Chapter 5. Physiology of the lateral position and one-lung ventilation. In: The practice of thoracic 
anesthesia. Editor: Cohen E. 1995. J.B. Lippincott Company, Philadelphia. 
Cohen E. Management of one-lung ventilation. Anesthesiol. Clin. North America. 2001. Sep. ;19. (3. ):475. -95. , vi. 
19: 475-95, vi, 2001. 
Cohen E and Eisenkraft JB. Positive end-expiratory pressure during one-lung ventilation improves oxygenation in 
patients with low arterial oxygen tensions. J. Cardiothorac. Vasc. Anesth. 10: 578-582, 1996. 
Cohen E, Eisenkraft JB, Thys DM, Kirschner PA, and Kaplan JA. Oxygenation and hemodynamic changes during 
one-lung ventilation: effects of CPAP10, PEEP10, and CPAP10/PEEP10. J. Cardiothorac. Anesth. 2: 34-40, 1988. 
Cohen E, Kirschner PA, and Goldofsky S. Intraoperative manipulation for positioning of double-lumen tubes [letter]. 
Anesthesiology 68: 170, 1988. 
Cohen E, Neustein SM, Goldofsky S, and Camunas JL. Incidence of malposition of polyvinyl chloride and red rubber 
left-sided double-lumen tubes and clinical sequelae. J Cardiothorac. Vasc. Anesth. 9: 122-127, 1995. 
References 
 
363 
Cohen E, Thys DM, Eisenkraft JB, and Kaplan JA. PEEP during one lung anesthesia improves oxygenation in 
patients with low arterial PaO2. Anesth. Analg. 64: 201, 1985b. 
Cohen E, Thys DM, Eisenkraft JB, Kirschner PA, and Kaplan JA. Effect of CPAP and PEEP during one lung 
anesthesia: left versus right thoracotomies. Anesthesiology 63: A564, 1985a. 
Cohn JN, Guiha NH, Broder MI, and Limas CJ. Right ventricular infarction. Clinical and hemodynamic features. Am. 
J. Cardiol. 33: 209-214, 1974. 
Colley PS, Cheney FW, and Butler J. Mechanism of change in pulmonary shunt flow with hemorrhage. J. Appl. 
Physiol. 42: 196-201, 1977. 
Conacher ID. Anaesthesia for the surgery of emphysema [see comments]. Br. J Anaesth. 79: 530-538, 1997. 
Conacher ID. Dynamic hyperinflation--the anaesthetist applying a tourniquet to the right heart [editorial]. Br. J. 
Anaesth. 81: 116-117, 1998. 
Connery LE, Deignan MJ, Gujer MW, and Richardson MG. Cardiovascular collapse associated with extreme 
iatrogenic PEEPi in patients with obstructive airways disease. Br. J. Anaesth. 83: 493-495, 1999. 
Conrad SA. Right ventricular volumetric measurements: New tricks for an old dog. Crit. Care Med. 29: 1081-1082, 
2001. 
Costarino AT and Marshall BE. Chapter 3. Ventilation-perfusion distribution and pulmonary gas exchange. In: The 
practice of thoracic anesthesia. Editor: Cohen E. 1st edition. 1995. J.B.Lippincott Company, Costarino, Philadelphia. 
Coyle JP, Carlin HM, Lake CR, Lee CK, and Chernow B. Left atrial infusion of norepinephrine in the management of 
right ventricular failure. J. Cardiothorac. Anesth. 4: 80-83, 1990. 
Cross CE.  Right ventricular pressure and coronary flow.  Am. J. Physiol. 202: 12-16, 1961. 
Crouch JD, Lucas CL, Keagy BA, Wilcox BR, and Ha B. The acute effects of pneumonectomy on pulmonary vascular 
impedance in the dog. Ann. Thorac. Surg. 43: 613-616, 1987. 
Cryer HG, Mavroudis C, Yu J, Roberts AM, Cue JI, Richardson JD, and Polk HCJ. Shock, transfusion, and 
pneumonectomy. Death is due to right heart failure and increased pulmonary vascular resistance. Ann. Surg. 212: 
197-201, 1990. 
References 
 
364 
D'Ambra MN, LaRaia PJ, Philbin DM, Watkins WD, Hilgenberg AD, and Buckley MJ. Prostaglandin E1. A new 
therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J. Thorac. 
Cardiovasc. Surg. 89: 567-572, 1985. 
Dahlgren G, Veintemilla F, Settergren G, and Liska J. Left ventricular end-systolic pressure estimated from 
measurements in a peripheral artery. J. Cardiothorac. Vasc. Anesth. 5: 551-553, 1991. 
Damiano RJ, Jr., La Follette P, Jr., Cox JL, Lowe JE, and Santamore WP. Significant left ventricular contribution to 
right ventricular systolic function. Am. J. Physiol. 261: H1514-24, 1991. 
Dantzker DR and Guiterrez G. Effects of circulatory failure on pulmonary and tissue gas exchange. Chapter 28 in 
Respiratory physiology.  An analytical approach.  Editors: Chang HK and Paiva M.  Volume 40 in the series: Lung 
biology in health and disease.  Executive editor: Claude Lenfant.  Marcel Dekker, New York, Basel.  1987.  
Dantzker DR, Wagner PD, and West JB. Instability of lung units with low VA/Q ratios during O2 breathing. Journal of 
Applied Physiology 38: 886-895, 2002. 
Das BB, Fenstermacher JM, and Keats AS. Endobronchial anesthesia for resection of aneurysms of the descending 
aorta. Anesthesiology 32: 152-155, 1970. 
Deeb GM, Bolling SF, Guynn TP, and Nicklas JM. Amrinone versus conventional therapy in pulmonary hypertensive 
patients awaiting cardiac transplantation. Ann. Thorac. Surg. 48: 665-669, 1989. 
Dell'Italia LJ, Starling MR, Blumhardt R, Lasher JC, and O'Rourke RA. Comparative effects of volume loading, 
dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation 72: 1327-1335, 
1985. 
Dhainaut JF, Lanore JJ, de Gournay JM, Huyghebaert MF, Brunet F, Villemant D, and Monsallier JF. Right 
ventricular dysfunction in patients with septic shock. Intensive. Care Med. 14 Suppl 2: 488-491, 1988. 
Dhainaut JF and Squara P. Right Ventricular Function. Current Opinion in Anesthesiology 5: 235-239, 1992. 
Diebel LN, Wilson RF, Tagett MG, and Kline RA. End-diastolic volume. A better indicator of preload in the critically ill 
[see comments]. Arch. Surg. 127: 817-821, 1992. 
Dodson LA, Nathan NS, and D'Ambra MN. New concepts of right heart failure. Current Opinion in Anesthesiology 10: 
21-28, 1997. 
Doering EB, Hanson CW, Reily DJ, Marshall C, and Marshall BE. Improvement in oxygenation by phenylephrine and 
nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 87: 18-25, 1997. 
References 
 
365 
Domino KB. Chapter 76. Anesthetic modulation of pulmonary vascular tone. In: Anesthesia: Biologic foundations. 
Editors Yaksh T L, Lynch C et al. 1997. Lippincot-Raven, Philadelphia, New York. 
Domino KB, Borowec L, Alexander CM, Williams JJ, Chen L, Marshall C, and Marshall BE. Influence of isoflurane on 
hypoxic pulmonary vasoconstriction in dogs. Anesthesiology 64: 423-429, 1986. 
Domino KB, Wetstein L, Glasser SA, Lindgren L, Marshall C, Harken A, and Marshall BE. Influence of mixed venous 
oxygen tension (PVO2) on blood flow to atelectatic lung. Anesthesiology 59: 428-434, 1983. 
Donald DE and Essex HE. Pressure Studies After Inactivation of the Major Part of the Canine Right Ventricle. 
American Journal of Physiology 176: 155-161, 1954. 
Doyle AR, Dhir AK, Moors AH, and Latimer RD. Treatment of perioperative low cardiac output syndrome. Ann. 
Thorac. Surg. 59: S3-11, 1995. 
Dries DJ and Mathru M. Cardiovascular Performance in Embolism. Anesthesiology Clinics of North America 10: 755-
780, 1992. 
Ducros L, Moutafis M, Castelain MH, Liu N, and Fischler M. Pulmonary air trapping during two-lung and one-lung 
ventilation. J. Cardiothorac. Vasc. Anesth. 13: 35-39, 1999. 
Dyke CM, Brunsting LA, Salter DR, Murphy CE, Abd-Elfattah A, and Wechsler AS. Preload dependence of right 
ventricular blood flow: 1. The normal right ventricle. Ann. Thorac. Surg. 43: 478-483, 1987. 
Eddy AC, Rice CL, and Anardi DM. Right ventricular dysfunction in multiple trauma victims. Am. J. Surg. 155: 712-
715, 1988. 
Eger EI. New inhaled anesthetics. Anesthesiology 80: 906-922, 1994. 
Elzinga G, Piene H, and de Jong JP. Left and right ventricular pump function and consequences of having two 
pumps in one heart. A study on the isolated cat heart. Circ. Res. 46: 564-574, 1980. 
Elzinga G and Westerhof N. Pressure and flow generated by the left ventricle against different impedances. Circ. 
Res. 32: 178-186, 1973. 
Ferlinz J. Right ventricular function in adult cardiovascular disease. Prog. Cardiovasc. Dis. 25: 225-267, 1982. 
Firestone L. Heart transplantation. Int. Anesthesiol. Clin. 29: 41-58, 1991. 
References 
 
366 
Fiser WP, Friday CD, and Read RC. Changes in arterial oxygenation and pulmonary shunt during thoracotomy with 
endobronchial anesthesia. J. Thorac. Cardiovasc. Surg. 83: 523-531, 1982. 
Fitzpatrick JM and Grant JB.  Effects of pulmonary vascular obstruction on right ventricular afterload.  Am Rev. Resp. 
Dis 141: 944-952, 1990. 
Fixler DE, Archie JP, Ullyot DJ, Buckberg GD, and Hoffman JI. Effects of acute right ventricular systolic hypertension 
on regional myocardial blood flow in anesthetized dogs. Am Heart J 85: 491-500, 1973. 
Flacke JW, Thompson DS, and Read RC. Influence of tidal volume and pulmonary artery occlusion on arterial 
oxygenation during endobronchial anesthesia. South. Med. J. 69: 619-626, 1976. 
Fontan F and Baudet E. Surgical repair of tricuspid atresia. Thorax 26: 240-248, 1971. 
Foster PA and Roelofse JA. Databook of anaesthesia and critical care. 4th edition. 1987. Springer-Verlag, Berlin. 
Fourie P, Coetzee A, Rebel A, and Bolliger CT. Modellering van die pompfunksie van die hart.  [Modelling of the 
function of the heart as a pump]. The Transactions of the SA Institute of Electrical Engineers  38-44, 1992. 
Fourie PF. The Evaluation Of Cardiac Function With reference to Pulmonary Hypertension.  PhD, 1989, University of 
Stellenbosch.  Promotor: Coetzee, AR. 
Fourie PR, Badenhorst E, and Coetzee AR. [Pressure transducers in the clinical and research field. A short critical 
review]. S. Afr. Med. J. 71: 651-654, 1987. 
Fourie PR and Coetzee AR. Effect of compliance on a time-domain estimate of the characteristic impedance of the 
pulmonary artery during acute pulmonary hypertension. Med. Biol. Eng. Comput. 31: 468-474, 1993. 
Fourie PR, Coetzee AR, and Bolliger CT. Pulmonary artery compliance: its role in right ventricular- arterial coupling. 
Cardiovasc. Res. 26: 839-844, 1992b. 
Freden F, Wei SZ, Berglund JE, Frostell C, and Hedenstierna G. Nitric oxide modulation of pulmonary blood flow 
distribution in lobar hypoxia. Anesthesiology 82: 1216-1225, 1995. 
Fretschner R, Deusch H, Weitnauer A, Brunne JX.  A simple method to estimate functional residual capacity in 
mechanically ventilated patients.  Intensive Care Med.  19: 372, 1993. 
Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, and Zapol WM. Inhaled nitric oxide selectively reverses 
human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427-435, 
1993. 
References 
 
367 
Fujita Y, Yamasaki T, Takaori M, and Sekioka K. Sevoflurane anaesthesia for one-lung ventilation with PEEP to the 
dependent lung in sheep: effects on right ventricular function and oxygenation. Can. J. Anaesth. 40: 1195-1200, 
1993. 
Fujita Y, Yamasaki T, Takaori M, and Sekioka K. Sevoflurane anaesthesia for one-lung ventilation with PEEP to the 
dependent lung in sheep: effects on right ventricular function and oxygenation. Can. J. Anaesth. 40: 1195-1200, 
1993. 
Fullerton DA, Jones SD, Grover FL, and McIntyre RC, Jr. Adenosine effectively controls pulmonary hypertension 
after cardiac operations [see comments]. Ann. Thorac. Surg. 61: 1118-1123, 1996. 
Gale AW, Danielson GK, McGoon DC, Wallace RB, and Mair DD. Fontan procedure for tricuspid atresia. Circulation 
62: 91-96, 1980. 
Gardner RM. Direct blood pressure measurement--dynamic response requirements. Anesthesiology 54: 227-236, 
1981. 
Gass GD and Olsen DB. Preoperative pulmonary function testing to predict postoperative morbidity and mortality. 
Chest 89: 127-135, 1986. 
Ghignone M, Girling L, and Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac 
output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 60: 132-135, 1984. 
Gilbert RD, Hessler JR, Eitzman DV, and Cassin S. Site of pulmonary vascular resistance in fetal goats. J. Appl. 
Physiol. 32: 47-53, 1972. 
Glantz SA, Misbach GA, Moores WY, Mathey DG, Levken J, Stowe DF, Parmley WW, and Tyberg JV. The 
pericardium substantially affects the left ventricular  diastolic pressure-volume relationship in the dog. Circ. Res. 43: 
433-441, 1978. 
Glass PSA, Shafer SL, and Reves JG. Chapter 11. Intravenous drug delivery systems. In: Anesthesia 5th edition. 
Editor Miller, RD. 2000. Churchill Livingstone, Philadelphia. 
Glasser SA, Domino KB, Lindgren L, Parcella P, Marshall C, and Marshall BE. Pulmonary pressure and flow during 
atelectasis. Anesthesiology 57: A504, 1983. 
Gold FL and Bache RJ. Transmural right ventricular blood flow during acute pulmonary artery hypertension in the 
sedated dog. Evidence for subendocardial ischemia despite residual vasodilator reserve. Circ. Res. 51: 196-204, 
1982. 
References 
 
368 
Goldhaber SZ. Chapter 46. Pulmonary Embolism. In: Heart Disease.  Editor Braunwald E. 5th edition. 1997. WB 
Saunders Company, 
Grant BJ and Lieber BB. Clinical significance of pulmonary arterial input impedance [editorial]. Eur. Respir. J 9: 2196-
2199, 1996. 
Grant BJ and Paradowski LJ. Characterization of pulmonary arterial input impedance with lumped parameter models. 
Am. J. Physiol. 252: H585-93, 1987. 
Grimby G and Sonderholm B. Spirometric studies in normal subjects, III: static lung volumes and maximum voluntary 
ventilation in adults with a note on physical fitness. Acta Med. Scandanavica 173: 199, 1967. 
Grocott-Mason RM and Shah AM. Cardiac dysfunction in sepsis: new theories and clinical implications. Intensive. 
Care Med. 24: 286-295, 1998. 
Groeneveld AB, Schreuder WO, Vermeij CG, and hijs LG. Effect of incremental positive end-expiratory pressure 
ventilation on right ventricular function in anesthetized pigs:  a thermodilution study. Journal Of Critical Care 5: 218-
227, 1990. 
Groh J, Kuhnle GE, Ney L, Sckell A, and Goetz AE. Effects of isoflurane on regional pulmonary blood flow during 
one-lung ventilation. Br. J. Anaesth. 74: 209-216, 1995. 
Guiha NH, Limas CJ, and Cohn JN. Predominant right ventricular dysfunction after right ventricular destruction in the 
dog. Am. J. Cardiol. 33: 254-258, 1974. 
Guntheroth WG, Kawabori I, Stevenson JG, and Cholvin NR. Pulmonary vascular resistance and right ventricular 
function in canine endotoxin shock. Proc. Soc. Exp. Biol. Med. 157: 610-614, 1978. 
Guyton AC, Lindsey AW, and Gilluly JJ. the limits of right ventricular compensation following acute increase in 
pulmonary circulatory resistance. Circ. Res. 2: 326-332, 1954. 
Hachenberg T and Rettig R. Stress failure of the blood-gs barrier. Current Opinion in Anesthesiology 11: 37-44, 
1998. 
Hannallah M, Benumof JL, Silverman PM, Kelly LC, and Lea D. Evaluation of an approach to choosing a left double-
lumen tube size based on chest computed tomographic scan measurement of left mainstem bronchial diameter. J 
Cardiothorac. Vasc. Anesth. 11: 168-171, 1997. 
References 
 
369 
Haraldsson A, Kieler Jensen N, and Ricksten SE. Inhaled prostacyclin for treatment of pulmonary hypertension after 
cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac. Vasc. Anesth. 10: 864-868, 
1996. 
Hasselstrom LJ, Eliasen K, Mogensen T, and Andersen JB. Lowering pulmonary artery pressure in a patient with 
severe acute respiratory failure. Intensive. Care Med. 11: 48-50, 1985. 
Hattingh P, Coetzee A, McGregor L, and Klopper JF. [Preoperative special tests and intraoperative arterial oxygen 
partial pressure during one-lung ventilation]. S. Afr. Med. J. 78: 104-108, 1990. 
Hedenstierna G. Gas exchange pathophysiology during anesthesia. Anesthesiology Clinics of North America 16: 
113-127, 1998. 
Hedenstierna G, Baehrendtz S, Klingstedt C, Santesson J, Soderborg B, Dahlborn M, and Bindslev L. Ventilation and 
perfusion of each lung during differential ventilation with selective PEEP. Anesthesiology 61: 369-376, 1984. 
Heerdt PM, Gandhi CD, and Dickstein ML. Disparity of isoflurane effects on left and right ventricular afterload and 
hydraulic power generation in swine. Anesth. Analg. 87: 511-521, 1998. 
Heerdt PM and Pleimann BE. The dose-dependent effects of halothane on right ventricular contraction pattern and 
regional inotropy in swine. Anesth. Analg. 82: 1152-1158, 1996. 
Hendry PJ, Ascah KJ, Rajagopalan K, and Calvin JE. Does septal position affect right ventricular function during left 
ventricular assist in an experimental porcine model? Circulation 90: II353-8, 1994. 
Hennebry TA and Gerstenblith G. Right ventricular physiology. Problems in Anesthesiology 13: 142-172, 2001. 
Hettrick DA, Pagel PS, and Warltier DC. Differential effects of isoflurane and halothane on aortic input impedance 
quantified using a three-element Windkessel model [see comments]. Anesthesiology 83: 361-373, 1995. 
Hijazi ZM and Hellenbrand WE. The right ventricle in congenital heart disease. Cardiol. Clin. 10: 91-109, 1992. 
Hilgenberg JC. Pulmonary vascular impedance: resistance versus pulmonary artery diastolic-pulmonary artery 
occluded pressure gradient [letter]. Anesthesiology 58: 484-486, 1983. 
Hines RL and Barash PG. Chapter 33. Right Ventricular Performance. In: Cardiac Anesthesia.  Editor: Kaplan JA. 3rd 
edition. 1993. W B Saunders Company. 
Hoffman MJ, Greenfield LJ, Sugerman HJ, and Tatum JL. Unsuspected right ventricular dysfunction in shock and 
sepsis. Ann. Surg. 198: 307-319, 1983. 
References 
 
370 
Hogue CWJ. Effectiveness of low levels of nonventilated lung continuous positive airway pressure in improving 
arterial oxygenation during one-lung ventilation. Anesth. Analg. 79: 364-367, 1994. 
Hosking MP and Beynen FM. The modified Fontan proceedure: physiology and anesthetic implications. Journal of 
Cardiothoracic and Vascular Anesthesia 6: 465-475, 1992. 
Hurford WE and Zapol WM. The right ventricle and critical illness: a review of anatomy, physiology, and clinical 
evaluation of its function. Intensive. Care Med. 14 Suppl 2: 448-457, 1988. 
Imai T, Saitoh K, Kani H, Fujita T, and Murata K. Combined dose ratios of dopamine and dobutamine and right 
ventricular performance after cardiac surgery. Chest 101: 1197-1202, 1992. 
Inomata S, Nishikawa T, Saito S, and Kihara S. "Best" PEEP during one-lung ventilation. Br. J. Anaesth. 78: 754-
756, 1997. 
Ishibe Y, Shiokawa Y, Umeda T, Uno H, Nakamura M, and Izumi T. The effect of thoracic epidural anesthesia on 
hypoxic pulmonary vasoconstriction in dogs: an analysis of the pressure-flow curve. Anesth. Analg. 82: 1049-1055, 
1996. 
Ishikawa S, Nakazawa K, and Makita K. Progressive changes in arterial oxygenation during one-lung anaesthesia 
are related to the response to compression of the non-dependent lung. Br. J. Anaesth. 90: 21-26, 2003. 
Jackson JM and Thomas SJ. Chapter 20. Valvular heart disease. In: Cardiac Anesthesia. Editor: Kaplan JA. 3rd 
edition. 1993. W B Saunders Company.  
Jacobsohn E, Chorn R, and O'Connor M. The role of the vasculature in regulating venous return and cardiac output: 
historical and graphical approach. Can. J. Anaesth. 44: 849-867, 1997. 
Janicki JS and Weber KT. The pericardium and ventricular interaction, distensibility and function. American Journal 
of Physiology 238: H494-H503, 1980. 
Jardin F, Dubourg O, Margairaz A, and Bourdarias JP. Inspiratory impairment in right ventricular performance during 
acute asthma. Chest 92: 789-795, 1987. 
Jardin F, Gueret P, Dubourg O, Farcot JC, Margairaz A, and Bourdarias JP. Right ventricular volumes by 
thermodilution in the adult respiratory distress syndrome. A comparative study using two- dimensional 
echocardiography as a reference method. Chest 88: 34-39, 1985. 
Jarmakani JM, Nakazawa M, Isabel-Jones J, and Marks RA. Right ventricular function in children with tetralogy of 
Fallot before and after aortic-to-pulmonary shunt. Circulation 53: 555-561, 1976. 
References 
 
371 
Jenkins J, Cameron EW, Milne AC, and Hunter RM. One lung anaesthesia. Cardiovascular and respiratory function 
compared during conventional ventilation and high frequency jet ventilation. Anaesthesia 42: 938-943, 1987. 
Johns RA. Endothelium-derived relaxing factor: basic review and clinical implications. Journal of Cardiothoracic and 
Vascular Anesthesia 5: 69-79, 1991. 
Joyce DE.  “Dave's Short Course on complex numbers”.  Department of Mathematics and Computer Science.  Clark 
University, Worcester, Massachusetts.  These pages are located at http://www.clarku.edu/~djoyce/complex/  
 
Kadowitz PJ and Hyman AL. Effect of sympathetic nerve stimulation on pulmonary vascular resistance in the dog. 
Circulation Research 32: 221-227, 1973. 
Kagan A. Dynamic Responses of the Right Ventricle following Extensive Damage by Cauterization. Circulation 5: 
816-823, 1952. 
Karunanithi MK, Michniewicz J, Copeland SE, and Feneley MP. Right ventricular preload recruitable stroke work, 
end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular 
contractile performance in conscious dogs. Circ. Res. 70: 1169-1179, 1992. 
Karzai W, Gunnicker M, Scharbert G, Vorgrimler-Karzai UM, and Priebe HJ. Effects of dopamine on oxygen 
consumption and gastric mucosal blood flow during cardiopulmonary bypass in humans. Br. J. Anaesth. 77: 603-606, 
1996. 
Karzai W, Gunnicker M, Vorgrimler-Karzai UM, Freund U, and Zerkowski HR. The effects of beta-adrenoreceptor 
blockade on oxygen consumption during cardiopulmonary bypass. Anesth. Analg. 79: 19-22, 1994. 
Karzai W, Lotte A, Gunnicker M, Vorgrimler-Karzai UM, and Priebe HJ. Dobutamine increases oxygen consumption 
during constant flow cardiopulmonary bypass. Br. J. Anaesth. 76: 5-8, 1996. 
Kass DA and Maughan WL. From 'Emax' to pressure-volume relations: a broader view. Circulation 77: 1203-1212, 
1988. 
Katz JA, Laverne RG, Fairley HB, and Thomas AN. Pulmonary oxygen exchange during endobronchial anesthesia: 
effect of tidal volume and PEEP. Anesthesiology 56: 164-171, 1982. 
Kellow NH, Scott AD, White SA, and Feneck RO. Comparison of the effects of propofol and isoflurane anaesthesia 
on right ventricular function and shunt fraction during thoracic surgery. Br. J. Anaesth. 75: 578-582, 1995. 
References 
 
372 
Kellow NH, Scott AD, White SA, and Feneck RO. Comparison of the effects of propofol and isoflurane anaesthesia 
on right ventricular function and shunt fraction during thoracic surgery [see comments]. Br. J. Anaesth. 75: 578-582, 
1995. 
Kelman GR, Nunn JF, Prys RC, and Greenbaum R. The influence of cardiac output on arterial oxygenation: a 
theoretical study. Br. J. Anaesth. 39: 450-458, 1967. 
Kendall SW, Bittner HB, Peterseim DS, Campbell KA, and Van Trigt P. Right ventricular function in the donor heart. 
Eur. J Cardiothorac. Surg. 11: 609-615, 1997. 
Kerr JH, Smith AC, Prys RC, Meloche R, and Foex P. Observations during endobronchial anaesthesia. II. 
Oxygenation. Br. J. Anaesth. 46: 84-92, 1974. 
Khanam T and Branthwaite MA. Arterial oxygenation during one-lung anaesthesia. 1. A study in man. Anaesthesia 
28: 132-138, 1973. 
Kingma I, Tyberg JV, and Smith ER. Effects of diastolic transseptal pressure gradient on ventricular septal position 
and motion. Circulation 68: 1304-1314, 1983. 
Kirshbom PM, Tapson VF, Harrison JK, Davis RD, and Gaynor JW. Delayed right heart failure following lung 
transplantation. Chest 109: 575-577, 1996. 
Klingstedt C, Hedenstierna G, Lundquist H, Strandberg A, Tokics L, and Brismar B. The influence of body position 
and differential ventilation on lung dimensions and atelectasis formation in anaesthetized man. Acta Anaesthesiol. 
Scand. 34: 315-322, 1990. 
Kondo U, Kim SO, Nakayama M, and Murray PA. Pulmonary vascular effects of propofol at baseline, during elevated 
vasomotor tone, and in response to sympathetic alpha- and beta-adrenoreceptor activation. Anesthesiology 94: 815-
823, 2001. 
Kondo U, Kim SO, and Murray PA. Propofol selectively attenuates endothelium-dependent pulmonary vasodilation in 
chronically instrumented dogs. Anesthesiology 93: 437-446, 2000.  
Konstam MA, Cohen SR, Salem DN, Das D, Aronovitz MJ, and Brockway BA. Effect of amrinone on right ventricular 
function: predominance of afterload reduction. Circulation 74: 359-366, 1986. 
Korr KS, Gandsman EJ, Winkler ML, Shulman RS, and Bough EW. Hemodynamic correlates of right ventricular 
ejection fraction measured with gated radionuclide angiography. Am J Cardiol. 49: 71-77, 1982. 
References 
 
373 
Kozhevnikov VA, Glonti IG, Ivanov AS, and Charnaia MA. [Approaches to prevention and treatment of arterial 
hypoxemia in the pre-perfusion period of radical correction of Fallot's tetrad]. Puti profilaktiki i lecheniia arterial'noi 
gipoksemii v predperfuzionnom periode radikal'noi korrektsii tetrady Fallo. Vestn. Ross. Akad. Med. Nauk.  26-30, 
1992. 
Krucylak PE, Naunheim KS, Keller CA, and Baudendistel LJ. Anesthetic management of patients undergoing 
unilateral video-assisted lung reduction for treatment of end-stage emphysema. J. Cardiothorac. Vasc. Anesth. 10: 
850-853, 1996. 
Kurz A, Kurz M, Poeschl G, Faryniak B, Redl G, and Hackl W. Forced-air warming maintains intraoperative 
normothermia better than circulating-water mattresses. Anesth. Analg. 77: 89-95, 1993. 
Kwak YL, Lee CS, Park YH, and Hong YW. The effect of phenylephrine and norepinephrine in patients with chronic 
pulmonary hypertension. 57: 9-14, 2002 
Lake CL. Perioperative management of increased pulmonary vascular resistance. Cardiothoracic and vascular 
anesthesia update 1: 1-21, 1990. 
Lake CL. Chapter 23. Anesthesia for patients with congenital heart disease. In: Cardiac anesthesia. Editor: Kaplan 
JA. 4th edition. 1999. W.B. Saunders Company, Philadelphia.   
Lang RM, Borow KM, Neumann A, and Janzen D. Systemic vascular resistance: an unreliable index of left ventricular 
afterload. Circulation 74: 1114-1123, 1986. 
Laskey WK, Parker HG, Ferrari VA, Kussmaul WG, and Noordergraaf A. Estimation of total systemic arterial 
compliance in humans. J. Appl. Physiol. 69: 112-119, 1990. 
Laver MB, Strauss HW, and Pohost GM. Right and left ventricular geometry: adjustments during acute respiratory 
failure. Crit. Care Med. 7: 509-519, 1979. 
Le Tulzo Y, Seguin P, Gacouin A, Camus C, Suprin E, Jouannic I, and Thomas R. Effects of epinephrine on right 
ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study. 
Intensive. Care Med. 23: 664-670, 1997. 
Leather HA, Segers P, Sun YY, De Ruyter HA, Vandermeersch E, and Wouters PF. The limitations of preload-
adjusted maximal power as an index of right ventricular contractility. Anesth. Analg. 95: 798-804, 2000. 
Lee TS and Hou X. Comparative vasoactive effects of amrinone on systemic and pulmonary arteries in rabbits. Chest 
108: 1364-1367, 1995. 
References 
 
374 
Lejeune P, Leeman M, Deloof T, and Naeije R. Pulmonary hemodynamic response to dopamine and dobutamine in 
hyperoxic and in hypoxic dogs. Anesthesiology 66: 49-54, 1987. 
Lejeune P, Naeije R, Leeman M, Melot C, Deloof T, and Delcroix M. Effects of dopamine and dobutamine on 
hyperoxic and hypoxic pulmonary vascular tone in dogs. Am. Rev. Respir. Dis. 136: 29-35, 1987. 
Levin AI, Coetzer M, Coetzee JF, and Coetzee AR. Sevoflurane compared with halothane to supplement computer 
controlled sufentanil infusions during anesthesia for coronary artery bypass surgery.  Unpublished.  2002.  
Levy BD, Kitch B, and Fanta CH. Medical and ventilatory management of status asthmaticus. Intensive. Care Med. 
24: 105-117, 1998. 
Lewis-JW J, Bastanfar M, Gabriel F, and Mascha E. Right heart function and prediction of respiratory morbidity in 
patients undergoing pneumonectomy with moderately severe cardiopulmonary dysfunction. J. Thorac. Cardiovasc. 
Surg. 108: 169-175, 1994. 
Leyton RA, Spotnitz HM, and Sonnenblick EH. Cardiac ultrastructure and function: sarcomeres in the right ventricle. 
Am. J. Physiol. 221: 902-910, 1971. 
Lichtwarck-Aschoff M, Leucht S, Kisch HW, Zimmermann G, Blumel G, and Pfeiffer UJ. Monitoring of right ventricular 
function using a conventional slow response thermistor catheter. Intensive. Care Med. 20: 348-353, 1994. 
Liu SF and Barnes PJ. Chapter 107. Neural control of pulmonary vascular tone. In: The Lung: Scientific Foundations.  
Editors Crystal RG and West JB. Second edition. 1997. Lippincot-Raven Publishers, Philadelphia. 
Liu Z, Brin KP, and Yin FC. Estimation of total arterial compliance: an improved method and evaluation of current 
methods. Am. J. Physiol. 251: H588-H600, 1986. 
Lodato RF, Michael JR, and Murray PA. Multipoint pulmonary vascular pressure-cardiac output plots in conscious 
dogs. Am J Physiol. 249: H351-H357, 1985. 
Lopes CR, Steendijk P, Baan J, Brouwers HA, De Vroomen M, and Van Bel F. Right ventricular function in 
respiratory distress syndrome and subsequent partial liquid ventilation. Homeometric autoregulation in the right 
ventricle of the newborn animal. Am. J. Respir. Crit. Care Med. 162: 374-379, 2000. 
Lowe D, Hettrick DA, Pagel PS and Warltier DC.  Influence of volatile anesthetics on left ventricular afterload in vitro.  
Anesthesiology 85: 112-120, 1996. 
References 
 
375 
Lowenstein E, Johnston WE, Lappas DG, D'Ambra MN, Schneider RC, Daggett WM, Akins CW, and Philbin DM. 
Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology  59: 470-
473, 1983. 
Maitre PO, Ausems ME, Vozeh S, and Stanski DR. Evaluating the accuracy of using population pharmacokinetic 
data to predict plasma concentrations of alfentanil. Anesthesiology 68: 59-67, 1988. 
Maitre PO, Vozeh S, Heykants J, Thomson DA, and Stanski DR. Population pharmacokinetics of alfentanil: the 
average dose-plasma concentration relationship and interindividual variability in patients. Anesthesiology 66: 3-12, 
1987. 
Malmkvist G, Fletcher R, Nordstrom L, and Werner O. Effect of pulmonary arterial pressure on venous admixture 
during thoracotomy and one-lung ventilation. J. Cardiothorac. Anesth. 3: 36, 1989. 
Mangano DT. The effect of the pericardium on ventricular systolic function in man. Circulation 61: 352-357, 1980. 
Manohar M, Tranquilli WJ, Parks CM, Benson GJ, Theodorakis MC, and Thurmon JC. Regional myocardial blood 
flow and coronary vasodilator reserve during acute right ventricular failure due to pressure overload in swine. J Surg. 
Res. 31: 382-391, 1981. 
Marin JL, Orchard C, Chakrabarti MK, and Sykes MK. Depression of hypoxic pulmonary vasoconstriction in the dog 
by dopamine and isoprenaline. Br. J. Anaesth. 51: 303-312, 1979. 
Marini JJ, Culver BH, and Kirk W. Flow resistance of exhalation valves and positive end-expiratory pressure devices 
used in mechanical ventilation. Am. Rev. Respir. Dis. 131: 850-854, 1985. 
Marino PM. The ICU book.  2003. Lea and Febiger, Philadelphia. 
Mark JB, Slaughter TF, and Reves JG. Chapter 30. Cardiovascular monitoring. In: Anesthesia.  Editor Miller RM. 5th 
edition. 2000. Churchill Livingstone, Philadelphia. 
Marshall BE and Marshall C. A model for hypoxic constriction of the pulmonary circulation. J. Appl. Physiol. 64: 68-
77, 1988. 
Marshall BE and Marshall C. Chapter 115. Pulmonary Hypertension. In: The Lung: Scientific Foundations.  Editors 
Crystal RG and West JB. Second edition. 1997. Lippincot-Raven Publishers, Philadelphia. 
Marshall C and Marshall B. Site and sensitivity for stimulation of hypoxic pulmonary vasoconstriction. J. Appl. 
Physiol. 55: 711-716, 1983. 
References 
 
376 
Martyn J, Wilson RS, and Burke JF. Right ventricular function and pulmonary hemodynamics during dopamine 
infusion in burned patients. Chest 89: 357-360, 1986. 
Martyn JA, Snider MT, Farago LF, and Burke JF. Thermodilution right ventricular volume: a novel and better 
predictor of volume replacement in acute thermal injury. J. Trauma. 21: 619-626, 1981. 
Martyn JA, Snider MT, Szyfelbein SK, Burke JF, and Laver MB. Right ventricular dysfunction in acute thermal injury. 
Ann. Surg. 191: 330-335, 1980. 
Mathers J, Benumof JL, and Wahrenbrock EA. General anesthetics and regional hypoxic pulmonary 
vasoconstriction. Anesthesiology 46: 111-114, 1977. 
Mathru M, Dries DJ, Kanuri D, Blakeman B, and Rao T. Effect of cardiac output on gas exchange in one-lung 
atelectasis. Chest 97: 1121-1124, 1990. 
Mathru M, Dries DJ, Kanuri D, Blakeman B, and Rao T. Effect of cardiac output on gas exchange in one-lung 
atelectasis. Chest 97: 1121-1124, 1990. 
Maughan WL. Ventricular Pressure-Volume Relations in heart Failure: Ventriculo-Vascular Coupling. Heart Failure 4: 
224-231, 1988. 
Maughan WL, Shoukas AA, Sagawa K, and Weisfeldt ML. Instantaneous pressure-volume relationship of the canine 
right ventricle. Circ. Res. 44: 309-315, 1979. 
McGregor M and Sniderman A. On pulmonary vascular resistance: the need for more precise definition. Am. J. 
Cardiol. 55: 217-221, 1985. 
McMurtry IF, Rodman DM, Yamaguchi T, and O'Brien RF. Pulmonary vascular reactivity. Chest 93: 88S-93S, 1988. 
Meadow WL, Rudinsky BF, and Strates E. Effects of phenylephrine on systemic and pulmonary artery pressure 
during sepsis-induced pulmonary hypertension in piglets. Dev. Pharmacol. Ther. 9: 249-259, 1986. 
Meier GD, Bove AA, Santamore WP, and Lynch PR. Contractile function in canine right ventricle. Am. J. Physiol. 
239: H794-804, 1980. 
Melot C, Lejeune P, Leeman M, Moraine JJ, and Naeije R. Prostaglandin E1 in the adult respiratory distress 
syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am. Rev. Respir. Dis. 139: 
106-110, 1989. 
References 
 
377 
Mercer M. Cardiac arrest after unrecognized dynamic inflation [letter; comment] [see comments]. Br. J Anaesth. 75: 
252, 1995. 
Merridew CG and Jones RDM. Non-dependent lung CPAP (5 cm H2O) with oxygen during ketamine, halothane or 
isoflurane anesthesia and one lung anesthesia. Anesthesiology 63: A567, 1985. 
Mikat M, Peters J, Zindler M, and Arndt JO. Whole body oxygen consumption in awake, sleeping, and anesthetized 
dogs. Anesthesiology 60: 220-227, 1984. 
Milnor WR. Arterial impedance as ventricular afterload. Circ. Res. 36: 565-570, 1975. 
Milnor WR. Chapter 10. Cardiac Dynamics. In: Hemodynamics. 1982a. Williams and Wilkins, Baltimore, London. 
Milnor WR. Chapter 5. Pulsatile Pressure Pressure and Flow. In: Hemodynamics. First edition. 1982. Williams and 
Wilkins, Baltimore, London. 
Milnor WR. Chapter 2. Steady Flow. In: Hemodynamics. First edition. 1982b. Williams and Wilkins, Baltimore, 
London. 
Milnor WR. Chapter 7. Vascular Impedance. In: Hemodynamics First edition. 1982c. Williams and Wilkins, Baltimore. 
Milnor WR, Conti CR, Lewis KB, and O'Rourke MF. Pulmonary arterial pulse wave velocity and impedance in man. 
Circ. Res. 25: 637-649, 1969. 
Mitsuo T, Shimazaki S, and Matsuda H. Right ventricular dysfunction in septic patients. Crit. Care Med. 20: 630-634, 
1992. 
Mitzner W. Resistance of the pulmonary circulation. Clin. Chest Med. 4: 127-137, 1983. 
Moon RE and Camporesi EM. Chapter 33. Respiratory monitoring. In: Anesthesia. Editor Miller, RD. 5th edition. 2000. 
Churchill Livingstone, Philadelphia. 
Morel DR, Costabella PM, and Pittet JF. Adverse cardiopulmonary effects and increased plasma thromboxane 
concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent 
[see comments]. Anesthesiology 73: 415-424, 1990. 
Morgan BC and Guntheroth WG. Pulmonary blood flow and resistance during acute atelectasis in intact dogs. J Appl. 
Physiol. 28: 609-613, 1970. 
References 
 
378 
Morisaki H, Serita R, Innami Y, Kotake Y, and Takeda J. Permissive hypercapnia during thoracic anaesthesia. Acta 
Anaesthesiol. Scand. 43: 845-849, 1999. 
Morpurgo M. Pulmonary input impedance or pulmonary vascular resistance? Monaldi. Arch. Chest Dis. 50: 282-285. 
Review., 1995. 
Moser KM. Venous thromboembolism [see comments]. Am. Rev. Respir. Dis. 141: 235-249, 1990. 
Murgo JP and Westerhof N. Chapter 6. Arterial reflections and pressure waveforms in humans. In: 
Ventricular/Vascular Coupling.Clincal, Physiological and Engineering Aspects. 1987. Springer-Verlag, New York. 
Mushin WW, Rendell-Baker L, and Thompson PW. Chapter 3. Physical aspects of automatic ventilators: basic 
principles. In: Automatic ventilation of the lungs. 3rd edition. 1980. Blackwell Scientific Publications, Oxford. 
Myhre ES, Johansen A, Bjornstad J, and Piene H. The effect of contractility and preload on matching between the 
canine left ventricle and afterload. Circulation 73: 161-171, 1986. 
Myhre ES, Johansen A, and Piene H. Optimal matching between canine left ventricle and afterload. Am. J. Physiol. 
254: H1051-8, 1988. 
Myles PS. Auto-PEEP may improve oxygenation during one-lung ventilation. Anesth. Analg. 83: 1131, 1996. 
Myles PS. Lessons from lung transplantation for everyday thoracic anesthesia. Anesthesiol. Clin. North America. 19: 
581-90, vii, 2001. 
Myles PS, Madder H, and Morgan EB. Intraoperative cardiac arrest after unrecognized dynamic hyperinflation. Br. J. 
Anaesth. 74: 340-342, 1995. 
Myles PS, Madder H, and Morgan EB. Intraoperative cardiac arrest after unrecognized dynamic hyperinflation [see 
comments]. Br. J Anaesth. 74: 340-342, 1995. 
Myles PS, Ryder IG, Weeks AM, Williams T, and Esmore DS. Case 1--1997. Diagnosis and management of dynamic 
hyperinflation during lung transplantation. J. Cardiothorac. Vasc. Anesth. 11: 100-104, 1997. 
Myles PS and Weeks AM. Alpha 1-antitrypsin deficiency: circulatory arrest following induction of anaesthesia. 
Anaesth. Intensive. Care 20: 358-362, 1992. 
Myles PS, Weeks AM, Buckland MR, Silvers A, Bujor M, and Langley M. Anesthesia for bilateral sequential lung 
transplantation: experience of 64 cases. J. Cardiothorac. Vasc. Anesth. 11: 177-183, 1997. 
References 
 
379 
Nakayama M and Murray PA. Ketamine preserves and propofol potentiates hypoxic pulmonary vasoconstriction 
compared with the conscious state in chronically instrumented dogs. Anesthesiology 91: 760-771, 1999. 
Naunheim KS and Ferguson MK. The current status of lung volume reduction operations for emphysema. Ann. 
Thorac. Surg. 62: 601-612, 1996. 
Nelson LD, Safcsak K, Cheatham ML, and Block EF. Mathematical coupling does not explain the relationship 
between right ventricular end-diastolic volume and cardiac output. Crit. Care Med. 29: 940-943, 2001. 
Newnan RW, Finer GE, and Downs JE. Routine use of the Carlens endobronchial catheter. Journal of Thoracic and 
Cardiovascular Surgery 42: 327-339, 1961. 
Nichols WW, Conti CR, Walker WE, and Milnor WR. Input impedance of the systemic circulation in man. Circ. Res. 
40: 451-458, 1977. 
Nimbkar NV and O'Neill TJE. The effect of acute autonomic denervation on pulmonary vascular resistance. The 
Annals of Thoracic Surgery 16: 574-582, 1973. 
Noe FE, Whitty AJ, Davies KR, and Wickham BL. Noninvasive measurement of pulmonary gas exchange during 
general anesthesia. Anesth. Analg. 59: 263-269, 1980. 
Nomoto Y and Kawamura M. Pulmonary gas exchange effects by nitroglycerin, dopamine and dobutamine during 
one-lung ventilation in man. Can. J. Anaesth. 36: 273-277, 1989. 
Noordergraaf A and Melbin J. Ventricular afterload: a succinct yet comprehensive definition. Am. Heart J. 95: 545-
547, 1978. 
Nozawa T, Cheng CP, Noda T, and Little WC. Effect of exercise on left ventricular mechanical efficiency in conscious 
dogs. Circulation 90: 3047-3054, 1994. 
Nuland SB, Glenn WWL, and Guilfoil PH. Circulatory bypass of the right heart.  III  Some observations on long-term 
survivors. Surgery 43: 184-201, 1958. 
Nunn JF. Applied respiratory physiology. 3rd edition. 1987. Butterworths, London. 
Nunn JF. Effects of anaesthesia on respiration. Br. J. Anaesth. 65: 54-62, 1990. 
Nyhan DP. Perioperative care of the cardio-pulmonary compromised patient. Problems in Anesthesiology 13: 2001. 
Nyhan DP. Pulmonary circulation. Problems in Anesthesiology 12: 109-141, 2001. 
References 
 
380 
Ogawa K, Tanaka S, and Murray PA. Propofol potentiates phenylephrine-induced contraction via cyclooxygenase 
inhibition in pulmonary artery smooth muscle. Anesthesiology 94: 833-839, 2001. 
Okada M, Ishii N, Yamashita C, Sugimoto T, Okada K, Yamagishi H, Yamashita T, and Matsuda H. Right ventricular 
ejection fraction in the preoperative risk evaluation of candidates for pulmonary resection. J. Thorac. Cardiovasc. 
Surg. 112: 364-370, 1996. 
Okada M, Ota T, Matsuda H, Okada K, and Ishii N. Right ventricular dysfunction after major pulmonary resection. J. 
Thorac. Cardiovasc. Surg. 108: 503-511, 1994. 
Pace JB, Keefe WF, Armour JA, and Randall WC. Influence of sympathetic nerve stimulation on right ventricular 
outflow- tract pressures in anesthetized dogs. Circ. Res. 24: 397-407, 1969. 
Packer M, Medina N, Yushak M, and Lee WH. Comparative effects of captopril and isosorbide dinitrate on pulmonary 
arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a 
randomized crossover study. Am. Heart J. 109: 1293-1299, 1985. 
Pagel PS, Farber NE, and Warltier DC. Chapter 5A. Cardiovascular pharmacology. In: Anesthesia. Editor Miller, RD. 
5th edition. 2000. Churchill Livingstone, Philadelphia. 
Pagel PS, Fu JL, Damask MC, Davis RF, Samuelson PN, Howie MB, and Warltier DC. Desflurane and isoflurane 
produce similar alterations in systemic and pulmonary hemodynamics and arterial oxygenation in patients 
undergoing one-lung ventilation during thoracotomy. Anesth. Analg. 87: 800-807, 1998. 
Pagel PS and Warltier DC. Chapter 67. Mechanical function of the left ventricle. In: Anesthesia: Biologic foundations. 
Editors Yaksh T L, Lynch C et al. 1997. Lippincot-Raven, Philadelphia, New York. 
Parbrook GD, Davis PD, and Parbrook EO. Chapter 2. Fluid Flow. In: Basic Physics and Measurement in 
Anaesthesia. 2nd edition. 1985. William Heinemann Medical Books Ltd, London. 
Parbrook GD, Davis PD, and Parbrook EO. Chapter 9. Temperature. In: Basic Physics and Measurement in 
Anaesthesia. 2nd edition. 1985. William Heinemann Medical Books Ltd, London. 
Parker MM, McCarthy KE, Ognibene FP, and Parrillo JE. Right ventricular dysfunction and dilatation, similar to left 
ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97: 126-131, 1990. 
Parsons RS and Wetzel RC. Is intravenous isosorbide dinitrate a selective pulmonary vasodilator? Anesthesiology 
63: A51, 1985. 
References 
 
381 
Patino JF, Glenn WWL, Guilfoil PH, Hume M, and Fenn JE. Circulatory bypass of the right heart.  II  Further 
observations on vena caval-pulmonary artery shunts. Surgical Forum 6: 189-193, 1956. 
Pearl RG and Siegel LC. Effects of prostaglandin E1 and hydralazine on the longitudinal distribution of pulmonary 
vascular resistance during vasoconstrictor pulmonary hypertension in sheep. Anesthesiology 76: 106-112, 1992. 
Pease RD, Benumof JL, and Trousdale FR. PAO2 and PVO2 interaction on hypoxic pulmonary vasoconstriction. J. 
Appl. Physiol. 53: 134-139, 1982. 
Petry A and Dutschke P. Effects of amrinone on left and right ventricular function in patients with impaired myocardial 
performance during general anaesthesia. Br. J. Anaesth. 72: 567-570, 1994. 
Piene H. Pulmonary arterial impedance and right ventricular function. Physiol. Rev. 66: 606-652, 1986. 
Piene H. Chapter 8. Matching between right ventricle and pulmonary bed. In: Ventricular/Vascular Coupling. Clincal, 
Physiological and Engineering Aspects. 1987. Springer-Verlag, New York. 
Piene H and Hauge A. Reduction of pulsatile hydraulic power in the pulmonary circulation caused by moderate 
vasoconstriction. Cardiovasc. Res. 10: 503-513, 1976. 
Piene H and Myhre ES. Left ventricle-aortic coupling: prediction of contraction pattern. Am. J. Physiol. 247: H531-40, 
1984. 
Piene H and Sund T. Flow and power output of right ventricle facing load with variable input impedance. Am. J. 
Physiol. 237: H125-30, 1979. 
Piene H and Sund T. Performance of the right ventricle: a pressure plane analysis. Cardiovasc. Res. 14: 217-222, 
1980. 
Piene H and Sund T. Does normal pulmonary impedance constitute the optimum load for the right ventricle? Am. J. 
Physiol. 242: H154-60, 1982. 
Pinsky MR, Desmet JM, and Vincent JL. Effect of positive end-expiratory pressure on right ventricular function in 
humans. Am. Rev. Respir. Dis. 146: 681-687, 1992. 
Pirlo AF, Benumof JL, and Trousdale FR. Atelectatic lobe blood flow: open vs. closed chest, positive pressure vs. 
spontaneous ventilation. J. Appl. Physiol. 50: 1022-1026, 1981. 
Pool PE, Piggott WJ, Seagren SC, and Skelton CL. Augmented right ventricular function in systemic hypertension-
induced hypertrophy. Cardiovasc. Res. 10: 124-128, 1976. 
References 
 
382 
Pouleur H, Lefevre J, van Eyll C, Jaumin PM, and Charlier AA. Significance of pulmonary input impedance in right 
ventricular performance. Cardiovasc. Res. 12: 617-629, 1978. 
Prewitt RM and Ghignone M. Treatment of right ventricular dysfunction in acute respiratory failure. Crit. Care Med. 
11: 346-352, 1983. 
Priebe HJ. Differential effects of isoflurane on regional right and left ventricular performances, and on coronary, 
systemic, and pulmonary hemodynamics in the dog. Anesthesiology 66: 262-272, 1987. 
Prielipp RC, Rosenthal MH, and Pearl RG. Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in 
sheep. Anesthesiology 68: 552-558, 1988. 
Quinlan JJ and Buffington CW. Deliberate hypoventilation in a patient with air trapping during lung transplantation. 
Anesthesiology 78: 1177-1181, 1993. 
Rafferty T, Durkin M, Harris S, Elefteriades J, Hines R, Prokop E, and O'Connor T. Transesophageal two-
dimensional echocardiographic analysis of right ventricular systolic performance indices during coronary artery 
bypass grafting. J. Cardiothorac. Vasc. Anesth. 7: 160-166, 1993. 
Raffin L, Michel-Cherqui M, Sperandio M, Bonnette P, Bisson A, Loirat P, and Fischler M. Anesthesia for bilateral 
lung transplantation without cardiopulmonary bypass: initial experience and review of intraoperative problems. J. 
Cardiothorac. Vasc. Anesth. 6: 409-417, 1992. 
Raffin L, Michel-Cherqui M, Sperandio M, Bonnette P, Bisson A, Loirat P, and Fischler M. Anesthesia for bilateral 
lung transplantation without cardiopulmonary bypass: initial experience and review of intraoperative problems. J. 
Cardiothorac. Vasc. Anesth. 6: 409-417, 1992. 
Raines RA, LeWinter MM, and Covell JW. Regional shortening patterns in canine right ventricle. Am. J. Physiol. 231: 
1395-1400, 1976. 
Randall JE and Stacy RW. Mechanical Impedance of the Dog's Hind Leg to Pulsatile Blood Flow. Am. J. Physiol.  94-
98, 1956. 
Ranieri VM, Mascia L, Fiore T, Bruno F, Brienza A, and Giuliani R. Cardiorespiratory effects of positive end-
expiratory pressure during progressive tidal volume reduction (permissive hypercapnia) in patients with acute 
respiratory distress syndrome. Anesthesiology 83: 710-720, 1995. 
Reed CE, Spinale FG, and Crawford FA, Jr. Effect of pulmonary resection on right ventricular function. Ann. Thorac. 
Surg. 53: 578-582, 1992. 
References 
 
383 
Rees DI and Gaines GY. One-lung anesthesia--a comparison of pulmonary gas exchange during anesthesia with 
ketamine or enflurane. Anesth. Analg. 63: 521-525, 1984. 
Rees DI and Wansbrough SR. One-lung anesthesia: percent shunt and arterial oxygen tension during continuous 
insufflation of oxygen to the nonventilated lung. Anesth. Analg. 61: 507-512, 1982. 
Reich D and Thys DM. Chapter 10. Invasive cardiovascular monitoring. In: The practice of thoracic anesthesia. 
Editor: Cohen E. 1995. J.B. Lippincott Company, Philadelphia. 
Reich DL, Moskowirz DL, and Kaplan JA. Chapter 11. Hemodynamic monitoring. In: Cardiac anesthesia. Editor: 
Kaplan JA. 4th edition. 1999. W.B. Saunders Company, Philadelphia. 
Reichart BA, Reichenspurner HC, Odell JA, Cooper DK, Novitzky D, Human PA, Von Oppell UO, Becerra EA, 
Boehm DH, and Rose AG. Heart transplantation at Groote Schuur Hospital, Cape Town. Twenty years' experience. 
S. Afr. Med. J. 72: 737-739, 1987. 
Reid CW, Slinger PD, and Lenis S. A comparison of the effects of propofol-alfentanil versus isoflurane anesthesia on 
arterial oxygenation during one-lung ventilation. J. Cardiothorac. Vasc. Anesth. 10: 860-863, 1996. 
Renard M, Jacobs P, Vainsel H, and Bernard R. Dobutamine effects on blood gases and hemodynamics in acute 
myocardial infarction with heart failure. Acta Cardiol. 39: 121-129, 1984. 
Reuben SR, Gersh BJ, Swadling JP, and Lee G-J. Measurement of pulmonary arterial distensibility in the dog. 
Cardiovasc. Res. 4: 473-481, 1970. 
Reuben SR, Swadling JP, Gersh BJ, and Lee G-J. Impedance and transmission properties of the pulmonary arterial 
system. Cardiovasc. Res. 5: 1-9, 1971. 
Reuse C, Frank N, Contempre B, and Vincent JL. Right ventricular function in septic shock. Intensive. Care Med. 14 
Suppl 2: 486-487, 1988. 
Reuse C, Vincent JL, and Pinsky MR. Measurements of right ventricular volumes during fluid challenge. Chest 98: 
1450-1454, 1990. 
Rich S, Gubin S, and Hart K. The effects of phenylephrine on right ventricular performance in patients with 
pulmonary hypertension [see comments]. Chest 98: 1102-1106, 1990. 
Rigolin VH, Robiolio PA, Wilson JS, Harrison JK, and Bashore TM. The forgotten chamber: the importance of the 
right ventricle. Cathet. Cardiovasc. Diagn. 35: 18-28, 1995. 
References 
 
384 
Rittenhouse EA, Berger K, Mansfield PB, and Sauvage LR. Enlargement of the right ventricle using a viable atrial 
pedicle graft. Journal of Cardiovascular Surgery 19: 443-448, 1978. 
Robicsek F. The history of right heart bypass before Fontan. Herz. 17: 199-212, 1992. 
Robotham JL, Takata M, Berman M, and Harasawa Y. Ejection fraction revisited. Anesthesiology 74: 172-183, 1991. 
Rock P, Beattie C, Kimball AW, Nyhan DP, Chen BB, Fehr DM, Derrer SA, Parker SD, and Murray PA. Halothane 
alters the oxygen consumption-oxygen delivery relationship compared with conscious state. Anesthesiology 73: 
1186-1197, 1990. 
Rodman DM and Voelkel NF. Chapter 108. Regulation of vascular tone. In: The Lung: Scientific Foundations.  
Editors Crystal RG and West JB. Second edition. 1997. Lippincot-Raven Publishers, Philadelphia. 
Rogers SN and Benumof JL. Halothane and isoflurane do not decrease PaO2 during one-lung ventilation in 
intravenously anesthetized patients. Anesth. Analg. 64: 946-954, 1985. 
Rose CEJ, Van Benthuysen K, Jackson JT, Tucker CE, Kaiser DL, Grover RF, and Weil JV. Right ventricular 
performance during increased afterload impaired by hypercapnic acidosis in conscious dogs. Circ. Res. 52: 76-84, 
1983. 
Rossi A, Polese G, Brandi G, and Conti G. Intrinsic positive end-expiratory pressure (PEEPi). Intensive. Care Med. 
21: 522-536, 1995. 
Rothen HU. Chapter 77. Ventilation and perfusion matching. In: Anesthesia: Biologic foundations. Editors Yaksh T L, 
Lynch C et al. 1997. Lippincot-Raven, Philadelphia, New York. 
Rothen HU, Sporre B, Engberg G, Wegenius G, Hogman M, and Hedenstierna G. Influence of gas composition on 
recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology 82: 832-842, 
1995. 
Rothen HU, Sporre B, Engberg G, Wegenius G, and Hedenstierna G. Reexpansion of atelectasis during general 
anaesthesia may have a prolonged effect. Acta Anaesthesiol. Scand. 39: 118-125, 1995a. 
Rothen HU, Sporre B, Engberg G, Wegenius G, and Hedenstierna G. Re-expansion of atelectasis during general 
anaesthesia: a computed tomography study. Br. J. Anaesth. 71: 788-795, 1993. 
Ruppel GL. Manual of pulmonary function testing. 7th edition. 1998. Mosby-Year Book Publishers, St. Louis, Missouri. 
References 
 
385 
Russell WJ and James MF. The effects on increasing cardiac output with adrenaline or isoprenaline on arterial 
haemoglobin oxygen saturation and shunt during one-lung ventilation. Anaesth. Intensive. Care 28: 636-641, 2000. 
Sade RM and Castaneda AR. The dispensable right ventricle. Surgery 77: 624-631, 1975. 
Sagawa K. The ventricular pressure-volume diagram revisited. Circ. Res. 43: 677-687, 1978. 
Sagawa K, Maughan WL, Suga H, and Sunagawa K. Cardiac Contraction and the Pressure-Volume Relationship. 
1988. Oxford University Press, New York, Oxford. 
Sandler H and Dodge HT. Left Ventricular Tension and Stress in Man. Circ. Res. 13: 91-104, 1963. 
Santamore WP, Constantinescu M, Minczak BM, Hock CE, and Papa L. Contribution of each ventricular wall to 
ventricular interdependence. Basic. Res. Cardiol. 83: 424-430, 1988a. 
Santamore WP, Constantinescu M, Vinten Johansen J, Johnston WE, and Little WC. Alterations in left ventricular 
compliance due to changes in right ventricular volume, pressure and compliance. Cardiovasc. Res. 22: 768-776, 
1988b. 
Santamore WP and Gray LA, Jr. Left ventricular contributions to right ventricular systolic function during LVAD 
support. Ann. Thorac. Surg. 61: 350-356, 1996. 
Santamore WP, Lynch PR, Heckman JL, Bove AA, and Meier GD. Left ventricular effects on right ventricular 
developed pressure. J. Appl. Physiol. 41: 925-930, 1976b. 
Santamore WP, Lynch PR, Meier G, Heckman J, and Bove AA. Myocardial interaction between the ventricles. J. 
Appl. Physiol. 41: 362-368, 1976a. 
Sarnoff SJ and Berglund E. 1. Starlings law of the heart studied by means of simultaneous right and left ventricular 
function curves in the dog. Circulation 9: 706-718, 1954. 
Satoh D, Sato M, Kaise A, Hagiwara Y, Saishu T, and Hashimoto Y. Effects of isoflurane on oxygenation during one-
lung ventilation in pulmonary emphysema patients. Acta Anaesthesiol. Scand. 42: 1145-1148, 1998. 
Scanlon TS, Benumof JL, Wahrenbrock EA, and Nelson WL. Hypoxic pulmonary vasoconstriction and the ratio of 
hypoxic lung to perfused normoxic lung. Anesthesiology 49: 177-181, 1978. 
Scheeren TW, Schwarte LA, and Arndt JO. Metabolic regulation of cardiac output during inhalation anaesthesia in 
dogs. Acta Anaesthesiol. Scand. 43: 421-430, 1999. 
References 
 
386 
Scherer R, Van Aken H, Schlegel W, and Lawin P. Cardio-respiratory changes and prostaglandins during one-lung- 
anesthesia. Acta Anaesthesiol. Belg. 35: 89-103, 1984. 
Schneider AJ, Groeneveld AB, Teule GJ, Nauta J, Heidendal GA, and Thijs LG. Volume expansion, dobutamine and 
noradrenaline for treatment of right ventricular dysfunction in porcine septic shock: a combined invasive and 
radionuclide study. Circ. Shock 23: 93-106, 1987. 
Schoenberg JB, Beck GS, and Bouhys A. Growth and decay of pulmonary function in healthy blacks and whites. 
Respir. Physiol. 33: 367-393, 1978. 
Schreuder WO, Schneider AJ, Groeneveld AB, and Thijs LG. The influence of catecholamines on right ventricular 
function in septic shock. Intensive. Care Med. 14 Suppl 2: 492-495, 1988. 
Schreuder WO, Schneider AJ, Groeneveld AB, and Thijs LG. Effect of dopamine vs. norepinephrine on 
hemodynamics in septic shock. Emphasis on right ventricular performance. Chest 95: 1282-1288, 1989. 
Schubert A. Should mild hypothermia be routinely used for human cerebral protection? The flip side. J. Neurosurg. 
Anesthesiol. 4: 216-220, 1992. 
Schulman DS and Matthay RA. The right ventricle in pulmonary disease. Cardiol. Clin. 10: 111-135, 1992. 
Schwartzman DS, Attubato MJ, and Feit F. Interatrial Septum and its Role in Systemic Embolism. Anesthesiology 
Clinics of North America 10: 795-823, 1993. 
Schwid HA. Frequency response evaluation of radial artery catheter-manometer systems: sinusoidal frequency 
analysis versus flush method. J. Clin. Monit. 4: 181-185, 1988. 
Senzaki H, Chen CH, and Kass DA. Single-beat estimation of end-systolic pressure-volume relation in humans. A 
new method with the potential for noninvasive application. Circulation 94: 2497-2506, 1996. 
Sessler DI. Chapter 37. Temperature monitoring. In: Anesthesia. Editor Miller, RD. 5th edition. 2000. Churchill 
Livingstone, Philadelphia. 
Shapiro HM, Smith G, Pribble AH, Murray JA, and Cheney FWJ. Errors in sampling pulmonary arterial blood with a 
Swan-Ganz catheter. Anesthesiology 40: 291-295, 1974. 
Shibutani K, Komatsu T, Kubal K, Sanchala V, Kumar V, and Bizzarri DV. Critical level of oxygen delivery in 
anesthetized man. Crit. Care Med. 11: 640-643, 1983. 
References 
 
387 
Shimizu T, Abe K, Kinouchi K, and Yoshiya I. Arterial oxygenation during one lung ventilation. Can. J. Anaesth. 44: 
1162-1166, 1997. 
Shintani H and Glantz SA. Chapter 6. The influence of the pericardium and ventricular interaction on diastolic 
function. In: Left ventricular diastolic function and heart failure. 1994b. Lea and Febiger, Philadelphia. 
Shintani H and Glantz SA. Chapter 4. The left ventricular diastolic pressure-volume relation, relaxation and filling. In: 
Left ventricular diastolic function and heart failure. 1994a. Lea and Febiger, Philadelphia. 
Shoemaker WC and Kram HB. Chapter 18. Pathophysiology, monitoring, outcome prediction and therapy of shock 
states. In: Scientific foundations of anesthesia.  Editors Scur and Feldman. 4th edition. 1998.  Lippincot-Raven 
Publishers, Philadelphia. 
Sibbald WJ and Driedger AA. Right ventricular function in acute disease states: pathophysiologic considerations. 
Crit. Care Med. 11: 339-345, 1983. 
Sibbald WJ, Driedger AA, Myers ML, Short AI, and Wells GA. Biventricular function in the adult respiratory distress 
syndrome. Chest 84: 126-134, 1983. 
Sibbald WJ, Paterson NA, Holliday RL, Anderson RA, Lobb TR, and Duff JH. Pulmonary hypertension in sepsis: 
measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive 
and active factors. Chest 73: 583-591, 1978. 
Sibbald WJ, Short AI, Driedger AA, and Wells GA. The immediate effects of isosorbide dinitrate on right ventricular 
function in patients with acute hypoxemic respiratory failure. A combined invasive and radionuclide study. Am. Rev. 
Respir. Dis. 131: 862-868, 1985. 
Siegel J and Brodsky JB. Chapter 13. Choice of anesthetic agents for intrathoracic surgery. In: Thoracic anesthesia.  
Editor: Cohen E. 2nd edition. 1991. Churchill Livingstone, New York. 
Simbruner G. Inadvertent positive end-expiratory pressure in mechanically ventilated newborn infants: detection and 
effect on lung mechanics and gas. J. Pediatr. 108: 589-595, 1986. 
Sivalingam P and Tio R. Tension pneumothorax, pneumomediastinum, pneumoperitoneum, and subcutaneous 
emphysema in a 15-year-old Chinese girl after a double-lumen tube intubation and one-lung ventilation. J. 
Cardiothorac. Vasc. Anesth. 13: 312-315, 1999. 
Skimming JW, Cassin S, and Nichols WW. Calculating vascular resistances. Clin. Cardiol. 20: 805-808, 1997. 
References 
 
388 
Slinger P. Choosing the appropriate double-lumen tube: a glimmer of science comes to a dark art [editorial; 
comment]. J Cardiothorac. Vasc. Anesth. 9: 117-118, 1995. 
Slinger P. Post-pneumonectomy pulmonary edema: is anesthesia to blame? Current Opinion in Anesthesiology 12: 
49-54, 1999. 
Slinger P and Scott WA. Arterial oxygenation during one-lung ventilation. A comparison of enflurane and isoflurane. 
Anesthesiology 82: 940-946, 1995. 
Slinger P and Scott WA. Arterial oxygenation during one-lung ventilation. A comparison of enflurane and isoflurane. 
Anesthesiology 82: 940-946, 1995. 
Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy pulmonary 
edema. J. Cardiothorac. Vasc. Anesth. 9: 442-451, 1995. 
Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy pulmonary 
edema. J. Cardiothorac. Vasc. Anesth. 9: 442-451, 1995. 
Slinger PD and Hickey DR. The interaction between applied PEEP and auto-PEEP during one-lung ventilation. J. 
Cardiothorac. Vasc. Anesth. 12: 133-136, 1998. 
Slinger PD, Hickey DR, Lenis SG, and Gottfried SB. Intrinsic PEEP during one lung ventilation. Anesth. Analg. 68: 
S269, 1989. 
Slinger PD, Kruger M, McRae K, and Winton T. Relation of the static compliance curve and positive end-expiratory 
pressure to oxygenation during one-lung ventilation. Anesthesiology 95: 1096-1102, 2001. 
Slinker BK, Chagas AC, and Glantz SA. Chronic pressure overload hypertrophy decreases direct ventricular 
interaction. Am J Physiol. 253: H347-H357, 1987. 
Slinker BK and Glantz SA. End-systolic and end-diastolic ventricular interaction. Am J Physiol. 251: H1062-H1075, 
1986. 
Solaro RJ, Lee JA, Kentish JC, and Allen DG. Effects of acidosis on ventricular muscle from adult and neonatal rats. 
Circ. Res. 63: 779-787, 1988. 
Spotnitz HM, Berman DS, and Epstein SE. Pathophysiology and experimental treatment of acute pulmonary 
embolism. Am. Heart J. 82: 511-520, 1971. 
References 
 
389 
Squara P, Journois D, Estagnasie P, Wysocki M, Brusset A, Dreyfuss D, and Teboul JL. Elastic energy as an index 
of right ventricular filling. Chest 111: 351-358, 1997. 
Stanski DR. Chapter 29. Monitoring depth of anesthesia. In: Anesthesia. Editor Miller, RD. 5th edition. 2000. Churchill 
Livingstone, Philadelphia. 
Starr I, Jeffers WA, and Meade RH. The absence of conspicuous increments of venous pressure after severe 
damage to the right ventricle of the dog, with a discussion of the relation between clinical congestive heart failure and 
heart disease. Am. Heart J. 26: 291-301, 1943. 
Steegers PA and Backx PJ. Propofol and alfentanil anesthesia during one-lung ventilation. J. Cardiothorac. Anesth. 
4: 194-199, 1990. 
Stein KL, Breisblatt W, Wolfe C, Gasior T, and Hardesty R. Depression and recovery of right ventricular function after 
cardiopulmonary bypass. Crit. Care Med. 18: 1197-1200, 1990. 
Steinhart CR, Permutt S, Gurtner GH, and Traystman RJ. beta-Adrenergic activity and cardiovascular response to 
severe respiratory acidosis. Am. J. Physiol. 244: H46-H54, 1983. 
Stenqvist O, Olegard C, Sondergaard S, Odenstedt H, Karason S, and Lundin S. Monitoring functional residual 
capacity (FRC) by quantifying oxygen/carbon dioxide fluxes during a short apnea. Acta Anaesthesiol. Scand.  46: 
732-739, 2002. 
Stoltzfus DP. Right ventricular function and failure in the perioperative period. Anesthesiology Clinics of North 
America 15: 797-822, 1997. 
Stool EW, Mullins CB, Leshin SJ, and Mitchell JH. Dimensional changes of the left ventricle during acute pulmonary 
hypertension in dogs. Am J Cardiol. 33: 868-875, 1974. 
Sturm JA, Lewis FR, Jr., Trentz O, Oestern HJ, Hempelman G, and Tscherne H. Cardiopulmonary parameters and 
prognosis after severe multiple trauma. J. Trauma. 19: 305-318, 1979. 
Sue DY and Wasserman K. Impact of integrative cardiopulmonary exercise testing on clinical decision making. Chest 
99: 981-992, 1991. 
Suga H, Hayashi T, Shirahata M, Suehiro S, and Hisano R. Regression of cardiac oxygen consumption on 
ventricular pressure- volume area in dog. Am. J. Physiol. 240: H320-5, 1981. 
Sunagawa K, Maughan WL, Burkhoff D, and Sagawa K. Left ventricular interaction with arterial load studied in 
isolated canine ventricle. Am. J. Physiol. 245: H773-80, 1983. 
References 
 
390 
Sunagawa K, Maughan WL, and Sagawa K. Optimal arterial resistance for the maximal stroke work studied in 
isolated canine left ventricle. Circ. Res. 56: 586-595, 1985. 
Sunagawa K, Maughan WL, and Sagawa K. Stroke volume effect of changing arterial input impedance over selected 
frequency ranges. Am. J. Physiol. 248: H477-84, 1985. 
Sutherland GR, Calvin JE, Driedger AA, Holliday RL, and Sibbald WJ. Anatomic and cardiopulmonary responses to 
trauma with associated blunt chest injury. J. Trauma. 21: 1-12, 1981. 
Sykes MK, Vickers MD, and Hull CJ. Chapter 13. Direct measurement of intravascular pressure. In: Principles of 
measurement and monitoring in anaesthesia and intensive care3th edition. 1994. Blackwell Scientific Publications, 
London. 
Szegedi LL. Pathophysiology of one-lung ventilation. Anesthesiol. Clin. North America. 19: 435-53, v, 2001. 
Szegedi LL, Bardoczky GI, Engelman EE, and d'Hollander AA. Airway pressure changes during one-lung ventilation. 
Anesth. Analg. 84: 1034-1037, 1997. 
Tanaka K, Oshita S, Kitahata H, Kimura H, Kawahito S, Park YC, and Sakabe T. Effects of nicardipine on ventriculo-
arterial coupling in humans. Br. J. Anaesth. 81: 180-185, 1998. 
Tanaka S, Kanaya N, Homma Y, Damron DS, and Murray PA. Propofol increases pulmonary artery smooth muscle 
myofilament calcium sensitivity: role of protein kinase C. Anesthesiology 97: 1557-1566, 2002. 
Tarhan S and Lundborg RO. Blood gas and pH studies during use of the Carlens catheter. Can. Anaesth. Soc. J. 15: 
458-467, 1968. 
Tarhan S and Lundborg RO. Effects of increased expiratory pressure on blood gas tensions and pulmonary shunting 
during thoracotomy with use of the Carlens catheter. Can. Anaesth. Soc. J. 17: 4-11, 1970. 
Taylor AE and Lausch RM. The lungs as an anti-inflammatory organ of the body. Crit. Care Med. 29: 1087-1088, 
2001. 
Taylor RR, Covell JW, Sonneblick EH, and Ross J, Jr. Dependence of ventricular distensibility on filling of the 
opposite ventricle. American Journal of Physiology 213: 711-718, 1967. 
The Acute Respiratory Distress Syndrome Network Study. Ventilation with lower tidal volumes as compared with 
traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory 
Distress Syndrome Network. N. Engl. J. Med. 342: 1301-1308, 2000. 
References 
 
391 
Theye RA and Michenfelder JD. Individual organ contributions to the decrease in whole-body Vo2 with isoflurane. 
Anesthesiology 42: 35-40, 1975. 
Theye RA and Michenfelder JD. Whole-body and organ Vo2 changes with enflurane, isoflurane, and halothane. Br. 
J. Anaesth. 47: 813-817, 1975. 
Theye RA and Sessler AD. Effect of halothane anesthesia on rate of canine oxygen consumption. Anesthesiology 
28: 661-669, 1967. 
Thomas CE. The Muscular Architecture of the Ventricles of Hog and Dog Hearts. American Journal of Anatomy 101: 
17-57, 1957. 
Thys DM, Cohen E, and Eisenkraft JB. Mixed venous oxygen saturation during thoracic anesthesia. Anesthesiology 
69: 1005-1009, 1988. 
Thys DM and Dauchot PJ. Chapter 7. Advances in cardiovascular physiology. In: Cardiac anesthesia. Editor: Kaplan 
JA. 4th edition. 1999. W.B. Saunders Company, Philadelphia. 
Tobin MJ and Lodato RF. PEEP, auto-PEEP, and waterfalls. Chest 96: 449-451, 1989. 
Torda TA, McCulloch CH, O'Brien HD, Wright JS, and Horton DA. Pulmonary venous admixture during one-lung 
anaesthesia. The effect of inhaled oxygen tension and respiration rate. Anaesthesia 29: 272-279, 1974. 
Troncy E, Francoeur M, and Blaise G. Inhaled nitric oxide: clinical applications, indications, and toxicology. Can. J. 
Anaesth. 44: 973-988, 1997. 
Tusman G, Bohm SH, Melkun F, Staltari D, Quinzio C, Nador C, and Turchetto E. Alveolar recruitment strategy 
increases arterial oxygenation during one-lung ventilation. Ann. Thorac. Surg. 73: 1204-1209, 2002 
Tuxen DV. Permissive hypercapnic ventilation. Am. J. Respir. Crit. Care Med. 150: 870-874, 1994. 
Tyson KRT and Fender HR. Direct influence of blood viscosity on pulmonary vascular resistance. Journal of Pediatric 
Surgery 10: 779-783, 1975. 
van den Horn GJ, Westerhof N, and Elzinga G. Optimal power generation by the left ventricle. A study in the 
anesthetized open thorax cat. Circ. Res. 56: 252-261, 1985. 
Van der Linden P, Schmartz D, Gilbart E, Engelman E, and Vincent JL. Effects of propofol, etomidate, and 
pentobarbital on critical oxygen delivery. Crit. Care Med. 28: 2492-2499, 2000. 
References 
 
392 
van der Werff YD, van der Houwen HK, Heijmans PJ, Duurkens VA, Leusink HA, van Heesewijk HP, and de Boer A. 
Postpneumonectomy pulmonary edema. A retrospective analysis of incidence and possible risk factors. Chest 111: 
1278-1284, 1997. 
Van Schalkwyk EM, Schultz C, Joubert JR, and White NW. South African thoracic society guide for ofice spirometry 
in adults.  2001.  
Van Trigt P, Bittner HB, Kendall SW, and Milano CA. Mechanisms of transplant right ventricular dysfunction. Ann. 
Surg. 221: 666-75; discussion 675-6, 1995. 
Versprille A. Pulmonary vascular resistance. A meaningless variable. Intensive. Care Med. 10: 51-53, 1984. 
Vincent JL, Reuse C, and Kahn RJ. Effects on right ventricular function of a change from dopamine to dobutamine in 
critically ill patients. Crit. Care Med. 16: 659-662, 1988. 
Vincent JL, Thirion M, Brimioulle S, Lejeune P, and Kahn RJ. Thermodilution measurement of right ventricular 
ejection fraction with a modified pulmonary artery catheter. Intensive. Care Med. 12: 33-38, 1986. 
Visser KR. Electric properties of flowing blood and impedance cardiography. Ann. Biomed. Eng. 17: 463-473, 1989. 
Vlahakes GJ, Turley K, and Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: 
hemodynamic and biochemical correlations. Circulation 63: 87-95, 1981. 
Voelkel NF. Mechanisms of hypoxic pulmonary vasoconstriction. Am. Rev. Respir. Dis. 133: 1186-1195, 1986. 
Wahba RW. Perioperative functional residual capacity [see comments]. Can. J. Anaesth. 38: 384-400, 1991. 
Waller DA and Turner N. Re-expansion pulmonary oedema. Anaesthesia 44: 446-447, 1989. 
Walley KR, Lewis TH, and Wood LD. Acute respiratory acidosis decreases left ventricular contractility but increases 
cardiac output in dogs. Circ. Res. 67: 628-635, 1990. 
Weber KT, Janicki JS, Hunter WC, Shroff S, Pearlman ES, and Fishman AP. The contractile behaviour of the heart 
and its functional coupling to the circulation. Prog. Cardiovasc. Dis. 24: 375-400, 1982. 
Weber KT, Janicki JS, Shroff SG, Likoff MJ, and St John Sutton MG. The right ventricle: physiologic and 
pathophysiologic considerations. Crit. Care Med. 11: 323-328, 1983. 
Weigelt JA, Gewertz BL, Aurbakken CM, and Snyder WH3. Pharmacologic alterations in pulmonary artery pressure 
in the adult respiratory distress syndrome. J Surg. Res. 32: 243-248, 1982. 
References 
 
393 
Weinreich AI, Silvay G, and Lumb PD. Continuous ketamine infusion for one-lung anaesthesia. Can. Anaesth. Soc. J. 
27: 485-490, 1980. 
Werner O, Malmkvist G, Beckman A, Stahle S, and Nordstrom L. Carbon dioxide elimination from each lung during 
endobronchial anaesthesia. Effects of posture and pulmonary arterial pressure. Br. J. Anaesth. 56: 995-1001, 1984. 
Werner O, Malmkvist G, Beckman A, Stahle S, and Nordstrom L. Gas exchange and haemodynamics during 
thoracotomy. Br. J. Anaesth. 56: 1343-1349, 1984. 
West JB. Pulmonary pathophysiology: the essentials. 2nd edition. 1985. Williams and Wilkins, Baltimore. 
West JB. Pulmonary Physiology: the essentials. 3rd edition. 1985. Williams and Wilkins, Baltimore. 
West JB. Chapter 12. The cardiac pump. In: Best and Taylor's Physiological basis of medical practice. 11th edition. 
1989. Williams and Wilkins, Baltimore. 
West JB. Ventilation / blood flow and gas exchange. 4th edition. 1990. Blackwell Scientific Publishers, Oxford. 
West JB, Dollery CT, and Heard BE. Increased pulmonary vascular resistance in the dependent zone of the isolated 
dog lung caused by perivascular edema. Circ. Res. 17: 191-206, 1965. 
Westerhof N and Elzinga G. Normalized input impedance and arterial decay time over heart period are independent 
of animal size. Am. J. Physiol. 261: R126-R133, 1991. 
Westerhof N, Elzinga G, and Sipkema P. An artificial arterial system for pumping hearts. Journal of Applied 
Physiology 31: 776-781, 1971. 
Westmoreland CL, Sebel PS, and Gropper A. Fentanyl or alfentanil decreases the minimum alveolar anesthetic 
concentration of isoflurane in surgical patients. Anesth. Analg. 78: 23-28, 1994. 
Wiedeman HP, Matthay MA, and Matthay RA. Cardiovascular-pulmonary monitoring in the intensive care unit (Part 
1). Chest 85: 537-548, 1984. 
Wiedemann HP and Matthay RA. Chapter 47. Cor Pulmonale. In: Heart Disease. A Textbook of Cardiovascular 
Medicine. 5th edition. 1997. WB Saunders Company. 
Wikipedia, the free encyclopedia.  These pages are located at http://www.wikipedia.org 
 
References 
 
394 
Williams EA, Evans TW, and Goldstraw P. Acute lung injury following lung resection: is one lung anaesthesia to 
blame? Thorax 51: 114-116, 1996. 
Wilson WC, Kapelanski DP, Benumof JL, Newhart, Johnson FW, and Channick RN. Inhaled nitric oxide (40 ppm) 
during one-lung ventilation, in the lateral decubitus position, does not decrease pulmonary vascular resistance or 
improve oxygenation in normal patients [see comments]. J. Cardiothorac. Vasc. Anesth. 11: 172-176, 1997. 
Wolfer RS, Krasna MJ, Hasnain JU, and McLaughlin JS. Hemodynamic effects of carbon dioxide insufflation during 
thoracoscopy. Ann. Thorac. Surg. 58: 404-407, 1994. 
Woodard JC, Chow E, and Farrar DJ. Isolated ventricular systolic interaction during transient reductions in left 
ventricular pressure. Circ. Res. 70: 944-951, 1992. 
Yin FCP, Liu Z, and Brin KP. Chapter 16. Estimation of arterial compliance. In: Ventricular/vascular coupling.  
Clinical, physiological and engineering aspects. 1987. Springer-Verlag, New York. 
Yokota K, Toriumi T, Sari A, Endou S, and Mihira M. Auto-positive end-expiratory pressure during one-lung 
ventilation using a double-lumen endobronchial tube. Anesth. Analg. 82: 1007-1010, 1996. 
Zapol WM. Pulmonary vascular resistance in acute respiratory failure. Crit. Care Med. 10: 554-554, 1982. 
Zapol WM and Snider MT. Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296: 476-
480, 1977. 
Zaune U, Knarr C, Kruselmann M, Pauli MH, Boeden G, and Martin E. Value and accuracy of dual oximetry during 
pulmonary resections. J. Cardiothorac. Anesth. 4: 441-452, 1990.  
 
 
